0001099800-24-000004.txt : 20240212 0001099800-24-000004.hdr.sgml : 20240212 20240212164729 ACCESSION NUMBER: 0001099800-24-000004 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 156 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 24620781 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 10-K 1 ew-20231231.htm 10-K ew-20231231
0001099800false2023FYhttp://fasb.org/us-gaap/2023#OtherNonrecurringIncomeExpensehttp://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20231231#AccruedAndOtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20231231#AccruedAndOtherLiabilitiesCurrentP3Y33900010998002023-01-012023-12-3100010998002023-06-30iso4217:USD00010998002024-01-31xbrli:shares00010998002023-12-3100010998002022-12-31iso4217:USDxbrli:shares00010998002022-01-012022-12-3100010998002021-01-012021-12-3100010998002021-12-3100010998002020-12-310001099800us-gaap:CommonStockMember2020-12-310001099800us-gaap:TreasuryStockCommonMember2020-12-310001099800us-gaap:AdditionalPaidInCapitalMember2020-12-310001099800us-gaap:RetainedEarningsMember2020-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001099800us-gaap:ParentMember2020-12-310001099800us-gaap:NoncontrollingInterestMember2020-12-310001099800us-gaap:RetainedEarningsMember2021-01-012021-12-310001099800us-gaap:ParentMember2021-01-012021-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001099800us-gaap:CommonStockMember2021-01-012021-12-310001099800us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001099800us-gaap:TreasuryStockCommonMember2021-01-012021-12-310001099800us-gaap:CommonStockMember2021-12-310001099800us-gaap:TreasuryStockCommonMember2021-12-310001099800us-gaap:AdditionalPaidInCapitalMember2021-12-310001099800us-gaap:RetainedEarningsMember2021-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001099800us-gaap:ParentMember2021-12-310001099800us-gaap:NoncontrollingInterestMember2021-12-310001099800us-gaap:RetainedEarningsMember2022-01-012022-12-310001099800us-gaap:ParentMember2022-01-012022-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001099800us-gaap:CommonStockMember2022-01-012022-12-310001099800us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001099800us-gaap:TreasuryStockCommonMember2022-01-012022-12-310001099800us-gaap:CommonStockMember2022-12-310001099800us-gaap:TreasuryStockCommonMember2022-12-310001099800us-gaap:AdditionalPaidInCapitalMember2022-12-310001099800us-gaap:RetainedEarningsMember2022-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001099800us-gaap:ParentMember2022-12-310001099800us-gaap:NoncontrollingInterestMember2022-12-310001099800us-gaap:RetainedEarningsMember2023-01-012023-12-310001099800us-gaap:ParentMember2023-01-012023-12-310001099800us-gaap:NoncontrollingInterestMember2023-01-012023-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001099800us-gaap:CommonStockMember2023-01-012023-12-310001099800us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001099800us-gaap:TreasuryStockCommonMember2023-01-012023-12-310001099800us-gaap:CommonStockMember2023-12-310001099800us-gaap:TreasuryStockCommonMember2023-12-310001099800us-gaap:AdditionalPaidInCapitalMember2023-12-310001099800us-gaap:RetainedEarningsMember2023-12-310001099800us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001099800us-gaap:ParentMember2023-12-310001099800us-gaap:NoncontrollingInterestMember2023-12-310001099800ew:HemodynamicMonitorsMembersrt:MinimumMember2023-12-310001099800ew:HemodynamicMonitorsMembersrt:MaximumMember2023-12-310001099800us-gaap:ShippingAndHandlingMember2023-01-012023-12-310001099800us-gaap:ShippingAndHandlingMember2022-01-012022-12-310001099800us-gaap:ShippingAndHandlingMember2021-01-012021-12-310001099800ew:InvesteesVotingStockMembersrt:MinimumMember2023-12-31xbrli:pure0001099800srt:MinimumMember2023-01-012023-12-310001099800srt:MaximumMember2023-01-012023-12-310001099800srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2023-12-310001099800srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2023-12-310001099800srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2023-12-310001099800srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2023-12-310001099800srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-12-310001099800srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-12-310001099800ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMember2022-01-012022-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2021-01-012021-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2023-01-012023-12-310001099800us-gaap:StockCompensationPlanMember2023-01-012023-12-310001099800us-gaap:StockCompensationPlanMember2022-01-012022-12-310001099800us-gaap:StockCompensationPlanMember2021-01-012021-12-310001099800us-gaap:CostOfSalesMember2023-01-012023-12-310001099800us-gaap:CostOfSalesMember2022-01-012022-12-310001099800us-gaap:CostOfSalesMember2021-01-012021-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310001099800us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-12-310001099800us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-3100010998002023-04-122023-04-120001099800ew:MedtronicIncMember2023-04-122023-04-120001099800ew:MedtronicIncMember2023-03-012023-03-310001099800ew:MedtronicIncMember2023-04-300001099800ew:MedtronicIncMember2023-04-012023-04-3000010998002023-12-072023-12-0700010998002022-09-012022-09-300001099800ew:SpecialChargeMember2022-09-012022-09-300001099800us-gaap:CostOfSalesMember2022-09-012022-09-300001099800ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMember2022-09-012022-09-300001099800srt:MinimumMember2023-12-310001099800srt:MaximumMember2023-12-310001099800us-gaap:BankTimeDepositsMember2023-12-310001099800us-gaap:BankTimeDepositsMember2022-12-310001099800us-gaap:USTreasuryAndGovernmentMember2023-12-310001099800us-gaap:USTreasuryAndGovernmentMember2022-12-310001099800us-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:AssetBackedSecuritiesMember2022-12-310001099800us-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:CorporateDebtSecuritiesMember2022-12-310001099800us-gaap:MunicipalBondsMember2023-12-310001099800us-gaap:MunicipalBondsMember2022-12-310001099800ew:NewMarketsTaxCreditMemberus-gaap:LimitedLiabilityCompanyMember2023-12-310001099800us-gaap:LimitedLiabilityCompanyMember2023-01-012023-12-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-012023-03-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-012023-12-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberew:ConvertiblePromissoryNoteMember2023-03-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-08-012022-08-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-08-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-06-012022-06-300001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-12-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2019-01-012019-12-310001099800ew:MedicalTechnologyCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-05-012022-05-310001099800ew:MedicalTechnologyCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-01-012021-12-3100010998002022-05-012022-05-31ew:note0001099800ew:MedicalTechnologyCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-12-310001099800ew:MedicalTechnologyCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-05-310001099800ew:MedicalDeviceCompanyMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-05-3100010998002021-04-300001099800us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberew:MedicalTechnologyCompanyMember2023-02-280001099800us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberew:MedicalTechnologyCompanyMember2023-02-282023-02-280001099800ew:MedicalTechnologyCompanyMemberus-gaap:MeasurementInputDiscountRateMember2023-02-280001099800ew:MedicalTechnologyCompanyMember2023-02-280001099800us-gaap:InProcessResearchAndDevelopmentMemberew:HarpoonMedicalInc.Member2022-09-012022-09-300001099800ew:CardiAQValveTechnologiesInc.Member2015-07-030001099800ew:CardiAQValveTechnologiesInc.Memberus-gaap:DevelopedTechnologyRightsMember2023-12-310001099800ew:UnitedStatesSegmentMember2021-12-310001099800ew:EuropeSegmentMember2021-12-310001099800ew:RestOfWorldSegmentMember2021-12-310001099800ew:UnitedStatesSegmentMember2022-01-012022-12-310001099800ew:EuropeSegmentMember2022-01-012022-12-310001099800ew:RestOfWorldSegmentMember2022-01-012022-12-310001099800ew:UnitedStatesSegmentMember2022-12-310001099800ew:EuropeSegmentMember2022-12-310001099800ew:RestOfWorldSegmentMember2022-12-310001099800ew:UnitedStatesSegmentMember2023-01-012023-12-310001099800ew:EuropeSegmentMember2023-01-012023-12-310001099800ew:RestOfWorldSegmentMember2023-01-012023-12-310001099800ew:UnitedStatesSegmentMember2023-12-310001099800ew:EuropeSegmentMember2023-12-310001099800ew:RestOfWorldSegmentMember2023-12-310001099800us-gaap:PatentsMember2023-12-310001099800us-gaap:PatentsMember2022-12-310001099800us-gaap:DevelopedTechnologyRightsMember2023-12-310001099800us-gaap:DevelopedTechnologyRightsMember2022-12-310001099800us-gaap:OtherIntangibleAssetsMember2023-12-310001099800us-gaap:OtherIntangibleAssetsMember2022-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2023-12-310001099800us-gaap:InProcessResearchAndDevelopmentMember2022-12-310001099800us-gaap:SeniorNotesMemberew:FixedRate4.3002018NotesMember2018-06-300001099800ew:SeniorNotesDue2018Member2018-06-012018-06-300001099800us-gaap:SeniorNotesMemberew:FixedRate4.3002018NotesMember2023-12-310001099800us-gaap:SeniorNotesMemberew:FixedRate4.3002018NotesMember2022-12-310001099800us-gaap:SeniorNotesMember2023-12-310001099800us-gaap:SeniorNotesMember2022-12-310001099800ew:SeniorNotesDue2018Memberus-gaap:FairValueInputsLevel2Member2023-12-310001099800ew:SeniorNotesDue2018Memberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMember2023-01-012023-12-310001099800us-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMember2023-12-310001099800srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMemberew:SecuredOvernightFinancingRateSOFRMember2023-01-012023-12-310001099800srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMemberew:SecuredOvernightFinancingRateSOFRMember2023-01-012023-12-310001099800srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMember2023-01-012023-12-310001099800srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMember2023-01-012023-12-310001099800us-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMemberew:SecuredOvernightFinancingRateSOFRMember2023-01-012023-12-310001099800us-gaap:RevolvingCreditFacilityMemberew:CreditAgreementMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2023-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2022-12-310001099800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001099800us-gaap:USTreasuryAndGovernmentMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001099800us-gaap:MunicipalBondsMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001099800ew:MeasurementInputProbabilityOfMilestoneAchievementMemberew:ContingentConsiderationLiabilityMember2023-12-310001099800ew:ContingentConsiderationLiabilityMember2023-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMember2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMember2022-01-012022-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMember2022-01-012022-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMember2022-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMember2022-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMember2023-01-012023-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMember2023-01-012023-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberew:ContingentConsiderationLiabilityMember2023-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:OtherLiabilitiesMember2023-12-310001099800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeForwardMember2022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMember2022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberew:AccruedAndOtherLiabilitiesCurrentMember2023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberew:AccruedAndOtherLiabilitiesCurrentMember2022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-12-310001099800us-gaap:ForeignExchangeContractMember2023-12-310001099800us-gaap:CurrencySwapMember2023-12-310001099800us-gaap:ForeignExchangeContractMember2022-12-310001099800us-gaap:CurrencySwapMember2022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2023-01-012023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2022-01-012022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2023-01-012023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2022-01-012022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2023-01-012023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMemberus-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2023-01-012023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestIncomeMemberus-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2022-01-012022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2023-12-31iso4217:EUR0001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMember2023-01-012023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2022-01-012022-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-01-012021-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2023-01-012023-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2023-01-012023-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2022-01-012022-12-310001099800us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2022-01-012022-12-310001099800us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2022-01-012022-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2021-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:OtherNoncurrentLiabilitiesMember2023-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-12-310001099800us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:DefinedBenefitPlanDebtSecurityMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2023-12-310001099800us-gaap:OtherInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2023-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2023-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2023-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanRealEstateMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2023-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2023-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberew:InsuranceContractsMember2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2023-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2023-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2022-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanEquitySecuritiesUsMember2022-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:USGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:USGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2022-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanRealEstateMember2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanRealEstateMember2022-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:MortgagesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:MortgagesMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2022-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberew:InsuranceContractsMember2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2022-12-310001099800us-gaap:FairValueInputsLevel1Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel12And3Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2021-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2022-01-012022-12-310001099800us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberew:InsuranceContractsMember2023-01-012023-12-310001099800country:US2023-01-012023-12-310001099800us-gaap:ForeignPlanMember2023-01-012023-12-310001099800ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember2023-12-310001099800ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember2022-12-310001099800ew:July2022StockRepurchaseProgramMember2022-07-310001099800ew:July2022StockRepurchaseProgramMember2023-12-310001099800ew:InitialDeliveryOfSharesSettledJanuary2022Member2022-01-310001099800ew:InitialDeliveryOfSharesSettledJanuary2022Member2022-01-012022-01-310001099800ew:January2022StockRepurchaseProgramSharesSoldInFebruary2022Member2022-02-012022-02-280001099800ew:InitialDeliveryOfSharesSettledOctober2022Member2022-10-010001099800ew:InitialDeliveryOfSharesSettledOctober2022Member2022-10-012022-10-310001099800ew:October2022StockRepurchaseProgramSharesSoldInDecember2022Member2022-12-012022-12-310001099800ew:InitialDeliveryOfSharesSettledFebruary2023Member2023-02-280001099800ew:InitialDeliveryOfSharesSettledFebruary2023Member2023-02-012023-02-280001099800ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member2023-03-012023-03-310001099800ew:InitialDeliveryOfSharesSettledDecember2023Member2023-12-310001099800ew:InitialDeliveryOfSharesSettledDecember2023Member2023-12-012023-12-310001099800ew:December2023StockRepurchaseProgramSharesSoldInDecember2023Member2023-12-012023-12-310001099800srt:MinimumMemberew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2023-01-012023-12-310001099800srt:MaximumMemberew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2023-01-012023-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMemberew:LongTermStockIncentiveCompensationProgramMember2023-01-012023-12-310001099800srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMemberew:LongTermStockIncentiveCompensationProgramMember2023-01-012023-12-310001099800ew:MarketBasedRestrictedStockUnitsMemberew:LongTermStockIncentiveCompensationProgramMember2023-01-012023-12-310001099800ew:LongTermStockIncentiveCompensationProgramMember2023-12-310001099800srt:MaximumMemberew:RestrictedStockAndRestrictedStockUnitAwardsMemberew:LongTermStockIncentiveCompensationProgramMember2023-12-310001099800srt:MaximumMemberew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMemberew:EmployeeAndNonemployeeStockOptionsMember2023-12-310001099800srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMemberew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMemberew:NonemployeeDirectorsStockIncentiveCompensationProgramMember2023-12-310001099800ew:NonemployeeDirectorsStockIncentiveCompensationProgramMemberew:EmployeeAndNonemployeeStockOptionsMemberew:ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember2023-01-012023-12-310001099800ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember2023-12-310001099800ew:EmployeeStockPurchasePlanMemberus-gaap:EmployeeStockMember2023-01-012023-12-310001099800ew:EmployeeStockPurchasePlanMemberus-gaap:EmployeeStockMember2023-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2023-01-012023-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2022-01-012022-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2021-01-012021-12-310001099800us-gaap:EmployeeStockMember2023-01-012023-12-310001099800us-gaap:EmployeeStockMember2022-01-012022-12-310001099800us-gaap:EmployeeStockMember2021-01-012021-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2023-01-012023-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2022-01-012022-12-310001099800ew:MarketBasedRestrictedStockUnitsMember2021-01-012021-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2022-12-310001099800ew:EmployeeAndNonemployeeStockOptionsMember2023-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2022-12-310001099800us-gaap:RestrictedStockUnitsRSUMember2023-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001099800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310001099800us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2023-01-012023-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-01-012023-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2022-01-012022-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-01-012022-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2021-01-012021-12-310001099800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-01-012021-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310001099800us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-12-310001099800us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-12-310001099800country:USew:CarryforwardPeriodEnds20332037Memberus-gaap:DomesticCountryMember2023-12-310001099800country:USew:TaxCarryforwardsNoExpirationMemberus-gaap:DomesticCountryMember2023-12-310001099800country:USew:TaxCarryforwardsExpirationPeriodYears20262041Memberus-gaap:StateAndLocalJurisdictionMember2023-12-310001099800country:USew:TaxCarryforwardsNoExpirationMemberus-gaap:StateAndLocalJurisdictionMember2023-12-310001099800us-gaap:NonUsMemberew:TaxCarryforwardsNoExpirationMemberus-gaap:ForeignCountryMember2023-12-310001099800country:USew:CapitalLossCarryforwardPeriodEnds2024Memberus-gaap:DomesticCountryMember2023-12-310001099800us-gaap:ResearchMemberstpr:CAew:TaxCarryforwardsNoExpirationMemberus-gaap:StateAndLocalJurisdictionMember2023-12-310001099800country:USus-gaap:ResearchMemberew:TaxCarryforwardsExpirationPeriodYears20262039Memberus-gaap:DomesticCountryMember2023-12-310001099800us-gaap:NonUsMemberew:TaxCarryforwardsExpirationPeriodYears20302033Memberew:ForeignTaxCreditMemberus-gaap:ForeignCountryMember2023-12-310001099800us-gaap:ForeignCountryMembercountry:PRew:TaxCarryforwardsExpirationPeriodEnds2025Memberew:PurchaseCreditMember2023-12-310001099800ew:TaxCarryforwardsNoExpirationMemberus-gaap:ForeignCountryMembercountry:PRew:PurchaseCreditMember2023-12-310001099800ew:TaxCarryforwardsNoExpirationMemberus-gaap:ForeignCountryMembercountry:PRew:PuertoRicoPurchasesCreditMember2023-12-310001099800us-gaap:ForeignCountryMember2023-01-012023-12-310001099800us-gaap:ForeignCountryMember2022-01-012022-12-310001099800us-gaap:ForeignCountryMember2021-01-012021-12-310001099800us-gaap:SubsequentEventMembersrt:MinimumMember2024-04-012024-06-300001099800us-gaap:SubsequentEventMembersrt:MaximumMember2024-04-012024-06-30ew:lawsuit0001099800ew:UnitedStatesSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001099800ew:UnitedStatesSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001099800ew:UnitedStatesSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001099800us-gaap:OperatingSegmentsMemberew:EuropeSegmentMember2023-01-012023-12-310001099800us-gaap:OperatingSegmentsMemberew:EuropeSegmentMember2022-01-012022-12-310001099800us-gaap:OperatingSegmentsMemberew:EuropeSegmentMember2021-01-012021-12-310001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2023-01-012023-12-310001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2022-01-012022-12-310001099800us-gaap:OperatingSegmentsMemberew:JapanSegmentMember2021-01-012021-12-310001099800ew:RestOfWorldSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-12-310001099800ew:RestOfWorldSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001099800ew:RestOfWorldSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001099800us-gaap:OperatingSegmentsMember2023-01-012023-12-310001099800us-gaap:OperatingSegmentsMember2022-01-012022-12-310001099800us-gaap:OperatingSegmentsMember2021-01-012021-12-310001099800us-gaap:MaterialReconcilingItemsMember2023-01-012023-12-310001099800us-gaap:MaterialReconcilingItemsMember2022-01-012022-12-310001099800us-gaap:MaterialReconcilingItemsMember2021-01-012021-12-310001099800us-gaap:CorporateNonSegmentMember2023-01-012023-12-310001099800us-gaap:CorporateNonSegmentMember2022-01-012022-12-310001099800us-gaap:CorporateNonSegmentMember2021-01-012021-12-310001099800country:US2023-01-012023-12-310001099800country:US2022-01-012022-12-310001099800country:US2021-01-012021-12-310001099800srt:EuropeMember2023-01-012023-12-310001099800srt:EuropeMember2022-01-012022-12-310001099800srt:EuropeMember2021-01-012021-12-310001099800country:JP2023-01-012023-12-310001099800country:JP2022-01-012022-12-310001099800country:JP2021-01-012021-12-310001099800ew:RestOfWorldMember2023-01-012023-12-310001099800ew:RestOfWorldMember2022-01-012022-12-310001099800ew:RestOfWorldMember2021-01-012021-12-310001099800ew:TranscatheterAorticValveReplacementMember2023-01-012023-12-310001099800ew:TranscatheterAorticValveReplacementMember2022-01-012022-12-310001099800ew:TranscatheterAorticValveReplacementMember2021-01-012021-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2023-01-012023-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2022-01-012022-12-310001099800ew:TranscatheterMitralAndTricuspidTherapiesMember2021-01-012021-12-310001099800ew:SurgicalHeartValveTherapyMember2023-01-012023-12-310001099800ew:SurgicalHeartValveTherapyMember2022-01-012022-12-310001099800ew:SurgicalHeartValveTherapyMember2021-01-012021-12-310001099800ew:CriticalCareMember2023-01-012023-12-310001099800ew:CriticalCareMember2022-01-012022-12-310001099800ew:CriticalCareMember2021-01-012021-12-310001099800country:US2023-12-310001099800country:US2022-12-310001099800country:US2021-12-310001099800srt:EuropeMember2023-12-310001099800srt:EuropeMember2022-12-310001099800srt:EuropeMember2021-12-310001099800country:JP2023-12-310001099800country:JP2022-12-310001099800country:JP2021-12-310001099800ew:RestOfWorldMember2023-12-310001099800ew:RestOfWorldMember2022-12-310001099800ew:RestOfWorldMember2021-12-310001099800us-gaap:AllowanceForCreditLossMember2022-12-310001099800us-gaap:AllowanceForCreditLossMember2023-01-012023-12-310001099800us-gaap:AllowanceForCreditLossMember2023-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2023-01-012023-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2023-12-310001099800us-gaap:AllowanceForCreditLossMember2021-12-310001099800us-gaap:AllowanceForCreditLossMember2022-01-012022-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2022-01-012022-12-310001099800us-gaap:AllowanceForCreditLossMember2020-12-310001099800us-gaap:AllowanceForCreditLossMember2021-01-012021-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2020-12-310001099800us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2021-01-012021-12-3100010998002023-10-012023-12-310001099800ew:DonaldBoboJrMember2023-01-012023-12-310001099800ew:DonaldBoboJrMember2023-10-012023-12-310001099800ew:DonaldBoboJrMember2023-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2023
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From            to
Commission File Number 1-15525
EDWARDS LIFESCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
Delaware36-4316614
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
One Edwards WayIrvineCalifornia92614
(Address of Principal Executive Offices)(Zip Code)
(949) 250-2500
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbols(s)Name of each exchange on which registered:
Common Stock, par value $1.00 per shareEWNew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act.    Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.    Yes ☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ý No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report ☒. 
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recover analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐ No ý
The aggregate market value of the registrant's common stock held by non-affiliates as of June 30, 2023 (the last trading day of the registrant's most recently completed second quarter): $56,849,824,065 based on the closing price of the registrant's common stock on the New York Stock Exchange. This calculation does not reflect a determination that persons are affiliates for any other purpose.
The number of shares outstanding of the registrant's common stock, $1.00 par value, as of January 31, 2024, was 601.3 million.

Documents Incorporated by Reference
Portions of the registrant's proxy statement for the 2024 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2023) are incorporated by reference into Part III, as indicated herein.

EDWARDS LIFESCIENCES CORPORATION
Form 10-K Annual Report—2023
Table of Contents

  
  
  
  


PART I

NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We intend the forward-looking statements contained in this report to be covered by the safe harbor provisions of such Acts. Statements other than statements of historical or current fact in this report or referred to or incorporated by reference into this report are "forward-looking statements" for purposes of these safe harbor provisions. These statements can sometimes be identified by the use of the forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "goal," "continue," "seek," "pro forma," "forecast," "intend," "guidance," "optimistic," "aspire," "confident," other forms of these words or similar words or expressions or the negatives thereof. Statements regarding past performance, efforts, or results about which inferences or assumptions may be made can also be forward-looking statements and are not indicative of future performance or results; these statements can be identified by the use of words such as "preliminary," "initial," "potential," "possible," "diligence," "industry-leading," "compliant," "indications," or "early feedback" or other forms of these words or similar words or expressions or the negatives thereof. These forward-looking statements are subject to substantial risks and uncertainties that could cause our results or future business, financial condition, results of operations or performance to differ materially from our historical results or experiences or those expressed or implied in any forward-looking statements contained in this report. These risks and uncertainties include, but are not limited to: the spin-off of our critical care product group, our ability to develop new products and avoid manufacturing and quality issues; clinical trial or commercial results or new product approvals and therapy adoption; the impact of domestic and global economic conditions; competition in the markets in which we operate; our reliance on vendors, suppliers, and other third parties; damage, failure, or interruption of our information technology systems; the impact of public health crises; consolidation in the healthcare industry; our ability to protect our intellectual property; our compliance with applicable regulations; our exposure to product liability claims; use of our products in unapproved circumstances; changes to reimbursement for our products; the impact of currency exchange rates; unanticipated actions by the United States Food and Drug Administration and other regulatory agencies; changes to tax laws; unexpected impacts or expenses of litigation or internal or government investigations; and other risks detailed under "Risk Factors" in Part I, Item 1A below, as such risks and uncertainties may be amended, supplemented or superseded from time to time by our subsequent reports on Forms 10-Q and 8-K we file with the United States Securities and Exchange Commission. These forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections.

Unless otherwise indicated or otherwise required by the context, the terms "we," "our," "it," "its," "Company," "Edwards," and "Edwards Lifesciences" refer to Edwards Lifesciences Corporation and its subsidiaries.

WEBSITE REFERENCES

In this Annual Report on Form 10-K, we make references to our website at www.edwards.com. References to our website through this Form 10-K are provided for convenience only and the content of our website does not constitute a part of, and shall not be deemed incorporated by reference into, this Annual Report on Form 10-K.
1
Item 1.    Business
       
Overview

Edwards Lifesciences Corporation is the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world’s leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care. Edwards Lifesciences has been a leader in our field for over six decades. Since our founder, Lowell Edwards, first dreamed of using engineering to address diseases of the human heart, we have steadily built a company on the premise of imagining, building, and realizing a better future for patients.

A pioneer in the development of heart valve therapies, we are the world's leading manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Our innovative work in heart valves encompasses both surgical and transcatheter therapies for heart valve replacement and repair. In addition, our robust pipeline of future technologies is focused on the less invasive repair or replacement of the mitral and tricuspid valves of the heart, which are more complex and more challenging to treat than the aortic valve. We are also a global leader in hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting.

Cardiovascular disease is the number-one cause of death in the world and is the top disease in terms of health care spending in nearly every country. In the U.S. alone, one cardiovascular patient dies every 33 seconds. Cardiovascular disease is progressive in that it tends to worsen over time and often affects the structure of an individual's heart. Our vision is to transform patient care where patients are diagnosed earlier, treated in a routine fashion, living longer and enjoying a better quality of life.

Patients undergoing treatment for cardiovascular disease can be treated with a number of our medical technologies, which are designed to address individual patient needs with respect to disease process, comorbidities, and health status. For example, an individual with a heart valve disorder may have a faulty valve that is affecting the function of his or her heart or blood flow throughout his or her body. A cardiac surgeon may elect to remove the valve and replace it with one of our bioprosthetic surgical tissue heart valves or surgically re-shape and repair the faulty valve with an Edwards Lifesciences annuloplasty ring. Alternatively, a clinician (typically an interventional cardiologist) may implant an Edwards Lifesciences transcatheter valve or repair system via a catheter-based approach that does not require traditional open-heart surgery and can be done while the heart continues to beat. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by our Critical Care products through multiple monitoring options, including noninvasive and minimally-invasive technologies. These technologies enable proactive clinical decisions while also providing the opportunity for improving diagnoses and developing individualized therapeutic management plans for patients.

Corporate Background

Our principal executive offices are located at One Edwards Way, Irvine, California 92614. The telephone number at that address is (949) 250-2500. We make available, free of charge on our website located at www.edwards.com, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and any amendments to those reports, as soon as reasonably practicable after filing such reports with the Securities and Exchange Commission ("SEC"). The contents of our website are not incorporated by reference into this report.

Edwards Lifesciences' Product and Technology Offerings

The following discussion summarizes the main groups of products and technologies we offer to treat advanced cardiovascular disease. Our products and technologies are categorized into four main groups: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. For more information on net sales from these four main groups, see "Net Sales by Product Group" in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations."

Transcatheter Aortic Valve Replacement

We are the global leader in transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves, including the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating patients who
2
have severe symptomatic aortic stenosis. The SAPIEN 3 valves are delivered while the heart is still beating. The majority of procedures are conducted without the use of general anesthesia and patients are discharged home within one to two days. Transcatheter aortic valve replacement with the SAPIEN 3 family of valves enables patients to recover more quickly and return to a better quality of life sooner than patients receiving traditional open heart surgical therapies. Edwards' transcatheter aortic heart valves were first commercialized in Europe in 2007, in the United States in 2011, and in Japan in 2013. Edwards has partnered with the physician community to generate groundbreaking data that has expanded access to patients of all risk profiles. In 2023, The PARTNER 3 Trial, which demonstrated a 99% freedom from stroke or mortality at 1 year, had 5-year data presented with a 90% freedom from all-cause mortality. The SAPIEN 3 platform remains the only transcatheter heart valve with a THV-in-THV indication for patients assessed at high-risk for surgical replacement, offering patients the ability to have a second minimally invasive procedure. The SAPIEN family of valves are the most widely implanted transcatheter heart valves in the world with over one million patients lives impacted since launch. Additionally, the Edwards SAPIEN 3 system and Alterra system offer a minimally invasive option for pulmonary valve replacement for patients with congenital heart disease.

Sales of our transcatheter aortic valve replacement products represented 65% of our net sales in each of 2023, 2022, and 2021.

Transcatheter Mitral and Tricuspid Therapies

We continue to make significant investments in the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases. While many of these technologies are in development and clinical phases, the PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair. As of 2023, the PASCAL PRECISION system is also commercially available in the U.S. and Japan for degenerative mitral regurgitation patients. The PASCAL PRECISION system addresses the needs of patients with mitral or tricuspid regurgitation through leaflet approximation, while the Cardioband system enables clinicians to reduce the valve's annulus and lower regurgitation. In addition to transcatheter repair, we believe transcatheter replacement is key to unlocking the full mitral and tricuspid opportunity. We believe our mitral replacement strategy positions us for leadership in the mid-to-long term. SAPIEN M3 is based on the proven SAPIEN valve and is designed specifically for mitral patients. For tricuspid valve replacement, our EVOQUE system is delivered through a low-profile transfemoral sub 30-French system, and available in a variety of valve sizes to enable treatment in a wide range of patient anatomies. In 2023, the EVOQUE system received CE Mark approval for the transcatheter treatment of eligible patients with tricuspid regurgitation. More recently, in February 2024, the EVOQUE system received United States Food and Drug Administration ("FDA") approval for the treatment of tricuspid regurgitation. This development will give a wide range of U.S. patients access to a treatment option that not only has the potential to improve quality-of-life, but also showed favorable clinical trends in all-cause mortality, re-intervention, and heart failure hospitalizations. The EVOQUE system is the world's first transcatheter valve replacement therapy to receive regulatory approval to treat tricuspid regurgitation.

Surgical Structural Heart

We continue to invest in bringing innovations to cardiac surgery patients. Our RESILIA tissue, with published clinical data showing 99% freedom from structural valve deterioration through seven years1, has set the new standard for tissue valve durability. Our flagship INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. INSPIRIS is the leading aortic surgical valve in the world. Sales of our surgical therapies in the United States also continue to gain traction with KONECT RESILIA, the first pre-assembled, ready to implant, tissue valved conduit for complex combined procedures.

Our latest innovation, the MITRIS RESILIA valve, is now commercially available in Europe as well as other geographies, including the U.S. and Japan, where it has been strongly adopted by surgeons as the leading product in our mitral valve portfolio. We believe the demand for surgical structural heart therapies is growing worldwide, and that our innovation strategy will continue to strengthen our leadership and positive impact on patients.

Sales of our surgical tissue heart valve products represented 16%, 15%, and 16% of our net sales in 2023, 2022, and 2021, respectively.

1 Bavaria, et al. Five-year Outcomes of the COMMENCE trial investigating Aortic Valve Replacement with a Bioprosthetic Valve with a Novel Tissue. The Society of Thoracic Surgeons 2021 Annual Meeting; Bartus, et al. Final 5-year outcomes following aortic valve replacement with RESILIA tissue bio prosthesis. European Journal of Cardio-Thoracic Surgery, 2020.
3
Critical Care

We are the world leader in advanced hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. Edwards’ complete hemodynamic portfolio helps clinicians make proactive clinical decisions that can improve patient recovery. The portfolio includes the minimally-invasive FloTrac and Acumen IQ sensors, the noninvasive ClearSight and Acumen IQ cuffs, and the ForeSight noninvasive tissue oximetry sensor. We also support clinical needs with our well-established Swan-Ganz pulmonary artery catheters and arterial pressure monitoring products. Compatible with our portfolio of sensors and catheters, the HemoSphere monitoring platform displays valuable physiological information. Our first predictive algorithm, Acumen Hypotension Prediction Index software, alerts clinicians in advance of a patient developing dangerously low blood pressure. Our latest algorithm, Acumen Assisted Fluid Management software, provides patient-specific fluid suggestions to help keep patients in an optimal range during surgery.

On December 7, 2023, we announced plans for a tax-free spin-off of our Critical Care product group as a separate publicly traded company to Edwards Lifesciences' shareholders. While we expect to complete the Critical Care spin-off around the end of 2024, we remain committed to supporting strong momentum and growth during the transition period. The team will advance innovative advanced patient monitoring solutions, with the goal of improving the quality of care for millions of patients annually. Critical Care is currently integrating a full range of smart monitoring technologies into the seventh generation of its HemoSphere platform, creating a unique offering of enhanced recovery tools.

Competition

The medical technology industry is highly competitive. We compete with divisions of larger companies as well as smaller companies that offer competitive product lines in certain geographies in which we operate. We also compete with both established and newer technologies that target the patients served by our products. New product development and technological change characterize the areas in which we compete. Our present or future products could be rendered obsolete or uneconomical as a result of technological advances by one or more of our present or future competitors or by other therapies, including drug therapies. We believe we hold leadership positions because we develop and produce safe and effective therapies supported by rigorous clinical studies with extensive data and with innovative features that can enhance patient benefit and product performance and reliability, as well as benefit healthcare systems. The benefits associated with our products are in part due to the level of customer and clinical support we provide.

The cardiovascular segment of the medical technology industry is dynamic and subject to significant change due to cost-of-care considerations, regulatory reform, industry and customer consolidation, and evolving patient needs. The ability to provide products and technologies that demonstrate value and improve clinical outcomes is becoming increasingly important for medical technology manufacturers.
    
We believe that we are a leading global competitor in each of our product lines. In Transcatheter Aortic Valve Replacement, our primary competitors include Medtronic PLC, Abbott Laboratories ("Abbott"), and Boston Scientific Corporation. In Transcatheter Mitral and Tricuspid Therapies, our primary competitor is Abbott, and there are a considerable number of large and small companies with development efforts in these fields. In Surgical Structural Heart, our primary competitors include Medtronic PLC, Abbott, and Artivion, Inc (formerly CryoLife). In Critical Care, we compete primarily with a variety of companies in specific product lines including ICU Medical, Inc., PULSION Medical Systems SE, a subsidiary of Getinge AB, Cheetah Medical, Inc., a subsidiary of Baxter International, and LiDCO Group PLC, a subsidiary of Masimo Corporation.

Sales and Marketing

Our portfolio includes some of the most recognizable cardiovascular device product brands in treating structural heart disease today. We have a number of product lines that require sales and marketing strategies tailored to deliver high-quality, cost-effective products and technologies to customers worldwide. Because of the diverse global needs of the population that we serve, our distribution system consists of several direct sales forces as well as independent distributors. We are not dependent on any single customer and no single customer accounted for 10% or more of our net sales in 2023.

To achieve optimal outcomes for patients, we conduct educational symposia and best practices training for our physician, hospital executive, service line leadership, nursing, and clinical-based customers. We rely extensively on our sales and field clinical specialist personnel who work closely with our customers in hospitals. Field clinical specialists routinely attend procedures where Edwards' products are being used in order to provide guidance on the use of our devices, thereby enabling physicians and staff to reach expert proficiency and deliver positive patient outcomes. In addition to working closely with
4
physicians, nurses, and other clinical personnel, our customers include decision makers such as service line leaders, material managers, biomedical staff, hospital administrators and executives, purchasing managers, and ministries of health. Also, for certain of our product lines and where appropriate, our corporate sales team actively pursues approval of Edwards Lifesciences as a qualified supplier for hospital group purchasing organizations ("GPOs") that negotiate contracts with suppliers of medical products. Additionally, we have contracts with a number of United States and European national and regional buying groups, including healthcare systems and Integrated Delivery Networks. Where we choose to market our products is also influenced by the existence of, or potential for, adequate reimbursement to hospitals and other providers by national healthcare systems.

United States.    In the United States, we sell substantially all of our products through our direct sales forces. In 2023, 58% of our net sales were derived from sales to customers in the United States.

Outside of the United States.    In 2023, 42% of our net sales were derived outside of the United States through our direct sales forces and independent distributors. Of the total sales outside of the United States, 53% were in Europe, 18% were in Japan, and 28% were in Rest of World. We sell our products in approximately 100 countries, including Japan, Germany, France, United Kingdom, Italy, China, and Canada. A majority of the sales and marketing approach outside of the United States is direct sales, although it varies depending on each country's size and state of development.

Raw Materials and Manufacturing

We operate manufacturing facilities in various geographies around the world. We manufacture our Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid technologies, and Structural Surgical Heart products primarily in the United States (California and Utah), Singapore, Costa Rica, and Ireland. We manufacture our Critical Care products primarily in the Dominican Republic and Puerto Rico.

We use a diverse and broad range of raw and organic materials in the design, development, and manufacture of our products. We manufacture our non-implantable products from fabricated raw materials including resins, chemicals, electronics, and metals. Most of our replacement heart valves are manufactured from natural tissues harvested from animal tissue as well as fabricated materials. We purchase certain materials and components used in manufacturing our products from external suppliers. In addition, we purchase certain supplies from single sources for reasons of sole source availability or constraints resulting from regulatory requirements.

We work with our suppliers to mitigate risk and seek continuity of supply while maintaining quality and reliability. Alternative supplier options are generally considered, identified, and approved for materials deemed critical to our products, although we do not typically pursue immediate regulatory qualification of alternative sources due to the strength of our existing supplier relationships and the time and expense associated with the regulatory validation process.

We comply with all current global guidelines regarding risks for products incorporating animal tissue intended to be implanted in humans. We follow rigorous sourcing and manufacturing procedures intended to safeguard humans from potential risks associated with diseases such as bovine spongiform encephalopathy ("BSE"). We obtain bovine tissue used in our pericardial tissue valve products only from sources within the United States and Australia, where strong control measures and surveillance programs exist. In addition, bovine tissue used in our pericardial tissue valve products is from tissue types considered by global health and regulatory organizations to have shown no risk of infectibility. Our manufacturing and sterilization processes are designed to render tissue biologically safe from all known infectious agents and viruses.

Quality Assurance

We are committed to providing quality products to patients and have implemented modern quality systems and concepts throughout the organization. The quality system starts with the initial design concept, risk management, and product specification, and continues through the design of the product, packaging and labeling, and the manufacturing, sales, support, and servicing of the product. The quality system is intended to design quality into the products and uses continuous improvement concepts, including Lean/Six Sigma principles, throughout the product lifecycle.

Our operations are frequently inspected by the many regulators that oversee medical device manufacturing, including the FDA, European Notified Bodies, and other regulatory entities. The medical technology industry is highly regulated and our facilities and operations are designed to comply with all applicable quality systems standards, including the International Organization for Standardization ("ISO") 13485:2016. These standards require, among other items, quality system controls that are applied to product design, component material, suppliers, and manufacturing operations. These regulatory approvals and ISO certifications can be obtained only after a successful audit of a company's quality system has been conducted by regulatory
5
or independent outside auditors. Periodic reexamination by an independent outside auditor is required to maintain these certifications.

Environmental, Health, and Safety

We are committed to providing a safe and healthy workplace and complying with all relevant regulations and medical technology industry standards. Through our corporate and site level Environmental, Health, and Safety functions, we establish and monitor programs to reduce pollution, prevent injuries, and maintain compliance with applicable regulations. In order to measure performance, we monitor and report on a number of metrics, including regulated and non-regulated waste disposal, energy usage, water consumption, air toxic emissions, and injuries from our production activities. Each of our manufacturing sites is evaluated regularly with respect to a broad range of Environmental, Health, and Safety criteria.

Research and Development

In 2023, we made significant investments in research and development as we worked to develop therapies that we believe have the potential to change the practice of medicine. Research and development spending increased 13% year over year, representing 18% of 2023 sales. This increase was primarily the result of significant investments in our transcatheter structural heart programs, including an increase in clinical research for our mitral, aortic, and tricuspid therapies. We are engaged in ongoing research and development to deliver clinically advanced new products, to enhance the effectiveness, ease of use, safety, and reliability of our current leading products, and to expand the applications of our products as appropriate. We focus on opportunities within specific areas of structural heart disease and critical care monitoring.

A considerable portion of our research and development investment includes clinical trials and the collection of evidence that provide data for use in regulatory submissions, and required post-market approval studies involving applications of our products. Our investment in clinical studies also includes outcomes and cost-effectiveness data for payers, clinicians, and healthcare systems.

In Transcatheter Aortic Valve Replacement, we are developing new products to further improve and streamline transcatheter aortic heart valve replacement procedures.

In Transcatheter Mitral and Tricuspid Therapies, we are making significant investments in innovation and clinical evidence to develop technologies designed to treat mitral and tricuspid valve diseases.

Our Surgical Structural Heart development programs include innovative platforms for patients who are best treated surgically, specifically active patients and patients with more complex combined procedures.

In our Critical Care product line, we are pursuing the development of a variety of decision support solutions for our clinicians.  This includes next-generation noninvasive and minimally-invasive hemodynamic monitoring systems, and a next-generation monitor platform.  We are also developing a decision support software suite with advanced algorithms for proactive hemodynamic management, including a semi-closed loop system for standardized management of patient fluid levels. Lastly, we are developing a connectivity platform that will offer clinicians additional clinical support, remote monitoring capability, analytics, and insights for their patients’ hemodynamic status.

Our research and development activities are conducted primarily in facilities located in the United States and Israel. Our experienced research and development staff are focused on product design and development, quality, clinical research, and regulatory compliance. To pursue primary research efforts, we have developed alliances with several leading research institutions and universities, and also work with leading clinicians around the world in conducting scientific studies on our existing and developing products.

Proprietary Technology

Patents, trademarks, and other proprietary rights are important to the success of our business. We also rely upon trade secrets, know-how, continuing innovations, licensing opportunities, and non-disclosure agreements to develop and maintain our competitive position.

We own or have rights to a substantial number of patents and have patent applications pending both in the United States and in foreign countries. We continue to innovate and file new patent applications to protect our new products and technologies.

6
Additionally, we are a party to license agreements and other arrangements with various third parties pursuant to which we have obtained, for varying terms, the exclusive or non-exclusive rights to certain patents held by such third parties in consideration for cross-licensing rights and/or royalty payments. We have also licensed certain patent rights to others.

We undertake reasonable measures to protect our intellectual property rights. Litigation has been necessary to enforce certain patent rights held by us, and we plan to continue to defend and prosecute our rights with respect to such patents.

Moreover, we own certain United States registered trademarks used in our business. Many of our trademarks have also been registered for use in certain foreign countries where registration is available and where we have determined it is commercially advantageous to do so.

Government Regulation and Other Matters

Our products and facilities are subject to regulation by numerous government agencies, including the FDA, European Union member states competent authorities, and the Japanese Pharmaceuticals and Medical Devices Agency, to confirm compliance with the various laws and regulations governing the development, testing, manufacturing, labeling, marketing, and distribution of our products.

We are also governed by federal, state, local, and international laws of general applicability, including, but not limited to, those regulating employee health and safety, labor, competition, securities, privacy, anti-corruption, trade secret, and the protection of the environment. Overall, the amount and scope of domestic and foreign laws and regulations applicable to our business has increased over time. Compliance with these regulations has not had a material effect on our capital expenditures, earnings, or competitive position to date, but new regulations or amendments to existing regulations to make them more stringent could have such an effect in the future. We cannot estimate the expenses we may incur to comply with potential new laws or changes to existing laws, or the other potential effects these laws may have on our business.

United States Regulation.    In the United States, the FDA has responsibility for regulating medical devices. The FDA regulates design, development, testing, clinical studies, manufacturing, labeling, promotion, and record keeping for medical devices, and reporting of adverse events, recalls, or other field actions by manufacturers and users to identify potential problems with marketed medical devices. Many of the devices that we develop and market are in a category for which the FDA has implemented stringent clinical investigation and pre-market clearance or approval requirements. The process of obtaining FDA clearance or approval to market a product is resource intensive, lengthy, and costly. FDA review may involve substantial delays that adversely affect the marketing and sale of our products. A number of our products are pending regulatory clearance or approval to begin commercial sales in various markets. Ultimately, the FDA may not authorize the commercial release of a medical device if it determines the device is not safe and effective or does not meet other regulatory standards. Additionally, even if a product is cleared or approved, the FDA may impose restrictions or require testing and surveillance programs to monitor the effects of these products once commercialized.

The FDA has the authority to halt the distribution of certain medical devices, detain or seize adulterated or misbranded medical devices, order the repair, replacement, or refund of the costs of such devices, or preclude the importation of devices that are or appear violative. The FDA also conducts inspections to determine compliance with the quality system regulations concerning the manufacturing and design of devices and current medical device reporting regulations, recall regulations, clinical testing regulations, and other requirements. The FDA may withdraw product clearances or approvals due to failure to comply with regulatory standards, or the occurrence of unforeseen problems following initial approval, and require notification of health professionals and others with regard to medical devices that present unreasonable risks of substantial harm to the public health. Additionally, the failure to comply with FDA or comparable regulatory standards or the discovery of previously unknown product problems could result in fines, delays, suspensions or withdrawals of regulatory clearances or approvals, seizures, injunctions, recalls, refunds, civil money penalties, or criminal prosecution. Our compliance with applicable regulatory requirements is subject to continual review. Moreover, the FDA and several other United States agencies administer controls over the export of medical devices from the United States and the import of medical devices into the United States, which could also subject us to sanctions for noncompliance.

We are also subject to additional laws and regulations that govern our business operations, products, and technologies, including:

•federal, state, and foreign anti-kickback laws and regulations, which generally prohibit payments to anyone, including physicians as an inducement to purchase or recommend a product;

7
•the Stark law, which prohibits physicians from referring Medicare or Medicaid patients to a provider that bills these programs for the provision of certain designated health services if the physician (or a member of the physician's immediate family) has a financial relationship with that provider;

•federal and state laws and regulations that protect the confidentiality of certain patient health information, including patient records, and restrict the use and disclosure of such information, in particular, the Health Insurance Portability and Accountability Act of 1996;

•the Physician Payments Sunshine Act, which requires public disclosure of the financial relationships of United States physicians and teaching hospitals with applicable manufacturers, including medical device, pharmaceutical, and biologics companies;

•the False Claims Act, which prohibits the submission of false or otherwise improper claims for payment to a federally funded health care program, and health care fraud statutes that prohibit false statements and improper claims to any third-party payor; and

•the United States Foreign Corrupt Practices Act, which can be used to prosecute United States companies for arrangements with foreign government officials or other parties, or for not keeping accurate financial records or maintaining adequate internal controls to prevent and detect arrangements with foreign government officials or other parties.

Failure to comply with these laws and regulations could result in criminal liability, significant fines or penalties, negative publicity, and substantial costs and expenses associated with investigation and enforcement activities. To assist in our compliance efforts, we work to adhere to many codes of ethics and conduct regarding our business activities in the United States and other countries in which we operate. In addition, we have in place a dedicated team to improve our internal business compliance programs and policies.

Regulation Outside of the United States.    Outside of the United States, the regulation of medical devices is complex. In Europe, our products are subject to extensive regulatory requirements. The regulatory regime in the European Union ("EU") for medical devices became mandatory in June 1998. It requires that medical devices may only be placed on the market if they do not compromise safety and health when properly installed, maintained, and used in accordance with their intended purpose. National laws conforming to the EU's legislation regulate our products under the medical devices regulatory system. Although the more variable national requirements under which medical devices were formerly regulated have been substantially replaced by the European Union Medical Devices Directive, individual nations can still impose unique requirements that may require supplemental submissions. The EU medical device laws require manufacturers to declare that their products conform to the essential regulatory requirements after which the products may be placed on the market bearing the CE Mark. Manufacturers' quality systems for products in all but the lowest risk classification are also subject to certification and audit by an independent notified body. In Europe, particular emphasis is being placed on more sophisticated and faster procedures for the reporting of adverse events to the competent authorities.

In May 2017, the EU implemented a new regulatory scheme for medical devices under the Medical Device Regulation ("MDR"). The MDR became effective on May 26, 2021 and brought significant new requirements for many medical devices, including enhanced requirements for clinical evidence and documentation, increased focus on device identification and traceability, new definitions and registration of economic operators throughout the distribution chain, and additional post-market surveillance and vigilance. Compliance with the MDR requires re-certification of many of our products to the enhanced standards, and has resulted in and will continue to result in substantial additional expense. In addition, in the EU, we import some of our devices through our offices in Switzerland. Switzerland is not a member state of the EU, but is linked to the EU through bilateral treaties; therefore, the free movement of goods, including medical devices, between the EU and Switzerland after implementation of the MDR requires a revised Mutual Recognition Agreement ("MRA"). If an MRA covering the MDR is not put in place, then non-EU manufacturers may be required to make significant changes, including replacement of Swiss economic operators with operators based in EU member states, and changes will need to be made to our device labeling and/or packaging to satisfy MDR requirements. If these measures are unable to be taken, it may no longer be possible to place such devices on the EU market.

In Japan, pre-market approval and clinical studies are required as is governmental pricing approval for medical devices. Clinical studies are subject to a stringent Japanese "Good Clinical Practices" standard. Approval time frames from the Japanese Ministry of Health, Labour and Welfare vary from simple notifications to review periods of one or more years, depending on the complexity and risk level of the device. In addition, importation of medical devices into Japan is subject to the "Good
8
Import Practices" regulations. As with any highly regulated market, significant changes in the regulatory environment could adversely affect future sales.

In many of the other foreign countries in which we market our products, we may be subject to regulations affecting, among other things:

•product standards and specifications;

•packaging requirements;

•labeling requirements;

•product collection and disposal requirements;

•quality system requirements;

•import restrictions;

•tariffs;

•duties; and

•tax requirements.

Many of the regulations applicable to our devices and products in these countries are similar to those of the FDA. In some regions, the level of government regulation of medical devices is increasing, which can lengthen time to market and increase registration and approval costs. In many countries, the national health or social security organizations require our products to be qualified before they can be marketed and considered eligible for reimbursement.

Health Care Initiatives.    Government and private sector initiatives to limit the growth of health care costs, including price regulation and competitive pricing, coverage and payment policies, comparative effectiveness reviews, technology assessments, increasing evidentiary demands, and managed-care arrangements, are continuing in many countries where we do business, including the United States, Europe, and Japan. As a result of these changes, the marketplace has placed increased emphasis on the delivery of more cost-effective medical therapies. For example, government programs, private health care insurance, and managed-care plans have attempted to control costs by restricting coverage and limiting the level of reimbursement for procedures or treatments, and some third-party payors require their pre-approval before new or innovative devices or therapies are utilized by patients. These various initiatives have created increased price sensitivity over medical products generally and may impact demand for our products and technologies.

The delivery of our products is subject to regulation by the United States Department of Health and Human Services ("HHS") and comparable state and foreign agencies responsible for reimbursement and regulation of health care items and services. Foreign governments also impose regulations in connection with their health care reimbursement programs and the delivery of health care items and services. Reimbursement schedules regulate the amount the United States government will reimburse hospitals and doctors for the inpatient care of persons covered by Medicare. HHS' Centers for Medicare & Medicaid Services ("CMS") may also review whether and/or under what circumstances a procedure or technology is reimbursable for Medicare beneficiaries. Changes in current coverage and reimbursement levels could have an adverse effect on market demand and our pricing flexibility. The CMS National Coverage Determination for Transcatheter Aortic Valve Replacement was issued in June 2019.  The modernized requirements and more streamlined patient evaluation process are meaningful enhancements that may help ensure equitable access for more patients suffering from severe aortic stenosis.

Health care cost containment efforts have also prompted domestic hospitals and other customers of medical device manufacturers to consolidate into larger purchasing groups to enhance purchasing power. The medical technology industry has also experienced some consolidation, partly in order to offer a broader range of products to large purchasers. As a result, transactions with customers are larger, more complex, and tend to involve more long-term contracts than in the past. These larger customers, due to their enhanced purchasing power, may have a material impact on product pricing.

These laws or any future legislation, including deficit reduction legislation, could impact medical procedure volumes, reimbursement for our products, and demand for our products or the prices at which we sell our products.

9
Seasonality

Our quarterly sales are influenced by many factors, including new product introductions, acquisitions, regulatory approvals, patient and physician holiday schedules, and other factors. Sales in the third quarter are typically lower than other quarters of the year due to the seasonality of the United States and European markets, where summer vacation schedules normally result in fewer medical procedures.

Human Capital Management Strategy

Human Capital Management ("HCM") Governance

The primary goals of our talent management strategy are to attract, develop and retain a motivated, professional workforce and to ensure alignment on our patient-focused innovation strategy.

Our Board of Directors routinely engages with leadership to review and discuss our human capital management ("HCM"), with time dedicated at each regularly scheduled meeting to discuss talent management, which include topics such as talent strategy, diversity, succession planning, employee development, employee health, safety, and welfare, results of employee surveys, and compensation. Our Board of Directors also annually approves the strategic talent imperatives that are tied to our Key Operating Drivers ("KODs"). Our KODs are tracked using a point system across our entire organization that focus the Company and management toward short-, medium-, and long-term goals. The strategic talent imperatives are developed to identify talent related initiatives that support achievement of the KODs.

In addition, the Chief Executive Officer ("CEO") and his leadership team have talent management related performance goals tied to their compensation; these Performance Management Objectives are reviewed on an annual basis, tracked, and then reported to and evaluated by our Board of Directors.

As we scale to reach more patients around the world, we have integrated our Talent & Organization (“T&O”) Strategy with our Edwards Strategic Planning process. The purpose of our T&O Strategy is to anticipate global trends related to our workforce, develop our talent to meet future organizational needs, and enable us to be well-poised to meet these needs. Our T&O Strategy enables us to explore external workforce signals, share insights, and identify and build emerging capabilities across our organization. We have also developed a comprehensive succession planning process that allows us to build strong talent from within while we pursue an aggressive recruiting process to fill any gaps with highly qualified external talent. This consistent and scalable approach looks across all our product groups, regions, and significant functions to align and elevate priorities, critical capabilities, and organizational evolutions in line with our strategic plan. This integrated approach informs our yearly objectives and fuels our talent roadmap across the strategic horizon.

Our HCM governance includes a global talent development review ("TDR") process to align our talent strategies with our business strategy, assess talent against future organizational needs, evaluate critical talent populations, and enhance the strength of our succession planning. We track our performance regularly.

Culture

Investing in our workforce means our employees can stay focused on our patient-focused innovation strategy and the development of life-saving therapies for the patients we serve. We are committed to maintaining an ethical culture where we celebrate diversity, promote good health and safety, empower employees to speak up, and ensure that employees' voices are heard. We strive to offer competitive employee well-being packages and are committed to fair and equitable pay practices. We track compensation patterns in all geographies where we operate, and we regularly look for ways to ensure fair and equitable pay.

Diversity, Inclusion, and Belonging

We are committed to fostering an environment where all employees can grow and thrive. A diverse workforce results in a broader range of perspectives, helping drive our commitment to innovation. We have established a Diversity, Inclusion, and Belonging strategy that includes our four focus areas of Business, People, Communication, and Community, and whose overriding priority is "The Patient." As a practice, all employees receive unconscious bias training as a foundational aspect of our culture, and we include a non-discrimination clause in our Global Business Practice Standards and Third Party Code of Conduct.

10
Employee Listening

We believe in empowering our employees and providing avenues that enable their voices to be heard. We conduct a multilingual global employee survey, called myVoice, to gain employees' feedback in a confidential manner. The CEO and Executive Leadership Team hold themselves accountable to consider and act on the results of the survey, and these results are reviewed by management with our Board of Directors. This initiative helps us gain insights on various topics including patient focus, diversity, inclusion and belonging, quality, innovation, engagement, as well as a sense of support at all levels of the organization. Speak-Up is a resource available to all employees to bring forth compliance related concerns; a key element of our compliance program is that each employee is accountable for maintaining ethical business practices. In addition, during each quarterly townhall meeting, our CEO answers questions that have been submitted to him by employees. Answers to questions that are not covered in the townhall meeting are posted online internally.

Total Benefits and Well-being

We understand that good health leads to better performance. We offer competitive employee benefits and well-being packages that include, among other things, health and wellness insurance, health savings accounts, family support services, and a variety of site-specific programs. We regularly evaluate our benefits package to make modifications that are aligned with the competitive landscape, legislative changes, and the unique needs of our population. We also provide robust well-being programs that address prevention, nutrition, mental health, physical activity, financial fitness, and community service. As part of our regular evaluation and commitment to putting employees first, we determined our employees could benefit from support in four main areas related to health: Mind+, metabolic, heart, and musculoskeletal health. We offer a variety of programs and education to support employees in these areas. In recent years, mental well-being has become a central topic for organizations worldwide. Mind+ offers a wide variety of mental well-being programs for our employees. This commitment extends to creating a work environment where employees can feel confident speaking about mental well-being with their managers and know how best to access the tools and resources available to support them. We believe there are strong benefits when employees are feeling their best. Employees who are mentally healthy are more innovative, resilient, better decision-makers, and able to build stronger relationships. We also believe that prioritizing and promoting Mind+ allows us to help patients around the world to live longer, healthier, and more productive lives and supports employees to be their best self at home and at work.

Talent Development

Developing talent around the globe is critical to achieving our mission at Edwards. We believe in developing talent from within and have a long-term commitment to building the leadership and technical skills for the present and future needs of the business. Edwards provides in-depth learning and development resources for employees at all levels, including blended learning opportunities such as in-person, virtual, and online courses, capability assessments, coaching, and developmental experiences. We are committed to enabling our employees to have long-term careers at Edwards by encouraging each employee to take ownership of their professional development, engage in the significant resources available, and leverage the performance management and feedback process to be on a journey of continuous growth. We also encourage managers to be involved in helping their employees develop enhanced personal, professional, and leadership skills. Our learning and development strategy aims to have a balanced focus on building leadership and technical capabilities, with resources dedicated to building learning and development for global leaders, such as our course on ethical decision making for managers, and developing technical skills and capabilities for unique talent segments. Our learning and development initiatives are designed to support and sustain Edwards’ values and unique culture, inspiring our employees to collaborate, innovate, and grow, ultimately enabling us to better serve our patients.

Headcount and Labor Representation

As of December 31, 2023, we had approximately 19,800 employees worldwide, the majority of whom were located in the United States, Singapore, the Dominican Republic, and Costa Rica. None of our North American employees are represented by a labor union. In various countries outside of North America, we interact with trade unions and work councils that represent employees.

Additional details regarding diversity, talent development, compensation, and employee health and safety can be found in our Sustainability Report posted on our website at www.edwards.com under "About Us — Corporate Responsibility."

References to our website in this Annual Report on Form 10-K are provided for convenience only and the content on our website does not constitute a part of this Report.

11
Item 1A.    Risk Factors

Our business and assets are subject to varying degrees of risk and uncertainty. An investor should carefully consider the risks described below, as well as other information contained in this Annual Report on Form 10-K and in our other filings with the SEC. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business. If any of these events or circumstances occurs, our business, financial condition, results of operations, or prospects could be materially harmed. In that case, the value of our securities could decline and an investor could lose part or all of his or her investment. In addition, forward-looking statements within the meaning of the federal securities laws that are contained in this Annual Report on Form 10-K or in our other filings or statements may be subject to the risks described below as well as other risks and uncertainties. Please read the cautionary notice regarding forward-looking statements in Part I above. Please note that the headers and summary provided below are only intended to assist the reader in navigating the risk factors; some risks, present or future, may implicate multiple types of risks. Please read all risk factors in their entirety.

Summary of Risk Factors

The following summarizes the principal risks and uncertainties affecting our business, financial condition, and results of operations. This summary should not be relied upon as an exhaustive summary of the material risks facing our business and you should read this summary together with the more detailed description of risks and uncertainties discussed below.

Business and Operating Risks

•Failure to successfully innovate and market products
•Unsuccessful clinical trials or procedures
•Manufacturing, logistics, or quality problems
•Public health crises, including pandemics and epidemics
•Competition
•Dependence on key physicians and research institutions
•Reliance on vendors, suppliers, and other third parties
•Damage, failure, or interruption of our information technology systems, including due to cyber-based attacks and breaches
•Failure to recruit and retain qualified talent or execute management succession plans
•Underperforming operations or unsuccessful business acquisitions or strategic alliances
•Risks related to the spin-off of our Critical Care product group

Market and Other External Risks

•Risks associated with international sales and operations
•Inability to obtain government reimbursement or reductions in reimbursement levels
•Industry consolidation

Legal, Compliance and Regulatory Risks

•Inability to protect our intellectual property
•Inability to defend against intellectual property claims from third parties
•Compliance with government regulations
•Losses from product liability claims
•Use of products in unapproved circumstances
•Substantial costs from environmental, health and safety regulations
•Climate change
•Regulatory actions relating to animal-borne illnesses

Business and Operating Risks

Failure to successfully innovate and develop new and differentiated products in a timely manner and effectively market these products could have a material effect on our prospects.

Our continued growth and success depend on our ability to innovate and develop new and differentiated products in a timely manner and effectively market these products. Without the timely innovation and development of products, our products
12
could be rendered obsolete or less competitive because of the introduction of a competitor’s newer technologies or changing customer preferences. Innovating products requires the devotion of significant financial and other resources to research and development activities; however, there is no certainty that the products we are currently developing will complete the development process, or that we will obtain the regulatory or other approvals required to market such products in a timely manner or at all. Even if we timely innovate and develop products, our ability to successfully market them could be constrained by a number of different factors, including competitive products and pricing, barriers in patient activation (including disease awareness, detection, and diagnosis), the need for regulatory clearance, restrictions imposed on approved indications, and uncertainty over third-party reimbursement. Failure in any of these areas could have a material effect on our prospects.

Unsuccessful clinical trials or procedures relating to products could have a material adverse effect on our prospects.

The regulatory approval process for new products and new indications for existing products requires extensive clinical trials and procedures, including early clinical feasibility and regulatory studies. Unfavorable or inconsistent clinical data from current or future clinical trials or procedures conducted by us, our competitors, or third parties, or perceptions regarding this clinical data, could adversely affect our ability to obtain necessary approvals and the market's view of our future prospects. Such clinical trials and procedures are inherently uncertain and there can be no assurance that these trials or procedures will be enrolled or completed in a timely or cost-effective manner or result in a commercially viable product or indication; failure to do so could have a material adverse effect on our prospects. Clinical trials or procedures may experience significant setbacks even after earlier trials have shown promising results. Further, preliminary results from clinical trials or procedures may be contradicted by subsequent analyses. In addition, results from our clinical trials or procedures may not be supported by actual long-term studies or clinical experience. If preliminary clinical results are later contradicted, or if initial results cannot be supported by actual long-term studies or clinical experience, our business could be adversely affected. Clinical trials or procedures may be delayed, suspended, or terminated by us, the FDA, or other regulatory authorities at any time if it is believed that the trial participants face unacceptable health risks or any other reasons, and any such delay, suspension, or termination could have a material adverse effect on our prospects or the market's view of our future prospects.

If we or one of our suppliers or logistics partners encounters manufacturing, logistics, safety, or quality problems, our business could be materially adversely affected.

The manufacture and sterilization of many of our products is highly complex due in part to rigorous regulatory requirements. Quality is extremely important due to the serious and costly consequences of a product failure. Safety is also critically important. Problems can arise for a number of reasons, including disruption of facility utilities, equipment malfunction, failure to follow protocols and procedures, raw material problems, software problems, cyber incidents, or human error. Disruptions can occur at any time, including during production line transfers and expansions. Disruptions can also occur if our manufacturing and warehousing facilities are damaged by earthquakes, hurricanes, volcanoes, fires, and other natural disasters or catastrophic circumstances. As we expand into new markets and scale new products for commercial production, we may face unanticipated delays or surges in demand which could strain our production capacity and lead to other types of disruption. If any of these manufacturing, logistics, or quality problems arise or if we or one of our suppliers or logistics partners otherwise fail to meet internal quality standards or those of the FDA or other applicable regulatory body, our reputation could be damaged, we could become subject to a safety alert or a recall, we could incur product liability and other costs, product approvals and production could be delayed, and our business could otherwise be materially adversely affected.

We are subject to risks associated with public health crises, particularly with respect to the pressures that such crises create on the hospital systems and supply chains in which we operate.

We are subject to risks associated with public health crises, including pandemics and epidemics, such as COVID-19. Other public health crises, including any future epidemics or pandemics, are highly uncertain and difficult to predict, and could result in material adverse impacts on our business and financial condition.

We operate in highly competitive markets, and if we do not compete effectively, our business will be harmed.

We face substantial competition and compete with technologies of many types and companies of all sizes on the basis of cost-effectiveness, technological innovations, product performance, brand name recognition, breadth of product offerings, real or perceived product advantages, pricing and availability and rate of reimbursement. In addition, given the trend toward value-based healthcare, if we are not able to continue to demonstrate the full value of our differentiated products to healthcare providers and payors, our competitive position could be adversely affected. See "Competition" under "Business" in Part I, Item 1 included herein.
13

The success of many of our products depends upon certain key physicians and research institutions.

We work with leading global physicians and research institutions who provide considerable knowledge and experience. These physicians may assist us as researchers, marketing consultants, product trainers and consultants, inventors, and as public speakers. If new laws, regulations, or other developments limit our ability to appropriately engage these professionals or with the research institutions of which they are a part or to continue to receive their advice and input or we are otherwise unsuccessful in maintaining strong working relationships with these physicians or their research institutions, the development, marketing, and successful use of our products could suffer, which could have a material adverse effect on our business, financial condition, and results of operations.


We rely on third parties in the design, manufacture, and sterilization of our products. Any failure by or loss of a vendor could result in delays and increased costs, which may adversely affect our business.

We rely on third parties for a broad range of raw and organic materials and other items in the design, manufacture, and sterilization of our products, and we purchase certain supplies and services from single sources for reasons of quality assurance, cost-effectiveness, availability, constraints resulting from regulatory requirements, and other reasons. We experience from time to time, and may continue to experience, supply interruptions due to a variety of factors, including:

•General economic conditions that could adversely affect the financial viability of our vendors;

•Vendors' election to no longer service or supply medical technology companies, including due to the burdens of applicable quality requirements and regulations or for no reason at all;

•The limitation or ban of certain chemicals or other materials used in the manufacture of our products; and

•Delays or shortages due to trade or regulatory embargoes.

Additionally, any significant increases in the cost of raw materials, whether due to inflationary pressure, supply constraints, regulatory changes, or otherwise, could adversely impact our operating results. A change or addition to our vendors could require significant effort due to the rigorous regulations and requirements of the FDA and other regulatory authorities; it could be difficult to establish additional or replacement sources on a timely basis or at all, which could have a material adverse effect on our business.

Failure to protect our information technology infrastructure and our products against cyber-based attacks, network security breaches, service interruptions, or data corruption could materially disrupt our operations and adversely affect our business and operating results.

The operation of our business depends on our information technology systems. We rely on our information technology systems to, among other things, effectively manage sales and marketing data, accounting and financial functions, inventory management, product development tasks, clinical data, customer service and technical support functions. Our information technology systems are vulnerable to damage or interruption from earthquakes, fires, floods and other natural disasters, terrorist attacks, power losses, computer system or data network failures, security breaches, and data corruption.

In addition, our information technology infrastructure and products are vulnerable to cyber-based attacks. Cyber-based attacks can include, but are not limited to, computer viruses, denial-of-service attacks, phishing attacks, ransomware attacks, and other introduction of malware to computers and networks; unauthorized access through the use of compromised credentials; exploitation of design flaws, bugs, or security vulnerabilities; intentional or unintentional acts by employees or other insiders with access privileges; and intentional acts of vandalism by third parties and sabotage. In addition, United States federal and state laws and regulations, and the laws and regulations of jurisdictions outside of the United States, such as the General Data Protection Regulation ("GDPR") adopted by the European Union and the California Privacy Rights Act ("CRPA") and the California Consumer Privacy Act, as amended by the CRPA (the "CCPA"), can expose us to investigations and enforcement actions by regulatory authorities and claims from individuals potentially resulting in penalties and significant legal liability, if our information technology security efforts are inadequate. In addition, we rely upon technology suppliers, including cloud‑based data management applications hosted by third‑party service providers, whose security and information technology systems are subject to similar risks.

14
Significant disruption in either our or our service providers’ or suppliers’ information technology or the security of our products could impede our operations or result in decreased sales, result in liability claims or regulatory penalties, or lead to increased overhead costs, product shortages, loss or misuse of proprietary or confidential information, intellectual property, or sensitive or personal information, all of which could have a material adverse effect on our reputation, business, financial condition, and operating results.

Our business and results of operations may be adversely affected if we are unable to recruit and retain qualified talent or are otherwise unsuccessful in the execution of our management succession plans.

Our continued success depends, in large part, on our ability to hire and retain qualified people and execute on our talent management and succession plans, and if we are unable to do so, our business and operations may be impaired or disrupted. See "Human Capital Management Strategy" under "Business" in Part I, Item 1 included herein. Competition for highly qualified people is intense, and there is no assurance that we will be successful in attracting or retaining replacements to fill vacant positions, successors to fill retirements or employees moving to new positions, or other highly qualified personnel.

If we identify underperforming operations or products or if there are unforeseen operating difficulties and expenditures in connection with business acquisitions or strategic alliances, we may be required, from time to time, to recognize charges, which could be substantial and which could adversely affect our results of operations.

We actively manage a portfolio of research and development products, and we regularly explore potential acquisitions of complementary businesses, technologies, services, or products, as well as potential strategic alliances. From time to time, we identify operations and products that are underperforming, do not fit with our longer-term business strategy or there may be unforeseen operating difficulties and significant expenditures during the integration of an acquired business, technology, service, or product into our existing operations. We may seek to dispose of these underperforming operations or products, and we may also seek to dispose of other operations or products for strategic or other business reasons. If we cannot dispose of an operation or product on acceptable terms, we may voluntarily cease operations related to that product. In addition, we may be required to take charges or write-downs in connection with acquisitions and divestitures. In particular, acquisitions of businesses engaged in the development of new products may give rise to developed technology and/or in-process research and development assets. To the extent that the value of these assets decline, we may be required to write down the value of the assets. Also, in connection with certain asset acquisitions, we may be required to take an immediate charge related to acquired in-process research and development assets. Any of these events could result in charges, which could be substantial and which could adversely affect our results of operations.

We may not be able to complete the announced spin-off of our Critical Care product group at all, or within the timeframes we anticipate, or pursuant to the tax-free structure that we anticipate, and we may not realize some or all of the expected benefits of this transaction.

On December 7, 2023, we announced our intention to complete a tax-free spin-off of our Critical Care product group at the end of 2024. We also announced our intention to submit a Form 10 with the SEC in mid-year 2024. In connection with this spin-off and the separation of the Critical Care product group from the rest of Edwards, we will be required to satisfy all necessary governance, contractual, and regulatory conditions, among other, including those required by third parties. A failure to satisfy all necessary conditions could delay or prevent the spin-off from occurring or could result in us completing the spin-off on terms less than favorable to us. In addition, we will incur significant costs associated with the spin-off, which may be significantly higher than projected. Our intention is to complete the spin-off on a tax-free basis, however, there is no assurance that the spin-off will qualify tax-free as intended, which may result in a significant tax liability. Lastly, preparing and structuring the spin-off requires significant resources from Edwards, including but not limited to management’s attention, financial support for the new company, and the collective employee effort to separate the Critical Care product group from the rest of Edwards while continuing to operate in the normal course of business. There is no assurance that the spin-off will occur at all or that the execution, timing, and structure of the spin-off will proceed as intended. There may be a sudden or unpredictable reaction to the spin-off by the investors and financial institutions, which would affect our stock market price. If we don’t realize some or all of the benefits of the spin-off, our business and financial condition and those of the newly spun-off company will be materially adversely affected.

15
Assuming the spin-off is successfully completed, the newly spun-off Critical Care company as a standalone public company may not deliver the returns that we or the shareholders anticipate.

The Company plans to spin-off the Critical Care product group into a successful independent public company to be able to increase focus and flexibility to build upon its global leadership position in advanced patient monitoring, transforming care through AI-enabled smart monitoring solutions while expanding its reach to millions of patients around the world. The intention for the newly spun-off company is to retain its Chief Executive Officer and other senior leaders, however, there is no assurance that we or the newly spun-off company will be able to do so, which may materially impact the operations of the newly spun-off company. In addition, the new spin-off will result in a smaller, less diversified standalone company than it was as part of Edwards, which may make it more susceptible to macroeconomic trends, geopolitical risks, financial volatility, and changing market and regulatory conditions, any of which could have a material adverse effect on its financial condition and operations. The newly spun-off company will incur ongoing costs related to the separation and its public listing, and its transition to a standalone public company, if executed at all, may not be executed as anticipated. Lastly, we cannot predict whether the market value of our stock and the stock of the spun-off company after the completion of the transaction, will be, in the aggregate, less than, equal to, or greater than the market value of our stock prior to the spin-off. There is no assurance that the newly spun-off company will be successful as a standalone public company, and if it is not successful, that would have a material adverse impact on the operations and financial condition of the newly spun-off company.

Market and Other External Risks

Because we operate globally, our business is subject to a variety of risks associated with international sales and operations.

Our extensive global operations and business activity as well as the fact that many of our manufacturing facilities and suppliers are outside of the United States exposes us to certain financial, economic, political, and other risks, including those listed below.

Domestic and Global Economic Conditions.  We have been impacted and may continue to be negatively impacted by general domestic and global economic conditions, although we cannot predict the extent to which such conditions may negatively impact our business. These include, but are not limited to, conditions impacting inflation, credit and capital markets, interest rates, tax law, including tax rate and policy changes, factors affecting global economic stability, and the political environment relating to health care. These and other conditions could also adversely affect our customers, payers, vendors and other stakeholders and may impact their ability or decision to purchase our products or make payments on a timely basis.

Health Care Legislation and Other Regulations. We are subject to various federal and foreign laws that govern our domestic and international business practices. For example, in the United States, the Affordable Care Act, the Medicare Access and CHIP Reauthorization Act of 2015, and the 21st Century Cures Act, or any future legislation, including deficit reduction legislation, could impact medical procedure volumes, reimbursement for our products, and demand for our products or the prices at which we sell our products. In addition, a Mutual Recognition Agreement still under negotiation for the Medical Device Regulation can result in a lack of free movement of medical devices between the European Union and Switzerland, can impact our access in the European Union and can, ultimately, have a material effect on our business, financial condition, and results of operations. For more information about these laws as they relate to our business, see the section entitled “Government Regulation and Other Matters” in Part I, Item 1, “Business.”

In addition, the United States Foreign Corrupt Practices Act, the United Kingdom Bribery Act, and similar laws in other jurisdictions contain prohibitions against bribery and other illegal payments, and make it an offense to fail to have procedures in place that prevent such payments. Penalties resulting from any violation of these laws could adversely affect us and our business.

Taxes. We are subject to income taxes in the United States as well as other jurisdictions.

•Provision for Income Taxes. Our provision for income taxes and our effective tax rate could fluctuate due to changes in the mix of earnings and losses in countries with differing statutory tax rates. Our income tax provision could also be impacted by changes in excess tax benefits of stock-based compensation, federal and state tax credits, non-deductible expenses, changes in the valuation of deferred tax assets and liabilities and our ability to utilize them, the applicability and creditability of withholding taxes, and effects from acquisitions.

•Tax Reform. Our provision for income taxes could be materially impacted by changes in accounting principles or evolving tax laws, including, but not limited to, global corporate tax reform and base-erosion and tax transparency efforts. For example, many countries are aligning their international tax rules with the Organisation for Economic Co-operation and Development’s Base Erosion and Profit Shifting recommendations and action plans that aim to
16
standardize and modernize international corporate tax policy, including changes to cross-border taxes, transfer pricing documentation rules, nexus-based tax practices, and taxation of digital activities. The effective dates of implementation, the interactions of tax reforms in multiple jurisdictions, and uncertainty related to dispute resolution mechanisms could impact our provision for income taxes.

•Tax Audits. We are subject to ongoing tax audits in the various jurisdictions in which we operate. Tax authorities have disagreed and may disagree with certain positions we have taken and assess additional taxes that could be material. Please review Note 18 (Income Taxes) to our "Consolidated Financial Statements" in this report for information regarding our current audits and disputes with tax authorities. Although we regularly assess the likely outcomes of the audits and record reserves for potential tax payments, the calculation of tax liabilities involves the application of complex tax laws, and our estimates could be different than the amounts for which we are ultimately liable. In addition, we may decide to challenge any assessments, if made, and may exercise our right to appeal, which could result in expensive and time-consuming litigation that may ultimately be unsuccessful.

•Tax Incentives. We benefit from various global tax incentives extended to encourage investment or employment. Several foreign jurisdictions have granted us tax incentives which require renewal at various times in the future. If our incentives are not renewed or we cannot or do not wish to satisfy all or part of the tax incentive conditions, we may lose the tax incentives and could be required to refund tax incentives previously realized. As a result, our provision for income taxes could be higher than it would have been had we maintained the benefits of the tax incentives.

Other economic, political, and social risks. In addition to the factors enumerated above, we are from time to time impacted by a variety of other factors associated with doing business internationally that can harm our future results, including the following:

•trade protection measures, quotas, embargoes, import or export requirements, and duties, tariffs, or surcharges;

•cultural or other local factors affecting financial terms with customers;

•differing labor regulations;

•military conflict, political unrest, or wars; and

•currency exchange rate fluctuations; that is, decreases in the value of the United States dollar to the Euro or the Japanese yen, as well as other currencies in which we transact business, have the effect of increasing our reported sales even when the volume of sales outside of the United States has remained constant. Increases in the value of the United States dollar relative to the Euro or the Japanese yen, as well as other currencies, have the opposite effect. Significant increases or decreases in the value of the United States dollar could have a material adverse effect on our sales, cost of sales, or results of operations.

If government and other third-party payors decline to reimburse our customers for our products or impose other cost containment measures to reduce reimbursement levels, our ability to profitably sell our products will be harmed.

We sell our products and technologies to hospitals and other health care providers, nearly all of which receive reimbursement for the health care services provided to patients from third-party payors, such as government programs (both domestic and outside of the United States), private insurance plans, and managed care programs. The ability of customers to obtain appropriate reimbursement for their products from private and governmental third-party payors is critical to our success. The availability of reimbursement affects which products customers purchase and the prices they are willing to pay. Reimbursement varies from country to country and can significantly impact acceptance of new products.

Government and other third-party payors are increasingly attempting to contain health care costs by limiting both coverage and the level of reimbursement for medical products and services. Reimbursement levels may be decreased in the future. Additionally, future legislation, regulation, or reimbursement policies of third-party payors may otherwise adversely affect the demand for and price levels of our products. The introduction of cost containment incentives, combined with closer scrutiny of health care expenditures by both private health insurers and employers, has resulted in increased discounts and contractual adjustments to hospital charges for services performed. Hospitals or physicians may respond to such cost-containment pressures by substituting lower cost products or other therapies.

17
Third-party payors may deny reimbursement if they determine that a device used in a procedure was not used in accordance with cost-effective treatment methods as determined by such third-party payors or was used for an unapproved indication. Third-party payors may also deny reimbursement for experimental procedures and devices. We believe that many of our existing products are cost-effective, even though the one-time cost may be significant, because they are intended to improve quality of life and reduce overall health care costs over a long period of time. We cannot be certain that these third-party payors will recognize these cost savings and quality of life benefits instead of merely focusing on the lower initial costs associated with competing therapies. If our products are not considered cost-effective by third-party payors, our customers may not be reimbursed for them, resulting in lower sales of our products.

Continued consolidation in the health care industry could have an adverse effect on our sales and results of operations.

The health care industry has been consolidating, and organizations such as GPOs, independent delivery networks, and large single accounts, such as the United States Veterans Administration, continue to consolidate purchasing decisions for many of our health care provider customers. As a result, transactions with customers are larger and more complex, and tend to involve more long-term contracts. The purchasing power of these larger customers has increased, and may continue to increase, causing downward pressure on product pricing. If we are not one of the providers selected by one of these organizations, we may be precluded from making sales to its members or participants. Even if we are one of the selected providers, we may be at a disadvantage relative to other selected providers that are able to offer volume discounts based on purchases of a broader range of medical equipment and supplies. Further, we may be required to commit to pricing that has a material adverse effect on our revenues, profit margins, business, financial condition, and results of operations. We expect that market demand, governmental regulation, third-party reimbursement policies, and societal pressures will continue to drive consolidation and increase pricing pressure.

Legal, Compliance, and Regulatory Risks

Our inability to protect our intellectual property or failure to maintain the confidentiality and integrity of data or other sensitive company information, by cyber-attack or other event, could have a material adverse effect on our business.

Our success and competitive position are dependent in part upon our ability to protect our proprietary intellectual property through a combination of patents and trade secrets. We cannot guarantee that the protective steps we take are adequate to protect these rights:

•Patents issued to or licensed by us in the past or in the future may be challenged and held invalid.

•As our patents expire, we may be unsuccessful in extending their protection through patent term extensions.

•Confidentiality agreements with certain employees, consultants, and other third parties intended to protect, in part, trade secrets and other proprietary information could be breached, and we may not have adequate remedies.

•Others could independently develop substantially equivalent proprietary information or gain access to our trade secrets or proprietary information, design around our technology, or develop competing technologies.

•Our intellectual property, other proprietary technology, and other sensitive company information is dependent on sophisticated information technology systems and is potentially vulnerable to cyber-attacks, loss, theft, damage, destruction from system malfunction, computer viruses, loss of data privacy, or misappropriation or misuse of it by those with permitted access, and other events.

•We may not detect infringement.

•Intellectual property protection may also be unavailable or limited in some foreign countries.

We spend significant resources to protect and enforce our intellectual property rights, sometimes resulting in expensive and time-consuming litigation that is complex and may ultimately be unsuccessful. Our inability to protect our intellectual property could have a material adverse effect on our business or prospects.

18
Third parties may claim we are infringing their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling products.

During recent years, we and our competitors have been involved in substantial litigation regarding patent and other intellectual property rights which is typically costly and time-consuming. We may be forced to defend against claims and legal actions alleging infringement of the intellectual property rights of others, and, if our defense is unsuccessful, we could have significant liabilities to third parties or face injunctions that bar the sale of our products, or could require us to seek licenses from third parties. Such licenses may not be available on commercially reasonable terms, may prevent us from manufacturing, selling, or using certain products, or may be non-exclusive, which could provide our competitors access to the same technologies.

In addition, third parties could also obtain patents that may require us to either redesign products, negotiate licenses from such third parties, which may be costly, unavailable or require us to exit a particular product offering.

We and our customers are subject to rigorous governmental regulations and we may incur significant expenses to comply with these regulations and develop products that are compatible with these regulations. In addition, failure to comply with these regulations could subject us to substantial sanctions which could adversely affect our business, results of operations, and financial condition.

The medical technologies we create, study, manufacture, and market globally are subject to rigorous regulation and scrutiny by the FDA and various other federal, state, and foreign governmental authorities, including the European Union's European Commission who promulgated the European Medical Device Regulation ("EU MDR"). Government regulation applies to nearly all aspects of our products’ lifecycles, including testing, clinical study, manufacturing, transporting, sourcing, safety, labeling, storing, packaging, recordkeeping, reporting, advertising, promoting, distributing, marketing, and importing or exporting of medical devices and products. In general, unless an exemption applies, a medical device or product must receive regulatory approval or clearance before it can be marketed or sold. Modifications to existing products or the marketing of new uses for existing products also may require regulatory approvals, approval supplements, or clearances. If we are unable to obtain these required approvals, we may be required to cease manufacturing and sale, or recall or restrict the use of such modified device, pay fines, or take other action until such time as appropriate clearance or approval is obtained. More specifically relating to the EU MDR which came into effect in May 2017 and became applicable in May 2021 with a staggered transition period, all regulated products must be assessed by notified bodies (organizations designated by EU member states) as to whether they meet the technical requirements of the EU MDR before entering the market in Europe. During the transition period, with the influx of submissions to the notified bodies, any delay on obtaining approvals may result in a disruption of device supply or a further delay in getting a device to market. In addition, in the EU, we import some of our devices through our offices in Switzerland. Switzerland is not a member state of the EU, but is linked to the EU through bilateral treaties; therefore, the free movement of goods, including medical devices, between the EU and Switzerland after implementation of the EU MDR requires a revised MRA. If an MRA covering the EU MDR is not put in place, then non-EU manufacturers may be required to make significant changes, including replacement of Swiss economic operators with operators based in EU member states, and changes will need to be made to our device labeling and/or packaging to satisfy EU MDR requirements. If these measures are unable to be taken, it may no longer be possible to place such devices on the EU market.

Regulatory agencies may refuse to grant approval or clearance, or review and disagree with our interpretation of approvals or clearances, or with our decision that regulatory approval is not required or has been maintained. Regulatory submissions may require the provision of additional data and may be time consuming and costly, and their outcome is uncertain. Regulatory agencies may also change policies, adopt additional regulations, or revise existing regulations, each of which could prevent or delay approval or clearance of devices, or could impact our ability to market a previously cleared, approved, or unregulated device. Our failure to comply with these regulatory requirements of the FDA, the European Commission, or other applicable regulatory requirements in the United States or elsewhere might subject us to administratively or judicially imposed sanctions. These sanctions include, among others, warning letters, fines, civil penalties, criminal penalties, injunctions, debarment, product seizure or detention, product recalls and total or partial suspension of production, sale and/or promotion. Any of the foregoing actions could result in decreased sales including as a result of negative publicity and product liability claims, and could have a material adverse effect on our financial condition, results of operations, and prospects. In addition to the sanctions for noncompliance described above, commencement of an enforcement proceeding, inspection, or investigation could divert substantial management attention from the operation of our business and have an adverse effect on our business, results of operations, and financial condition.

We are also subject to various United States and foreign laws pertaining to health care pricing, anti-competition, anti-corruption, and fraud and abuse, including prohibitions on kickbacks and the submission of false claims laws and restrictions on
19
relationships with physicians and other referral sources. These laws are broad in scope and are subject to evolving interpretation, which could require us to incur substantial costs to monitor compliance. If we are found not to be in compliance, we may be required to alter our practices or have sanctions imposed against us and our officers and employees, including substantial fines, imprisonment, and exclusion from participation in governmental health care programs.

In addition, as a global company, we are subject to global data privacy and security laws, regulations and codes of conduct that apply to our businesses. We are required to comply with increasingly complex and changing legal and regulatory requirements that govern the collection, use, storage, security, transfer, disclosure and other processing of personal data in the United States and in other countries, which may include, but are not limited to, The Health Insurance Portability and Accountability Act, as amended ("HIPAA"), The Health Information Technology for Economic and Clinical Health Act, the CCPA, the CRPA, and the GDPR. The GDPR imposes stringent European Union data protection requirements and provides for significant penalties for noncompliance. HIPAA also imposes stringent data privacy and security requirements and the regulatory authority has imposed significant fines and penalties on organizations found to be out of compliance. The CCPA and the CRPA provides consumers with a private right of action against companies who have a security breach due to lack of appropriate security measures. We or our third-party providers and business partners may also be subjected to audits or investigations by one or more domestic or foreign government agencies relating to compliance with information security and privacy laws and regulations, and noncompliance with the laws and regulations could result in substantial and material fines or class action litigation.

Additional risks related to government regulation are also described under "Health Care Legislation and Other Regulations" in the risk factor above titled "Because we operate globally, our business is subject to a variety of risks associated with international sales and operations."

We may incur losses from product liability or other claims that could adversely affect our operating results.

Our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical technologies. Our products are often used in surgical and intensive care settings with seriously ill patients. In addition, many of the devices we manufacture and sell are designed to be implanted in the human body for long periods of time. Component failures, manufacturing and assembly flaws, design defects, software defects, medical procedure errors, or inadequate disclosure of product-related risks or information could result in an unsafe condition, injury to, or death of, patients. Such problems could result in product liability, medical malpractice or other lawsuits and claims, safety alerts, or product recalls in the future. We establish reserves and may incur charges in excess of those reserves. Although we maintain product liability and other insurance with coverages we believe are adequate, product liability or other claims may exceed insurance coverage limits, fines, and penalties. In addition, regulatory sanctions may not be covered by insurance, or insurance may not continue to be available or available on commercially reasonable terms. These litigation matters and regulatory actions, recalls or other actions, regardless of outcome, could have a material adverse effect on our business, reputation, and ability to attract and retain customers.

Use of our products in unapproved circumstances could expose us to liabilities.

The marketing approval from the FDA and other regulators of certain of our products are, or are expected to be, limited to specific indications. We are prohibited from marketing or promoting any unapproved use of our products. Physicians, however, can use these products in ways or circumstances other than those strictly within the scope of the regulatory approval. Although the product training we provide to physicians and other health care professionals is conducted in compliance with applicable laws, and therefore, is mainly limited to approved uses or for clinical trials, no assurance can be given that claims might not be asserted against us if our products are used in ways or for procedures that are not approved.

20
Our operations are subject to environmental, health, and safety regulations that could result in substantial costs.

Our operations are subject to environmental, health, and safety laws, and regulations concerning, among other things, the generation, handling, transportation, and disposal of hazardous substances or wastes, the cleanup of hazardous substance releases, and emissions or discharges into the air or water. We have incurred and may incur in the future expenditures in connection with environmental, health and safety laws, and regulations. New laws and regulations, violations of these laws or regulations, stricter enforcement of existing requirements, or the discovery of previously unknown contamination could require us to incur costs or could become the basis for litigation or new or increased liabilities that could be material.

Climate change, or legal, regulatory or market measures to address climate change, may materially adversely affect our financial condition and business operations.

Climate change resulting from increased concentrations of carbon dioxide and other greenhouse gases in the atmosphere could present risks to our future operations from natural disasters and extreme weather conditions, such as hurricanes, tornadoes, seismic events, wildfires, or flooding. Such extreme weather conditions could pose physical risks to our facilities and disrupt operation of our supply chain and may impact operational costs. Concern over climate change could result in new legal or regulatory requirements designed to mitigate the effects of climate change on the environment. If such laws or regulations are more stringent than current legal or regulatory requirements, we may experience increased compliance burdens and costs to meet the regulatory obligations, and it may adversely affect our raw material sourcing, manufacturing operations, and the distribution of our products.

We are subject to risks arising from concerns and/or regulatory actions relating to animal-borne illnesses, including “mad cow disease.”

Certain of our products, including pericardial tissue valves, are manufactured using bovine tissue. Concerns relating to the potential transmission of animal-borne illnesses, including BSE, commonly known as "mad cow disease," from cows to humans may result in reduced acceptance of products containing bovine materials. Certain medical device regulatory agencies have considered whether to continue to permit the sale of medical devices that incorporate bovine material. We obtain bovine tissue only from closely controlled sources within the United States and Australia. The bovine tissue used in our pericardial tissue valves is from tissue types considered by global health and regulatory organizations to have shown no risk of infectibility for the suspected BSE infectious agent. We have not experienced any significant adverse impact on our sales as a result of concerns regarding BSE, but no assurance can be given that such an impact may not occur in the future.

Item 1B.    Unresolved Staff Comments

None.

Item 1C.    Cybersecurity

Risk Management and Strategy

Our Information Security team manages Edwards’ Information Security Program, which is focused on assessing, identifying, and managing cyber risk and information security threats. We evaluate cybersecurity risk on an ongoing basis, and it is a risk monitored through our overall enterprise risk management program, including by the executive leadership and the board of directors, described below under "Governance."

To proactively manage cybersecurity risk in our organization, our management team has instituted an Edwards Information Technology Security Policy that is available to all employees through the employee handbook and on our intranet. We also conduct regular cybersecurity awareness and training campaigns for existing employees. Internal and external stakeholders can access the Edwards Integrity Helpline 24/7 online or by phone, to report any security incidents for escalation. We also disclose information about our product security and provide relevant contact information for our stakeholders to report any product vulnerabilities.

To proactively identify, mitigate, and prepare for potential cybersecurity incidents, we maintain both a business continuity plan and cyber incident response plan with formalized workflows and playbooks. We periodically conduct simulation exercises involving employees at various levels of the organization. We also periodically engage external partners to conduct annual audits of our systems, and test our IT infrastructure. Through these channels and others, we work to proactively identify potential vulnerabilities in our information security system. We recognize that we are exposed to cybersecurity threats associated with our use of third-party service providers. To minimize the risk and vulnerabilities to our own systems stemming
21
from such use, our Information Security team identifies and addresses known cybersecurity threats and incidents at third-party service providers on a continuous basis. In addition, we strive to minimize cybersecurity risks when we first select or renew a vendor by including cybersecurity risk as part of our overall vendor evaluation and due diligence process.

We have not had previous cybersecurity incidents that have materially affected us. Our risks associated with cybersecurity threats are set forth under “Risk Factors” in Part I, Item 1A in this report.

Governance

Our Board of Directors and our Audit Committee oversee our enterprise-wide risk management, including with respect to cybersecurity. Our Chief Financial Officer presents information on our enterprise-wide risks to the Board of Directors at each of its regularly scheduled meetings. Our SVP, Enterprise Risk Management presents to our Board of Directors and our Audit Committee at least once a year on our significant enterprise-wide risks as well as our enterprise-wide risk program. In addition, our Chief Information Officer (“CIO”) and our Chief Information Security Officer (“CISO”) present to the Audit Committee at each regularly scheduled Audit Committee meeting on information technology infrastructure as well as risks related to cybersecurity and information security.

The oversight of our cybersecurity program at the management level rests with the Executive Leadership Team (“ELT”) who has designated the CISO to lead and execute on the cybersecurity program. The CISO provides regular updates to the executive leadership team, including the CEO, on our cybersecurity program and cybersecurity risks. Our cybersecurity leaders have extensive experience in cybersecurity, including in consulting and corporate roles at Forbes 100 companies and experience leading security incident detection and response, security architecture, and strategy programs.

Finally, management has instituted our Information Security Council and Enterprise Risk Management Council both of which are made up of senior leaders of the Company. The Information Security Council is tasked with overseeing information security matters at Edwards, including cybersecurity. This council serves as an escalation point for issues requiring concerted action, and in turn, informs executive management regarding information security and cybersecurity risks and issues. The Enterprise Risk Management Council is tasked with proactive management of our enterprise-wide risks, including information security risks that also include cybersecurity. This council is responsible for assessing, and providing input into, the enterprise risks that are presented to the Board of Directors.


22
Item 2.    Properties

The locations and uses of our major properties are as follows:
North America  
Irvine, California(1)Corporate Headquarters, Research and Development, Regulatory and Clinical Affairs, Manufacturing, Marketing, Administration
Draper, Utah(1),(2)Manufacturing, Administration
Haina, Dominican Republic(1),(2)Manufacturing
Añasco, Puerto Rico(2)Manufacturing
Central America  
Cartago, Costa Rica(1),(2)Manufacturing
Europe  
Nyon, Switzerland(1)Administration, Marketing
Prague, Czech Republic(2)Administration
Shannon, Limerick, Ireland(1),(2)Manufacturing
Asia  
Singapore(1),(2)Manufacturing, Distribution, Administration
Tokyo, Japan(2)Administration, Marketing, Distribution
Shanghai, China(2)Administration, Marketing
Caesarea, Israel(2)Research and Development
_______________________________________________________________________________
(1)     Owned property.
(2)    Leased property.

We believe our properties have been well maintained, are in good operating condition, and are adequate for current needs. We do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.

Item 3.    Legal Proceedings

In 2021, we initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA"). We voluntarily notified the United States Securities and Exchange Commission ("SEC") and the United States Department of Justice ("DOJ") during 2021 that we engaged outside counsel to conduct this review and investigation. We have provided status updates to the SEC and DOJ since that time. Any determination that our operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. We cannot currently predict the final outcome of the investigation or any potential impact on our financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries (“Edwards”) in the United States District Court for the District of Delaware, alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. We are unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amount has been accrued. We intend to vigorously defend ourselves in this litigation.

The European Commission (the "Commission") is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices. We are committed to healthy competition and are cooperating with the Commission. We cannot predict the outcome of the investigation or the potential impact on its financial statements.

We are subject to various environmental laws and regulations both within and outside of the United States. Our operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on our financial results. Our threshold for disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.
23

Item 4.    Mine Safety Disclosures

Not applicable.
24
PART II

Item 5.    Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our common stock is traded on the New York Stock Exchange (the "NYSE") under the symbol "EW."

Number of Stockholders

On January 31, 2024, there were 7,599 stockholders of record of our common stock.

Dividends

We have never paid any cash dividends on our capital stock and have no current plans to pay any cash dividends. Our current policy is to retain any future earnings for use in our business.

Issuer Purchases of Equity Securities

PeriodTotal Number
 of Shares 
Purchased		Average
Price Paid
per Share		Total Number of 
Shares 
Purchased as Part of Publicly Announced Plans or Programs		Approximate 
Dollar Value of 
Shares that
May Yet Be 
Purchased
Under the Plans
or Programs
(in millions) (a), (b)
October 1, 2023 through October 31, 2023
— $— — $492.8 
November 1, 2023 through November 30, 2023
649,918 64.76 649,918 450.7 
December 1, 2023 through December 31, 2023
5,333,315 75.41 5,333,315 1,048.5 
Total5,983,233 74.25 5,983,233 
(a)    In July 2022, the Board of Directors approved a stock repurchase program providing for up to $1.5 billion of repurchases of our common stock, effective July 28, 2022. In December 2023, the Board of Directors approved an additional $1.0 billion of repurchases under this program. Repurchases under the program may be made on the open market, including pursuant to a Rule 10b5-1 plan, and in privately negotiated transactions. The repurchase program does not have an expiration date.
(b)    In December 2023, we entered into a $400.0 million accelerated share repurchase ("ASR") agreement and received, on December 12, 2023, an initial delivery of 4.6 million shares of our common stock, representing approximately 80 percent of the total contract value. The ASR concluded and on December 29, 2023 we received an additional 0.7 million shares. Shares purchased pursuant to the ASR agreement are presented in the table above in the periods in which they were received.
25
Performance Graph

The following graph compares the performance of our common stock with that of the S&P 500 Index and the S&P 500 Health Care Equipment Index. The cumulative total return listed below assumes an initial investment of $100 at the market close on December 31, 2018 and reinvestment of dividends. Stockholder returns over the indicated period should not be considered indicative of future stockholder returns.
429
Total Cumulative Return
20192020202120222023
Edwards Lifesciences$152.31 $178.68 $253.74 $146.13 $149.34 
S&P 500131.49 155.68 200.37 164.08 207.21 
S&P 500 Health Care Equipment129.32 152.12 181.56 147.32 160.64 

Item 6.    [Reserved]


26
Item 7.    Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis presents the factors that had a material effect on our results of operations during the two years ended December 31, 2023. Also discussed is our financial position as of December 31, 2023 and our consolidated cash flows for 2023 compared to 2022. You should read this discussion in conjunction with the historical consolidated financial statements and related notes included elsewhere in this Form 10-K. For a discussion related to the results of operations for 2022 compared to 2021 and a discussion related to our consolidated cash flows for 2022 compared to 2021, refer to Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2022 Annual Report on Form 10–K filed with the Securities and Exchange Commission on February 13, 2023.

Overview

We are the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world's leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care. We conduct operations worldwide and are managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Our products are categorized into the following groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care. On December 7, 2023, we announced our intention to complete a tax-free spin-off of our Critical Care product group around the end of 2024. The planned separation will enable us to pursue expanded opportunities for TAVR, TMTT, and Surgical patients, as well as new investments in interventional heart failure technologies.

Financial Highlights and Market Update
812813
COVID-19 and Macroeconomic Uncertainties

While conditions related to the COVID-19 pandemic have improved compared to 2022, we have continued to experience the impacts of the COVID-19 pandemic in 2023, particularly in Japan and disruptions related to staffing shortages in the United States and Europe. We continued to remain fully committed to our patient-focused innovation strategy, and our teams were relentless in doing the right things for patients. Our priority has been to maintain access for patients to our life-saving technologies while providing continuous front-line support to our clinician partners, and protecting the well-being of our employees. We expect to continue to experience adverse effects related to COVID-19 for some time, particularly as hospital systems continue experiencing budget constraints and staffing shortages, the supply chains continue to adjust to the market, and medical procedure rates and demand for our products continue to fluctuate as the medical system rebalances its infrastructure and resources in a post-COVID-19 market.

27
In addition to the impacts described above, the global economy, including the financial and credit markets, continues to experience volatility and disruptions, including conditions impacting inflation, credit and capital markets, interest rates, and factors affecting global economic stability and the political environment relating to health care. The severity and duration of the impact of these conditions on our business cannot be predicted. See Item 1A, "Risk Factors," for additional information.

Financial Highlights

Despite the challenges to our business due to COVID-19 and macroeconomic headwinds, our net sales for 2023 were $6.0 billion, representing an increase of $622.4 million over 2022, driven by sales growth of our TAVR products.

Our gross profit increased in 2023, driven by our sales growth. Gross profit as a percentage of sales decreased primarily due to the impact of foreign currency exchange rate fluctuations. The decrease in our net income and diluted earnings per share in 2023 was driven primarily by an after-tax charge of $134.9 million related to an intellectual property agreement. See Note 3 to the "Consolidated Financial Statements" for further information.

Healthcare Environment, Opportunities, and Challenges

The medical technology industry is highly competitive and continues to evolve. Our success is measured both by the development of innovative products and the value we bring to our stakeholders. We are committed to developing new technologies and providing innovative patient care, and we are committed to defending our intellectual property in support of those developments. Our vision for growth is to treat patients with both valvular and non-valvular structural heart disease, such as heart failure, which is a natural progression of the disease for many patients suffering from aortic stenosis and mitral and tricuspid regurgitation. In 2023, we invested 17.8% of our net sales in research and development. The following is a summary of important developments since January 1, 2023:

•we launched the Edwards SAPIEN 3 Ultra RESILIA valve in Japan;
•we received CE Mark approval for the Edwards SAPIEN 3 Ultra RESILIA valve in Europe;
•we received CE Mark approval for the EVOQUE tricuspid valve replacement system for the transcatheter treatment of eligible patients with tricuspid regurgitation and United States Food and Drug Administration ("FDA") approval for the treatment of tricuspid regurgitation, making it the world's first transcatheter valve replacement therapy to receive regulatory approval to treat tricuspid regurgitation;
•we received approval in Japan for PASCAL Precision to treat patients with degenerative mitral regurgitation;
•we received CE Mark approval for our MITRIS RESILIA surgical mitral valve;
•we completed enrollment in the ENCIRCLE Trial, the first pivotal trial for our transfemoral mitral replacement therapy, SAPIEN M3;

•we received FDA approval for a SAPIEN M3 continued access program;

•we restarted enrollment in our pivotal trial, ALLIANCE, designed to study our next generation TAVR technology, SAPIEN X4;

•we completed enrollment in PROGRESS, a pivotal trial studying the treatment of moderate aortic stenosis patients;
•we completed the enrollment of the full cohort of the TRISCEND II pivotal trial of the EVOQUE replacement system; and

•we announced our intention to complete a tax-free spin-off of our Critical Care product group around the end of 2024. The planned separation will enable sharpened focus as we pursue expanded opportunities for TAVR, TMTT, and Surgical patients, as well as new investments in interventional heart failure technologies.

We are dedicated to generating robust clinical, economic, and quality-of-life evidence increasingly expected by patients, clinicians, and payors in the current healthcare environment, with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes.

28
Results of Operations

Net Sales by Geographic Region
(dollars in millions)
 Years Ended December 31,Change
 20232022$%
United States$3,508.7 $3,132.6 $376.1 12.0 %
Europe1,334.5 1,174.8 159.7 13.6 %
Japan452.4 473.6 (21.2)(4.5)%
Rest of World709.2 601.4 107.8 17.9 %
Outside of the United States2,496.1 2,249.8 246.3 10.9 %
Total net sales$6,004.8 $5,382.4 $622.4 11.6 %

Net sales outside of the United States include the impact of foreign currency exchange rate fluctuations. The impact of foreign currency exchange rate fluctuations on net sales is not necessarily indicative of the impact on net income due to the corresponding effect of foreign currency exchange rate fluctuations on international manufacturing and operating costs, and our hedging activities. For more information, see "Quantitative and Qualitative Disclosures About Market Risk."

Net Sales by Product Group
(dollars in millions)
 Years Ended December 31,Change
 2023 2022$%
Transcatheter Aortic Valve Replacement$3,879.8  $3,518.2  $361.6 10.3 %
Transcatheter Mitral and Tricuspid Therapies197.6 116.1 81.5 70.1 %
Surgical Heart Valve Therapy999.3  893.1  106.2 11.9 %
Critical Care928.1  855.0  73.1 8.5 %
Total net sales$6,004.8  $5,382.4  $622.4 11.6 %

Transcatheter Aortic Valve Replacement
654
29
The increase in net sales of TAVR products was driven by:

•higher sales of the Edwards SAPIEN platform in 2023, primarily the Edwards SAPIEN 3 Ultra RESILIA valve in the United States and Japan, and the Edwards SAPIEN 3 Ultra valve in Europe and Rest of World;

partially offset by:

•foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $11.3 million primarily due to the weakening of the Japanese yen against the United States dollar, partially offset by the strengthening of the Euro against the United States dollar.

In March 2023, we launched the Edwards SAPIEN 3 Ultra RESILIA valve in Japan. In July 2023, we announced the restart of enrollment in our pivotal trial, ALLIANCE, designed to study our next generation TAVR technology, SAPIEN X4. In January 2024, we completed enrollment in our PROGRESS pivotal trial, studying the treatment of moderate aortic stenosis patients, and we received CE Mark approval for the Edwards SAPIEN 3 Ultra RESILIA valve in Europe.

Transcatheter Mitral and Tricuspid Therapies
1723
The increase in net sales of TMTT products was due primarily to the launch of our PASCAL system in the United States and its continued adoption in Europe.

During 2023, we continued to enroll the CLASP IIF pivotal trial with PASCAL for patients with functional mitral regurgitation. In mitral replacement, we completed enrollment in the ENCIRCLE pivotal trial for SAPIEN M3 and, in January 2024, we received FDA approval for a SAPIEN M3 continued access program. In tricuspid, we completed the enrollment of the full cohort of the TRISCEND II pivotal trial of the EVOQUE replacement system. In October 2023, we received CE Mark approval in Europe for EVOQUE and in February 2024 we received FDA approval for EVOQUE for the treatment of tricuspic regurgitation. In October 2023, we also received approval in Japan for PASCAL Precision to treat patients with degenerative mitral regurgitation. In addition, enrollment continued in the CLASP IITR pivotal trial with the PASCAL repair system in patients with symptomatic, severe tricuspid regurgitation.

30
Surgical Structural Heart
2555
Net sales of Surgical products increased in 2023 primarily due to sales of the INSPIRIS RESILIA aortic valve in the United States and Europe, and the MITRIS RESILIA valve in the United States. These increases were partially offset by the impact of foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $6.4 million, primarily due to the weakening of the Japanese yen against the United States dollar, partially offset by the strengthening of the Euro against the United States dollar.

We are continuing to enroll patients in our MOMENTIS clinical study to demonstrate the durability of RESILIA tissue in the mitral position. In October 2023, we received CE Mark approval for our MITRIS RESILIA mitral valve and have begun its launch in several European countries.

Critical Care
3481
The increase in net sales of Critical Care products was driven by:

•increased demand for our enhanced surgical recovery products and pressure monitoring products, primarily in the United States;
31

partially offset by:

•foreign currency exchange rate fluctuations, which decreased net sales outside of the United States by $10.3 million primarily due to the weakening of the Japanese yen against the United States dollar.

Gross Profit

4085
The decrease in gross profit as a percentage of net sales in 2023 compared to 2022 was driven primarily by a 2.5 percentage point decrease from the impact of foreign currency exchange rate fluctuations, primarily the weakening of the United States dollar against multiple currencies, partially offset by the strengthening of the United States dollar against the Japanese yen.

Selling, General, and Administrative ("SG&A") Expenses
4487
SG&A expenses increased in 2023 compared to 2022 due primarily to higher performance-based compensation and higher field-based personnel-related costs in support of our growth strategy and patient activation initiatives, primarily related to TAVR and TMTT in the United States and Europe.

32
Research and Development ("R&D") Expenses
4938
R&D expenses increased in 2023 compared to 2022 due primarily to continued investments in our transcatheter innovations, including increased clinical trial activity.

Intellectual Property Agreement and Litigation Expense

We incurred intellectual property agreement and litigation expenses of $203.5 million and $15.8 million during 2023 and 2022, respectively. On April 12, 2023, we entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") and recorded a $37.0 million charge in March 2023 and a $139.0 million charge in April 2023. For more information, see Note 3 to the "Consolidated Financial Statements."

Change in Fair Value of Contingent Consideration Liabilities, net

The change in fair value of contingent consideration liabilities resulted in gains of $26.2 million and $35.8 million during 2023 and 2022, respectively. The gains in 2023 were primarily due to changes in projected probabilities of milestone achievement. The gains in 2022 were due to changes in projected probabilities of milestone achievement and our decision in the third quarter of 2022 to exit our HARPOON surgical mitral repair system program.

Special Charge and Separation Costs

On December 7, 2023, we announced our intention to complete a tax-free spin-off of our Critical Care product group as a separate publicly traded company to Edwards Lifesciences' shareholders. We recorded a charge of $17.2 million, primarily related to costs incurred for consulting, legal, tax, and other professional advisory services associated with the planned spin-off.

In September 2022, in connection with our decision to exit our HARPOON surgical mitral repair system program, we recorded a charge of $62.3 million, of which $60.7 million was included in "Special Charges and Separation Costs" and $1.6 million was included in "Cost of Sales" on the consolidated statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology for $52.7 million and other related exit costs.

For more information, see Note 4 to the "Consolidated Financial Statements."

Interest Expense

Interest expense was $17.6 million and $19.2 million in 2023 and 2022, respectively. The decrease in interest expense resulted primarily from higher capitalized interest related to facilities construction.

33
Interest Income

Interest income was $67.2 million and $35.5 million in 2023 and 2022, respectively. The increase in interest income resulted primarily from a higher average yield on our investments.

Other Income, net

Other income was $14.4 million and $2.6 million in 2023 and 2022, respectively. The increase in other income was driven primarily by higher forward points from derivative instruments entered into to offset foreign currency revaluation of mainly global intercompany receivable and payable balances.

Provision for Income Taxes
($ in millions)
 Years Ended December 31,Change
 2023 2022$%
Provision for income taxes$198.7 $245.5 $(46.8)(19.1)%
Effective tax rate12.4 %13.9 %
Our effective income tax rate in 2023 and 2022 was 12.4% and 13.9%, respectively. Our effective tax rate for 2023 decreased in comparison to 2022 primarily due to the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations. On July 21, 2023, the IRS issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited our ability to claim credits on certain foreign taxes for tax years 2022 and 2023. In addition, there was a tax benefit from the Intellectual Property Agreement with Medtronic (see Note 3 to the "Consolidated Financial Statements"), partially offset by a reduced tax benefit from employee share-based compensation. The effective rates for 2023 and 2022 were lower than the federal statutory rate of 21% primarily due to (1) foreign earnings taxed at lower rates, (2) Federal and California research and development credits, and (3) the tax benefit from employee share-based compensation.

As of December 31, 2023, we had $211.3 million of gross California research expenditure tax credits that we expect to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, we expect that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future.

As of December 31, 2023, our gross uncertain tax positions were $583.9 million. We estimate that these liabilities would be reduced by $250.7 million from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amount of $333.2 million, if not required, would favorably affect our effective tax rate.

In the normal course of business, the Internal Revenue Service ("IRS") and other taxing authorities are in different stages of examining various years of our tax filings. During these audits we may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on our results of operations and financial condition. We strive to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While we have accrued for matters we believe are more likely than not to require settlement, the eventual outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, we may later decide to challenge any assessments, if made, and may exercise our right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. We believe that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from our uncertain tax positions.

We executed an Advance Pricing Agreement ("APA") in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS Examination for further consideration as part of the respective years' regular tax audits. In addition, we executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan
34
covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. We have filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The execution of some or all these APA renewals depends on many variables outside of our control.

The audits of our United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for certain transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years.

The audits of our material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, we continue to address matters in India for years from 2010 and on.

During 2021, we received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between our United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to our United States taxable income, which could result in additional tax expense for this period of approximately $230.0 million and represented a departure from a transfer pricing method we had previously agreed upon with the IRS. We have disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The opening conference was held with Appeals during March 2023 and discussions with Appeals continued into the third quarter of 2023. The Appeals process culminated in the third quarter of 2023 when we and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.

During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing our 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of our filing position is $269.3 million before consideration of interest and a repatriation tax offset.

We plan to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. We believe the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to our facts and, accordingly, have not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on our consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, we made a partial deposit in November 2022 to prevent the further accrual of interest on that portion of any additional tax we may ultimately be found to owe. We intend to make an additional deposit in the range of $200 million to $300 million with the IRS by the second quarter of 2024 in order to further mitigate interest on potential tax liabilities while we prepare to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS.

Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2023. We have considered this information, as well as information regarding the NOD and other proceedings described above, in our evaluation of our uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to our consolidated financial statements. Based on the information currently available and numerous possible outcomes, we cannot reasonably estimate what, if any, changes in our existing uncertain tax positions may occur in the next 12 months and, therefore, have continued to record the uncertain tax positions as a long-term liability.

We have received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $333.2 million ($0.55 per diluted share) and $247.4 million ($0.40 per diluted share) for the years ended December 31, 2023 and 2022, respectively.

Many countries are implementing some or all the Organisation for Economic Co-operation and Development’s Base Erosion and Profit Shifting Two-Pillar response to tax challenges arising from the digitalization of the global economy. While we continue to evaluate those countries’ implementations, we do not expect those implementations to have a material impact on our consolidated financial statements in 2024.


35
Liquidity and Capital Resources

Our sources of cash liquidity include cash and cash equivalents, short-term investments, cash from operations, and amounts available under credit facilities. We believe that these sources are sufficient to fund the current and long-term requirements of working capital, capital expenditures, and other financial commitments. However, we periodically consider various financing alternatives and may, from time to time, seek to take advantage of favorable interest rate environments or other market conditions.

The Tax Cuts and Jobs Act of 2017 (the "2017 Act") included extensive changes to the international tax regime. The 2017 Act required a deemed repatriation of post-1986 undistributed foreign earnings and profits. The one-time transition tax liability, as adjusted, is payable in three remaining annual installments, as outlined in the contractual obligations table presented under "Material Cash Requirements" below. As of December 31, 2023, we had a remaining tax obligation of $141.4 million related to the deemed repatriation. See Note 18 to the "Consolidated Financial Statements" for additional information about the one-time transition tax.

As of December 31, 2023, cash and cash equivalents and short-term investments held in the United States and outside of the United States were $1,097.1 million and $547.4 million, respectively. During 2023, we repatriated cash of $790.0 million. We assert that $1.0 billion of our foreign earnings continue to be permanently reinvested and our intent is to repatriate, in the future, $1.2 billion of our foreign earnings as of December 31, 2023. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $5.1 million.

We have a Five-year Credit Agreement (the "Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027. We may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year, subject to agreement of the lenders. As of December 31, 2023, no amounts were outstanding under the Credit Agreement.

In June 2018, we issued $600.0 million of 4.3% fixed-rate unsecured senior notes (the "2018 Notes") due June 15, 2028. We may redeem the 2018 Notes, in whole or in part, at any time and from time to time at specified redemption prices. As of December 31, 2023, we have not elected to redeem any of the 2018 Notes. As of December 31, 2023, the carrying value of the 2018 Notes was $597.0 million. For further information on our debt, see Note 11 to the "Consolidated Financial Statements."

From time to time, we repurchase shares of our common stock under share repurchase programs authorized by the Board of Directors. We consider several factors in determining when to execute share repurchases, including, among other things, expected dilution from stock plans, cash capacity, and the market price of our common stock. During 2023, under the Board authorized repurchase program, we repurchased a total of 11.3 million shares at an aggregate cost of $867.1 million. As of December 31, 2023, we had remaining authority to purchase $1.0 billion of our common stock under the share repurchase program.

On April 12, 2023, we entered into the Intellectual Property Agreement with Medtronic pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS, we paid Medtronic a one-time, lump sum payment of $300.0 million and are paying annual royalty payments that are tied to net sales of certain Edwards products. For more information, see Note 3 to the "Consolidated Financial Statements."

On February 28, 2023, we acquired a majority equity interest in a medical technology company. In addition, we amended and restated our previous option agreement with the medical technology company. The option agreement gives us the option to acquire the remaining equity interest in the medical technology company. For more information, see Note 8 to the "Consolidated Financial Statements."

We have purchased options to acquire and have agreed to provide promissory notes to various entities. These arrangements could result in additional cash outlays in the future should we decide to exercise the options or should the entities draw on the promissory notes. For further information, see Note 8 to the "Consolidated Financial Statements."

On July 12, 2020, we reached a settlement agreement with Abbott to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. The settlement agreement resulted in us recording an estimated $367.9 million pretax charge in June 2020 related to past damages. In addition, we will incur royalty expenses through May 2024 totaling an estimated $70 million. We made a one-time $100.0 million payment to Abbott in July 2020, and are making quarterly payments in subsequent years.
36
Consolidated Cash Flows - For the twelve months ended December 31, 2023 and 2022
4973 4977 4980
Net cash flows provided by operating activities of $895.8 million for 2023 decreased $322.4 million from 2022 due primarily to a $300.0 million payment in 2023 under the Intellectual Property Agreement, partially offset by a higher bonus payout in 2022 associated with 2021 performance.

Net cash provided by investing activities of $173.8 million in 2023 consisted primarily of net proceeds from investments of $627.9 million, partially offset by capital expenditures of $253.0 million and payments of $95.2 million to acquire a majority interest in another company. For further information, see Note 9 to the "Consolidated Financial Statements."

Net cash provided by investing activities of $252.3 million in 2022 consisted primarily of net proceeds from investments of $661.0 million, partially offset by capital expenditures of $244.6 million and payments of $109.6 million for options to acquire other companies. For further information, see Note 8 to the "Consolidated Financial Statements."

We currently anticipate making capital expenditures of approximately $300.0 million in 2024 as we continue to invest in our operations.
Net cash used in financing activities of $711.0 million in 2023 consisted primarily of purchases of treasury stock of $879.6 million, partially offset by proceeds from stock plans of $169.9 million.

Net cash used in financing activities of $1.6 billion in 2022 consisted primarily of purchases of treasury stock of $1.7 billion, partially offset by proceeds from stock plans of $146.4 million.

Material Cash Requirements

A summary of our material cash requirements as of December 31, 2023 is as follows (in millions):
 Payments Due by Period
Contractual ObligationsTotalYear 1
Years 2-3
Years 4-5		After 5
Years
Debt$600.0 $— $— $600.0 $— 
Operating leases105.8 26.8 35.9 22.4 20.7 
Interest on debt87.7 19.8 39.7 28.2 — 
Transition tax on unremitted foreign earnings and profits (a)141.4 62.8 78.6 — — 
Litigation settlement obligation (minimum payments)112.5 50.0 62.5 — — 
Pension obligations (b)2.7 2.7 — — — 
Purchase and other commitments (c)106.3 34.5 46.5 24.7 0.6 
Total contractual cash obligations (d), (e)$1,156.4 $196.6 $263.2 $675.3 $21.3 
_______________________________________________________________________________
(a)     As of December 31, 2023, we had recorded $141.4 million of income tax liabilities related to the one-time transition tax that resulted from the enactment of the 2017 Act. The transition tax is due in eight annual installments, with the first six installments paid in 2018 through 2023. The remaining installment amounts will be equal to 20% of the total liability payable in 2024 and 25% in 2025. See Note 18 to the "Consolidated Financial Statements" for additional information about the one-time transition tax.
37

(b)    The amount included in "Less Than 1 Year" reflects anticipated contributions to our various pension plans. Anticipated contributions beyond one year are not determinable. The total accrued benefit liability for our pension plans recognized as of December 31, 2023 was $36.2 million. This amount is impacted by, among other items, pension expense funding levels, changes in plan demographics and assumptions, and investment returns on plan assets. Therefore, we are unable to make a reasonably reliable estimate of the amount and period in which the liability might be paid, and did not include this amount in the contractual obligations table. See Note 14 to the "Consolidated Financial Statements" for further information.

(c)    Purchase and other commitments consists primarily of open purchase orders for the acquisition of goods and services in the normal course of business. We have excluded open purchase orders with a remaining term of less than one year. For certain purchase and other commitments, such as commitments to fund equity method or other investments, the timing of the payment is not certain. In these cases, the maturity dates in the table reflect our best estimates.

(d)    As of December 31, 2023, the gross liability for uncertain tax positions, including interest, was $655.2 million and relates primarily to transfer pricing matters. Based upon the information currently available and numerous possible outcomes, we cannot reasonably estimate the amount and period in which the liability might be paid, and did not include this amount in the contractual obligations table. In addition, we plan to vigorously contest through the judicial process the additional tax claimed by the IRS related to transfer pricing issues for the 2015 through 2017 tax years which may require additional cash outflows. See Note 18 to the "Consolidated Financial Statements" for further information on these matters.

(e)    We acquire assets still in development, enter into research and development arrangements, acquire businesses, and sponsor certain clinical trials that often require milestone, royalty, or other future payments to third-parties, contingent upon the occurrence of certain future events. In situations where we have no ability to influence the achievement of the milestone or otherwise avoid the payment, we have included those payments in the table above. However, we have excluded from the table contingent milestone payments and other contingent liabilities for which we cannot reasonably predict future payments or for which we can avoid making payment by unilaterally deciding to stop development of a product or cease progress of a clinical trial. We estimate that these contingent payments could be up to $1.6 billion if all milestones or other contingent obligations are met. This amount includes certain milestone-based contingent obligations that may be paid through a combination of cash and issuance of common stock, and certain sales-based royalties in excess of minimum payment thresholds related to litigation settlements.

Critical Accounting Policies and Estimates

Our results of operations and financial position are determined based upon the application of our accounting policies, as discussed in the notes to the "Consolidated Financial Statements." Certain of our accounting policies represent a selection among acceptable alternatives under GAAP. In evaluating our transactions, management assesses all relevant GAAP and chooses the accounting policy that most accurately reflects the nature of the transactions.

The application of accounting policies requires the use of judgments and estimates. These matters that are subject to judgments and estimates are inherently uncertain, and different amounts could be reported using different assumptions and estimates. Management uses its best estimates and judgments in determining the appropriate amount to reflect in the consolidated financial statements, using historical experience and all available information. We also use outside experts where appropriate. We apply estimation methodologies consistently from year to year.

We believe the following are the critical accounting policies which could have the most significant effect on our reported results and require subjective or complex judgments by management.

38
Revenue Recognition

When we recognize revenue from the sale of our products, the amount of consideration we ultimately receive varies depending upon the return terms, sales rebates, discounts, and other incentives that we may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The estimate of variable consideration requires significant judgment. We include estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers. Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. If the historical data and inventory estimates used to calculate the variable consideration do not approximate future activity, our financial position, results of operations, and cash flows could be impacted.

In addition, in limited circumstances, we may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, we defer recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer. Uncertain timing of next-generation product approvals, variability in product launch strategies, product recalls, and variation in product utilization all affect the estimates related to sales returns and could cause actual returns to differ from these estimates.

Our sales adjustment related to distributor rebates given to our United States distributors represents the difference between our sales price to the distributor and the negotiated price to be paid by the end-customer. We validate the distributor rebate accrual quarterly through either a review of the inventory reports obtained from our distributors or an estimate of the distributor's inventory. This distributor inventory information is used to verify the estimated liability for future distributor rebate claims based on historical rebates and contract rates. We periodically monitor current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

Intangible Assets and Long-lived Assets

We acquire intangible assets in connection with business combinations and asset purchases. The acquired intangible assets are recorded at fair value, which is determined based on a discounted cash flow analysis. The determination of fair value requires significant estimates, including, but not limited to, the amount and timing of projected future cash flows, the discount rate used to discount those cash flows, the assessment of the asset's life cycle, including the timing and expected costs to complete in-process projects, and the consideration of legal, technical, regulatory, economic, and competitive risks.

In-process research and development assets acquired in business combinations is reviewed for impairment annually, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. Additionally, management reviews the carrying amounts of other intangible and long-lived assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. The impairment reviews require significant estimates about fair value, including estimation of future cash flows, selection of an appropriate discount rate, and estimates of long-term growth rates.

Contingent Consideration

We record contingent consideration resulting from a business combination at its fair value on the acquisition date. We determine the fair value of the contingent consideration based primarily on the following factors:

•discount rates used to present value the projected cash flows;

•the probability of success of clinical events and regulatory approvals, and/or meeting commercial milestones; and

•projected payment dates.

On a quarterly basis, we revalue these obligations and record changes in their fair value as an adjustment to earnings. Changes to contingent consideration obligations can result from adjustments to discount rates, accretion of the discount rates due to the passage of time, changes in our estimates of the likelihood or timing of achieving development or commercial milestones, changes in the probability of certain clinical events, or changes in the assumed probability associated with regulatory approval.
39

The assumptions related to determining the value of contingent consideration include a significant amount of judgment, and any changes in the underlying estimates could have a material impact on the amount of contingent consideration expense recorded in any given period.

Income Taxes

The determination of our provision for income taxes requires significant judgment, the use of estimates, and the interpretation and application of complex tax laws. Realization of certain deferred tax assets, primarily tax credits, net operating loss and other carryforwards, is dependent upon generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in our effective tax rate on future earnings.

We have made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

We are subject to income taxes in the United States and numerous foreign jurisdictions. Our income tax returns are periodically audited by domestic and foreign tax authorities. These audits include questions regarding our tax filing positions, including the timing and amount of deductions and the allocation of income amongst various tax jurisdictions. We evaluate our tax positions and establish liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. Significant judgment is required in evaluating our uncertain tax positions, including estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes. We review these tax uncertainties quarterly and adjust the liability as events occur that affect potential liabilities for additional taxes, such as the progress of tax audits, lapsing of applicable statutes of limitations, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law.

For additional details on our income taxes, see Note 2 and Note 18 to the "Consolidated Financial Statements."

Legal Contingencies

We are or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits, including those related to products and services currently or formerly manufactured or performed by us, workplace and employment matters, matters involving real estate, our operations or health care regulations, or governmental investigations. We accrue for loss contingencies to the extent that we conclude that it is probable that a loss will be incurred and the amount of the loss can be reasonably estimated. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If we determine that a loss is possible, but not probable, and the range of the loss can be reasonably determined, then we disclose the range of the possible loss. These matters raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. As such, significant judgment is required in determining our legal accruals. We describe our legal proceedings in Note 19 to the "Consolidated Financial Statements."

New Accounting Standards

Information regarding new accounting standards is included in Note 2 to the "Consolidated Financial Statements."

Item 7A.    Quantitative and Qualitative Disclosures About Market Risk

Our business and financial results are affected by fluctuations in world financial markets, including changes in currency exchange rates and interest rates. We manage these risks through a combination of normal operating and financing activities and derivative financial instruments. We do not use derivative financial instruments for trading or speculative purposes.

Interest Rate Risk

Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio and our long-term debt. Our investment strategy is focused on preserving capital and supporting our liquidity requirements, while earning a reasonable market return. We invest in a variety of debt securities, primarily time deposits, commercial paper, United States and foreign government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. The market value of our investments may decline if current market interest rates rise. As of December 31, 2023, we had $963.2
40
million of investments in debt securities which had an average remaining term to maturity of 0.53 years. Taking into consideration the average maturity of our debt securities, a hypothetical 0.5% to 1.0% absolute increase in interest rates at December 31, 2023 would have resulted in a $3.2 million to $6.5 million decrease in the fair value of these investments. Such a decrease would only result in a realized loss if we choose or are forced to sell the investments before the scheduled maturity, which we currently do not anticipate.

For more information related to investments, see Note 7 to the "Consolidated Financial Statements."

We are also exposed to interest rate risk on our debt obligations. As of December 31, 2023, we had $600.0 million of 2018 Notes outstanding that carry a fixed rate, and also had available a $750.0 million Credit Agreement that carries a variable interest rate based on the Secured Overnight Financing Rate ("SOFR"). As of December 31, 2023, there were no borrowings outstanding under the Credit Agreement. Based on our December 31, 2023 variable debt levels, a hypothetical 1.0% absolute increase in floating market interest rates would not have impacted our interest expense since we had no variable debt outstanding during the year. As of December 31, 2023, a hypothetical 1.0% absolute increase in market interest rates would decrease the fair value of the fixed-rate debt by approximately $23.1 million. This hypothetical change in interest rates would not impact the interest expense on the fixed-rate debt.

For more information related to outstanding debt obligations, see Note 11 to the "Consolidated Financial Statements."

Currency Risk

We are exposed to foreign currency risks that arise from normal business operations. These risks include the translation of local currency balances and results of our non-United States subsidiaries into United States dollars, currency gains and losses related to intercompany and third-party transactions denominated in currencies other than a subsidiary's functional currency, and currency gains and losses associated with global intercompany receivable and payable balances. Our principal currency exposures relate to the Euro and the Japanese yen. Our objective is to minimize the volatility of our exposure to these risks through a combination of normal operating and financing activities and the use of derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts. The total notional amount of our derivative financial instruments entered into for foreign currency management purposes at December 31, 2023 was $2.1 billion. A hypothetical 10% increase (or decrease) in the value of the United States dollar against all hedged currencies would increase (or decrease) the fair value of these derivative contracts by $165.5 million. Any gains or losses on the fair value of derivative contracts would generally be offset by gains and losses on the underlying transactions and the net investment, so the net impact would not be significant to our financial condition or results of operations.

For more information related to outstanding foreign exchange contracts, see Note 2 and Note 13 to the "Consolidated Financial Statements."

Credit Risk

Derivative financial instruments involve credit risk in the event the financial institution counterparty should default. It is our policy to execute such instruments with major financial institutions that we believe to be creditworthy. At December 31, 2023, all derivative financial instruments were with bank counterparties assigned investment grade ratings by national rating agencies. We further diversify our derivative financial instruments among counterparties to minimize exposure to any one of these entities. We have not experienced a counterparty default and do not anticipate any non-performance by our current derivative counterparties.

Concentrations of Risk

We invest excess cash in a variety of debt securities, and diversify the investments amongst financial institutions. Our investment policy limits the amount of credit exposure to any one issuer.

In the normal course of business, we provide credit to customers in the health care industry, perform credit evaluations of these customers, and maintain allowances for potential credit losses, which have historically been adequate compared to actual losses. In 2023, we had no customers that represented 10% or more of our total net sales or accounts receivable, net.

41
Investment Risk

We are exposed to investment risks related to changes in the underlying financial condition and credit capacity of certain of our investments. As of December 31, 2023, we had $963.2 million of investments in debt securities of various companies, of which $462.7 million were long-term. In addition, we had $121.2 million of investments in equity instruments. Should these companies experience a decline in financial performance, financial condition or credit capacity, or fail to meet certain development milestones, a decline in the investments' value may occur, resulting in unrealized or realized losses. See Note 7 to the "Consolidated Financial Statements" for additional information.

42
Item 8.    Financial Statements and Supplementary Data


INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023

Financial Statements: 
For the Years Ended December 31, 2023, 2022, and 2021:
 
All other schedules are omitted as they are not applicable or the required information is furnished in the Consolidated Financial Statements or notes thereto. 

43
Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Edwards Lifesciences Corporation

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Edwards Lifesciences Corporation and its subsidiaries (the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of operations, of comprehensive income, of stockholders’ equity and of cash flows for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

44
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Uncertain Tax Positions Related to Intercompany Transfer Pricing

As described in Note 18 to the consolidated financial statements, the Company had an uncertain gross tax position liability balance of $583.9 million as of December 31, 2023, of which a majority is related to intercompany transfer pricing. As disclosed by management, the Company is subject to income taxes in the United States and numerous foreign jurisdictions. The Company’s income tax returns in these jurisdictions are periodically audited by domestic and foreign tax authorities. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income amongst various tax jurisdictions. Significant judgment is required by management in evaluating uncertain tax positions, including estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes.

The principal considerations for our determination that performing procedures relating to uncertain tax positions related to intercompany transfer pricing is a critical audit matter are the significant judgment by management when determining uncertain tax positions related to intercompany transfer pricing, including a high degree of estimation uncertainty in estimating the ultimate resolution to intercompany pricing controversies between countries when there are numerous possible outcomes. This in turn led to a high degree of auditor judgment, effort, and subjectivity in performing procedures to evaluate the accurate measurement of uncertain tax positions related to intercompany transfer pricing. In addition, the audit effort involved the use of professionals with specialized skill and knowledge.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to intercompany transfer pricing, and controls over measurement of the liability. These procedures also included, among others, (i) testing the information used in the calculation of the liability for uncertain tax positions related to intercompany transfer pricing, including US federal filing positions, and the related final income tax returns; (ii) testing the calculation of the liability for uncertain tax positions related to intercompany transfer pricing, by jurisdiction, including management’s assessment of the technical merits of tax positions and estimates of the amount of tax benefit expected to be sustained; (iii) testing management’s assessment of possible outcomes of uncertain tax positions related to intercompany transfer pricing controversies between countries; and (iv) evaluating the status and results of income tax audits with the relevant tax authorities. Professionals with specialized skill and knowledge were used to assist in the evaluation of the accurate measurement of the Company’s uncertain tax positions related to intercompany transfer pricing, including evaluating the reasonableness of management’s assessment of whether tax positions are more-likely-than not to be sustained and the amount of potential tax benefit to be realized, and the application of relevant tax laws.




/s/ PricewaterhouseCoopers LLP
Irvine, California
February 12, 2024

We have served as the Company’s auditor since 1999.
45
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED BALANCE SHEETS
(in millions, except par value)
December 31,
20232022
ASSETS
Current assets  
Cash and cash equivalents$1,144.0 $769.0 
Short-term investments (Note 7)500.5 446.3 
Accounts receivable, net of allowances of $8.3 and $7.9, respectively
775.1 643.0 
Other receivables61.8 56.1 
Inventories (Note 5)1,168.2 875.5 
Prepaid expenses146.8 110.0 
Other current assets239.3 195.9 
Total current assets4,035.7 3,095.8 
Long-term investments (Note 7)583.9 1,239.0 
Property, plant, and equipment, net (Note 5)1,749.4 1,632.8 
Operating lease right-of-use assets (Note 6)94.0 92.3 
Goodwill (Note 10)1,253.5 1,164.3 
Other intangible assets, net (Note 10)428.4 285.2 
Deferred income taxes754.6 484.0 
Other assets463.7 299.1 
Total assets$9,363.2 $8,292.5 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities  
Accounts payable$201.4 $201.9 
Accrued and other liabilities (Note 5)969.1 795.0 
Operating lease liabilities (Note 6)24.9 25.5 
Total current liabilities1,195.4 1,022.4 
Long-term debt (Note 11)597.0 596.3 
Contingent consideration liabilities (Note 12)— 26.2 
Taxes payable (Note 18)80.6 143.4 
Operating lease liabilities (Note 6)73.0 69.5 
Uncertain tax positions (Note 18)339.3 267.5 
Litigation settlement accrual (Note 3)94.2 143.0 
Other liabilities264.3 217.5 
Total liabilities2,643.8 2,485.8 
Commitments and contingencies (Notes 6, 11, and 19)
Stockholders' equity (Note 15)
  
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding
— — 
Common stock, $1.00 par value, 1,050.0 shares authorized, 650.5 and 646.3 shares issued, and 601.1 and 608.3 shares outstanding, respectively
650.5 646.3 
Additional paid-in capital2,274.4 1,969.3 
Retained earnings8,992.4 7,590.0 
Accumulated other comprehensive loss (Note 16)(242.8)(254.9)
Treasury stock, at cost, 49.4 and 38.0 shares, respectively
(5,024.5)(4,144.0)
Total Edwards Lifesciences Corporation stockholders' equity6,650.0 5,806.7 
Noncontrolling interest (Note 9)69.4 — 
Total stockholders' equity6,719.4 5,806.7 
Total liabilities and stockholders' equity$9,363.2 $8,292.5 
  
 The accompanying notes are an integral part of these consolidated financial statements.
46
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share information)
Years Ended December 31,
 202320222021
Net sales$6,004.8 $5,382.4 $5,232.5 
Cost of sales1,379.8 1,080.4 1,248.9 
Gross profit4,625.0 4,302.0 3,983.6 
Selling, general, and administrative expenses1,824.6 1,567.6 1,493.7 
Research and development expenses1,071.8 945.2 903.1 
Intellectual property agreement and litigation expense (Note 3)
203.5 15.8 20.6 
Change in fair value of contingent consideration liabilities (Note 12)(26.2)(35.8)(124.1)
Special charge and separation costs (Note 4)17.2 60.7 — 
Operating income1,534.1 1,748.5 1,690.3 
Interest expense17.6 19.2 18.4 
Interest income(67.2)(35.5)(17.4)
Other income, net (Note 17)(14.4)(2.6)(12.7)
Income before provision for income taxes1,598.1 1,767.4 1,702.0 
Provision for income taxes (Note 18)198.7 245.5 198.9 
Net income1,399.4 1,521.9 1,503.1 
Net loss attributable to noncontrolling interest (Note 9)
(3.0)— — 
Net income attributable to Edwards Lifesciences Corporation.$1,402.4 $1,521.9 $1,503.1 
Share information (Note 2):
   
Earnings per share attributable to Edwards Lifesciences Corporation:   
Basic$2.31 $2.46 $2.41 
Diluted$2.30 $2.44 $2.38 
Weighted-average number of common shares outstanding attributable to Edwards Lifesciences Corporation:  
Basic606.7 619.0 623.3 
Diluted609.4 624.2 631.2 

   The accompanying notes are an integral part of these consolidated financial statements.

47
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
 Years Ended December 31,
 202320222021
Net income$1,399.4 $1,521.9 $1,503.1 
Other comprehensive income (loss), net of tax (Note 16):
   
Foreign currency translation adjustments4.3 (46.3)(50.1)
Unrealized (loss) gain on hedges
(23.1)(5.9)57.4 
Unrealized pension (costs) credits
(9.9)13.7 11.6 
Unrealized gain (loss) on available-for-sale investments
40.8 (58.7)(15.5)
Other comprehensive income (loss), net of tax
12.1 (97.2)3.4 
Comprehensive income1,411.5 1,424.7 1,506.5 
Comprehensive loss attributable to noncontrolling interest
(3.0)— — 
Comprehensive income attributable to Edwards Lifesciences Corporation$1,414.5 $1,424.7 $1,506.5 
   
The accompanying notes are an integral part of these consolidated financial statements.

48
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
 Years Ended December 31,
 202320222021
Cash flows from operating activities   
Net income$1,399.4 $1,521.9 $1,503.1 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization144.9 139.6 134.8 
Non-cash operating lease cost28.2 27.2 28.5 
Stock-based compensation (Notes 2 and 15)139.4 126.8 109.3 
Impairment charges (Note 4)— 55.1 4.0 
Change in fair value of contingent consideration liabilities (Note 12)(26.2)(35.8)(124.1)
Loss (gain) on investments, net0.1 51.5 (36.8)
Deferred income taxes(272.1)(254.5)(41.4)
Other8.4 7.8 9.4 
Changes in operating assets and liabilities:  
Accounts and other receivables, net(141.2)(84.1)(91.1)
Inventories(289.0)(213.4)19.0 
Prepaid expenses and other current assets(81.8)0.1 7.9 
Accounts payable and accrued liabilities146.0 (21.4)195.2 
Intellectual property agreement accrual(33.0)(45.0)(29.2)
Income taxes(5.8)(5.6)62.0 
Long-term prepaid royalties (Note 3)(109.9)— — 
Other(11.6)(52.0)(18.5)
Net cash provided by operating activities895.8 1,218.2 1,732.1 
Cash flows from investing activities  
Capital expenditures(253.0)(244.6)(325.8)
Purchases of held-to-maturity investments (Note 7)(66.4)(353.5)(250.0)
Proceeds from sales and maturities of held-to-maturity investments (Note 7)97.9 419.5 138.0 
Purchases of available-for-sale investments (Note 7)(9.1)(315.8)(1,629.3)
Proceeds from sales and maturities of available-for-sale investments (Note 7)617.9 939.6 391.2 
Business combination, net of cash (Note 9)(95.2)— — 
Payments for acquisition options (Note 8)(30.0)(109.6)(13.1)
Issuances of notes receivable(62.5)(52.3)(5.1)
Collections of notes receivable— 18.0 20.0 
Investments in intangible assets(13.3)(20.2)(4.0)
Other(12.5)(28.8)(44.4)
Net cash provided by (used in) investing activities173.8 252.3 (1,722.5)
Cash flows from financing activities   
Proceeds from issuance of debt— — 5.2 
Payments on debt and finance lease obligations(0.3)(0.2)(7.0)
Purchases of treasury stock(879.6)(1,727.1)(512.8)
Proceeds from stock plans169.9 146.4 158.6 
Other(1.0)(3.6)(0.3)
Net cash used in financing activities(711.0)(1,584.5)(356.3)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash16.8 19.2 13.9 
Net increase (decrease) in cash, cash equivalents, and restricted cash375.4 (94.8)(332.8)
Cash, cash equivalents, and restricted cash at beginning of year772.6 867.4 1,200.2 
Cash, cash equivalents, and restricted cash at end of year (Note 5)$1,148.0 $772.6 $867.4 

The accompanying notes are an integral part of these consolidated financial statements.
49
EDWARDS LIFESCIENCES CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in millions)
 Common StockTreasury Stock
 SharesPar ValueSharesAmountAdditional Paid-in CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Edwards Lifesciences Corporation Stockholders' EquityNoncontrolling InterestTotal Stockholders'Equity
BALANCE AT DECEMBER 31, 2020636.4 $636.4 12.1 $(1,904.1)$1,438.1 $4,565.0 $(161.1)$4,574.3 $— $4,574.3 
Net income     1,503.1  1,503.1 1,503.1 
Other comprehensive loss, net of tax      3.4 3.4 3.4 
Common stock issued under equity plans
5.6 5.6   153.0   158.6 158.6 
Stock-based compensation expense    109.3   109.3 109.3 
Purchases of treasury stock  5.8 (512.8)  (512.8)(512.8)
BALANCE AT DECEMBER 31, 2021642.0 642.0 17.9 (2,416.9)1,700.4 6,068.1 (157.7)5,835.9 — 5,835.9 
Net income     1,521.9  1,521.9 — 1,521.9 
Other comprehensive income, net of tax      (97.2)(97.2)(97.2)
Common stock issued under equity plans
4.3 4.3   142.1   146.4 146.4 
Stock-based compensation expense    126.8   126.8 126.8 
Purchases of treasury stock  20.1 (1,727.1)  (1,727.1)(1,727.1)
BALANCE AT DECEMBER 31, 2022646.3 646.3 38.0 (4,144.0)1,969.3 7,590.0 (254.9)5,806.7 — 5,806.7 
Net income (loss)     1,402.4  1,402.4 (3.0)1,399.4 
Other comprehensive loss, net of tax      12.1 12.1 12.1 
Common stock issued under equity plans
4.2 4.2   165.7   169.9 169.9 
Stock-based compensation expense    139.4   139.4 139.4 
Purchases of treasury stock  11.4 (880.5)   (880.5)(880.5)
Changes to noncontrolling interest (Note 9)  — 72.4 72.4 
BALANCE AT DECEMBER 31, 2023650.5 $650.5 49.4 $(5,024.5)$2,274.4 $8,992.4 $(242.8)$6,650.0 $69.4 $6,719.4 
   
The accompanying notes are an integral part of these consolidated financial statements.
50
EDWARDS LIFESCIENCES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.    DESCRIPTION OF BUSINESS

Edwards Lifesciences Corporation ("Edwards Lifesciences," "Edwards," or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care. On December 7, 2023, the Company announced its intention to complete a tax-free spin-off of its Critical Care product group around the end of 2024. The planned separation will enable the Company to pursue expanded opportunities for TAVR, TMTT, and Surgical patients, as well as new investments in interventional heart failure technologies.

2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences, its wholly-owned subsidiaries, and variable interest entities for which the Company is the primary beneficiary (see Note 8). The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, which is recognized ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company
51
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.

The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2023 and 2022, $13.3 million and $10.6 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Liabilities." During 2023, the Company recognized as revenue $7.6 million that was included in the balance of deferred revenue as of December 31, 2022, and during 2022, the Company recognized as revenue $7.2 million that was included in the balance of deferred revenue as of December 31, 2021.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs

Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales." For the years ended December 31, 2023, 2022, and 2021, shipping costs of $99.4 million, $87.4 million, and $85.3 million, respectively, were included in "Selling, General, and Administrative Expenses."

52
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. These investments are valued at cost, which approximates fair value.

Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 3% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."

Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."

Debt securities in an unrealized loss position are written down to fair value through "Other Income, net" if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the length of time and the extent to which the security's fair value has been below cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any.

Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract inception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.

53
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).

The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. During the years ended December 31, 2023, 2022, and 2021, the Company allocated $96.9 million, $88.1 million, and $77.9 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2023 and 2022 were $45.7 million and $43.7 million, respectively.

At December 31, 2023 and 2022, $164.6 million and $128.6 million, respectively, of the Company's finished goods inventories were held on consignment.

Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.

Depreciation expense for property, plant, and equipment was $138.9 million, $133.9 million, and $127.0 million for the years ended December 31, 2023, 2022, and 2021, respectively.

Leases

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.
54
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)



Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.

Acquisitions

Businesses that the Company acquires are included in its results of operations as of the acquisition date. The purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. Contingent consideration obligations incurred in connection with a business combination are recorded at their fair values on the acquisition date and remeasured on a quarterly basis, with changes in their fair value recorded as an adjustment to earnings, until the related contingencies have been resolved. When the assets acquired do not meet the definition of a business combination, the transactions is accounted for as an asset acquisition. In an asset acquisition, the cost of the acquisition is allocated to the assets acquired and liabilities assumed based on their relative fair values. Upfront payments related to in-process research and development projects with no alternative future use are expensed upon acquisition.

Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2023, 2022, and 2021, the Company did not record any goodwill impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

In 2022, the Company recorded a $52.7 million impairment of certain developed technology and in-process research and development assets. For further information, see Note 4 and Note 9. In 2023 and 2021, the Company did not record any impairment loss related to its in-process research and development assets.
55
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)



Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.

Research and Development Costs

Research and development costs are charged to expense when incurred.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202320222021
Basic:   
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Basic earnings per share$2.31 $2.46 $2.41 
Diluted:
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Dilutive effect of stock plans2.7 5.2 7.9 
Dilutive weighted-average shares outstanding609.4 624.2 631.2 
Diluted earnings per share$2.30 $2.44 $2.38 

Outstanding stock options, unvested restricted stock units, and unvested market-based restricted stock units to purchase approximately 6.6 million, 3.6 million, and 1.8 million shares for the years ended December 31, 2023, 2022, and 2021,
56
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.

Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over each award's requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.

Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202320222021
Cost of sales$23.6 $22.8 $20.4 
Selling, general, and administrative expenses82.4 75.3 65.6 
Research and development expenses33.4 28.7 23.3 
Total stock-based compensation expense139.4 126.8 109.3 
Income tax benefit(24.1)(21.6)(18.9)
Total stock-based compensation expense, net of tax$115.3 $105.2 $90.4 

Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.

Derivatives

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies, resulting principally from intercompany and local currency transactions.

57
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)


All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Upon settlement, cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

New Accounting Standards Not Yet Adopted

In December 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.

In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is curently evaluating the impact the guidance will have on its consolidated financial statements.

In March 2023, the FASB issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial results or disclosures.

3.    INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE

The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $203.5 million, $15.8 million and $20.6 million during 2023, 2022 and 2021, respectively.

On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and is paying annual royalty payments that are tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April
58
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
3.    INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE (Continued)
2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in April 2023 related to products currently in development.

4. SPECIAL CHARGE AND SEPARATION COSTS

On December 7, 2023, the Company announced its intention to complete a spin-off of its Critical Care product group as a separate publicly traded company to Edwards Lifesciences' shareholders. The proposed spin-off is intended to be a tax-free transaction for U.S. federal income tax purposes and is expected to be completed around the end of 2024, subject to the satisfaction of customary conditions including final approval by the Company's board of directors, receipt of a favorable opinion and Internal Revenue Service ruling with respect to the tax-free nature of the transaction, and the effectiveness of a registration statement on Form 10. The Company recorded a charge to its United States segment of $17.2 million, primarily related to costs incurred for consulting, legal, tax, and other professional advisory services associated with the planned spin-off.

In September 2022, the Company decided to exit its HARPOON surgical mitral repair system program. As a result, the Company recorded a charge to its United States segment of $62.3 million, of which $60.7 million was included in "Special Charge and Separation Costs" and $1.6 million was included in "Cost of Sales" on the consolidated statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology for $52.7 million (see Note 9 and Note 10) and other related exit costs. The Company believes that no additional contingent consideration is due and, in September 2022, recorded an $11.7 million contingent consideration gain associated with the exit (see Note 12).

5. OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS

Composition of Certain Financial Statement Captions

Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20232022
 (in millions)
Inventories  
Raw materials$252.6 $156.4 
Work in process220.1 177.4 
Finished products695.5 541.7 
$1,168.2 $875.5 
Property, plant, and equipment, net  
Land$116.4 $116.3 
Buildings and leasehold improvements1,234.2 1,189.2 
Machinery and equipment775.8 697.6 
Equipment with customers37.9 37.4 
Software87.2 87.5 
Construction in progress355.3 255.2 
2,606.8 2,383.2 
Accumulated depreciation(857.4)(750.4)
$1,749.4 $1,632.8 
Accrued and other liabilities  
Employee compensation and withholdings$371.2 $268.7 
Accrued rebates131.4 116.1 
Property, payroll, and other taxes63.0 45.6 
59
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
5. OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Continued)
 As of December 31,
 20232022
 (in millions)
Research and development accruals74.1 66.9 
Legal and insurance (Notes 3 and 19)30.7 28.1 
Litigation settlement69.1 53.3 
Taxes payable59.3 50.6 
Fair value of derivatives15.2 20.7 
Accrued marketing expenses15.0 17.0 
Accrued professional services8.8 6.6 
Accrued realignment reserves12.3 15.6 
Accrued relocation costs19.2 25.2 
Accrued warranties10.08.4 
Other accrued liabilities89.8 72.2 
$969.1 $795.0 
Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202320222021
Cash paid during the year for:   
Interest$19.9 $19.3 $20.2 
Income taxes$470.1 $504.1 $182.5 
Amounts included in the measurement of operating lease liabilities$28.8 $28.1 $31.9 
Non-cash investing and financing transactions:   
Right-of-use assets obtained in exchange for new lease liabilities$29.3 $31.9 $28.7 
Capital expenditures accruals$45.5 $42.6 $54.3 
Conversion of notes receivable to equity investment$— $— $21.5 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202320222021
Cash and cash equivalents$1,144.0 $769.0 $862.8 
Restricted cash included in other current assets3.3 0.5 1.5 
Restricted cash included in other assets0.7 3.1 3.1 
Total cash, cash equivalents, and restricted cash$1,148.0 $772.6 $867.4 

Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.

6. LEASES

The Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 17 years, some of which include options to extend or terminate the leases.

60
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
6. LEASES (Continued)

Operating lease costs for the years ended December 31, 2023, 2022, and 2021 were $30.1 million, $28.8 million, and $29.7 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2023, 2022, and 2021.

Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20232022
Operating lease right-of-use assets$94.0 $92.3 
Operating lease liabilities, current portion$24.9 $25.5 
Operating lease liabilities, long-term portion73.0 69.5 
Total operating lease liabilities
$97.9 $95.0 

Maturities of operating lease liabilities at December 31, 2023 were as follows (in millions):
2024$26.8 
202519.6 
202616.3 
202712.9 
20289.5 
Thereafter20.7 
Total lease payments
105.8 
Less: imputed interest
(7.9)
Total lease liabilities
$97.9 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20232022
Weighted-average remaining lease term (in years)5.96.4
Weighted-average discount rate2.3 %1.8 %

As of December 31, 2023, the Company had additional operating lease commitments of $16.0 million for office spaces that have not yet commenced.

61
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

7. INVESTMENTS

Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2023December 31, 2022
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$64.5 $— $— $64.5 $96.0 $— $— $96.0 
Available-for-sale
U.S. government and agency securities$72.7 $0.1 $(2.8)$70.0 $137.7 $— $(6.1)$131.6 
Asset-backed securities192.1 — (7.8)184.3 380.6 — (14.0)366.6 
Corporate debt securities658.5 — (16.7)641.8 1,028.1 — (47.8)980.3 
Municipal securities2.8 — (0.2)2.6 2.7 — (0.2)2.5 
$926.1 $0.1 $(27.5)$898.7 $1,549.1 $— $(68.1)$1,481.0 

The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2023 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$64.5 $64.5 $443.2 $436.0 
Due after 1 year through 5 years— — 267.8 257.0 
Due after 10 years— — 0.9 0.9 
Instruments not due at a single maturity date (a)
— — 214.2 204.8 
$64.5 $64.5 $926.1 $898.7 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.

Actual maturities may differ from the contractual maturities due to call or prepayment rights.

62
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. INVESTMENTS (Continued)

The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2023 and 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2023
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$— $— $67.1 $(2.8)$67.1 $(2.8)
Asset-backed securities10.2 (1.8)172.7 (6.0)182.9 (7.8)
Corporate debt securities25.0 (0.1)601.3 (16.6)626.3 (16.7)
Municipal securities— — 2.6 (0.2)2.6 (0.2)
$35.2 $(1.9)$843.7 $(25.6)$878.9 $(27.5)
December 31, 2022
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$61.6 $(1.5)$69.5 $(4.6)$131.1 $(6.1)
Asset-backed securities103.3 (1.3)254.6 (12.7)357.9 (14.0)
Corporate debt securities189.0 (5.3)784.8 (42.5)973.8 (47.8)
Municipal securities— — 2.5 (0.2)2.5 (0.2)
$353.9 $(8.1)$1,111.4 $(60.0)$1,465.3 $(68.1)

The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of December 31, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.

Investments in Unconsolidated Entities

The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:

 December 31,
 20232022
 (in millions)
Equity method investments  
Carrying value of equity method investments$33.6 $21.4 
Equity securities  
Carrying value of non-marketable equity securities87.6 86.9 
Total investments in unconsolidated entities$121.2 $108.3 

63
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
7. INVESTMENTS (Continued)

During 2023, the Company made $12.1 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs, and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. During 2023, the Company did not record any upward or downward adjustments due to observable price changes or impairments. During 2022, the Company recorded an upward adjustment of $0.8 million based on observable price changes and a downward adjustment of $0.5 million due to an impairment. As of December 31, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes.

During 2023, 2022, and 2021, the gross realized gains or losses from sales of available-for-sale investments were not material.

8.    INVESTMENTS IN VARIABLE INTEREST ENTITIES

The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.

Consolidated VIEs

In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. See Note 9 for additional information.

Unconsolidated VIEs

Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.

In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option to acquire the medical device company, of which $30.0 million had been paid as of December 31, 2023. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. The option and the note are included in "Other Assets" on the consolidated balance sheet as of December 31, 2023.

In August 2022, the Company entered into an option agreement with a medical device company. Under the option agreement, Edwards paid $47.1 million for an option to acquire the medical device company. The $47.1 million option is included in "Other Assets" on the consolidated balance sheets.

In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $32.5 million had been advanced as of December 31, 2023. In addition, in 2019, the Company paid $35.0 million for an option to acquire the medical device company. The $35.0 million option and the $32.5 million note receivable are included in "Other Assets" on the consolidated balance sheets.
64
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
8.    INVESTMENTS IN VARIABLE INTEREST ENTITIES (Continued)

In May 2022, the Company entered into an option agreement with a medical technology company. Under the option agreement, Edwards paid $60.0 million for an option to acquire the medical technology company, of which $10.0 million was paid in 2021. In addition, during 2023, the Company entered into two promissory notes totaling $25.0 million with the medical technology company. The $60.0 million option and the $25.0 million note receivable are included in "Other Assets" on the consolidated balance sheets.

In April 2021, the Company entered into a $45.0 million secured promissory note agreement with a privately-held medical device company (the "Investee"), of which $30.0 million had been advanced as of December 31, 2023. Also in 2021, the Company invested $39.3 million, included in "Long-term Investments," in the Investee's preferred equity securities and paid $13.1 million, included in "Other Assets," for an option to acquire the Investee. Pursuant to the agreement, the Company may be required to invest up to an additional $6.5 million in the Investee's preferred equity securities and up to an additional $14.4 million for the option to acquire the Investee.

In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 7.

9.    BUSINESS COMBINATIONS

On February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction. The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company.

The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination. Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):

Assets$8.1 
Goodwill (b)
133.2 
In-process research and development136.6 
Liabilities assumed(1.7)
Deferred tax liabilities(28.0)
Fair value of net assets acquired248.2 
Less: Noncontrolling interest (a)
(72.4)
Total purchase price
175.8 
Less: cash acquired(6.8)
Total purchase price, net of cash acquired (b)
$169.0 
_______________________________________
(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.
(b)     Includes $22.5 million paid in a previous year under option agreements, $5.3 million for the settlement of a pre-existing note, and $46.0 million of cash paid directly to the acquired company which was included in Edwards' consolidated cash balance and offset against goodwill post acquisition.

Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s Rest of World segment and is not deductible for tax purposes.

65

EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
9.    BUSINESS COMBINATIONS (Continued)
Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.

In-process Research and Development Assets

The business combination referred to above and the Company's previous acquisitions of Harpoon Medical, Inc ("Harpoon") on December 1, 2017 and CardiAQ Valve Technologies, Inc. ("CardiAQ") on July 3, 2015 included the acquisition of in-process research and development assets. The in-process research and development assets were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals.

The discount rate used to determine the fair value of the in-process research and development assets acquired from the medical technology company referred to above was 13.0%. The valuation assumed $68.6 million of additional research and development expenditures would be incurred prior to the date of product introduction and net cash inflows were modeled to commence in 2028. Upon completion of development, the underlying research and development intangible asset will be amortized over its estimated useful life.

In September 2022, the Company decided to exit the HARPOON program and recorded a $28.1 million impairment charge to fully write off the in-process research and development assets. See Note 4 for further information.

The valuation for CardiAQ assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures. Net cash inflows commenced in Europe in late 2023 and the associated in-process research and development assets of $69.0 million were reclassified to developed technology. Net cash inflows in the United States are now expected to commence in 2024.

Upon completion of development, the underlying research and development intangible assets will commence amortization over their estimated useful lives.

10.    GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.

The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2023 and 2022 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2021
$773.7 $63.0 $331.2 $1,167.9 
Currency translation adjustment— (3.6)— (3.6)
Goodwill at December 31, 2022
773.7 59.4 331.2 1,164.3 
Goodwill acquired during the year (Note 9)— — 87.2 87.2 
Currency translation adjustment— 2.0 — 2.0 
Goodwill at December 31, 2023
$773.7 $61.4 $418.4 $1,253.5 
66
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
10.    GOODWILL AND OTHER INTANGIBLE ASSETS (Continued)


Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20232022
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents9.9$119.3 $(87.6)$31.7 $205.5 $(185.0)$20.5 
Developed technology10.8197.6 (61.9)135.7 128.1 (57.9)70.2 
Other10.012.3 (8.9)3.4 12.2 (7.7)4.5 
10.6329.2 (158.4)170.8 345.8 (250.6)95.2 
Indefinite-lived intangible assets      
In-process research and development257.6 — 257.6 190.0 — 190.0 
$586.8 $(158.4)$428.4 $535.8 $(250.6)$285.2 

Amortization expense related to other intangible assets for the years ended December 31, 2023, 2022, and 2021 was $6.1 million, $5.7 million, and $7.7 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2024$5.8 
20257.0 
20269.4 
202710.9 
202814.8 

11.    DEBT AND CREDIT FACILITIES

In June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets.

The following is a summary of the Notes as of December 31, 2023 and 2022:
 December 31,
 2023 2022
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.3% Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(0.7)  (0.9) 
Unamortized debt issuance costs(2.3)(2.8)
Total carrying amount$597.0   $596.3  

67
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
11.    DEBT AND CREDIT FACILITIES (Continued)

As of December 31, 2023 and 2022, the fair value of the Notes was $591.6 million and $575.2 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 12). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the Notes.

The Company has a Five-Year Credit Agreement ("the Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027. Subject to certain terms and conditions and the agreement of the lenders, the Company may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year. Borrowings under the Credit Agreement bear interest at a variable rate based on the Secured Overnight Financing Rate ("SOFR"), plus a spread ranging from 0.785% to 1.3%, depending on the leverage ratio or credit rating, as defined in the Credit Agreement, plus a 0.1% credit spread adjustment. The Company will also pay a facility fee ranging from 0.09% to 0.20%, depending on the Company's leverage ratio or credit rating, on the entire credit commitment available, whether or not drawn. The facility fee is expensed as incurred. During 2023, under the Credit Agreement, the spread over SOFR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.1 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2023 and 2022, there were no borrowings outstanding. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants under the Credit Agreement at December 31, 2023.

The weighted-average interest rate under all debt obligations, including the impact of the cross currency swap contract (see Note 13), was 3.4% at both December 31, 2023 and 2022.
12.    FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.

Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include Notes payable. See Note 11 for further information on the fair value of the Notes payable.

68
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    FAIR VALUE MEASUREMENTS (Continued)
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2023 and 2022 (in millions):

December 31, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$579.2 $— $— $579.2 
Available-for-sale investments: 
Corporate debt securities— 641.8 — 641.8 
Asset-backed securities— 184.3 — 184.3 
United States government and agency securities— 70.0 — 70.0 
Municipal securities— 2.6 — 2.6 
Investments held for deferred compensation plans125.8 — — 125.8 
Derivatives— 47.1 — 47.1 
$705.0 $945.8 $— $1,650.8 
Liabilities    
Derivatives$— $15.2 $— $15.2 
Other— — 10.3 10.3 
$— $15.2 $10.3 $25.5 
December 31, 2022
Assets
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments: 
Corporate debt securities— 980.3 — 980.3 
Asset-backed securities— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other— — 14.0 14.0 
$— $27.2 $40.2 $67.4 

69
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
12.    FAIR VALUE MEASUREMENTS (Continued)
Cash Equivalents and Available-for-sale Investments

Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in a variety of money market and mutual funds related to its deferred compensation plans. The fair values of these investments are based on quoted market prices.

Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. As of December 31, 2023, the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was zero.

The following table summarizes the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis for the years ended December 31, 2023 and 2022 (in millions):

Contingent ConsiderationOtherTotal
Fair value, December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(35.8)— (35.8)
Fair value, December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)(3.7)(29.9)
Fair value, December 31, 2023
$— $10.3 $10.3 


70
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

13.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
As of December 31,
 20232022
 (in millions)
Foreign currency forward exchange contracts$1,786.2 $1,678.4 
Cross currency swap contracts300.0 300.0 

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
As of December 31,
 Balance Sheet Location20232022
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$23.7 $24.9 
Cross currency swap contractsOther assets$23.4 $40.6 
Liabilities   
Foreign currency contractsAccrued and other liabilities$15.2 $20.7 
Foreign currency contractsOther liabilities$— $6.5 

The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$23.7 $— $23.7 $(9.4)$— $14.3 
Cross currency swap contracts$23.4 $— $23.4 $— $— $23.4 
Derivative Liabilities      
Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
December 31, 2022      
Derivative Assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative Liabilities      
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
 
71
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2023202220232022
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$29.2 $81.7 Cost of sales$58.9 $88.4 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
2023202220232022
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$(17.3)$21.6 Interest income, net$6.9 $7.0 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202320222021
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$13.9 $(3.9)$11.6 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202320222021
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$7.4 $44.0 $27.4 

72
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
13.    DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Continued)
The following tables present the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2023
 Cost of salesOther income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,379.8)$14.4 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— (9.2)
Derivatives designated as hedging instruments
— 9.2 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— 4.7 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
58.9 — 
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2022
 Cost of salesOther income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.4)$2.6 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— 5.5 
Derivatives designated as hedging instruments
— (5.5)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— 1.6 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
88.4 — 
The Company expects that during 2024 it will reclassify to earnings a $2.7 million gain currently recorded in "Accumulated Other Comprehensive Loss." For the years ended December 31, 2023, 2022, and 2021, the Company did not record any gains or losses due to hedge ineffectiveness.

73
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

14.    EMPLOYEE BENEFIT PLANS

Defined Benefit Plans

The Company maintains defined benefit pension plans in Japan and certain European countries.
 Years Ended December 31,
 20232022
(in millions)
Change in projected benefit obligation:  
Beginning of year$94.1 $117.9 
Service cost4.3 5.5 
Interest cost2.3 0.5 
Participant contributions1.9 1.6 
Actuarial loss (gain)9.9 (22.6)
Benefits paid(3.8)(0.6)
Plan amendment(0.4)(0.3)
Settlements and curtailment gain— (1.8)
Currency exchange rate changes and other3.4 (6.1)
End of year$111.7 $94.1 
Change in fair value of plan assets:  
Beginning of year$70.6 $76.9 
Actual return on plan assets0.8 (4.9)
Employer contributions3.5 3.5 
Participant contributions1.9 1.6 
Settlements— (1.8)
Benefits paid(3.8)(0.6)
Currency exchange rate changes and other2.5 (4.1)
End of year$75.5 $70.6 
Funded Status  
Projected benefit obligation$(111.7)$(94.1)
Plan assets at fair value75.5 70.6 
Underfunded status$(36.2)$(23.5)
Net amounts recognized on the consolidated balance sheet:  
Other liabilities$36.2 $23.5 
Accumulated other comprehensive loss, net of tax:  
Net actuarial (loss) gain$(10.3)$1.5 
Net prior service credit5.2 5.3 
Deferred income tax benefit (expense)0.9 (1.1)
Total$(4.2)$5.7 

The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $106.8 million and $86.7 million as of December 31, 2023 and 2022, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2023 and 2022.

74
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    EMPLOYEE BENEFIT PLANS (Continued)
The components of net periodic pension benefit cost are as follows (in millions):

 Years Ended December 31,
 202320222021
Service cost, net$4.3 $5.5 $6.5 
Interest cost2.3 0.5 0.4 
Expected return on plan assets(2.7)(1.5)(1.1)
Settlements and curtailment gain— 0.1 — 
Amortization of actuarial loss— 0.5 1.7 
Amortization of prior service credit (0.8)(0.7)(0.7)
Net periodic pension benefit cost$3.1 $4.4 $6.8 

Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.

To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.

The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20232022
Discount rate1.8 %2.5 %
Rate of compensation increase2.9 %2.9 %
Cash balance interest crediting rate1.5 %1.5 %
Social securities increase1.8 %1.8 %
Pension increase2.2 %2.2 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202320222021
Discount rate2.5 %0.5 %0.3 %
Expected return on plan assets3.7 %2.1 %1.5 %
Rate of compensation increase2.9 %2.6 %2.6 %
Cash balance interest crediting rate1.5 %1.5 %2.5 %
Social securities increase1.8 %1.6 %1.6 %
Pension increase2.2 %1.8 %1.8 %

75
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    EMPLOYEE BENEFIT PLANS (Continued)
Plan Assets

The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.

The Company's Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2023, by asset category, are as follows:
Equity securities31.3 %
Debt securities38.9 %
Real estate11.4 %
Other18.4 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2023 and 2022, by asset category, are as follows (in millions):
December 31, 2023Level 1Level 2Level 3Total
Asset Category    
Cash$2.0 $— $— $2.0 
Equity securities:    
United States equities2.6 — — 2.6 
International equities21.0 — — 21.0 
Debt securities:    
United States government bonds3.5 — — 3.5 
International government bonds26.0 — — 26.0 
Real estate— 8.7 — 8.7 
Mortgages— 4.0 — 4.0 
Insurance contracts— — 0.8 0.8 
Total plan assets measured at fair value
$55.1 $12.7 $0.8 $68.6 
Alternative investments measured at net asset value (a)6.9 
Total plan assets
$75.5 
76
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    EMPLOYEE BENEFIT PLANS (Continued)
 
December 31, 2022Level 1Level 2Level 3Total
Asset Category
Cash$3.6 $— $— $3.6 
Equity securities:
United States equities1.5 — — 1.5 
International equities17.5 — — 17.5 
Debt securities:
United States government bonds4.4 — — 4.4 
International government bonds25.6 — — 25.6 
Real estate— 7.6 — 7.6 
Mortgages— 3.5 — 3.5 
Insurance contracts— — 0.8 0.8 
Total plan assets $52.6 $11.1 $0.8 $64.5 
Alternative investments measured at net asset value (a)6.1 
Total plan assets $70.6 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.

The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2023 and 2022 (in millions):

 Insurance
Contracts
Balance at December 31, 2021$0.9 
Actual return on plan assets: 
Relating to assets still held at December 31, 2022
0.2 
Purchases, sales and settlements(0.2)
Currency exchange rate impact(0.1)
Balance at December 31, 20220.8 
Actual return on plan assets: 
Relating to assets still held at December 31, 2023
0.2 
Purchases, sales and settlements(0.2)
Balance at December 31, 2023$0.8 

Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.

77
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
14.    EMPLOYEE BENEFIT PLANS (Continued)
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2023, are expected to be paid (in millions):

2024$7.3 
20255.9 
20266.9 
20276.8 
20288.1 
2029-203339.0 

As of December 31, 2023, expected employer contributions for 2024 are $2.7 million.

Defined Contribution Plans

The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $51.0 million, $45.1 million, and $38.6 million in 2023, 2022, and 2021, respectively.

The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $125.6 million and $112.6 million at December 31, 2023 and 2022, respectively.

15.    COMMON STOCK

Treasury Stock

In July 2022, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.5 billion of the Company's common stock, effective July 28, 2022. In December 2023, the Board of Directors approved an additional $1.0 billion of repurchases of the Company's common stock under this program. The repurchase program does not have an expiration date. Stock repurchased under these programs may be used to offset the impact of the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.

During 2023, 2022, and 2021, the Company repurchased 11.4 million, 20.1 million, and 5.8 million shares, respectively, at an aggregate cost of $880.5 million, $1,727.1 million, and $512.8 million, respectively, including shares purchased under a Rule 10b5-1 trading plan, the accelerated share repurchase ("ASR") agreements described below, and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.

78
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
15.    COMMON STOCK (Continued)
Accelerated Share Repurchase

During 2023 and 2022, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share
January 2022$250.0 1.9 $104.87 80 %February 20222.3 $110.31 
October 2022$750.0 8.3 $72.43 80 %December 202210.3 $72.91 
February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 
December 2023$400.0 4.6 $70.31 80 %December 20235.3 $72.91 

The ASR agreements were each accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "Additional Paid-in Capital" and subsequently, upon settlement, was transferred to "Treasury Stock" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.

Employee and Director Stock Plans

The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between three to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods, typically four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Under the Program, the number of shares of common stock authorized for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.

The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.

The Company has an employee stock purchase plan for United States employees and a plan for employees outside of the United States (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of purchase. Under the ESPP, employees can authorize the Company to withhold up to 15% of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside of the United States, to the extent permitted
79
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
15.    COMMON STOCK (Continued)
by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 50.4 million shares.

The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the United States Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.

The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
Years Ended December 31,
202320222021
Risk-free interest rate3.4 %3.0 %0.8 %
Expected dividend yieldNoneNoneNone
Expected volatility32.8 %31.4 %33.5 %
Expected term (years)5.15.05.0
Fair value, per share$30.97 $34.59 $28.90 

The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
Years Ended December 31,
202320222021
Risk-free interest rate4.6 %0.5 %0.1 %
Expected dividend yieldNoneNoneNone
Expected volatility31.5 %32.0 %36.6 %
Expected term (years)0.60.60.6
Fair value, per share$19.03 $28.18 $23.07 

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the years ended December 31, 2023, 2022, and 2021 included a risk-free interest rate of 3.6%, 2.9%, and 0.4%, respectively, and an expected volatility rate of 32.6%, 33.9%, and 34.4%, respectively.

80
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
15.    COMMON STOCK (Continued)
Stock option activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 2022
11.6 $63.67   
Options granted2.0 88.27   
Options exercised(2.2)38.54   
Options forfeited(0.4)97.32   
Outstanding as of December 31, 2023
11.0 71.90 3.5 years$136.9 
Exercisable as of December 31, 2023
7.3 61.68 2.4 years$135.5 
Vested and expected to vest as of December 31, 2023
10.5 70.91 3.4 years$136.7 

The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 2022
2.0 $92.30 
Granted1.1 89.03 
Vested(0.8)83.17 
Forfeited(0.2)99.82 
Nonvested as of December 31, 2023
2.1 94.35 



The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2023, 2022, and 2021 were $162.7 million, $264.5 million, and $359.8 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2023, 2022, and 2021, the Company received cash from exercises of stock options of $83.4 million, $64.8 million, and $82.2 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $35.9 million, $56.9 million, and $76.5 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2023, 2022, and 2021 were $41.3 million, $40.4 million, and $36.2 million, respectively.

As of December 31, 2023, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan subscription awards amounted to $224.9 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 31 months.

81
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

16.    ACCUMULATED OTHER COMPREHENSIVE LOSS

Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2023, 2022, and 2021.

 Foreign
Currency
Translation
Adjustments		Unrealized (Loss) Gain on HedgesUnrealized Gain (Loss) on
Available-for-sale
Investments		Unrealized
Pension
(Costs) Credits (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2020$(122.4)$(27.7)$8.6 $(19.6)$(161.1)
Other comprehensive (loss) income before reclassifications
(39.2)66.3 (29.2)12.8 10.7 
Amounts reclassified from accumulated other comprehensive loss(6.4)12.0 8.6 1.0 15.2 
Deferred income tax (expense) benefit
(4.5)(20.9)5.1 (2.2)(22.5)
December 31, 2021(172.5)29.7 (6.9)(8.0)(157.7)
Other comprehensive (loss) income before reclassifications
(33.9)75.2 (77.9)17.3 (19.3)
Amounts reclassified from accumulated other comprehensive loss(7.0)(84.5)18.8 (0.1)(72.8)
Deferred income tax (expense) benefit
(5.4)3.4 0.4 (3.5)(5.1)
December 31, 2022(218.8)23.8 (65.6)5.7 (254.9)
Other comprehensive income (loss) before reclassifications
6.9 43.3 32.6 (11.1)71.7 
Amounts reclassified from accumulated other comprehensive loss(6.9)(72.8)8.1 (0.8)(72.4)
Deferred income tax benefit
4.3 6.4 0.1 2.0 12.8 
December 31, 2023$(214.5)$0.7 $(24.8)$(4.2)$(242.8)
_______________________________________________________________________________

82
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
16.    ACCUMULATED OTHER COMPREHENSIVE LOSS (Continued)

(a)For the years ended December 31, 2023, 2022, and 2021, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2023   
Prior service credit arising during period$0.7 $0.9 $1.6 
Amortization of prior service credit(0.8)0.1 (0.7)
Net prior service cost arising during period(0.1)1.0 0.9 
Net actuarial loss arising during period(11.8)1.0 (10.8)
Unrealized pension costs, net$(11.9)$2.0 $(9.9)
2022   
Prior service credit arising during period$— $(1.1)$(1.1)
Amortization of prior service credit(0.7)0.3 (0.4)
Net prior service cost arising during period(0.7)(0.8)(1.5)
Net actuarial gain arising during period17.9 (2.7)15.2 
Unrealized pension credits, net$17.2 $(3.5)$13.7 
2021   
Prior service credit arising during period$0.1 $— $0.1 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.6)0.1 (0.5)
Net actuarial gain arising during period14.4 (2.3)12.1 
Unrealized pension credits, net$13.8 $(2.2)$11.6 

The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20232022Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.9 $7.0 Other income, net
(1.7)(1.7)Provision for income taxes
$5.2 $5.3 Net of tax
(Loss) gain on hedges$58.9 $88.4 Cost of sales
13.9 (3.9)Other income, net
72.8 84.5 Total before tax
(15.8)(22.2)Provision for income taxes
$57.0 $62.3 Net of tax
Gain (loss) on available-for-sale investments$(8.1)$(18.8)Other income, net
2.2 4.6 Provision for income taxes
$(5.9)$(14.2)Net of tax
Amortization of pension adjustments$0.8 $0.1 Other income, net
(0.2)— Provision for income taxes
$0.6 $0.1 Net of tax

83
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

17.    OTHER INCOME, NET
 Years Ended December 31,
 202320222021
(in millions)
Foreign exchange (gains) losses, net$(10.5)$1.2 $(5.0)
Loss (gain) on investments0.7 1.1 (5.8)
Non-service cost components of net periodic pension benefit cost(1.2)(1.1)0.3 
Gain on insurance settlement— (3.8)— 
Other(3.4)— (2.2)
Total other income, net$(14.4)$(2.6)$(12.7)

18.    INCOME TAXES

The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):
 Years Ended December 31,
 202320222021
United States$348.0 $634.4 $610.9 
Outside of the United States, including Puerto Rico1,250.1 1,133.0 1,091.1 
$1,598.1 $1,767.4 $1,702.0 

The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202320222021
Current   
United States:   
Federal$317.3 $369.1 $125.2 
State and local58.1 60.6 25.1 
Outside of the United States, including Puerto Rico85.3 66.7 92.6 
Current income tax expense$460.7 $496.4 $242.9 
Deferred   
United States:   
Federal$(187.5)$(187.7)$(9.4)
State and local(54.2)(58.9)(25.4)
Outside of the United States, including Puerto Rico(20.3)(4.3)(9.2)
Deferred income tax benefit(262.0)(250.9)(44.0)
Total income tax provision$198.7 $245.5 $198.9 

84
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
18.    INCOME TAXES (Continued)
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20232022
Deferred tax assets  
   Capitalized research and development expenses (a)
$371.1 $199.7 
Compensation and benefits117.9 100.6 
Benefits from uncertain tax positions63.4 42.1 
Net tax credit carryforwards172.9 160.8 
Net operating loss carryforwards75.9 71.7 
Accrued liabilities132.8 93.7 
Inventories15.3 11.9 
Cash flow and net investment hedges1.6 6.6 
State income taxes0.2 0.3 
Investments0.6 0.6 
Lease liability obligations5.8 6.7 
Other0.8 1.9 
Total deferred tax assets958.3 696.6 
Deferred tax liabilities  
Property, plant, and equipment(78.2)(80.2)
Deferred tax on foreign earnings(3.6)(19.2)
Right-of-use assets (4.7)(6.0)
Other intangible assets(53.0)(19.9)
Other(2.5)(2.9)
Total deferred tax liabilities(142.0)(128.2)
Valuation allowance(90.2)(99.1)
Net deferred tax assets$726.1 $469.3 
______________________________________
(a)     As required by the 2017 Tax Cuts and Jobs Act, effective January 1, 2022, the Company's research and development expenditures were capitalized and amortized which resulted in substantially higher cash paid for taxes in 2023 and 2022 with an equal amount of deferred tax benefits.

During 2023, net deferred tax assets increased $256.8 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.

The valuation allowance of $90.2 million as of December 31, 2023 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.

85
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
18.    INCOME TAXES (Continued)
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$9.0 $1.9 $— $1.9 2033-2037
United States federal net operating losses1.8 0.4 — 0.4 Indefinite
United States state net operating losses35.7 1.8 (1.7)0.1 2026-2041
United States state net operating losses2.6 0.1 (0.1)— Indefinite
Non-United States net operating losses416.5 71.6 (54.5)17.1 Indefinite
United States capital losses33.4 0.1 (0.1)— 2024
Total$499.0 $75.9 $(56.4)$19.5  

Certain tax attributes are subject to an annual limitation as a result of the acquisition of CASMED, which constitute a change of ownership as defined under Internal Revenue Code Section 382.

The gross tax credit carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$211.3 $— $211.3 Indefinite
Federal research expenditure tax credits1.3 — 1.3 2026-2039
Foreign tax and general business credits0.7 — 0.7 2030-2033
Puerto Rico purchases credits26.2 (26.2)— 2025
Puerto Rico purchases credits1.2 (1.2)— Indefinite
Total$240.7 $(27.4)$213.3  

The Company has $211.3 million of gross California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future. Accordingly, no valuation allowance has been provided. The Company has $27.4 million of Puerto Rico purchases credits. Throughout its history and into the future, the Company's Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits currently have an indefinite life, the Company continues to record a valuation allowance on the purchases credits carryforwards. The Company recently renegotiated its tax grant under Puerto Rico Act 52-2022 ("Act 52") effective January 1, 2023. Among other items, Act 52 introduced new requirements and limitations on the availability and claiming of tax credits. As a result, the Company now expects that its purchases credits generated through December 31, 2022 will expire in 2025 while the purchases credits generated after December 31, 2022 will have an indefinite life.

On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the United States federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years. The Company elected to pay the repatriation tax in installments over eight years.

The Company asserts that $961.6 million of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $1.2 billion of its foreign earnings as of December 31, 2023. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $5.1 million.

86
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
18.    INCOME TAXES (Continued)
The Company has received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $333.2 million ($0.55 per diluted share), $247.4 million ($0.40 per diluted share), and $208.0 million ($0.33 per diluted share) for the years ended December 31, 2023, 2022, and 2021, respectively.

A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202320222021
Income tax expense at United States federal statutory rate$335.6 $371.1 $357.4 
Foreign income taxed at different rates(128.3)(123.9)(122.2)
State and local taxes, net of federal tax benefit18.7 21.1 11.9 
Tax credits, federal and state(62.5)(50.0)(48.4)
Build of reserve for prior years' uncertain tax positions(2.9)11.6 3.6 
Tax on global intangible low-taxed income78.7 61.4 56.5 
Foreign-derived intangible income deduction(23.0)(15.0)(1.3)
Contingent consideration liabilities(5.5)(7.5)(26.1)
United States federal deductible employee share-based compensation(13.1)(31.6)(47.8)
Nondeductible employee share-based compensation6.6 5.8 5.3 
Other(5.6)2.5 10.0 
Income tax provision$198.7 $245.5 $198.9 

The Company's effective tax rate for 2023 decreased in comparison to 2022 primarily due to the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations. On July 21, 2023, the IRS issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited the Company's ability to claim credits on certain foreign taxes for tax years 2022 and 2023. In addition, there was a tax benefit from the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation. The Company's effective tax rate for 2022 increased in comparison to 2021 primarily due to the decrease in the tax benefit from the change in fair value of contingent consideration liabilities and the decrease in the excess tax benefit from employee share-based compensation.
Uncertain Tax Positions

As of December 31, 2023 and 2022, the gross uncertain tax positions were $583.9 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $250.7 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $333.2 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate.

87
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
18.    INCOME TAXES (Continued)
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202320222021
Uncertain gross tax positions, January 1$475.3 $358.4 $281.8 
Current year tax positions
127.0 120.6 82.1 
Increase in prior year tax positions
0.8 3.8 2.3 
Decrease in prior year tax positions
(16.2)(0.6)(4.8)
Settlements
(3.0)(0.4)(0.3)
Lapse of statutes of limitations
— (6.5)(2.7)
Uncertain gross tax positions, December 31$583.9 $475.3 $358.4 

The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled.

The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2023, the Company had accrued $41.4 million (net of $29.9 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2022, the Company had accrued $29.1 million (net of $15.4 million tax benefit) of interest related to uncertain tax positions. During 2023, 2022, and 2021, the Company recognized interest expense, net of tax benefit, of $12.3 million, $9.6 million, and $5.2 million, respectively, in "Provision for Income Taxes" on the consolidated statements of operations.

In the normal course of business, the IRS and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.

The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The execution of some or all these APA renewals depends on many variables outside of Edwards' control.

The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years.

At December 31, 2023, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010 and on.
88
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
18.    INCOME TAXES (Continued)

During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $230.0 million and represented a departure from a transfer pricing method the Company had previously agreed upon with the IRS. The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.

During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of the Company's filing position is $269.3 million before consideration of interest and a repatriation tax offset.

The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe. The Company intends to make an additional deposit in the range of $200 million to $300 million with the IRS by the second quarter of 2024 in order to further mitigate interest on potential tax liabilities while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS.

Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2023. The Company has considered this information, as well as information regarding the NOD and other proceedings described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.

19.    LEGAL PROCEEDINGS

In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.

89
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
19.    LEGAL PROCEEDINGS (Continued)

The European Commission (the "Commission") is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices. The Company is committed to healthy competition and is cooperating with the Commission. The Company cannot predict the outcome of the investigation or the potential impact on its financial statements.

The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent consideration, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.

20.    SEGMENT INFORMATION

Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.

Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.

90
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
20.    SEGMENT INFORMATION (Continued)
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202320222021
Segment Net Sales   
United States$3,508.7 $3,132.6 $2,963.1 
Europe1,337.4 1,213.7 1,099.6 
Japan436.7 559.3 528.0 
Rest of World716.9 610.7 533.2 
Total segment net sales$5,999.7 $5,516.3 $5,123.9 
Segment Operating Income  
United States$2,306.1 $2,130.9 $2,051.0 
Europe709.5 652.2 569.1 
Japan259.1 376.7 348.0 
Rest of World310.4 247.7 185.2 
Total segment operating income$3,585.1 $3,407.5 $3,153.3 

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Years Ended December 31,
 202320222021
Net Sales Reconciliation   
Segment net sales$5,999.7 $5,516.3 $5,123.9 
Foreign currency5.1 (133.9)108.6 
Consolidated net sales$6,004.8 $5,382.4 $5,232.5 
Pre-tax Income Reconciliation  
Segment operating income$3,585.1 $3,407.5 $3,153.3 
Unallocated amounts:
Corporate items(1,920.9)(1,714.1)(1,613.8)
Special charge and separation costs(17.2)(60.7)— 
Intellectual property agreement and litigation expense(203.5)(15.8)(20.6)
Change in fair value of contingent consideration liabilities26.2 35.8 124.1 
Foreign currency64.4 95.8 47.3 
Consolidated operating income1,534.1 1,748.5 1,690.3 
Non-operating income64.0 18.9 11.7 
Consolidated pre-tax income$1,598.1 $1,767.4 $1,702.0 

91
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
20.    SEGMENT INFORMATION (Continued)
Enterprise-Wide Information
(in millions)

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202320222021
Net Sales by Geographic Region   
United States$3,508.7 $3,132.6 $2,963.1 
Europe1,334.5 1,174.8 1,190.3 
Japan452.4 473.6 528.9 
Rest of World709.2 601.4 550.2 
$6,004.8 $5,382.4 $5,232.5 
Net Sales by Major Product Group  
Transcatheter Aortic Valve Replacement$3,879.8 $3,518.2 $3,422.5 
Transcatheter Mitral and Tricuspid Therapies197.6 116.1 86.0 
Surgical Structural Heart999.3 893.1 889.1 
Critical Care928.1 855.0 834.9 
$6,004.8 $5,382.4 $5,232.5 
Long-lived Tangible Assets by Geographic Region   
United States$1,269.7 $1,188.5 $1,195.8 
Europe196.4191.8197.9
Japan23.813.219.7
Rest of World353.5331.6335.5
$1,843.4 $1,725.1 $1,748.9 

92
EDWARDS LIFESCIENCES CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)


21.    VALUATION AND QUALIFYING ACCOUNTS

  Additions  
 Balance at
Beginning
of Period		Charged to
Costs and
Expenses		Charged to
Other
Accounts		DeductionsBalance at
End of
Period
 (in millions)
Year ended December 31, 2023
     
Allowance for credit losses (a)$11.7 $2.0 $— $(1.9)$11.8 
Tax valuation allowance (b)99.1 — 0.1 (9.0)90.2 
Year ended December 31, 2022
     
Allowance for credit losses (a)$15.7 $0.9 $0.1 $(5.0)$11.7 
Tax valuation allowance (b)82.5 3.0 14.2 (0.6)99.1 
Year ended December 31, 2021
     
Allowance for credit losses (a)$16.4 $1.2 $0.6 $(2.5)$15.7 
Tax valuation allowance (b)71.6 12.4 — (1.5)82.5 
_______________________________________________________________________________
(a)    The deductions related to allowances for credit losses represent accounts receivable which are written off.

(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.


93
Item 9.    Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A.    Controls and Procedures

Evaluation of Disclosure Controls and Procedures.    The Company's management, including the Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2023.

Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded as of December 31, 2023 that the Company's disclosure controls and procedures are designed at a reasonable assurance level and are effective in providing reasonable assurance that the information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to the Company's management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Management's Report on Internal Control Over Financial Reporting.    The Company's management, including the Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. Under the supervision and with the participation of the Company's management, including the Chief Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, the Company's management concluded that its internal control over financial reporting was effective as of December 31, 2023. The effectiveness of the Company's internal control over financial reporting as of December 31, 2023 has been audited by PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited the financial statements included in this Annual Report on Form 10-K, as stated in their report which appears herein.

Changes in Internal Control Over Financial Reporting.    There have been no changes in the Company's internal control over financial reporting that occurred during the Company's fourth fiscal quarter of 2023 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Item 9B.    Other Information

Rule 10b5-1 Trading Plans

On December 14, 2023, Donald Bobo, Jr., Corporate Vice President, Strategy & Corporate Development, entered into a 10b5-1 trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The Plan provides for the potential sale of 70,500 shares of the Company’s stock commencing May 10, 2024. The Plan terminates on the earlier of April 14, 2025 or the date all shares are sold.

Item 9C.    Information Regarding Foreign Jurisdictions That Prevent Inspections

None.
94
PART III

Item 10.    Directors, Executive Officers and Corporate Governance

Certain information required by this Item will be set forth under the headings "Board of Directors Matters—Proposal 1 - Election of Directors—Board of Director Nominees," "Board of Directors Matters—Corporate Governance Policies and Practices," and "Executive Compensation and Other Information—Executive Officers" in the definitive proxy statement to be filed in connection with the Company's 2024 Annual Meeting of Stockholders (the "Proxy Statement") (which Proxy Statement will be filed with the SEC within 120 days of December 31, 2023). The information required by this Item to be contained in the Proxy Statement is incorporated herein by reference. The Company has adopted a code of ethics that applies to all directors and employees, including the Company's principal executive officer, principal financial officer, and principal accounting officer, or persons performing similar functions. The code of ethics (business practice standards) is posted on the Company's website, which is found at https://ir.edwards.com under "Governance & Sustainability—Corporate Responsibility & Sustainability—Corporate Responsibility—Global Integrity Program." To the extent required by applicable rules of the SEC and the New York Stock Exchange, the Company intends to disclose on its website any amendments to, or waivers from, any provision of its code of ethics that apply to the Company's directors and executive officers, including the principal executive officer, principal financial officer or controller or persons performing similar functions.

Item 11.    Executive Compensation

The information contained under the heading "Executive Compensation and Other Information" in the Proxy Statement is incorporated herein by reference.

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information contained under the headings "Security Ownership of Certain Beneficial Owners and Management" and "Equity Compensation Plan Information" in the Proxy Statement is incorporated herein by reference.

Item 13.    Certain Relationships and Related Transactions, and Director Independence

The information contained under the heading "Other Matters and Business—Related Persons Transactions" and under the heading "Board of Directors Matters—Corporate Governance Policies and Practices—Director Independence" in the Proxy Statement is incorporated herein by reference.

Item 14.    Principal Accounting Fees and Services

The information contained under the headings "Audit Matters—Fees Paid to Principal Accountants" and "Audit Matters—Pre-Approval of Services" in the Proxy Statement is incorporated herein by reference.

95
PART IV

Item 15.    Exhibits and Financial Statement Schedules

(a)  The following documents are filed as part of this report:

1.  Consolidated Financial Statements.  See “Index to Consolidated Financial Statements” in Part II, Item 8 herein.

2.  Financial Statement Schedules.  Other schedules are not applicable and have not been included herein.

3.  Exhibits. 
Exhibit No.Description
3.1 
3.2 
3.3 
3.4 
4.1 
4.2 
4.3 
4.4 
4.5 
10.1 
*10.2
*10.3
*10.4
*10.5
*10.6
*10.7
*10.8
*10.9
*10.10
96
Exhibit No.Description
*10.11
*10.12
*10.13
*10.14
*10.15
*10.16
*10.17
*10.18
*10.19
*10.20
21.1
23 
31.1 
31.2 
+32
97.1
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________________________________________________________________________
# Pursuant to a request for confidential treatment, confidential portions of this exhibit have been redacted and have been filed separately with the Securities and Exchange Commission
* Represents management contract or compensatory plan
+ Furnished herewith

Item 16.    Form 10-K Summary

None.
97
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 EDWARDS LIFESCIENCES CORPORATION
February 12, 2024By: /s/ BERNARD J. ZOVIGHIAN
Bernard J. Zovighian
 Director and
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
   
/s/ BERNARD J. ZOVIGHIANDirector and Chief Executive OfficerFebruary 12, 2024
Bernard J. Zovighian(Principal Executive Officer)
/s/ SCOTT B. ULLEMCorporate Vice President, Chief Financial OfficerFebruary 12, 2024
Scott B. Ullem(Principal Financial Officer)
/s/ ROBERT W.A. SELLERSSenior Vice President, Principal Accounting OfficerFebruary 12, 2024
Robert W.A. Sellers(Principal Accounting Officer)
/s/ MICHAEL A. MUSSALLEMChairman of the Board February 12, 2024
Michael A. Mussallem
/s/ KIERAN T. GALLAHUEDirectorFebruary 12, 2024
Kieran T. Gallahue
/s/ LESLIE S. HEISZDirectorFebruary 12, 2024
Leslie S. Heisz
/s/ PAUL A. LAVIOLETTEDirectorFebruary 12, 2024
Paul A. LaViolette
/s/ STEVEN R. LORANGERDirectorFebruary 12, 2024
Steven R. Loranger
/s/ MARTHA H. MARSHDirectorFebruary 12, 2024
Martha H. Marsh
/s/ RAMONA SEQUEIRADirectorFebruary 12, 2024
Ramona Sequeira
/s/ NICHOLAS J. VALERIANIDirectorFebruary 12, 2024
Nicholas J. Valeriani

98
 EX-10.3 2 ex-10310xkq42023.htm EX-10.3 Document


Exhibit 10.3
Edwards Lifesciences LLC
One Edwards Way, Irvine, CA USA 92614
Phone: 949.250.2500, Fax: 949.250.2525
www.edwards.com
Employment
Agreement


NOTICE TO EMPLOYEE:

BEFORE SIGNING, PLEASE READ THE FOLLOWING AGREEMENT IN ITS ENTIRETY,
MAKE CERTAIN THAT YOU UNDERSTAND IT, AND, IF DESIRED,
REVIEW IT WITH YOUR ATTORNEYS AND ADVISORS.


THIS EMPLOYMENT AGREEMENT (the “Agreement”) is executed by and between Edwards Lifesciences LLC and _________________________________________ (the “Employee”). In consideration of this offer of employment, continued employment, future promotions, training, future pay increases, access to additional compensation opportunities including stock options or restricted stock unit awards and other benefits, access to Confidential Information, and/or other things of value provided contemporaneously herewith, the receipt and sufficiency of which is expressly acknowledged, the Employee acknowledges and agrees as follows:

1.Employment Relationship. Edwards will employ or continue to employ the Employee, effective on the Employee’s most recent hire date, and the Employee hereby accepts or reaffirms such employment consistent with the terms and conditions provided herein.

1.1.The Employee agrees to perform such duties as are customarily performed by those in the Employee’s position, and such duties and responsibilities as may be required from time to time, and shall also be subject to the instructions, regulations, and policies of Edwards now in effect and as may be revised at any time. The Employee further agrees that he/she will devote utmost knowledge and best skill and efforts to the performance of his/her duties, that he/she will remain loyal to Edwards during the term of his/her employment, and that he/she is not presently engaged in, and shall not during the term of his/her employment with Edwards enter into, any employment or consulting or agency relationship, whether for pay or otherwise, with any third party whose interests might conflict with those of Edwards. The Employee understands that during his/her employment with Edwards, other employment, activities or businesses may conflict with the Company’s rules regarding conflicts of interest. Therefore, during the Employee’s employment with Edwards, the Employee will not, other than for the Company, engage in any other employment, activity or business: (i) in which the Company is now or may hereafter become engaged; (ii) that competes with the current or future business of the Company; (iii) that uses any Company information, equipment, supplies, facilities, or materials; or (iv) otherwise conflicts with the Company’s business interest or causes, or may reasonably be expected to cause, a disruption of its operations.

1.2.The Employee and Edwards understand and expressly agree that the Employee’s employment is not for a specified term and that it may be terminated by Edwards or by the Employee at any time, with or without notice, for any cause or without cause. The Employee further understands and agrees that Edwards may change the Employee’s hours, wages, benefits, position, working conditions, and other terms of employment, with the exception of this at-will provision, and may take disciplinary action, as it deems appropriate, at any time, with or without cause or advance notice. The Employee and Edwards expressly agree that this at-will provision is intended by both the Employee and Edwards to be the complete and final expression of their understanding regarding the terms and conditions under which the Employee’s employment may be terminated, or under which Edwards may take disciplinary or other employment action, and that it is intended as an integrated agreement with respect thereto. The Employee and Edwards further understand and expressly agree that there are no express or implied agreements contrary to this provision, that no representation contrary to this provision is valid, and that this provision may not be augmented, contradicted, or modified in any way, except by a formal written agreement, signed by both the Employee and a Corporate Vice-President of Edwards.

2.Protection of Confidential Information and Fair Competition.

2.1     Definitions. For all purposes relevant to this Agreement, including the Schedules hereto, the following terms shall have the specified meanings:

Revised January 2024 (v. 2024.1)
1


2.1.1 “Competing Organization” means persons or organizations, including the Employee, engaged in, or about to become engaged in, research or development, production, distribution, marketing, providing, servicing, selling or conducting or supporting training regarding a Competing Product. The Employee acknowledges and agrees that Edwards sells and distributes, and/or is preparing to sell and distribute, its products nationwide, in Europe, and throughout the world, and that accordingly, “Competing Organization” includes all such persons or organizations throughout the United States, Europe, and the rest of the world.
2.1.2 “Competing Product” means products, processes, product lines, or services, and each and every component thereof, of any person or organization other than Edwards, in existence or under development, which are substantially the same, may be substituted for, or applied to substantially the same end use as Edwards products, processes, product lines, or services in existence or under development (“Edwards’ Products”) while the Employee works or worked for Edwards.

2.1.3 “Confidential Information” means information of a confidential or secret nature disclosed to the Employee by Edwards or created, discovered, received or learned by the Employee by reason of the Employee’s employment with Edwards, relating to the present or planned business of Edwards, which has not been released publicly by authorized representatives of Edwards, including, but not limited to, Trade Secrets, Items, unpublished Inventions, know-how, products, experiments, clinical and product research; vendor and customer data, designs, concepts, customer, patient, supplier, and competitor information; sales, pricing, cost, and financial data; research, development, marketing, and sales programs and strategies; manufacturing, marketing, and service techniques, processes and practices; training materials, training techniques, techniques for using Edwards’ Products; and physician and/or client lists, information regarding prescribing physicians, related personnel information, and regulatory strategies, plans, and approaches. Confidential Information also includes all information received by Edwards under an obligation of confidentiality to a third party.

2.1.4 “Covenant Period” shall have the meaning set forth in Schedule A with respect to the Employee’s State of Employment.

2.1.5 “Edwards” means Edwards Lifesciences LLC and all of its parents, subsidiaries, or affiliated entities, and their successors and assigns that exist or may exist during all or any portion of the time this Agreement is in effect.

2.1.6 “Edwards’ Customer” means any person, entity, or institution, including the employees, agents, or representatives who controlled, directed, or influenced the purchasing decisions of any such person, entity, or institution, with which the Employee had business contact on behalf of Edwards, as to which the Employee supervised or supported business contact on behalf of Edwards, or about which the Employee learned Confidential Information, during the last 12 months in which the Employee was employed by Edwards. Edwards’ Customers specifically include (without limitation) all physicians and medical personnel to whom the Employee provided training regarding the use of Edwards’ Products, during the last 12 months in which the Employee was employed by Edwards. The Employee acknowledges that Edwards’ Customers may be responsible for purchasing decisions of a variety of Competing Products. However, if (and only if) the law of the Employee’s State of Employment so requires, “Edwards’ Customer” shall be limited to any person, entity, or institution, including the employees, agents, or representatives who controlled, directed, or influenced the purchasing decisions of any such person, entity, or institution, which had an actual business relationship with Edwards and with whom the Employee had personal and material contact during the last 12 months of the Employee’s employment with Edwards.

2.1.7 “Invention” means procedures, systems, machines, methods, processes, uses, discoveries, apparatuses, compositions of matter, designs or configurations, computer programs of any kind, ideas, concepts, or any improvements of the foregoing, discovered, conceived, reduced to practice, developed, made, or produced, alone or with others, whether or not patentable, copyrightable, or protectable as Trade Secrets. “Invention” shall not be limited to the meaning of “Invention” under the United States patent laws.

2.1.8 “Items” include documents, reports, drawings, diagrams, photographs, designs, specifications, formulae, plans, samples, research or development information, records, or test results, prototypes, tools, equipment, proposals, marketing or sales plans, customer information, customer lists, the terms and expiration dates of customer contracts, patient lists, patient information, regulatory files, financial data, costs, pricing information, supplier information, business, marketing, acquisition, or pricing strategies, written, printed or graphic matter, or other information and materials that concern Edwards that come into Employee’s possession, which Employee developed alone or with others during employment with Edwards, or about which Employee has knowledge by reason of his/her employment with Edwards.

2.1.9 “State of Employment” shall refer to the primary state or territory of the United States within which the Employee performs or performed the duties and responsibilities of his/her employment for Edwards at the time of his/her termination from Edwards.

Revised January 2024 (v. 2024.1)
2


2.1.10 “Trade Secrets” shall mean information, including a formula, pattern, compilation or combination; program, device, method, technique, process, or drawing; cost data, business data or customer data, contracts, or information; or development, sales or business strategies, or other information or Items that derive independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from their disclosure or use, and which are the subject of efforts that are reasonable under the circumstances to maintain their secrecy.

2.2 Protection of Confidential Information.

2.2.1 The Employee understands that Edwards has developed or acquired valuable Confidential Information that is not generally known to its competitors or to the public. The Employee recognizes and further understands that the Employee’s employment with Edwards creates a relationship of confidence and trust with respect to this Confidential Information which is disclosed to, developed by or learned by the Employee during the Employee’s employment. The Employee expressly acknowledges that Edwards would not permit the Employee to have access to Confidential Information but for the Employee’s promises in this Agreement. The Employee further agrees that the Confidential Information is and will remain the exclusive property of Edwards.

2.2.2 The Employee agrees that he/she is not authorized to and will not at any time publish or disclose, or allow to be published or disclosed, Confidential Information to any person who is not an employee of Edwards, unless such disclosure is necessary for the performance of the Employee’s obligations under this Agreement, in which case (i) a properly executed confidentiality agreement is in effect by and between Edwards and the recipient of such information, or (ii) such disclosure is authorized in writing by Edwards, through its General Counsel. The Employee further agrees that he/she is not authorized to and will not remove any Confidential Information or Edwards’ medical devices from the offices of Edwards or the premises of any facility in which Edwards is performing work, or allow such removal, except in the customary execution of the Employee’s duties for the sole and exclusive benefit of Edwards, unless permitted in writing by Edwards, through its General Counsel.

2.2.3 The Employee expressly agrees that the Employee will not make use of Confidential Information for his/her personal benefit or that of any Competing Organization, or disclose, copy, retain, distribute, access, reverse engineer, or use Confidential Information to engage in competition with Edwards at any time, including after the termination of his/her employment with Edwards, or for any purpose other than furthering the legitimate business interests of Edwards. The Employee acknowledges and agrees that at all times he/she is prohibited from using the Confidential Information of Edwards for any purposes other than furthering the legitimate business interests of Edwards.

2.2.4 Upon termination of his/her employment with Edwards for any reason or upon request of Edwards at any time, the Employee shall immediately deliver to Edwards all property and Items owned by Edwards and all documents and materials of any nature in any form, whether whole or incomplete, containing any Confidential Information. Employee shall advise Edwards of the location of any such Items or Confidential Information on any computers or digital storage media or accounts, including cloud storage accounts, not owned by Edwards, and shall cooperate with Edwards in arranging for the deletion or other appropriate handling of said Confidential Information. Upon Edwards’ request, the Employee shall reaffirm in writing his/her recognition of the importance of protecting and maintaining the confidentiality of the Confidential Information and shall reaffirm all of the obligations set forth in this Agreement regarding such information.

2.2.5 Notice of Immunity. Pursuant to the Defend Trade Secrets Act of 2016 (“DTSA”), the Employee will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  If the Employee were to file a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Employee may disclose the trade secret to the Employee’s attorney and use the trade secret information in the court proceeding, if the Employee (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.  The Employee understands that if a court of law or arbitrator determines that the Employee misappropriated Company Trade Secrets willfully or maliciously, including by making permitted disclosures without following the requirements of the DTSA as detailed in this paragraph, then the Company may be entitled to an award of exemplary damages and attorneys’ fees against the Employee. Nothing in this Agreement prevents the Employee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct the Employee has reason to believe is unlawful.

Revised January 2024 (v. 2024.1)
3


2.3 Restriction on Solicitation of Employees.

2.3.1 The Employee acknowledges that Edwards has made, and continues to make, considerable investments in the recruitment, screening, and training of its employees and that, in the course of such recruitment, screening, and training, Edwards has obtained information regarding the unique skills, knowledge, training, backgrounds, talents, and capabilities of such employees. The Employee further acknowledges and agrees that a person or entity other than Edwards, if it desired to assemble a workforce of employees with comparable skills, knowledge, and capabilities, would also need to make considerable investments to obtain information regarding such employees and that such a person or entity would gain an unfair competitive advantage if it were to utilize the information developed by Edwards through the efforts referred to above. Accordingly, the Employee agrees that Edwards’ internal personnel information regarding the qualifications, talents, skills, abilities, backgrounds, training, work histories, compensation, career paths, and prospects for promotion constitutes Confidential Information, and the Employee further agrees that he/she will not, at any time, directly or indirectly, use or disclose such information to any person or entity, except in the customary execution of the Employee’s duties for the sole and exclusive benefit of Edwards.

2.3.2 The Employee further agrees that he/she will neither directly nor indirectly, during his/her employment with Edwards and for one (1) year thereafter, solicit, cause to be solicited, hired or engaged, or participate in or promote or assist the solicitation, hiring or engaging to perform services of any individual who is, or has been in the six (6) months prior to termination of the Employee’s employment with Edwards, an Edwards employee or consultant or induce or assist others to induce any employee or consultant of Edwards to leave Edwards or to terminate his/her employment or engagement with Edwards.

2.4 Prevention of Unfair Competition. As a material inducement to Edwards to enter into this Agreement and to provide the Employee with access to Confidential Information, including without limitation, access to its Trade Secrets, and in order to protect Edwards’ Confidential Information, including its Trade Secrets, the Employee agrees as follows:

2.4.1 The Employee agrees not to render services of any kind (including training services) in connection with or relating to any Competing Product, directly or indirectly, to any person or entity, during the Covenant Period for the benefit of a Competing Organization, in the areas where Edwards does business throughout the United States, Europe, and the rest of the world.

2.4.2 The Employee agrees during the Covenant Period not to, personally or through or with or on behalf of another person or entity, (a) solicit, contact, divert, entice or attempt to divert the business of any Edwards’ Customer in relation to a Competing Product, or assist or support others to engage in these acts, or (b) solicit, contact, divert, entice, or attempt to solicit, contact, divert or entice, or assist or support others in soliciting, contacting, diverting, enticing or attempting to divert or entice any Edwards’ Customer to terminate or reduce the Customer’s relationship with Edwards.

2.4.3 The foregoing restrictions in Sections 2.4.1 and 2.4.2 shall apply only to the extent the Employee’s compensation meets the compensation requirements for covenants not to compete or solicit, if any, established by federal law or the law in Employee’s State of Employment.
2.5 Duty to Provide Notice to New or Prospective Employer. The Employee shall notify any new or prospective employer of his/her obligations under Section 2 of this Agreement. The Employee acknowledges that Edwards may notify any new or prospective employer of the Employee of such obligations and authorizes Edwards to do so. The Employee agrees to notify Edwards of the identity of his/her new employer and position with the new employer, or other planned work for compensation, if any, upon the Employee’s separation from employment with Edwards, but no later than the Employee’s last day worked at Edwards. The Employee agrees to notify Edwards of any changes in his/her employment or other planned work for compensation throughout the Covenant Period.

2.6 No Use of Third-Party Confidential Information. The Employee and Edwards expressly agree that they do not intend or seek to do business using the Confidential Information of any former employer of the Employee. The Employee represents and agrees that he/she will not use or disclose Confidential Information belonging to any former employer or other third party, which he/she has an obligation not to disclose or use, without obtaining prior written permission from the former employer or other third party.

2.7 Remedies. The Employee agrees and acknowledges that the violation of any of the provisions contained herein would cause irreparable injury to Edwards, that the remedy at law for any violation or threatened violation thereof would be inadequate, and that Edwards shall be entitled to temporary and permanent injunctive or other equitable relief to prevent such harm, without need for a bond.

PLEASE NOTE THAT EDWARDS IS ENTITLED TO SEEK JUDICIAL ENFORCEMENT OF ITS RIGHT TO PROTECT CONFIDENTIAL INFORMATION AND TO PURSUE ALL LEGAL REMEDIES, UP TO AND INCLUDING, AS PROVIDED HEREIN, PROHIBITION OF COMPETITIVE
Revised January 2024 (v. 2024.1)
4


EMPLOYMENT OPPORTUNITIES. UPON TERMINATION OF EMPLOYMENT WITH EDWARDS, THE EMPLOYEE’S ABILITY TO ACCEPT OR PERFORM EMPLOYMENT WITH COMPETITIVE COMPANIES MAY BE LIMITED AS PROVIDED IN THIS AGREEMENT.

The Employee further agrees and acknowledges that the violation of Section 2.3.2 of this Agreement will cause injury that is inherently difficult to quantify with precision in that it will encompass business disruption, time and expense to retain or replace and train the employee or consultant, injury to ongoing business relationships, and other harm, and therefore stipulates and agrees that, given the nature of the losses that may result, as a reasonable measure of damages that is not grossly disproportionate to the probable loss likely to be incurred, and not as a penalty, in the event of a finding of a violation of Section 2.3.2 the Employee shall pay to Edwards an amount equal to 10% of the last annual Edwards base salary of the employee who was solicited or induced to terminate his/her relationship with Edwards by reason of the breach or, as applicable, 10% of the total compensation Edwards paid the consultant who was solicited or induced to terminate his/her relationship with Edwards by reason of the breach in the last year prior to the breach. This remedy shall be in addition to and not in lieu of injunctive relief to prevent further or continuing violations.

3.Inventions and Works for Hire.

3.1 Property of, and Assignment to, Edwards Lifesciences Corporation. (This Section 3.1 shall be subject to the terms of Schedule B.)

3.1.1 The Employee agrees that all Inventions related to the present or planned business of Edwards, which are conceived or reduced to practice by the Employee, either alone or with others, during the period of his/her employment, whether or not done during the Employee’s regular working hours, and whether or not patentable, are the sole property of Edwards Lifesciences Corporation. The Employee hereby assigns to Edwards Lifesciences Corporation, or an affiliate designated by Edwards, all of the Employee’s right, title, and interest in, and to, such Inventions. The provisions of this Section 3.1.1 shall not apply to an Invention for which none of Edwards’ equipment, supplies, facilities, or Confidential Information were used and which was developed entirely on the Employee’s own time, unless (a) the Invention relates to the business of Edwards, or the actual or demonstrably anticipated research or development of Edwards, or (b) the Invention results from any work performed by the Employee for Edwards or from the use of any Edwards time, materials, or Confidential Information. The Employee understands and intends that this assignment, as set forth in Section 3.1.1, extends to works not presently in existence.

3.1.2 To the extent permitted by law, the Employee agrees that all Inventions related to the present or planned business of Edwards, which are conceived or reduced to practice by the Employee, either alone or with others, during a period of one hundred twenty (120) days after termination of such employment, whether or not patentable, are the property of Edwards Lifesciences Corporation. The Employee hereby assigns to Edwards Lifesciences Corporation, or an affiliate designated by Edwards, all of the Employee’s right, title, and interest in, and to, such Inventions. However, to the extent any law or legal decision does not allow Edwards Lifesciences Corporation to claim all of the Employee’s right, title, and interest in, and to, such Inventions, the Employee agrees that Edwards Lifesciences Corporation has at least a shared property interest in such Inventions, and the Employee hereby assigns to Edwards Lifesciences Corporation, or an affiliate designated by Edwards, joint ownership with the Employee of the Employee’s right, title, and interest in, and to, such Inventions. The provisions of this Section 3.1.2 shall not apply to an Invention for which none of Edwards’ equipment, supplies, facilities, or Confidential Information was used and which was developed entirely on the Employee’s own time, unless (a) the Invention relates to the business of Edwards, or the actual or demonstrably anticipated research or development of Edwards, or (b) the Invention results from any work performed by the Employee for Edwards or from the use of any Edwards time, materials or Confidential Information. The Employee understands and intends that this assignment, as set forth in Section 3.1.2, extends to works not presently in existence. It is the express intent of the Employee and Edwards that if any obligations in Section 3.1.2 are not allowed by law or legal decision, that the obligations in Section 3.1.1 and Sections 3.2–3.8 will otherwise remain in full effect and binding.

3.2 Disclosure. The Employee agrees to disclose promptly and in writing to Edwards, through the Employee’s supervisor, all Inventions which are related to the present or planned business, research, or development of Edwards. The Employee further agrees not to disclose any of these Inventions or any research of Edwards to others, without the express consent of Edwards, except as required by his/her employment with Edwards.

3.3 Cooperation. The Employee agrees that he/she will, at any time during or after his/her employment with Edwards, on request of Edwards, execute specific further documents in favor of Edwards Lifesciences Corporation, or an affiliate designated by Edwards, relating to ownership, rights, or interest in, and to, any of the Inventions that are assigned to Edwards Lifesciences Corporation, or an affiliate designated by Edwards, under Section 3.1, as well as execute all papers, render all assistance, and perform all lawful acts which Edwards considers necessary or advisable for the preparation, filing, prosecution, issuance, procurement, maintenance, or enforcement of patent applications and patents of the United States and foreign countries for these Inventions and for the transfer of any interest which the Employee may have. The
Revised January 2024 (v. 2024.1)
5


Employee will execute any and all papers and documents required to vest title in Edwards Lifesciences Corporation, or an affiliate designated by Edwards, in these Inventions, patent applications, patents, and interests. The Employee understands and intends that the obligations in this Section 3.3 extend to works not presently in existence.

3.4 No Waiver. The Employee further understands and agrees that the absence of a request by Edwards for information, or for the making of an oath, or for the execution of any document, shall in no way be construed to constitute a waiver of Edwards’ rights under this Agreement.

3.5 Prior Inventions. The Employee represents that the Employee has disclosed to Edwards all continuing obligations which the Employee has with respect to the assignment of Inventions to any previous employers, and the Employee claims no previous unpatented Inventions as the Employee’s own, except for those which are shown on Schedule C, or any similar schedules previously provided by the Employee to the Company, if any. The Employee understands that Edwards does not seek any Confidential Information which the Employee may have acquired from a previous employer, and the Employee will not disclose any such information to Edwards.

3.6 Works for Hire. All writings and other works, which may be copyrighted (including computer programs), which are related to the present or planned business or research and development of Edwards and are prepared by the Employee during his/her employment with Edwards or using the time, material or Confidential Information of Edwards, shall be, to the extent permitted by law, works made for hire, and the authorship and copyright of the work shall be in Edwards’ name. To the extent that any such writings and works are not works for hire, the Employee agrees to the waiver of “moral rights” in such writings and works and hereby assigns to Edwards all right, title, and interest in, and to, such writings and works, including copyright. The Employee will execute any and all papers and documents required to vest title in Edwards, or its nominee, in all such works. The Employee understands and intends that this assignment extends to works that are not currently in existence.

3.7 Power of Attorney. If Edwards is unable, after reasonable effort, to secure the Employee’s signature on any papers required under this Section 3, the Employee hereby irrevocably designates and appoints each officer of Edwards as the Employee’s agent and attorney-in-fact to execute any such papers on the Employee’s behalf, and to take any and all actions as Edwards may reasonably deem necessary to protect its patents, trademarks, copyrights, Trade Secrets and other intellectual property rights worldwide.

3.8 Right of Publication. The Employee will permit Edwards to use and distribute for any purpose any pictorial images, which are taken of the Employee during his/her employment with Edwards, as often as desired for any lawful purpose. The Employee waives all rights of prior inspection or approval and releases Edwards from any and all claims or demands, which the Employee may have on account of the lawful use or publication of such pictorial images.
    
4.No Authority to Bind Edwards. Without the express written consent of Edwards, the Employee shall have no apparent, actual, or implied authority to pledge the credit of Edwards or any of its other employees, to bind Edwards under any contract, agreement, note, mortgage, or otherwise to release or discharge any debt due to Edwards, unless Edwards has received the full amount thereof, or to sell, mortgage, transfer, or otherwise dispose of any assets of Edwards.

5.Personnel Policies and Procedures. Edwards shall have the authority to establish, from time to time, personnel policies and procedures to be followed by its employees. The Employee agrees to comply with the policies and procedures of Edwards. To the extent that any provisions in Edwards’ personnel policies and procedures, handbooks, manuals, and/or other materials differ from the terms of this Agreement, the terms of this Agreement shall apply. In no case shall any personnel policies, procedures, handbooks, manuals, or other materials modify, contradict, add to, or alter the effect of the at-will employment provision contained in this Agreement.

6.Cooperation. The Employee agrees that, following the termination of his/her employment with Edwards for any reason, the Employee will make every practicable effort to contact Edwards’ General Counsel, promptly and in any event before the deadline for compliance, to provide notice if the Employee is served with a subpoena or other legal process asking for a deposition, testimony, or other statement, or other potential evidence of any kind, to be used in connection with any lawsuit, demand, subpoena, or proceeding involving or related to Edwards in any way.

7.Drug-Free Workplace. The Employee acknowledges that Edwards intends to maintain a drug-free workplace and that Edwards has advised the Employee that it utilizes drug testing as a means to maintain such a drug-free workplace. The Employee understands that he/she may be asked to submit to drug testing as a condition of employment or continued employment, and the Employee expressly consents to such testing, at such times and under such conditions, as determined by Edwards, in its sole discretion, to be appropriate.

Revised January 2024 (v. 2024.1)
6


8.Edwards’ Values. At Edwards, the Credo and the Titanium Book set forth a number of positive behaviors and values that are key to Edwards’ culture and success. These behaviors and values include such things as becoming trusted partners with customers, colleagues, and patients, increasing personal accountability, behaving like owners, and building customer loyalty. To accomplish this, the Employee agrees to act in a responsible, ethical, and professional manner in all of his/her business dealings, as stated in the Credo, the Titanium Book, and any other of Edwards’ documents related to ethics. The Employee understands that there is no compromise with regard to his/her commitment to maintaining the highest standards of business conduct.

9.Severability; Amendment; Waiver; and Construction. Each term, condition, covenant, or provision of this Agreement, including any and all Schedules, shall be viewed as separate and distinct, and, in the event that any such term, covenant, or provision shall be held by a court of competent jurisdiction to be invalid, the remaining provisions shall continue in full force and effect. If any provision of this Agreement shall be determined by a court of competent jurisdiction to be overly broad, in any respect, or overly long, the Employee agrees and requests that the court shall reform said provision and this Agreement, to the least degree necessary to render it enforceable. No amendment or modification of the terms or conditions of this Agreement (other than judicial modification) shall be valid, unless in writing and signed by the party to be bound. A waiver by either party of a breach of any provision(s) of this Agreement shall not constitute a general waiver or prejudice the other party’s right otherwise to demand strict compliance with that provision or any other provision in this Agreement. Except as otherwise provided herein, this Agreement shall be governed by the laws of the Employee’s State of Employment. The Employee hereby agrees that Edwards may, at any time and without further action or writing by the Employee, assign this Agreement to any of its affiliated companies with which the Employee might be employed, and further agrees that Edwards may assign this Agreement and its rights and duties hereunder to any other person or entity in connection with a corporate reorganization or a sale or merger of all or part of Edwards, in which case the assignee company shall succeed to all of the rights held by Edwards under this Agreement and shall be entitled to enforce this Agreement.

10.Review of Agreement and Consultation with Legal Counsel. The Employee acknowledges that he/she has been provided with notice and a copy of this Agreement on or before receiving an employment offer and at least ten business days prior to any deadline to sign the Agreement and begin employment. The Employee acknowledges that he/she has a right to consult with counsel and has been given the opportunity to consult with counsel of his/her choosing, at Employee’s expense, to review the terms of the Agreement before entering it.

11.Entire Agreement. The Employee acknowledges receipt of this Agreement and agrees that this Agreement constitutes the entire and final agreement related to the subject matter herein between the Employee and Edwards and supersedes any previous oral or written communications, representations, or understandings between the Employee and Edwards. The Employee understands and agrees that no representative of Edwards has been authorized to enter into any agreement or commitment with the Employee that is inconsistent in any way with the terms of this Agreement.

ACKNOWLEDGED AND AGREED:


Employee
/s/ Christine McCauley
(Employee Signature)DateChristine McCauley
Corporate Vice President,
Human Resources
(Employee Name)



Revised January 2024 (v. 2024.1)
7


SCHEDULE A

(a)If the Employee’s State of Employment is:
Alabama, Alaska, Arkansas, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Mississippi, Missouri, Nevada, Ohio, New Jersey, New York, New Mexico, North Carolina, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Texas, Vermont, West Virginia or Wyoming
“Covenant Period” shall mean the period beginning as of the first date of the Employee’s employment with Edwards and ending 18 months after termination of the Employee’s employment, regardless of the reason for the termination.
(b)If the Employee’s State of Employment is:
Arizona, District of Columbia, Illinois, Indiana, Massachusetts, Michigan, Montana, Nebraska, New Hampshire, Puerto Rico, Tennessee, Utah, Virginia, Washington, or Wisconsin
“Covenant Period” shall mean the period beginning as of the first date of the Employee’s employment with Edwards and ending 12 months after termination of the Employee’s employment, regardless of the reason for the termination.

(c)If the Employee’s State of Employment is:
California or North Dakota
“Covenant Period” shall mean the period beginning as of the first date of the Employee’s employment with Edwards and ending upon the termination of the Employee’s employment with Edwards.
The provisions of Section 2.3.2 are hereby replaced with the following language, which shall become Section 2.3.2 for said Employees:
The Employee further agrees that he/she will neither directly nor indirectly, during his/her employment with Edwards and for one (1) year thereafter, solicit any individual, who at the time of termination of Employee’s employment with Edwards for any reason was an Edwards employee or consultant, to leave Edwards or to terminate his/her employment or consulting engagement with Edwards.
(d)If the Employee’s State of Employment is:
Oklahoma
“Covenant Period” shall mean the period beginning as of the first date of the Employee’s employment with Edwards and ending 12 months after termination of the Employee’s employment, regardless of the reason for the termination. Provided, however, that the restrictions set forth in Section 2.4.1 and 2.4.2 shall prohibit the Employee during the Covenant Period only from soliciting or contacting, directly or indirectly, an established Edwards’ Customer in connection with or relating to a Competing Product.
Revised January 2024 (v. 2024.1)
8


(e)If the Employee’s State of Employment is:
Minnesota
For purposes of Section 2.4.1, “Covenant Period” shall mean the period beginning as of the first date of the Employee’s employment with Edwards and ending upon the termination of the Employee’s employment with Edwards. For purposes of Section 2.4.2, “Covenant Period” shall mean the period beginning as of the first date of the Employee’s employment with Edwards and ending 12 months after termination of the Employee’s employment, regardless of the reason for the termination.
(f)If the Employee’s State of Employment is Massachusetts, this Agreement shall be governed by the laws of the Commonwealth of Massachusetts and any civil action relating to this Agreement shall be brought in the county in which the Employee resides or, if mutually agreed, in Suffolk County, Massachusetts in the Superior Court or the Business Section of the Superior Court. Section 2.4.1 applies only to the specific types of services provided by the Employee at any time during the last two (2) years of employment and applies only in geographic areas in which the Employee, during any time within the last two (2) years of employment, provided services or had a material presence or influence. The Employee and Edwards mutually agree that Sections 2.4.1 and 2.4.2 are supported by the sign-on bonus provided to the Employee in connection with Edwards’ offer of employment.
(g)If the Employee is employed in Louisiana at the time of signature, the Restrictive Covenants set forth in Sections 2.3, 2.4.1, 2.4.2 shall apply only within the parish in which the Employee resides and adjacent parishes, at the time of executing this Agreement and only for so long as Edwards or its assignee carries on a like business therein. Any civil action relating to this Agreement shall be brought in the state or Federal court in or for the parish in which the Employee resides at the time of executing this Agreement and shall be governed by the laws of Louisiana.
(h)If the Employee’s State of Employment is Illinois, the following terms shall apply: The Employee and Edwards mutually agree that Sections 2.4.1 and 2.4.2 are supported by the sign-on bonus provided to the Employee in connection with Edwards’ offer of employment.
(i)If the Employee’s State of Employment is Maine, section 2.4.1 shall apply only to the extent that the Employee is employed at least one (1) year by Edwards or remains employed by Edwards for at least six (6) months after signing this Agreement, whichever is longer.


Revised January 2024 (v. 2024.1)
9


SCHEDULE B


(a)If the Employee’s State of Employment is California: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of Cal. Lab. Code § 2870, where the Employee developed the Invention entirely on his/her own time, without using Edwards’ equipment, supplies, facilities, or trade secret information, except for those Inventions that either: (1) relate at the time of conception or reduction to practice of the Invention to Edwards’ business, or actual or demonstrably anticipated research or development of Edwards, or (ii) result from any work performed by the Employee for Edwards.
(b)If the Employee’s State of Employment is Delaware: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of Delaware Code Title 19 § 805, where the Employee developed the Invention entirely on his/her own time, without using Edwards’ equipment, supplies, facility, or trade secret information, except for those Inventions that: (i) relate to Edwards' business or actual or demonstrably anticipated research or development, or (ii) result from any work performed by the Employee for Edwards.
(c)If the Employee’s State of Employment is Illinois: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of 765 Ill. Comp. Stat. 1060/2, to an Invention for which no equipment, supplies, facilities, or trade secret information of Edwards was used and which was developed entirely on the Employee’s own time, unless (a) the Invention relates (i) to the business of Edwards, or (ii) to Edwards' actual or demonstrably anticipated research or development, or (b) the Invention results from any work performed by the Employee for Edwards.
(d)If the Employee’s State of Employment is Kansas: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of K.S.A. § 44-130, to an Invention for which no equipment, supplies, facility, or trade secret information of Edwards was used and which was developed entirely on the Employee’s own time, unless: (1) the Invention relates directly to the business of Edwards or to Edwards’ actual or demonstrably anticipated research or development; or (2) the Invention results from any work performed by the Employee for Edwards. Even though the Employee meets the burden of proving the conditions specified in this section, the Employee shall disclose, at the time of employment or thereafter, all Inventions being developed by the Employee, for the purpose of determining employer and employee rights in an Invention.
(e)If the Employee’s State of Employment is Minnesota: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of M.S.A. § 181.78, to an Invention for which no equipment, supplies, facility, or trade secret information of Edwards was used and which was developed entirely on the Employee’s own time, and (1) which does not relate (a) directly to the business of Edwards or (b) to Edwards' actual or demonstrably anticipated research or development, or (2) which does not result from any work performed by the Employee for Edwards.
(f)If the Employee’s State of Employment is North Carolina: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of North Carolina General Statute § 66-57.1, to an Invention for which no equipment, supplies, facility, or trade secret information of Edwards was used and which was developed entirely on the Employee’s own time, unless: (1) the Invention relates to the business of Edwards or to Edwards’ actual or demonstrably anticipated research or development; or (2) the Invention results from any work performed by the Employee for Edwards. The employee shall bear the burden of proof in establishing that the Invention qualifies under this section.
(g)If the Employee’s State of Employment is Utah: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of U.C.A. § 34-39-3, to an Invention that is (1) created by the Employee entirely on his/her own time, and (2) is not an employment Invention.
(h)If the Employee’s State of Employment is Washington: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of R.C.W. § 49.44.140, to an Invention for which no equipment, supplies, facilities, or trade secret information of Edwards was used and which was developed entirely on the Employee’s own time, unless (a) the Invention relates (i) directly to the business of Edwards, or (ii) to Edwards' actual or demonstrably anticipated research or development, or (b) the Invention results from any work performed by the Employee for Edwards.

(i)If the Employee’s State of Employment is New York: The Employee’s assignment to Edwards, as set forth in Section 3.1, shall not apply to any Invention that qualifies fully under the provisions of New York Labor Law, Art 7, § 203-f, to an Invention that the Employee developed entirely on his or her own time without using Edwards’ equipment, supplies, facilities, or trade secret information except for those Inventions that either: (a) relate at the time of conception or reduction to practice of the Invention to Edwards’
Revised January 2024 (v. 2024.1)
10


business, or actual or demonstrably anticipated research or development of Edwards; or (b) result from any work performed by the Employee for Edwards.


Revised January 2024 (v. 2024.1)
11


SCHEDULE C

DISCLOSURES PURSUANT TO SECTION 3.5 “PRIOR INVENTIONS”


_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________

_________________________________________________________________________________________________
Revised January 2024 (v. 2024.1)
12
 EX-21.1 3 ex-21110xkq42023.htm EX-21.1 Document

Exhibit 21.1

The following is a list of subsidiaries of Edwards Lifesciences Corporation, omitting subsidiaries which, considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary as of December 31, 2023:


Legal Entity  State of
Incorporation/
Formation		 Country of
Incorporation/
Formation
Edwards Lifesciences LLC Delaware U.S.
Edwards Lifesciences Services GmbH   Germany
Edwards Lifesciences (U.S.) Inc.DelawareU.S.
Edwards Lifesciences (Japan) Limited   Japan


 EX-23 4 ex-2310xkq42023.htm EX-23 Document

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-33054, 333-33056, 333-40434, 333-52334, 333-52346, 333-60670, 333-98219, 333-105961, 333-127260, 333-150810, 333-154242, 333-168462, 333-183106, 333-192229, 333-195853, 333-204180, 333-211333, 333-217909, 333-255853, and 333-255854) and Form S-3 (No. 333-266272) of Edwards Lifesciences Corporation of our report dated February 12, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP
Irvine, California
February 12, 2024


EX-31.1 5 ex-31110xkq42023.htm EX-31.1 Document

Exhibit 31.1

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Bernard J. Zovighian, certify that:
1.I have reviewed this annual report on Form 10-K of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By:/s/ BERNARD J. ZOVIGHIAN
Bernard J. Zovighian
Chief Executive Officer
February 12, 2024


 EX-31.2 6 ex-31210xkq42023.htm EX-31.2 Document

Exhibit 31.2

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATIONS PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Scott B. Ullem, certify that:
1.I have reviewed this annual report on Form 10-K of Edwards Lifesciences Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
By:/s/ SCOTT B. ULLEM
Scott B. Ullem
 Corporate Vice President,
Chief Financial Officer
February 12, 2024

EX-32 7 ex-3210xkq42023.htm EX-32 Document

Exhibit 32

EDWARDS LIFESCIENCES CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Edwards Lifesciences Corporation (the "Company") on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Bernard J. Zovighian, Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ BERNARD J. ZOVIGHIAN
February 12, 2024
Bernard J. Zovighian
 Chief Executive Officer
/s/ SCOTT B. ULLEM
February 12, 2024
Scott B. Ullem
 Corporate Vice President,
 Chief Financial Officer


 EX-97.1 8 ex-97110xkq42023.htm EX-97.1 Document
Exhibit 97.1
EDWARDS LIFESCIENCES CORPORATION
Policy for Recovery of Erroneously Awarded Compensation
This Policy for Recovery of Erroneously Awarded Compensation (the “Policy”) has been adopted by the Compensation and Governance Committee (the Committee”) of the Board of Directors (the “Board”) of Edwards Lifesciences Corporation (the “Company”) on October 31, 2023. Capitalized terms used in this Policy but not otherwise defined at the time when first used are defined in Section 9 herein.
1.Purpose
This Policy is intended to comply with the requirements of Rule 10D-1 promulgated by the Securities and Exchange Commission and the related listing rules of the New York Stock Exchange (“NYSE”), and the terms hereof shall be construed consistent with that intent.
2.Persons Subject to Policy
This Policy applies to any person who received Incentive-Based Compensation (i) after beginning service as an Officer, (ii) who served as an Officer at any time during the performance period for that compensation, (iii) while the Company had a class of its securities listed on a national securities exchange or association, and (iv) during the applicable Three-Year Period.
3.Compensation Subject to Policy
This Policy shall apply to Incentive-Based Compensation received on or after October 2, 2023 (the “Effective Date”).
For purposes of this Policy, Incentive-Based Compensation is considered “received” by an Officer in the Company’s fiscal period during which the Financial Reporting Measure applicable to that Incentive-Based Compensation is attained, even if, for example, the payment or grant of the Incentive-Based Compensation occurs after the end of that fiscal period.
4.Recovery of Compensation
In the event the Company is required to prepare a Restatement, the Company shall recover reasonably promptly the amount of any Erroneously Awarded Compensation from each Officer unless an exception (set forth in Section 6 below) applies.
Recovery shall be required in accordance with this Policy regardless of whether the applicable Officer engaged in misconduct or otherwise caused or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company. The Company shall not indemnify any Officer against the loss of Erroneously Awarded Compensation that is recovered by the Company pursuant to this Policy. Further, any action by the Company to recover Erroneously Awarded Compensation under this Policy from an Officer will not, whether alone or in combination with any other action, event, or condition, (i) give rise to such Officer’s right to voluntarily terminate employment or resign for “good reason,” or due to a “constructive termination” (or any similar term of like effect) under any plan, program, policy of, or an agreement with the Company or any of its affiliates, or (ii) constitute a breach of a contract or other arrangement to which such Officer is a party.
5.Manner of Recovery
The Committee shall determine the amount of recovery of any Erroneously Awarded Compensation based on the parameters set forth in Rule 10D-1(d) under the Securities Exchange Act of 1934, as amended, which may include, without limitation, a reimbursement or repayment of the Erroneously Awarded Compensation; a reduction or cancellation of Incentive-Based Compensation, or an offset of the Erroneously Awarded Compensation against other compensation payable to a person subject to this Policy, to the extent permitted by law. Notwithstanding the foregoing, unless otherwise prohibited by the
- 1 -

Applicable Rules, to the extent this Policy provides for recovery of Erroneously Awarded Compensation already recovered by the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 or any employment agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable law (the “Other Recovery Arrangements”), the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation may be credited to the amount of Erroneously Awarded Compensation required to be recovered pursuant to this Policy from such person.
For Incentive-Based Compensation based on stock price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in a Restatement, the amount of Erroneously Awarded Compensation will be determined by the Committee based on a reasonable estimate of the effect of the Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was received. The Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to the NYSE as required by NYSE listing rules.
If the Erroneously Awarded Compensation consists of shares (including share-denominated equity awards) or options that are still held by the Officer at the time of recovery, the recoverable amount is the number of shares or options received in excess of the number of shares or options that would have been received based on the Restatement (or the value of that excess number). If the options have been exercised but the underlying shares have not been sold, the recoverable amount is the number of shares underlying the excess options based on the Restatement (or the value thereof).
6.Exceptions to Recovery
The Company shall not be required under this Policy to recover Erroneously Awarded Compensation if the Committee has made a determination that recovery would be impracticable and (a) after making a reasonable attempt to recover an Erroneously Awarded Compensation, the Committee determines that the direct costs paid to a third party to assist in enforcing recovery would exceed the amount to be recovered (documentation evidencing the reasonable attempt to recover the Erroneously Awarded Compensation must be maintained and provided to NYSE as required by NYSE listing rules); or (b) the recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of Internal Revenue Code Section 401(a)(13) or Internal Revenue Code Section 411(a) and regulations thereunder.
7.Application; Enforceability
Except as otherwise determined by the Committee or the Board, the adoption of this Policy does not limit, and is intended to apply in addition to, any other clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such policies or provisions of such effect contained in Other Recovery Arrangements. The remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company or an affiliate of the Company.
8.Interpretation; Amendment
The Committee shall have the sole authority to construe and interpret this Policy and to make all determinations required to be made pursuant to this Policy. Any such construction, interpretation or determination by the Committee shall be final and binding. The Committee may amend, modify, terminate, or revise this Policy in whole or in part from time to time in its sole discretion.
9.Definitions

•“Erroneously Awarded Compensation” means the amount of Incentive-Based Compensation received by an Officer that exceeds the amount of Incentive-Based Compensation that would have been received by such Officer had it been determined based
- 2 -

on a restated Financial Reporting Measure; these amounts are computed without regard to any taxes paid.

•“Financial Reporting Measures” means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures (including, for purposes of this Policy, stock price and total shareholder return). A Financial Reporting Measure need not be presented within the Company’s financial statements or included in a filing with the Securities and Exchange Commission.

•“Incentive-Based Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures.

•“Officer” means any current or former officer of the Company subject to Section 16 of the Securities Exchange Act of 1934, as amended, at any time during the applicable performance period for the relevant Incentive-Based Compensation, regardless of whether such individual continues to hold such position or continues to be employed by the Company or any of its subsidiaries.

•“Restatement” means an accounting restatement that the Company is required to prepare due to the Company’s material noncompliance with any financial reporting requirement under securities laws, including any required restatement (a) to correct an error in previously issued financial statements that is material to the previously issued financial statements, or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

•“Three-Year Period” means, with respect to a Restatement, the three completed fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare such Restatement, or, if earlier, the date on which a court, regulator, or other legally authorized body directs the Company to prepare such Restatement. The “Three-Year Period” also includes any transition period (that results from a change in the Company’s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence. However, a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months shall be deemed a completed fiscal year.
- 3 -
 EX-101.SCH 9 ew-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - SPECIAL CHARGE AND SEPARATION COSTS link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - DEBT AND CREDIT FACILITIES link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - EMPLOYEE BENEFIT PLANS link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - OTHER INCOME, NET link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - LEGAL PROCEEDINGS link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - BUSINESS COMBINATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - DEBT AND CREDIT FACILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - COMMON STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - OTHER INCOME, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - SPECIAL CHARGE AND SEPARATION COSTS (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - LEASES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - INVESTMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - DEBT AND CREDIT FACILITIES - Schedule of the Notes (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954529 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954530 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9954531 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954532 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954533 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954534 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 9954535 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 9954536 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) link:presentationLink link:calculationLink link:definitionLink 9954537 - Disclosure - COMMON STOCK - Treasury Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954538 - Disclosure - COMMON STOCK - Schedule of Accelerated Share Repurchases (Details) link:presentationLink link:calculationLink link:definitionLink 9954539 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9954540 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954541 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details) link:presentationLink link:calculationLink link:definitionLink 9954542 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954543 - Disclosure - COMMON STOCK - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954544 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9954545 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Change in Unrealized Pension Costs (Details) link:presentationLink link:calculationLink link:definitionLink 9954545 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Change in Unrealized Pension Costs (Details) link:presentationLink link:calculationLink link:definitionLink 9954546 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9954547 - Disclosure - OTHER INCOME, NET (Details) link:presentationLink link:calculationLink link:definitionLink 9954548 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954549 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954550 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954551 - Disclosure - INCOME TAXES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954552 - Disclosure - INCOME TAXES - Schedule of Net Operating Loss Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 9954553 - Disclosure - INCOME TAXES - Schedule of Tax Credit Carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 9954554 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 9954555 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Uncertain Tax Positions (Details) link:presentationLink link:calculationLink link:definitionLink 9954556 - Disclosure - LEGAL PROCEEDINGS (Details) link:presentationLink link:calculationLink link:definitionLink 9954557 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954558 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) link:presentationLink link:calculationLink link:definitionLink 9954559 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954560 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 ew-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 ew-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 ew-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Amount excluded from effectiveness testing recognized in earnings based on an amortization approach Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax Secured Overnight Financing Rate Secured Overnight Financing Rate (SOFR) [Member] Secured Overnight Financing Rate [Member] Other liabilities Other Noncurrent Liabilities [Member] Aggregate borrowings in multiple currencies Line of Credit Facility, Maximum Borrowing Capacity Research and development expenses Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Expiration date (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Investment, Name [Domain] Investment, Name [Domain] Revenue, remaining performance obligation, expected timing of satisfaction, period (in years) Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Accrued relocation costs Accrued Relocation Costs, Current Accrued Relocation Costs, Current Debt and Equity Securities, FV-NI [Line Items] Debt and Equity Securities, FV-NI [Line Items] Litigation settlement accrual (Note 3) Estimated Litigation Liability, Noncurrent Due after 10 years Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Fair Value Schedule of Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Held-to-Maturity Debt Securities, Held-to-Maturity, Maturity [Abstract] Net Tax Benefit Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance Intrinsic value of stock options exercised and restricted stock units vested Share Based Compensation Arrangement by Share Based Payment Award, Intrinsic Value of Stock Options Exercised and Vested Restricted Stock Units This element represents the intrinsic value of stock options exercised and restricted stock units that vested during the period. Option Awards Stock option activity Employee and Nonemployee Stock Options [Member] An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Due after 10 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Fair Value Insider Trading Policies and Procedures [Line Items] Exercisable as of period end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Intrinsic Value Aggregate Intrinsic Value [Abstract] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five Conversion of notes receivable to equity investment Notes Receivable Converted To Equity Investment Notes Receivable Converted To Equity Investment Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] COMMON STOCK Equity [Text Block] Vested and expected to vest as of period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Schedule of Enterprise-Wide Information Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Proceeds from stock plans Proceeds from Stock Plans Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Build of reserve for prior years' uncertain tax positions Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations Defined Benefit Plan, Assumptions [Table Text Block] Current liabilities Liabilities, Current [Abstract] Federal Deferred Federal Income Tax Expense (Benefit) Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding Preferred Stock, Value, Issued Subsequent Event Type [Domain] Subsequent Event Type [Domain] Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Line Items] Diluted (in dollars per share) Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Accounts receivable, net of allowances of $8.3 and $7.9, respectively Accounts Receivable, after Allowance for Credit Loss, Current Amount of gain (loss) reclassified from accumulated OCI into income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Rate of compensation increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Schedule of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Litigation Case [Axis] Litigation Case [Axis] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Trading Symbol Trading Symbol Purchase credit Purchase Credit [Member] Represents information pertaining to purchase credit carryforward. Options granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Less: cash acquired Cash Acquired from Acquisition Due in 1 year or less Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Impairment of Goodwill and Long-lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Machinery and equipment Machinery and Equipment [Member] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Cost Intangible Assets, Gross (Excluding Goodwill) Net actuarial (loss) gain Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax ESPP Employee Stock [Member] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] INVESTMENTS Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Deferred revenue Contract with Customer, Liability Measurement Input, Probability of Milestone Achievement Measurement Input, Probability Of Milestone Achievement [Member] Measurement Input, Probability Of Milestone Achievement [Member] Other Other Intangible Assets [Member] Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Schedule of Computation of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Service cost Service cost, net Defined Benefit Plan, Service Cost Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Executive Category: Executive Category [Axis] CardiAQ CardiAQ Valve Technologies, Inc. [Member] CardiAQ Valve Technologies, Inc. [Member] Valuation Allowance Capital Loss Carryforwards, Valuation Allowance Capital Loss Carryforwards, Valuation Allowance Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Options exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Equity Components [Axis] Equity Components [Axis] Research expenditure tax credits Research Tax Credit Carryforward [Member] Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Entity Small Business Entity Small Business 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Option to acquire investment amount Option To Acquire Investment, Amount Option To Acquire Investment, Amount Notional Amount Derivative, Notional Amount Measurement Frequency [Axis] Measurement Frequency [Axis] Amounts reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Retirement Plan Type [Domain] Retirement Plan Type [Domain] Restricted stock units Nonvested restricted stock unit activity Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Depreciation expense for property, plant and equipment Depreciation Nondeductible employee share-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Retirement Benefits [Abstract] Retirement Benefits [Abstract] Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract] Rest of World Rest of World Rest of World Segment [Member] Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World). Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Schedule of the Notes Schedule of Long-Term Debt Instruments [Table Text Block] Changes to noncontrolling interest (Note 9) Noncontrolling Interest, Period Increase (Decrease) Harpoon Medical Harpoon Medical, Inc. [Member] Harpoon Medical, Inc. [Member] Transcatheter Mitral and Tricuspid Therapies Transcatheter Mitral And Tricuspid Therapies [Member] Transcatheter Mitral And Tricuspid Therapies [Member] Mortgages Mortgages [Member] Taxes payable Accrued Income Taxes, Current Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Domestic Plan Domestic Plan [Member] Special Charge Special Charge [Member] Special Charge Research and development expenses Research and Development Expense [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Award Type [Axis] Award Type [Axis] Anti-dilutive securities excluded from the computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Insurance contracts Insurance Contracts Insurance Contracts [Member] This element represents the information about insurance contracts. October 2022 Stock Repurchase Program Shares Sold In December 2022 October 2022 Stock Repurchase Program Shares Sold In December 2022 [Member] October 2022 Stock Repurchase Program Shares Sold In December 2022 Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Hedging Designation [Axis] Hedging Designation [Axis] Carrying amount of goodwill Goodwill [Line Items] Total property, plant and equipment, gross Property, Plant and Equipment, Gross Right-of-use assets obtained in exchange for new lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Derivatives designated as hedging instruments Derivatives, Fair Value [Line Items] Schedule of Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Derivative Liabilities Offsetting Derivative Liabilities [Abstract] Operating lease liabilities (Note 6) Operating lease liabilities, current portion Operating Lease, Liability, Current Prepaid expenses Prepaid Expense, Current Proceeds from sales and maturities of available-for-sale investments (Note 7) Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Net Carrying Value Finite-Lived Intangible Assets, Net Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] New Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Tax valuation allowance SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Expected employer contributions Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities Offsetting Liabilities [Table Text Block] Tax Benefit Amount Deferred Tax Assets, Capital Loss Carryforwards Compensation and benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Counterparty Name [Domain] Counterparty Name [Domain] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Fair value of the notes, based on Level 2 inputs Debt Instrument, Fair Value Disclosure Schedule of Income Before Provisions for Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Outside of the United States, including Puerto Rico Income (Loss) from Continuing Operations before Income Taxes, Foreign Less: Noncontrolling interest Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net Weighted-average assumptions used to determine the benefit obligations Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Gross profit Gross Profit Schedule of Weighted-Average Assumptions for Options Granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Selling, general, and administrative expenses Selling, general, and administrative expenses Selling, General and Administrative Expense Payment for option to acquire company Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment Accumulated other comprehensive loss (Note 16) Accumulated Other Comprehensive Income (Loss), Net of Tax Prior service credit arising during period Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Percentage vesting upon retirement for each full year of employment subsequent to the grant date (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Employee Stock Option Employee Stock Option [Member] DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] Initial Delivery Of Shares Settled December 2023 Initial Delivery Of Shares Settled December 2023 [Member] Initial Delivery Of Shares Settled December 2023 Investments Investment, Policy [Policy Text Block] Value of Shares as % of Contract Value Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement. Financial Instruments Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Corporate items Costs and Expenses Interest expense (benefit), net of tax benefit Unrecognized Tax Benefits, Interest on Income Taxes Expense Net Amount Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election 2018 Notes Senior Notes Due 2018 [Member] Represents information pertaining to senior notes which are due in 2018. Maximum High Maximum [Member] Employee stock purchase subscriptions Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Property, plant, and equipment, net Property, Plant and Equipment, Net [Abstract] Document Type Document Type Goodwill acquired during the year Goodwill, Acquired During Period Audit Information [Abstract] Audit Information [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Settlements and curtailment gain Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Number of lawsuits that if settled could have a material adverse impact on net income or cash flows Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number Tabular List, Table Tabular List [Table Text Block] Net actuarial gain (loss) arising during period Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Cross currency swap contracts Cross currency swap contracts Currency Swap [Member] Purchases of treasury stock Purchases of treasury stock Treasury Stock, Value, Acquired, Cost Method General and administrative costs included in inventory General and Administrative Costs in Inventory, Amount Remaining Inventories Inventory, Policy [Policy Text Block] Gross Unrealized Gains Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Fair value of derivatives Derivative Liability, Current Federal Current Federal Tax Expense (Benefit) Other Other Noncash Income (Expense) Purchases of available-for-sale investments (Note 7) Payments to Acquire Debt Securities, Available-for-Sale Business Acquisition [Axis] Business Acquisition [Axis] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Annual award to nonemployee director Share-based Compensation Arrangements Award Granted Annually to Nonemployee Director [Member] This element represents details pertaining to an award granted annually to a nonemployee director. Derivative [Table] Derivative [Table] Restricted cash included in other assets Restricted Cash, Noncurrent State and local Deferred State and Local Income Tax Expense (Benefit) Variable Rate [Axis] Variable Rate [Axis] Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Special charge and separation costs (Note 4) Special charge and separation costs Other Nonrecurring (Income) Expense Raw materials Inventory, Raw Materials, Net of Reserves Options forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Actuarial loss (gain) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Related Party [Domain] Related Party, Type [Domain] BUSINESS COMBINATIONS Business Combination Disclosure [Text Block] Accelerated Share Repurchases [Table] Accelerated Share Repurchases [Table] In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Operating segments Operating Segments [Member] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Additional authorized amount Stock Repurchase Program, Additional Authorized Amount Stock Repurchase Program, Additional Authorized Amount Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Gain on insurance settlement Insured Event, Gain (Loss) Entity Tax Identification Number Entity Tax Identification Number Currency translation adjustment Goodwill, Foreign Currency Translation Gain (Loss) Carryforward Period Ends 2026-2041 Tax Carryforwards Expiration Period Years 2026-2041 [Member] Tax Carryforwards Expiration Period Years 2026-2041 [Member] Europe Europe Europe Segment [Member] Represents the Europe reportable segment of the entity. Inventories Deferred Tax Assets, Inventory Statistical Measurement [Axis] Statistical Measurement [Axis] MRSUs Market Based Restricted Stock Units [Member] Market Based Restricted Stock Units [Member] Instruments not due at a single maturity date Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Total purchase price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Due after 1 year through 5 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost Surgical Structural Heart Surgical Heart Valve Therapy [Member] This element represents the surgical heart valve therapy product line. Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Due in 1 year or less Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Revenue Recognition and Shipping and Handling Costs Revenue from Contract with Customer [Policy Text Block] Other intangible assets Deferred Tax Liabilities, Goodwill and Intangible Assets Financial Instruments Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Settlements and curtailment gain Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment Percentage of discount rate Business Combination, Assets Acquired, Measurement Input Business Combination, Assets Acquired, Measurement Input Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Derivatives Derivatives, Policy [Policy Text Block] State income taxes Deferred Tax Assets, State Taxes Settlements Defined Benefit Plan, Plan Assets, Payment for Settlement Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Credit Agreement Credit Agreement [Member] Credit Agreement 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Amounts included in the measurement of operating lease liabilities Operating Lease, Payments Common stock, shares outstanding (in shares) Common stock, beginning balance (in shares) Common stock, ending balance (in shares) Common Stock, Shares, Outstanding Company match, second level (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent of Match, Second Level Percentage employer matches for the second level of the employee's percentage contribution matched. Interest cost Interest cost Defined Benefit Plan, Interest Cost Maximum additional option to acquire investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] PEO PEO [Member] Held-to-maturity Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract] Auditor Location Auditor Location Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] EMPLOYEE BENEFIT PLANS Retirement Benefits [Text Block] Change in fair value of plan assets: Insurance Contracts Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Cash Defined Benefit Plan, Cash and Cash Equivalents [Member] Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred Tax benefit of accrued interest Unrecognized Tax Benefits, Accrued Interest, Tax Benefit The tax benefits pertaining to the amount of interest expense accrued on unrecognized tax benefits. Defined Contribution Plans Defined Contribution Plan Disclosure [Line Items] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] State and local taxes, net of federal tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Litigation settlement Estimated Litigation Liability, Current Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Carrying value of non-marketable equity securities Equity Securities, FV-NI, Current Taxes payable (Note 18) Taxes Payable Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Due after 1 year through 5 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Measurement Input Type [Domain] Measurement Input Type [Domain] Credit Facility [Axis] Credit Facility [Axis] Prepaid royalty asset Prepaid Royalties Total liabilities Liabilities Current income tax expense Current Income Tax Expense (Benefit) Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Total fair value Debt Securities, Available-for-Sale, Unrealized Loss Position Measurement Frequency [Domain] Measurement Frequency [Domain] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Capitalized research and development expenses Deferred Tax Assets, in Process Research and Development Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Weighted-average assumptions used to determine the net periodic benefit cost Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Decrease in unrecognized tax benefits is reasonably possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Tax Carryforwards Expiration Period Years 2026-2039 Tax Carryforwards Expiration Period Years 2026-2039 [Member] Tax Carryforwards Expiration Period Years 2026-2039 Other comprehensive income (loss) Other Comprehensive Income (Loss), before Tax United States government bonds US Government Debt Securities [Member] Fair value, less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Deferred income tax (expense) benefit Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Accrued professional services Accrued Professional Fees, Current Net deferred tax assets increase Increase (Decrease) in Deferred Tax Assets (Liabilities), Net The increase or decrease during the year in net deferred tax assets. Includes items recorded to stockholders' equity and which did not impact the income tax provision. Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] State and local Current State and Local Tax Expense (Benefit) Total current assets Assets, Current Pre-Tax Amount Other Comprehensive Income (Loss), before Tax [Abstract] Total investments in unconsolidated entities Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Net periodic pension benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Impairment charges (Note 4) Asset Impairment Charges Contingent consideration, liability Business Combination, Contingent Consideration, Liability Cash paid during the year for: Supplemental Cash Flow Information [Abstract] Long-term prepaid royalties (Note 3) Increase (Decrease) in Prepaid Royalties Equity securities Defined Benefit Plan, Equity Securities [Member] Carryforward Amount Capital Loss Carryforwards Capital Loss Carryforwards Retirement Plan Name [Domain] Retirement Plan Name [Domain] Japan JAPAN Earnings per Share Earnings Per Share, Policy [Policy Text Block] GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Fair value beginning balance Fair value ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Due after 1 year through 5 years Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value Current Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Schedule of Tax Credit Carryforwards Summary of Tax Credit Carryforwards [Table Text Block] Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Five U.S. government and agency securities United States government and agency securities US Treasury and Government [Member] Accelerated Share Repurchase Accelerated Share Repurchases [Line Items] Asset-backed securities Asset-Backed Securities [Member] Accounts Receivable Accounts Receivable [Policy Text Block] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Exercisable as of period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Estimated Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Amortization of prior service credit Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Company match of eligible compensation after dollar-for-dollar basis (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent, Second Level Represents the percentage of the second level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Depreciation and amortization Depreciation, Depletion and Amortization Other income, net Other Operating Income (Expense), Net Due after 10 years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Due in 1 year or less Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss Allowance for credit losses SEC Schedule, 12-09, Allowance, Credit Loss [Member] Business Combination and Asset Acquisition [Abstract] Consolidation Items [Axis] Consolidation Items [Axis] Long-lived tangible assets Long-Lived Assets Valuation allowance Valuation allowance that reduces certain deferred tax assets Deferred Tax Assets, Valuation Allowance Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Revenue recognized that was previously deferred Contract with Customer, Liability, Revenue Recognized Valuation and Qualifying Accounts Disclosure SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Period used to evaluate slow-moving inventory levels (in years) Inventory Write Down Slow Moving Period Trigger The time period used to identify slow-moving inventory which triggers an inventory write-down. Unrealized (Loss) Gain on Hedges (Loss) gain on hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] INVESTMENTS IN VARIABLE INTEREST ENTITIES Variable Interest Entity Disclosure [Text Block] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Additional research and development expenditures to be incurred prior to product introduction Business Combination, In-process Research and Development, Expected Costs Business Combination, In-process Research and Development, Expected Costs Other comprehensive (loss) income before reclassifications Prior service credit arising during period OCI, before Reclassifications, before Tax, Attributable to Parent Retirement Plan Name [Axis] Retirement Plan Name [Axis] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Entity Emerging Growth Company Entity Emerging Growth Company United States equities Defined Benefit Plan, Equity Securities, US [Member] Unamortized debt issuance costs Debt Issuance Costs, Net January 2022 Stock Repurchase Program Shares Sold In February 2022 January 2022 Stock Repurchase Program Shares Sold In February 2022 [Member] January 2022 Stock Repurchase Program Shares Sold In February 2022 Other intangible assets, net (Note 10) Net Carrying Value Intangible Assets, Net (Excluding Goodwill) Total deferred tax assets Deferred Tax Assets, Gross Charged to Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Additional deposit Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities In-process research and development Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Common Stock Common Stock [Member] Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Unrealized pension (costs) credits Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Lapse of statutes of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Equity securities Investments, All Other Investments [Abstract] Income Statement Location [Domain] Income Statement Location [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Schedule of Changes in Fair Value of Contingent Consideration Obligation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Total stockholders' equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Carryforward Period Ends 2022 Capital Loss Carryforward Period Ends 2024 [Member] Capital Loss Carryforward Period Ends 2022 [Member] Minimum Low Minimum [Member] Benefits from uncertain tax positions Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves Weighted-average number of common shares outstanding attributable to Edwards Lifesciences Corporation: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Property, plant, and equipment, net (Note 5) Total property, plant and equipment, net Property, Plant and Equipment, Net Other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Cash flow hedge loss to be reclassified Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Accrued and other liabilities Accrued Liabilities and Other Liabilities [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Beginning of year End of year Projected benefit obligation Defined Benefit Plan, Benefit Obligation ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Proceeds from issuance of debt Proceeds from Issuance of Long-Term Debt 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Foreign exchange (gains) losses, net Foreign currency Gain (Loss), Foreign Currency Transaction, before Tax VALUATION AND QUALIFYING ACCOUNTS SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Other Deferred Tax Assets, Other Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Deferred income taxes Deferred Income Tax Assets, Net Retirement Plan Type [Axis] Retirement Plan Type [Axis] Property, payroll, and other taxes Accrual for Property Payroll and Other Taxes Other than Income Taxes Current Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] LEGAL PROCEEDINGS Commitments and Contingencies Disclosure [Text Block] Other Payments for (Proceeds from) Other Investing Activities Percentage of interest acquired Business Acquisition, Percentage of Voting Interests Acquired Retained Earnings Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Currency exchange rate changes and other Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Unrealized (loss) gain on hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Basic (in dollars per share) Basic earnings per share (in dollars per share) Earnings Per Share, Basic Accounting Policies [Abstract] Accounting Policies [Abstract] Weighted- Average Remaining Contractual Term Weighted Average Remaining Contractual Term Years [Abstract] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Net deferred tax assets Deferred Tax Assets, Net Beginning of year End of year Plan assets at fair value Defined Benefit Plan, Plan Assets, Amount Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Loss (gain) on investments Gain (Loss) on Investments, Other Income Expense, Net This item represents the portion of gain (loss) on investments categorized by the entity as other income (expense). Includes, but is not limited to, (1) the net realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including those trading securities held for investment under deferred compensation agreements net of the gain (loss) of the related deferred compensation liability; (2) the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied; (3) gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting; (4) losses recognized for other than temporary impairments (OTTI) of the subject investments; and (5) the amount of recovery of investments which had previously been fully or partially written-off. Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Share information (Note 2): Share Information [Abstract] Income taxes Income Taxes Paid Other liabilities Liability, Defined Benefit Pension Plan, Noncurrent Principles of Consolidation Consolidation, Policy [Policy Text Block] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Finished goods inventories held on consignment Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Annual downward price adjustment Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount Accounts receivable, required payment terms (in days) Accounts Receivable, Payment Terms Accounts Receivable, Payment Terms Due after 1 year through 5 years Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years Collections of notes receivable Proceeds from Collection of Notes Receivable Schedule of Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions Summary of Income Tax Contingencies [Table Text Block] Entity Public Float Entity Public Float Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Legal and insurance (Notes 3 and 19) Accrued Litigation And Insurance Reserves Accrued Litigation And Insurance Reserves Net Tax Benefit Tax Credit Carryforward, Deferred Tax Asset, Net of Valuation Allowance Represents the amount after allocation of valuation allowances of deferred tax asset attributable to tax credit carryforwards. Equipment with customers Equipment with Customers The gross amount, as of the balance sheet date, of long-lived, depreciable equipment at customer locations. Derivative Instrument [Axis] Derivative Instrument [Axis] Amount Long-Term Debt, Gross Foreign earnings to be repatriated Foreign Earnings To Be Repatriated Foreign Earnings To Be Repatriated Issuance costs Debt Issuance Cost, Gross, Noncurrent Liability Class [Axis] Liability Class [Axis] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Maximum secured promissory note Equity Securities, FV-NI, Maximum Secured Promissory Note Equity Securities, FV-NI, Maximum Secured Promissory Note Compensation Amount Outstanding Recovery Compensation Amount Period when cash flows associated with future transactions and certain local currency expenses are expected to occur (in months) Maximum Length of Time, Foreign Currency Cash Flow Hedge Other comprehensive income (loss), net of tax (Note 16): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Derivatives Fair value of derivative assets Net Amounts Presented in the Consolidated Balance Sheet Derivative Asset Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Deferred income tax benefit Deferred Income Tax Expense (Benefit) Subsequent Event Type [Axis] Subsequent Event Type [Axis] Cash from exercises of stock options Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Dollar-for-dollar match of employee's annual eligible compensation (as a percent) Defined Contribution Plan Employer Matching Contribution Percent, First Level Represents the percentage of the first level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan. Schedule of Investments in Unconsolidated Affiliates Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block] Options forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] Net amounts recognized on the consolidated balance sheet: Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Accumulated benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Cash balance interest crediting rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate Accrued realignment reserves Restructuring Reserve, Current Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Machinery and equipment Machinery and Equipment, Gross Weighted-average interest rate under all debt obligations (as a percent) Long-Term Debt, Weighted Average Interest Rate, at Point in Time Dilutive effect of stock plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Payments on debt and finance lease obligations Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security Document Period End Date Document Period End Date Adoption Date Trading Arrangement Adoption Date February 2023 Stock Repurchase Program, Shares Sold In March 2023 February 2023 Stock Repurchase Program, Shares Sold In March 2023 [Member] February 2023 Stock Repurchase Program, Shares Sold In March 2023 Treasury Stock Treasury Stock, Common [Member] Amount Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Puerto Rico PUERTO RICO Provision for income taxes (Note 18) Provision for income taxes Total income tax provision Income Tax Expense (Benefit) International Foreign Non-US [Member] Amount accrued under nonqualified plans Deferred Compensation Liability, Current and Noncurrent Loans receivables, maximum lending amount Loans Receivables, Maximum Lending Capacity Loans Receivables, Maximum Lending Capacity Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Amortization of prior service credit Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Valuation Allowance Operating Loss Carryforwards, Valuation Allowance Payments for legal settlements Payments for Legal Settlements Gross unrealized losses, 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Equity [Abstract] Equity [Abstract] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Fair value of net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Weighted-average discount rate Lessee, Operating Lease, Discount Rate Schedule of Information Regarding Defined Benefit Pension Plans Defined Benefit Plan, Change in Benefit Obligation Plan Assets, Net Amount Recognized on Balance Sheet [Table Text Block] This element represents the changes in benefit obligations, plan assets and the net amount recognized in the balance sheet for defined benefit plans. Amortization of actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Schedule of Weighted-Average Assumptions for ESPP Subscriptions Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Deferred income taxes Increase (Decrease) in Deferred Income Taxes Carryforward amount Carryforward Amount Tax Credit Carryforward, Amount Gross unrealized losses, less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Repayments of pre-existing notes Repayments of Notes Payable Total purchase price, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Expected return on plan assets (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets Equity method investments Equity Method Investment, Financial Statement, Reported Amounts [Abstract] Credit Facility [Domain] Credit Facility [Domain] Bank time deposits Bank Time Deposits [Member] Purchases of treasury stock (in shares) Shares Received (in shares) Treasury Stock, Shares, Acquired Contingent consideration liabilities Obligations, Fair Value Disclosure Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Estimated useful life (in years) Property, Plant and Equipment, Useful Life Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Lease liability obligations Deferred Tax Assets, Lease Liability Obligations Deferred Tax Assets, Lease Liability Obligations Contingent Consideration Contingent Consideration Liability [Member] Contingent Consideration Liability Discount rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Variable Interest Entities [Abstract] Variable Interest Entities Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Additional paid-in capital Additional Paid in Capital, Common Stock Interest income, net Interest Income [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Document Annual Report Document Annual Report Balance Sheet Location [Axis] Balance Sheet Location [Axis] Accrued and other liabilities (Note 5) Total accrued and other liabilities Accrued And Other Liabilities, Current Other Other Liabilities [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Tax Period [Axis] Tax Period [Axis] United States UNITED STATES Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Fair Value on a Recurring Basis Fair Value, Recurring [Member] Other liabilities Other Liabilities, Noncurrent Total lease payments Lessee, Operating Lease, Liability, to be Paid Schedule of Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Short-term investments (Note 7) Short-Term Investments Other income, net Other Nonoperating Income (Expense) [Member] Cash flow hedges Cash Flow Hedging [Member] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] International government bonds Debt Security, Government, Non-US [Member] Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Rest of World Rest of World [Member] Represents the geographic areas of the world other than the United States, Europe and Japan. Equity Component [Domain] Equity Component [Domain] Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets Offsetting Assets [Table Text Block] Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent State and local jurisdiction United States state net operating losses California research expenditure tax credits State and Local Jurisdiction [Member] Work in process Inventory, Work in Process, Net of Reserves Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Other Deferred Tax Liabilities, Other Estimated annual forfeiture rate (as a percent) Estimated Annual Forfeiture Rate Percent This element represents the estimated annual forfeiture rate of the entity's stock-based compensation plans, percentage. Entity Current Reporting Status Entity Current Reporting Status Offsetting Assets [Line Items] Offsetting Assets [Line Items] Donald Bobo, Jr [Member] Donald Bobo, Jr Operating income Operating income Operating Income (Loss) Rate of compensation increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Shipping and Handling Shipping and Handling [Member] Total deferred tax liabilities Deferred Tax Liabilities, Gross Company match, first level (as a percent) Defined Contribution Plan, Employer Matching Contribution Percent of Match First Level Percentage employer matches for the first level of the employee's percentage contribution matched. Consolidated Entities [Domain] Consolidated Entities [Domain] Participant contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Period prior to expiration date which triggers write-down of inventory (in months) Inventory Write Down Expiration Period Trigger The period prior to the expiration date which triggers the write down of inventory, expressed in months. Segments [Axis] Segments [Axis] Cumulative increase in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Net of Tax Amount Other Comprehensive Income (Loss), Net of Tax [Abstract] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Borrowings outstanding Long-Term Line of Credit Initial Delivery Of Shares Settled February 2023 Initial Delivery Of Shares Settled February 2023 [Member] Initial Delivery Of Shares Settled February 2023 Investment option to acquire Equity Securities, FV-NI, Option To Acquire Investment Equity Securities, FV-NI, Option To Acquire Investment Segment Operating Income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Stockholders' equity (Note 15) Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] International equities Defined Benefit Plan, Equity Securities, Non-US [Member] Business combination, net of cash (Note 9) Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options Consolidated Entities [Axis] Consolidated Entities [Axis] Revenue recognized that was previously deferred excluding opening balance Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Variable Rate [Domain] Variable Rate [Domain] Investees Voting Stock Investees Voting Stock [Member] Investees Voting Stock [Member] Net loss attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Entity Voluntary Filers Entity Voluntary Filers Statistical Measurement [Domain] Statistical Measurement [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number DEBT AND CREDIT FACILITIES Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Offsetting Assets [Table] Offsetting Assets [Table] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Revolving Credit Facility Revolving Credit Facility [Member] Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Accrued and other liabilities Accrued And Other Liabilities, Current [Member] Accrued And Other Liabilities, Current Total Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Exercisable as of period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Real estate Defined Benefit Plan, Real Estate [Member] Instruments not due at a single maturity date Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Restatement Determination Date: Restatement Determination Date [Axis] Investment, Name [Axis] Investment, Name [Axis] Corporate debt securities Corporate Debt Securities [Member] Non-operating income Nonoperating Income (Expense) Commitments and contingencies (Notes 6, 11, and 19) Commitments and Contingencies Impairment of intangible assets Impairment charges Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Construction in progress Construction in Progress, Gross Debt securities Defined Benefit Plan, Debt Security [Member] Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] Foreign Plan Foreign Plan [Member] INCOME TAXES Income Tax Disclosure [Text Block] 2028 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Leases Lessee, Leases [Policy Text Block] SPECIAL CHARGE AND SEPARATION COSTS Unusual or Infrequent Items, or Both, Disclosure [Text Block] Gain (loss) on fair value hedging relationships: Effect of Fair Value Hedges on Results of Operations [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Business Acquisition [Line Items] Business Acquisition [Line Items] Weighted- Average Grant-Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Inventories Inventory, Net [Abstract] Issuances of notes receivable Payments to Acquire Receivables Gross Amounts Derivative Liability, Subject to Master Netting Arrangement, before Offset PEO Total Compensation Amount PEO Total Compensation Amount Tax reductions compared to local statutory rates per diluted share (in dollars per share) Income Tax Holiday, Income Tax Benefits Per Share Hedging Relationship [Axis] Hedging Relationship [Axis] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Land Land Goodwill Goodwill [Roll Forward] Vested and expected to vest as of period end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Schedule of Target Weighted-Average Asset Allocations and Fair Value Schedule of Allocation of Plan Assets [Table Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Treasury stock (in shares) Treasury stock, beginning balance (in shares) Treasury stock, ending balance (in shares) Treasury Stock, Common, Shares Carryforward Period Ends 2033-2037 Carryforward Period Ends 2033-2037 [Member] Carryforward Period Ends 2033-2037 [Member] 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year One Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Buildings and improvements Building and Building Improvements [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Fair value, per share (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Other comprehensive income (loss) Other Comprehensive Income (Loss), Tax Net income attributable to Edwards Lifesciences Corporation. Net Income (Loss) Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Schedule of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name LEASES Lessee, Operating Leases [Text Block] Tax reductions compared to local statutory rates Income Tax Holiday, Aggregate Dollar Amount LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Currency exchange rate changes and other Currency exchange rate impact Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Total plan assets measured at fair value Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member] Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Cost of sales Cost of sales Cost of Goods and Services Sold Vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Schedule of Indefinite-Lived Other Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Foreign currency contracts Foreign Exchange Contract [Member] Fair Value Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract] Name Measure Name Patents Patents [Member] Name Forgone Recovery, Individual Name Intellectual property agreement accrual Increase (Decrease) In Legal Settlement Accrual Increase (Decrease) In Legal Settlement Accrual Net Tax Benefit Deferred Tax Assets Operating Loss Carryforwards Net of Valuation Allowance Represents the amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Goodwill (Note 10) Goodwill Beginning balance Ending balance Goodwill Increase in prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Maximum additional required investment Equity Securities, FV-NI, Maximum Additional Required Equity Securities, FV-NI, Maximum Additional Required Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Measurement Basis [Axis] Measurement Basis [Axis] Underlying Securities Award Underlying Securities Amount Medical Technology Company Medical Technology Company [Member] Medical Technology Company ACCUMULATED OTHER COMPREHENSIVE LOSS Comprehensive Income (Loss) Note [Text Block] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Selling, general, and administrative expenses Selling, General and Administrative Expenses [Member] Unrealized gain (loss) on available-for-sale investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Funded Status Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract] Lease commitments for leases not yet commenced Lessee, Operating Lease, Lease Not Yet Commenced, Amount Lessee, Operating Lease, Lease Not Yet Commenced, Amount Operating lease liabilities (Note 6) Operating lease liabilities, long-term portion Operating Lease, Liability, Noncurrent Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Term of the credit agreement (in years) Debt Instrument, Term Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Deferred tax on foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Amortization of prior service credit Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Income Statement Location [Axis] Income Statement Location [Axis] Total stock-based compensation expense, net of tax Share-Based Payment Arrangement, Expense, after Tax Valuation Allowance Tax Credit Carryforward, Valuation Allowance Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Change in projected benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Foreign currency forward exchange contracts Foreign Exchange Forward [Member] Europe Europe [Member] Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Foreign earnings to be indefinitely reinvested Undistributed Earnings of Foreign Subsidiaries Defined Contribution Plan [Table] Defined Contribution Plan [Table] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Cash Collateral Received Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset Inventories Increase (Decrease) in Inventories Profit sharing contribution calculated on eligible earnings (as a percent) Defined Contribution Plan Profit Sharing Contribution Rate For a defined contribution plan, the percent of the participant's eligible compensation that the employer will contribute to the profit sharing plan. Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Plan Name [Domain] Plan Name [Domain] Interest expense Interest Expense Capital expenditures accruals Capital Expenditures Incurred but Not yet Paid Common stock available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Outstanding as of period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Trading Arrangement: Trading Arrangement [Axis] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] ESPP Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] Contingent consideration liability measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Use of Estimates Use of Estimates, Policy [Policy Text Block] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Available-for-sale Debt Securities, Available-for-Sale [Abstract] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Unamortized discount Debt Instrument, Unamortized Discount Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Unrealized Gain (Loss) on Available-for-sale Investments Gain (loss) on available-for-sale investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Debt Securities, Trading, and Equity Securities, FV-NI [Table] Accrued warranties Product Warranty Accrual, Current Decrease in prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Auditor Firm ID Auditor Firm ID Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Amortization expense related to other intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company Noncontrolling interest, gross Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Long-term investments (Note 7) Long-Term Investments Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Restatement Determination Date Restatement Determination Date Award Date [Domain] Award Date [Domain] Income taxes Increase (Decrease) in Income Taxes Payable Current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash, cash equivalents, and restricted cash at beginning of year Cash, cash equivalents, and restricted cash at end of year (Note 5) Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Realized tax benefits from exercises of stock options and vesting of restricted stock units Employee Service Share Based Compensation, Tax Benefit Realized from Exercise of Stock Options and Vesting of Restricted Stock Units Disclosure of aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock units during the period. Operating lease cost Operating Lease, Cost Fair value, 12 months or greater Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Common stock, shares issued (in shares) Common Stock, Shares, Issued Pension increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Pension Increase This element represents the percentage of increase in pension. Schedule of Restricted Stock Unit Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Schedule of Investments in Debt Securities Unrealized Gain (Loss) on Investments [Table Text Block] Gross Unrealized Losses Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss Treasury stock, at cost, 49.4 and 38.0 shares, respectively Treasury Stock, Common, Value Total assets Assets, Fair Value Disclosure Total carrying amount Long-Term Debt Total gross unrealized losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Schedule of Components of Selected Captions in the Consolidated Balance Sheets Schedule of Selected Captions Balance Sheet Disclosures [Table Text Block] Schedule of the aggregate supplemental balance sheet disclosures, including descriptions and amounts, related to assets and liabilities. Foreign Currency Translation Adjustments Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Weighted-average remaining requisite service period (in months) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Other Proceeds from (Payments for) Other Financing Activities Comprehensive income attributable to Edwards Lifesciences Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Puerto Rico purchases credit Puerto Rico Purchases Credit [Member] Puerto Rico Purchases Credit [Member] Schedule of Benefit Payments Which Reflect Expected Future Service Schedule of Expected Benefit Payments [Table Text Block] Underfunded status Defined Benefit Plan, Funded (Unfunded) Status of Plan United States federal net operating losses Federal research expenditure tax credits Domestic Tax Authority [Member] Entity Address, Address Line One Entity Address, Address Line One December 2023 Stock Repurchase Program, Shares Sold In December 2023 December 2023 Stock Repurchase Program, Shares Sold In December 2023 [Member] December 2023 Stock Repurchase Program, Shares Sold In December 2023 Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Deferred income tax benefit (expense) Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] New Markets Tax Credit New Markets Tax Credit [Member] New Markets Tax Credit Subsequent Event Subsequent Event [Member] Carryforward Amount Operating Loss Carryforwards Maximum percentage of compensation employees can authorize to be withheld for common stock purchases (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Proceeds from sales and maturities of held-to-maturity investments (Note 7) Proceeds from Sale and Maturity of Held-to-Maturity Securities Schedule of Finite-Lived Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Final Settlement Average Price per Share (in dollars per share) Accelerated Share Repurchases, Final Price Paid Per Share General and administrative costs allocated to inventory General and Administrative Costs in Inventory, Amount Incurred Income Statement [Abstract] Income Statement [Abstract] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Contingent consideration liabilities Effective Income Tax Rate Reconciliation, Contingent Consideration Liability Effective Income Tax Rate Reconciliation, Contingent Consideration Liability Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Prior service credit arising during period Other Comprehensive Income (Loss) before Reclassifications, Tax Derivatives Fair value of derivative liabilities Net Amounts Presented in the Consolidated Balance Sheet Derivative Liability Accrued liabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Instruments not due at a single maturity date Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value Tax credit carryforwards and the related carryforward periods Tax Credit Carryforward [Line Items] Common stock issued under equity plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other current assets Other Assets, Current Intellectual property agreement and litigation expense (Note 3) Intellectual property litigation expenses, settlements, and legal costs Litigation, Settlements And Legal Costs Litigation, Settlements And Legal Costs Income tax expense at United States federal statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Diluted: Earnings Per Share, Diluted [Abstract] Tax (Expense) Benefit Other Comprehensive Income (Loss), Tax [Abstract] Carrying value of equity method investments Equity Method Investments United States: Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Inventories (Note 5) Total inventories Inventory, Net Cash flow and net investment hedges Deferred Tax Assets, Hedging Transactions Other Other Investments [Member] United States federal deductible employee share-based compensation Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount Financial Instrument [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Cash balance interest crediting rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate Cash paid directly to acquired company, netted against goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Investments taken period Equity Method Investments, Investment Period Equity Method Investments, Investment Period Total Shareholder Return Amount Total Shareholder Return Amount United States United States United States Segment [Member] Represents the United States reportable segment of the entity. Purchases of treasury stock Payments for Repurchase of Common Stock Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Special charge Restructuring Costs and Asset Impairment Charges Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Outside of the United States, including Puerto Rico Deferred Foreign Income Tax Expense (Benefit) Foreign tax and general business credits Foreign Tax Credit [Member] Foreign Tax Credit Non-cash investing and financing transactions: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Total Edwards Lifesciences Corporation Stockholders' Equity Parent [Member] Segments [Domain] Segments [Domain] Investments held for deferred compensation plans Deferred Compensation Plan Assets Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Schedule of Other Income, Net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Fixed-rate unsecured senior notes Debt Instrument, Face Amount Capital Loss Carryforward [Abstract] Capital Loss Carryforward [Abstract] Capital Loss Carryforward [Abstract] Current assets Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Japan Japan Segment [Member] Represents the Japan reportable segment of the entity. Deferred tax assets Components of Deferred Tax Assets [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Basic: Earnings Per Share, Basic [Abstract] Accounts and other receivables, net Increase (Decrease) in Accounts and Other Receivables Schedule of Accelerated Share Repurchases Accelerated Share Repurchases [Table Text Block] Other receivables Other Receivables Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement [Member] Transcatheter Aortic Valve Replacement [Member] California CALIFORNIA Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Additional tax sought in excess of filing position Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority Gross Amounts Derivative Asset, Subject to Master Netting Arrangement, before Offset Maximum contributions of a participant's eligible compensation (as a percent) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Net income attributable to Edwards Lifesciences Corporation Net Income (Loss) Available to Common Stockholders, Basic Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Enterprise-Wide Information Revenues from External Customers and Long-Lived Assets [Line Items] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Intellectual property litigation expenses Intellectual property agreement and litigation expense Litigation Settlement, Expense Total operating lease liabilities Total lease liabilities Operating Lease, Liability Uncertain tax positions (Note 18) Liability for Uncertainty in Income Taxes, Noncurrent Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Allocation of stock-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accumulated Other Comprehensive Loss Total Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Charged to Costs and Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Matching contributions relating to entity's employees Defined Contribution Plan, Cost Gain (loss) on cash flow hedging relationships: Effect of Cash Flow Hedges on Results of Operations [Abstract] All Executive Categories All Executive Categories [Member] Hemodynamic Monitors Hemodynamic Monitors [Member] Hemodynamic Monitors [Member] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Unrealized Pension (Costs) Credits Unrealized pension costs, net Amortization of pension adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Intellectual property agreement term Intellectual Property Agreement Term Intellectual Property Agreement Term Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Income tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Earnings per share attributable to Edwards Lifesciences Corporation: Earnings Per Share [Abstract] Threshold of disclosing material environmental legal proceedings Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure Hedged items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Common stock, $1.00 par value, 1,050.0 shares authorized, 650.5 and 646.3 shares issued, and 601.1 and 608.3 shares outstanding, respectively Common Stock, Value, Issued Price equal to principal amount, plus accrued and unpaid interest (as a percent) Debt Instrument, Redemption Price, Percentage Alternative investments measured at net asset value Fair Value Measured at Net Asset Value Per Share [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Non-cash operating lease cost Operating Lease, Right-of-Use Asset, Periodic Reduction INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE Legal Matters and Contingencies [Text Block] Tax Carryforwards Expiration Period Ends 2025 Tax Carryforwards Expiration Period Ends 2025 [Member] Tax Carryforwards Expiration Period Ends 2025 Senior Notes Senior Notes [Member] Limited Liability Company Limited Liability Company [Member] Deferred Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] All Individuals All Individuals [Member] Litigation Case [Domain] Litigation Case [Domain] Other income, net (Note 17) Other income, net Other income, net Total other income, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Purchases of held-to-maturity investments (Note 7) Payments to Acquire Held-to-Maturity Securities Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Contingent consideration liabilities (Note 12) Business Combination, Contingent Consideration, Liability, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date Authorized amount for share repurchase Amount Paid Stock Repurchase Program, Authorized Amount Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block] Derivatives designated as hedging instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Fair Value Fair Value Debt Securities, Held-to-Maturity, Fair Value Carryforward period indefinite Carryforward Period Indefinite Tax Carryforwards, No Expiration [Member] Represents tax carryforwards with no expiration. Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Liability for income taxes associated with uncertain tax positions Uncertain gross tax positions, beginning balance Uncertain gross tax positions, ending balance Unrecognized Tax Benefits Income Tax Authority [Axis] Income Tax Authority [Axis] PEO Name PEO Name Schedule of Product Information [Table] Schedule of Product Information [Table] Preferred stock, authorized shares (in shares) Preferred Stock, Shares Authorized Restricted cash included in other current assets Restricted Cash, Current 2029-2033 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Medical Device Company Medical Device Company [Member] Medical Device Company Schedule of Changes in the Carrying Amount of Goodwill, by Segment Schedule of Goodwill [Table Text Block] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Net tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Net prior service cost arising during period Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member] Medtronic Inc Medtronic Inc [Member] Medtronic Inc Other Other Liabilities, Fair Value Disclosure Other accrued liabilities Other Accrued Liabilities, Current SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Corporate items Corporate, Non-Segment [Member] Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Axis] Investee drew additional amount Equity Securities, FV-NI Promissory Note Outstanding Equity Securities, FV-NI Promissory Note Outstanding Other comprehensive income (loss) Other Comprehensive Income, Other, Net of Tax DESCRIPTION OF BUSINESS Nature of Operations [Text Block] Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Fixed interest rate Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total Edwards Lifesciences Corporation stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Net amounts that would favorably affect effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Annual upward price adjustments Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Due after 10 years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Amortized Cost Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Income before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest OTHER INCOME, NET Other Income and Other Expense Disclosure [Text Block] Investments in intangible assets Payments to Acquire Intangible Assets Cumulative decrease in non-marketable equity securities due to observable price changes Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Schedule of Change in Unrealized Pension Costs Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Net investment hedges Net Investment Hedging [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Effective Interest Rate Debt Instrument, Interest Rate, Effective Percentage Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income Derivative Instruments, Gain (Loss) [Table Text Block] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Initial Delivery Of Shares Settled October 2022 Initial Delivery Of Shares Settled October 2022 [Member] Initial Delivery Of Shares Settled October 2022 Document Fiscal Period Focus Document Fiscal Period Focus Weighted-Average Useful Life (in years) Finite-Lived Intangible Asset, Useful Life 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Stock compensation plan Share-Based Payment Arrangement [Member] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation (Notes 2 and 15) Share-Based Payment Arrangement, Noncash Expense Maximum secured promissory note Equity Securities, FV-NI, Maximum Promissory Note Equity Securities, FV-NI, Maximum Promissory Note Non-U.S. Non-United States net operating losses Foreign tax authority Foreign Tax Authority [Member] Developed Technology and In-Process Research and Development Developed Technology And In-Process Research And Development [Member] Developed Technology And In-Process Research And Development [Member] City Area Code City Area Code Product and Service [Axis] Product and Service [Axis] Equity method investment, ownership percentage (as a percent) Investment percentage (in percent) Equity Method Investment, Ownership Percentage Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Accrued marketing expenses Accrued Marketing Costs, Current Lease term (in years) Lessee, Operating Lease, Term of Contract Stock-based Compensation Compensation Related Costs, Policy [Policy Text Block] Nonqualified deferred compensation plans Nonqualified Deferred Compensation Plan Select Employee Group [Member] Represents a nonqualified deferred compensation plan for a select group of employees. Software Software and Software Development Costs [Member] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Fair Value Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract] Treasury Stock Equity, Class of Treasury Stock [Line Items] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Total liabilities Liabilities, Fair Value Disclosure Available-for-Sale Available-for-Sale Securities, Debt Maturities [Abstract] Liabilities Derivative Liability [Abstract] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Net income Net income Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other Other Income Expense Items Reflects all other income and expense recognized by the entity in the period not otherwise specified in the income statement. Estimate of additional tax expense Income Tax Assessment, Estimate Of Additional Tax Expense Income Tax Assessment, Estimate Of Additional Tax Expense Developed technology Developed Technology Rights [Member] Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Total liabilities and stockholders' equity Liabilities and Equity Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Operating lease right-of-use assets (Note 6) Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Long-lived Tangible Assets by Geographic Region Geographic Areas, Long-Lived Assets [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Unallocated amounts: Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract] Outside of the United States, including Puerto Rico Current Foreign Tax Expense (Benefit) Net operating loss carryforwards Deferred Tax Assets Operating Loss Carryforwards Net of Reduction Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards, net of the reduction for the benefit related to windfall to be recorded to additional paid in capital when realized as a reduction to income taxes payable. Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Discount rate (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Net income attributable to Edwards Lifesciences Corporation Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration Initial Delivery Of Shares Settled January 2022 Initial Delivery Of Shares Settled January 2022 [Member] Initial Delivery Of Shares Settled January 2022 In-process research and development In-process Research and Development In Process Research and Development [Member] Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Participant contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income Schedule of Segment Reporting Information, by Segment [Table Text Block] Instruments not due at a single maturity date Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Due in 1 year or less Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year Vested and expected to vest as of period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Tax credits, federal and state Effective Income Tax Rate Reconciliation, Tax Credit, Amount OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Supplemental Balance Sheet Disclosures [Text Block] Accrued rebates Accrued Rebates Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates. Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Common Stock, Shares Authorized Fair Value Fair Value Available-for-sale investments: Debt Securities, Available-for-Sale Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Debt instrument, credit spread adjustment Debt Instrument, Credit Spread Adjustment Debt Instrument, Credit Spread Adjustment Accordion feature, increase limit Line of Credit Facility, Accordion Feature, Increase Limit Line of Credit Facility, Accordion Feature, Increase Limit Measurement Input Type [Axis] Measurement Input Type [Axis] Amortized Cost Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract] Pension increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Pension Increase This element represents the percentage of increase in pension. Amortization of prior service credit Reclassification from AOCI, Current Period, Tax Derivative [Line Items] Derivative [Line Items] Award Timing Disclosures [Line Items] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Comprehensive loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest The Program Long Term Stock Incentive Compensation Program [Member] This element represents details pertaining to the Long-Term Stock Incentive Compensation Program of the entity. Cash Collateral Received Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset Loss (gain) on investments, net Gain (Loss) on Investments Plan amendment Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment Relating to assets still held at December 31, 2023 Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held Gross Amounts Not Offset in the Consolidated Balance Sheet Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Income Taxes Income Tax, Policy [Policy Text Block] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Financing receivable Financing Receivable, before Allowance for Credit Loss Municipal securities Municipal securities Municipal Bonds [Member] Insider Trading Arrangements [Line Items] AOCI Attributable to Parent, Net of Tax AOCI Attributable to Parent, Net of Tax [Roll Forward] Net prior service credit Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax Research and development accruals Research And Development Accruals Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials. July 2022 Stock Repurchase Program July 2022 Stock Repurchase Program [Member] July 2022 Stock Repurchase Program Related Party [Axis] Related Party, Type [Axis] Outstanding as of period end Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Accumulated other comprehensive loss, net of tax: Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract] Common stock issued under equity plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Social securities increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Social Securities Increase This element represents the percentage of increase in social security. Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Adjustment to Compensation, Amount Adjustment to Compensation Amount Cost of sales Cost of sales Cost of Sales [Member] Change in fair value of contingent consideration liabilities (Note 12) Change in fair value of contingent consideration liabilities (Note 12) Change in fair value of contingent consideration liabilities Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Deferred tax liabilities Components of Deferred Tax Liabilities [Abstract] Number of promissory notes entered Number Of Promissory Notes Entered Number Of Promissory Notes Entered Noncontrolling interest (Note 9) Equity, Attributable to Noncontrolling Interest Auditor Name Auditor Name Total grant date fair value of stock options vested Share-based Compensation Arrangement by Share-based Payment Award, Options Vested in Period, Grant Date Fair Value Represents the total grant-date fair value of options that vested during the period. Social securities increase (as a percent) Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Social Securities Increase This element represents the percentage of increase in social security. Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Exercisable as of period end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Entity Central Index Key Entity Central Index Key Liabilities Liabilities, Fair Value Disclosure [Abstract] Amount of Gain or (Loss) Recognized in Income on Derivative Derivative, Gain (Loss) on Derivative, Net Total stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Developed technology Cost Finite-Lived Intangible Assets, Gross Finished products Inventory, Finished Goods, Net of Reserves Income Tax Authority [Domain] Income Tax Authority [Domain] Right-of-use assets Deferred Tax Liability, Operating Lease Right Of Use Amortization Deferred Tax Liability, Operating Lease Right Of Use Amortization Non-service cost components of net periodic pension benefit cost Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Purchases, sales and settlements Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement Employee compensation and withholdings Employee-related Liabilities, Current Schedule of Net Operating Loss Carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Name Trading Arrangement, Individual Name Award Date [Axis] Award Date [Axis] Foreign income taxed at different rates Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Net sales Total segment net sales Revenue from Contract with Customer, Excluding Assessed Tax Critical Care Critical Care [Member] This element represents the critical care product line. Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Schedule of Assets And Liabilities of Lessee Assets And Liabilities Of Lessee [Table Text Block] Assets And Liabilities Of Lessee [Table Text Block] Amendment Flag Amendment Flag Finite-lived intangible assets Finite-Lived Intangible Assets, Net [Abstract] Fair value hedges Fair Value Hedging [Member] Gross Amounts Offset in the Consolidated Balance Sheet Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Tax Period [Domain] Tax Period [Domain] Movement in Valuation Allowances and Reserves SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Assets Assets, Fair Value Disclosure [Abstract] Acquisitions Business Combinations Policy [Policy Text Block] Long-term debt (Note 11) Long-Term Debt, Excluding Current Maturities Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Diluted (in shares) Dilutive weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Tax on global intangible low-taxed income Effective Income Tax Rate Reconciliation, GILTI, Amount Assets Derivative Asset [Abstract] Software Capitalized Computer Software, Gross Accelerated Share Repurchases, Date [Domain] Accelerated Share Repurchases, Date [Domain] Derivative Assets Offsetting Derivative Assets [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Net Amount Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election Debt Securities, Held-to-maturity [Table] Debt Securities, Held-to-Maturity [Table] 2027 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Share Repurchase Program [Axis] Share Repurchase Program [Axis] Restricted stock or restricted stock units Restricted Stock and Restricted Stock Unit Awards [Member] Restricted stock and restricted stock units awarded by a company to their employees as a form of incentive compensation. Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Awards granted in 2012 and later Share Based Compensation Arrangements Awards Granted 2012 and after [Member] This element represents details pertaining to awards granted in 2012 and years after. Reconciling items Segment Reconciling Items [Member] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Tax Carryforwards Expiration Period Years 2030-2033 Tax Carryforwards Expiration Period Years 2030-2033 [Member] Tax Carryforwards Expiration Period Years 2030-2033 Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Defined benefit pension plans Pension Plan [Member] Total segment operating income Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Non-PEO NEO Non-PEO NEO [Member] Target asset allocations (as a percent) Defined Benefit Plan, Plan Assets, Target Allocation, Percentage Adjustment to Compensation: Adjustment to Compensation [Axis] Gross Amounts Offset in the Consolidated Balance Sheet Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Tax Benefit Amount Deferred Tax Assets, Operating Loss Carryforwards Debt Instrument [Line Items] Debt Instrument [Line Items] Basic (in shares) Weighted-average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Initial delivery, price per Share (in dollars per share) Accelerated Share Repurchases, Initial Price Paid Per Share Property, plant, and equipment Deferred Tax Liabilities, Property, Plant and Equipment Segment Net Sales Net Sales by Geographic Area and by Major Product Area Revenues [Abstract] Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Product Information [Line Items] Product Information [Line Items] Fixed-rate 4.3% Notes Fixed Rate 4.300% 2018 Notes [Member] Fixed Rate 4.300% 2018 Notes [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] United States: Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract] Payments for acquisition options (Note 8) Payment for acquisition options Other Payments to Acquire Businesses Accrued interest related to unrecognized tax benefits, net of tax benefit Unrecognized Tax Benefits, Interest on Income Taxes Accrued Foreign-derived intangible income deduction Effective Income Tax Rate Reconciliation, FDII, Amount Vested and expected to vest as of period end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Restructuring contingent consideration gain Restructuring, Contingent Consideration, Gain (Loss) Restructuring, Contingent Consideration, Gain (Loss) Estimated net tax liability on permanently reinvested earnings Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Buildings and leasehold improvements Buildings and Leasehold Improvements Gross Gross amount, as of the balance sheet date, of long-lived, depreciable assets, that includes building structures and leasehold improvements. Nonemployee Directors Program Nonemployee Directors Stock Incentive Compensation Program [Member] This element represents details pertaining to the Nonemployee Directors Stock Incentive Compensation Program of the entity. Investments Deferred Tax Assets, Investments in Unconsolidated Affiliates Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments. Includes equity method investments; excludes investments in subsidiaries. Convertible Promissory Note Convertible Promissory Note [Member] Convertible Promissory Note Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Noncontrolling Interest Noncontrolling Interest [Member] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] EX-101.PRE 13 ew-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 ew-20231231_g1.jpg begin 644 ew-20231231_g1.jpg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end GRAPHIC 15 ew-20231231_g10.jpg begin 644 ew-20231231_g10.jpg M_]C_X 02D9)1@ ! @$ 8 !@ #_[@ .061O8F4 90 !_]L 0P " 0$! M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D* M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\ $0@" M.@/T P$B (1 0,1 ?_$ !\ $% 0$! 0$! ! @,$!08'" D* M"__$ +40 (! P,"! ,%!00$ !?0$" P $$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "OSX_X.;]0\5_#G_@DI\0?C_\ "WXD^+O"/C'PG>Z&=$UW MPCXNO]*FB%QK-G;2HWV6:,2JT4\@PX8 D$8(!'Z#U^>W_!T]_P H,_C+_P!? M7AK_ -2+3: /0%_8,_9M\=?LI>%3XP^-GQC\+ZUXP\-Z9:6/BC2OC[XLCO(] M5O+9!'+$IU)HWD\UMP1T:,X.Y=H->[+\4?!7[(_P"\$Z7^TS\7;0:K!I.G:& M]_*\UQ=>(-62V576U@ :XO)Y&CDD$<:/*0&8C@FO"/@Q_P $LOV:-7\&? OX MZ>&6\667B?P.=$\1:;<:C\0];U*T=_L0CGB-I=WDENN^*:0*RH"AV[2%RI\I M^)_Q+U:7_@Z.^&7PQ^*CE- M/V8-6N/A=!<'/'GFRM)(VQR(X MQV;D ^T_@C^V3^S)^T2OB2+X2_%W3[Z\\&R^7XPT>_BFT[4="8J7!O;.\2*X MM05#,&EC4,%)!.#7F/BG_@LW_P $K_!GAR_\8:]^W1\/QI.F^)X_#USJ=IJW MVF!M1:,2>3')"KK,%1@SR1EDC!&]EKYQ_:T\(:[X(_X.6/V6OB!\&X#;WGCO MX4^*],^*J68VI>Z+8V[RVLET%^\!=2PJC-SNBB7.% &9_P $=?@3\%?B)^UY M^W^OQ"^%'AW7X[S]I6YM;JWUS2(;N*2%?]("&.563'G$2'CEE0G)1< 'Z6Z_ MXG\/^%_#-YXRU_5H;;2]/L9+R\OG;,<4"(7:0D9R H)XKXT_8)_X*I?L[?\ M!4V]^+'PIM-5UC3+6U^)>I>&O!^G0)J>D:E?:39Z;822W;W$'ER6KOE5\ MR*58A&K*&R#]M # %?G;_P;I?\ )/OVLQZ?MR>/L_\ ?&G4 >,?\$)/^"AW M['?[#W_!*7P\_P"V'^T]I?AF[UGXF^*A92>(+R:ZO;Q5U1XS<2*BR2E-Q56G M/B#XEZ':>#?[,BU%?%$^IQ"P>UE"F*99M MVQDD#IL()W[U"Y+#/Y.?\$>OAOX!O?\ @W'^/%]=>#M->X\06/Q)36[AK)#) M>K$MZL0D;&7"#[H/WDO(;V">V$<]^*GQ2\!_!/X>:M\5_B?KPTOP]H5H;K5]2:VEE6U@! :5UB5F"+G+-C"J" MS84$CY=^(O\ P3E^"S?MK?!K]N/XX?MD_%/6OB#X+OKG0_A]%=G0+:'5/MEO M.TME+%IVCP27,?DBYE(W@1HLKDJH8U]?W%O!=P/:W4"2Q2H4DCD4,KJ1@@@] M01VH \X^ '[7W[.G[5'PONOC3^SM\2(_&'A6T:56US1=-NI8)WB!\Q(#Y0-P MRE2I6(.0WRXW$"H/!'[:O[+'Q%^!EW^TQX4^-.DR^ ;&[DM9_%=WYEK9F9)% MB:-'G1/-;S6$(";MTN8QEP5K\R_@U\9O''_!(7XR?M _\$@O R""\\:7L7BC M]C99D)BSXAO4L)+!1T\K3[Z;[0R_>,%O=RL0!FO1/^"FNE^$/V(_&G_!/_\ M9LM_BCJO@7X1Z'\19]'U'Q9:I9,]KJ=OHK6VD7,[7\$]L7:XGEF>2:-P&WRY M5T$B@'W/\$/VZ/V5/VB?B3K/P9^%?Q9BN/&7A^S2[UCP?K&E7FE:M;VSD!;C M['?0PSM"2RCS50IEU&?F&<+XC?\ !37]AGX3:KK6G^/?C]965KX9UV/1?%'B M"/2;Z?1=#U)RJBSOM4A@:RLIP74&*:9&4L P&:\W\6?\$Y_@KI?[?'PB_;J^ M,O[87Q2USXE^'4O?#/@:UU$Z#;6VK13V=[--93Q:=I$#SHL/VJ<9V)I3<2ND63# 2&(!^I_QJ_;8_9)_9T\0^%O!_QL_:&\*>'M9\ M;:C:6/A'1;W5D-[J\MU,L$!@MT+221M(P7S0OEKGYF YKE_AY_P4^_8!^+?A M3QAXX^&'[5'A;7]+\!Z[;Z-XFNM)N'G\B_N',=M;Q*J%KIYY 8X1 )/.<%8] M[#%?GO\ \%2O#'A[QY_P2_\ ^"<.D>,-)AU&VU7X^_"*RU!+E=WGV\^BW*S1 ML>NUQUYYK[ _X*??L+K\%?@_\ &&#XKZ9XM\ ^(6T*);?7 MO$.F6%Z\5M?B.,M<1_8ENCEED*+ #M95V$ ]X^#?[77[/WQ\\;ZW\,OAIXUN M9O$WAJSM[OQ#X:U?P_?Z7J.F0SLX@>>UO8(98A)Y;[=RC<%)&1S7HE[>V>FV M))=-56G&CSZS90WRJ&!5@] MN\D3!@5*2/N&,T >X>%/^"DW[$/C/XK:#\%=#^/^FKX@\6H[^#HK^PN[.U\2 M*@!+:;=SPI;:B,$$&VDDW#D9H\3?\%+?V O!_CWQ7\,?$7[7?@2WUSP+H,K :]'(=%MDN(K9OM+H2D4OGSPQB!B)F:10J'->!?M3?L"_LU_MO_LV^!OC M5\^#=6TWQ]X'\2:"/"UH(9H8F^R36\MEH*RN&$P584.7YM$=K:[_ +;B@%PA(^64 M1,T8&?"^@>(/#L5C'_J-4;PQJERUTJ#K(9E$I[LR^ MIKTS]E:P^%/C'_@U4FB\*V]EJ6FWO[+?B.;6"<2B;5_[.O7OY)") M$4%F/+.[*BJ,L[,JJ"2 ?9?@C^W3^RI^T1\2M8^"_P +/BS%/XST"S2\U;P? MK&E7FDZM!:N0%N/L=_##,T)+*/-5"F649^89_*-OBVWPW_8B_P""4FG>./BO MJ/@CX>:KJ5LOB+Q58)9%=/U4:&\.D22&^@GM@%N+B1]TL3*GEF0;6C5U^]O& M7_!.?X,:;^WC\(OVZ?C)^V!\4M=^)?AI;WPUX$M-0;0;:VU>.XL[R66RGBT[ M2('GC6'[5/RX$>POD &@#U/]HO\ :_\ V/\ P1+XB^#/QB^+=[:SV&D1W/C" M+PPFJO-X>LIN4N+^[TI"^D1NH++--) "H+!MN37RK_P:Y7IU'_@EN+W_ (2" M?5A)\5?%)34[J^:YDNE^WMME:9B3*6&#O)).>*/A__ ,$B MOB=\>OAC\1O%GA+QAX0;0Y=!U_PCXLOM+G@\_7+"UE5C:S1B16AGE4JX8?," M.0".I^$?_!-'X8_%#]DCP5KN@?M&_M!>$O%VM>!],O7\::)^T+XIGNH[N:TC MD>4P7M_/:RJ9&+&*2%D[ # QRO\ P=!_\H+?CI_US\.?^I+I5?6W[(C*O[)G MPP9F ^'6BDDGI_H$- 'Q=_P1]_X*!?M0:Q^UM\9/^"1O_!0'Q39^)?BO\& MFHZ!X]L[!+0^*_#TA@\JYGAC 1)U2ZLW)7[RW.&R\3/)]1_%3_@I9^PW\$O$ M;^&_BG^T+I>C+!KBZ+?:U<65TVD6.I$X^QW.II$;.UG!X:*69'4_> K\R/V9 MM5\:?M6_\%NOVV/^"F/[*T3ZEX0^'?P:O/!/@WQ)8IYD&M^)8=/LPJ6[C*W" MK)8S'*EAM>V;I(N?6O\ @F'^RQ\+/^"G/_!#CP/\+-=_;>^)%UX*\1^"QHWC M[PQI$'A8"RU2*7S+V-I9=%DN4E^T@W DEE:5O,24NQ<.0#](_BU\=OA#\"_" M5OXW^*WCRQTC3KV\BM-->0M++J-U*"8K:UAB#2W4S@$K%$KNP!(4X-8?[/O[ M7W[.'[4MSX@TOX&_%"UU?4_"=\MGXIT&XL[BQU/1IG!9$NK*[CBN+?< 2IDC M4-M;:3@X_.KP)XO^%/P3_P""T'['G[.,/Q3U;Q-\*M,_9,OK+X%^)/%ETDDF MI:T\Y@-QYHBBCDGDTJSCC2147>LRA,B4;OIC]MWX/_ 7]GNP_:1_:W_9X\+G M3OVD_&?[./B"\&K:=J%V]Q>P:3IZQ6LOD[S#'(DK6:*P57D\L $['P >H^./ M^"F7["OPU\86O@WQY^T5I.EO>:^=#M]:N[.Z71CJBLR-8G5?*^PK<*ZLC0M. M'5E*L 1BM_XA_MS_ +'?PG^->E_LX?$7]I/P?I/CO6+>XN+3PI=:U%]MC@@M M)+R6>>,$FVA6WADE\V;8A5#ACTKX:_9 _8M^ O\ P4\_X(A?#CX8^*OVX?B- M]G=W6Z*,/ M,V$F),:8D8D(G0 'VI\+?^"L/_!.'XSV_C6[^'7[8?@N\B^'=C]N\927.H&T M73;3;; MQ=I^E7']F>)T\/:G>Z9?Z;(X;:K%?(NK8L$?;(NW=L?:QVMCY ^,OP^\"ZO_ M ,'2_P +M6U;PAIMSZ;^V+^U1I/A6\UGXZ>+X='7Q)J4]WJ%^D5XD9F8*))G48 : M=QMSU;)K]68?C?\ !JX^$2?M 0?%7PZW@631QJR>,!K$/]F&P*;Q<_:=WE^5 MMYW[L8[U^)QJ>CPS M'4[1;O:L$S,I+QJ&;:I.%+,1@DFOB3X*^.O%'[.__!(/X(Z1XH^)6M:#\%+? M_@H<=/M?%T/D3K:>$;:ZN9;:Z_TN*:![>/4K>2X)DCDC\RW'RDG! /VX^%7_ M 4!_9"^,_Q*O$7B+]N'P#]@\%:G8Z;XDO=/U;[9%;7EX)S; MVRM;AQ/*PM;@M'%O:,0N7"@9KB_CM_P3F^"7CW]H+X(?ME_M"?MO?%36O$'P MO\6Q?\*VGW>'+:&_N=2E@C-G(-.T:*6Z@G"*K*' 6(S/N1=[CQ#_ ()R_!3X M0?$;_@LU_P %%[?XA?#'0=>@DU;P-826FLZ7%=0/;7.E3S7$312*R,LDD$+N M"/F,:D]!0!^EWA_7]$\5Z#9>*/#6JP7^FZE:176GWUK*'BN()%#QR(PX964@ M@C@@BOSS_P""K?\ P38B\8?LT_%7]L3QK^V7\7]+^*OAG0-1USP)JGA+QU>Z M;INBW$"O)I^E66FV[B-Q(ZP6[.0US<2R%@X9T1?T3L[.TTZTBT_3[6."W@C6 M.""% J1HHPJJHX Z5\Z?\%)?^"8_P'_X*:?!J?X7?&7Q+XNTBYMH_.\. MZOX=\77UK'IE\FYH;MK-)A:W+HYSF6)FQPK(<, #N/V(9/VB-0_8P^&,W[6# MM!\3I_ .F'QPRQ(LL>IFU3SRZ@;!*'SO"C8'W8&W KX^_P""?6I_%S0O^"[' M[7OP;\=_M">-O'&B^'O!?@VX\/1>+M629=.%W:FYFCAAACBMX%,LCD"*)!C& MS-+-JUE::G=6 MMI=/(WS2EX(8\2MDRJ%D))?)\S_8M_Y6+?VT_P#LGOP__P#3:M 'Z)44A= X MC+@,V=JD\G%+0!^??[1O_!%KQY^U]X=U_P"-_P 8OV\OC)X9^,>HI<7WA2Y\ M'>/IK#0/!,F2]I8VUG %62&$"-)IB1-.RR2[XRZA/*/A#_P6)_:*^%?_ ;) M67_!2;XWB+4_B?%H=UHV@ZA?6ZA=8U#^UI=+L;^6, !\*%GD' E\F0C < ?: M_P"UGXH\6?M"7.J_L+?L_P#B6;3]8UK35A^)GC2P(/\ PAFB7*$.L;8(_M2Z MA+I;1=8E8W3C;'$D_P B?\''W[,7A.+_ ((1>+O@9^S1H%G;Z5\&F\/W*^&- M(D#MIVF6DD2%74$LNRVF^T,7Y*(SDG.2 2?MN?#SXI?\$SO^"97A_P#X*)_# M7XE>+-9^,GPT_P"$>USXG:GKWBJ\N4\>0W=S;6^K6%[!+(T(@)NGDA5(U-KY M$8@V $'Z1_:#_9%=6UO]H3QUX5^"-]X*L=:L-&^'/B1M'OO$]] M>[Y ;^YB!D%K!;BW:.&-@));EV84B5>7)1RP Y(4XKZ+^'OBFQ_85_8:^%?P[\? MV%WJWB;1/ ^A>%=%\+:05EO_ !!K,&G1PBRM5+!6=C#(S2,1'%&DDTKI%&[J M ?(O_!+'PY^T1^Q-_P %8?C-_P $OKOX_>+_ (F?!S2OAEIWCGP3?^.M4;4- M1\,S7%TEN---RW)60&X<)PNVW5E56:0MO?\ !5O_ ()L1>,/V:?BK^V)XU_; M+^+^E_%7PSH&HZYX$U3PEXZO=-TW1;B!7DT_2K+3;=Q&XD=8+=G(:YN)9"P< M,Z(OU!^R-^SJGP U+Q+\8?CAXDTBZ^+_ ,:O$,=_XQOK:YQ"9(+5Q9Z)I_F! M7EMK&SBD5/E#R%;BX95,C*N/_P %)?\ @F/\!_\ @II\&I_A=\9?$OB[2+FV MC\[P[J_AWQ=?6L>F7R;FANVLTF%KSXF2^ ]+;QRIC5'&IFV0SB14^59=^=X7Y0^[;QBNE^-GQ[^#O[.7@Q M?B!\;?B!8>'M*EU""PM)KUF,EY>3-MAM;>) TEQ/(W"0Q*TCD':IQ7S1_P $ M"?BE^T%\8?\ @E#\+/&7[37B2YUSQ0L.IZ?_ ,)!>S-+-JUE::G=6MI=/(WS M2EX(8\2MDRJ%D))?)3_@JMXT_9TT;XG?LX>$/'GPIN?''Q9U'XMK>_ CPX/$ MZ?!_]M?]E_XZZSXK\+_# M[XKVXUGP+$DOC3P_K^GW6CZEH<3H9$FNK/4(H9X(F0%A(Z!" 2#7GOB'_@L3 M_P $P?#'P[UGXLZE^VSX&E\.:#XA;0[[5M.U)KR*34%A2=X+?R%&=#EL+.,?\ M"06Z)$$FN)WE**"#*S@OG(2,807/^"#_ ,.O $G[0G[>/B&;P7I;WUQ^USXI MTV:[DL8VD>R9TD:V)(SY1=V8I]TD\@T ?H%\-?CA\(/C#\(]-^/GPQ^).CZU MX+U;2SJ6G^)K*^0VQ^*OBKX3?\&H6B^'=&O[VU\*:O^T)<^&O&(_&G[4?[5'Q8T#2X[EK M/X=^#_AEXW?1['0[2- @OIA$A^V7TTOF3%Y=RQQO%"$^1V?[(KR3]IGXZ^*_ M"3VGP,^ 5K9ZI\5_%MG(?#EE=J7M=%M0=DNM:@%.4LX"1AXO+[%TTDR?O3':)$"OGN1\_?!WX%?&?_@E'_P6 MO^#O[*GP#_:,^(/C;X*?'SP?XCNM>\$_$'Q)+K#^&+S2K0S_ &ZWFDYB221K M:+U8R2*Q/O$?C3]J/]JCXL:!I<=RUG\._!_PR\;OH]CH=I&@07TPB0_;+ MZ:7S)B\NY8XWBA"?([/Q7_!O[\5?VIM=^$'QH_9O_:C^*5_\09_@1\==:\ ^ M'OB)JK,]UK5E9B/ GD8LTLL9?)9F9@)50D[,GZB_:9^.OBOPD]I\#/@%:V>J M?%?Q;9R'PY97:E[71;4'9+K6H!3E+. D87(:XEV01D,[.EC]DC]GCX4?L=_" M+2/V:_A_KYO;VSAGU76;_4KE&U/7+ZYG:6]U:Z P6DGN9)'9@-H+!%PJJH - M#]F7]K#]G/\ ;+^'$GQ=_9>^+>E>-/#<.K7&F2ZOH[L8ENX"!+$=ZJ<@,K X MPRNK*2K GT.N=^%_P@^$WP1\,MX*^"_PO\.^$=&>]FO&TGPQHL%A;&XF;?+, M8H$5=[L=S-C+'DDUT5 !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>'?MV M_L!_!_\ X**?"67X"?M#^+/%H\%7'/#VK1V4-]+#*)8GFD$)F;:X5@ M@D"9125) ->XT4 TW1+6*TTFX\374,]U;VL M421QP&6.*,RA0GWY-\A+'+D8 X7]K[]@C]G_ /;4E\)^(/BC::QI7BOP!JYU M/P'X\\):JVGZUX?NCM#M;W"@@HX50\4BO$X4;D)4$>TT4 >0_!W]C+X??"3Q MYK'QJOO&WBGQA\1];T&/1+OXC^,;RWN=4ATV-S)':6Z1016EK")6,ICA@19) M,/()" 1S?[)O_!.'X-_L:?%GQ]\9/A-\0?'5SJGQ0UM]9\>0>(->CN[;5=18 MN?M1C,(\EP9&_P!28UQA2"JJ!]!44 %?-7PN_P""5/[,WP0^-GC_ ./?P:_J=C8>,)WTO3]9O$9+O5+33Y@]M'>2H\B&9XW9%D98_+4XKZ M5HH ^7/@A_P27_9^_9U_90\4?L4_"3XF_$73?A[XN%ZNK:7)X@@N)U6]1DO% MBN9;9IHA,KG=M?(/S(48L3;MO^"2O['5Y^PDO_!.#Q_XN^/O%NMV>FR:;X?U/XD>,9=7;P_8N5\RVT^,JD-HC!45F1-Y5=I;:2 M#]!_'+XS> _V=?@WXH^//Q2OKFU\-^#]"NM7URYL[&2YEBM;>-I)&6*)6=R% M4G %=52,JNI1U!!&""."* /A7]F[XG?LY?\ !77]LOX>?M^? _P=>ZIX ^"G MA#5K;PIXZUSPO6*RM;>59'"F,S:@HC.&&) L442!511P . /:GT ?+7[!W_!(3]E/_@GU MKS^,OAEKOCSQ;KT>F-IFD:Y\2?&$NKSZ+I[,K-9V*LJ16D3%$W>6@9@BAF(& M*XOPY_P0 _X)\>&/ OQ ^$&GV?C]_ /Q!DO9[CX<3_$&];P]HMU=+A[NPL-P MACG4[6CED65HF12A7:*^V:* /D#QO_P1._9'\>_ [X;?L[:QXU^)J>%_A3K- MCK7A*&+QS*URFKV<1AM=0ENI$:>26&';#$F\0PQ1I'%'&J@5[%^T=^QMX%_: MC\">#?!WQ)^(OC2UOO ?BFU\2>'?%7AW6TT[5(M4@M;FV2X:2")8VS'=3;H_ M+$;[L,A4E3Z[10!Y'\'?V.? ?PK^,FJ_M(>(_&WB7QW\1M6\.P^'YO&WC*6T M-W;Z/%,TZ6$$5C;6UM;P^1]K2,Y1=OH?Q%^'?@;XN> M9^%WQ.\* MV6N^'?$.FS:?K>CZE )(+RUE0I)$ZGJK*2*V:* /B']E/_@W[_8!_8_^*MA\ M2OAK+\0]3L-"U@ZMX4\">*?'ES?>'M!OPQ9+JWLFPK31L=R23F5D8!P=ZJX] M ]"\>_# MCX:>/_B[X7^'GQ#M[Y=8^%.@?$FYM_#=O-=PM%)/!9A3M8!@1&[/"=B*T;(H M2OMRB@#YAN/^"/O[">J_L)P_\$YO%?PZU?7_ (8VD<9T^R\1>*[Z^N[">//E MW%K<32L]HZEF*K!Y<0#NNS8[*:_[!W_!(']E+_@GUX@?QG\,M=\>^+=>BTQM M,T?6_B3XPEU>;1-/9E9[.Q1E2*TB8HF[RT#,$4%B!BOJ:B@#Y)E_X(P_LFZ3 M^TWXG_:B^%'C3XG_ ZU'QY" M2(YDD8$-(Y;OOV"/^"X*N[<1FO>** /$OVZ?V#?A+_P4-^#]S^S[^T#XM\6) MX)U"2"35_#GAW58K*+49(9EGA::01&9@DB(P0.$)125)4$<4_P#P2<^"&K_# M2W^"7COX]_''Q'X(@L([!_"6I?%[4H+2XLT0(MM*UF\,TL.P!3&TA4J,$$5] M144 (IIVAZ#8I;V\63EFVJ/F=CEF M=LLS$LQ))-?'>L?\&Y7_ 39O?CWK7QP\.:5X]\,V/BB^-WXM^'7A/QW-/B#XEGUK6M72$.L,4]U.<^5&)) D* M!(U,CD+N=B?;Z* /@S0_^#<'_@FCX5^-6I_%3PAH/CG1]!UO5/[0USX3Z5XX MN;?PCJ4^[=B?3TQYL6[G[.TAAQ\GE^7\E>X_'W_@G#\'?VB?VE_ /[67B_XA M^.-.\7_"P7(^'CZ%J]O!:Z']IB6*Y\N!K=DE\Y% ?SA("/EX4!1]!44 ?/OB M/_@G+\)O$_[:^F?\% -0^)WCQ/B-HNAOH>EW4.L6ZV5OI+RO*]@+7[-Y;1,T MCDLP,N2&\S3:FV%NL<:1^6A5HPCY4DL=[[OH&B@#Y4\(_P#!(;]GKX7S>+=!^"?Q M;^*_@7P3X[U*YO\ Q=\-O"WCAHM&O;BY_P"/F2(RQ27=@9NC_8[B#(X& !Z MK\2_V(/V4OBY^RI-^Q'XW^"&B3_"V318=*A\(6T!M[:UMHMIA\@Q%6A>-E5T MD0AU90P.>:]6HH ^0?V&O^")?[&_[ WC:T^(/PRUSXA>)]2T6UFMO!__ L+ MQI+JMOX6AE0QRKIMN52&V9HR8S)L,FQF0,%=PW.OV ML_ /Q,\?77B[XG2P2_$)]9UR&>TUUX(WCMVD@%NJ1&$2-Y?D^7M'R_<+*?H: MB@ KY4\!?\$D?@_\/[KQ)I5I^TW\?-1\(^*]1N;O6/A_J_Q:O)M*;SW+2PQM M@7<<+;B&1;@!P2'W G/U710!0\,^%O#?@GPQI_@OP9H-GI&D:38Q66E:9IML MD-O9V\:!(XHHU 5$10%50, #%>#?"/_@FS\)O@Q^UIXK_;9\,_%CX@W7C_ M ,=VMI:^-;[4]9MI;;6+>VC2."&2V%LL42HB*%,*QL!G!&YL_1%% 'QE_P % M /\ @GOX;_:D_;2^!7[1O@Z;QW8?$;X9>(M.N[/Q!IVJR6VA:9HD6I176H+< M*R[;B>Z@AFL5AB;>1=J\RF*,$?95Q$T\#PI.\1="HDCQN3(ZC((R/<>4 ? M FI_\&X_["VK^)-8\87WQ<^/1U/Q!JLVIZW>1_&;44>]O)2#)/)M(W.V!ECS M@ = *^E/V3?V"/VOM1\,ZY?WMYXA7Q=J+:I<:Q-=HL ML?#_5_BU>3:4WGN6EAC; NXX6W$,BW #@D/N!.?JNB@"AX7\+^&O!'AK3_ M 9X-T"RTG2-)LHK/2]+TZV6&WL[>) D<,4: *B*JA54 "O%?VZO^"8 MT88901[S10!\K>&?^".?[&_@W]I[2OVPO#1\<0>/]-\*KHESK<_CN]NGUG9< M?:8[S4OM#R'4KB.98I$-R9(@UO;GR_W$.S=_9K_X)I?"C]DK4?B1K/P/^,/Q M%T^\^*_B"YU_QI=7FM6EV]SJ]P^Z6_C\^U80S-EE.P!,-]S*H5^C** /F#X& M_P#!(C]CKX&_LD>*?V$[;1]=\4?"?Q?)/+JO@_QEJXO8TEF<22RQ3!$GC=I% M20$2?)(BR1['RQ\RU#_@WL_8O\3? "S_ &7/B1\8OCCXM\!Z1J=I=>'/#?B/ MXJW,UKHD=N^Y+:UC5%6./'[L,09HTRL+;E9=6NM*^*][9Q^6F[R;>..':L<$2LRQQCA 3CDDG[9HH ^ M?_V%?^":O[-O_!/2+Q3+\"9?%5]?^,IK1]?UGQEXGGU:]G2U61;>$33DLL:> M=,0G3,K'O61JG_!*3]ES5+'6/ )O/%=O\,_$7B9_$.O_ ;M-<$?AB_U%YA< M2.\ C\Y8))P)I+-)EM)'+%X&W,#]+T4 ?/'[=/\ P3-^ /\ P4*TWPOH/QT\ M7>/=/TOPA=F[T72O!?C";2+=+K;M2X=8 -\J+E8V)_=AW"XWMGS+X$_\$%?V M'O@'\;/"_P >=%\2_%3Q#J_@[5/[2T.R\:?$R^U2QCNQ&Z1S-;S$JSQE]Z'^ M%U4]J^U** /B;XY?\$%?V.?VA_CIXF_:+^(OQ5^-7_"4>+;E9=6NM*^*][9Q M^6F[R;>..':L<$2LRQQCA 3CDDGUG]A?_@FI^S9_P3UA\5/\"I?%5]?^,YK1 M]?UGQEXHGU:]G2U618(A-,=RQIYTQ"C@&5CWKZ HH \9_82_83^"7_!.[X'R M_L_? &]\1W&@R^(K[6GD\4:X^H7/VFZ_C;X9_9W^%6L?%WQ=X=\ M1ZK8:-9RW,]CX4\.W&IWLJQQM(0D,"L1\J'YG*H#C+#(KD/V!_VRO __ 4$ M_9+\)?M?_#7PMJNBZ#XR6]DTS3=<\O[7%%;WUQ: RB)F168P%]JLP&[&3C-= MU\:0&^#GBU6&0?#-_D'_ *]Y*^.?^#9W_E!Y\!_^P9K7_I]U&@#[EU+4M.T; M3KC6-7OX;6TM('FNKJXE"1PQJ"S.S'A5 !))X %?GI\7/^#AWP+\$C:?%KX@ M_P#!/SX_6'P)O=0AMK?XY77A%8M-DAF<)#?BU=Q<+9R$JT MX'B/_@G]XU_9F\)^&8==\9_&?3W\"?#WPUM&Z[U.^1D$_0A(K2$2WLDI^6.. MT=B> " >K_';]L[]G;]G;]EVY_;&^(7CZ%_ <>CVNHZ?J>E1FY?5DNMGV..T M1.9Y+AI8EB5?O&1>0,D<7X+_ &^Q:_&WP7\ OVEO@%X@^%.N?$VPN;GX=-KV MJV-[;ZK-;QK+/ITLEI*ZVNH)$PD\AMR.H?RY9&1E'PC_ ,%;OA++^SWH/_!, MW_@GG::Y+J'A32_CMX.TC6)Y!M&I#1TLK6,R#TD$TS;>@)'H*]!_X.B/$6H? M#G]F?]G[XS^%9&@\1>$OVKO"E]H5U"<2"46^H,8P1R0VQ*=$N-5]OT* M_"B1 QB=XYH)HF66&XC9DEC;((8.B_$7_!.36]5^)G_!Q+^W-XT\52L]QX3\ M.^$/#>A12'/V:P:U\QD3/17D@$I'0M(33_V<_$6H>%O^#JC]H/X?:%(T>E^+ M/V;=$UW7X8SA9;^RGTVTMY''0LL%Q(H)YPQ]Z /TTHHHH **\O\ BM\>?B5\ M/O%S^'/"_P"S+XH\4VBP)(-6TF>%869ARF'.L_#CQ)\4OB MG\0M>^-/_"KOB"?B]?V7Q#U+2M=\-:XNN>'%MC:Q03QC3+>.-W$$4*) P4AT MD=)0/U+^ ?A_X[>&_P!E7PC\+/B[XH\0W?C?3O"%GIWB'QI;O:R7ES?QPJDM MX/.CDB:1V4N=R,,L>* /8:*_.#_@@;\0?C%>WW[6OA3XG_$3QI\0+GPI^UEX MDT#3M;\7:R;R\2RLXK:"&)F;"IM1!\D:I&"3M51Q7Z#_ /"2ZO\ ]"A>_P#? M2T ;%%?FE^PWX^?_ (*__&[]H?X]?&:+Q1J/PZ\#?$FY^''PG\,Z+XGO--M= M,6PAC>[U8?9)HC)?7#W$3I<,2\"*J1E?F+._8&_:2_:J_;A_8R^./[".L_%K M5=/^+/PC^)6K?"_7/BE&X&J-I,5UY*:PFS;C4#9B>-),K^_A68G)(H _2NBO MQD_X*$_\$GO$_P"RU^SO%XC^$?\ P5$_;AU#XA>*O%FB^$OAYIFO_'OS+*\U MG4KV*WC\U(;2.1HXXVFG<+(IV0-\PZU^E7QQ\%>-X/V0=4^%G@CXA^/_ S= MZ+X+DM;3Q?I>I6\FK.;>R9%EDN+J*8F1BJNTHQ*6&0X).0#W&BOA7_@WE^+/ MQ*^(G_!'3X,^-_B'?:_XHUO4[36IM2U_6-2>ZNKV0ZYJ&7DEE9GD;@#+$GBO MLZ[\4:^EK*]GX*NY)A&QBC>55#-C@$]AGO0!N45^,G[)'[67P$_:._X)J?%G MXV?M6_$'Q79_M.^"Y]>B^(4W_"77MCXA\+>(3=W$6E6FDVLJ_M6>!;J'XDW/@?39/&\2Q1Q$:D; M=#/OC7"QR;\ET4!5?< * /:**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_O MI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ M +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8 MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ MA)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL? M_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A) M=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$E MU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A M0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z% M"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_ M[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"] M_P"^EJ.V\7WUY&9;7PM=2*&*EDD4C(ZCK0!N45C_ /"2ZO\ ]"A>_P#?2T?\ M)+J__0H7O_?2T ;%%8__ DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ M /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__ DNK_\ 0H7O_?2T?\)+ MJ_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__ M DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\ M)+J__0H7O_?2T ;%%8__ DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ M /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__ DNK_\ 0H7O_?2UXMHW M[;'CSQ6+J[\#_LF>+=;L;6_FM/M^G7]J\;R1.589W<'(Z'D4 ?0-%>??!GXQ M^/?B;J=[8^+_ ( ^(?!T=K LD-SK4T3+<,6P4783R!SS7H- ''_';XV>$OV? M/AG??$[QAI^K:A%:M'#8Z-X?TYKS4=5NY7$<%G:6ZD?$#]L[2/V$OVFOV-_B9\#?'7B_2KG4?A\OCE;.>S\10P(\DL< M=Q9S2(DZQH[F/+ ;2I<,45_L^6W@F>.2:!':)]\3,H)1L%ORZ M^/'[8VB?\/V?@)H_[=W[%_CKX=:/I-CJ^A?LZ^--6OM/N['5/$FKB"WN9+IK M*:9(RT44-M!$)6='N#)*@\Q&B /N/]IW]M#P5^SIXX\#_!+2_"6I^,?B3\2K MVY@\$^!="EACGNHK:+S;N]GFG=8[6T@CP9)7))+*L:2.0M._9I_;+\(?M ^/ M_&WP*UWPCJ'@WXE?#BXM4\8^"-9N(9I8;>ZB\VTOK:>%FCNK29-VV5<,K(R2 M)&XVU\5_#+6]5^)'_!V+\1;+Q3,TMM\//V4;:U\,P.?EA%SJ.G3R2J.Q)NIU M)ZD$ ]!3_BWXBU#P%_P=??"W3_"\C0Q^.?V4;RQ\311'Y9XH-1U*XBD<=R'M MHE#'LH% 'Z:4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110!P_P"TGXCE\,_ OQ3=VGA?6]:NKC0K MNVL=*\/:1->W5U/) ZQQJD2G&6P-[;47/S,!S7R[_P &]WP_^*GP)_X)8_#; M]FGX[_"/Q/X,\:>![?48-=TCQ%HTD"_O]5O;B%X9L&*<&*1"=C$H3A@N1G[: MHH ^0_@=_P %.?BSX^_:!^-WP%^+G_!/[XB>#;KX8VEYJ?@>2*1+Z;X@:5!= M/:BXLXBD2QO+((S&OF/&PEYE'EM7S5\,?^"@?_!06Q^*^K_M$?&?_@AG\=-? M\9W23Z?X<2UU'35L?#&C-(&6QLP[EO,E\N*2YN2 \\B(,+%##%'^DG@7X,>$ M_ OC37_B7')/$ODQ:IKNK3K).;2!I6MK*,(JI#;P^=+LC15!:621]\D MDDC=;0!\#?MT?LN_M5?\%%?V#_A7^T$?@[8^#/C[\+_B%IGQ0\%?#^[U08AG ML[MY8]$N;IL*)I+0QJ\F%C%S&N=B D-_:W^#_CO_ (*V_&O]G[P0?@AXU\(? M"[X6?$.V^(OQ*OO'_A]]*EN=2LH'2PT2V@E^>[9I)YO/GBS;+&/DFD9E6OON MB@#X;\3_ +._CG]B[_@K?XH_X*%>#?AWK_B?X<_&WX?6FA_$RV\):1+J.HZ% MKVFF-;'4/L< :>XM9;5# P@CD>.4!V&QB1I_L!?LD_$>[_;L^//_ 5'^.?@ MF\\+ZK\5ETSP]\/?".JE/M^D^&=/MXHQ-=JC,(IKR:)+@P;BT*J@?#ED3[1H MH **** "O"_VL/\ DMGP/_['N7_TF:O=*\+_ &L/^2V? _\ ['N7_P!)FH ] MTHHHH **** "BBB@ HHHH **** "BBB@ K-\8^+O#O@#PCJOCSQ?J0L])T33 M9[_5+QHV<06\,;222;4!9MJ*QP 2<< FM*LWQGX0\._$'P?JO@+Q?IPO-)US M39]/U2T,KIY]M-&T"#0!^8/\ P5"_X)=V_P 1OVX_"/[5 M_P#P3B^)>'D@M]1B!\J2*:/4;A9)2 MK;]R&59E0+7V-_P29_;'\7_\% /^"=GPN_:Z^('A.#1==\7Z+,VLV%HC+#]J MMKN>SEFB5B2L4KVYE1220DBC#H?$7ACP=IW[4WQ<_X53H/P M^UWPI)X"N?&0>5=/O[C27&GPZCY']H)9&+3C&Z?:O,VK"L;QIYJO]4^%OA5X M/^'/PJL/@W\)-/C\(:'HVCQZ9H%MX?MH8UTJWCC"1B!)$>,;% P&1AQR#0!\ M(_\ ! C_ )*)^W-_V?'XV_\ 0X*_1$.A!?L=_\$Z/ M@[^P]XM\;>+?@QX_\<3M\1O$]UXD\:67B+6XKV#4]8N&W37QW0AXY6/7RV13 MQE3@8\PUS_@GOX;U#_@LGHG_ 4%^&,WCO3]EVELZ@S.9IH+R21"T$;V.#B:1A0!X[_P;,^$M0^"?PD_:5_9<\80M;^)O M ?[5'B./4[608=[>>UL?LUS@\E)5A=D;HRJ",YJC_P &]/AO5-?_ &A_VWOV MEX(F_P"$>\??M-ZY%X9N2/DO+>SO+D&XC_O(QN NX<;HV'\)K[.^)_[!GPM\ M>_%W7/COX-\>^-/AYXK\6Z+;Z1XWU;X>ZW'8OXCLH PMTNA)%*!+$KND=U"( MKF-'*K,% ZSX!? _P"$_P"S;X>L/@;\#? ]GX<\*>'-&BM='T>P#;((]S,Q M+,2TCL[,[R.6=W=F8LS$D \$^,*?\-,?\%>/AE\'D_TCP[^S[X'O/B'XD0?/ M$?$&J^=I.C1..BR1VJ:Q<#/(W1L.QKZ8^-'_ "1WQ9_V+-__ .D[UA?"/]F? MX?\ P<^*WQ*^-6@7VJ7WB'XJ:]9ZGXDO=5N(Y/*6TL8;*VM+<(B>7;Q1Q%E0 M[FWS2L6.[ WOB_\ #6+XP?#S4_AO=^,];T*UU>UDM;Z]\/3PQ7302(R21K)+ M%)Y>Y6(W* XZJRGF@#XW_P"#9W_E!Y\!_P#L&ZU_Z?=1K[A\1:Y9^&/#]_XE MU".9[?3[.6YG2WCWR,D:%V"J/O-@' [FO*/V'_V(OA9_P3^^"=E^SI\"?$_B M>;P7I+2'0M$\1:G'>+IGFSRSS"&7REEVO+,[%7=P#]T+DY9^SG^PG\$OV7OC MO\7OVB?AK?>))=?^-FO6FK>,8]8UU[JUCGMXY$C%K$P'DKB5\C+'&U00B(B@ M'Y>P?\$_/BG_ ,%2OV<=&_X+X_LO^.X/AO\ M1:E?WWB;X?V>B6MN-+;2[.: M>TM-%O!Y?^EW,D$'[R\FW%I)VA9?(2-(OTS_ ."9?[6^L_MW?L%?"_\ :U\2 M>%8]$U3QIX92ZU738 PBBNXY'@G,08EA$TD3N@))V,N23R_NKS6/AMX5UV"#2@]T[/=K:.]N]YIDRT3P_P"']-AT_1='TV 1065K"@2. M*-!PJJJ@ >U &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 5C^!_^01+_P!?LW_H5;%8 M_@?_ )!$O_7[-_Z%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 5X7_P3W_Y(GJW_8]ZS_Z4FO=*\+_X)[_\D3U;_L>]9_\ 2DT >Z44 M44 >5_MA?M$^._V7OA&GQ3\ _LO>-_BW/'K-M:WWACX>Q02ZE#:R;O,NTBFD M3S@F%'EH2Q+KT4,R_/7QV^'WB3_@JIXZ^!.[]G;QMX$\%_"OXLZ;\2==U[XD MZ(NE7\UYIL4XM-*M+-I&G9I)YD>:9U2%8H2J-*[@)]LT4 ?$G[3/[,7Q ^!' M_!5CP-_P56^$O@/5?$VB:E\.KOX=?&;0O#=D;K4K?3VG6[L=6M[5/WEWY=Q' M'%-'$&E$2HT<ZM<6Q.^SWSR210Q2[9C&TC21QEE%?;5% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %>%_M8?\EL^!_\ V/Z5X7^UA_P EL^!__8]R_P#I,U 'NE%%% !1110 4444 %%9GC;Q'_PAW@S5 M_%WV/[3_ &5I=Q>?9_,V>;Y4;/MW8.W.W&<'&>AKYL_X>6_]45_\N/\ ^YJ M/J:BOEG_ (>6_P#5%?\ RX__ +FH_P"'EO\ U17_ ,N/_P"YJ /J:BOEG_AY M;_U17_RX_P#[FH_X>6_]45_\N/\ ^YJ /J:BOEG_ (>6_P#5%?\ RX__ +FH M_P"'EO\ U17_ ,N/_P"YJ /J:BOEG_AY;_U17_RX_P#[FH_X>6_]45_\N/\ M^YJ /J:BOEG_ (>6_P#5%?\ RX__ +FH_P"'EO\ U17_ ,N/_P"YJ /J:L>R M_P"1WO?^O*+^9KYQ_P"'EO\ U17_ ,N/_P"YJIP?\%%_)UN?6?\ A3N?.A6/ MR_\ A(>F.^?L] 'UE17RS_P\M_ZHK_YS^S_;O/W;8XWW;MB8_UF,8[=>:[^@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH ^<_^"I_[=Z?\$ZOV0]2_:#M/#MCJFKSZ MYIN@^';;5[IH+".^OKA8(Y[N5?F2VB!>5]O+"/:"I8,/'O"OC[_@IC\-?B#\ M1_%<7QP\'?$S2_#7QX\-^'/%'A6]\#3V'EZ5?Z/X9>YN])EBO9#:BW.I2S^1 M,+A7"2L9 [<_4W[6W[*'P0_;>_9Z\2?LP_M$>%/[7\*>*+,0WT"2F.:%T=9( MKB&0;9I936-KD<8M"8_+.RWD /T.^,/[7_Q M)^(7_!02R_X)L?LT^(]+\/ZQI?PY?QO\1_&VIZ5]O?2[![I+6TL+.W+HC7WQ _X)?_M;76CZAXV\-^%K;QE\/_&N MB::UA#XK\-S2"%VFM6D=8+NWN"8G\MMDH!=4C"$'S;]I7]DG]LO]G;_@K[IG M_!4W]D'X/)\5?#WC'X<+X(^+'P[M?$ECI>J01Q3)+!J-E)J$L-M)M\F &-Y$ M;]VX!/F[H_ _!?QO\6_%O_@X4^*W[;GQ0^&,_A3PA^RM^RU)IWCBWT[4X]6G M@FD:?4UM)6ME\EKOR+BZ8PPR3(K6NWS"Q( !]A_\%FO^"B?C']@']DOQ)XF^ M WAFW\0?$^7PS?ZGH.FW*;[?2K"U"?:]8NQD8MX#+#&J_P#+6XN((APS,OI_ M[-_[0VFV_P"P1X<_:L^.WB.STZU'PXMO%7C#53'Y<%NAT]+NZFVC[JCYVVCL M,"OR+_:]_P""Q'_!-KXW?\$UOVA=6U[]I&;5?CW\;/!36QT)/A_XA2#1+1&) MT_P];W4^GI (K99)&DF+JDUU-"[+PUI7A'Q_I4MKJ>DC[?:6%C-+:EV6WED4%HB7B8QN"5W,-PH P_@%\0 M?^#@/]H#QCX5^--OJ?[)>@_!GQ5JMMJATHG7K[Q/IOA^:59#:NT6+.348[=O M+8K)Y/G*V#M%??U?D3\6O^"?=W_P0?\ VH/A-^U-_P $W/''B73_ (0?$+XL MZ)X(^+OP1U;6Y]0T\Q:K<+:P:C9F=FD$L3LN-[-)N9 '\MI$/Z[4 ?%7[2^N M_P#!:/XY^,/$VH_L":Q\(OAWX/\ "NH7&FZ&WQ,TF\O=3\87ML3'<2D1CR[" MR\]7AB;#R2>4TV5C>.NC_P"".'_!1'QS_P %&_V7-6\<_&;X60^"_B-X \=: MCX)^)/AZS=FM8-9L5B:5H-S,PC*S)\A9BCAUW.%#M[E^TI\?=(_9V^&DOB]] M N=>UV_N%T[P=X0TUU%YXBU>56-O8P9X!8JS/(WR0Q1RS2%8XG8+M7M-4\<^,/%.I^-/B?K6GH5@O_$>IS>?>/$#SY2?)!&2 3' MA8!B: /?Z*** "BBB@ HHHH **** "BBB@ HHHH **** "O"_P#@GO\ \D3U M;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^E)H ]THHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O"_VL/^2V? _P#['N7_ M -)FKW2O"_VL/^2V? __ +'N7_TF:@#W2BBB@ HHHH **** .8^-G_)&?%W_ M &+%_P#^D\E?FU7Z2_&S_DC/B[_L6+__ -)Y*_-J@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[-_P""='_)&=6_ M[&>7_P!)[>O?Z\ _X)T?\D9U;_L9Y?\ TGMZ]_H **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** /(?VRO@I\B&.:&:QN8XI8G6&>&XEC9T8LH;*C."/E'QA_P3 MZ_:X_;MU3XH_!+]L;3_!/@SX6^)OC;HGBGQA9>%-0O-4NO&$&GZ!X?CBL[66 MXM[9;.S>YT]3+*5DFWQ2PJ%"B>3]#** /,_CU8_M:^)K>;P;^SOJG@GPO#?6 M@C?QWK\ESJ-YI;MN#O#I2PQPSNHP4:2[5 WWHG4;6SOV+_V*O@W^PS\*)OAE M\)TU"^N]7U>XUKQAXMU^Z^TZMXFUBX;=<:C?3X'FS2-Z *H 554 "O7:* /& M/^"B/[+^O?MJ?L1?$S]E/POXHM-$U#QWX7FTJTU:_A:2&U=RI#NJ?,0,=!7# M:C^S_P#ME>$O^"?/A/X#_L9?'WPOX1^)/@W3M(T^'Q%XE\.&_P!,U&.RBCAN M()(SEXHY@A_>*"ZC@8)W+]05C^!_^01+_P!?LW_H5 '@W@?]FC]J3XV>(O!G MCC_@H)XY^']]_P ('J\>MZ'X*^&.CWL.F2ZW%&Z0ZA=7%]*\UQY/F.\$"I$D ME?!'2]!U&'XC> ;SP\DNI: MU?O&XM)H+HH6B6-S&Q"N@Q&P*R^8/+]FHH _/CXQ_L5_\%M?%_[7.N_M,_#' M]M'X(Z-;&WDTSP1HFL_#^\U'_A'-+9]S1PL[@">?;&UQ, &E,:+Q'''&OT/^ MPG\&?V[?AI;>*O$W[?'[4FB?$;Q%K-U:PZ%;>$O#YTO2M(L($%_\ M$]_^2)ZM_P!CWK/_ *4FO=*\+_X)[_\ )$]6_P"Q[UG_ -*30![I1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 45X9!_P4$^"<4WQ5U3Q+X?\5:#X8^#37R^./'>N:,L& MC1/:1K+,EO/YA:[8(P.(D8AOD;:_R5YE_P $_?\ @L/\./V_=,_C%^R?\ $_X1_#C4!:>(O%7P\UK1]!NVE\L0WMS830P.6_AQ M(ZG/;&:_-/\ X)L?\%'?V6?AI_P1COOV.OVJ-6E\'_%'X1?#;7?#7Q ^%&M: M1P"[B ?HI\8OVX_V9O@A^R9)^VWXM M^)$%S\.WT2UU/2M8TB,W+:O'=;!9QVD:_--+.TL:1H.2SC.!DCD_!?[?8M?C M;X+^ 7[2WP"\0?"G7/B;87-S\.FU[5;&]M]5FMXUEGTZ62TE=;74$B82>0VY M'4/YWUM-OE^@K[W_X.B/$6H?#G]F?]G[XS^%9&@\1>$OVKO"E]H5U" M<2"46^H,8P1R0VQ*=$N-< MM/".D7D%LFFZ/!((I-3O[F=@MK;&5EA0@/)+*VU$;#LNI^RG^V%\/OVJ[;Q7 MHFCZ)J7ASQA\/O$3Z#\0? ^O>5]OT*_"B1 QB=XYH)HF66&XC9DEC;((8.B_ M$7_!.36]5^)G_!Q+^W-XT\52L]QX3\.^$/#>A12'/V:P:U\QD3/17D@$I'0M M(33_ -G/Q%J'A;_@ZH_:#^'VA2-'I?BS]FW1-=U^&,X66_LI]-M+>1QT++!< M2*"><,?>@#]-**** "O"_P!K#_DMGP/_ .Q[E_\ 29J[CX@_M/? #X5>(V\) M?$3XJ:7I&I)"DK6=W(P<(W*MP#P:\0^.7[2'P,^*?QQ^#<'P]^)FFZL]AXV: M2\6TD8^4C0%%)R!P6(% 'U716;_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U0!I45 MF_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?5 &E16;_PF/AC_H-0?]]4?\)CX8_Z M#4'_ 'U0!E?&S_DC/B[_ +%B_P#_ $GDK\VJ_17XS>*_#EQ\'_%=O!J\+._A MJ^5%!Y)-NX K\ZJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** /LW_ ()T?\D9U;_L9Y?_ $GMZ]_KYU_X)[Z]H^E? M!_5;?4=0CA=O$LK!7/)'V>W&?TKWC_A,?#'_ $&H/^^J -*BLW_A,?#'_0:@ M_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ $&H/^^J -*B MLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J#_OJC_A,?#'_ M $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J M#_OJC_A,?#'_ $&H/^^J ,CXE_&GX9_!];)OB+XE_LX:@9!9_P"AS3>9LV[_ M /5(V,;UZXZ\=ZY7_AM7]F;_ **7_P"4:]_^,UY+_P %&]9TO5H?!_\ 9MZD MWEM?[]AZ9%OC^1KY@H ^^?\ AM7]F;_HI?\ Y1KW_P",T?\ #:O[,W_12_\ MRC7O_P 9KX&HH ^^?^&U?V9O^BE_^4:]_P#C-'_#:O[,W_12_P#RC7O_ ,9K MX&HH ^^?^&U?V9O^BE_^4:]_^,T?\-J_LS?]%+_\HU[_ /&:^!J* /OG_AM7 M]F;_ **7_P"4:]_^,T?\-J_LS?\ 12__ "C7O_QFO@:B@#[Y_P"&U?V9O^BE M_P#E&O?_ (S1_P -J_LS?]%+_P#*->__ !FO@:B@#[Y_X;5_9F_Z*7_Y1KW_ M .,UF^%?VQ?V<=-TZ2"]^(NQVN9' _LB\/!;(/$-?#%% 'WS_P -J_LS?]%+ M_P#*->__ !FC_AM7]F;_ **7_P"4:]_^,U\#44 ??/\ PVK^S-_T4O\ \HU[ M_P#&:/\ AM7]F;_HI?\ Y1KW_P",U\#44 ??/_#:O[,W_12__*->_P#QFC_A MM7]F;_HI?_E&O?\ XS7P-10!]\_\-J_LS?\ 12__ "C7O_QFC_AM7]F;_HI? M_E&O?_C-? U% 'WS_P -J_LS?]%+_P#*->__ !FC_AM7]F;_ **7_P"4:]_^ M,U\#44 ??/\ PVK^S-_T4O\ \HU[_P#&:/\ AM7]F;_HI?\ Y1KW_P",U\#4 M4 ?J6K!E#*>",BEK*@\8^&!"G_$Z@^Z/XO:G_P#"8^&/^@U!_P!]4 :5%9O_ M F/AC_H-0?]]4?\)CX8_P"@U!_WU0!I45F_\)CX8_Z#4'_?5'_"8^&/^@U! M_P!]4 :5>%_\$]_^2)ZM_P!CWK/_ *4FO8O^$Q\,?]!J#_OJOEW]C#]J?]GK MX:_"[5?#GCOXL:5I=\WC+59Q;74C!C&]P2C<#H1S0!]:45QWPS_:"^"_QEOK MK3/A?\1-.UNXLHA+=163DF-"'-+>^U36+Z>18K:QLK:/YKBXFE=41!@,/]NZSX6\.^(K[2]3US1H+JXT34#?:3+,F3:W)@EMS*GHWE3S M)GTD:OBC_@I3\%K']N/]N;]F7]FWPK9+-*/ 7BOQ?<-J%OIV@^ M"_ >C'4=;U^^G?"6ME:AE,\H19)2H(Q'#(YX4UY]^PC_ ,%%/$/[ MH?L ?M!?!VW\/V,,YU3XT^ UT.#4'E=E6&U#3,\[@(S-M7:@V[B"Z@\E_P % M0/\ @G]^V/\ MA>,?A[\6OV0OV^&^#?B'X7_ &^\\/6DG@F'5+:_U"ZA\AII MWEEP@$!DA'[F3:L\_#"0@8'_ 26_;Z_:L^,OQ&^)7[!7_!17X>Z3H7QV^#8 MLY]3U;PX"-+\6:1=!OL^J6PP N2HW@!5S(N$C;?%& ?<-%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y\_MT? M\$H_VQ/VO=+O?V0=$_:G\)^'/V:_%GQ"F\5>.=.M_#UT/%EPEQJ#:E=Z3'R2S+(R))'NC0B58L2>T:Y\+/B9H?[7_P5\*-JOPY\*?"+P##J$7@# MP/I-U=2:SJ-_'HUQ903;3 L4%M;6,MW'Y08@&5292WEI7P!\0?V2O^"*O[17 M[=_[0FJ?\%?_ -L[P-XD\;6/Q&<>"[#Q%^T!%I-EHGAQK:$0:?%##>P^1=6] MQ'>03V\F'4QQR% )E=_9/V"OV,/^" '[/?[;'@;QK_P3%^,G@O4/B+/;:M:7 M6D^"/BU_PE/VC3&L9&F>XC:^G-JB2)"5F R68)M(?=& ?IS1110 4444 17U MY#IUC-J%PDK1P1-(ZP0/*Y"C)"H@+.>.%4$D\ $U\8?MS>!?C_\ \%1O"!_8 MO^$WACQ/\//A#K]S$OQ=^)WB;2)=*U#4M+1U>31M'L+I5NO-N"H26[N(HX$B M+!/M!'6 MN!;VUR=(*JND^:YQ$LL"A5=CCS(XM[!=S#F?VM_@_P"._P#@K;\:_P!G[P0? M@AXU\(?"[X6?$.V^(OQ*OO'_ (??2I;G4K*!TL-$MH)?GNV:2>;SYXLVRQCY M)I&95K[[HH ^&_$_[._CG]B[_@K?XH_X*%>#?AWK_B?X<_&WX?6FA_$RV\): M1+J.HZ%KVFF-;'4/L< :>XM9;5# P@CD>.4!V&QB1I_L!?LD_$>[_;L^//\ MP5'^.?@F\\+ZK\5ETSP]\/?".JE/M^D^&=/MXHQ-=JC,(IKR:)+@P;BT*J@? M#ED3[1HH **** ,O5O!'@O7KPZAKGA#2[VX*A3/=Z?'(Y Z#\"W8@':!GGFOH>O"_P!K#_DMGP/_ .Q[ ME_\ 29J /;O[.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* (?[.T_P#Y\8?^_0H_ ML[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* .3^-5A8I\ M&_%KI91 CPS?D$1CC_1Y*_-^OTE^-G_)&?%W_8L7_P#Z3R5^;5 !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'V3_P M3MM;6?X-ZL\]M&Y'B:4 N@/_ "[V]>^_V=I__/C#_P!^A7@W_!.C_DC.K?\ M8SR_^D]O7O\ 0!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ%344 0_V=I__ #XP M_P#?H4?V=I__ #XP_P#?H5-10!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ%344 M 0_V=I__ #XP_P#?H4?V=I__ #XP_P#?H5-10!#_ &=I_P#SXP_]^A1_9VG_ M //C#_WZ%344 0_V=I__ #XP_P#?H4?V=I__ #XP_P#?H5-10!\L?\%)K:WM MX?!OD0(F6U#.Q0,\6U?+5?5/_!2S_4>#/]_4/Y6U?*U !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'ZB0:=I_DI_H M,/W1_P LAZ4[^SM/_P"?&'_OT*D@_P!0G^X/Y4Z@"'^SM/\ ^?&'_OT*/[.T M_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&' M_OT*^?/V"O O@C6O@YJUYK'@[2KN8>.-802W.G12-M%R<#+*3@>E?1->%_\ M!/?_ )(GJW_8]ZS_ .E)H ]DT;PEX4\.2O/X>\,Z?8/(NV1[*RCB+CT)4#(K M0HHH \._X*"?M'_'K]F;]GJ^\8_LP_LN^(_BUX[O9/L?A[PYH-LKPV\K*3]K MNV:2/$$8&2BL'D;:@*!C(GQO^SW^W)^WI\,_#Y^'_P /?^")WQGD\:>,M:CE M\2?$?XB:YIT<%]JMP8X6U346MR6%O$H3$$05(K>!(8O+1%V_IS10!\W?M"_M MV?&+]G;]I;3/@]<_\$^/BUXZ\%ZMX>CNK?XE_#;3X-4@@U R.KV=S:;T>W55 M5&\YG(/F !<*S"7]F7X ^,]>_:L\=_\ !0+XQ^ '\):_XQ\)Z3X2\+^$;J[@ MGO=*T*PFN;GS+Z2V=X?M=Q'#I7AZ\NQXA\2^";NVT[2_+@ M=_M5U*]F5C@CQO=FX"J2>*_5+PA?76J>$]+U.^E\R>YTZ"69]H&YVC4DX' Y M/:OQW^*/_!7;_@H[_P %)_ >K?\ !,;X;_\ !(SXB?#;Q_\ $32Y?"OQ&\8^ M,%G&B^$]-ND-OJ%\K/;1[U\AYO*+.O+)L\YMJO\ LGIUA;:7I\&F6:%8;:%8 MHE)SA5 'Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@#\A_\ @H3XI_X)5?#C]MWX@^ _!'_!(+6_VN/CEXAU*SUSXBV7ACP+ M'J5OX7+6%M!##<71BD%LTD<"3F,(V7GD=W4N%KV#_@E_H'_!-SQI\?-,UWX> M?\$Q]?\ V5?C=X:TB\O8O"_B;P NA7&MZ5+&+:Y>VF1?*U&U1YH-Y7;)%((\ MJJL=^O\ $3]O#P9_P1X\9^/_ M^T?\ LE?$^\\+>,/B!JGB[1OBQ\._"*ZO MI^K'49?/:WU!HY%DM+RW8FU19 5DM[:!D?JBU_V1/VV/B_\ \%:OVO\ P+\; M/A7^R1XV^'/P,^$PU34E\%_M8?\EL^!__ &/< MO_I,U>Z5X7^UA_R6SX'_ /8]R_\ I,U 'NE%%% !1110 4444 ?\$Z/^2,ZM_P!C/+_Z3V]>_P! !1110 4444 %%%% !111 M0 4444 %%%% 'RY_P4L_U'@S_?U#^5M7RM7U3_P4L_U'@S_?U#^5M7RM0 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0!^I4'^H3_<'\J=38/\ 4)_N#^5.H **** "BBB@ KPO_@GO_P D3U;_ +'O M6?\ TI->Z5X7_P $]_\ DB>K?]CWK/\ Z4F@#W2BBB@ HHHH **** "BBB@# MPO\ X*8?M@W/[ W[!_Q-_:\T[PLFMWO@KPZ;G3-+F+"*>\EECM[<2[<-Y0FF MC+X(.P-@@\U\)^ /V5O^"PE_\ _!_P"V/^U#_P %>/'>@^.?&OBCPI&G@'P- MX:TJ/1/#UMK.L6%I]GDBG@DCNI(8;LDY0#>NTM* 7?\ 0/\ ;U\5_L\>"OV/ MO'NO?M:^'(=6^&/]B?9O'EG<1/(G]ESRI!<2%8_G/EI(9/W?[SY/DPVTU^?/ MQN_X*#_\$7/C=^P9??L$ZK_P6=NK#2_/TE/#_CBQBN(_$&E6FG7MI=VT0N4M M5665#:",7!02%&!SU2Y@A@N$N4A+OY#M!=0>;"&813B:-6*J#7KU?*/_!%J[_8@N/V M"]$M/^"?FL7NJ> +'Q)K=D=;U>[>?4=7OX=0FCN-1NY'1':6Z*K\)^!'^!+^!IY=?UJZN[D>(H_$(N&$4,,8/DFU,.PDE=VX MO\R[55_5:^//V_\ PM_P6<\4?M#^&=(_X)R?&7X7^%O!%SX-N9O$5Q\0O#DM MWY&J072*JI)$CM^^AN5*J0 /L^&O$PLO"OB+Q]=:S:W6J6DEI;W22;8+EA(4%P(7D5%4RPR@ ;:V?V9_ M&W_!=?4?VL?!6C_MX_"_X*:/\,I8M2:]O_@[>:E/,]^+.0VT5W]LD8I;\2," MJX,JQ L"55N&_P"%$_\ !T7_ -'Q?LO_ /A$7_\ \C5V?[+GP?\ ^"Y7AS]J MSP3XC_;P_:,^%/C'X;6J:F+O3/AIHMQ93PW[V4BVT]SYL">9 !YJ8#8$DL9* MMPR 'W71110 4444 %%%% !1110 4444 %%%% !7A?[6'_);/@?_ -CW+_Z3 M-7NE>%_M8?\ );/@?_V/2OS:K])?C9_R1GQ=_P!BQ?\ _I/)7YM4 %%%% !1110 4444 %%% M(S*BEW8 9))X H 6BN>^'GQ:^&/Q:AU.Z^&'CW2O$$.C:HVFZI<:1>I<1V] MVL:2-"70E=ZK(A(!.-V#R"*Y+XD?MI_LD_![Q?<_#_XI_M&>#] UNS6-KO2M M5UV&&>$.@=-R,V5RC*PSU# ]Z /3J*YGX4?&?X3_ !U\-2>,O@W\0](\3:3% M=M:R:CHMZL\*S*JLT9921N =21_M"K/COXE^ _AE8VU_XZ\3VVGK?70MM/AD M)::\G(+"*&) 7FDVJS;$5FPI., F@#=HK!\$?$_P!\1].N]4\%>*K6^CTZY: MWU*-6*2V,RJ&,4\3@/"X4JVUU4X8'&"#6=\.OCY\'/BUJD^B_#GX@Z?JUU;V M:7GDV[L#-:N[(MS"6 $\#.C*)H]T992 V: .OHK-U?Q?X:T'6M*\.:MJT<-_ MK<\D.E6F"SW#1Q-+)@ '"JBDECA1E03EE!TJ "BBB@ HHHH **** "BBB@#[ M-_X)T?\ )&=6_P"QGE_])[>O?Z\ _P""='_)&=6_[&>7_P!)[>O?Z "BBB@ MHHHH **** "BBB@ HHHH **** /ES_@I9_J/!G^_J'\K:OE:OJG_ (*6?ZCP M9_OZA_*VKY6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH _4J#_4)_N#^5.IL'^H3_<'\J=0 4444 %%%% !7A?\ MP3W_ .2)ZM_V/>L_^E)KW2O"_P#@GO\ \D3U;_L>]9_]*30![I1110 4444 M%%%% !1110!RWQJ^$_PV^.'PRU/X7_;4O#&I"%M:TZ^"FWNH(IDF,4P< M%6B;RPKJ>&0L#UKX3\3_ /!5/_@VFT/QS-\"-?\ BI\"Y+IG:PGB@^'8N=*( M^XR->Q6+67EX."3+LQGG -?0O_!7OX(_';]I#_@F=\9O@?\ LT7>.-!L?"*3>();FTLO.O+74;9T$\FH\,'AGP^Y@.%Q0!T__ M 22^"GQK^!/[)/_ B_QJ\1?#S4VU'Q=JNK^$9OAC(TVEQ>'[F;S-/B2X9% M:ZV0D*LS;V,0A4NY4L?IROE7_@C[XD_X3K]EK5/B3X5^!&N_##X?>)_'FIZK M\*/ 7B2P2SN])T"982,VR,RVL!Y]!NOA+;RI_8>H74EPTJZG*I M^;[0JL(P>N$3#*-ZN ?&O_#M/_@OA_TL-?\ FM^B?_':Z_\ 9B_8;_X*G_!S M]K'P)\3_ -L#_@J/%\1E?&+_@D-^VS\;/VCOB/\5+'_ (+)_'7X>^%M;\4"Z\%^#_".ML]O MIUD]I;M*A\R0; +MKI4C50JQ+%R22!>_9J_X)E_'7]DS]L#X>?%GXL?\%6?B ME\8K,G5K"T\$_$S4C)$9I=/E;[7:JKL#+&L;*=R\),^'4_*X!][T444 %%%% M !7B7QI_;H^&_P ,OC;IW[+/@#PEKGQ%^*FI:=_:)\#>#D@:72M.SM_M#4KB MXECM]/MMQ 5I7\R4G$,"/V2/V9M3_ &E_VKS;>&+'1+97U+3](NWU-Y)Y)1%;VEL1%$US<3.T2*@0 M?.^,E1OKC/!?[?8M?C;X+^ 7[2WP"\0?"G7/B;87-S\.FU[5;&]M]5FMXUEG MTZ62TE=;74$B82>0VY'4/Y/@O_@I9X!_X)O?$;X9VEY8^ M"/BU^T_H]]XBT*]D!>WN].OHK66QF(P) DLMRH. '"HX R,>T?\ !T1XBU#X M<_LS_L_?&?PK(T'B+PE^U=X4OM"NH3B02BWU!C&".2&V+E>^T4 ?8WQ\_;9\ M.?"CXZ^&_P!D[X;_ _U+Q]\5/%.B7&N6GA'2+R"V33='@D$4FIW]S.P6UMC M*RPH0'DEE;:B-AV74_93_;"^'W[5=MXKT31]$U+PYXP^'WB)]!^(/@?7O*^W MZ%?A1(@8Q.\J_$S_@XE_;F\:>*I6>X\ M)^'?"'AO0HI#G[-8-:^8R)GHKR0"4CH6D)I_[.?B+4/"W_!U1^T'\/M"D:/2 M_%G[-NB:[K\,9PLM_93Z;:6\CCH66"XD4$\X8^] 'Z:4444 %>%_M8?\EL^! M_P#V/#7B' MQR_:0^!GQ3^./P;@^'OQ,TW5GL/&S27BVDC'RD: HI.0."Q H ^JZ*S?^$Q\ M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ MZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#*^-G_)&?%W_8L7__ *3R M5^;5?HK\9O%?ARX^#_BNW@U>%G?PU?*B@\DFW< 5^=5 !1110 4444 %%%% M!45]8V6J64NFZE9Q7%O<1M'/;SQATD0C!5E/!!'!!J6HKV[BL+.6^G25DAB: M1UAA:1R ,D*B LQXX5023P 30!\K?\$L],T[1;W]HO2M(L(;6U@_:8\2)!;V M\81(U$5IA54<*!V X%>I_$OX0?LL_"#P3XT^.OC[X/\ AK4#:V]_X@\1ZOJ^ MC6]S=7/EH\K!I94+$*BB.-A_\ M)1\;M;\2^'Y=9T&XMH[W3+A;=(IE=T"JQ,;'RV(D Y*]<=Y^V/X6\2_%71?! MWP'T?P]?76E^+O&UD/&%Y!:.T%IHUF3?W"S2 %8Q.UM%:@,1N^T$#O0!+^PA M\([OX-?LM>&-!UO1K>PUK5H9==\1VMM;B)(M1OY6NYX@H $;2^4H P%B4#@ M5Y=_P46U3XG? 3XG_#+]M[P/H,7B?3?!$M_HWB+P;]I5+R[M]2\E/.L W^LN M5,0_=J"SKP/EWD>^?M!_%;Q%\%/A1J7Q'\*_"+Q!XZOK%X%A\->&(1)>7(DF M2,LBGJ$#%S@'A3VR1YC\>_#?C_3_ -K/X4_M!WGA35]9\%:#HNKV6I:;I5B] MW?#7AK1[>[Q-I)M+&Y@A?4,<17/_ (!KX?\ ! TG19[X/>K]J233,1(WE/+) M<12C?M5@6.?W;[?I']F'PAXV^'_[-O@#P)\2KDS>(=&\%Z98ZY(9?,)NXK6- M)T?2O@_JMOJ.H1PNWB65@KGDC[/;C/Z5[Q_P )CX8_Z#4' M_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!] M4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ MPF/AC_H-0?\ ?5'_ F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z# M4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 'S=_P4L_U'@S_?U# M^5M7RM7T_P#\%&]9TO5H?!_]FWJ3>6U_OV'ID6^/Y&OF"@ HHHH **** "BB MB@ KSS]JWX@_$OX3_L\>,/BA\)]/T2YU?PYX:_MG_ /)GGQ8_[)IKO_IOGH ;^SM\6/&/Q#_8^\%?&_Q! MI1U77]:^'=AK5Y8Z=&L1N[N6R2=HXE)PNYV*J"<#(KYV^-7C?_@KG\#?@IK/ MQJ\:?$KX'JNE6(F.AZ?X;U*>6:XD=8X;2)VE4/(\KQQ*2 "S"O>?V O^3&/@ MW_V2_0?_ $WPUD?M+K_PM/\ :!^$_P"SK#^\M(]8E\;^*8UY LM*V?9$<=,/ MJ%Q:. >HMG]#0![#X,3Q5'X/TF/QU<6LNMKID UF6QC*0/=>6OFM&I)*H7W$ M DX&.37E'Q5_:6\37?QYM/V3/V>=-TZ_\9G3%U7Q1K.KH\FG>%M-+!4EGCC9 M&N+B4D"*V5T)!WLZ(,M[37PC^QK^S]X2^.G[1'[5>H?&2^U_^V)_BO)ISPZ9 MXFO=.=--BB;[!(?LTL9;$3_NR^X+M^4#)R >]?M,?&'XB?L\^$? 7A#2/%9U M?Q'\1/B7IGA:#7M3TZ$1Z:MR'>:=(8E16V102>6CECO==S.JD&W^RO\ 'OQ7 MX[\5_%/X3?$N_M[G4?A?XP_LW^W4@6!;ZPFMH[JWEE5<(LRH[))L"H=@8*N[ M:/(?V%?"7BG]IG]G'Q)\(?VDO%>KZYJ'PC^.&H:3X2\;/<#^T6DTF>)K6_$K MJPDE1WDC+.KJZ@JX;+9[RS^!_A*7QGKO[.G@:]U"_L],?# A3_B=0?='\7M3_ /A,?#'_ M $&H/^^J -*BLW_A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZH TJ*S?^$Q\,?]!J M#_OJC_A,?#'_ $&H/^^J -*O"_\ @GO_ ,D3U;_L>]9_]*37L7_"8^&/^@U! M_P!]5\N_L8?M3_L]?#7X7:KX<\=_%C2M+OF\9:K.+:ZD8,8WN"4;@=".: /K M2BN.^&?[07P7^,M]=:9\+_B)IVMW%E$);J*R^M;.6"VL-$\.:6]]JFL7T\BQ6UC96T?S7%Q-*ZHB# MY+,5568?)_P3_P""Z'@WQ%^UAX8_8[_:U_8R^+'P \3?$%V3X;WOQ'TZ 6'B M"4$ 6RSPR,L=PQ9%$?S#'?$5]I>IZYHT%U<:)J!OM)EF3 M)M;DP2VYE3T;RIYDSZ2-7Q1_P4I^"UC^W'^W-^S+^S;X5LEFN/A%\1[3XN?$ M#7(4S_8>FV(D2PLW?M)J%X-JQ@[C'8SR8Q&,@'T%^T[^VAX*_9T\<>!_@EI? MA+4_&/Q)^)5[

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end GRAPHIC 16 ew-20231231_g11.jpg begin 644 ew-20231231_g11.jpg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end GRAPHIC 17 ew-20231231_g12.jpg begin 644 ew-20231231_g12.jpg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end GRAPHIC 18 ew-20231231_g13.jpg begin 644 ew-20231231_g13.jpg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ew-20231231_g2.jpg begin 644 ew-20231231_g2.jpg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end GRAPHIC 20 ew-20231231_g3.jpg begin 644 ew-20231231_g3.jpg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end XML 27 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2023
Jan. 31, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 1-15525    
Entity Registrant Name EDWARDS LIFESCIENCES CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 36-4316614    
Entity Address, Address Line One One Edwards Way    
Entity Address, City or Town Irvine    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92614    
City Area Code 949    
Local Phone Number 250-2500    
Title of 12(b) Security Common Stock, par value $1.00 per share    
Trading Symbol EW    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 56,849,824,065
Entity Common Stock, Shares Outstanding   601.3  
Documents Incorporated by Reference
Portions of the registrant's proxy statement for the 2024 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2023) are incorporated by reference into Part III, as indicated herein.
    
Entity Central Index Key 0001099800    
Amendment Flag false    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
XML 28 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Audit Information
 12 Months Ended
Dec. 31, 2023
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Irvine, California
XML 29 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 1,144.0 $ 769.0
Short-term investments (Note 7) 500.5 446.3
Accounts receivable, net of allowances of $8.3 and $7.9, respectively 775.1 643.0
Other receivables 61.8 56.1
Inventories (Note 5) 1,168.2 875.5
Prepaid expenses 146.8 110.0
Other current assets 239.3 195.9
Total current assets 4,035.7 3,095.8
Long-term investments (Note 7) 583.9 1,239.0
Property, plant, and equipment, net (Note 5) 1,749.4 1,632.8
Operating lease right-of-use assets (Note 6) 94.0 92.3
Goodwill (Note 10) 1,253.5 1,164.3
Other intangible assets, net (Note 10) 428.4 285.2
Deferred income taxes 754.6 484.0
Other assets 463.7 299.1
Total assets 9,363.2 8,292.5
Current liabilities    
Accounts payable 201.4 201.9
Accrued and other liabilities (Note 5) 969.1 795.0
Operating lease liabilities (Note 6) 24.9 25.5
Total current liabilities 1,195.4 1,022.4
Long-term debt (Note 11) 597.0 596.3
Contingent consideration liabilities (Note 12) 0.0 26.2
Taxes payable (Note 18) 80.6 143.4
Operating lease liabilities (Note 6) 73.0 69.5
Uncertain tax positions (Note 18) 339.3 267.5
Litigation settlement accrual (Note 3) 94.2 143.0
Other liabilities 264.3 217.5
Total liabilities 2,643.8 2,485.8
Commitments and contingencies (Notes 6, 11, and 19)
Stockholders' equity (Note 15)    
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding 0.0 0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 650.5 and 646.3 shares issued, and 601.1 and 608.3 shares outstanding, respectively 650.5 646.3
Additional paid-in capital 2,274.4 1,969.3
Retained earnings 8,992.4 7,590.0
Accumulated other comprehensive loss (Note 16) (242.8) (254.9)
Treasury stock, at cost, 49.4 and 38.0 shares, respectively (5,024.5) (4,144.0)
Total Edwards Lifesciences Corporation stockholders' equity 6,650.0 5,806.7
Noncontrolling interest (Note 9) 69.4 0.0
Total stockholders' equity 6,719.4 5,806.7
Total liabilities and stockholders' equity $ 9,363.2 $ 8,292.5
XML 30 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 8.3 $ 7.9
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized shares (in shares) 50,000,000.0 50,000,000.0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 1.00 $ 1.00
Common stock, shares authorized (in shares) 1,050,000,000 1,050,000,000
Common stock, shares issued (in shares) 650,500,000 646,300,000
Common stock, shares outstanding (in shares) 601,100,000 608,300,000
Treasury stock (in shares) 49,400,000 38,000,000.0
XML 31 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net sales $ 6,004.8 $ 5,382.4 $ 5,232.5
Cost of sales 1,379.8 1,080.4 1,248.9
Gross profit 4,625.0 4,302.0 3,983.6
Selling, general, and administrative expenses 1,824.6 1,567.6 1,493.7
Research and development expenses 1,071.8 945.2 903.1
Intellectual property agreement and litigation expense (Note 3) 203.5 15.8 20.6
Change in fair value of contingent consideration liabilities (Note 12) (26.2) (35.8) (124.1)
Special charge and separation costs (Note 4) 17.2 60.7 0.0
Operating income 1,534.1 1,748.5 1,690.3
Interest expense 17.6 19.2 18.4
Interest income (67.2) (35.5) (17.4)
Other income, net (Note 17) (14.4) (2.6) (12.7)
Income before provision for income taxes 1,598.1 1,767.4 1,702.0
Provision for income taxes (Note 18) 198.7 245.5 198.9
Net income 1,399.4 1,521.9 1,503.1
Net loss attributable to noncontrolling interest (3.0) 0.0 0.0
Net income attributable to Edwards Lifesciences Corporation. $ 1,402.4 $ 1,521.9 $ 1,503.1
Earnings per share attributable to Edwards Lifesciences Corporation:      
Basic (in dollars per share) $ 2.31 $ 2.46 $ 2.41
Diluted (in dollars per share) $ 2.30 $ 2.44 $ 2.38
Weighted-average number of common shares outstanding attributable to Edwards Lifesciences Corporation:      
Basic (in shares) 606.7 619.0 623.3
Diluted (in shares) 609.4 624.2 631.2
XML 32 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Comprehensive Income [Abstract]      
Net income $ 1,399.4 $ 1,521.9 $ 1,503.1
Other comprehensive income (loss), net of tax (Note 16):      
Foreign currency translation adjustments 4.3 (46.3) (50.1)
Unrealized (loss) gain on hedges (23.1) (5.9) 57.4
Unrealized pension (costs) credits (9.9) 13.7 11.6
Unrealized gain (loss) on available-for-sale investments 40.8 (58.7) (15.5)
Other comprehensive income (loss), net of tax 12.1 (97.2) 3.4
Comprehensive income 1,411.5 1,424.7 1,506.5
Comprehensive loss attributable to noncontrolling interest (3.0) 0.0 0.0
Comprehensive income attributable to Edwards Lifesciences Corporation $ 1,414.5 $ 1,424.7 $ 1,506.5
XML 33 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities      
Net income $ 1,399.4 $ 1,521.9 $ 1,503.1
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 144.9 139.6 134.8
Non-cash operating lease cost 28.2 27.2 28.5
Stock-based compensation (Notes 2 and 15) 139.4 126.8 109.3
Impairment charges (Note 4) 0.0 55.1 4.0
Change in fair value of contingent consideration liabilities (Note 12) (26.2) (35.8) (124.1)
Loss (gain) on investments, net 0.1 51.5 (36.8)
Deferred income taxes (272.1) (254.5) (41.4)
Other 8.4 7.8 9.4
Changes in operating assets and liabilities:      
Accounts and other receivables, net (141.2) (84.1) (91.1)
Inventories (289.0) (213.4) 19.0
Prepaid expenses and other current assets (81.8) 0.1 7.9
Accounts payable and accrued liabilities 146.0 (21.4) 195.2
Intellectual property agreement accrual (33.0) (45.0) (29.2)
Income taxes (5.8) (5.6) 62.0
Long-term prepaid royalties (Note 3) (109.9) 0.0 0.0
Other (11.6) (52.0) (18.5)
Net cash provided by operating activities 895.8 1,218.2 1,732.1
Cash flows from investing activities      
Capital expenditures (253.0) (244.6) (325.8)
Purchases of held-to-maturity investments (Note 7) (66.4) (353.5) (250.0)
Proceeds from sales and maturities of held-to-maturity investments (Note 7) 97.9 419.5 138.0
Purchases of available-for-sale investments (Note 7) (9.1) (315.8) (1,629.3)
Proceeds from sales and maturities of available-for-sale investments (Note 7) 617.9 939.6 391.2
Business combination, net of cash (Note 9) (95.2) 0.0 0.0
Payments for acquisition options (Note 8) (30.0) (109.6) (13.1)
Issuances of notes receivable (62.5) (52.3) (5.1)
Collections of notes receivable 0.0 18.0 20.0
Investments in intangible assets (13.3) (20.2) (4.0)
Other (12.5) (28.8) (44.4)
Net cash provided by (used in) investing activities 173.8 252.3 (1,722.5)
Cash flows from financing activities      
Proceeds from issuance of debt 0.0 0.0 5.2
Payments on debt and finance lease obligations (0.3) (0.2) (7.0)
Purchases of treasury stock (879.6) (1,727.1) (512.8)
Proceeds from stock plans 169.9 146.4 158.6
Other (1.0) (3.6) (0.3)
Net cash used in financing activities (711.0) (1,584.5) (356.3)
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash 16.8 19.2 13.9
Net increase (decrease) in cash, cash equivalents, and restricted cash 375.4 (94.8) (332.8)
Cash, cash equivalents, and restricted cash at beginning of year 772.6 867.4 1,200.2
Cash, cash equivalents, and restricted cash at end of year (Note 5) $ 1,148.0 $ 772.6 $ 867.4
XML 34 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Edwards Lifesciences Corporation Stockholders' Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Common stock, beginning balance (in shares) at Dec. 31, 2020     636.4          
Beginning balance at Dec. 31, 2020 $ 4,574.3 $ 4,574.3 $ 636.4 $ (1,904.1) $ 1,438.1 $ 4,565.0 $ (161.1) $ 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2020       12.1        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 1,503.1 1,503.1       1,503.1    
Other comprehensive income (loss), net of tax 3.4 3.4         3.4  
Common stock issued under equity plans (in shares)     5.6          
Common stock issued under equity plans 158.6 158.6 $ 5.6   153.0      
Stock-based compensation expense 109.3 109.3     109.3      
Purchases of treasury stock (in shares)       5.8        
Purchases of treasury stock (512.8) (512.8)   $ (512.8)        
Common stock, ending balance (in shares) at Dec. 31, 2021     642.0          
Ending balance at Dec. 31, 2021 5,835.9 5,835.9 $ 642.0 $ (2,416.9) 1,700.4 6,068.1 (157.7) 0.0
Treasury stock, ending balance (in shares) at Dec. 31, 2021       17.9        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 1,521.9 1,521.9       1,521.9    
Other comprehensive income (loss), net of tax (97.2) (97.2)         (97.2)  
Common stock issued under equity plans (in shares)     4.3          
Common stock issued under equity plans 146.4 146.4 $ 4.3   142.1      
Stock-based compensation expense 126.8 126.8     126.8      
Purchases of treasury stock (in shares)       20.1        
Purchases of treasury stock $ (1,727.1) (1,727.1)   $ (1,727.1)        
Common stock, ending balance (in shares) at Dec. 31, 2022 608.3   646.3          
Ending balance at Dec. 31, 2022 $ 5,806.7 5,806.7 $ 646.3 $ (4,144.0) 1,969.3 7,590.0 (254.9) 0.0
Treasury stock, ending balance (in shares) at Dec. 31, 2022 38.0     38.0        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) $ 1,399.4 1,402.4       1,402.4   (3.0)
Other comprehensive income (loss), net of tax 12.1 12.1         12.1  
Common stock issued under equity plans (in shares)     4.2          
Common stock issued under equity plans 169.9 169.9 $ 4.2   165.7      
Stock-based compensation expense 139.4 139.4     139.4      
Purchases of treasury stock (in shares)       11.4        
Purchases of treasury stock (880.5) (880.5)   $ (880.5)        
Changes to noncontrolling interest (Note 9) $ 72.4             72.4
Common stock, ending balance (in shares) at Dec. 31, 2023 601.1   650.5          
Ending balance at Dec. 31, 2023 $ 6,719.4 $ 6,650.0 $ 650.5 $ (5,024.5) $ 2,274.4 $ 8,992.4 $ (242.8) $ 69.4
Treasury stock, ending balance (in shares) at Dec. 31, 2023 49.4     49.4        
XML 35 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
DESCRIPTION OF BUSINESS
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESS
Edwards Lifesciences Corporation ("Edwards Lifesciences," "Edwards," or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care. On December 7, 2023, the Company announced its intention to complete a tax-free spin-off of its Critical Care product group around the end of 2024. The planned separation will enable the Company to pursue expanded opportunities for TAVR, TMTT, and Surgical patients, as well as new investments in interventional heart failure technologies.
XML 36 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Edwards Lifesciences, its wholly-owned subsidiaries, and variable interest entities for which the Company is the primary beneficiary (see Note 8). The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.

Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."

Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, which is recognized ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company
receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.

The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2023 and 2022, $13.3 million and $10.6 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Liabilities." During 2023, the Company recognized as revenue $7.6 million that was included in the balance of deferred revenue as of December 31, 2022, and during 2022, the Company recognized as revenue $7.2 million that was included in the balance of deferred revenue as of December 31, 2021.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs

Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales." For the years ended December 31, 2023, 2022, and 2021, shipping costs of $99.4 million, $87.4 million, and $85.3 million, respectively, were included in "Selling, General, and Administrative Expenses."
Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. These investments are valued at cost, which approximates fair value.

Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 3% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."

Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."

Debt securities in an unrealized loss position are written down to fair value through "Other Income, net" if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the length of time and the extent to which the security's fair value has been below cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any.

Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract inception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.
The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).

The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. During the years ended December 31, 2023, 2022, and 2021, the Company allocated $96.9 million, $88.1 million, and $77.9 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2023 and 2022 were $45.7 million and $43.7 million, respectively.

At December 31, 2023 and 2022, $164.6 million and $128.6 million, respectively, of the Company's finished goods inventories were held on consignment.

Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.

Depreciation expense for property, plant, and equipment was $138.9 million, $133.9 million, and $127.0 million for the years ended December 31, 2023, 2022, and 2021, respectively.

Leases

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.
Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.

Acquisitions

Businesses that the Company acquires are included in its results of operations as of the acquisition date. The purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. Contingent consideration obligations incurred in connection with a business combination are recorded at their fair values on the acquisition date and remeasured on a quarterly basis, with changes in their fair value recorded as an adjustment to earnings, until the related contingencies have been resolved. When the assets acquired do not meet the definition of a business combination, the transactions is accounted for as an asset acquisition. In an asset acquisition, the cost of the acquisition is allocated to the assets acquired and liabilities assumed based on their relative fair values. Upfront payments related to in-process research and development projects with no alternative future use are expensed upon acquisition.

Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2023, 2022, and 2021, the Company did not record any goodwill impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

In 2022, the Company recorded a $52.7 million impairment of certain developed technology and in-process research and development assets. For further information, see Note 4 and Note 9. In 2023 and 2021, the Company did not record any impairment loss related to its in-process research and development assets.
Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.

Research and Development Costs

Research and development costs are charged to expense when incurred.

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.

The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202320222021
Basic:   
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Basic earnings per share$2.31 $2.46 $2.41 
Diluted:
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Dilutive effect of stock plans2.7 5.2 7.9 
Dilutive weighted-average shares outstanding609.4 624.2 631.2 
Diluted earnings per share$2.30 $2.44 $2.38 

Outstanding stock options, unvested restricted stock units, and unvested market-based restricted stock units to purchase approximately 6.6 million, 3.6 million, and 1.8 million shares for the years ended December 31, 2023, 2022, and 2021,
respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.

Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over each award's requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.

Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202320222021
Cost of sales$23.6 $22.8 $20.4 
Selling, general, and administrative expenses82.4 75.3 65.6 
Research and development expenses33.4 28.7 23.3 
Total stock-based compensation expense139.4 126.8 109.3 
Income tax benefit(24.1)(21.6)(18.9)
Total stock-based compensation expense, net of tax$115.3 $105.2 $90.4 

Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.

Derivatives

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies, resulting principally from intercompany and local currency transactions.
All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Upon settlement, cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.

New Accounting Standards Not Yet Adopted

In December 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.

In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is curently evaluating the impact the guidance will have on its consolidated financial statements.

In March 2023, the FASB issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial results or disclosures.
XML 37 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE
The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $203.5 million, $15.8 million and $20.6 million during 2023, 2022 and 2021, respectively.

On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and is paying annual royalty payments that are tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April
2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in "Intellectual Property Agreement and Litigation Expense" in April 2023 related to products currently in development.
XML 38 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
SPECIAL CHARGE AND SEPARATION COSTS
 12 Months Ended
Dec. 31, 2023
Other Income and Expenses [Abstract]  
SPECIAL CHARGE AND SEPARATION COSTS SPECIAL CHARGE AND SEPARATION COSTS
On December 7, 2023, the Company announced its intention to complete a spin-off of its Critical Care product group as a separate publicly traded company to Edwards Lifesciences' shareholders. The proposed spin-off is intended to be a tax-free transaction for U.S. federal income tax purposes and is expected to be completed around the end of 2024, subject to the satisfaction of customary conditions including final approval by the Company's board of directors, receipt of a favorable opinion and Internal Revenue Service ruling with respect to the tax-free nature of the transaction, and the effectiveness of a registration statement on Form 10. The Company recorded a charge to its United States segment of $17.2 million, primarily related to costs incurred for consulting, legal, tax, and other professional advisory services associated with the planned spin-off.
In September 2022, the Company decided to exit its HARPOON surgical mitral repair system program. As a result, the Company recorded a charge to its United States segment of $62.3 million, of which $60.7 million was included in "Special Charge and Separation Costs" and $1.6 million was included in "Cost of Sales" on the consolidated statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology for $52.7 million (see Note 9 and Note 10) and other related exit costs. The Company believes that no additional contingent consideration is due and, in September 2022, recorded an $11.7 million contingent consideration gain associated with the exit (see Note 12).
XML 39 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS
Composition of Certain Financial Statement Captions

Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20232022
 (in millions)
Inventories  
Raw materials$252.6 $156.4 
Work in process220.1 177.4 
Finished products695.5 541.7 
$1,168.2 $875.5 
Property, plant, and equipment, net  
Land$116.4 $116.3 
Buildings and leasehold improvements1,234.2 1,189.2 
Machinery and equipment775.8 697.6 
Equipment with customers37.9 37.4 
Software87.2 87.5 
Construction in progress355.3 255.2 
2,606.8 2,383.2 
Accumulated depreciation(857.4)(750.4)
$1,749.4 $1,632.8 
Accrued and other liabilities  
Employee compensation and withholdings$371.2 $268.7 
Accrued rebates131.4 116.1 
Property, payroll, and other taxes63.0 45.6 
 As of December 31,
 20232022
 (in millions)
Research and development accruals74.1 66.9 
Legal and insurance (Notes 3 and 19)30.7 28.1 
Litigation settlement69.1 53.3 
Taxes payable59.3 50.6 
Fair value of derivatives15.2 20.7 
Accrued marketing expenses15.0 17.0 
Accrued professional services8.8 6.6 
Accrued realignment reserves12.3 15.6 
Accrued relocation costs19.2 25.2 
Accrued warranties10.08.4 
Other accrued liabilities89.8 72.2 
$969.1 $795.0 
Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202320222021
Cash paid during the year for:   
Interest$19.9 $19.3 $20.2 
Income taxes$470.1 $504.1 $182.5 
Amounts included in the measurement of operating lease liabilities$28.8 $28.1 $31.9 
Non-cash investing and financing transactions:   
Right-of-use assets obtained in exchange for new lease liabilities$29.3 $31.9 $28.7 
Capital expenditures accruals$45.5 $42.6 $54.3 
Conversion of notes receivable to equity investment$— $— $21.5 

Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202320222021
Cash and cash equivalents$1,144.0 $769.0 $862.8 
Restricted cash included in other current assets3.3 0.5 1.5 
Restricted cash included in other assets0.7 3.1 3.1 
Total cash, cash equivalents, and restricted cash$1,148.0 $772.6 $867.4 
Amounts included in restricted cash primarily represent funds placed in escrow related to litigation.
XML 40 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES LEASES
The Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 17 years, some of which include options to extend or terminate the leases.
Operating lease costs for the years ended December 31, 2023, 2022, and 2021 were $30.1 million, $28.8 million, and $29.7 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2023, 2022, and 2021.

Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20232022
Operating lease right-of-use assets$94.0 $92.3 
Operating lease liabilities, current portion$24.9 $25.5 
Operating lease liabilities, long-term portion73.0 69.5 
Total operating lease liabilities
$97.9 $95.0 

Maturities of operating lease liabilities at December 31, 2023 were as follows (in millions):
2024$26.8 
202519.6 
202616.3 
202712.9 
20289.5 
Thereafter20.7 
Total lease payments
105.8 
Less: imputed interest
(7.9)
Total lease liabilities
$97.9 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20232022
Weighted-average remaining lease term (in years)5.96.4
Weighted-average discount rate2.3 %1.8 %
As of December 31, 2023, the Company had additional operating lease commitments of $16.0 million for office spaces that have not yet commenced.
XML 41 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS
 12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
INVESTMENTS INVESTMENTS
Debt Securities

Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2023December 31, 2022
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$64.5 $— $— $64.5 $96.0 $— $— $96.0 
Available-for-sale
U.S. government and agency securities$72.7 $0.1 $(2.8)$70.0 $137.7 $— $(6.1)$131.6 
Asset-backed securities192.1 — (7.8)184.3 380.6 — (14.0)366.6 
Corporate debt securities658.5 — (16.7)641.8 1,028.1 — (47.8)980.3 
Municipal securities2.8 — (0.2)2.6 2.7 — (0.2)2.5 
$926.1 $0.1 $(27.5)$898.7 $1,549.1 $— $(68.1)$1,481.0 

The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2023 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$64.5 $64.5 $443.2 $436.0 
Due after 1 year through 5 years— — 267.8 257.0 
Due after 10 years— — 0.9 0.9 
Instruments not due at a single maturity date (a)
— — 214.2 204.8 
$64.5 $64.5 $926.1 $898.7 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.

Actual maturities may differ from the contractual maturities due to call or prepayment rights.
The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2023 and 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2023
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$— $— $67.1 $(2.8)$67.1 $(2.8)
Asset-backed securities10.2 (1.8)172.7 (6.0)182.9 (7.8)
Corporate debt securities25.0 (0.1)601.3 (16.6)626.3 (16.7)
Municipal securities— — 2.6 (0.2)2.6 (0.2)
$35.2 $(1.9)$843.7 $(25.6)$878.9 $(27.5)
December 31, 2022
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$61.6 $(1.5)$69.5 $(4.6)$131.1 $(6.1)
Asset-backed securities103.3 (1.3)254.6 (12.7)357.9 (14.0)
Corporate debt securities189.0 (5.3)784.8 (42.5)973.8 (47.8)
Municipal securities— — 2.5 (0.2)2.5 (0.2)
$353.9 $(8.1)$1,111.4 $(60.0)$1,465.3 $(68.1)

The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of December 31, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary.

Investments in Unconsolidated Entities

The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:

 December 31,
 20232022
 (in millions)
Equity method investments  
Carrying value of equity method investments$33.6 $21.4 
Equity securities  
Carrying value of non-marketable equity securities87.6 86.9 
Total investments in unconsolidated entities$121.2 $108.3 
During 2023, the Company made $12.1 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs, and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.

Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. During 2023, the Company did not record any upward or downward adjustments due to observable price changes or impairments. During 2022, the Company recorded an upward adjustment of $0.8 million based on observable price changes and a downward adjustment of $0.5 million due to an impairment. As of December 31, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes.

During 2023, 2022, and 2021, the gross realized gains or losses from sales of available-for-sale investments were not material.
XML 42 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS IN VARIABLE INTEREST ENTITIES
 12 Months Ended
Dec. 31, 2023
Variable Interest Entities [Abstract]  
INVESTMENTS IN VARIABLE INTEREST ENTITIES INVESTMENTS IN VARIABLE INTEREST ENTITIES
The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.

Consolidated VIEs

In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. See Note 9 for additional information.

Unconsolidated VIEs

Edwards has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.

In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option to acquire the medical device company, of which $30.0 million had been paid as of December 31, 2023. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. The option and the note are included in "Other Assets" on the consolidated balance sheet as of December 31, 2023.

In August 2022, the Company entered into an option agreement with a medical device company. Under the option agreement, Edwards paid $47.1 million for an option to acquire the medical device company. The $47.1 million option is included in "Other Assets" on the consolidated balance sheets.

In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $32.5 million had been advanced as of December 31, 2023. In addition, in 2019, the Company paid $35.0 million for an option to acquire the medical device company. The $35.0 million option and the $32.5 million note receivable are included in "Other Assets" on the consolidated balance sheets.
In May 2022, the Company entered into an option agreement with a medical technology company. Under the option agreement, Edwards paid $60.0 million for an option to acquire the medical technology company, of which $10.0 million was paid in 2021. In addition, during 2023, the Company entered into two promissory notes totaling $25.0 million with the medical technology company. The $60.0 million option and the $25.0 million note receivable are included in "Other Assets" on the consolidated balance sheets.

In April 2021, the Company entered into a $45.0 million secured promissory note agreement with a privately-held medical device company (the "Investee"), of which $30.0 million had been advanced as of December 31, 2023. Also in 2021, the Company invested $39.3 million, included in "Long-term Investments," in the Investee's preferred equity securities and paid $13.1 million, included in "Other Assets," for an option to acquire the Investee. Pursuant to the agreement, the Company may be required to invest up to an additional $6.5 million in the Investee's preferred equity securities and up to an additional $14.4 million for the option to acquire the Investee.

In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 7.
XML 43 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS COMBINATIONS
 12 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
BUSINESS COMBINATIONS BUSINESS COMBINATIONS
On February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction. The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company.

The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination. Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):

Assets$8.1 
Goodwill (b)
133.2 
In-process research and development136.6 
Liabilities assumed(1.7)
Deferred tax liabilities(28.0)
Fair value of net assets acquired248.2 
Less: Noncontrolling interest (a)
(72.4)
Total purchase price
175.8 
Less: cash acquired(6.8)
Total purchase price, net of cash acquired (b)
$169.0 
_______________________________________
(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.
(b)     Includes $22.5 million paid in a previous year under option agreements, $5.3 million for the settlement of a pre-existing note, and $46.0 million of cash paid directly to the acquired company which was included in Edwards' consolidated cash balance and offset against goodwill post acquisition.

Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s Rest of World segment and is not deductible for tax purposes.
Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.

In-process Research and Development Assets

The business combination referred to above and the Company's previous acquisitions of Harpoon Medical, Inc ("Harpoon") on December 1, 2017 and CardiAQ Valve Technologies, Inc. ("CardiAQ") on July 3, 2015 included the acquisition of in-process research and development assets. The in-process research and development assets were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals.

The discount rate used to determine the fair value of the in-process research and development assets acquired from the medical technology company referred to above was 13.0%. The valuation assumed $68.6 million of additional research and development expenditures would be incurred prior to the date of product introduction and net cash inflows were modeled to commence in 2028. Upon completion of development, the underlying research and development intangible asset will be amortized over its estimated useful life.

In September 2022, the Company decided to exit the HARPOON program and recorded a $28.1 million impairment charge to fully write off the in-process research and development assets. See Note 4 for further information.

The valuation for CardiAQ assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures. Net cash inflows commenced in Europe in late 2023 and the associated in-process research and development assets of $69.0 million were reclassified to developed technology. Net cash inflows in the United States are now expected to commence in 2024.
Upon completion of development, the underlying research and development intangible assets will commence amortization over their estimated useful lives.
XML 44 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.

The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2023 and 2022 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2021
$773.7 $63.0 $331.2 $1,167.9 
Currency translation adjustment— (3.6)— (3.6)
Goodwill at December 31, 2022
773.7 59.4 331.2 1,164.3 
Goodwill acquired during the year (Note 9)— — 87.2 87.2 
Currency translation adjustment— 2.0 — 2.0 
Goodwill at December 31, 2023
$773.7 $61.4 $418.4 $1,253.5 
Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20232022
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents9.9$119.3 $(87.6)$31.7 $205.5 $(185.0)$20.5 
Developed technology10.8197.6 (61.9)135.7 128.1 (57.9)70.2 
Other10.012.3 (8.9)3.4 12.2 (7.7)4.5 
10.6329.2 (158.4)170.8 345.8 (250.6)95.2 
Indefinite-lived intangible assets      
In-process research and development257.6 — 257.6 190.0 — 190.0 
$586.8 $(158.4)$428.4 $535.8 $(250.6)$285.2 

Amortization expense related to other intangible assets for the years ended December 31, 2023, 2022, and 2021 was $6.1 million, $5.7 million, and $7.7 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2024$5.8 
20257.0 
20269.4 
202710.9 
202814.8 
XML 45 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND CREDIT FACILITIES
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
DEBT AND CREDIT FACILITIES DEBT AND CREDIT FACILITIES
In June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets.

The following is a summary of the Notes as of December 31, 2023 and 2022:
 December 31,
 2023 2022
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.3% Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(0.7)  (0.9) 
Unamortized debt issuance costs(2.3)(2.8)
Total carrying amount$597.0   $596.3  
As of December 31, 2023 and 2022, the fair value of the Notes was $591.6 million and $575.2 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 12). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the Notes.

The Company has a Five-Year Credit Agreement ("the Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027. Subject to certain terms and conditions and the agreement of the lenders, the Company may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year. Borrowings under the Credit Agreement bear interest at a variable rate based on the Secured Overnight Financing Rate ("SOFR"), plus a spread ranging from 0.785% to 1.3%, depending on the leverage ratio or credit rating, as defined in the Credit Agreement, plus a 0.1% credit spread adjustment. The Company will also pay a facility fee ranging from 0.09% to 0.20%, depending on the Company's leverage ratio or credit rating, on the entire credit commitment available, whether or not drawn. The facility fee is expensed as incurred. During 2023, under the Credit Agreement, the spread over SOFR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.1 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2023 and 2022, there were no borrowings outstanding. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants under the Credit Agreement at December 31, 2023.
The weighted-average interest rate under all debt obligations, including the impact of the cross currency swap contract (see Note 13), was 3.4% at both December 31, 2023 and 2022.
XML 46 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:

Level 1—Quoted market prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.

Level 3—Unobservable inputs that are not corroborated by market data.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.

The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include Notes payable. See Note 11 for further information on the fair value of the Notes payable.
Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2023 and 2022 (in millions):

December 31, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$579.2 $— $— $579.2 
Available-for-sale investments: 
Corporate debt securities— 641.8 — 641.8 
Asset-backed securities— 184.3 — 184.3 
United States government and agency securities— 70.0 — 70.0 
Municipal securities— 2.6 — 2.6 
Investments held for deferred compensation plans125.8 — — 125.8 
Derivatives— 47.1 — 47.1 
$705.0 $945.8 $— $1,650.8 
Liabilities    
Derivatives$— $15.2 $— $15.2 
Other— — 10.3 10.3 
$— $15.2 $10.3 $25.5 
December 31, 2022
Assets
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments: 
Corporate debt securities— 980.3 — 980.3 
Asset-backed securities— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other— — 14.0 14.0 
$— $27.2 $40.2 $67.4 
Cash Equivalents and Available-for-sale Investments

Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service.

Deferred Compensation Plans

The Company holds investments in a variety of money market and mutual funds related to its deferred compensation plans. The fair values of these investments are based on quoted market prices.

Derivative Instruments

The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.

Contingent Consideration Liabilities

Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. As of December 31, 2023, the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was zero.

The following table summarizes the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis for the years ended December 31, 2023 and 2022 (in millions):

Contingent ConsiderationOtherTotal
Fair value, December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(35.8)— (35.8)
Fair value, December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)(3.7)(29.9)
Fair value, December 31, 2023
$— $10.3 $10.3 
XML 47 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
As of December 31,
 20232022
 (in millions)
Foreign currency forward exchange contracts$1,786.2 $1,678.4 
Cross currency swap contracts300.0 300.0 

The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
As of December 31,
 Balance Sheet Location20232022
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$23.7 $24.9 
Cross currency swap contractsOther assets$23.4 $40.6 
Liabilities   
Foreign currency contractsAccrued and other liabilities$15.2 $20.7 
Foreign currency contractsOther liabilities$— $6.5 

The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$23.7 $— $23.7 $(9.4)$— $14.3 
Cross currency swap contracts$23.4 $— $23.4 $— $— $23.4 
Derivative Liabilities      
Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
December 31, 2022      
Derivative Assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative Liabilities      
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
 
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2023202220232022
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$29.2 $81.7 Cost of sales$58.9 $88.4 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
2023202220232022
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$(17.3)$21.6 Interest income, net$6.9 $7.0 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202320222021
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$13.9 $(3.9)$11.6 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202320222021
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$7.4 $44.0 $27.4 
The following tables present the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2023
 Cost of salesOther income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,379.8)$14.4 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— (9.2)
Derivatives designated as hedging instruments
— 9.2 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— 4.7 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
58.9 — 
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2022
 Cost of salesOther income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.4)$2.6 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— 5.5 
Derivatives designated as hedging instruments
— (5.5)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— 1.6 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
88.4 — 
The Company expects that during 2024 it will reclassify to earnings a $2.7 million gain currently recorded in "Accumulated Other Comprehensive Loss." For the years ended December 31, 2023, 2022, and 2021, the Company did not record any gains or losses due to hedge ineffectiveness.
XML 48 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS
 12 Months Ended
Dec. 31, 2023
Retirement Benefits [Abstract]  
EMPLOYEE BENEFIT PLANS EMPLOYEE BENEFIT PLANS
Defined Benefit Plans

The Company maintains defined benefit pension plans in Japan and certain European countries.
 Years Ended December 31,
 20232022
(in millions)
Change in projected benefit obligation:  
Beginning of year$94.1 $117.9 
Service cost4.3 5.5 
Interest cost2.3 0.5 
Participant contributions1.9 1.6 
Actuarial loss (gain)9.9 (22.6)
Benefits paid(3.8)(0.6)
Plan amendment(0.4)(0.3)
Settlements and curtailment gain— (1.8)
Currency exchange rate changes and other3.4 (6.1)
End of year$111.7 $94.1 
Change in fair value of plan assets:  
Beginning of year$70.6 $76.9 
Actual return on plan assets0.8 (4.9)
Employer contributions3.5 3.5 
Participant contributions1.9 1.6 
Settlements— (1.8)
Benefits paid(3.8)(0.6)
Currency exchange rate changes and other2.5 (4.1)
End of year$75.5 $70.6 
Funded Status  
Projected benefit obligation$(111.7)$(94.1)
Plan assets at fair value75.5 70.6 
Underfunded status$(36.2)$(23.5)
Net amounts recognized on the consolidated balance sheet:  
Other liabilities$36.2 $23.5 
Accumulated other comprehensive loss, net of tax:  
Net actuarial (loss) gain$(10.3)$1.5 
Net prior service credit5.2 5.3 
Deferred income tax benefit (expense)0.9 (1.1)
Total$(4.2)$5.7 

The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $106.8 million and $86.7 million as of December 31, 2023 and 2022, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2023 and 2022.
The components of net periodic pension benefit cost are as follows (in millions):

 Years Ended December 31,
 202320222021
Service cost, net$4.3 $5.5 $6.5 
Interest cost2.3 0.5 0.4 
Expected return on plan assets(2.7)(1.5)(1.1)
Settlements and curtailment gain— 0.1 — 
Amortization of actuarial loss— 0.5 1.7 
Amortization of prior service credit (0.8)(0.7)(0.7)
Net periodic pension benefit cost$3.1 $4.4 $6.8 

Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.

To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.

The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20232022
Discount rate1.8 %2.5 %
Rate of compensation increase2.9 %2.9 %
Cash balance interest crediting rate1.5 %1.5 %
Social securities increase1.8 %1.8 %
Pension increase2.2 %2.2 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202320222021
Discount rate2.5 %0.5 %0.3 %
Expected return on plan assets3.7 %2.1 %1.5 %
Rate of compensation increase2.9 %2.6 %2.6 %
Cash balance interest crediting rate1.5 %1.5 %2.5 %
Social securities increase1.8 %1.6 %1.6 %
Pension increase2.2 %1.8 %1.8 %
Plan Assets

The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.

The Company's Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2023, by asset category, are as follows:
Equity securities31.3 %
Debt securities38.9 %
Real estate11.4 %
Other18.4 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2023 and 2022, by asset category, are as follows (in millions):
December 31, 2023Level 1Level 2Level 3Total
Asset Category    
Cash$2.0 $— $— $2.0 
Equity securities:    
United States equities2.6 — — 2.6 
International equities21.0 — — 21.0 
Debt securities:    
United States government bonds3.5 — — 3.5 
International government bonds26.0 — — 26.0 
Real estate— 8.7 — 8.7 
Mortgages— 4.0 — 4.0 
Insurance contracts— — 0.8 0.8 
Total plan assets measured at fair value
$55.1 $12.7 $0.8 $68.6 
Alternative investments measured at net asset value (a)6.9 
Total plan assets
$75.5 
 
December 31, 2022Level 1Level 2Level 3Total
Asset Category
Cash$3.6 $— $— $3.6 
Equity securities:
United States equities1.5 — — 1.5 
International equities17.5 — — 17.5 
Debt securities:
United States government bonds4.4 — — 4.4 
International government bonds25.6 — — 25.6 
Real estate— 7.6 — 7.6 
Mortgages— 3.5 — 3.5 
Insurance contracts— — 0.8 0.8 
Total plan assets $52.6 $11.1 $0.8 $64.5 
Alternative investments measured at net asset value (a)6.1 
Total plan assets $70.6 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.

The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2023 and 2022 (in millions):

 Insurance
Contracts
Balance at December 31, 2021$0.9 
Actual return on plan assets: 
Relating to assets still held at December 31, 2022
0.2 
Purchases, sales and settlements(0.2)
Currency exchange rate impact(0.1)
Balance at December 31, 20220.8 
Actual return on plan assets: 
Relating to assets still held at December 31, 2023
0.2 
Purchases, sales and settlements(0.2)
Balance at December 31, 2023$0.8 

Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2023, are expected to be paid (in millions):

2024$7.3 
20255.9 
20266.9 
20276.8 
20288.1 
2029-203339.0 

As of December 31, 2023, expected employer contributions for 2024 are $2.7 million.

Defined Contribution Plans

The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $51.0 million, $45.1 million, and $38.6 million in 2023, 2022, and 2021, respectively.

The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $125.6 million and $112.6 million at December 31, 2023 and 2022, respectively.
XML 49 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
COMMON STOCK COMMON STOCK
Treasury Stock

In July 2022, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.5 billion of the Company's common stock, effective July 28, 2022. In December 2023, the Board of Directors approved an additional $1.0 billion of repurchases of the Company's common stock under this program. The repurchase program does not have an expiration date. Stock repurchased under these programs may be used to offset the impact of the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.

During 2023, 2022, and 2021, the Company repurchased 11.4 million, 20.1 million, and 5.8 million shares, respectively, at an aggregate cost of $880.5 million, $1,727.1 million, and $512.8 million, respectively, including shares purchased under a Rule 10b5-1 trading plan, the accelerated share repurchase ("ASR") agreements described below, and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.
Accelerated Share Repurchase

During 2023 and 2022, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share
January 2022$250.0 1.9 $104.87 80 %February 20222.3 $110.31 
October 2022$750.0 8.3 $72.43 80 %December 202210.3 $72.91 
February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 
December 2023$400.0 4.6 $70.31 80 %December 20235.3 $72.91 

The ASR agreements were each accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "Additional Paid-in Capital" and subsequently, upon settlement, was transferred to "Treasury Stock" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.

Employee and Director Stock Plans

The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between three to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods, typically four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Under the Program, the number of shares of common stock authorized for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.

The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.

The Company has an employee stock purchase plan for United States employees and a plan for employees outside of the United States (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of purchase. Under the ESPP, employees can authorize the Company to withhold up to 15% of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside of the United States, to the extent permitted
by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 50.4 million shares.

The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the United States Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.

The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
Years Ended December 31,
202320222021
Risk-free interest rate3.4 %3.0 %0.8 %
Expected dividend yieldNoneNoneNone
Expected volatility32.8 %31.4 %33.5 %
Expected term (years)5.15.05.0
Fair value, per share$30.97 $34.59 $28.90 

The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
Years Ended December 31,
202320222021
Risk-free interest rate4.6 %0.5 %0.1 %
Expected dividend yieldNoneNoneNone
Expected volatility31.5 %32.0 %36.6 %
Expected term (years)0.60.60.6
Fair value, per share$19.03 $28.18 $23.07 

The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the years ended December 31, 2023, 2022, and 2021 included a risk-free interest rate of 3.6%, 2.9%, and 0.4%, respectively, and an expected volatility rate of 32.6%, 33.9%, and 34.4%, respectively.
Stock option activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 2022
11.6 $63.67   
Options granted2.0 88.27   
Options exercised(2.2)38.54   
Options forfeited(0.4)97.32   
Outstanding as of December 31, 2023
11.0 71.90 3.5 years$136.9 
Exercisable as of December 31, 2023
7.3 61.68 2.4 years$135.5 
Vested and expected to vest as of December 31, 2023
10.5 70.91 3.4 years$136.7 

The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 2022
2.0 $92.30 
Granted1.1 89.03 
Vested(0.8)83.17 
Forfeited(0.2)99.82 
Nonvested as of December 31, 2023
2.1 94.35 



The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2023, 2022, and 2021 were $162.7 million, $264.5 million, and $359.8 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2023, 2022, and 2021, the Company received cash from exercises of stock options of $83.4 million, $64.8 million, and $82.2 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $35.9 million, $56.9 million, and $76.5 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2023, 2022, and 2021 were $41.3 million, $40.4 million, and $36.2 million, respectively.

As of December 31, 2023, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan subscription awards amounted to $224.9 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 31 months.
XML 50 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE LOSS ACCUMULATED OTHER COMPREHENSIVE LOSS
Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2023, 2022, and 2021.

 Foreign
Currency
Translation
Adjustments		Unrealized (Loss) Gain on HedgesUnrealized Gain (Loss) on
Available-for-sale
Investments		Unrealized
Pension
(Costs) Credits (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2020$(122.4)$(27.7)$8.6 $(19.6)$(161.1)
Other comprehensive (loss) income before reclassifications
(39.2)66.3 (29.2)12.8 10.7 
Amounts reclassified from accumulated other comprehensive loss(6.4)12.0 8.6 1.0 15.2 
Deferred income tax (expense) benefit
(4.5)(20.9)5.1 (2.2)(22.5)
December 31, 2021(172.5)29.7 (6.9)(8.0)(157.7)
Other comprehensive (loss) income before reclassifications
(33.9)75.2 (77.9)17.3 (19.3)
Amounts reclassified from accumulated other comprehensive loss(7.0)(84.5)18.8 (0.1)(72.8)
Deferred income tax (expense) benefit
(5.4)3.4 0.4 (3.5)(5.1)
December 31, 2022(218.8)23.8 (65.6)5.7 (254.9)
Other comprehensive income (loss) before reclassifications
6.9 43.3 32.6 (11.1)71.7 
Amounts reclassified from accumulated other comprehensive loss(6.9)(72.8)8.1 (0.8)(72.4)
Deferred income tax benefit
4.3 6.4 0.1 2.0 12.8 
December 31, 2023$(214.5)$0.7 $(24.8)$(4.2)$(242.8)
_______________________________________________________________________________
(a)For the years ended December 31, 2023, 2022, and 2021, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2023   
Prior service credit arising during period$0.7 $0.9 $1.6 
Amortization of prior service credit(0.8)0.1 (0.7)
Net prior service cost arising during period(0.1)1.0 0.9 
Net actuarial loss arising during period(11.8)1.0 (10.8)
Unrealized pension costs, net$(11.9)$2.0 $(9.9)
2022   
Prior service credit arising during period$— $(1.1)$(1.1)
Amortization of prior service credit(0.7)0.3 (0.4)
Net prior service cost arising during period(0.7)(0.8)(1.5)
Net actuarial gain arising during period17.9 (2.7)15.2 
Unrealized pension credits, net$17.2 $(3.5)$13.7 
2021   
Prior service credit arising during period$0.1 $— $0.1 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.6)0.1 (0.5)
Net actuarial gain arising during period14.4 (2.3)12.1 
Unrealized pension credits, net$13.8 $(2.2)$11.6 

The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20232022Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.9 $7.0 Other income, net
(1.7)(1.7)Provision for income taxes
$5.2 $5.3 Net of tax
(Loss) gain on hedges$58.9 $88.4 Cost of sales
13.9 (3.9)Other income, net
72.8 84.5 Total before tax
(15.8)(22.2)Provision for income taxes
$57.0 $62.3 Net of tax
Gain (loss) on available-for-sale investments$(8.1)$(18.8)Other income, net
2.2 4.6 Provision for income taxes
$(5.9)$(14.2)Net of tax
Amortization of pension adjustments$0.8 $0.1 Other income, net
(0.2)— Provision for income taxes
$0.6 $0.1 Net of tax
XML 51 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER INCOME, NET
 12 Months Ended
Dec. 31, 2023
Other Income and Expenses [Abstract]  
OTHER INCOME, NET OTHER INCOME, NET
 Years Ended December 31,
 202320222021
(in millions)
Foreign exchange (gains) losses, net$(10.5)$1.2 $(5.0)
Loss (gain) on investments0.7 1.1 (5.8)
Non-service cost components of net periodic pension benefit cost(1.2)(1.1)0.3 
Gain on insurance settlement— (3.8)— 
Other(3.4)— (2.2)
Total other income, net$(14.4)$(2.6)$(12.7)
XML 52 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):
 Years Ended December 31,
 202320222021
United States$348.0 $634.4 $610.9 
Outside of the United States, including Puerto Rico1,250.1 1,133.0 1,091.1 
$1,598.1 $1,767.4 $1,702.0 

The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202320222021
Current   
United States:   
Federal$317.3 $369.1 $125.2 
State and local58.1 60.6 25.1 
Outside of the United States, including Puerto Rico85.3 66.7 92.6 
Current income tax expense$460.7 $496.4 $242.9 
Deferred   
United States:   
Federal$(187.5)$(187.7)$(9.4)
State and local(54.2)(58.9)(25.4)
Outside of the United States, including Puerto Rico(20.3)(4.3)(9.2)
Deferred income tax benefit(262.0)(250.9)(44.0)
Total income tax provision$198.7 $245.5 $198.9 
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20232022
Deferred tax assets  
   Capitalized research and development expenses (a)
$371.1 $199.7 
Compensation and benefits117.9 100.6 
Benefits from uncertain tax positions63.4 42.1 
Net tax credit carryforwards172.9 160.8 
Net operating loss carryforwards75.9 71.7 
Accrued liabilities132.8 93.7 
Inventories15.3 11.9 
Cash flow and net investment hedges1.6 6.6 
State income taxes0.2 0.3 
Investments0.6 0.6 
Lease liability obligations5.8 6.7 
Other0.8 1.9 
Total deferred tax assets958.3 696.6 
Deferred tax liabilities  
Property, plant, and equipment(78.2)(80.2)
Deferred tax on foreign earnings(3.6)(19.2)
Right-of-use assets (4.7)(6.0)
Other intangible assets(53.0)(19.9)
Other(2.5)(2.9)
Total deferred tax liabilities(142.0)(128.2)
Valuation allowance(90.2)(99.1)
Net deferred tax assets$726.1 $469.3 
______________________________________
(a)     As required by the 2017 Tax Cuts and Jobs Act, effective January 1, 2022, the Company's research and development expenditures were capitalized and amortized which resulted in substantially higher cash paid for taxes in 2023 and 2022 with an equal amount of deferred tax benefits.

During 2023, net deferred tax assets increased $256.8 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.

The valuation allowance of $90.2 million as of December 31, 2023 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$9.0 $1.9 $— $1.9 2033-2037
United States federal net operating losses1.8 0.4 — 0.4 Indefinite
United States state net operating losses35.7 1.8 (1.7)0.1 2026-2041
United States state net operating losses2.6 0.1 (0.1)— Indefinite
Non-United States net operating losses416.5 71.6 (54.5)17.1 Indefinite
United States capital losses33.4 0.1 (0.1)— 2024
Total$499.0 $75.9 $(56.4)$19.5  

Certain tax attributes are subject to an annual limitation as a result of the acquisition of CASMED, which constitute a change of ownership as defined under Internal Revenue Code Section 382.

The gross tax credit carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$211.3 $— $211.3 Indefinite
Federal research expenditure tax credits1.3 — 1.3 2026-2039
Foreign tax and general business credits0.7 — 0.7 2030-2033
Puerto Rico purchases credits26.2 (26.2)— 2025
Puerto Rico purchases credits1.2 (1.2)— Indefinite
Total$240.7 $(27.4)$213.3  

The Company has $211.3 million of gross California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future. Accordingly, no valuation allowance has been provided. The Company has $27.4 million of Puerto Rico purchases credits. Throughout its history and into the future, the Company's Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits currently have an indefinite life, the Company continues to record a valuation allowance on the purchases credits carryforwards. The Company recently renegotiated its tax grant under Puerto Rico Act 52-2022 ("Act 52") effective January 1, 2023. Among other items, Act 52 introduced new requirements and limitations on the availability and claiming of tax credits. As a result, the Company now expects that its purchases credits generated through December 31, 2022 will expire in 2025 while the purchases credits generated after December 31, 2022 will have an indefinite life.

On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the United States federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years. The Company elected to pay the repatriation tax in installments over eight years.

The Company asserts that $961.6 million of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $1.2 billion of its foreign earnings as of December 31, 2023. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $5.1 million.
The Company has received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $333.2 million ($0.55 per diluted share), $247.4 million ($0.40 per diluted share), and $208.0 million ($0.33 per diluted share) for the years ended December 31, 2023, 2022, and 2021, respectively.

A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202320222021
Income tax expense at United States federal statutory rate$335.6 $371.1 $357.4 
Foreign income taxed at different rates(128.3)(123.9)(122.2)
State and local taxes, net of federal tax benefit18.7 21.1 11.9 
Tax credits, federal and state(62.5)(50.0)(48.4)
Build of reserve for prior years' uncertain tax positions(2.9)11.6 3.6 
Tax on global intangible low-taxed income78.7 61.4 56.5 
Foreign-derived intangible income deduction(23.0)(15.0)(1.3)
Contingent consideration liabilities(5.5)(7.5)(26.1)
United States federal deductible employee share-based compensation(13.1)(31.6)(47.8)
Nondeductible employee share-based compensation6.6 5.8 5.3 
Other(5.6)2.5 10.0 
Income tax provision$198.7 $245.5 $198.9 

The Company's effective tax rate for 2023 decreased in comparison to 2022 primarily due to the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations. On July 21, 2023, the IRS issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited the Company's ability to claim credits on certain foreign taxes for tax years 2022 and 2023. In addition, there was a tax benefit from the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation. The Company's effective tax rate for 2022 increased in comparison to 2021 primarily due to the decrease in the tax benefit from the change in fair value of contingent consideration liabilities and the decrease in the excess tax benefit from employee share-based compensation.
Uncertain Tax Positions

As of December 31, 2023 and 2022, the gross uncertain tax positions were $583.9 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $250.7 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $333.2 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate.
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202320222021
Uncertain gross tax positions, January 1$475.3 $358.4 $281.8 
Current year tax positions
127.0 120.6 82.1 
Increase in prior year tax positions
0.8 3.8 2.3 
Decrease in prior year tax positions
(16.2)(0.6)(4.8)
Settlements
(3.0)(0.4)(0.3)
Lapse of statutes of limitations
— (6.5)(2.7)
Uncertain gross tax positions, December 31$583.9 $475.3 $358.4 

The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled.

The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2023, the Company had accrued $41.4 million (net of $29.9 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2022, the Company had accrued $29.1 million (net of $15.4 million tax benefit) of interest related to uncertain tax positions. During 2023, 2022, and 2021, the Company recognized interest expense, net of tax benefit, of $12.3 million, $9.6 million, and $5.2 million, respectively, in "Provision for Income Taxes" on the consolidated statements of operations.

In the normal course of business, the IRS and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.

The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The execution of some or all these APA renewals depends on many variables outside of Edwards' control.

The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years.

At December 31, 2023, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010 and on.
During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $230.0 million and represented a departure from a transfer pricing method the Company had previously agreed upon with the IRS. The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible.

During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of the Company's filing position is $269.3 million before consideration of interest and a repatriation tax offset.

The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe. The Company intends to make an additional deposit in the range of $200 million to $300 million with the IRS by the second quarter of 2024 in order to further mitigate interest on potential tax liabilities while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS.
Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2023. The Company has considered this information, as well as information regarding the NOD and other proceedings described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.
XML 53 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEGAL PROCEEDINGS
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
LEGAL PROCEEDINGS LEGAL PROCEEDINGS
In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.

On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ SAPIEN 3 Ultra product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.
The European Commission (the "Commission") is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices. The Company is committed to healthy competition and is cooperating with the Commission. The Company cannot predict the outcome of the investigation or the potential impact on its financial statements.

The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent consideration, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.
XML 54 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.

The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.

Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202320222021
Segment Net Sales   
United States$3,508.7 $3,132.6 $2,963.1 
Europe1,337.4 1,213.7 1,099.6 
Japan436.7 559.3 528.0 
Rest of World716.9 610.7 533.2 
Total segment net sales$5,999.7 $5,516.3 $5,123.9 
Segment Operating Income  
United States$2,306.1 $2,130.9 $2,051.0 
Europe709.5 652.2 569.1 
Japan259.1 376.7 348.0 
Rest of World310.4 247.7 185.2 
Total segment operating income$3,585.1 $3,407.5 $3,153.3 

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Years Ended December 31,
 202320222021
Net Sales Reconciliation   
Segment net sales$5,999.7 $5,516.3 $5,123.9 
Foreign currency5.1 (133.9)108.6 
Consolidated net sales$6,004.8 $5,382.4 $5,232.5 
Pre-tax Income Reconciliation  
Segment operating income$3,585.1 $3,407.5 $3,153.3 
Unallocated amounts:
Corporate items(1,920.9)(1,714.1)(1,613.8)
Special charge and separation costs(17.2)(60.7)— 
Intellectual property agreement and litigation expense(203.5)(15.8)(20.6)
Change in fair value of contingent consideration liabilities26.2 35.8 124.1 
Foreign currency64.4 95.8 47.3 
Consolidated operating income1,534.1 1,748.5 1,690.3 
Non-operating income64.0 18.9 11.7 
Consolidated pre-tax income$1,598.1 $1,767.4 $1,702.0 
Enterprise-Wide Information
(in millions)

Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202320222021
Net Sales by Geographic Region   
United States$3,508.7 $3,132.6 $2,963.1 
Europe1,334.5 1,174.8 1,190.3 
Japan452.4 473.6 528.9 
Rest of World709.2 601.4 550.2 
$6,004.8 $5,382.4 $5,232.5 
Net Sales by Major Product Group  
Transcatheter Aortic Valve Replacement$3,879.8 $3,518.2 $3,422.5 
Transcatheter Mitral and Tricuspid Therapies197.6 116.1 86.0 
Surgical Structural Heart999.3 893.1 889.1 
Critical Care928.1 855.0 834.9 
$6,004.8 $5,382.4 $5,232.5 
Long-lived Tangible Assets by Geographic Region   
United States$1,269.7 $1,188.5 $1,195.8 
Europe196.4191.8197.9
Japan23.813.219.7
Rest of World353.5331.6335.5
$1,843.4 $1,725.1 $1,748.9 
XML 55 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
VALUATION AND QUALIFYING ACCOUNTS VALUATION AND QUALIFYING ACCOUNTS
  Additions  
 Balance at
Beginning
of Period		Charged to
Costs and
Expenses		Charged to
Other
Accounts		DeductionsBalance at
End of
Period
 (in millions)
Year ended December 31, 2023
     
Allowance for credit losses (a)$11.7 $2.0 $— $(1.9)$11.8 
Tax valuation allowance (b)99.1 — 0.1 (9.0)90.2 
Year ended December 31, 2022
     
Allowance for credit losses (a)$15.7 $0.9 $0.1 $(5.0)$11.7 
Tax valuation allowance (b)82.5 3.0 14.2 (0.6)99.1 
Year ended December 31, 2021
     
Allowance for credit losses (a)$16.4 $1.2 $0.6 $(2.5)$15.7 
Tax valuation allowance (b)71.6 12.4 — (1.5)82.5 
_______________________________________________________________________________
(a)    The deductions related to allowances for credit losses represent accounts receivable which are written off.

(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.
XML 56 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure      
Net Income (Loss) $ 1,402.4 $ 1,521.9 $ 1,503.1
XML 57 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Donald Bobo, Jr [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On December 14, 2023, Donald Bobo, Jr., Corporate Vice President, Strategy & Corporate Development, entered into a 10b5-1 trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The Plan provides for the potential sale of 70,500 shares of the Company’s stock commencing May 10, 2024. The Plan terminates on the earlier of April 14, 2025 or the date all shares are sold.
Name Donald Bobo, Jr  
Title Corporate Vice President, Strategy & Corporate Development  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 14, 2023  
Arrangement Duration 339 days  
Aggregate Available 70,500 70,500
XML 58 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Edwards Lifesciences, its wholly-owned subsidiaries, and variable interest entities for which the Company is the primary beneficiary (see Note 8). The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.
Foreign Currency Translation
Foreign Currency Translation

When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "Accumulated Other Comprehensive Loss." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "Other Income, net."
Revenue Recognition and Shipping and Handling Costs
Revenue Recognition

Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.

The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, which is recognized ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company
receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.

The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.

The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.

The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.

Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.

The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2023 and 2022, $13.3 million and $10.6 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “Accrued and Other Liabilities” and "Other Liabilities." During 2023, the Company recognized as revenue $7.6 million that was included in the balance of deferred revenue as of December 31, 2022, and during 2022, the Company recognized as revenue $7.2 million that was included in the balance of deferred revenue as of December 31, 2021.

A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.

The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Shipping and Handling Costs
Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "Selling, General, and Administrative Expenses." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "Cost of Sales."
Cash Equivalents
Cash Equivalents

The Company considers highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. These investments are valued at cost, which approximates fair value.
Investments
Investments

The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "Accumulated Other Comprehensive Loss." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.

The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 3% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid.

Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "Other Income, net." Income relating to investments in debt securities is recorded to "Interest Income."

Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "Other Income, net."
Debt securities in an unrealized loss position are written down to fair value through "Other Income, net" if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the length of time and the extent to which the security's fair value has been below cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any.
Accounts Receivable
Accounts Receivable

The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract inception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.
The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.
Inventories
Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.

A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply).
The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology.
Property, Plant and Equipment
Property, Plant, and Equipment

Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.
Leases
Leases

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.

The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.

The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.
Operating leases are included in “Operating Lease Right-of-Use Assets” and “Operating Lease Liabilities” on the Company’s consolidated balance sheets. See Note 6 for further information.
Acquisitions
Acquisitions

Businesses that the Company acquires are included in its results of operations as of the acquisition date. The purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. Contingent consideration obligations incurred in connection with a business combination are recorded at their fair values on the acquisition date and remeasured on a quarterly basis, with changes in their fair value recorded as an adjustment to earnings, until the related contingencies have been resolved. When the assets acquired do not meet the definition of a business combination, the transactions is accounted for as an asset acquisition. In an asset acquisition, the cost of the acquisition is allocated to the assets acquired and liabilities assumed based on their relative fair values. Upfront payments related to in-process research and development projects with no alternative future use are expensed upon acquisition.
Impairment of Goodwill and Long-lived Assets
Impairment of Goodwill and Long-lived Assets

Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2023, 2022, and 2021, the Company did not record any goodwill impairment loss.

Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use.

Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.
In 2022, the Company recorded a $52.7 million impairment of certain developed technology and in-process research and development assets. For further information, see Note 4 and Note 9. In 2023 and 2021, the Company did not record any impairment loss related to its in-process research and development assets.
Income Taxes
Income Taxes

The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises.

Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.
Research and Development Costs
Research and Development Costs

Research and development costs are charged to expense when incurred.
Earnings per Share
Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.
Stock-based Compensation
Stock-based Compensation

The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over each award's requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.
Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.
Derivatives
Derivatives

The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes.

Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.

The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies, resulting principally from intercompany and local currency transactions.
All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "Accumulated Other Comprehensive Loss" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "Accumulated Other Comprehensive Loss" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Upon settlement, cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.
New Accounting Standards Not Yet Adopted
New Accounting Standards Not Yet Adopted

In December 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.

In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is curently evaluating the impact the guidance will have on its consolidated financial statements.

In March 2023, the FASB issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial results or disclosures.
XML 59 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202320222021
Basic:   
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Basic earnings per share$2.31 $2.46 $2.41 
Diluted:
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Dilutive effect of stock plans2.7 5.2 7.9 
Dilutive weighted-average shares outstanding609.4 624.2 631.2 
Diluted earnings per share$2.30 $2.44 $2.38 
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202320222021
Cost of sales$23.6 $22.8 $20.4 
Selling, general, and administrative expenses82.4 75.3 65.6 
Research and development expenses33.4 28.7 23.3 
Total stock-based compensation expense139.4 126.8 109.3 
Income tax benefit(24.1)(21.6)(18.9)
Total stock-based compensation expense, net of tax$115.3 $105.2 $90.4 
XML 60 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Components of Selected Captions in the Consolidated Balance Sheets
Components of selected captions in the consolidated balance sheets are as follows:
 As of December 31,
 20232022
 (in millions)
Inventories  
Raw materials$252.6 $156.4 
Work in process220.1 177.4 
Finished products695.5 541.7 
$1,168.2 $875.5 
Property, plant, and equipment, net  
Land$116.4 $116.3 
Buildings and leasehold improvements1,234.2 1,189.2 
Machinery and equipment775.8 697.6 
Equipment with customers37.9 37.4 
Software87.2 87.5 
Construction in progress355.3 255.2 
2,606.8 2,383.2 
Accumulated depreciation(857.4)(750.4)
$1,749.4 $1,632.8 
Accrued and other liabilities  
Employee compensation and withholdings$371.2 $268.7 
Accrued rebates131.4 116.1 
Property, payroll, and other taxes63.0 45.6 
 As of December 31,
 20232022
 (in millions)
Research and development accruals74.1 66.9 
Legal and insurance (Notes 3 and 19)30.7 28.1 
Litigation settlement69.1 53.3 
Taxes payable59.3 50.6 
Fair value of derivatives15.2 20.7 
Accrued marketing expenses15.0 17.0 
Accrued professional services8.8 6.6 
Accrued realignment reserves12.3 15.6 
Accrued relocation costs19.2 25.2 
Accrued warranties10.08.4 
Other accrued liabilities89.8 72.2 
$969.1 $795.0 
Schedule of Cash Flow Information
Supplemental Cash Flow Information
(in millions)
Years Ended December 31,
202320222021
Cash paid during the year for:   
Interest$19.9 $19.3 $20.2 
Income taxes$470.1 $504.1 $182.5 
Amounts included in the measurement of operating lease liabilities$28.8 $28.1 $31.9 
Non-cash investing and financing transactions:   
Right-of-use assets obtained in exchange for new lease liabilities$29.3 $31.9 $28.7 
Capital expenditures accruals$45.5 $42.6 $54.3 
Conversion of notes receivable to equity investment$— $— $21.5 
Schedule of Cash and Cash Equivalents
Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202320222021
Cash and cash equivalents$1,144.0 $769.0 $862.8 
Restricted cash included in other current assets3.3 0.5 1.5 
Restricted cash included in other assets0.7 3.1 3.1 
Total cash, cash equivalents, and restricted cash$1,148.0 $772.6 $867.4 
Schedule of Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
(in millions)
Years Ended December 31,
202320222021
Cash and cash equivalents$1,144.0 $769.0 $862.8 
Restricted cash included in other current assets3.3 0.5 1.5 
Restricted cash included in other assets0.7 3.1 3.1 
Total cash, cash equivalents, and restricted cash$1,148.0 $772.6 $867.4 
XML 61 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES (Tables)
 12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Schedule of Assets And Liabilities of Lessee
Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):
As of December 31,
20232022
Operating lease right-of-use assets$94.0 $92.3 
Operating lease liabilities, current portion$24.9 $25.5 
Operating lease liabilities, long-term portion73.0 69.5 
Total operating lease liabilities
$97.9 $95.0 
Schedule of Lessee, Operating Lease, Liability, Maturity
Maturities of operating lease liabilities at December 31, 2023 were as follows (in millions):
2024$26.8 
202519.6 
202616.3 
202712.9 
20289.5 
Thereafter20.7 
Total lease payments
105.8 
Less: imputed interest
(7.9)
Total lease liabilities
$97.9 

The following table provides information on the lease terms and discount rates:
Years Ended December 31,
20232022
Weighted-average remaining lease term (in years)5.96.4
Weighted-average discount rate2.3 %1.8 %
XML 62 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS (Tables)
 12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Schedule of Investments in Debt Securities
Investments in debt securities at the end of each period were as follows (in millions):

 December 31, 2023December 31, 2022
Held-to-maturityAmortized CostGross Unrealized GainsGross Unrealized LossesFair ValueAmortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Bank time deposits$64.5 $— $— $64.5 $96.0 $— $— $96.0 
Available-for-sale
U.S. government and agency securities$72.7 $0.1 $(2.8)$70.0 $137.7 $— $(6.1)$131.6 
Asset-backed securities192.1 — (7.8)184.3 380.6 — (14.0)366.6 
Corporate debt securities658.5 — (16.7)641.8 1,028.1 — (47.8)980.3 
Municipal securities2.8 — (0.2)2.6 2.7 — (0.2)2.5 
$926.1 $0.1 $(27.5)$898.7 $1,549.1 $— $(68.1)$1,481.0 
Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity
The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2023 were as follows:

 Held-to-MaturityAvailable-for-Sale
 Amortized CostFair ValueAmortized CostFair Value
 (in millions)
Due in 1 year or less$64.5 $64.5 $443.2 $436.0 
Due after 1 year through 5 years— — 267.8 257.0 
Due after 10 years— — 0.9 0.9 
Instruments not due at a single maturity date (a)
— — 214.2 204.8 
$64.5 $64.5 $926.1 $898.7 
_______________________________________
(a)     Consists of mortgage- and asset-backed securities.
Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position
The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2023 and 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):
December 31, 2023
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$— $— $67.1 $(2.8)$67.1 $(2.8)
Asset-backed securities10.2 (1.8)172.7 (6.0)182.9 (7.8)
Corporate debt securities25.0 (0.1)601.3 (16.6)626.3 (16.7)
Municipal securities— — 2.6 (0.2)2.6 (0.2)
$35.2 $(1.9)$843.7 $(25.6)$878.9 $(27.5)
December 31, 2022
Less than 12 Months12 Months or GreaterTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
U.S. government and agency securities$61.6 $(1.5)$69.5 $(4.6)$131.1 $(6.1)
Asset-backed securities103.3 (1.3)254.6 (12.7)357.9 (14.0)
Corporate debt securities189.0 (5.3)784.8 (42.5)973.8 (47.8)
Municipal securities— — 2.5 (0.2)2.5 (0.2)
$353.9 $(8.1)$1,111.4 $(60.0)$1,465.3 $(68.1)
Schedule of Investments in Unconsolidated Affiliates
The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "Long-term Investments" on the consolidated balance sheets, and are as follows:

 December 31,
 20232022
 (in millions)
Equity method investments  
Carrying value of equity method investments$33.6 $21.4 
Equity securities  
Carrying value of non-marketable equity securities87.6 86.9 
Total investments in unconsolidated entities$121.2 $108.3 
XML 63 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS COMBINATIONS (Tables)
 12 Months Ended
Dec. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Fair Values of Assets Acquired and Liabilities Assumed The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):
Assets$8.1 
Goodwill (b)
133.2 
In-process research and development136.6 
Liabilities assumed(1.7)
Deferred tax liabilities(28.0)
Fair value of net assets acquired248.2 
Less: Noncontrolling interest (a)
(72.4)
Total purchase price
175.8 
Less: cash acquired(6.8)
Total purchase price, net of cash acquired (b)
$169.0 
_______________________________________
(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.
(b)     Includes $22.5 million paid in a previous year under option agreements, $5.3 million for the settlement of a pre-existing note, and $46.0 million of cash paid directly to the acquired company which was included in Edwards' consolidated cash balance and offset against goodwill post acquisition.
XML 64 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in the Carrying Amount of Goodwill, by Segment
The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2023 and 2022 were as follows:
 United
States		EuropeRest of WorldTotal
 (in millions)
Goodwill at December 31, 2021
$773.7 $63.0 $331.2 $1,167.9 
Currency translation adjustment— (3.6)— (3.6)
Goodwill at December 31, 2022
773.7 59.4 331.2 1,164.3 
Goodwill acquired during the year (Note 9)— — 87.2 87.2 
Currency translation adjustment— 2.0 — 2.0 
Goodwill at December 31, 2023
$773.7 $61.4 $418.4 $1,253.5 
Schedule of Finite-Lived Other Intangible Assets
Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20232022
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents9.9$119.3 $(87.6)$31.7 $205.5 $(185.0)$20.5 
Developed technology10.8197.6 (61.9)135.7 128.1 (57.9)70.2 
Other10.012.3 (8.9)3.4 12.2 (7.7)4.5 
10.6329.2 (158.4)170.8 345.8 (250.6)95.2 
Indefinite-lived intangible assets      
In-process research and development257.6 — 257.6 190.0 — 190.0 
$586.8 $(158.4)$428.4 $535.8 $(250.6)$285.2 
Schedule of Indefinite-Lived Other Intangible Assets
Other intangible assets consist of the following (in millions):

 December 31,
 Weighted-Average Useful Life (in years)20232022
 CostAccumulated
Amortization		Net
Carrying
Value		CostAccumulated
Amortization		Net
Carrying
Value
Finite-lived intangible assets      
Patents9.9$119.3 $(87.6)$31.7 $205.5 $(185.0)$20.5 
Developed technology10.8197.6 (61.9)135.7 128.1 (57.9)70.2 
Other10.012.3 (8.9)3.4 12.2 (7.7)4.5 
10.6329.2 (158.4)170.8 345.8 (250.6)95.2 
Indefinite-lived intangible assets      
In-process research and development257.6 — 257.6 190.0 — 190.0 
$586.8 $(158.4)$428.4 $535.8 $(250.6)$285.2 
Schedule of Estimated Amortization Expense Estimated amortization expense for each of the years ending December 31 is as follows (in millions):
2024$5.8 
20257.0 
20269.4 
202710.9 
202814.8 
XML 65 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND CREDIT FACILITIES (Tables)
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of the Notes
The following is a summary of the Notes as of December 31, 2023 and 2022:
 December 31,
 2023 2022
 AmountEffective
Interest Rate		 AmountEffective
Interest Rate
(in millions)(in millions)
Fixed-rate 4.3% Notes
$600.0 4.329 %$600.0 4.329 %
Unamortized discount(0.7)  (0.9) 
Unamortized debt issuance costs(2.3)(2.8)
Total carrying amount$597.0   $596.3  
XML 66 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2023 and 2022 (in millions):

December 31, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$579.2 $— $— $579.2 
Available-for-sale investments: 
Corporate debt securities— 641.8 — 641.8 
Asset-backed securities— 184.3 — 184.3 
United States government and agency securities— 70.0 — 70.0 
Municipal securities— 2.6 — 2.6 
Investments held for deferred compensation plans125.8 — — 125.8 
Derivatives— 47.1 — 47.1 
$705.0 $945.8 $— $1,650.8 
Liabilities    
Derivatives$— $15.2 $— $15.2 
Other— — 10.3 10.3 
$— $15.2 $10.3 $25.5 
December 31, 2022
Assets
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments: 
Corporate debt securities— 980.3 — 980.3 
Asset-backed securities— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other— — 14.0 14.0 
$— $27.2 $40.2 $67.4 
Schedule of Changes in Fair Value of Contingent Consideration Obligation
The following table summarizes the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis for the years ended December 31, 2023 and 2022 (in millions):

Contingent ConsiderationOtherTotal
Fair value, December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(35.8)— (35.8)
Fair value, December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)(3.7)(29.9)
Fair value, December 31, 2023
$— $10.3 $10.3 
XML 67 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk
The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.
 Notional Amount
As of December 31,
 20232022
 (in millions)
Foreign currency forward exchange contracts$1,786.2 $1,678.4 
Cross currency swap contracts300.0 300.0 
Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets
The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):

  Fair Value
As of December 31,
 Balance Sheet Location20232022
Derivatives designated as hedging instruments   
Assets   
Foreign currency contractsOther current assets$23.7 $24.9 
Cross currency swap contractsOther assets$23.4 $40.6 
Liabilities   
Foreign currency contractsAccrued and other liabilities$15.2 $20.7 
Foreign currency contractsOther liabilities$— $6.5 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$23.7 $— $23.7 $(9.4)$— $14.3 
Cross currency swap contracts$23.4 $— $23.4 $— $— $23.4 
Derivative Liabilities      
Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
December 31, 2022      
Derivative Assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative Liabilities      
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities
The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):

    Gross Amounts Not Offset in the Consolidated Balance Sheet 
  Gross Amounts
Offset in the
Consolidated
Balance Sheet		Net Amounts
Presented in the
Consolidated
Balance Sheet
December 31, 2023Gross
Amounts		Financial
Instruments		Cash
Collateral
Received		Net
Amount
Derivative Assets      
Foreign currency contracts$23.7 $— $23.7 $(9.4)$— $14.3 
Cross currency swap contracts$23.4 $— $23.4 $— $— $23.4 
Derivative Liabilities      
Foreign currency contracts$15.2 $— $15.2 $(9.4)$— $5.8 
December 31, 2022      
Derivative Assets      
Foreign currency contracts$24.9 $— $24.9 $(12.0)$— $12.9 
Cross currency swap contracts$40.6 $— $40.6 $— $— $40.6 
Derivative Liabilities      
Foreign currency contracts$27.2 $— $27.2 $(12.0)$— $15.2 
Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income
The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:

 Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
 2023202220232022
(in millions)(in millions)
Cash flow hedges
Foreign currency contracts$29.2 $81.7 Cost of sales$58.9 $88.4 
 Amount of Gain or (Loss)
Recognized in OCI
on Derivative
(Effective Portion)		Location of Gain or (Loss) Reclassified from Accumulated OCI into IncomeAmount of Gain or (Loss)
Recognized in Income on Derivative (Amount Excluded from
 Effectiveness Testing)
2023202220232022
(in millions) (in millions)
Net investment hedges
Cross currency swap contracts$(17.3)$21.6 Interest income, net$6.9 $7.0 

The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.
  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202320222021
 (in millions)
Fair value hedges
Foreign currency contractsOther income, net$13.9 $(3.9)$11.6 

  Amount of Gain or
(Loss) Recognized in
Income on Derivative
 Location of Gain or
(Loss) Recognized in
Income on Derivative
 202320222021
 (in millions)
Derivatives not designated as hedging instruments
Foreign currency contractsOther income, net$7.4 $44.0 $27.4 
Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations
The following tables present the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:

Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2023
 Cost of salesOther income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,379.8)$14.4 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— (9.2)
Derivatives designated as hedging instruments
— 9.2 
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— 4.7 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
58.9 — 
Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships
 Twelve Months Ended December 31, 2022
 Cost of salesOther income, net
Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded$(1,080.4)$2.6 
The effects of fair value and cash flow hedging:
Gain (loss) on fair value hedging relationships:
Foreign currency contracts:
Hedged items
— 5.5 
Derivatives designated as hedging instruments
— (5.5)
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach
— 1.6 
Gain (loss) on cash flow hedging relationships:
Foreign currency contracts:
Amount of gain (loss) reclassified from accumulated OCI into income
88.4 — 
XML 68 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS (Tables)
 12 Months Ended
Dec. 31, 2023
Retirement Benefits [Abstract]  
Schedule of Information Regarding Defined Benefit Pension Plans
The Company maintains defined benefit pension plans in Japan and certain European countries.
 Years Ended December 31,
 20232022
(in millions)
Change in projected benefit obligation:  
Beginning of year$94.1 $117.9 
Service cost4.3 5.5 
Interest cost2.3 0.5 
Participant contributions1.9 1.6 
Actuarial loss (gain)9.9 (22.6)
Benefits paid(3.8)(0.6)
Plan amendment(0.4)(0.3)
Settlements and curtailment gain— (1.8)
Currency exchange rate changes and other3.4 (6.1)
End of year$111.7 $94.1 
Change in fair value of plan assets:  
Beginning of year$70.6 $76.9 
Actual return on plan assets0.8 (4.9)
Employer contributions3.5 3.5 
Participant contributions1.9 1.6 
Settlements— (1.8)
Benefits paid(3.8)(0.6)
Currency exchange rate changes and other2.5 (4.1)
End of year$75.5 $70.6 
Funded Status  
Projected benefit obligation$(111.7)$(94.1)
Plan assets at fair value75.5 70.6 
Underfunded status$(36.2)$(23.5)
Net amounts recognized on the consolidated balance sheet:  
Other liabilities$36.2 $23.5 
Accumulated other comprehensive loss, net of tax:  
Net actuarial (loss) gain$(10.3)$1.5 
Net prior service credit5.2 5.3 
Deferred income tax benefit (expense)0.9 (1.1)
Total$(4.2)$5.7 
Schedule of Net Periodic Benefit Cost
The components of net periodic pension benefit cost are as follows (in millions):

 Years Ended December 31,
 202320222021
Service cost, net$4.3 $5.5 $6.5 
Interest cost2.3 0.5 0.4 
Expected return on plan assets(2.7)(1.5)(1.1)
Settlements and curtailment gain— 0.1 — 
Amortization of actuarial loss— 0.5 1.7 
Amortization of prior service credit (0.8)(0.7)(0.7)
Net periodic pension benefit cost$3.1 $4.4 $6.8 
Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations
The weighted-average assumptions used to determine the benefit obligations are as follows:
 December 31,
 20232022
Discount rate1.8 %2.5 %
Rate of compensation increase2.9 %2.9 %
Cash balance interest crediting rate1.5 %1.5 %
Social securities increase1.8 %1.8 %
Pension increase2.2 %2.2 %

The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:
 Years ended December 31,
 202320222021
Discount rate2.5 %0.5 %0.3 %
Expected return on plan assets3.7 %2.1 %1.5 %
Rate of compensation increase2.9 %2.6 %2.6 %
Cash balance interest crediting rate1.5 %1.5 %2.5 %
Social securities increase1.8 %1.6 %1.6 %
Pension increase2.2 %1.8 %1.8 %
Schedule of Target Weighted-Average Asset Allocations and Fair Value Target weighted-average asset allocations at December 31, 2023, by asset category, are as follows:
Equity securities31.3 %
Debt securities38.9 %
Real estate11.4 %
Other18.4 %
Total100.0 %

The fair values of the Company's defined benefit plan assets at December 31, 2023 and 2022, by asset category, are as follows (in millions):
December 31, 2023Level 1Level 2Level 3Total
Asset Category    
Cash$2.0 $— $— $2.0 
Equity securities:    
United States equities2.6 — — 2.6 
International equities21.0 — — 21.0 
Debt securities:    
United States government bonds3.5 — — 3.5 
International government bonds26.0 — — 26.0 
Real estate— 8.7 — 8.7 
Mortgages— 4.0 — 4.0 
Insurance contracts— — 0.8 0.8 
Total plan assets measured at fair value
$55.1 $12.7 $0.8 $68.6 
Alternative investments measured at net asset value (a)6.9 
Total plan assets
$75.5 
 
December 31, 2022Level 1Level 2Level 3Total
Asset Category
Cash$3.6 $— $— $3.6 
Equity securities:
United States equities1.5 — — 1.5 
International equities17.5 — — 17.5 
Debt securities:
United States government bonds4.4 — — 4.4 
International government bonds25.6 — — 25.6 
Real estate— 7.6 — 7.6 
Mortgages— 3.5 — 3.5 
Insurance contracts— — 0.8 0.8 
Total plan assets $52.6 $11.1 $0.8 $64.5 
Alternative investments measured at net asset value (a)6.1 
Total plan assets $70.6 
_______________________________________
(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3
The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2023 and 2022 (in millions):

 Insurance
Contracts
Balance at December 31, 2021$0.9 
Actual return on plan assets: 
Relating to assets still held at December 31, 2022
0.2 
Purchases, sales and settlements(0.2)
Currency exchange rate impact(0.1)
Balance at December 31, 20220.8 
Actual return on plan assets: 
Relating to assets still held at December 31, 2023
0.2 
Purchases, sales and settlements(0.2)
Balance at December 31, 2023$0.8 
Schedule of Benefit Payments Which Reflect Expected Future Service
The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2023, are expected to be paid (in millions):

2024$7.3 
20255.9 
20266.9 
20276.8 
20288.1 
2029-203339.0 
XML 69 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK (Tables)
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Accelerated Share Repurchases The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):
  Initial DeliveryFinal Settlement
Agreement DateAmount
Paid		Shares
Received		Price per
Share		Value of
Shares as %
of Contract
Value		Settlement
Date		Total Shares
Received		Average Price
per Share
January 2022$250.0 1.9 $104.87 80 %February 20222.3 $110.31 
October 2022$750.0 8.3 $72.43 80 %December 202210.3 $72.91 
February 2023$200.0 2.0 $80.44 80 %March 20232.5 $79.28 
December 2023$400.0 4.6 $70.31 80 %December 20235.3 $72.91 
Schedule of Weighted-Average Assumptions for Options Granted
The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:

Option Awards
Years Ended December 31,
202320222021
Risk-free interest rate3.4 %3.0 %0.8 %
Expected dividend yieldNoneNoneNone
Expected volatility32.8 %31.4 %33.5 %
Expected term (years)5.15.05.0
Fair value, per share$30.97 $34.59 $28.90 
Schedule of Weighted-Average Assumptions for ESPP Subscriptions
The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:

ESPP
Years Ended December 31,
202320222021
Risk-free interest rate4.6 %0.5 %0.1 %
Expected dividend yieldNoneNoneNone
Expected volatility31.5 %32.0 %36.6 %
Expected term (years)0.60.60.6
Fair value, per share$19.03 $28.18 $23.07 
Schedule of Stock Option Activity
Stock option activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):

 SharesWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term		Aggregate
Intrinsic Value
Outstanding as of December 31, 2022
11.6 $63.67   
Options granted2.0 88.27   
Options exercised(2.2)38.54   
Options forfeited(0.4)97.32   
Outstanding as of December 31, 2023
11.0 71.90 3.5 years$136.9 
Exercisable as of December 31, 2023
7.3 61.68 2.4 years$135.5 
Vested and expected to vest as of December 31, 2023
10.5 70.91 3.4 years$136.7 
Schedule of Restricted Stock Unit Activity
The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):

 SharesWeighted-
Average
Grant-Date
Fair Value
Nonvested as of December 31, 2022
2.0 $92.30 
Granted1.1 89.03 
Vested(0.8)83.17 
Forfeited(0.2)99.82 
Nonvested as of December 31, 2023
2.1 94.35 
XML 70 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss
Presented below is a summary of activity for each component of "Accumulated Other Comprehensive Loss" for the years ended December 31, 2023, 2022, and 2021.

 Foreign
Currency
Translation
Adjustments		Unrealized (Loss) Gain on HedgesUnrealized Gain (Loss) on
Available-for-sale
Investments		Unrealized
Pension
(Costs) Credits (a)		Total
Accumulated
Other
Comprehensive
Loss
 (in millions)
December 31, 2020$(122.4)$(27.7)$8.6 $(19.6)$(161.1)
Other comprehensive (loss) income before reclassifications
(39.2)66.3 (29.2)12.8 10.7 
Amounts reclassified from accumulated other comprehensive loss(6.4)12.0 8.6 1.0 15.2 
Deferred income tax (expense) benefit
(4.5)(20.9)5.1 (2.2)(22.5)
December 31, 2021(172.5)29.7 (6.9)(8.0)(157.7)
Other comprehensive (loss) income before reclassifications
(33.9)75.2 (77.9)17.3 (19.3)
Amounts reclassified from accumulated other comprehensive loss(7.0)(84.5)18.8 (0.1)(72.8)
Deferred income tax (expense) benefit
(5.4)3.4 0.4 (3.5)(5.1)
December 31, 2022(218.8)23.8 (65.6)5.7 (254.9)
Other comprehensive income (loss) before reclassifications
6.9 43.3 32.6 (11.1)71.7 
Amounts reclassified from accumulated other comprehensive loss(6.9)(72.8)8.1 (0.8)(72.4)
Deferred income tax benefit
4.3 6.4 0.1 2.0 12.8 
December 31, 2023$(214.5)$0.7 $(24.8)$(4.2)$(242.8)
Schedule of Change in Unrealized Pension Costs For the years ended December 31, 2023, 2022, and 2021, the change in unrealized pension costs consisted of the following (in millions):
 Pre-Tax
Amount		Tax (Expense) BenefitNet of Tax
Amount
2023   
Prior service credit arising during period$0.7 $0.9 $1.6 
Amortization of prior service credit(0.8)0.1 (0.7)
Net prior service cost arising during period(0.1)1.0 0.9 
Net actuarial loss arising during period(11.8)1.0 (10.8)
Unrealized pension costs, net$(11.9)$2.0 $(9.9)
2022   
Prior service credit arising during period$— $(1.1)$(1.1)
Amortization of prior service credit(0.7)0.3 (0.4)
Net prior service cost arising during period(0.7)(0.8)(1.5)
Net actuarial gain arising during period17.9 (2.7)15.2 
Unrealized pension credits, net$17.2 $(3.5)$13.7 
2021   
Prior service credit arising during period$0.1 $— $0.1 
Amortization of prior service credit(0.7)0.1 (0.6)
Net prior service cost arising during period(0.6)0.1 (0.5)
Net actuarial gain arising during period14.4 (2.3)12.1 
Unrealized pension credits, net$13.8 $(2.2)$11.6 
Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss
The following table provides information about amounts reclassified from "Accumulated Other Comprehensive Loss" (in millions):
 Years Ended December 31, 
Details about Accumulated Other Comprehensive Loss
Components		20232022Affected Line on Consolidated
Statements of Operations
Foreign currency translation adjustments$6.9 $7.0 Other income, net
(1.7)(1.7)Provision for income taxes
$5.2 $5.3 Net of tax
(Loss) gain on hedges$58.9 $88.4 Cost of sales
13.9 (3.9)Other income, net
72.8 84.5 Total before tax
(15.8)(22.2)Provision for income taxes
$57.0 $62.3 Net of tax
Gain (loss) on available-for-sale investments$(8.1)$(18.8)Other income, net
2.2 4.6 Provision for income taxes
$(5.9)$(14.2)Net of tax
Amortization of pension adjustments$0.8 $0.1 Other income, net
(0.2)— Provision for income taxes
$0.6 $0.1 Net of tax
XML 71 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER INCOME, NET (Tables)
 12 Months Ended
Dec. 31, 2023
Other Income and Expenses [Abstract]  
Schedule of Other Income, Net
 Years Ended December 31,
 202320222021
(in millions)
Foreign exchange (gains) losses, net$(10.5)$1.2 $(5.0)
Loss (gain) on investments0.7 1.1 (5.8)
Non-service cost components of net periodic pension benefit cost(1.2)(1.1)0.3 
Gain on insurance settlement— (3.8)— 
Other(3.4)— (2.2)
Total other income, net$(14.4)$(2.6)$(12.7)
XML 72 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Income Before Provisions for Income Taxes
The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):
 Years Ended December 31,
 202320222021
United States$348.0 $634.4 $610.9 
Outside of the United States, including Puerto Rico1,250.1 1,133.0 1,091.1 
$1,598.1 $1,767.4 $1,702.0 
Schedule of Provision for Income Taxes
The provision for income taxes consists of the following (in millions):
 Years Ended December 31,
 202320222021
Current   
United States:   
Federal$317.3 $369.1 $125.2 
State and local58.1 60.6 25.1 
Outside of the United States, including Puerto Rico85.3 66.7 92.6 
Current income tax expense$460.7 $496.4 $242.9 
Deferred   
United States:   
Federal$(187.5)$(187.7)$(9.4)
State and local(54.2)(58.9)(25.4)
Outside of the United States, including Puerto Rico(20.3)(4.3)(9.2)
Deferred income tax benefit(262.0)(250.9)(44.0)
Total income tax provision$198.7 $245.5 $198.9 
Schedule of Deferred Tax Assets and Liabilities
The components of deferred tax assets and liabilities are as follows (in millions):
 December 31,
 20232022
Deferred tax assets  
   Capitalized research and development expenses (a)
$371.1 $199.7 
Compensation and benefits117.9 100.6 
Benefits from uncertain tax positions63.4 42.1 
Net tax credit carryforwards172.9 160.8 
Net operating loss carryforwards75.9 71.7 
Accrued liabilities132.8 93.7 
Inventories15.3 11.9 
Cash flow and net investment hedges1.6 6.6 
State income taxes0.2 0.3 
Investments0.6 0.6 
Lease liability obligations5.8 6.7 
Other0.8 1.9 
Total deferred tax assets958.3 696.6 
Deferred tax liabilities  
Property, plant, and equipment(78.2)(80.2)
Deferred tax on foreign earnings(3.6)(19.2)
Right-of-use assets (4.7)(6.0)
Other intangible assets(53.0)(19.9)
Other(2.5)(2.9)
Total deferred tax liabilities(142.0)(128.2)
Valuation allowance(90.2)(99.1)
Net deferred tax assets$726.1 $469.3 
______________________________________
(a)     As required by the 2017 Tax Cuts and Jobs Act, effective January 1, 2022, the Company's research and development expenditures were capitalized and amortized which resulted in substantially higher cash paid for taxes in 2023 and 2022 with an equal amount of deferred tax benefits.
Schedule of Net Operating Loss Carryforwards
Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):
 Carryforward
Amount		Tax Benefit
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
United States federal net operating losses$9.0 $1.9 $— $1.9 2033-2037
United States federal net operating losses1.8 0.4 — 0.4 Indefinite
United States state net operating losses35.7 1.8 (1.7)0.1 2026-2041
United States state net operating losses2.6 0.1 (0.1)— Indefinite
Non-United States net operating losses416.5 71.6 (54.5)17.1 Indefinite
United States capital losses33.4 0.1 (0.1)— 2024
Total$499.0 $75.9 $(56.4)$19.5  
Schedule of Tax Credit Carryforwards
The gross tax credit carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):
 Carryforward
Amount		Valuation
Allowance		Net Tax
Benefit		Carryforward
Period Ends
California research expenditure tax credits$211.3 $— $211.3 Indefinite
Federal research expenditure tax credits1.3 — 1.3 2026-2039
Foreign tax and general business credits0.7 — 0.7 2030-2033
Puerto Rico purchases credits26.2 (26.2)— 2025
Puerto Rico purchases credits1.2 (1.2)— Indefinite
Total$240.7 $(27.4)$213.3  
Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate
A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):
 Years Ended December 31,
 202320222021
Income tax expense at United States federal statutory rate$335.6 $371.1 $357.4 
Foreign income taxed at different rates(128.3)(123.9)(122.2)
State and local taxes, net of federal tax benefit18.7 21.1 11.9 
Tax credits, federal and state(62.5)(50.0)(48.4)
Build of reserve for prior years' uncertain tax positions(2.9)11.6 3.6 
Tax on global intangible low-taxed income78.7 61.4 56.5 
Foreign-derived intangible income deduction(23.0)(15.0)(1.3)
Contingent consideration liabilities(5.5)(7.5)(26.1)
United States federal deductible employee share-based compensation(13.1)(31.6)(47.8)
Nondeductible employee share-based compensation6.6 5.8 5.3 
Other(5.6)2.5 10.0 
Income tax provision$198.7 $245.5 $198.9 
Schedule of Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions
A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):
 December 31,
 202320222021
Uncertain gross tax positions, January 1$475.3 $358.4 $281.8 
Current year tax positions
127.0 120.6 82.1 
Increase in prior year tax positions
0.8 3.8 2.3 
Decrease in prior year tax positions
(16.2)(0.6)(4.8)
Settlements
(3.0)(0.4)(0.3)
Lapse of statutes of limitations
— (6.5)(2.7)
Uncertain gross tax positions, December 31$583.9 $475.3 $358.4 
XML 73 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income
The table below presents information about Edwards Lifesciences' reportable segments (in millions):
 Years Ended December 31,
 202320222021
Segment Net Sales   
United States$3,508.7 $3,132.6 $2,963.1 
Europe1,337.4 1,213.7 1,099.6 
Japan436.7 559.3 528.0 
Rest of World716.9 610.7 533.2 
Total segment net sales$5,999.7 $5,516.3 $5,123.9 
Segment Operating Income  
United States$2,306.1 $2,130.9 $2,051.0 
Europe709.5 652.2 569.1 
Japan259.1 376.7 348.0 
Rest of World310.4 247.7 185.2 
Total segment operating income$3,585.1 $3,407.5 $3,153.3 

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):
 Years Ended December 31,
 202320222021
Net Sales Reconciliation   
Segment net sales$5,999.7 $5,516.3 $5,123.9 
Foreign currency5.1 (133.9)108.6 
Consolidated net sales$6,004.8 $5,382.4 $5,232.5 
Pre-tax Income Reconciliation  
Segment operating income$3,585.1 $3,407.5 $3,153.3 
Unallocated amounts:
Corporate items(1,920.9)(1,714.1)(1,613.8)
Special charge and separation costs(17.2)(60.7)— 
Intellectual property agreement and litigation expense(203.5)(15.8)(20.6)
Change in fair value of contingent consideration liabilities26.2 35.8 124.1 
Foreign currency64.4 95.8 47.3 
Consolidated operating income1,534.1 1,748.5 1,690.3 
Non-operating income64.0 18.9 11.7 
Consolidated pre-tax income$1,598.1 $1,767.4 $1,702.0 
Schedule of Enterprise-Wide Information
Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.

 As of or for the Years Ended December 31,
 202320222021
Net Sales by Geographic Region   
United States$3,508.7 $3,132.6 $2,963.1 
Europe1,334.5 1,174.8 1,190.3 
Japan452.4 473.6 528.9 
Rest of World709.2 601.4 550.2 
$6,004.8 $5,382.4 $5,232.5 
Net Sales by Major Product Group  
Transcatheter Aortic Valve Replacement$3,879.8 $3,518.2 $3,422.5 
Transcatheter Mitral and Tricuspid Therapies197.6 116.1 86.0 
Surgical Structural Heart999.3 893.1 889.1 
Critical Care928.1 855.0 834.9 
$6,004.8 $5,382.4 $5,232.5 
Long-lived Tangible Assets by Geographic Region   
United States$1,269.7 $1,188.5 $1,195.8 
Europe196.4191.8197.9
Japan23.813.219.7
Rest of World353.5331.6335.5
$1,843.4 $1,725.1 $1,748.9 
XML 74 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Deferred revenue $ 13.3 $ 10.6
Revenue recognized that was previously deferred excluding opening balance $ 7.6  
Revenue recognized that was previously deferred   $ 7.2
Hemodynamic Monitors | Minimum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Revenue, remaining performance obligation, expected timing of satisfaction, period (in years) 12 months  
Hemodynamic Monitors | Maximum    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Revenue, remaining performance obligation, expected timing of satisfaction, period (in years) 36 months  
XML 75 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]      
Cost of sales $ 1,379.8 $ 1,080.4 $ 1,248.9
Shipping and Handling      
Product Information [Line Items]      
Cost of sales $ 99.4 $ 87.4 $ 85.3
XML 76 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)
Dec. 31, 2023
Minimum | Investees Voting Stock  
Schedule of Equity Method Investments [Line Items]  
Equity method investment, ownership percentage (as a percent) 3.00%
XML 77 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)
 12 Months Ended
Dec. 31, 2023
Minimum  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Accounts receivable, required payment terms (in days) 30 days
Maximum  
Accounts, Notes, Loans and Financing Receivable [Line Items]  
Accounts receivable, required payment terms (in days) 90 days
XML 78 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]      
Period prior to expiration date which triggers write-down of inventory (in months) 6 months    
Period used to evaluate slow-moving inventory levels (in years) 2 years    
General and administrative costs allocated to inventory $ 96.9 $ 88.1 $ 77.9
General and administrative costs included in inventory 45.7 43.7  
Finished goods inventories held on consignment $ 164.6 $ 128.6  
XML 79 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]      
Depreciation expense for property, plant and equipment $ 138.9 $ 133.9 $ 127.0
Buildings and improvements | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 10 years    
Buildings and improvements | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 40 years    
Machinery and equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 3 years    
Machinery and equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 15 years    
Software | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 3 years    
Software | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated useful life (in years) 5 years    
XML 80 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Developed Technology and In-Process Research and Development        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets $ 52,700,000   $ 52,700,000  
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]     Special charge and separation costs (Note 4)  
In-process research and development        
Indefinite-lived Intangible Assets [Line Items]        
Impairment of intangible assets   $ 0   $ 0
XML 81 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Basic:      
Net income attributable to Edwards Lifesciences Corporation $ 1,402.4 $ 1,521.9 $ 1,503.1
Weighted-average shares outstanding (in shares) 606.7 619.0 623.3
Basic earnings per share (in dollars per share) $ 2.31 $ 2.46 $ 2.41
Diluted:      
Net income attributable to Edwards Lifesciences Corporation $ 1,402.4 $ 1,521.9 $ 1,503.1
Weighted-average shares outstanding (in shares) 606.7 619.0 623.3
Dilutive effect of stock plans (in shares) 2.7 5.2 7.9
Dilutive weighted-average shares outstanding (in shares) 609.4 624.2 631.2
Diluted earnings per share (in dollars per share) $ 2.30 $ 2.44 $ 2.38
XML 82 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share - Narrative (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Stock compensation plan      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from the computation of earnings per share (in shares) 6.6 3.6 1.8
XML 83 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Allocation of stock-based compensation expense      
Total stock-based compensation expense $ 139.4 $ 126.8 $ 109.3
Income tax benefit (24.1) (21.6) (18.9)
Total stock-based compensation expense, net of tax 115.3 105.2 90.4
Cost of sales      
Allocation of stock-based compensation expense      
Total stock-based compensation expense 23.6 22.8 20.4
Selling, general, and administrative expenses      
Allocation of stock-based compensation expense      
Total stock-based compensation expense 82.4 75.3 65.6
Research and development expenses      
Allocation of stock-based compensation expense      
Total stock-based compensation expense $ 33.4 $ 28.7 $ 23.3
XML 84 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation Narrative (Details)
 12 Months Ended
Dec. 31, 2023
Restricted stock units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Percentage vesting upon retirement for each full year of employment subsequent to the grant date (as a percent) 25.00%
XML 85 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Period when cash flows associated with future transactions and certain local currency expenses are expected to occur (in months) 1 year
XML 86 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Apr. 12, 2023
Apr. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Loss Contingencies [Line Items]            
Intellectual property litigation expenses, settlements, and legal costs       $ 203.5 $ 15.8 $ 20.6
Intellectual property agreement term 15 years          
Medtronic Inc            
Loss Contingencies [Line Items]            
Payments for legal settlements $ 300.0          
Intellectual property litigation expenses   $ 139.0 $ 37.0      
Prepaid royalty asset   $ 124.0        
XML 87 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
SPECIAL CHARGE AND SEPARATION COSTS (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Dec. 07, 2023
Sep. 30, 2022
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]      
Special charge $ 17.2 $ 62.3  
Restructuring contingent consideration gain   11.7  
Developed Technology and In-Process Research and Development      
Restructuring Cost and Reserve [Line Items]      
Impairment of intangible assets   52.7 $ 52.7
Special Charge      
Restructuring Cost and Reserve [Line Items]      
Special charge   60.7  
Cost of sales      
Restructuring Cost and Reserve [Line Items]      
Special charge   $ 1.6  
XML 88 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Inventories    
Raw materials $ 252.6 $ 156.4
Work in process 220.1 177.4
Finished products 695.5 541.7
Total inventories 1,168.2 875.5
Property, plant, and equipment, net    
Land 116.4 116.3
Buildings and leasehold improvements 1,234.2 1,189.2
Machinery and equipment 775.8 697.6
Equipment with customers 37.9 37.4
Software 87.2 87.5
Construction in progress 355.3 255.2
Total property, plant and equipment, gross 2,606.8 2,383.2
Accumulated depreciation (857.4) (750.4)
Total property, plant and equipment, net 1,749.4 1,632.8
Accrued and other liabilities    
Employee compensation and withholdings 371.2 268.7
Accrued rebates 131.4 116.1
Property, payroll, and other taxes 63.0 45.6
Research and development accruals 74.1 66.9
Legal and insurance (Notes 3 and 19) 30.7 28.1
Litigation settlement 69.1 53.3
Taxes payable 59.3 50.6
Fair value of derivatives 15.2 20.7
Accrued marketing expenses 15.0 17.0
Accrued professional services 8.8 6.6
Accrued realignment reserves 12.3 15.6
Accrued relocation costs 19.2 25.2
Accrued warranties 10.0 8.4
Other accrued liabilities 89.8 72.2
Total accrued and other liabilities $ 969.1 $ 795.0
XML 89 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash paid during the year for:      
Interest $ 19.9 $ 19.3 $ 20.2
Income taxes 470.1 504.1 182.5
Amounts included in the measurement of operating lease liabilities 28.8 28.1 31.9
Non-cash investing and financing transactions:      
Right-of-use assets obtained in exchange for new lease liabilities 29.3 31.9 28.7
Capital expenditures accruals 45.5 42.6 54.3
Conversion of notes receivable to equity investment $ 0.0 $ 0.0 $ 21.5
XML 90 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 1,144.0 $ 769.0 $ 862.8  
Restricted cash included in other current assets 3.3 0.5 1.5  
Restricted cash included in other assets 0.7 3.1 3.1  
Total cash, cash equivalents, and restricted cash $ 1,148.0 $ 772.6 $ 867.4 $ 1,200.2
XML 91 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Lessee, Lease, Description [Line Items]      
Operating lease cost $ 30.1 $ 28.8 $ 29.7
Lease commitments for leases not yet commenced $ 16.0    
Minimum      
Lessee, Lease, Description [Line Items]      
Lease term (in years) 1 year    
Maximum      
Lessee, Lease, Description [Line Items]      
Lease term (in years) 17 years    
XML 92 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Assets and Liabilities of Operating Leases (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease right-of-use assets $ 94.0 $ 92.3
Operating lease liabilities, current portion 24.9 25.5
Operating lease liabilities, long-term portion 73.0 69.5
Total operating lease liabilities $ 97.9 $ 95.0
XML 93 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES - Maturities Of Operating Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
2024 $ 26.8  
2025 19.6  
2026 16.3  
2027 12.9  
2028 9.5  
Thereafter 20.7  
Total lease payments 105.8  
Less: imputed interest (7.9)  
Total lease liabilities $ 97.9 $ 95.0
Weighted-average remaining lease term (in years) 5 years 10 months 24 days 6 years 4 months 24 days
Weighted-average discount rate 2.30% 1.80%
XML 94 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Schedule of Investments in Debt Securities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Held-to-maturity    
Amortized Cost $ 64.5  
Fair Value 64.5  
Available-for-sale    
Amortized Cost 926.1 $ 1,549.1
Gross Unrealized Gains 0.1 0.0
Gross Unrealized Losses (27.5) (68.1)
Fair Value 898.7 1,481.0
Bank time deposits    
Held-to-maturity    
Amortized Cost 64.5 96.0
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Fair Value 64.5 96.0
U.S. government and agency securities    
Available-for-sale    
Amortized Cost 72.7 137.7
Gross Unrealized Gains 0.1 0.0
Gross Unrealized Losses (2.8) (6.1)
Fair Value 70.0 131.6
Asset-backed securities    
Available-for-sale    
Amortized Cost 192.1 380.6
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (7.8) (14.0)
Fair Value 184.3 366.6
Corporate debt securities    
Available-for-sale    
Amortized Cost 658.5 1,028.1
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (16.7) (47.8)
Fair Value 641.8 980.3
Municipal securities    
Available-for-sale    
Amortized Cost 2.8 2.7
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (0.2) (0.2)
Fair Value $ 2.6 $ 2.5
XML 95 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Amortized Cost    
Due in 1 year or less $ 64.5  
Due after 1 year through 5 years 0.0  
Due after 10 years 0.0  
Instruments not due at a single maturity date 0.0  
Amortized Cost 64.5  
Fair Value    
Due in 1 year or less 64.5  
Due after 1 year through 5 years 0.0  
Due after 10 years 0.0  
Instruments not due at a single maturity date 0.0  
Fair Value 64.5  
Amortized Cost    
Due in 1 year or less 443.2  
Due after 1 year through 5 years 267.8  
Due after 10 years 0.9  
Instruments not due at a single maturity date 214.2  
Amortized Cost 926.1 $ 1,549.1
Fair Value    
Due in 1 year or less 436.0  
Due after 1 year through 5 years 257.0  
Due after 10 years 0.9  
Instruments not due at a single maturity date 204.8  
Fair Value $ 898.7 $ 1,481.0
XML 96 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months $ 35.2 $ 353.9
Gross unrealized losses, less than 12 months (1.9) (8.1)
Fair value, 12 months or greater 843.7 1,111.4
Gross unrealized losses, 12 months or greater (25.6) (60.0)
Total fair value 878.9 1,465.3
Total gross unrealized losses (27.5) (68.1)
U.S. government and agency securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 0.0 61.6
Gross unrealized losses, less than 12 months 0.0 (1.5)
Fair value, 12 months or greater 67.1 69.5
Gross unrealized losses, 12 months or greater (2.8) (4.6)
Total fair value 67.1 131.1
Total gross unrealized losses (2.8) (6.1)
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 10.2 103.3
Gross unrealized losses, less than 12 months (1.8) (1.3)
Fair value, 12 months or greater 172.7 254.6
Gross unrealized losses, 12 months or greater (6.0) (12.7)
Total fair value 182.9 357.9
Total gross unrealized losses (7.8) (14.0)
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 25.0 189.0
Gross unrealized losses, less than 12 months (0.1) (5.3)
Fair value, 12 months or greater 601.3 784.8
Gross unrealized losses, 12 months or greater (16.6) (42.5)
Total fair value 626.3 973.8
Total gross unrealized losses (16.7) (47.8)
Municipal securities    
Debt Securities, Available-for-sale [Line Items]    
Fair value, less than 12 months 0.0 0.0
Gross unrealized losses, less than 12 months 0.0 0.0
Fair value, 12 months or greater 2.6 2.5
Gross unrealized losses, 12 months or greater (0.2) (0.2)
Total fair value 2.6 2.5
Total gross unrealized losses $ (0.2) $ (0.2)
XML 97 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Equity method investments      
Carrying value of equity method investments $ 33.6 $ 21.4  
Equity securities      
Carrying value of non-marketable equity securities 87.6 86.9 $ 39.3
Total investments in unconsolidated entities $ 121.2 $ 108.3  
XML 98 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Debt and Equity Securities, FV-NI [Line Items]    
Carrying value of equity method investments $ 33,600,000 $ 21,400,000
Annual upward price adjustments 0 800,000
Annual downward price adjustment 0 $ 500,000
Cumulative increase in non-marketable equity securities due to observable price changes 8,800,000  
Cumulative decrease in non-marketable equity securities due to observable price changes $ 3,100,000  
Limited Liability Company    
Debt and Equity Securities, FV-NI [Line Items]    
Investments taken period 7 years  
New Markets Tax Credit | Limited Liability Company    
Debt and Equity Securities, FV-NI [Line Items]    
Carrying value of equity method investments $ 12,100,000  
Investment percentage (in percent) 39.00%  
XML 99 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)
$ in Millions
 1 Months Ended 10 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
Aug. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
May 31, 2022
USD ($)
note
Dec. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2019
USD ($)
Apr. 30, 2021
USD ($)
Variable Interest Entity [Line Items]                    
Payment for acquisition options           $ 30.0 $ 109.6 $ 13.1    
Number of promissory notes entered | note       2            
Maximum secured promissory note                   $ 45.0
Investee drew additional amount         $ 30.0 30.0        
Carrying value of non-marketable equity securities         87.6 87.6 $ 86.9 39.3    
Investment option to acquire               13.1    
Maximum additional required investment               6.5    
Maximum additional option to acquire investment               14.4    
Medical Device Company | Variable Interest Entity, Not Primary Beneficiary                    
Variable Interest Entity [Line Items]                    
Loans receivables, maximum lending amount $ 45.0   $ 47.5              
Payment for acquisition options   $ 47.1     30.0       $ 35.0  
Financing receivable         32.5 32.5        
Option to acquire investment amount   $ 47.1     35.0 35.0        
Maximum secured promissory note       $ 25.0            
Medical Device Company | Variable Interest Entity, Not Primary Beneficiary | Convertible Promissory Note                    
Variable Interest Entity [Line Items]                    
Financing receivable $ 5.0                  
Medical Technology Company | Variable Interest Entity, Not Primary Beneficiary                    
Variable Interest Entity [Line Items]                    
Payment for acquisition options       60.0       $ 10.0    
Option to acquire investment amount       $ 60.0            
Maximum secured promissory note         $ 25.0 $ 25.0        
XML 100 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS COMBINATIONS - Narrative (Details) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2023
Dec. 31, 2021
Feb. 28, 2023
Dec. 31, 2022
Jul. 03, 2015
Business Acquisition [Line Items]            
Developed technology   $ 329,200,000     $ 345,800,000  
In-process Research and Development            
Business Acquisition [Line Items]            
Impairment charges   0 $ 0      
Developed technology            
Business Acquisition [Line Items]            
Developed technology   197,600,000     $ 128,100,000  
Medical Technology Company            
Business Acquisition [Line Items]            
Additional research and development expenditures to be incurred prior to product introduction       $ 68,600,000    
Medical Technology Company | Measurement Input, Discount Rate            
Business Acquisition [Line Items]            
Percentage of discount rate       13.00%    
Medical Technology Company | Variable Interest Entity, Primary Beneficiary            
Business Acquisition [Line Items]            
Percentage of interest acquired       61.00%    
Harpoon Medical | In-process Research and Development            
Business Acquisition [Line Items]            
Impairment charges $ 28,100,000          
CardiAQ            
Business Acquisition [Line Items]            
Additional research and development expenditures to be incurred prior to product introduction           $ 97,700,000
CardiAQ | Developed technology            
Business Acquisition [Line Items]            
Developed technology   $ 69,000,000        
XML 101 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
 12 Months Ended
Feb. 28, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]        
Goodwill   $ 1,253.5 $ 1,164.3 $ 1,167.9
Payment for acquisition options   $ 30.0 $ 109.6 $ 13.1
Variable Interest Entity, Primary Beneficiary | Medical Technology Company        
Business Acquisition [Line Items]        
Assets $ 8.1      
Goodwill 133.2      
In-process research and development 136.6      
Liabilities assumed (1.7)      
Deferred tax liabilities (28.0)      
Fair value of net assets acquired 248.2      
Less: Noncontrolling interest (72.4)      
Total purchase price 175.8      
Less: cash acquired (6.8)      
Total purchase price, net of cash acquired 169.0      
Noncontrolling interest, gross 94.4      
Payment for option to acquire company 22.0      
Payment for acquisition options 22.5      
Repayments of pre-existing notes 5.3      
Cash paid directly to acquired company, netted against goodwill $ 46.0      
XML 102 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Goodwill    
Beginning balance $ 1,164.3 $ 1,167.9
Currency translation adjustment 2.0 (3.6)
Goodwill acquired during the year 87.2  
Ending balance 1,253.5 1,164.3
United States    
Goodwill    
Beginning balance 773.7 773.7
Currency translation adjustment 0.0 0.0
Goodwill acquired during the year 0.0  
Ending balance 773.7 773.7
Europe    
Goodwill    
Beginning balance 59.4 63.0
Currency translation adjustment 2.0 (3.6)
Goodwill acquired during the year 0.0  
Ending balance 61.4 59.4
Rest of World    
Goodwill    
Beginning balance 331.2 331.2
Currency translation adjustment 0.0 0.0
Goodwill acquired during the year 87.2  
Ending balance $ 418.4 $ 331.2
XML 103 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 10 years 7 months 6 days  
Cost $ 329.2 $ 345.8
Accumulated Amortization (158.4) (250.6)
Net Carrying Value 170.8 95.2
Indefinite-lived intangible assets    
Cost 586.8 535.8
Net Carrying Value $ 428.4 285.2
Patents    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 9 years 10 months 24 days  
Cost $ 119.3 205.5
Accumulated Amortization (87.6) (185.0)
Net Carrying Value $ 31.7 20.5
Developed technology    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 10 years 9 months 18 days  
Cost $ 197.6 128.1
Accumulated Amortization (61.9) (57.9)
Net Carrying Value $ 135.7 70.2
Other    
Finite-lived intangible assets    
Weighted-Average Useful Life (in years) 10 years  
Cost $ 12.3 12.2
Accumulated Amortization (8.9) (7.7)
Net Carrying Value 3.4 4.5
In-process research and development    
Indefinite-lived intangible assets    
In-process research and development $ 257.6 $ 190.0
XML 104 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization expense related to other intangible assets $ 6.1 $ 5.7 $ 7.7
XML 105 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2024 $ 5.8
2025 7.0
2026 9.4
2027 10.9
2028 $ 14.8
XML 106 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND CREDIT FACILITIES - Narrative (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]      
Weighted-average interest rate under all debt obligations (as a percent)   3.40% 3.40%
Credit Agreement | Revolving Credit Facility      
Debt Instrument [Line Items]      
Term of the credit agreement (in years)   5 years  
Aggregate borrowings in multiple currencies   $ 750,000,000  
Accordion feature, increase limit   $ 250,000,000  
Basis spread on variable rate (as a percent)   0.10%  
Debt instrument, credit spread adjustment   0.10%  
Issuance costs   $ 2,100,000  
Borrowings outstanding   $ 0 $ 0
Credit Agreement | Revolving Credit Facility | Secured Overnight Financing Rate      
Debt Instrument [Line Items]      
Basis spread on variable rate (as a percent)   0.90%  
Credit Agreement | Revolving Credit Facility | Low      
Debt Instrument [Line Items]      
Basis spread on variable rate (as a percent)   0.09%  
Credit Agreement | Revolving Credit Facility | Low | Secured Overnight Financing Rate      
Debt Instrument [Line Items]      
Basis spread on variable rate (as a percent)   0.785%  
Credit Agreement | Revolving Credit Facility | High      
Debt Instrument [Line Items]      
Basis spread on variable rate (as a percent)   0.20%  
Credit Agreement | Revolving Credit Facility | High | Secured Overnight Financing Rate      
Debt Instrument [Line Items]      
Basis spread on variable rate (as a percent)   1.30%  
Senior Notes | Fixed-rate 4.3% Notes      
Debt Instrument [Line Items]      
Fixed-rate unsecured senior notes $ 600,000,000    
2018 Notes      
Debt Instrument [Line Items]      
Price equal to principal amount, plus accrued and unpaid interest (as a percent) 101.00%    
2018 Notes | Level 2      
Debt Instrument [Line Items]      
Fair value of the notes, based on Level 2 inputs   $ 591,600,000 $ 575,200,000
XML 107 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
DEBT AND CREDIT FACILITIES - Schedule of the Notes (Details) - Senior Notes - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Unamortized discount $ (0.7) $ (0.9)
Unamortized debt issuance costs (2.3) (2.8)
Total carrying amount $ 597.0 596.3
Fixed-rate 4.3% Notes    
Debt Instrument [Line Items]    
Fixed interest rate 4.30%  
Amount $ 600.0 $ 600.0
Effective Interest Rate 4.329% 4.329%
XML 108 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets    
Available-for-sale investments: $ 898.7 $ 1,481.0
Corporate debt securities    
Assets    
Available-for-sale investments: 641.8 980.3
Asset-backed securities    
Assets    
Available-for-sale investments: 184.3 366.6
United States government and agency securities    
Assets    
Available-for-sale investments: 70.0 131.6
Municipal securities    
Assets    
Available-for-sale investments: 2.6 2.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis    
Assets    
Cash equivalents 579.2 280.4
Investments held for deferred compensation plans 125.8 112.1
Derivatives 47.1 65.5
Total assets 1,650.8 1,939.0
Liabilities    
Derivatives 15.2 27.2
Contingent consideration liabilities   26.2
Other 10.3 14.0
Total liabilities 25.5 67.4
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Corporate debt securities    
Assets    
Available-for-sale investments: 641.8 980.3
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Asset-backed securities    
Assets    
Available-for-sale investments: 184.3 366.6
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | United States government and agency securities    
Assets    
Available-for-sale investments: 70.0 131.6
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Municipal securities    
Assets    
Available-for-sale investments: 2.6 2.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1    
Assets    
Cash equivalents 579.2 280.4
Investments held for deferred compensation plans 125.8 112.1
Derivatives 0.0 0.0
Total assets 705.0 429.6
Liabilities    
Derivatives 0.0 0.0
Contingent consideration liabilities   0.0
Other 0.0 0.0
Total liabilities 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Corporate debt securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Asset-backed securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | United States government and agency securities    
Assets    
Available-for-sale investments: 0.0 37.1
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 1 | Municipal securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2    
Assets    
Cash equivalents 0.0 0.0
Investments held for deferred compensation plans 0.0 0.0
Derivatives 47.1 65.5
Total assets 945.8 1,509.4
Liabilities    
Derivatives 15.2 27.2
Contingent consideration liabilities   0.0
Other 0.0 0.0
Total liabilities 15.2 27.2
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Corporate debt securities    
Assets    
Available-for-sale investments: 641.8 980.3
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Asset-backed securities    
Assets    
Available-for-sale investments: 184.3 366.6
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | United States government and agency securities    
Assets    
Available-for-sale investments: 70.0 94.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 2 | Municipal securities    
Assets    
Available-for-sale investments: 2.6 2.5
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3    
Assets    
Cash equivalents 0.0 0.0
Investments held for deferred compensation plans 0.0 0.0
Derivatives 0.0 0.0
Total assets 0.0 0.0
Liabilities    
Derivatives 0.0 0.0
Contingent consideration liabilities   26.2
Other 10.3 14.0
Total liabilities 10.3 40.2
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Corporate debt securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Asset-backed securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | United States government and agency securities    
Assets    
Available-for-sale investments: 0.0 0.0
Estimate of Fair Value Measurement | Fair Value on a Recurring Basis | Level 3 | Municipal securities    
Assets    
Available-for-sale investments: $ 0.0 $ 0.0
XML 109 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Narrative (Details) - Contingent Consideration
Dec. 31, 2023
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Contingent consideration, liability $ 0
Measurement Input, Probability of Milestone Achievement  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Contingent consideration liability measurement input 0
XML 110 R84.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration Obligation (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Change in fair value of contingent consideration liabilities (Note 12) Change in fair value of contingent consideration liabilities (Note 12)
Level 3 | Fair Value on a Recurring Basis    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value beginning balance $ 40.2 $ 76.0
Changes in fair value (29.9) (35.8)
Fair value ending balance 10.3 40.2
Contingent Consideration | Level 3 | Fair Value on a Recurring Basis    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value beginning balance 26.2 62.0
Changes in fair value (26.2) (35.8)
Fair value ending balance 0.0 26.2
Other | Level 3 | Fair Value on a Recurring Basis    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value beginning balance 14.0 14.0
Changes in fair value (3.7) 0.0
Fair value ending balance $ 10.3 $ 14.0
XML 111 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) - Derivatives designated as hedging instruments - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Foreign currency forward exchange contracts    
Derivative [Line Items]    
Notional Amount $ 1,786.2 $ 1,678.4
Cross currency swap contracts    
Derivative [Line Items]    
Notional Amount $ 300.0 $ 300.0
XML 112 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets    
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other current assets, Other assets Other current assets, Other assets
Liabilities    
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Other liabilities, Accrued and other liabilities (Note 5) Other liabilities, Accrued and other liabilities (Note 5)
Foreign currency contracts    
Assets    
Fair value of derivative assets $ 23.7 $ 24.9
Liabilities    
Fair value of derivative liabilities 15.2 27.2
Cross currency swap contracts    
Assets    
Fair value of derivative assets 23.4 40.6
Derivatives designated as hedging instruments | Foreign currency contracts    
Assets    
Fair value of derivative assets 23.7 24.9
Derivatives designated as hedging instruments | Foreign currency contracts | Accrued and other liabilities    
Liabilities    
Fair value of derivative liabilities 15.2 20.7
Derivatives designated as hedging instruments | Foreign currency contracts | Other liabilities    
Liabilities    
Fair value of derivative liabilities 0.0 6.5
Derivatives designated as hedging instruments | Cross currency swap contracts    
Assets    
Fair value of derivative assets $ 23.4 $ 40.6
XML 113 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Foreign currency contracts    
Derivative Assets    
Gross Amounts $ 23.7 $ 24.9
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 23.7 24.9
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (9.4) (12.0)
Cash Collateral Received 0.0 0.0
Net Amount 14.3 12.9
Derivative Liabilities    
Gross Amounts 15.2 27.2
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 15.2 27.2
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments (9.4) (12.0)
Cash Collateral Received 0.0 0.0
Net Amount 5.8 15.2
Cross currency swap contracts    
Derivative Assets    
Gross Amounts 23.4 40.6
Gross Amounts Offset in the Consolidated Balance Sheet 0.0 0.0
Net Amounts Presented in the Consolidated Balance Sheet 23.4 40.6
Gross Amounts Not Offset in the Consolidated Balance Sheet    
Financial Instruments 0.0 0.0
Cash Collateral Received 0.0 0.0
Net Amount $ 23.4 $ 40.6
XML 114 R88.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Foreign currency contracts | Derivatives not designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative $ 7.4 $ 44.0 $ 27.4
Cash flow hedges | Foreign currency contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) 29.2 81.7  
Cash flow hedges | Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income 58.9 88.4  
Net investment hedges | Cross currency swap contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) (17.3) 21.6  
Net investment hedges | Cross currency swap contracts | Interest income, net | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing) 6.9 7.0  
Fair value hedges | Foreign currency contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Amount of Gain or (Loss) Recognized in Income on Derivative $ 13.9 $ (3.9) $ 11.6
XML 115 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)
€ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
USD ($)
Derivative Instruments, Gain (Loss)      
Cash flow hedge loss to be reclassified $ 2.7    
Cross currency swap contracts | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Notional Amount 300.0   $ 300.0
Cross currency swap contracts | Net investment hedges | Derivatives designated as hedging instruments      
Derivative Instruments, Gain (Loss)      
Notional Amount $ 300.0 € 257.2  
XML 116 R90.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Derivative Instruments, Gain (Loss)      
Cost of sales $ (1,379.8) $ (1,080.4) $ (1,248.9)
Selling, general, and administrative expenses (1,824.6) (1,567.6) (1,493.7)
Other income, net 14.4 2.6 $ 12.7
Foreign currency contracts | Cost of sales      
Gain (loss) on fair value hedging relationships:      
Hedged items 0.0 0.0  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 0.0 0.0  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 58.9 88.4  
Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments 0.0 0.0  
Foreign currency contracts | Other income, net      
Gain (loss) on fair value hedging relationships:      
Hedged items (9.2) 5.5  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 4.7 1.6  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 0.0 0.0  
Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments $ 9.2 $ (5.5)  
XML 117 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Change in projected benefit obligation:      
Beginning of year $ 94.1 $ 117.9  
Service cost 4.3 5.5 $ 6.5
Interest cost 2.3 0.5 0.4
Participant contributions 1.9 1.6  
Actuarial loss (gain) 9.9 (22.6)  
Benefits paid (3.8) (0.6)  
Plan amendment (0.4) (0.3)  
Settlements and curtailment gain 0.0 (1.8)  
Currency exchange rate changes and other 3.4 (6.1)  
End of year 111.7 94.1 117.9
Change in fair value of plan assets:      
Beginning of year 70.6 76.9  
Actual return on plan assets 0.8 (4.9)  
Employer contributions 3.5 3.5  
Participant contributions 1.9 1.6  
Settlements 0.0 (1.8)  
Benefits paid (3.8) (0.6)  
Currency exchange rate changes and other 2.5 (4.1)  
End of year 75.5 70.6 76.9
Funded Status      
Projected benefit obligation (111.7) (94.1) (117.9)
Plan assets at fair value 75.5 70.6 $ 76.9
Underfunded status (36.2) (23.5)  
Accumulated other comprehensive loss, net of tax:      
Net actuarial (loss) gain (10.3) 1.5  
Net prior service credit 5.2 5.3  
Deferred income tax benefit (expense) 0.9 (1.1)  
Total (4.2) 5.7  
Other liabilities      
Net amounts recognized on the consolidated balance sheet:      
Other liabilities $ 36.2 $ 23.5  
XML 118 R92.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Defined Contribution Plans      
Expected employer contributions $ 2.7    
Matching contributions relating to entity's employees 51.0 $ 45.1 $ 38.6
Nonqualified deferred compensation plans      
Defined Contribution Plans      
Amount accrued under nonqualified plans $ 125.6 112.6  
United States      
Defined Contribution Plans      
Maximum contributions of a participant's eligible compensation (as a percent) 25.00%    
Dollar-for-dollar match of employee's annual eligible compensation (as a percent) 4.00%    
Company match of eligible compensation after dollar-for-dollar basis (as a percent) 2.00%    
Company match, second level (as a percent) 50.00%    
Foreign Plan      
Defined Contribution Plans      
Maximum contributions of a participant's eligible compensation (as a percent) 25.00%    
Dollar-for-dollar match of employee's annual eligible compensation (as a percent) 4.00%    
Company match, first level (as a percent) 50.00%    
Profit sharing contribution calculated on eligible earnings (as a percent) 2.00%    
Defined benefit pension plans      
Defined Contribution Plans      
Accumulated benefit obligation $ 106.8 $ 86.7  
XML 119 R93.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Net Periodic Benefit Cost (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]      
Service cost, net $ 4.3 $ 5.5 $ 6.5
Interest cost 2.3 0.5 0.4
Expected return on plan assets (2.7) (1.5) (1.1)
Settlements and curtailment gain 0.0 0.1 0.0
Amortization of actuarial loss 0.0 0.5 1.7
Amortization of prior service credit (0.8) (0.7) (0.7)
Net periodic pension benefit cost $ 3.1 $ 4.4 $ 6.8
XML 120 R94.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) - Defined benefit pension plans
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Weighted-average assumptions used to determine the benefit obligations      
Discount rate (as a percent) 1.80% 2.50%  
Rate of compensation increase (as a percent) 2.90% 2.90%  
Cash balance interest crediting rate (as a percent) 1.50% 1.50%  
Social securities increase (as a percent) 1.80% 1.80%  
Pension increase (as a percent) 2.20% 2.20%  
Weighted-average assumptions used to determine the net periodic benefit cost      
Discount rate (as a percent) 2.50% 0.50% 0.30%
Expected return on plan assets (as a percent) 3.70% 2.10% 1.50%
Rate of compensation increase (as a percent) 2.90% 2.60% 2.60%
Cash balance interest crediting rate (as a percent) 1.50% 1.50% 2.50%
Social securities increase (as a percent) 1.80% 1.60% 1.60%
Pension increase (as a percent) 2.20% 1.80% 1.80%
XML 121 R95.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) - Defined benefit pension plans - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 100.00%    
Plan assets at fair value $ 75.5 $ 70.6 $ 76.9
Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 68.6 64.5  
Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 55.1 52.6  
Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 12.7 11.1  
Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.8 0.8  
Alternative investments measured at net asset value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 6.9 6.1  
Cash | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 2.0 3.6  
Cash | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 2.0 3.6  
Cash | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Cash | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Equity securities      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 31.30%    
United States equities | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 2.6 1.5  
United States equities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 2.6 1.5  
United States equities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
United States equities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International equities | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 21.0 17.5  
International equities | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 21.0 17.5  
International equities | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International equities | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Debt securities      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 38.90%    
United States government bonds | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 3.5 4.4  
United States government bonds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 3.5 4.4  
United States government bonds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
United States government bonds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International government bonds | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 26.0 25.6  
International government bonds | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 26.0 25.6  
International government bonds | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
International government bonds | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.0 0.0  
Real estate      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 11.40%    
Real estate | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 8.7 7.6  
Real estate | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Real estate | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 8.7 7.6  
Real estate | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Mortgages | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 4.0 3.5  
Mortgages | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Mortgages | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 4.0 3.5  
Mortgages | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Total plan assets measured at fair value      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.8 0.8  
Insurance contracts | Level 1      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Level 2      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value 0.0 0.0  
Insurance contracts | Level 3      
Defined Benefit Plan Disclosure [Line Items]      
Plan assets at fair value $ 0.8 $ 0.8 $ 0.9
Other      
Defined Benefit Plan Disclosure [Line Items]      
Target asset allocations (as a percent) 18.40%    
XML 122 R96.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Insurance Contracts    
Beginning of year $ 70.6 $ 76.9
Currency exchange rate impact 2.5 (4.1)
End of year 75.5 70.6
Level 3    
Insurance Contracts    
Beginning of year 0.8  
End of year 0.8 0.8
Level 3 | Insurance Contracts    
Insurance Contracts    
Beginning of year 0.8 0.9
Relating to assets still held at December 31, 2023 0.2 0.2
Purchases, sales and settlements (0.2) (0.2)
Currency exchange rate impact   (0.1)
End of year $ 0.8 $ 0.8
XML 123 R97.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Retirement Benefits [Abstract]  
2024 $ 7.3
2025 5.9
2026 6.9
2027 6.8
2028 8.1
2029-2033 $ 39.0
XML 124 R98.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK - Treasury Stock (Details) - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Jul. 31, 2022
Treasury Stock        
Purchases of treasury stock $ 880,500,000 $ 1,727,100,000 $ 512,800,000  
Treasury Stock        
Treasury Stock        
Purchases of treasury stock (in shares) 11.4 20.1 5.8  
Purchases of treasury stock $ 880,500,000 $ 1,727,100,000 $ 512,800,000  
July 2022 Stock Repurchase Program        
Treasury Stock        
Authorized amount for share repurchase       $ 1,500,000,000
Additional authorized amount $ 1,000,000,000      
XML 125 R99.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK - Schedule of Accelerated Share Repurchases (Details) - USD ($)
$ / shares in Units, shares in Millions
 1 Months Ended
Dec. 31, 2023
Mar. 31, 2023
Feb. 28, 2023
Dec. 31, 2022
Oct. 31, 2022
Feb. 28, 2022
Jan. 31, 2022
Oct. 01, 2022
Initial Delivery Of Shares Settled January 2022                
Accelerated Share Repurchase                
Amount Paid             $ 250,000,000.0  
Shares Received (in shares)             1.9  
Initial delivery, price per Share (in dollars per share)             $ 104.87  
Value of Shares as % of Contract Value             80.00%  
January 2022 Stock Repurchase Program Shares Sold In February 2022                
Accelerated Share Repurchase                
Shares Received (in shares)           2.3    
Final Settlement Average Price per Share (in dollars per share)           $ 110.31    
Initial Delivery Of Shares Settled October 2022                
Accelerated Share Repurchase                
Amount Paid               $ 750,000,000.0
Shares Received (in shares)         8.3      
Initial delivery, price per Share (in dollars per share)         $ 72.43      
Value of Shares as % of Contract Value         80.00%      
October 2022 Stock Repurchase Program Shares Sold In December 2022                
Accelerated Share Repurchase                
Shares Received (in shares)       10.3        
Final Settlement Average Price per Share (in dollars per share)       $ 72.91        
Initial Delivery Of Shares Settled February 2023                
Accelerated Share Repurchase                
Amount Paid     $ 200,000,000.0          
Shares Received (in shares)     2.0          
Initial delivery, price per Share (in dollars per share)     $ 80.44          
Value of Shares as % of Contract Value     80.00%          
February 2023 Stock Repurchase Program, Shares Sold In March 2023                
Accelerated Share Repurchase                
Shares Received (in shares)   2.5            
Final Settlement Average Price per Share (in dollars per share)   $ 79.28            
Initial Delivery Of Shares Settled December 2023                
Accelerated Share Repurchase                
Amount Paid $ 400,000,000.0              
Shares Received (in shares) 4.6              
Initial delivery, price per Share (in dollars per share) $ 70.31              
Value of Shares as % of Contract Value 80.00%              
December 2023 Stock Repurchase Program, Shares Sold In December 2023                
Accelerated Share Repurchase                
Shares Received (in shares) 5.3              
Final Settlement Average Price per Share (in dollars per share) $ 72.91              
XML 126 R100.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK - Employee and Director Stock Plans (Details) - shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Option Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Estimated annual forfeiture rate (as a percent) 6.40%    
Risk-free interest rate 3.40% 3.00% 0.80%
Expected volatility 32.80% 31.40% 33.50%
MRSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate 3.60% 2.90% 0.40%
Expected volatility 32.60% 33.90% 34.40%
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate 4.60% 0.50% 0.10%
Expected volatility 31.50% 32.00% 36.60%
The Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 327,600,000    
The Program | Option Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration date (in years) 7 years    
The Program | Option Awards | Low      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 3 years    
The Program | Option Awards | High      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 4 years    
The Program | Restricted stock units | High      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 4 years    
The Program | MRSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 3 years    
The Program | Restricted stock or restricted stock units | High      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 33,600,000    
Nonemployee Directors Program      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 8,400,000    
Nonemployee Directors Program | Option Awards | Awards granted in 2012 and later      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period (in years) 1 year    
Nonemployee Directors Program | Option Awards | High | Annual award to nonemployee director      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 120,000    
Nonemployee Directors Program | Restricted stock units | High | Annual award to nonemployee director      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 48,000    
ESPP | ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock available for issuance (in shares) 50,400,000    
Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase (as a percent) 85.00%    
Maximum percentage of compensation employees can authorize to be withheld for common stock purchases (as a percent) 15.00%    
XML 127 R101.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Option Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate 3.40% 3.00% 0.80%
Expected dividend yield 0.00% 0.00% 0.00%
Expected volatility 32.80% 31.40% 33.50%
Expected term (years) 5 years 1 month 6 days 5 years 5 years
Fair value, per share (in dollars per share) $ 30.97 $ 34.59 $ 28.90
ESPP      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate 4.60% 0.50% 0.10%
Expected dividend yield 0.00% 0.00% 0.00%
Expected volatility 31.50% 32.00% 36.60%
Expected term (years) 7 months 6 days 7 months 6 days 7 months 6 days
Fair value, per share (in dollars per share) $ 19.03 $ 28.18 $ 23.07
XML 128 R102.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK - Schedule of Stock Option (Details) - Stock option activity
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
$ / shares
shares
Shares  
Beginning balance (in shares) | shares 11.6
Options granted (in shares) | shares 2.0
Options exercised (in shares) | shares (2.2)
Options forfeited (in shares) | shares (0.4)
Ending balance (in shares) | shares 11.0
Exercisable as of period end (in shares) | shares 7.3
Vested and expected to vest as of period end (in shares) | shares 10.5
Weighted- Average Exercise Price  
Beginning balance (in dollars per share) | $ / shares $ 63.67
Options granted (in dollars per share) | $ / shares 88.27
Options exercised (in dollars per share) | $ / shares 38.54
Options forfeited (in dollars per share) | $ / shares 97.32
Ending balance (in dollars per share) | $ / shares 71.90
Exercisable as of period end (in dollars per share) | $ / shares 61.68
Vested and expected to vest as of period end (in dollars per share) | $ / shares $ 70.91
Weighted- Average Remaining Contractual Term  
Outstanding as of period end 3 years 6 months
Exercisable as of period end 2 years 4 months 24 days
Vested and expected to vest as of period end 3 years 4 months 24 days
Aggregate Intrinsic Value  
Outstanding as of period end | $ $ 136.9
Exercisable as of period end | $ 135.5
Vested and expected to vest as of period end | $ $ 136.7
XML 129 R103.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) - Nonvested restricted stock unit activity
shares in Millions
 12 Months Ended
Dec. 31, 2023
$ / shares
shares
Shares  
Beginning balance (in shares) | shares 2.0
Granted (in shares) | shares 1.1
Vested (in shares) | shares (0.8)
Forfeited (in shares) | shares (0.2)
Ending balance (in shares) | shares 2.1
Weighted- Average Grant-Date Fair Value  
Beginning balance (in dollars per share) | $ / shares $ 92.30
Granted (in dollars per share) | $ / shares 89.03
Vested (in dollars per share) | $ / shares 83.17
Forfeited (in dollars per share) | $ / shares 99.82
Ending balance (in dollars per share) | $ / shares $ 94.35
XML 130 R104.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]      
Intrinsic value of stock options exercised and restricted stock units vested $ 162.7 $ 264.5 $ 359.8
Cash from exercises of stock options 83.4 64.8 82.2
Realized tax benefits from exercises of stock options and vesting of restricted stock units 35.9 56.9 76.5
Total grant date fair value of stock options vested 41.3 $ 40.4 $ 36.2
Employee stock purchase subscriptions $ 224.9    
Weighted-average remaining requisite service period (in months) 31 months    
XML 131 R105.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
AOCI Attributable to Parent, Net of Tax      
Beginning balance $ 5,806.7    
Ending balance 6,650.0 $ 5,806.7  
Total Accumulated Other Comprehensive Loss      
AOCI Attributable to Parent, Net of Tax      
Beginning balance (254.9) (157.7) $ (161.1)
Other comprehensive (loss) income before reclassifications 71.7 (19.3) 10.7
Amounts reclassified from accumulated other comprehensive loss (72.4) (72.8) 15.2
Deferred income tax (expense) benefit 12.8 (5.1) (22.5)
Ending balance (242.8) (254.9) (157.7)
Foreign Currency Translation Adjustments      
AOCI Attributable to Parent, Net of Tax      
Beginning balance (218.8) (172.5) (122.4)
Other comprehensive (loss) income before reclassifications 6.9 (33.9) (39.2)
Amounts reclassified from accumulated other comprehensive loss (6.9) (7.0) (6.4)
Deferred income tax (expense) benefit 4.3 (5.4) (4.5)
Ending balance (214.5) (218.8) (172.5)
Unrealized (Loss) Gain on Hedges      
AOCI Attributable to Parent, Net of Tax      
Beginning balance 23.8 29.7 (27.7)
Other comprehensive (loss) income before reclassifications 43.3 75.2 66.3
Amounts reclassified from accumulated other comprehensive loss (72.8) (84.5) 12.0
Deferred income tax (expense) benefit 6.4 3.4 (20.9)
Ending balance 0.7 23.8 29.7
Unrealized Gain (Loss) on Available-for-sale Investments      
AOCI Attributable to Parent, Net of Tax      
Beginning balance (65.6) (6.9) 8.6
Other comprehensive (loss) income before reclassifications 32.6 (77.9) (29.2)
Amounts reclassified from accumulated other comprehensive loss 8.1 18.8 8.6
Deferred income tax (expense) benefit 0.1 0.4 5.1
Ending balance (24.8) (65.6) (6.9)
Unrealized Pension (Costs) Credits      
AOCI Attributable to Parent, Net of Tax      
Beginning balance 5.7 (8.0) (19.6)
Other comprehensive (loss) income before reclassifications (11.1) 17.3 12.8
Amounts reclassified from accumulated other comprehensive loss (0.8) (0.1) 1.0
Deferred income tax (expense) benefit 2.0 (3.5) (2.2)
Ending balance $ (4.2) $ 5.7 $ (8.0)
XML 132 R106.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Change in Unrealized Pension Costs (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net prior service cost arising during period      
Pre-Tax Amount      
Prior service credit arising during period $ 0.7 $ 0.0 $ 0.1
Amortization of prior service credit (0.8) (0.7) (0.7)
Other comprehensive income (loss) (0.1) (0.7) (0.6)
Tax (Expense) Benefit      
Prior service credit arising during period 0.9 (1.1) 0.0
Amortization of prior service credit 0.1 0.3 0.1
Other comprehensive income (loss) 1.0 (0.8) 0.1
Net of Tax Amount      
Prior service credit arising during period 1.6 (1.1) 0.1
Amortization of prior service credit (0.7) (0.4) (0.6)
Other comprehensive income (loss) 0.9 (1.5) (0.5)
Net actuarial gain (loss) arising during period      
Pre-Tax Amount      
Other comprehensive income (loss) (11.8) 17.9 14.4
Tax (Expense) Benefit      
Other comprehensive income (loss) 1.0 (2.7) (2.3)
Net of Tax Amount      
Other comprehensive income (loss) (10.8) 15.2 12.1
Unrealized pension costs, net      
Pre-Tax Amount      
Prior service credit arising during period (11.1) 17.3 12.8
Other comprehensive income (loss) (11.9) 17.2 13.8
Tax (Expense) Benefit      
Other comprehensive income (loss) 2.0 (3.5) (2.2)
Net of Tax Amount      
Other comprehensive income (loss) $ (9.9) $ 13.7 $ 11.6
XML 133 R107.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net $ 14.4 $ 2.6 $ 12.7
Provision for income taxes (198.7) (245.5) (198.9)
Net income 1,399.4 1,521.9 1,503.1
Cost of sales (1,379.8) (1,080.4) $ (1,248.9)
Amount Reclassified from Accumulated Other Comprehensive Loss | Foreign currency translation adjustments      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net 6.9 7.0  
Provision for income taxes (1.7) (1.7)  
Net income 5.2 5.3  
Amount Reclassified from Accumulated Other Comprehensive Loss | (Loss) gain on hedges      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Provision for income taxes (15.8) (22.2)  
Net income 57.0 62.3  
Cost of sales 58.9 88.4  
Other income, net 13.9 (3.9)  
Total segment operating income 72.8 84.5  
Amount Reclassified from Accumulated Other Comprehensive Loss | Gain (loss) on available-for-sale investments      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net (8.1) (18.8)  
Provision for income taxes 2.2 4.6  
Net income (5.9) (14.2)  
Amount Reclassified from Accumulated Other Comprehensive Loss | Amortization of pension adjustments      
Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations      
Other income, net 0.8 0.1  
Provision for income taxes (0.2) 0.0  
Net income $ 0.6 $ 0.1  
XML 134 R108.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER INCOME, NET (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Other Income and Expenses [Abstract]      
Foreign exchange (gains) losses, net $ (10.5) $ 1.2 $ (5.0)
Loss (gain) on investments 0.7 1.1 (5.8)
Non-service cost components of net periodic pension benefit cost (1.2) (1.1) 0.3
Gain on insurance settlement 0.0 (3.8) 0.0
Other (3.4) 0.0 (2.2)
Total other income, net $ (14.4) $ (2.6) $ (12.7)
XML 135 R109.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]      
United States $ 348.0 $ 634.4 $ 610.9
Outside of the United States, including Puerto Rico 1,250.1 1,133.0 1,091.1
Income before provision for income taxes $ 1,598.1 $ 1,767.4 $ 1,702.0
XML 136 R110.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Schedule of Provision for Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
United States:      
Federal $ 317.3 $ 369.1 $ 125.2
State and local 58.1 60.6 25.1
Outside of the United States, including Puerto Rico 85.3 66.7 92.6
Current income tax expense 460.7 496.4 242.9
United States:      
Federal (187.5) (187.7) (9.4)
State and local (54.2) (58.9) (25.4)
Outside of the United States, including Puerto Rico (20.3) (4.3) (9.2)
Deferred income tax benefit (262.0) (250.9) (44.0)
Total income tax provision $ 198.7 $ 245.5 $ 198.9
XML 137 R111.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets    
Capitalized research and development expenses $ 371.1 $ 199.7
Compensation and benefits 117.9 100.6
Benefits from uncertain tax positions 63.4 42.1
Net tax credit carryforwards 172.9 160.8
Net operating loss carryforwards 75.9 71.7
Accrued liabilities 132.8 93.7
Inventories 15.3 11.9
Cash flow and net investment hedges 1.6 6.6
State income taxes 0.2 0.3
Investments 0.6 0.6
Lease liability obligations 5.8 6.7
Other 0.8 1.9
Total deferred tax assets 958.3 696.6
Deferred tax liabilities    
Property, plant, and equipment (78.2) (80.2)
Deferred tax on foreign earnings (3.6) (19.2)
Right-of-use assets (4.7) (6.0)
Other intangible assets (53.0) (19.9)
Other (2.5) (2.9)
Total deferred tax liabilities (142.0) (128.2)
Valuation allowance (90.2) (99.1)
Net deferred tax assets $ 726.1 $ 469.3
XML 138 R112.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Loss Carryforwards [Line Items]          
Net deferred tax assets increase   $ 256.8      
Valuation allowance that reduces certain deferred tax assets   90.2 $ 99.1    
Carryforward amount   240.7      
Foreign earnings to be indefinitely reinvested   961.6      
Foreign earnings to be repatriated   1,200.0      
Estimated net tax liability on permanently reinvested earnings   5.1      
Liability for income taxes associated with uncertain tax positions   583.9 475.3 $ 358.4 $ 281.8
Decrease in unrecognized tax benefits is reasonably possible   250.7 182.1    
Net amounts that would favorably affect effective tax rate   333.2 293.2    
Accrued interest related to unrecognized tax benefits, net of tax benefit   41.4 29.1    
Tax benefit of accrued interest   29.9 15.4    
Interest expense (benefit), net of tax benefit   12.3 9.6 5.2  
Estimate of additional tax expense   230.0      
Additional tax sought in excess of filing position   269.3      
Low | Subsequent Event          
Operating Loss Carryforwards [Line Items]          
Additional deposit $ 200.0        
High | Subsequent Event          
Operating Loss Carryforwards [Line Items]          
Additional deposit $ 300.0        
Non-U.S.          
Operating Loss Carryforwards [Line Items]          
Tax reductions compared to local statutory rates   $ 333.2 $ 247.4 $ 208.0  
Tax reductions compared to local statutory rates per diluted share (in dollars per share)   $ 0.55 $ 0.40 $ 0.33  
Carryforward period indefinite | California | State and local jurisdiction | Research expenditure tax credits          
Operating Loss Carryforwards [Line Items]          
Carryforward amount   $ 211.3      
Carryforward period indefinite | Puerto Rico | Non-U.S. | Puerto Rico purchases credit          
Operating Loss Carryforwards [Line Items]          
Carryforward amount   $ 27.4      
XML 139 R113.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Schedule of Net Operating Loss Carryforwards (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Operating Loss Carryforwards [Line Items]  
Carryforward Amount $ 499.0
Tax Benefit Amount 75.9
Valuation Allowance (56.4)
Net Tax Benefit 19.5
United States federal net operating losses | United States | Carryforward Period Ends 2033-2037  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 9.0
Tax Benefit Amount 1.9
Valuation Allowance 0.0
Net Tax Benefit 1.9
United States federal net operating losses | United States | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 1.8
Tax Benefit Amount 0.4
Valuation Allowance 0.0
Net Tax Benefit 0.4
United States federal net operating losses | United States | Carryforward Period Ends 2022  
Capital Loss Carryforward [Abstract]  
Carryforward Amount 33.4
Tax Benefit Amount 0.1
Valuation Allowance (0.1)
Net Tax Benefit 0.0
United States state net operating losses | United States | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 2.6
Tax Benefit Amount 0.1
Valuation Allowance (0.1)
Net Tax Benefit 0.0
United States state net operating losses | United States | Carryforward Period Ends 2026-2041  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 35.7
Tax Benefit Amount 1.8
Valuation Allowance (1.7)
Net Tax Benefit 0.1
Non-United States net operating losses | International | Carryforward Period Indefinite  
Operating Loss Carryforwards [Line Items]  
Carryforward Amount 416.5
Tax Benefit Amount 71.6
Valuation Allowance (54.5)
Net Tax Benefit $ 17.1
XML 140 R114.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Schedule of Tax Credit Carryforwards (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount $ 240.7
Valuation Allowance (27.4)
Net Tax Benefit 213.3
California research expenditure tax credits | California | Research expenditure tax credits | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 211.3
Valuation Allowance 0.0
Net Tax Benefit 211.3
Federal research expenditure tax credits | United States | Research expenditure tax credits | Tax Carryforwards Expiration Period Years 2026-2039  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 1.3
Valuation Allowance 0.0
Net Tax Benefit 1.3
Foreign tax authority | Foreign | Foreign tax and general business credits | Tax Carryforwards Expiration Period Years 2030-2033  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 0.7
Valuation Allowance 0.0
Net Tax Benefit 0.7
Foreign tax authority | Puerto Rico | Purchase credit | Carryforward Period Indefinite  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 1.2
Valuation Allowance (1.2)
Net Tax Benefit 0.0
Foreign tax authority | Puerto Rico | Purchase credit | Tax Carryforwards Expiration Period Ends 2025  
Tax credit carryforwards and the related carryforward periods  
Carryforward Amount 26.2
Valuation Allowance (26.2)
Net Tax Benefit $ 0.0
XML 141 R115.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]      
Income tax expense at United States federal statutory rate $ 335.6 $ 371.1 $ 357.4
Foreign income taxed at different rates (128.3) (123.9) (122.2)
State and local taxes, net of federal tax benefit 18.7 21.1 11.9
Tax credits, federal and state (62.5) (50.0) (48.4)
Build of reserve for prior years' uncertain tax positions (2.9) 11.6 3.6
Tax on global intangible low-taxed income 78.7 61.4 56.5
Foreign-derived intangible income deduction (23.0) (15.0) (1.3)
Contingent consideration liabilities (5.5) (7.5) (26.1)
United States federal deductible employee share-based compensation (13.1) (31.6) (47.8)
Nondeductible employee share-based compensation 6.6 5.8 5.3
Other (5.6) 2.5 10.0
Total income tax provision $ 198.7 $ 245.5 $ 198.9
XML 142 R116.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES - Schedule of Reconciliation of Uncertain Tax Positions (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns      
Uncertain gross tax positions, beginning balance $ 475.3 $ 358.4 $ 281.8
Current year tax positions 127.0 120.6 82.1
Increase in prior year tax positions 0.8 3.8 2.3
Decrease in prior year tax positions (16.2) (0.6) (4.8)
Settlements (3.0) (0.4) (0.3)
Lapse of statutes of limitations 0.0 (6.5) (2.7)
Uncertain gross tax positions, ending balance $ 583.9 $ 475.3 $ 358.4
XML 143 R117.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEGAL PROCEEDINGS (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
lawsuit
Commitments and Contingencies Disclosure [Abstract]  
Number of lawsuits that if settled could have a material adverse impact on net income or cash flows | lawsuit 1
Threshold of disclosing material environmental legal proceedings | $ $ 1
XML 144 R118.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Net Sales      
Total segment net sales $ 6,004.8 $ 5,382.4 $ 5,232.5
Operating segments      
Segment Net Sales      
Total segment net sales 5,999.7 5,516.3 5,123.9
Segment Operating Income      
Total segment operating income 3,585.1 3,407.5 3,153.3
Operating segments | United States      
Segment Net Sales      
Total segment net sales 3,508.7 3,132.6 2,963.1
Segment Operating Income      
Total segment operating income 2,306.1 2,130.9 2,051.0
Operating segments | Europe      
Segment Net Sales      
Total segment net sales 1,337.4 1,213.7 1,099.6
Segment Operating Income      
Total segment operating income 709.5 652.2 569.1
Operating segments | Japan      
Segment Net Sales      
Total segment net sales 436.7 559.3 528.0
Segment Operating Income      
Total segment operating income 259.1 376.7 348.0
Operating segments | Rest of World      
Segment Net Sales      
Total segment net sales 716.9 610.7 533.2
Segment Operating Income      
Total segment operating income $ 310.4 $ 247.7 $ 185.2
XML 145 R119.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Net Sales      
Net sales $ 6,004.8 $ 5,382.4 $ 5,232.5
Segment Operating Income      
Operating income 1,534.1 1,748.5 1,690.3
Unallocated amounts:      
Special charge and separation costs (17.2) (60.7) 0.0
Change in fair value of contingent consideration liabilities 26.2 35.8 124.1
Foreign currency 10.5 (1.2) 5.0
Income before provision for income taxes 1,598.1 1,767.4 1,702.0
Operating segments      
Segment Net Sales      
Net sales 5,999.7 5,516.3 5,123.9
Segment Operating Income      
Operating income 3,585.1 3,407.5 3,153.3
Reconciling items      
Segment Net Sales      
Net sales 5.1 (133.9) 108.6
Unallocated amounts:      
Special charge and separation costs (17.2) (60.7) 0.0
Intellectual property agreement and litigation expense (203.5) (15.8) (20.6)
Foreign currency 64.4 95.8 47.3
Non-operating income 64.0 18.9 11.7
Corporate items      
Unallocated amounts:      
Corporate items $ (1,920.9) $ (1,714.1) $ (1,613.8)
XML 146 R120.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Sales by Geographic Area and by Major Product Area      
Net sales $ 6,004.8 $ 5,382.4 $ 5,232.5
Long-lived Tangible Assets by Geographic Region      
Long-lived tangible assets 1,843.4 1,725.1 1,748.9
Transcatheter Aortic Valve Replacement      
Net Sales by Geographic Area and by Major Product Area      
Net sales 3,879.8 3,518.2 3,422.5
Transcatheter Mitral and Tricuspid Therapies      
Net Sales by Geographic Area and by Major Product Area      
Net sales 197.6 116.1 86.0
Surgical Structural Heart      
Net Sales by Geographic Area and by Major Product Area      
Net sales 999.3 893.1 889.1
Critical Care      
Net Sales by Geographic Area and by Major Product Area      
Net sales 928.1 855.0 834.9
United States      
Net Sales by Geographic Area and by Major Product Area      
Net sales 3,508.7 3,132.6 2,963.1
Long-lived Tangible Assets by Geographic Region      
Long-lived tangible assets 1,269.7 1,188.5 1,195.8
Europe      
Net Sales by Geographic Area and by Major Product Area      
Net sales 1,334.5 1,174.8 1,190.3
Long-lived Tangible Assets by Geographic Region      
Long-lived tangible assets 196.4 191.8 197.9
Japan      
Net Sales by Geographic Area and by Major Product Area      
Net sales 452.4 473.6 528.9
Long-lived Tangible Assets by Geographic Region      
Long-lived tangible assets 23.8 13.2 19.7
Rest of World      
Net Sales by Geographic Area and by Major Product Area      
Net sales 709.2 601.4 550.2
Long-lived Tangible Assets by Geographic Region      
Long-lived tangible assets $ 353.5 $ 331.6 $ 335.5
XML 147 R121.htm IDEA: XBRL DOCUMENT v3.24.0.1
VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Allowance for credit losses      
Movement in Valuation Allowances and Reserves      
Balance at Beginning of Period $ 11.7 $ 15.7 $ 16.4
Charged to Costs and Expenses 2.0 0.9 1.2
Charged to Other Accounts 0.0 0.1 0.6
Deductions (1.9) (5.0) (2.5)
Balance at End of Period 11.8 11.7 15.7
Tax valuation allowance      
Movement in Valuation Allowances and Reserves      
Balance at Beginning of Period 99.1 82.5 71.6
Charged to Costs and Expenses 0.0 3.0 12.4
Charged to Other Accounts 0.1 14.2 0.0
Deductions (9.0) (0.6) (1.5)
Balance at End of Period $ 90.2 $ 99.1 $ 82.5
EXCEL 149 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 150 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 151 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 153 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 532 670 1 false 148 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.edwards.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.edwards.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 8 false false R9.htm 0000009 - Disclosure - DESCRIPTION OF BUSINESS Sheet http://www.edwards.com/role/DESCRIPTIONOFBUSINESS DESCRIPTION OF BUSINESS Notes 9 false false R10.htm 0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 0000011 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSE INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE Notes 11 false false R12.htm 0000012 - Disclosure - SPECIAL CHARGE AND SEPARATION COSTS Sheet http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTS SPECIAL CHARGE AND SEPARATION COSTS Notes 12 false false R13.htm 0000013 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Notes 13 false false R14.htm 0000014 - Disclosure - LEASES Sheet http://www.edwards.com/role/LEASES LEASES Notes 14 false false R15.htm 0000015 - Disclosure - INVESTMENTS Sheet http://www.edwards.com/role/INVESTMENTS INVESTMENTS Notes 15 false false R16.htm 0000016 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES Sheet http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES INVESTMENTS IN VARIABLE INTEREST ENTITIES Notes 16 false false R17.htm 0000017 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONS BUSINESS COMBINATIONS Notes 17 false false R18.htm 0000018 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS GOODWILL AND OTHER INTANGIBLE ASSETS Notes 18 false false R19.htm 0000019 - Disclosure - DEBT AND CREDIT FACILITIES Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIES DEBT AND CREDIT FACILITIES Notes 19 false false R20.htm 0000020 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTS FAIR VALUE MEASUREMENTS Notes 20 false false R21.htm 0000021 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Notes 21 false false R22.htm 0000022 - Disclosure - EMPLOYEE BENEFIT PLANS Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANS EMPLOYEE BENEFIT PLANS Notes 22 false false R23.htm 0000023 - Disclosure - COMMON STOCK Sheet http://www.edwards.com/role/COMMONSTOCK COMMON STOCK Notes 23 false false R24.htm 0000024 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS ACCUMULATED OTHER COMPREHENSIVE LOSS Notes 24 false false R25.htm 0000025 - Disclosure - OTHER INCOME, NET Sheet http://www.edwards.com/role/OTHERINCOMENET OTHER INCOME, NET Notes 25 false false R26.htm 0000026 - Disclosure - INCOME TAXES Sheet http://www.edwards.com/role/INCOMETAXES INCOME TAXES Notes 26 false false R27.htm 0000027 - Disclosure - LEGAL PROCEEDINGS Sheet http://www.edwards.com/role/LEGALPROCEEDINGS LEGAL PROCEEDINGS Notes 27 false false R28.htm 0000028 - Disclosure - SEGMENT INFORMATION Sheet http://www.edwards.com/role/SEGMENTINFORMATION SEGMENT INFORMATION Notes 28 false false R29.htm 0000029 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS Sheet http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS VALUATION AND QUALIFYING ACCOUNTS Notes 29 false false R30.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 30 false false R31.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 31 false false R32.htm 9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 32 false false R33.htm 9954472 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 33 false false R34.htm 9954473 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables) Tables http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS 34 false false R35.htm 9954474 - Disclosure - LEASES (Tables) Sheet http://www.edwards.com/role/LEASESTables LEASES (Tables) Tables http://www.edwards.com/role/LEASES 35 false false R36.htm 9954475 - Disclosure - INVESTMENTS (Tables) Sheet http://www.edwards.com/role/INVESTMENTSTables INVESTMENTS (Tables) Tables http://www.edwards.com/role/INVESTMENTS 36 false false R37.htm 9954476 - Disclosure - BUSINESS COMBINATIONS (Tables) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONSTables BUSINESS COMBINATIONS (Tables) Tables http://www.edwards.com/role/BUSINESSCOMBINATIONS 37 false false R38.htm 9954477 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS 38 false false R39.htm 9954478 - Disclosure - DEBT AND CREDIT FACILITIES (Tables) Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables DEBT AND CREDIT FACILITIES (Tables) Tables http://www.edwards.com/role/DEBTANDCREDITFACILITIES 39 false false R40.htm 9954479 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.edwards.com/role/FAIRVALUEMEASUREMENTS 40 false false R41.htm 9954480 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Tables http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES 41 false false R42.htm 9954481 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables EMPLOYEE BENEFIT PLANS (Tables) Tables http://www.edwards.com/role/EMPLOYEEBENEFITPLANS 42 false false R43.htm 9954482 - Disclosure - COMMON STOCK (Tables) Sheet http://www.edwards.com/role/COMMONSTOCKTables COMMON STOCK (Tables) Tables http://www.edwards.com/role/COMMONSTOCK 43 false false R44.htm 9954483 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables) Tables http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS 44 false false R45.htm 9954484 - Disclosure - OTHER INCOME, NET (Tables) Sheet http://www.edwards.com/role/OTHERINCOMENETTables OTHER INCOME, NET (Tables) Tables http://www.edwards.com/role/OTHERINCOMENET 45 false false R46.htm 9954485 - Disclosure - INCOME TAXES (Tables) Sheet http://www.edwards.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://www.edwards.com/role/INCOMETAXES 46 false false R47.htm 9954486 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONTables SEGMENT INFORMATION (Tables) Tables http://www.edwards.com/role/SEGMENTINFORMATION 47 false false R48.htm 9954487 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Details) Details http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables 48 false false R49.htm 9954488 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Details) Details 49 false false R50.htm 9954489 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details) Details 50 false false R51.htm 9954490 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details) Details 51 false false R52.htm 9954491 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) Details 52 false false R53.htm 9954492 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Details) Details 53 false false R54.htm 9954493 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details) Details 54 false false R55.htm 9954494 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Details 55 false false R56.htm 9954495 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share - Narrative (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share - Narrative (Details) Details 56 false false R57.htm 9954496 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details) Details 57 false false R58.htm 9954497 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation Narrative (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation Narrative (Details) Details 58 false false R59.htm 9954498 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details) Sheet http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details) Details 59 false false R60.htm 9954499 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE (Details) Sheet http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE (Details) Details http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSE 60 false false R61.htm 9954500 - Disclosure - SPECIAL CHARGE AND SEPARATION COSTS (Details) Sheet http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails SPECIAL CHARGE AND SEPARATION COSTS (Details) Details http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTS 61 false false R62.htm 9954501 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details) Details 62 false false R63.htm 9954502 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details) Details 63 false false R64.htm 9954503 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details) Details 64 false false R65.htm 9954504 - Disclosure - LEASES - Narrative (Details) Sheet http://www.edwards.com/role/LEASESNarrativeDetails LEASES - Narrative (Details) Details 65 false false R66.htm 9954505 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details) Sheet http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails LEASES - Assets and Liabilities of Operating Leases (Details) Details 66 false false R67.htm 9954506 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details) Sheet http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails LEASES - Maturities Of Operating Lease Liabilities (Details) Details 67 false false R68.htm 9954507 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails INVESTMENTS - Schedule of Investments in Debt Securities (Details) Details 68 false false R69.htm 9954508 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details) Details 69 false false R70.htm 9954509 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details) Details 70 false false R71.htm 9954510 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Sheet http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details) Details 71 false false R72.htm 9954511 - Disclosure - INVESTMENTS - Narrative (Details) Sheet http://www.edwards.com/role/INVESTMENTSNarrativeDetails INVESTMENTS - Narrative (Details) Details 72 false false R73.htm 9954512 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) Sheet http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details) Details http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES 73 false false R74.htm 9954513 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails BUSINESS COMBINATIONS - Narrative (Details) Details 74 false false R75.htm 9954514 - Disclosure - BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) Details 75 false false R76.htm 9954515 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details) Details 76 false false R77.htm 9954516 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details) Details 77 false false R78.htm 9954517 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) Details 78 false false R79.htm 9954518 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) Sheet http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details) Details 79 false false R80.htm 9954519 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details) Sheet http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails DEBT AND CREDIT FACILITIES - Narrative (Details) Details 80 false false R81.htm 9954520 - Disclosure - DEBT AND CREDIT FACILITIES - Schedule of the Notes (Details) Notes http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails DEBT AND CREDIT FACILITIES - Schedule of the Notes (Details) Details 81 false false R82.htm 9954521 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Details 82 false false R83.htm 9954522 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails FAIR VALUE MEASUREMENTS - Narrative (Details) Details 83 false false R84.htm 9954523 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration Obligation (Details) Sheet http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration Obligation (Details) Details 84 false false R85.htm 9954524 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details) Details 85 false false R86.htm 9954525 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details) Details 86 false false R87.htm 9954526 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details) Details 87 false false R88.htm 9954527 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details) Details 88 false false R89.htm 9954528 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details) Details 89 false false R90.htm 9954529 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details) Sheet http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details) Details 90 false false R91.htm 9954530 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details) Details 91 false false R92.htm 9954531 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails EMPLOYEE BENEFIT PLANS - Narrative (Details) Details 92 false false R93.htm 9954532 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Net Periodic Benefit Cost (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails EMPLOYEE BENEFIT PLANS - Schedule of Net Periodic Benefit Cost (Details) Details 93 false false R94.htm 9954533 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details) Details 94 false false R95.htm 9954534 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details) Details 95 false false R96.htm 9954535 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details EMPLOYEE BENEFIT PLANS - Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details) Details 96 false false R97.htm 9954536 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) Sheet http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details) Details 97 false false R98.htm 9954537 - Disclosure - COMMON STOCK - Treasury Stock (Details) Sheet http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails COMMON STOCK - Treasury Stock (Details) Details 98 false false R99.htm 9954538 - Disclosure - COMMON STOCK - Schedule of Accelerated Share Repurchases (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails COMMON STOCK - Schedule of Accelerated Share Repurchases (Details) Details 99 false false R100.htm 9954539 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Details) Sheet http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails COMMON STOCK - Employee and Director Stock Plans (Details) Details 100 false false R101.htm 9954540 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails COMMON STOCK - Schedule of Weighted-Average Assumptions (Details) Details 101 false false R102.htm 9954541 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails COMMON STOCK - Schedule of Stock Option (Details) Details 102 false false R103.htm 9954542 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) Sheet http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details) Details 103 false false R104.htm 9954543 - Disclosure - COMMON STOCK - Narrative (Details) Sheet http://www.edwards.com/role/COMMONSTOCKNarrativeDetails COMMON STOCK - Narrative (Details) Details 104 false false R105.htm 9954544 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details) Details 105 false false R106.htm 9954545 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Change in Unrealized Pension Costs (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Change in Unrealized Pension Costs (Details) Details 106 false false R107.htm 9954546 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Sheet http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) Details 107 false false R108.htm 9954547 - Disclosure - OTHER INCOME, NET (Details) Sheet http://www.edwards.com/role/OTHERINCOMENETDetails OTHER INCOME, NET (Details) Details http://www.edwards.com/role/OTHERINCOMENETTables 108 false false R109.htm 9954548 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details) Details 109 false false R110.htm 9954549 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails INCOME TAXES - Schedule of Provision for Income Taxes (Details) Details 110 false false R111.htm 9954550 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details) Details 111 false false R112.htm 9954551 - Disclosure - INCOME TAXES - Narrative (Details) Sheet http://www.edwards.com/role/INCOMETAXESNarrativeDetails INCOME TAXES - Narrative (Details) Details 112 false false R113.htm 9954552 - Disclosure - INCOME TAXES - Schedule of Net Operating Loss Carryforwards (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails INCOME TAXES - Schedule of Net Operating Loss Carryforwards (Details) Details 113 false false R114.htm 9954553 - Disclosure - INCOME TAXES - Schedule of Tax Credit Carryforwards (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails INCOME TAXES - Schedule of Tax Credit Carryforwards (Details) Details 114 false false R115.htm 9954554 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails INCOME TAXES - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Details 115 false false R116.htm 9954555 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Uncertain Tax Positions (Details) Sheet http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails INCOME TAXES - Schedule of Reconciliation of Uncertain Tax Positions (Details) Details 116 false false R117.htm 9954556 - Disclosure - LEGAL PROCEEDINGS (Details) Sheet http://www.edwards.com/role/LEGALPROCEEDINGSDetails LEGAL PROCEEDINGS (Details) Details http://www.edwards.com/role/LEGALPROCEEDINGS 117 false false R118.htm 9954557 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details) Details 118 false false R119.htm 9954558 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details) Details 119 false false R120.htm 9954559 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Sheet http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) Details 120 false false R121.htm 9954560 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details) Sheet http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails VALUATION AND QUALIFYING ACCOUNTS (Details) Details http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS 121 false false All Reports Book All Reports ew-20231231.htm ew-20231231.xsd ew-20231231_cal.xml ew-20231231_def.xml ew-20231231_lab.xml ew-20231231_pre.xml ew-20231231_g1.jpg ew-20231231_g10.jpg ew-20231231_g11.jpg ew-20231231_g12.jpg ew-20231231_g13.jpg ew-20231231_g2.jpg ew-20231231_g3.jpg ew-20231231_g4.jpg ew-20231231_g5.jpg ew-20231231_g6.jpg ew-20231231_g7.jpg ew-20231231_g8.jpg ew-20231231_g9.jpg http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 156 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ew-20231231.htm": { "nsprefix": "ew", "nsuri": "http://www.edwards.com/20231231", "dts": { "inline": { "local": [ "ew-20231231.htm" ] }, "schema": { "local": [ "ew-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "ew-20231231_cal.xml" ] }, "definitionLink": { "local": [ "ew-20231231_def.xml" ] }, "labelLink": { "local": [ "ew-20231231_lab.xml" ] }, "presentationLink": { "local": [ "ew-20231231_pre.xml" ] } }, "keyStandard": 596, "keyCustom": 74, "axisStandard": 47, "axisCustom": 0, "memberStandard": 88, "memberCustom": 57, "hidden": { "total": 13, "http://fasb.org/us-gaap/2023": 8, "http://xbrl.sec.gov/dei/2023": 4, "http://xbrl.sec.gov/ecd/2023": 1 }, "contextCount": 532, "entityCount": 1, "segmentCount": 148, "elementCount": 1164, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1894, "http://xbrl.sec.gov/dei/2023": 38, "http://xbrl.sec.gov/ecd/2023": 10, "http://fasb.org/srt/2023": 1 }, "report": { "R1": { "role": "http://www.edwards.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.edwards.com/role/AuditInformation", "longName": "0000002 - Document - Audit Information", "shortName": "Audit Information", "isDefault": "false", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "dei:AuditorFirmId", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:AuditorFirmId", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:ShortTermInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R4": { "role": "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GrossProfit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R6": { "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R7": { "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R8": { "role": "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.edwards.com/role/DESCRIPTIONOFBUSINESS", "longName": "0000009 - Disclosure - DESCRIPTION OF BUSINESS", "shortName": "DESCRIPTION OF BUSINESS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "longName": "0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSE", "longName": "0000011 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE", "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTS", "longName": "0000012 - Disclosure - SPECIAL CHARGE AND SEPARATION COSTS", "shortName": "SPECIAL CHARGE AND SEPARATION COSTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS", "longName": "0000013 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.edwards.com/role/LEASES", "longName": "0000014 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.edwards.com/role/INVESTMENTS", "longName": "0000015 - Disclosure - INVESTMENTS", "shortName": "INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES", "longName": "0000016 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES", "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONS", "longName": "0000017 - Disclosure - BUSINESS COMBINATIONS", "shortName": "BUSINESS COMBINATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS", "longName": "0000018 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIES", "longName": "0000019 - Disclosure - DEBT AND CREDIT FACILITIES", "shortName": "DEBT AND CREDIT FACILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS", "longName": "0000020 - Disclosure - FAIR VALUE MEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES", "longName": "0000021 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANS", "longName": "0000022 - Disclosure - EMPLOYEE BENEFIT PLANS", "shortName": "EMPLOYEE BENEFIT PLANS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.edwards.com/role/COMMONSTOCK", "longName": "0000023 - Disclosure - COMMON STOCK", "shortName": "COMMON STOCK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS", "longName": "0000024 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.edwards.com/role/OTHERINCOMENET", "longName": "0000025 - Disclosure - OTHER INCOME, NET", "shortName": "OTHER INCOME, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.edwards.com/role/INCOMETAXES", "longName": "0000026 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.edwards.com/role/LEGALPROCEEDINGS", "longName": "0000027 - Disclosure - LEGAL PROCEEDINGS", "shortName": "LEGAL PROCEEDINGS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.edwards.com/role/SEGMENTINFORMATION", "longName": "0000028 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS", "longName": "0000029 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS", "shortName": "VALUATION AND QUALIFYING ACCOUNTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R30": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": null }, "R31": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "c-529", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-529", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "longName": "9954471 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "longName": "9954472 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables", "longName": "9954473 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.edwards.com/role/LEASESTables", "longName": "9954474 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:AssetsAndLiabilitiesOfLesseeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.edwards.com/role/INVESTMENTSTables", "longName": "9954475 - Disclosure - INVESTMENTS (Tables)", "shortName": "INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONSTables", "longName": "9954476 - Disclosure - BUSINESS COMBINATIONS (Tables)", "shortName": "BUSINESS COMBINATIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables", "longName": "9954477 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables", "longName": "9954478 - Disclosure - DEBT AND CREDIT FACILITIES (Tables)", "shortName": "DEBT AND CREDIT FACILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables", "longName": "9954479 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables", "longName": "9954480 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables", "longName": "9954481 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)", "shortName": "EMPLOYEE BENEFIT PLANS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.edwards.com/role/COMMONSTOCKTables", "longName": "9954482 - Disclosure - COMMON STOCK (Tables)", "shortName": "COMMON STOCK (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AcceleratedShareRepurchasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables", "longName": "9954483 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.edwards.com/role/OTHERINCOMENETTables", "longName": "9954484 - Disclosure - OTHER INCOME, NET (Tables)", "shortName": "OTHER INCOME, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.edwards.com/role/INCOMETAXESTables", "longName": "9954485 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONTables", "longName": "9954486 - Disclosure - SEGMENT INFORMATION (Tables)", "shortName": "SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails", "longName": "9954487 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails", "longName": "9954488 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Shipping and Handling Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-59", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R50": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails", "longName": "9954489 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-62", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "us-gaap:InvestmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-62", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "us-gaap:InvestmentPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "longName": "9954490 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-63", "name": "ew:AccountsReceivablePaymentTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-63", "name": "ew:AccountsReceivablePaymentTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesDetails", "longName": "9954491 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "ew:InventoryWriteDownExpirationPeriodTrigger", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:InventoryWriteDownExpirationPeriodTrigger", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:InventoryPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails", "longName": "9954492 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property, Plant, and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails", "longName": "9954493 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-96", "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails", "longName": "9954494 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails", "longName": "9954495 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share - Narrative (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-74", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-74", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails", "longName": "9954496 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Stock-Based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails", "longName": "9954497 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation Narrative (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based Compensation Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-86", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-86", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails", "longName": "9954498 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:DerivativesPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:DerivativesPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails", "longName": "9954499 - Disclosure - INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE (Details)", "shortName": "INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-1", "name": "ew:LitigationSettlementsAndLegalCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-87", "name": "ew:IntellectualPropertyAgreementTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R61": { "role": "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "longName": "9954500 - Disclosure - SPECIAL CHARGE AND SEPARATION COSTS (Details)", "shortName": "SPECIAL CHARGE AND SEPARATION COSTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-92", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-92", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails", "longName": "9954501 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Schedule of Components of Selected Captions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ew:ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails", "longName": "9954502 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Supplemental Cash Flow Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails", "longName": "9954503 - Disclosure - OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "shortName": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS - Cash, Cash Equivalents, and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R65": { "role": "http://www.edwards.com/role/LEASESNarrativeDetails", "longName": "9954504 - Disclosure - LEASES - Narrative (Details)", "shortName": "LEASES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails", "longName": "9954505 - Disclosure - LEASES - Assets and Liabilities of Operating Leases (Details)", "shortName": "LEASES - Assets and Liabilities of Operating Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": null }, "R67": { "role": "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails", "longName": "9954506 - Disclosure - LEASES - Maturities Of Operating Lease Liabilities (Details)", "shortName": "LEASES - Maturities Of Operating Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "longName": "9954507 - Disclosure - INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "shortName": "INVESTMENTS - Schedule of Investments in Debt Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:HeldToMaturitySecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R69": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "longName": "9954508 - Disclosure - INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "shortName": "INVESTMENTS - Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails", "longName": "9954509 - Disclosure - INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)", "shortName": "INVESTMENTS - Schedule of Unrealized Losses on Debt Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails", "longName": "9954510 - Disclosure - INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "shortName": "INVESTMENTS - Schedule of Investments in Unconsolidated Affiliates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R72": { "role": "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "longName": "9954511 - Disclosure - INVESTMENTS - Narrative (Details)", "shortName": "INVESTMENTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:EquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R73": { "role": "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "longName": "9954512 - Disclosure - INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)", "shortName": "INVESTMENTS IN VARIABLE INTEREST ENTITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherPaymentsToAcquireBusinesses", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-121", "name": "ew:NumberOfPromissoryNotesEntered", "unitRef": "note", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R74": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "longName": "9954513 - Disclosure - BUSINESS COMBINATIONS - Narrative (Details)", "shortName": "BUSINESS COMBINATIONS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-129", "name": "ew:BusinessCombinationInprocessResearchandDevelopmentExpectedCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R75": { "role": "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "longName": "9954514 - Disclosure - BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "shortName": "BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-126", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R76": { "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "longName": "9954515 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Changes in the Carrying Amount of Goodwill, by Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R77": { "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "longName": "9954516 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails", "longName": "9954517 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails", "longName": "9954518 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "longName": "9954519 - Disclosure - DEBT AND CREDIT FACILITIES - Narrative (Details)", "shortName": "DEBT AND CREDIT FACILITIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:LongtermDebtWeightedAverageInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails", "longName": "9954520 - Disclosure - DEBT AND CREDIT FACILITIES - Schedule of the Notes (Details)", "shortName": "DEBT AND CREDIT FACILITIES - Schedule of the Notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-160", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-160", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R82": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954521 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-175", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R83": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "longName": "9954522 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-213", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-213", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R84": { "role": "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails", "longName": "9954523 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration Obligation (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Changes in Fair Value of Contingent Consideration Obligation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-222", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-216", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R85": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "longName": "9954524 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Derivative Financial Instruments Used to Manage Currency Exchange Rate Risk and Interest Rate Risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c-229", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-229", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "longName": "9954525 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c-239", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-233", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R87": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "longName": "9954526 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Master-Netting Agreements and Rights of Offset, Derivative Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c-239", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-239", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R88": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "longName": "9954527 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c-255", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-255", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R89": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "longName": "9954528 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R90": { "role": "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "longName": "9954529 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-258", "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R91": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "longName": "9954530 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details)", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Information Regarding Defined Benefit Pension Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c-266", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-268", "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R92": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "longName": "9954531 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details)", "shortName": "EMPLOYEE BENEFIT PLANS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R93": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails", "longName": "9954532 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Net Periodic Benefit Cost (Details)", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Net Periodic Benefit Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c-268", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-268", "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R94": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails", "longName": "9954533 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details)", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c-270", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-270", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R95": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "longName": "9954534 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details)", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Target Weighted-Average Asset Allocations and Fair Value (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c-270", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-270", "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R96": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "longName": "9954535 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details)", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3 (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c-266", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ew:DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-354", "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R97": { "role": "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails", "longName": "9954536 - Disclosure - EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)", "shortName": "EMPLOYEE BENEFIT PLANS - Schedule of Benefit Payments Which Reflect Expected Future Service (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R98": { "role": "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails", "longName": "9954537 - Disclosure - COMMON STOCK - Treasury Stock (Details)", "shortName": "COMMON STOCK - Treasury Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-359", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R99": { "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails", "longName": "9954538 - Disclosure - COMMON STOCK - Schedule of Accelerated Share Repurchases (Details)", "shortName": "COMMON STOCK - Schedule of Accelerated Share Repurchases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c-361", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-361", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R100": { "role": "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "longName": "9954539 - Disclosure - COMMON STOCK - Employee and Director Stock Plans (Details)", "shortName": "COMMON STOCK - Employee and Director Stock Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "c-386", "name": "ew:EstimatedAnnualForfeitureRatePercent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-386", "name": "ew:EstimatedAnnualForfeitureRatePercent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R101": { "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "longName": "9954540 - Disclosure - COMMON STOCK - Schedule of Weighted-Average Assumptions (Details)", "shortName": "COMMON STOCK - Schedule of Weighted-Average Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "c-386", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-386", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R102": { "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "longName": "9954541 - Disclosure - COMMON STOCK - Schedule of Stock Option (Details)", "shortName": "COMMON STOCK - Schedule of Stock Option (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "c-395", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-395", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R103": { "role": "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "longName": "9954542 - Disclosure - COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details)", "shortName": "COMMON STOCK - Schedule of Restricted Stock Unit Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "c-397", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-397", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R104": { "role": "http://www.edwards.com/role/COMMONSTOCKNarrativeDetails", "longName": "9954543 - Disclosure - COMMON STOCK - Narrative (Details)", "shortName": "COMMON STOCK - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "c-4", "name": "ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "ew:ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R105": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "longName": "9954544 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-14", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R106": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails", "longName": "9954545 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Change in Unrealized Pension Costs (Details)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Change in Unrealized Pension Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "c-427", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-427", "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R107": { "role": "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "longName": "9954546 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS - Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherNonoperatingIncomeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-433", "name": "us-gaap:OtherNonoperatingIncomeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R108": { "role": "http://www.edwards.com/role/OTHERINCOMENETDetails", "longName": "9954547 - Disclosure - OTHER INCOME, NET (Details)", "shortName": "OTHER INCOME, NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:GainLossOnInvestmentsOtherIncomeExpenseNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R109": { "role": "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails", "longName": "9954548 - Disclosure - INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details)", "shortName": "INCOME TAXES - Schedule of Income Before Provisions for Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R110": { "role": "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails", "longName": "9954549 - Disclosure - INCOME TAXES - Schedule of Provision for Income Taxes (Details)", "shortName": "INCOME TAXES - Schedule of Provision for Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R111": { "role": "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails", "longName": "9954550 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)", "shortName": "INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R112": { "role": "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "longName": "9954551 - Disclosure - INCOME TAXES - Narrative (Details)", "shortName": "INCOME TAXES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "c-1", "name": "ew:IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R113": { "role": "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "longName": "9954552 - Disclosure - INCOME TAXES - Schedule of Net Operating Loss Carryforwards (Details)", "shortName": "INCOME TAXES - Schedule of Net Operating Loss Carryforwards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R114": { "role": "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails", "longName": "9954553 - Disclosure - INCOME TAXES - Schedule of Tax Credit Carryforwards (Details)", "shortName": "INCOME TAXES - Schedule of Tax Credit Carryforwards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:TaxCreditCarryforwardAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:TaxCreditCarryforwardValuationAllowance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R115": { "role": "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails", "longName": "9954554 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "shortName": "INCOME TAXES - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R116": { "role": "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails", "longName": "9954555 - Disclosure - INCOME TAXES - Schedule of Reconciliation of Uncertain Tax Positions (Details)", "shortName": "INCOME TAXES - Schedule of Reconciliation of Uncertain Tax Positions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R117": { "role": "http://www.edwards.com/role/LEGALPROCEEDINGSDetails", "longName": "9954556 - Disclosure - LEGAL PROCEEDINGS (Details)", "shortName": "LEGAL PROCEEDINGS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "c-1", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "unitRef": "lawsuit", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ew:LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "unitRef": "lawsuit", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true, "unique": true } }, "R118": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "longName": "9954557 - Disclosure - SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)", "shortName": "SEGMENT INFORMATION - Schedule of Information about Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-470", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R119": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails", "longName": "9954558 - Disclosure - SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)", "shortName": "SEGMENT INFORMATION - Schedule of Reconciliation of Segment Net Sales and Pre-Tax Income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-470", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R120": { "role": "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "longName": "9954559 - Disclosure - SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "shortName": "SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:NoncurrentAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } }, "R121": { "role": "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails", "longName": "9954560 - Disclosure - VALUATION AND QUALIFYING ACCOUNTS (Details)", "shortName": "VALUATION AND QUALIFYING ACCOUNTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "c-515", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-525", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ew-20231231.htm", "unique": true } } }, "tag": { "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AcceleratedShareRepurchasesDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesDateAxis", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated Share Repurchases, Date [Axis]", "label": "Accelerated Share Repurchases, Date [Axis]", "documentation": "Information by date of execution of accelerated share repurchases." } } }, "auth_ref": [ "r228" ] }, "us-gaap_AcceleratedShareRepurchasesDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesDateDomain", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated Share Repurchases, Date [Domain]", "label": "Accelerated Share Repurchases, Date [Domain]", "documentation": "Date upon which the accelerated share repurchase agreement was executed." } } }, "auth_ref": [ "r228" ] }, "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Final Settlement Average Price per Share (in dollars per share)", "label": "Accelerated Share Repurchases, Final Price Paid Per Share", "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time." } } }, "auth_ref": [ "r228" ] }, "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial delivery, price per Share (in dollars per share)", "label": "Accelerated Share Repurchases, Initial Price Paid Per Share", "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement." } } }, "auth_ref": [ "r228" ] }, "us-gaap_AcceleratedShareRepurchasesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesLineItems", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated Share Repurchase", "label": "Accelerated Share Repurchases [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AcceleratedShareRepurchasesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesTable", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated Share Repurchases [Table]", "label": "Accelerated Share Repurchases [Table]", "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program." } } }, "auth_ref": [ "r228" ] }, "us-gaap_AcceleratedShareRepurchasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesTextBlock", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accelerated Share Repurchases", "label": "Accelerated Share Repurchases [Table Text Block]", "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity." } } }, "auth_ref": [ "r228" ] }, "ew_AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AcceleratedShareRepurchasesValueOfSharesRepurchasedAsPercentageOfContractAmount", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of Shares as % of Contract Value", "label": "Accelerated Share Repurchases, Value Of Shares Repurchased As Percentage Of Contract Amount", "documentation": "Represents the value of the initial shares repurchased as a percentage of the contract amount under accelerated share repurchase agreement." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsNotesAndLoansReceivableLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r45", "r1177" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowances of $8.3 and $7.9, respectively", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r473", "r474" ] }, "ew_AccountsReceivablePaymentTerms": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccountsReceivablePaymentTerms", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, required payment terms (in days)", "label": "Accounts Receivable, Payment Terms", "documentation": "Accounts Receivable, Payment Terms" } } }, "auth_ref": [] }, "ew_AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccrualForEnvironmentalLossContingenciesThresholdAmountForDisclosure", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold of disclosing material environmental legal proceedings", "label": "Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure", "documentation": "Accrual for Environmental Loss Contingencies, Threshold Amount For Disclosure" } } }, "auth_ref": [] }, "ew_AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccrualForPropertyPayrollAndOtherTaxesOtherThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, payroll, and other taxes", "label": "Accrual for Property Payroll and Other Taxes Other than Income Taxes Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes, payroll taxes and other taxes, excluding income taxes payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "ew_AccruedAndOtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccruedAndOtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities (Note\u00a05)", "totalLabel": "Total accrued and other liabilities", "label": "Accrued And Other Liabilities, Current", "documentation": "" } } }, "auth_ref": [] }, "ew_AccruedAndOtherLiabilitiesCurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccruedAndOtherLiabilitiesCurrentMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities", "label": "Accrued And Other Liabilities, Current [Member]", "documentation": "Accrued And Other Liabilities, Current" } } }, "auth_ref": [] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes payable", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r178", "r258" ] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities", "label": "Accrued Liabilities and Other Liabilities [Abstract]" } } }, "auth_ref": [] }, "ew_AccruedLitigationAndInsuranceReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccruedLitigationAndInsuranceReserves", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal and insurance (Notes 3 and\u00a019)", "label": "Accrued Litigation And Insurance Reserves", "documentation": "Accrued Litigation And Insurance Reserves" } } }, "auth_ref": [] }, "us-gaap_AccruedMarketingCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedMarketingCostsCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued marketing expenses", "label": "Accrued Marketing Costs, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued professional services", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r48" ] }, "ew_AccruedRebates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccruedRebates", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued rebates", "label": "Accrued Rebates", "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with sales rebates." } } }, "auth_ref": [] }, "ew_AccruedRelocationCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AccruedRelocationCostsCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued relocation costs", "label": "Accrued Relocation Costs, Current", "documentation": "Accrued Relocation Costs, Current" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Pension (Costs) Credits", "netLabel": "Unrealized pension costs, net", "verboseLabel": "Amortization of pension adjustments", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r8", "r25", "r59", "r1300", "r1301", "r1302" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net prior service cost arising during period", "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r10", "r25", "r59", "r372", "r373", "r1300" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net actuarial gain (loss) arising during period", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r7", "r25", "r59", "r372", "r373", "r1300" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r96", "r335", "r968" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized (Loss) Gain on Hedges", "verboseLabel": "(Loss) gain on hedges", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r362", "r372", "r373", "r824", "r1138", "r1300" ] }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Gain (Loss) on Available-for-sale Investments", "verboseLabel": "Gain (loss) on available-for-sale investments", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r358", "r359", "r360", "r362", "r372", "r373", "r1300" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)." } } }, "auth_ref": [ "r9", "r59", "r1418" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated Other Comprehensive Loss", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r371", "r372", "r869", "r871", "r872", "r873", "r874", "r875" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss (Note 16)", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r58", "r59", "r193", "r344", "r963", "r1005", "r1006" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r371", "r372", "r869", "r871", "r872", "r873", "r874", "r875" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "verboseLabel": "Total Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r25", "r59", "r836", "r839", "r890", "r1001", "r1002", "r1300", "r1301", "r1302", "r1317", "r1318", "r1319" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation Adjustments", "verboseLabel": "Foreign currency translation adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r6", "r25", "r59", "r372", "r373", "r871", "r872", "r873", "r874", "r875", "r1300" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r1231" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r184" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r770", "r771", "r772", "r1017", "r1317", "r1318", "r1319", "r1477", "r1506" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r1237" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r1237" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r1237" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r1237" ] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r116", "r117", "r739" ] }, "ew_AggregateIntrinsicValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AggregateIntrinsicValueAbstract", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value", "label": "Aggregate Intrinsic Value [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1201", "r1213", "r1223", "r1249" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r1204", "r1216", "r1226", "r1252" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r1237" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r1244" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r1208", "r1217", "r1227", "r1244", "r1253", "r1257", "r1265" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r1263" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r768", "r773" ] }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total stock-based compensation expense, net of tax", "label": "Share-Based Payment Arrangement, Expense, after Tax", "documentation": "Amount, after tax, of expense for award under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AllowanceForCreditLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForCreditLossMember", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit losses", "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]", "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r1312", "r1313", "r1314", "r1315", "r1316" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r345", "r477", "r522" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense related to other intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r16", "r88", "r93" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r436" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r76" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r76" ] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset-backed securities", "label": "Asset-Backed Securities [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r1158", "r1326", "r1330", "r1334" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment charges (Note 4)", "label": "Asset Impairment Charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r16", "r94" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r256", "r339", "r392", "r443", "r458", "r464", "r519", "r577", "r578", "r580", "r581", "r582", "r584", "r586", "r588", "r589", "r820", "r825", "r862", "r959", "r1051", "r1177", "r1190", "r1369", "r1370", "r1485" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "ew_AssetsAndLiabilitiesOfLesseeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AssetsAndLiabilitiesOfLesseeTableTextBlock", "presentation": [ "http://www.edwards.com/role/LEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets And Liabilities of Lessee", "label": "Assets And Liabilities Of Lessee [Table Text Block]", "documentation": "Assets And Liabilities Of Lessee [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r329", "r350", "r392", "r519", "r577", "r578", "r580", "r581", "r582", "r584", "r586", "r588", "r589", "r820", "r825", "r862", "r1177", "r1369", "r1370", "r1485" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r168" ] }, "us-gaap_AssetsFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosureAbstract", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "ew_AuditInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "AuditInformationAbstract", "lang": { "en-us": { "role": { "label": "Audit Information [Abstract]", "documentation": "Audit Information [Abstract]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://www.edwards.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r1195", "r1196", "r1209" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://www.edwards.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r1195", "r1196", "r1209" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://www.edwards.com/role/AuditInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r1195", "r1196", "r1209" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gains", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r486" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Unrealized Losses", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r487" ] }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r483", "r529", "r958" ] }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-sale", "label": "Debt Securities, Available-for-Sale [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available-for-Sale", "label": "Available-for-Sale Securities, Debt Maturities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasisRollingMaturityAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1327" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1327" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 10 years", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after rolling tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1329" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 10 years", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after rolling tenth fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1329" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1328" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [ "r1328" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r1325", "r1326" ] }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r489", "r956", "r1325" ] }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AvailableForSaleSecuritiesDebtSecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 2.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0, "order": 3.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "totalLabel": "Fair Value", "verboseLabel": "Available-for-sale investments:", "label": "Debt Securities, Available-for-Sale", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r484", "r529", "r947", "r1323" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date [Axis]", "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1463", "r1464", "r1465", "r1466", "r1467" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date [Domain]", "label": "Award Date [Domain]", "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1463", "r1464", "r1465", "r1466", "r1467" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r1260" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r1261" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r1256" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r1256" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r1256" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r1256" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r1256" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r1256" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r1259" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r1258" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r1257" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r1257" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r152", "r157" ] }, "us-gaap_BankTimeDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BankTimeDepositsMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank time deposits", "label": "Bank Time Deposits [Member]", "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest." } } }, "auth_ref": [ "r268" ] }, "us-gaap_BuildingAndBuildingImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingAndBuildingImprovementsMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings and improvements", "label": "Building and Building Improvements [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing." } } }, "auth_ref": [] }, "ew_BuildingsAndLeaseholdImprovementsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "BuildingsAndLeaseholdImprovementsGross", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Buildings and leasehold improvements", "label": "Buildings and Leasehold Improvements Gross", "documentation": "Gross amount, as of the balance sheet date, of long-lived, depreciable assets, that includes building structures and leasehold improvements." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r815", "r1162", "r1165" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r124", "r126", "r815", "r1162", "r1165" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r815" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of interest acquired", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r125" ] }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest, gross", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date." } } }, "auth_ref": [ "r129" ] }, "ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueNet", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Noncontrolling interest", "label": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net", "documentation": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Net" } } }, "auth_ref": [] }, "ew_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValueOptionAdjustment", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment for option to acquire company", "label": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment", "documentation": "Business Combination, Acquisition Of Less Than 100 Percent, Noncontrolling Interest, Fair Value, Option Adjustment" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "ew_BusinessCombinationAssetsAcquiredMeasurementInput": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "BusinessCombinationAssetsAcquiredMeasurementInput", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of discount rate", "label": "Business Combination, Assets Acquired, Measurement Input", "documentation": "Business Combination, Assets Acquired, Measurement Input" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 5.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of contingent consideration liabilities (Note 12)", "verboseLabel": "Change in fair value of contingent consideration liabilities (Note 12)", "negatedTerseLabel": "Change in fair value of contingent consideration liabilities", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement." } } }, "auth_ref": [ "r818", "r1305" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration, liability", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r1", "r131", "r817" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Contingent consideration liability measurement input", "label": "Business Combination, Contingent Consideration, Liability, Measurement Input", "documentation": "Value of input used to measure contingent consideration liability from business combination." } } }, "auth_ref": [ "r853" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liabilities (Note 12)", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r131" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "BUSINESS COMBINATIONS", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r244", "r816" ] }, "ew_BusinessCombinationInprocessResearchandDevelopmentExpectedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "BusinessCombinationInprocessResearchandDevelopmentExpectedCosts", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional research and development expenditures to be incurred prior to product introduction", "label": "Business Combination, In-process Research and Development, Expected Costs", "documentation": "Business Combination, In-process Research and Development, Expected Costs" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid directly to acquired company, netted against goodwill", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred", "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete." } } }, "auth_ref": [ "r130" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r128" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Liabilities assumed", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r128" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred tax liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r128" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-process research and development", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r127", "r128" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total purchase price", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree." } } }, "auth_ref": [ "r128" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Fair value of net assets acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r128" ] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions", "label": "Business Combinations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r123" ] }, "stpr_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CA", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "California", "label": "CALIFORNIA" } } }, "auth_ref": [] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Capital expenditures accruals", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r73", "r74", "r75" ] }, "ew_CapitalLossCarryforwardAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CapitalLossCarryforwardAbstract", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital Loss Carryforward [Abstract]", "label": "Capital Loss Carryforward [Abstract]", "documentation": "Capital Loss Carryforward [Abstract]" } } }, "auth_ref": [] }, "ew_CapitalLossCarryforwardPeriodEnds2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CapitalLossCarryforwardPeriodEnds2024Member", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carryforward Period Ends 2022", "label": "Capital Loss Carryforward Period Ends 2024 [Member]", "documentation": "Capital Loss Carryforward Period Ends 2022 [Member]" } } }, "auth_ref": [] }, "ew_CapitalLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CapitalLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carryforward Amount", "label": "Capital Loss Carryforwards", "documentation": "Capital Loss Carryforwards" } } }, "auth_ref": [] }, "ew_CapitalLossCarryforwardsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CapitalLossCarryforwardsValuationAllowance", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails": { "parentTag": "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Valuation Allowance", "label": "Capital Loss Carryforwards, Valuation Allowance", "documentation": "Capital Loss Carryforwards, Valuation Allowance" } } }, "auth_ref": [] }, "us-gaap_CapitalizedComputerSoftwareGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedComputerSoftwareGross", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software", "label": "Capitalized Computer Software, Gross", "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software." } } }, "auth_ref": [ "r1512" ] }, "ew_CardiAQValveTechnologiesInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CardiAQValveTechnologiesInc.Member", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CardiAQ", "label": "CardiAQ Valve Technologies, Inc. [Member]", "documentation": "CardiAQ Valve Technologies, Inc. [Member]" } } }, "auth_ref": [] }, "ew_CarryforwardPeriodEnds20332037Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CarryforwardPeriodEnds20332037Member", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carryforward Period Ends 2033-2037", "label": "Carryforward Period Ends 2033-2037 [Member]", "documentation": "Carryforward Period Ends 2033-2037 [Member]" } } }, "auth_ref": [] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: cash acquired", "label": "Cash Acquired from Acquisition", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r62" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r70", "r332", "r1126" ] }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsFairValueDisclosure", "crdr": "debit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r71" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year (Note 5)", "totalLabel": "Total cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r70", "r210", "r388" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r210" ] }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedge loss to be reclassified", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months." } } }, "auth_ref": [ "r167" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedges", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r149" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-cash investing and financing transactions:", "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives designated as hedging instruments", "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments", "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement." } } }, "auth_ref": [ "r251" ] }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedged items", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement." } } }, "auth_ref": [ "r251" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r1235" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfTreasuryStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfTreasuryStockTable", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Treasury Stock [Table]", "label": "Class of Treasury Stock [Table]", "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r100", "r101", "r102", "r103" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1236" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r1236" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Notes\u00a06, 11, and 19)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r53", "r174", "r960", "r1037" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGS" ], "lang": { "en-us": { "role": { "terseLabel": "LEGAL PROCEEDINGS", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r221", "r569", "r570", "r1110", "r1359" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r1180", "r1181", "r1182", "r1184", "r1185", "r1186", "r1187", "r1317", "r1318", "r1477", "r1503", "r1506" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r183" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r183", "r1038" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r183" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Common stock, beginning balance (in shares)", "periodEndLabel": "Common stock, ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r26", "r183", "r1038", "r1057", "r1506", "r1507" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock, $1.00 par value, 1,050.0 shares authorized, 650.5 and 646.3 shares issued, and 601.1 and 608.3 shares outstanding, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r183", "r962", "r1177" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r1241" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r1240" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r1242" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r1239" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Retirement Benefits [Abstract]", "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based Compensation", "label": "Compensation Related Costs, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r111" ] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Components of Deferred Tax Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Components of Deferred Tax Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to Edwards Lifesciences Corporation", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r60", "r367", "r369", "r378", "r951", "r978" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive loss attributable to noncontrolling interest", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r13", "r134", "r143", "r367", "r369", "r377", "r950", "r977" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r143", "r248", "r367", "r369", "r376", "r949", "r976" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r192", "r375", "r948", "r974" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r305", "r398", "r820", "r821", "r825", "r826", "r894", "r1120", "r1286", "r1289", "r1290", "r1368", "r1371", "r1372" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r305", "r398", "r820", "r821", "r825", "r826", "r894", "r1120", "r1286", "r1289", "r1290", "r1368", "r1371", "r1372" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r398", "r445", "r456", "r457", "r458", "r459", "r460", "r462", "r466", "r577", "r578", "r579", "r580", "r582", "r583", "r585", "r587", "r588", "r1287", "r1288", "r1369", "r1370" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r398", "r445", "r456", "r457", "r458", "r459", "r460", "r462", "r466", "r577", "r578", "r579", "r580", "r582", "r583", "r585", "r587", "r588", "r1287", "r1288", "r1369", "r1370" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r135", "r1139" ] }, "us-gaap_ConstructionInProgressGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConstructionInProgressGross", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in progress", "label": "Construction in Progress, Gross", "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [ "r220" ] }, "ew_ContingentConsiderationLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ContingentConsiderationLiabilityMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Consideration", "label": "Contingent Consideration Liability [Member]", "documentation": "Contingent Consideration Liability" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r636", "r637", "r648" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized that was previously deferred", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r649" ] }, "ew_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized that was previously deferred excluding opening balance", "label": "Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance", "documentation": "Contract With Customer, Liability, Revenue Recognized Excluding Opening Balance" } } }, "auth_ref": [] }, "ew_ConvertiblePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ConvertiblePromissoryNoteMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Promissory Note", "label": "Convertible Promissory Note [Member]", "documentation": "Convertible Promissory Note" } } }, "auth_ref": [] }, "us-gaap_CorporateDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateDebtSecuritiesMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate debt securities", "label": "Corporate Debt Securities [Member]", "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment." } } }, "auth_ref": [ "r1158", "r1160", "r1502" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Corporate items", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r37", "r457", "r458", "r459", "r460", "r466", "r1322" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "negatedLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r200", "r931" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of sales", "verboseLabel": "Cost of sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Corporate items", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r197" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r324", "r395", "r396", "r594", "r623", "r893", "r1134", "r1137" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "ew_CreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CreditAgreementMember", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Agreement", "label": "Credit Agreement [Member]", "documentation": "Credit Agreement" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "ew_CriticalCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "CriticalCareMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Critical Care", "label": "Critical Care [Member]", "documentation": "This element represents the critical care product line." } } }, "auth_ref": [] }, "us-gaap_CurrencySwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrencySwapMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cross currency swap contracts", "verboseLabel": "Cross currency swap contracts", "label": "Currency Swap [Member]", "documentation": "Swap involving the exchange of principal and interest in one currency for another currency." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States:", "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1277", "r1310", "r1473" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outside of the United States, including Puerto Rico", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r1277", "r1310" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Current income tax expense", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r243", "r800", "r806", "r1310" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current", "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and local", "label": "Current State and Local Tax Expense (Benefit)", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1277", "r1310", "r1473" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIES" ], "lang": { "en-us": { "role": { "terseLabel": "DEBT AND CREDIT FACILITIES", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r223", "r390", "r590", "r596", "r597", "r598", "r599", "r600", "r601", "r606", "r613", "r614", "r616" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r44", "r177", "r178", "r257", "r260", "r398", "r591", "r592", "r593", "r594", "r595", "r597", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r610", "r611", "r612", "r878", "r1150", "r1151", "r1152", "r1153", "r1154", "r1308" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate (as a percent)", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r44", "r260", "r617" ] }, "ew_DebtInstrumentCreditSpreadAdjustment": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DebtInstrumentCreditSpreadAdjustment", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, credit spread adjustment", "label": "Debt Instrument, Credit Spread Adjustment", "documentation": "Debt Instrument, Credit Spread Adjustment" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed-rate unsecured senior notes", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r171", "r173", "r591", "r878", "r1151", "r1152" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of the notes, based on Level 2 inputs", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r604", "r861", "r1151", "r1152" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective Interest Rate", "label": "Debt Instrument, Interest Rate, Effective Percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r50", "r171", "r619", "r878" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r50", "r592" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r398", "r591", "r592", "r593", "r594", "r595", "r597", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r610", "r611", "r612", "r615", "r878", "r1150", "r1151", "r1152", "r1153", "r1154", "r1308" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r51", "r398", "r591", "r592", "r593", "r594", "r595", "r597", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r610", "r611", "r612", "r878", "r1150", "r1151", "r1152", "r1153", "r1154", "r1308" ] }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPricePercentage", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Price equal to principal amount, plus accrued and unpaid interest (as a percent)", "label": "Debt Instrument, Redemption Price, Percentage", "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer." } } }, "auth_ref": [ "r36" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r51", "r98", "r99", "r170", "r171", "r173", "r175", "r225", "r226", "r398", "r591", "r592", "r593", "r594", "r595", "r597", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r610", "r611", "r612", "r615", "r878", "r1150", "r1151", "r1152", "r1153", "r1154", "r1308" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of the credit agreement (in years)", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Unamortized discount", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r170", "r173", "r1374" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, 12 months or greater", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r281", "r533", "r1147" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross unrealized losses, 12 months or greater", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r281", "r533" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, less than 12 months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r281", "r533", "r1147" ] }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross unrealized losses, less than 12 months", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r281", "r533" ] }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleTable", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Available-for-sale [Table]", "label": "Debt Securities, Available-for-Sale [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total fair value", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position", "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss." } } }, "auth_ref": [ "r279", "r531", "r1147" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total gross unrealized losses", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r280", "r532" ] }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Gross Unrealized Losses and Fair Values for Investments in Unrealized Loss Position", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset." } } }, "auth_ref": [ "r278", "r1147", "r1342" ] }, "ew_December2023StockRepurchaseProgramSharesSoldInDecember2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "December2023StockRepurchaseProgramSharesSoldInDecember2023Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "December 2023 Stock Repurchase Program, Shares Sold In December 2023", "label": "December 2023 Stock Repurchase Program, Shares Sold In December 2023 [Member]", "documentation": "December 2023 Stock Repurchase Program, Shares Sold In December 2023" } } }, "auth_ref": [] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r118" ] }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount accrued under nonqualified plans", "label": "Deferred Compensation Liability, Current and Noncurrent", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationPlanAssets", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments held for deferred compensation plans", "label": "Deferred Compensation Plan Assets", "documentation": "Carrying amount as of the balance sheet date of assets held under deferred compensation agreements." } } }, "auth_ref": [ "r1295" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1310", "r1472", "r1473" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States:", "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized debt issuance costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r172", "r1374" ] }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNoncurrentGross", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance costs", "label": "Debt Issuance Cost, Gross, Noncurrent", "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r172" ] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outside of the United States, including Puerto Rico", "label": "Deferred Foreign Income Tax Expense (Benefit)", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r243", "r1310", "r1472" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r781", "r782" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred income tax benefit", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r16", "r243", "r296", "r805", "r806", "r1310" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred", "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r180", "r181", "r259", "r794" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and local", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1310", "r1472", "r1473" ] }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails": { "parentTag": "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Benefit Amount", "label": "Deferred Tax Assets, Capital Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards." } } }, "auth_ref": [ "r122", "r1471" ] }, "ew_DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DeferredTaxAssetsCapitalLossCarryforwardsNetOfValuationAllowance", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Tax Benefit", "label": "Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance", "documentation": "Deferred Tax Assets, Capital Loss Carryforwards, Net Of Valuation Allowance" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r795" ] }, "us-gaap_DeferredTaxAssetsHedgingTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsHedgingTransactions", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow and net investment hedges", "label": "Deferred Tax Assets, Hedging Transactions", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from hedging transactions." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized research and development expenses", "label": "Deferred Tax Assets, in Process Research and Development", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxAssetsInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInventory", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Deferred Tax Assets, Inventory", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory." } } }, "auth_ref": [ "r122", "r1471" ] }, "ew_DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DeferredTaxAssetsInvestmentsInUnconsolidatedAffiliates", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Deferred Tax Assets, Investments in Unconsolidated Affiliates", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments. Includes equity method investments; excludes investments in subsidiaries." } } }, "auth_ref": [] }, "ew_DeferredTaxAssetsLeaseLiabilityObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DeferredTaxAssetsLeaseLiabilityObligations", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liability obligations", "label": "Deferred Tax Assets, Lease Liability Obligations", "documentation": "Deferred Tax Assets, Lease Liability Obligations" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1470" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails": { "parentTag": "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Benefit Amount", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r122", "r1471" ] }, "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfReduction", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net operating loss carryforwards", "label": "Deferred Tax Assets Operating Loss Carryforwards Net of Reduction", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards, net of the reduction for the benefit related to windfall to be recorded to additional paid in capital when realized as a reduction to income taxes payable." } } }, "auth_ref": [] }, "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Tax Benefit", "label": "Deferred Tax Assets Operating Loss Carryforwards Net of Valuation Allowance", "documentation": "Represents the amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxAssetsStateTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsStateTaxes", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "State income taxes", "label": "Deferred Tax Assets, State Taxes", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net tax credit carryforwards", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r121", "r122", "r1471" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and benefits", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued liabilities", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefits from uncertain tax positions", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "terseLabel": "Valuation allowance that reduces certain deferred tax assets", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r796" ] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other intangible assets", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesOther", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Deferred Tax Liabilities, Other", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Property, plant, and equipment", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r122", "r1471" ] }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred tax on foreign earnings", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences." } } }, "auth_ref": [ "r1471" ] }, "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated net tax liability on permanently reinvested earnings", "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries", "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries." } } }, "auth_ref": [ "r814" ] }, "ew_DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DeferredTaxLiabilityOperatingLeaseRightOfUseAmortization", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Right-of-use assets", "label": "Deferred Tax Liability, Operating Lease Right Of Use Amortization", "documentation": "Deferred Tax Liability, Operating Lease Right Of Use Amortization" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan." } } }, "auth_ref": [ "r104", "r105", "r179", "r230" ] }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated benefit obligation", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level." } } }, "auth_ref": [ "r683" ] }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss, net of tax:", "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]" } } }, "auth_ref": [] }, "ew_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTaxExpenseBenefitNetofTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTaxExpenseBenefitNetofTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred income tax benefit (expense)", "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax", "documentation": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax Expense (Benefit), Net of Tax" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net actuarial (loss) gain", "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax", "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit." } } }, "auth_ref": [ "r59", "r695" ] }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net prior service credit", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax", "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit)." } } }, "auth_ref": [ "r59", "r695" ] }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Actual return on plan assets", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses." } } }, "auth_ref": [ "r665", "r1160" ] }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Relating to assets still held at December\u00a031, 2023", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held", "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held." } } }, "auth_ref": [ "r679", "r1160" ] }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanActuarialGainLoss", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Actuarial loss (gain)", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan." } } }, "auth_ref": [ "r658" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization of actuarial loss", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r652", "r690", "r716", "r1160", "r1161" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of prior service credit", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r652", "r691", "r717", "r1160", "r1161" ] }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net amounts recognized on the consolidated balance sheet:", "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Discount rate (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan." } } }, "auth_ref": [ "r697" ] }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPensionIncrease": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPensionIncrease", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Pension increase (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Pension Increase", "documentation": "This element represents the percentage of increase in pension." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Rate of compensation increase (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan." } } }, "auth_ref": [ "r698" ] }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationSocialSecuritiesIncrease": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationSocialSecuritiesIncrease", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Social securities increase (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Social Securities Increase", "documentation": "This element represents the percentage of increase in social security." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationWeightedAverageInterestCreditingRate", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash balance interest crediting rate (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate", "documentation": "Weighted-average interest crediting rate used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate." } } }, "auth_ref": [ "r700" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Discount rate (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan." } } }, "auth_ref": [ "r697" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected return on plan assets (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets", "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan." } } }, "auth_ref": [ "r699", "r721" ] }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionIncrease": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionIncrease", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Pension increase (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Pension Increase", "documentation": "This element represents the percentage of increase in pension." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Rate of compensation increase (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan." } } }, "auth_ref": [ "r698" ] }, "ew_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostSocialSecuritiesIncrease": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostSocialSecuritiesIncrease", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Social securities increase (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Social Securities Increase", "documentation": "This element represents the percentage of increase in social security." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash balance interest crediting rate (as a percent)", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate", "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate." } } }, "auth_ref": [ "r700" ] }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanBenefitObligation", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of year", "periodEndLabel": "End of year", "negatedLabel": "Projected benefit obligation", "label": "Defined Benefit Plan, Benefit Obligation", "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r653" ] }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Benefits paid", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services." } } }, "auth_ref": [ "r660", "r724" ] }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Participant contributions", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation." } } }, "auth_ref": [ "r657" ] }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "documentation": "Information by defined benefit plan asset investment." } } }, "auth_ref": [ "r674", "r675", "r677", "r678", "r679", "r680", "r681", "r682", "r702", "r1158", "r1159", "r1160" ] }, "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]", "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested." } } }, "auth_ref": [ "r1158" ] }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in projected benefit obligation:", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value of plan assets:", "verboseLabel": "Insurance Contracts", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ew_DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedBenefitPlanChangeinBenefitObligationPlanAssetsNetAmountRecognizedonBalanceSheetTableTextBlock", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Information Regarding Defined Benefit Pension Plans", "label": "Defined Benefit Plan, Change in Benefit Obligation Plan Assets, Net Amount Recognized on Balance Sheet [Table Text Block]", "documentation": "This element represents the changes in benefit obligations, plan assets and the net amount recognized in the balance sheet for defined benefit plans." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employer contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r667", "r677", "r720", "r1158", "r1159", "r1160", "r1161" ] }, "us-gaap_DefinedBenefitPlanDebtSecurityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDebtSecurityMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt securities", "label": "Defined Benefit Plan, Debt Security [Member]", "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested." } } }, "auth_ref": [ "r1400" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEquitySecuritiesMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Defined Benefit Plan, Equity Securities [Member]", "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant." } } }, "auth_ref": [ "r1158", "r1160" ] }, "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International equities", "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]", "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant." } } }, "auth_ref": [ "r1158", "r1159", "r1160" ] }, "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanEquitySecuritiesUsMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States equities", "label": "Defined Benefit Plan, Equity Securities, US [Member]", "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant." } } }, "auth_ref": [ "r1158", "r1159", "r1160" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2029-2033", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year." } } }, "auth_ref": [ "r684" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year." } } }, "auth_ref": [ "r684" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year." } } }, "auth_ref": [ "r684" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year." } } }, "auth_ref": [ "r684" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year." } } }, "auth_ref": [ "r684" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofBenefitPaymentsWhichReflectExpectedFutureServiceDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year." } } }, "auth_ref": [ "r684" ] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected employer contributions", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year", "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year." } } }, "auth_ref": [ "r685", "r1161" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r652", "r689", "r715", "r1160", "r1161" ] }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of year", "periodEndLabel": "End of year", "terseLabel": "Plan assets at fair value", "label": "Defined Benefit Plan, Plan Assets, Amount", "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee." } } }, "auth_ref": [ "r664", "r675", "r677", "r678", "r1158", "r1159", "r1160" ] }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Currency exchange rate changes and other", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan." } } }, "auth_ref": [ "r659" ] }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFundedStatusOfPlan", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Underfunded status", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status." } } }, "auth_ref": [ "r651", "r673", "r1160" ] }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFundedStatusOfPlanAbstract", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Funded Status", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "verboseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r652", "r656", "r688", "r714", "r1160", "r1161" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net periodic pension benefit cost", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r686", "r712", "r1160", "r1161" ] }, "us-gaap_DefinedBenefitPlanPlanAmendments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAmendments", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Plan amendment", "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment", "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan." } } }, "auth_ref": [ "r661" ] }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Benefits paid", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services." } } }, "auth_ref": [ "r669", "r1438" ] }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Participant contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets." } } }, "auth_ref": [ "r668" ] }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency exchange rate changes and other", "terseLabel": "Currency exchange rate impact", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan." } } }, "auth_ref": [ "r666" ] }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Target asset allocations (as a percent)", "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage", "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan." } } }, "auth_ref": [ "r674", "r1160" ] }, "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases, sales and settlements", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement", "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment." } } }, "auth_ref": [ "r680", "r1160" ] }, "us-gaap_DefinedBenefitPlanRealEstateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanRealEstateMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate", "label": "Defined Benefit Plan, Real Estate [Member]", "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested." } } }, "auth_ref": [ "r1158", "r1160" ] }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1", "crdr": "credit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Settlements and curtailment gain", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment." } } }, "auth_ref": [ "r1377", "r1416", "r1435" ] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "verboseLabel": "Service cost, net", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r654", "r687", "r713", "r1160", "r1161" ] }, "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanSettlementsBenefitObligation", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Settlements and curtailment gain", "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement", "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement." } } }, "auth_ref": [ "r655" ] }, "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanSettlementsPlanAssets", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Settlements", "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement", "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract." } } }, "auth_ref": [ "r672" ] }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average assumptions used to determine the benefit obligations", "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average assumptions used to determine the net periodic benefit cost", "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Matching contributions relating to entity's employees", "label": "Defined Contribution Plan, Cost", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r725" ] }, "us-gaap_DefinedContributionPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanDisclosureLineItems", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Contribution Plans", "label": "Defined Contribution Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r725" ] }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentFirstLevel": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedContributionPlanEmployerMatchingContributionPercentFirstLevel", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dollar-for-dollar match of employee's annual eligible compensation (as a percent)", "label": "Defined Contribution Plan Employer Matching Contribution Percent, First Level", "documentation": "Represents the percentage of the first level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan." } } }, "auth_ref": [] }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchFirstLevel": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchFirstLevel", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company match, first level (as a percent)", "label": "Defined Contribution Plan, Employer Matching Contribution Percent of Match First Level", "documentation": "Percentage employer matches for the first level of the employee's percentage contribution matched." } } }, "auth_ref": [] }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentOfMatchSecondLevel": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatchSecondLevel", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company match, second level (as a percent)", "label": "Defined Contribution Plan, Employer Matching Contribution Percent of Match, Second Level", "documentation": "Percentage employer matches for the second level of the employee's percentage contribution matched." } } }, "auth_ref": [] }, "ew_DefinedContributionPlanEmployerMatchingContributionPercentSecondLevel": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedContributionPlanEmployerMatchingContributionPercentSecondLevel", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company match of eligible compensation after dollar-for-dollar basis (as a percent)", "label": "Defined Contribution Plan, Employer Matching Contribution Percent, Second Level", "documentation": "Represents the percentage of the second level of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum contributions of a participant's eligible compensation (as a percent)", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan." } } }, "auth_ref": [] }, "ew_DefinedContributionPlanProfitSharingContributionRate": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DefinedContributionPlanProfitSharingContributionRate", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Profit sharing contribution calculated on eligible earnings (as a percent)", "label": "Defined Contribution Plan Profit Sharing Contribution Rate", "documentation": "For a defined contribution plan, the percent of the participant's eligible compensation that the employer will contribute to the profit sharing plan." } } }, "auth_ref": [] }, "us-gaap_DefinedContributionPlanTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanTable", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Contribution Plan [Table]", "label": "Defined Contribution Plan [Table]", "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r725" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense for property, plant and equipment", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r16", "r95" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r16", "r448" ] }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetFairValueGrossLiability", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross Amounts Offset in the Consolidated Balance Sheet", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r32", "r43", "r155", "r1101", "r1102" ] }, "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Amount", "label": "Derivative Asset, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election", "documentation": "Fair value, after effects of master netting arrangements, deduction of assets not subject to a master netting arrangement and elected not to be offset, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against an obligation to return collateral." } } }, "auth_ref": [ "r35", "r41" ] }, "us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNotOffsetPolicyElectionDeduction", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Financial Instruments", "label": "Derivative Asset, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative asset." } } }, "auth_ref": [ "r34", "r41", "r292" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r827" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "verboseLabel": "Fair value of derivative assets", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r352", "r355", "r861", "r1019", "r1020", "r1021", "r1022", "r1023", "r1025", "r1026", "r1027", "r1028", "r1029", "r1044", "r1045", "r1094", "r1097", "r1100", "r1101", "r1103", "r1104", "r1137", "r1182", "r1504" ] }, "us-gaap_DerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Derivative Asset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeCollateralObligationToReturnCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeCollateralObligationToReturnCash", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash Collateral Received", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset", "documentation": "Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets." } } }, "auth_ref": [ "r41", "r164", "r353", "r1135" ] }, "us-gaap_DerivativeCollateralRightToReclaimCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeCollateralRightToReclaimCash", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash Collateral Received", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset", "documentation": "Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities." } } }, "auth_ref": [ "r41", "r164", "r353", "r1135" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r1027", "r1029", "r1043", "r1044", "r1045", "r1047", "r1048", "r1049", "r1050", "r1052", "r1053", "r1054", "r1055", "r1066", "r1067", "r1068", "r1069", "r1072", "r1073", "r1074", "r1075", "r1094", "r1095", "r1100", "r1103", "r1180", "r1182" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r38", "r155", "r191", "r351", "r1137" ] }, "ew_DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DerivativeFairValueOfDerivativeAssetGrossAmountsNotOffsetAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet", "label": "Derivative Fair Value of Derivative Asset Gross Amounts Not Offset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r38", "r155", "r191", "r351", "r1137" ] }, "ew_DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DerivativeFairValueOfDerivativeLiabilityGrossAmountsNotOffsetAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Amounts Not Offset in the Consolidated Balance Sheet", "label": "Derivative Fair Value of Derivative Liability Gross Amounts Not Offset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain or (Loss) Recognized in Income on Derivative", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r1476" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r153", "r156", "r158", "r160", "r1027", "r1029", "r1043", "r1044", "r1045", "r1047", "r1048", "r1049", "r1050", "r1052", "r1053", "r1054", "r1055", "r1066", "r1067", "r1068", "r1069", "r1072", "r1073", "r1074", "r1075", "r1094", "r1095", "r1100", "r1103", "r1137", "r1180", "r1182" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" ], "lang": { "en-us": { "role": { "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r250", "r833", "r842" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r27", "r153", "r158" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r27", "r153", "r158", "r160", "r165", "r166", "r832" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss)", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r832" ] }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain or (Loss) Recognized in\u00a0Income on Derivative (Amount Excluded from Effectiveness Testing)", "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred", "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings." } } }, "auth_ref": [ "r841" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "verboseLabel": "Fair value of derivative liabilities", "totalLabel": "Net Amounts Presented in the Consolidated Balance Sheet", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r352", "r355", "r861", "r1019", "r1020", "r1021", "r1022", "r1025", "r1026", "r1027", "r1028", "r1029", "r1052", "r1054", "r1055", "r1095", "r1096", "r1097", "r1100", "r1101", "r1103", "r1104", "r1137", "r1504" ] }, "us-gaap_DerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Derivative Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivatives", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r352" ] }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityFairValueGrossAsset", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gross Amounts Offset in the Consolidated Balance Sheet", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r32", "r43", "r155", "r1101", "r1102", "r1135" ] }, "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Amount", "label": "Derivative Liability, Fair Value, Offset Against Collateral, Net of Not Subject to Master Netting Arrangement, Policy Election", "documentation": "Fair value, after effects of master netting arrangements, deduction of liabilities not subject to a master netting arrangement and elected not to be offset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, offset against the right to receive collateral." } } }, "auth_ref": [ "r35", "r41" ] }, "us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNotOffsetPolicyElectionDeduction", "crdr": "debit", "calculation": { "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Financial Instruments", "label": "Derivative Liability, Subject to Master Netting Arrangement, Deduction of Financial Instrument Not Offset", "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and contract can be net settled by means outside contract or delivery of asset, subject to master netting arrangement or similar agreement and not elected or qualified to offset, deducted from derivative liability." } } }, "auth_ref": [ "r34", "r41", "r292" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r827" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r842" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional Amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1474", "r1475" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r27", "r144", "r145", "r147", "r151", "r154", "r158", "r161", "r163", "r166", "r842" ] }, "us-gaap_DerivativesFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesFairValueLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives designated as hedging instruments", "label": "Derivatives, Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r27", "r144", "r145", "r151", "r162", "r397" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives designated as hedging instruments", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r27" ] }, "ew_DevelopedTechnologyAndInProcessResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DevelopedTechnologyAndInProcessResearchAndDevelopmentMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed Technology and In-Process Research and Development", "label": "Developed Technology And In-Process Research And Development [Member]", "documentation": "Developed Technology And In-Process Research And Development [Member]" } } }, "auth_ref": [] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Developed technology", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r246" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r1195", "r1196", "r1209" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Financial Statement Error Correction [Flag]", "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r1195", "r1196", "r1209", "r1245" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1230" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Documents Incorporated by Reference", "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r1193" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "United States federal net operating losses", "terseLabel": "Federal research expenditure tax credits", "label": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "us-gaap_DomesticPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticPlanMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic Plan", "label": "Domestic Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r1439", "r1440", "r1441" ] }, "ew_DonaldBoboJrMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "DonaldBoboJrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Donald Bobo, Jr [Member]", "documentation": "Donald Bobo, Jr" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share attributable to Edwards Lifesciences Corporation:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Basic earnings per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r379", "r412", "r413", "r414", "r415", "r416", "r420", "r423", "r433", "r434", "r435", "r437", "r845", "r846", "r952", "r979", "r1141" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Diluted earnings per share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r379", "r412", "r413", "r414", "r415", "r416", "r423", "r433", "r434", "r435", "r437", "r845", "r846", "r952", "r979", "r1141" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted:", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r76", "r77" ] }, "us-gaap_EffectOfCashFlowHedgesOnResultsOfOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfCashFlowHedgesOnResultsOfOperationsAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on cash flow hedging relationships:", "label": "Effect of Cash Flow Hedges on Results of Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r868" ] }, "us-gaap_EffectOfFairValueHedgesOnResultsOfOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfFairValueHedgesOnResultsOfOperationsAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on fair value hedging relationships:", "label": "Effect of Fair Value Hedges on Results of Operations [Abstract]" } } }, "auth_ref": [] }, "ew_EffectiveIncomeTaxRateReconciliationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationContingentConsiderationLiability", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Contingent consideration liabilities", "label": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability", "documentation": "Effective Income Tax Rate Reconciliation, Contingent Consideration Liability" } } }, "auth_ref": [] }, "ew_EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationDeductionSharebasedCompensationCostAmount", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "United States federal deductible employee share-based compensation", "label": "Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount", "documentation": "Effective Income Tax Rate Reconciliation, Deduction, Share-based Compensation Cost, Amount" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationFdiiAmount", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign-derived intangible income deduction", "label": "Effective Income Tax Rate Reconciliation, FDII, Amount", "documentation": "Amount of reported income tax benefit from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII)." } } }, "auth_ref": [ "r1468" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationGiltiAmount", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax on global intangible low-taxed income", "label": "Effective Income Tax Rate Reconciliation, GILTI, Amount", "documentation": "Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)." } } }, "auth_ref": [ "r1468" ] }, "ew_EmployeeAndNonemployeeStockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EmployeeAndNonemployeeStockOptionsMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Option Awards", "verboseLabel": "Stock option activity", "label": "Employee and Nonemployee Stock Options [Member]", "documentation": "An arrangement whereby an employee or nonemployee (including a member of the entity's Board of Directors) is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement." } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee compensation and withholdings", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r48" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allocation of stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock purchase subscriptions", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r769" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining requisite service period (in months)", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r769" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax benefit", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r768" ] }, "ew_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndVestingOfRestrictedStockUnits", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Realized tax benefits from exercises of stock options and vesting of restricted stock units", "label": "Employee Service Share Based Compensation, Tax Benefit Realized from Exercise of Stock Options and Vesting of Restricted Stock Units", "documentation": "Disclosure of aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock units during the period." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "ESPP", "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "ew_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ESPP", "label": "Employee Stock Purchase Plan [Member]", "documentation": "Employee Stock Purchase Plan [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1192" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "verboseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1192" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1192" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1270" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1192" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1192" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1192" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1192" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "verboseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "verboseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r1271" ] }, "ew_EquipmentWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquipmentWithCustomers", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment with customers", "label": "Equipment with Customers", "documentation": "The gross amount, as of the balance sheet date, of long-lived, depreciable equipment at customer locations." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityClassOfTreasuryStockLineItems", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Equity, Class of Treasury Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r26", "r325", "r371", "r372", "r373", "r407", "r408", "r409", "r411", "r417", "r419", "r438", "r520", "r521", "r635", "r770", "r771", "r772", "r801", "r802", "r835", "r836", "r837", "r838", "r839", "r840", "r844", "r869", "r871", "r872", "r873", "r874", "r875", "r890", "r1001", "r1002", "r1003", "r1017", "r1079" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r516", "r517", "r518" ] }, "us-gaap_EquityMethodInvestmentFinancialStatementReportedAmountsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentFinancialStatementReportedAmountsAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investments", "label": "Equity Method Investment, Financial Statement, Reported Amounts [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment, ownership percentage (as a percent)", "verboseLabel": "Investment percentage (in percent)", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r516" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value of equity method investments", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r453", "r515", "r1293", "r1339" ] }, "ew_EquityMethodInvestmentsInvestmentPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquityMethodInvestmentsInvestmentPeriod", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments taken period", "label": "Equity Method Investments, Investment Period", "documentation": "Equity Method Investments, Investment Period" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquitySecuritiesFVNIMaximumAdditionalOptionToAcquireInvestment", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum additional option to acquire investment", "label": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment", "documentation": "Equity Securities, FV-NI, Maximum Additional Option To Acquire Investment" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIMaximumAdditionalRequired": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquitySecuritiesFVNIMaximumAdditionalRequired", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum additional required investment", "label": "Equity Securities, FV-NI, Maximum Additional Required", "documentation": "Equity Securities, FV-NI, Maximum Additional Required" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIMaximumPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquitySecuritiesFVNIMaximumPromissoryNote", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum secured promissory note", "label": "Equity Securities, FV-NI, Maximum Promissory Note", "documentation": "Equity Securities, FV-NI, Maximum Promissory Note" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIMaximumSecuredPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquitySecuritiesFVNIMaximumSecuredPromissoryNote", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum secured promissory note", "label": "Equity Securities, FV-NI, Maximum Secured Promissory Note", "documentation": "Equity Securities, FV-NI, Maximum Secured Promissory Note" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIOptionToAcquireInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquitySecuritiesFVNIOptionToAcquireInvestment", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment option to acquire", "label": "Equity Securities, FV-NI, Option To Acquire Investment", "documentation": "Equity Securities, FV-NI, Option To Acquire Investment" } } }, "auth_ref": [] }, "ew_EquitySecuritiesFVNIPromissoryNoteOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EquitySecuritiesFVNIPromissoryNoteOutstanding", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investee drew additional amount", "label": "Equity Securities, FV-NI Promissory Note Outstanding", "documentation": "Equity Securities, FV-NI Promissory Note Outstanding" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNi": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNi", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "parentTag": "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value of non-marketable equity securities", "label": "Equity Securities, FV-NI, Current", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current." } } }, "auth_ref": [ "r340", "r859", "r1128" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual downward price adjustment", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount", "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r513" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative decrease in non-marketable equity securities due to observable price changes", "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount", "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r513" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual upward price adjustments", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount", "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r514" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative increase in non-marketable equity securities due to observable price changes", "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount", "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r514" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r1238" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r1201", "r1213", "r1223", "r1249" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r1198", "r1210", "r1220", "r1246" ] }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EstimateOfFairValueFairValueDisclosureMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimate of Fair Value Measurement", "label": "Estimate of Fair Value Measurement [Member]", "documentation": "Measured as an estimate of fair value." } } }, "auth_ref": [ "r604", "r861", "r1151", "r1152" ] }, "ew_EstimatedAnnualForfeitureRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EstimatedAnnualForfeitureRatePercent", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual forfeiture rate (as a percent)", "label": "Estimated Annual Forfeiture Rate Percent", "documentation": "This element represents the estimated annual forfeiture rate of the entity's stock-based compensation plans, percentage." } } }, "auth_ref": [] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe [Member]", "documentation": "Continent of Europe." } } }, "auth_ref": [ "r1508", "r1509", "r1510", "r1511" ] }, "ew_EuropeSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "EuropeSegmentMember", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Europe", "terseLabel": "Europe", "label": "Europe Segment [Member]", "documentation": "Represents the Europe reportable segment of the entity." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r1244" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r849", "r850", "r855" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r849", "r850", "r855" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r604", "r677", "r678", "r679", "r680", "r681", "r682", "r850", "r899", "r900", "r901", "r1151", "r1152", "r1158", "r1159", "r1160" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Class [Axis]", "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r169", "r252" ] }, "us-gaap_FairValueByMeasurementBasisAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementBasisAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Basis [Axis]", "label": "Measurement Basis [Axis]", "documentation": "Information by measurement basis." } } }, "auth_ref": [ "r39", "r168", "r604", "r1151", "r1152" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r849", "r850", "r852", "r853", "r856" ] }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosureItemAmountsDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurement [Domain]", "label": "Fair Value Measurement [Domain]", "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value." } } }, "auth_ref": [ "r604", "r1151", "r1152" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTS" ], "lang": { "en-us": { "role": { "terseLabel": "FAIR VALUE MEASUREMENTS", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r848" ] }, "us-gaap_FairValueHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueHedgingMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value hedges", "label": "Fair Value Hedging [Member]", "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk." } } }, "auth_ref": [ "r148" ] }, "us-gaap_FairValueInputsLevel12And3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel12And3Member", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total plan assets measured at fair value", "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]", "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3)." } } }, "auth_ref": [ "r1401" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a01", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r604", "r677", "r682", "r850", "r899", "r1158", "r1159", "r1160" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a02", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r604", "r677", "r682", "r850", "r900", "r1151", "r1152", "r1158", "r1159", "r1160" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level\u00a03", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r604", "r677", "r678", "r679", "r680", "r681", "r682", "r850", "r901", "r1151", "r1152", "r1158", "r1159", "r1160" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations", "crdr": "credit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liabilities", "label": "Obligations, Fair Value Disclosure", "documentation": "Fair value of obligations measured on a recurring basis." } } }, "auth_ref": [ "r168", "r253" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Liability Class [Domain]", "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r28" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r28", "r169" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in Fair Value of Contingent Consideration Obligation", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r28", "r169" ] }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alternative investments measured at net asset value", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "documentation": "Fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r677", "r847", "r856" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in fair value", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r854" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Fair value beginning balance", "periodEndLabel": "Fair value ending balance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r28" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r604", "r677", "r678", "r679", "r680", "r681", "r682", "r899", "r900", "r901", "r1151", "r1152", "r1158", "r1159", "r1160" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value on a Recurring Basis", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r848", "r856" ] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r854" ] }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r152", "r154", "r165" ] }, "ew_February2023StockRepurchaseProgramSharesSoldInMarch2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "February2023StockRepurchaseProgramSharesSoldInMarch2023Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "February 2023 Stock Repurchase Program, Shares Sold In March 2023", "label": "February 2023 Stock Repurchase Program, Shares Sold In March 2023 [Member]", "documentation": "February 2023 Stock Repurchase Program, Shares Sold In March 2023" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r523", "r524", "r525", "r526", "r527", "r530", "r534", "r535", "r615", "r633", "r842", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r975", "r1147", "r1278", "r1279", "r1280", "r1281", "r1282", "r1283", "r1284", "r1335", "r1336", "r1337", "r1338" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Useful Life (in years)", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r337", "r556" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r218" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r218" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r218" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r218" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofEstimatedAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r218" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r553", "r555", "r556", "r558", "r932", "r933" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Developed technology", "terseLabel": "Cost", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r217", "r933" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r932" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r89", "r92" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Carrying Value", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r217", "r932" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-lived intangible assets", "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "auth_ref": [] }, "ew_FixedRate4.3002018NotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "FixedRate4.3002018NotesMember", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed-rate 4.3% Notes", "label": "Fixed Rate 4.300% 2018 Notes [Member]", "documentation": "Fixed Rate 4.300% 2018 Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "netLabel": "Non-U.S.", "terseLabel": "Non-United States net operating losses", "verboseLabel": "Foreign tax authority", "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign exchange (gains) losses, net", "terseLabel": "Foreign currency", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r864", "r865", "r866", "r867", "r1076" ] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r863" ] }, "ew_ForeignEarningsToBeRepatriated": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ForeignEarningsToBeRepatriated", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign earnings to be repatriated", "label": "Foreign Earnings To Be Repatriated", "documentation": "Foreign Earnings To Be Repatriated" } } }, "auth_ref": [] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r1137", "r1158", "r1174" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency forward exchange contracts", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r1044", "r1049", "r1054", "r1068", "r1074", "r1098", "r1099", "r1100", "r1182" ] }, "us-gaap_ForeignGovernmentDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignGovernmentDebtSecuritiesMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International government bonds", "label": "Debt Security, Government, Non-US [Member]", "documentation": "Debt security issued by government not domiciled in United States of America (US)." } } }, "auth_ref": [ "r1400", "r1502" ] }, "us-gaap_ForeignPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignPlanMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Plan", "label": "Foreign Plan [Member]", "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r1439", "r1440", "r1441" ] }, "ew_ForeignTaxCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ForeignTaxCreditMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign tax and general business credits", "label": "Foreign Tax Credit [Member]", "documentation": "Foreign Tax Credit" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1205", "r1217", "r1227", "r1253" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1205", "r1217", "r1227", "r1253" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1205", "r1217", "r1227", "r1253" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r1205", "r1217", "r1227", "r1253" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r1205", "r1217", "r1227", "r1253" ] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestments", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss (gain) on investments, net", "label": "Gain (Loss) on Investments", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r203", "r1272" ] }, "ew_GainLossOnInvestmentsOtherIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "GainLossOnInvestmentsOtherIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss (gain) on investments", "label": "Gain (Loss) on Investments, Other Income Expense, Net", "documentation": "This item represents the portion of gain (loss) on investments categorized by the entity as other income (expense). Includes, but is not limited to, (1) the net realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including those trading securities held for investment under deferred compensation agreements net of the gain (loss) of the related deferred compensation liability; (2) the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied; (3) gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting; (4) losses recognized for other than temporary impairments (OTTI) of the subject investments; and (5) the amount of recovery of investments which had previously been fully or partially written-off." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeCostsInInventoryAmountIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeCostsInInventoryAmountIncurred", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative costs allocated to inventory", "label": "General and Administrative Costs in Inventory, Amount Incurred", "documentation": "Aggregate amount of general and administrative costs incurred in each period and charged to inventory." } } }, "auth_ref": [ "r346" ] }, "us-gaap_GeneralAndAdministrativeCostsInInventoryAmountRemaining": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeCostsInInventoryAmountRemaining", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative costs included in inventory", "label": "General and Administrative Costs in Inventory, Amount Remaining", "documentation": "Actual or estimated amount of general and administrative costs remaining in inventory." } } }, "auth_ref": [ "r346" ] }, "us-gaap_GeographicAreasLongLivedAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicAreasLongLivedAssetsAbstract", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-lived Tangible Assets by Geographic Region", "label": "Geographic Areas, Long-Lived Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0, "order": 4.0 }, "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill (Note\u00a010)", "netLabel": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r336", "r541", "r946", "r1149", "r1177", "r1345", "r1352" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill acquired during the year", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r544", "r1149" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r216" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustment", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r548" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying amount of goodwill", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r1149" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r199", "r392", "r443", "r457", "r463", "r466", "r519", "r577", "r578", "r580", "r581", "r582", "r584", "r586", "r588", "r589", "r862", "r1143", "r1369" ] }, "ew_HarpoonMedicalInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "HarpoonMedicalInc.Member", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Harpoon Medical", "label": "Harpoon Medical, Inc. [Member]", "documentation": "Harpoon Medical, Inc. [Member]" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r27", "r832" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeFinancialInstrumentsUsedtoManageCurrencyExchangeRateRiskandInterestRateRiskDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r27" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r27" ] }, "us-gaap_HeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Amortized Cost", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r295", "r495", "r525", "r1341" ] }, "us-gaap_HeldToMaturitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held-to-maturity", "label": "Debt Securities, Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Unrealized Gains", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain", "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r275", "r505" ] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Gross Unrealized Losses", "label": "Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r276", "r506" ] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Held-to-Maturity", "label": "Debt Securities, Held-to-Maturity, Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesFairValueRollingMaturityAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Debt Securities, Held-to-Maturity, Fair Value, Rolling Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortized Cost", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingAfterTenYearsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingAfterTenYearsFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 10 years", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing after tenth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Held-to-Maturity, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date." } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecuritiesFairValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Held-to-Maturity, Maturity, without Single Maturity Date, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity), without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r277", "r507", "r956" ] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Instruments not due at a single maturity date", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, without Single Maturity Date", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) without single maturity date and not allocated over maturity grouping." } } }, "auth_ref": [ "r499", "r955" ] }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesFairValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 3.0 }, "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "totalLabel": "Fair Value", "label": "Debt Securities, Held-to-Maturity, Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r274", "r504", "r947", "r958" ] }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldtomaturitySecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due in 1\u00a0year or less", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling within One Year", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach." } } }, "auth_ref": [ "r1331", "r1495" ] }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingAfterTenYearsAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingAfterTenYearsAmortizedCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 10 years", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after rolling tenth fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach." } } }, "auth_ref": [ "r1333", "r1497" ] }, "us-gaap_HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldtomaturitySecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails": { "parentTag": "us-gaap_HeldToMaturitySecurities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofCostandFairValueofInvestmentsinDebtSecuritiesbyContractualMaturityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due after 1\u00a0year through 5\u00a0years", "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Rolling after One through Five Years", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth rolling fiscal year following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach." } } }, "auth_ref": [ "r1332", "r1496" ] }, "ew_HemodynamicMonitorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "HemodynamicMonitorsMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hemodynamic Monitors", "label": "Hemodynamic Monitors [Member]", "documentation": "Hemodynamic Monitors [Member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r1195", "r1196", "r1209" ] }, "us-gaap_ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of indefinite-lived intangible asset excluding goodwill." } } }, "auth_ref": [ "r559" ] }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of intangible assets", "verboseLabel": "Impairment charges", "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)", "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value." } } }, "auth_ref": [ "r1306", "r1355" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Goodwill and Long-lived Assets", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets." } } }, "auth_ref": [] }, "us-gaap_InProcessResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InProcessResearchAndDevelopmentMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "In-process research and development", "terseLabel": "In-process Research and Development", "label": "In Process Research and Development [Member]", "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations." } } }, "auth_ref": [ "r393", "r807" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income before provision for income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r195", "r265", "r443", "r457", "r463", "r466", "r953", "r970", "r1143" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofIncomeBeforeProvisionsforIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outside of the United States, including Puerto Rico", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile." } } }, "auth_ref": [ "r393", "r807" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total segment operating income", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r443", "r457", "r463", "r466", "r981", "r1143" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Operating Income", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r560", "r564", "r1062" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r564", "r1062" ] }, "ew_IncomeTaxAssessmentEstimateOfAdditionalTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "IncomeTaxAssessmentEstimateOfAdditionalTaxExpense", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimate of additional tax expense", "label": "Income Tax Assessment, Estimate Of Additional Tax Expense", "documentation": "Income Tax Assessment, Estimate Of Additional Tax Expense" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Axis]", "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r22" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Tax Authority [Domain]", "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXES" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r394", "r776", "r785", "r792", "r798", "r803", "r808", "r811", "r812", "r1014" ] }, "ew_IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "IncomeTaxExaminationAmountDepositedToMitigateInterestOnTaxLiabilities", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional deposit", "label": "Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities", "documentation": "Income Tax Examination, Amount Deposited To Mitigate Interest On Tax Liabilities" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional tax sought in excess of filing position", "label": "Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority", "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INCOMETAXESScheduleofProvisionforIncomeTaxesDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes (Note\u00a018)", "negatedLabel": "Provision for income taxes", "totalLabel": "Total income tax provision", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r282", "r297", "r418", "r419", "r451", "r783", "r804", "r982" ] }, "us-gaap_IncomeTaxHolidayAggregateDollarAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxHolidayAggregateDollarAmount", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax reductions compared to local statutory rates", "label": "Income Tax Holiday, Aggregate Dollar Amount", "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction." } } }, "auth_ref": [ "r808" ] }, "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax reductions compared to local statutory rates per diluted share (in dollars per share)", "label": "Income Tax Holiday, Income Tax Benefits Per Share", "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions." } } }, "auth_ref": [ "r808" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r370", "r779", "r780", "r792", "r793", "r797", "r799", "r1011" ] }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign income taxed at different rates", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)." } } }, "auth_ref": [ "r1468" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense at United States federal statutory rate", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r784" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nondeductible employee share-based compensation", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r1468" ] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r1468" ] }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Build of reserve for prior years' uncertain tax positions", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)." } } }, "auth_ref": [ "r1468" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and local taxes, net of federal tax benefit", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r1468" ] }, "us-gaap_IncomeTaxReconciliationTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationTaxCredits", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofFederalStatutoryIncomeTaxRatetoEffectiveIncomeTaxRateDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax credits, federal and state", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits." } } }, "auth_ref": [ "r1468" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Income taxes", "label": "Income Taxes Paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r69", "r72" ] }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts and other receivables, net", "label": "Increase (Decrease) in Accounts and Other Receivables", "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Increase (Decrease) in Income Taxes Payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred income taxes", "label": "Increase (Decrease) in Deferred Income Taxes", "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa." } } }, "auth_ref": [ "r15" ] }, "ew_IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "IncreaseDecreaseInDeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net deferred tax assets increase", "label": "Increase (Decrease) in Deferred Tax Assets (Liabilities), Net", "documentation": "The increase or decrease during the year in net deferred tax assets. Includes items recorded to stockholders' equity and which did not impact the income tax provision." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r15" ] }, "ew_IncreaseDecreaseInLegalSettlementAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "IncreaseDecreaseInLegalSettlementAccrual", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Intellectual property agreement accrual", "label": "Increase (Decrease) In Legal Settlement Accrual", "documentation": "Increase (Decrease) In Legal Settlement Accrual" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncreaseDecreaseInPrepaidRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidRoyalties", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Long-term prepaid royalties (Note 3)", "label": "Increase (Decrease) in Prepaid Royalties", "documentation": "Amount of increase (decrease) of consideration paid in advance for royalties that provide economic benefits in future periods." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of stock plans (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r424", "r425", "r426", "r435", "r741" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r554", "r557" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets [Line Items]", "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-process research and development", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r219" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived intangible assets", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r90", "r219" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r1208", "r1217", "r1227", "r1244", "r1253", "r1257", "r1265" ] }, "ew_InitialDeliveryOfSharesSettledDecember2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InitialDeliveryOfSharesSettledDecember2023Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Delivery Of Shares Settled December 2023", "label": "Initial Delivery Of Shares Settled December 2023 [Member]", "documentation": "Initial Delivery Of Shares Settled December 2023" } } }, "auth_ref": [] }, "ew_InitialDeliveryOfSharesSettledFebruary2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InitialDeliveryOfSharesSettledFebruary2023Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Delivery Of Shares Settled February 2023", "label": "Initial Delivery Of Shares Settled February 2023 [Member]", "documentation": "Initial Delivery Of Shares Settled February 2023" } } }, "auth_ref": [] }, "ew_InitialDeliveryOfSharesSettledJanuary2022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InitialDeliveryOfSharesSettledJanuary2022Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Delivery Of Shares Settled January 2022", "label": "Initial Delivery Of Shares Settled January 2022 [Member]", "documentation": "Initial Delivery Of Shares Settled January 2022" } } }, "auth_ref": [] }, "ew_InitialDeliveryOfSharesSettledOctober2022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InitialDeliveryOfSharesSettledOctober2022Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial Delivery Of Shares Settled October 2022", "label": "Initial Delivery Of Shares Settled October 2022 [Member]", "documentation": "Initial Delivery Of Shares Settled October 2022" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r1263" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r1197", "r1269" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r1197", "r1269" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r1197", "r1269" ] }, "ew_InsuranceContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InsuranceContractsMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance contracts", "verboseLabel": "Insurance Contracts", "label": "Insurance Contracts [Member]", "documentation": "This element represents the information about insurance contracts." } } }, "auth_ref": [] }, "us-gaap_InsuredEventGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InsuredEventGainLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain on insurance settlement", "label": "Insured Event, Gain (Loss)", "documentation": "Amount of excess (deficiency) of insurance recovery over the loss incurred from an insured event." } } }, "auth_ref": [ "r1365" ] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost", "label": "Intangible Assets, Gross (Excluding Goodwill)", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r336" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 }, "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets, net (Note\u00a010)", "totalLabel": "Net Carrying Value", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r87", "r91" ] }, "ew_IntellectualPropertyAgreementTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "IntellectualPropertyAgreementTerm", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intellectual property agreement term", "label": "Intellectual Property Agreement Term", "documentation": "Intellectual Property Agreement Term" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r172", "r267", "r374", "r447", "r877", "r1063", "r1188", "r1505" ] }, "us-gaap_InterestIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income, net", "label": "Interest Income [Member]", "documentation": "Primary financial statement caption in which reported facts about interest income have been included." } } }, "auth_ref": [] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r383", "r386", "r387" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished products", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r215", "r1131" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories (Note\u00a05)", "totalLabel": "Total inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r347", "r1127", "r1177" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNetAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventories", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r284", "r331", "r346", "r536", "r537", "r538", "r930", "r1140" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials", "label": "Inventory, Raw Materials, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r215", "r1133" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work in process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r215", "r1132" ] }, "ew_InventoryWriteDownExpirationPeriodTrigger": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InventoryWriteDownExpirationPeriodTrigger", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period prior to expiration date which triggers write-down of inventory (in months)", "label": "Inventory Write Down Expiration Period Trigger", "documentation": "The period prior to the expiration date which triggers the write down of inventory, expressed in months." } } }, "auth_ref": [] }, "ew_InventoryWriteDownSlowMovingPeriodTrigger": { "xbrltype": "durationItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InventoryWriteDownSlowMovingPeriodTrigger", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period used to evaluate slow-moving inventory levels (in years)", "label": "Inventory Write Down Slow Moving Period Trigger", "documentation": "The time period used to identify slow-moving inventory which triggers an inventory write-down." } } }, "auth_ref": [] }, "ew_InvesteesVotingStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "InvesteesVotingStockMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investees Voting Stock", "label": "Investees Voting Stock [Member]", "documentation": "Investees Voting Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r202", "r446" ] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r980", "r1007", "r1008", "r1009", "r1010", "r1087", "r1088" ] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAllOtherInvestmentsAbstract", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity securities", "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cost and Fair Value of Investments in Debt Securities, by Contractual Maturity", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments." } } }, "auth_ref": [] }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Investments, Debt and Equity Securities [Abstract]", "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinUnconsolidatedAffiliatesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total investments in unconsolidated entities", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate." } } }, "auth_ref": [ "r1296" ] }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTS" ], "lang": { "en-us": { "role": { "verboseLabel": "INVESTMENTS", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "documentation": "The entire disclosure for investments in certain debt and equity securities." } } }, "auth_ref": [ "r254", "r269", "r270", "r300", "r479", "r481", "r857", "r858" ] }, "country_JP": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "JP", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japan", "label": "JAPAN" } } }, "auth_ref": [] }, "ew_January2022StockRepurchaseProgramSharesSoldInFebruary2022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "January2022StockRepurchaseProgramSharesSoldInFebruary2022Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 2022 Stock Repurchase Program Shares Sold In February 2022", "label": "January 2022 Stock Repurchase Program Shares Sold In February 2022 [Member]", "documentation": "January 2022 Stock Repurchase Program Shares Sold In February 2022" } } }, "auth_ref": [] }, "ew_JapanSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "JapanSegmentMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japan", "label": "Japan Segment [Member]", "documentation": "Represents the Japan reportable segment of the entity." } } }, "auth_ref": [] }, "ew_July2022StockRepurchaseProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "July2022StockRepurchaseProgramMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "July 2022 Stock Repurchase Program", "label": "July 2022 Stock Repurchase Program [Member]", "documentation": "July 2022 Stock Repurchase Program" } } }, "auth_ref": [] }, "us-gaap_Land": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Land", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land", "label": "Land", "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale." } } }, "auth_ref": [ "r1294" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LegalMattersAndContingenciesTextBlock", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSE" ], "lang": { "en-us": { "role": { "verboseLabel": "INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE", "label": "Legal Matters and Contingencies [Text Block]", "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies." } } }, "auth_ref": [ "r222" ] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Line Items]", "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r884" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Table]", "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r884" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r883" ] }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDiscountRate", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-average discount rate", "label": "Lessee, Operating Lease, Discount Rate", "documentation": "Discount rate used by lessee to determine present value of operating lease payments." } } }, "auth_ref": [ "r1175" ] }, "ew_LesseeOperatingLeaseLeaseNotYetCommencedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "LesseeOperatingLeaseLeaseNotYetCommencedAmount", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease commitments for leases not yet commenced", "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Amount", "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Amount" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.edwards.com/role/LEASESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1483" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r889" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease term (in years)", "label": "Lessee, Operating Lease, Term of Contract", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1482" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.edwards.com/role/LEASES" ], "lang": { "en-us": { "role": { "terseLabel": "LEASES", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r879" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r47", "r392", "r519", "r577", "r578", "r580", "r581", "r582", "r584", "r586", "r588", "r589", "r821", "r825", "r826", "r862", "r1036", "r1142", "r1190", "r1369", "r1485", "r1486" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r188", "r262", "r966", "r1177", "r1309", "r1340", "r1479" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r49", "r330", "r392", "r519", "r577", "r578", "r580", "r581", "r582", "r584", "r586", "r588", "r589", "r821", "r825", "r826", "r862", "r1177", "r1369", "r1485", "r1486" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r168" ] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions (Note 18)", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent." } } }, "auth_ref": [ "r52" ] }, "us-gaap_LimitedLiabilityCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedLiabilityCompanyMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Liability Company", "label": "Limited Liability Company [Member]", "documentation": "Legal form of business company offering limited liability to its owners (denoted by L.L.C. or LLC in the U.S.)." } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings outstanding", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r44", "r260", "r1499" ] }, "ew_LineOfCreditFacilityAccordionFeatureIncreaseLimit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accordion feature, increase limit", "label": "Line of Credit Facility, Accordion Feature, Increase Limit", "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Aggregate borrowings in multiple currencies", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r46" ] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseAxis", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Axis]", "label": "Litigation Case [Axis]", "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim." } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Domain]", "label": "Litigation Case [Domain]", "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information." } } }, "auth_ref": [] }, "us-gaap_LitigationReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationReserveCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation settlement", "label": "Estimated Litigation Liability, Current", "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position." } } }, "auth_ref": [ "r53", "r1360" ] }, "us-gaap_LitigationReserveNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationReserveNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation settlement accrual (Note 3)", "label": "Estimated Litigation Liability, Noncurrent", "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r53", "r1360" ] }, "us-gaap_LitigationSettlementExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationSettlementExpense", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Intellectual property litigation expenses", "negatedLabel": "Intellectual property agreement and litigation expense", "label": "Litigation Settlement, Expense", "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees." } } }, "auth_ref": [] }, "ew_LitigationSettlementsAndLegalCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "LitigationSettlementsAndLegalCosts", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intellectual property agreement and litigation expense (Note 3)", "verboseLabel": "Intellectual property litigation expenses, settlements, and legal costs", "label": "Litigation, Settlements And Legal Costs", "documentation": "Litigation, Settlements And Legal Costs" } } }, "auth_ref": [] }, "ew_LoansReceivablesMaximumLendingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "LoansReceivablesMaximumLendingCapacity", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans receivables, maximum lending amount", "label": "Loans Receivables, Maximum Lending Capacity", "documentation": "Loans Receivables, Maximum Lending Capacity" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total carrying amount", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r44", "r260", "r603", "r618", "r1151", "r1152", "r1499" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt (Note\u00a011)", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r341" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term investments (Note\u00a07)", "label": "Long-Term Investments", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r333" ] }, "ew_LongTermStockIncentiveCompensationProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "LongTermStockIncentiveCompensationProgramMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Program", "label": "Long Term Stock Incentive Compensation Program [Member]", "documentation": "This element represents details pertaining to the Long-Term Stock Incentive Compensation Program of the entity." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r51" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r51", "r97" ] }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtWeightedAverageInterestRate", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average interest rate under all debt obligations (as a percent)", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time." } } }, "auth_ref": [] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r571", "r572", "r573", "r576", "r1361", "r1362" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r571", "r572", "r573", "r576", "r1361", "r1362" ] }, "ew_LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber": { "xbrltype": "integerItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "LossContingencyClaimsThatIfSettledCouldHaveAMaterialAdverseImpactNumber", "presentation": [ "http://www.edwards.com/role/LEGALPROCEEDINGSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of lawsuits that if settled could have a material adverse impact on net income or cash flows", "label": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number", "documentation": "Loss Contingency, Claims That If Settled Could Have A Material Adverse Impact, Number" } } }, "auth_ref": [] }, "us-gaap_MachineryAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Machinery and equipment", "label": "Machinery and Equipment, Gross", "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [ "r220" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Machinery and equipment", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "ew_MarketBasedRestrictedStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "MarketBasedRestrictedStockUnitsMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MRSUs", "label": "Market Based Restricted Stock Units [Member]", "documentation": "Market Based Restricted Stock Units [Member]" } } }, "auth_ref": [] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciling items", "label": "Segment Reconciling Items [Member]", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r84" ] }, "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period when cash flows associated with future transactions and certain local currency expenses are expected to occur (in months)", "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge", "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments." } } }, "auth_ref": [ "r21" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Maximum", "terseLabel": "High", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r572", "r573", "r574", "r575", "r731", "r929", "r1000", "r1028", "r1029", "r1085", "r1089", "r1091", "r1092", "r1105", "r1121", "r1122", "r1144", "r1155", "r1168", "r1179", "r1373", "r1487", "r1488", "r1489", "r1490", "r1491", "r1492" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r1236" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r1236" ] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Discount Rate", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r1478" ] }, "ew_MeasurementInputProbabilityOfMilestoneAchievementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "MeasurementInputProbabilityOfMilestoneAchievementMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input, Probability of Milestone Achievement", "label": "Measurement Input, Probability Of Milestone Achievement [Member]", "documentation": "Measurement Input, Probability Of Milestone Achievement [Member]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Axis]", "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r851" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input Type [Domain]", "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "ew_MedicalDeviceCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "MedicalDeviceCompanyMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Device Company", "label": "Medical Device Company [Member]", "documentation": "Medical Device Company" } } }, "auth_ref": [] }, "ew_MedicalTechnologyCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "MedicalTechnologyCompanyMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Technology Company", "label": "Medical Technology Company [Member]", "documentation": "Medical Technology Company" } } }, "auth_ref": [] }, "ew_MedtronicIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "MedtronicIncMember", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Medtronic Inc", "label": "Medtronic Inc [Member]", "documentation": "Medtronic Inc" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Minimum", "terseLabel": "Low", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r572", "r573", "r574", "r575", "r731", "r929", "r1000", "r1028", "r1029", "r1085", "r1089", "r1091", "r1092", "r1105", "r1121", "r1122", "r1144", "r1155", "r1168", "r1179", "r1373", "r1487", "r1488", "r1489", "r1490", "r1491", "r1492" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest (Note 9)", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r57", "r261", "r392", "r519", "r577", "r580", "r581", "r582", "r588", "r589", "r862", "r965", "r1040" ] }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestPeriodIncreaseDecrease", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Changes to noncontrolling interest (Note 9)", "label": "Noncontrolling Interest, Period Increase (Decrease)", "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period." } } }, "auth_ref": [ "r133" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r1256" ] }, "us-gaap_MortgagesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgagesMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgages", "label": "Mortgages [Member]", "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan." } } }, "auth_ref": [] }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MovementInValuationAllowancesAndReservesRollForward", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Movement in Valuation Allowances and Reserves", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r1264" ] }, "us-gaap_MunicipalBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MunicipalBondsMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Municipal securities", "terseLabel": "Municipal securities", "label": "Municipal Bonds [Member]", "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments." } } }, "auth_ref": [] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r1237" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://www.edwards.com/role/DESCRIPTIONOFBUSINESS" ], "lang": { "en-us": { "role": { "terseLabel": "DESCRIPTION OF BUSINESS", "label": "Nature of Operations [Text Block]", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r285", "r298" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r385" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r385" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r210", "r211", "r212" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to Edwards Lifesciences Corporation.", "terseLabel": "Net Income (Loss)", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r196", "r212", "r266", "r328", "r365", "r368", "r373", "r392", "r410", "r412", "r413", "r414", "r415", "r418", "r419", "r431", "r443", "r457", "r463", "r466", "r519", "r577", "r578", "r580", "r581", "r582", "r584", "r586", "r588", "r589", "r846", "r862", "r973", "r1059", "r1077", "r1078", "r1143", "r1188", "r1369" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss attributable to noncontrolling interest", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r142", "r249", "r365", "r368", "r418", "r419", "r972", "r1302" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income attributable to Edwards Lifesciences Corporation", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r380", "r412", "r413", "r414", "r415", "r420", "r421", "r432", "r435", "r443", "r457", "r463", "r466", "r1143" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to Edwards Lifesciences Corporation", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r380", "r422", "r427", "r428", "r429", "r430", "r432", "r435" ] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESNarrativeDetails", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net investment hedges", "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [ "r150" ] }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-service cost components of net periodic pension benefit cost", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits." } } }, "auth_ref": [ "r652" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Standards Not Yet Adopted", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ew_NewMarketsTaxCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "NewMarketsTaxCreditMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New Markets Tax Credit", "label": "New Markets Tax Credit [Member]", "documentation": "New Markets Tax Credit" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r1236" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r1205", "r1217", "r1227", "r1244", "r1253" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1234" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1233" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r1244" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1264" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1264" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International", "verboseLabel": "Foreign", "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r1508", "r1509", "r1510", "r1511" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r132", "r635", "r1317", "r1318", "r1319", "r1506" ] }, "us-gaap_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncurrentAssets", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-lived tangible assets", "label": "Long-Lived Assets", "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets." } } }, "auth_ref": [ "r471" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivatives not designated as hedging instruments", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r27" ] }, "ew_NonemployeeDirectorsStockIncentiveCompensationProgramMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "NonemployeeDirectorsStockIncentiveCompensationProgramMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonemployee Directors Program", "label": "Nonemployee Directors Stock Incentive Compensation Program [Member]", "documentation": "This element represents details pertaining to the Nonemployee Directors Stock Incentive Compensation Program of the entity." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-operating income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r204" ] }, "ew_NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonqualified deferred compensation plans", "label": "Nonqualified Deferred Compensation Plan Select Employee Group [Member]", "documentation": "Represents a nonqualified deferred compensation plan for a select group of employees." } } }, "auth_ref": [] }, "ew_NotesReceivableConvertedToEquityInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "NotesReceivableConvertedToEquityInvestment", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of notes receivable to equity investment", "label": "Notes Receivable Converted To Equity Investment", "documentation": "Notes Receivable Converted To Equity Investment" } } }, "auth_ref": [] }, "us-gaap_NotesReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesReceivableGross", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing receivable", "label": "Financing Receivable, before Allowance for Credit Loss", "documentation": "Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease." } } }, "auth_ref": [ "r295", "r301", "r302", "r343", "r525", "r528", "r1145", "r1146", "r1285", "r1341" ] }, "ew_NumberOfPromissoryNotesEntered": { "xbrltype": "integerItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "NumberOfPromissoryNotesEntered", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of promissory notes entered", "label": "Number Of Promissory Notes Entered", "documentation": "Number Of Promissory Notes Entered" } } }, "auth_ref": [] }, "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income before reclassifications", "verboseLabel": "Prior service credit arising during period", "label": "OCI, before Reclassifications, before Tax, Attributable to Parent", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r59" ] }, "ew_October2022StockRepurchaseProgramSharesSoldInDecember2022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "October2022StockRepurchaseProgramSharesSoldInDecember2022Member", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 2022 Stock Repurchase Program Shares Sold In December 2022", "label": "October 2022 Stock Repurchase Program Shares Sold In December 2022 [Member]", "documentation": "October 2022 Stock Repurchase Program Shares Sold In December 2022" } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsLineItems", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Offsetting Assets [Line Items]", "label": "Offsetting Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTable", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Offsetting Assets [Table]", "label": "Offsetting Assets [Table]", "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements." } } }, "auth_ref": [ "r189", "r190" ] }, "us-gaap_OffsettingAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Assets", "label": "Offsetting Assets [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r189", "r354" ] }, "us-gaap_OffsettingDerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingDerivativeAssetsAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Assets", "label": "Offsetting Derivative Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingDerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingDerivativeLiabilitiesAbstract", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofMasterNettingAgreementsandRightsofOffsetDerivativeAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liabilities", "label": "Offsetting Derivative Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingLiabilitiesTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effect of Master-Netting Agreements and Rights of Offset, Liabilities", "label": "Offsetting Liabilities [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r189", "r354" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "terseLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r443", "r457", "r463", "r466", "r1143" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/LEASESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r885", "r1176" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 }, "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails", "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease liabilities", "verboseLabel": "Total lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r881" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liabilities (Note 6)", "terseLabel": "Operating lease liabilities, current portion", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r881" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liabilities (Note 6)", "terseLabel": "Operating lease liabilities, long-term portion", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r881" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts included in the measurement of operating lease liabilities", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r882", "r886" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/LEASESAssetsandLiabilitiesofOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease right-of-use assets (Note 6)", "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r880" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash operating lease cost", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r1306" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.edwards.com/role/LEASESMaturitiesOfOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average remaining lease term (in years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r888", "r1176" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carryforward Amount", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r121" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforwards [Line Items]", "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforwards [Table]", "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r120" ] }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsValuationAllowance", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails": { "parentTag": "ew_DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAllowance", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation Allowance", "label": "Operating Loss Carryforwards, Valuation Allowance", "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r119" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r456", "r457", "r458", "r459", "r460", "r466" ] }, "ew_OptionToAcquireInvestmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "OptionToAcquireInvestmentAmount", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Option to acquire investment amount", "label": "Option To Acquire Investment, Amount", "documentation": "Option To Acquire Investment, Amount" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r48" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r349", "r1177" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r338" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Prior service credit arising during period", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r42", "r59", "r372", "r869", "r872", "r875", "r1300" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Prior service credit arising during period", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r11", "r371", "r974" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails_1": { "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive income (loss)", "label": "Other Comprehensive Income (Loss), before Tax", "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r375", "r869", "r870", "r875", "r948", "r974", "r1300", "r1301" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-Tax Amount", "label": "Other Comprehensive Income (Loss), before Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized (loss) gain on hedges", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r356", "r361" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r356", "r361", "r828", "r829", "r834" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of gain (loss) reclassified from accumulated OCI into income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r361", "r363" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r293", "r361", "r363" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount excluded from effectiveness testing recognized in earnings based on an amortization approach", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), Adjustments, after Tax", "documentation": "Amount, after tax, of adjustments from accumulated other comprehensive income (AOCI) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r357", "r361", "r363", "r830" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5" ] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofDerivativeInstrumentsonConsolidatedCondensedStatementsofOperationsandConsolidatedCondensedStatementsofComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r831" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive income (loss), net of tax", "terseLabel": "Other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r26", "r42", "r366", "r369", "r375", "r869", "r870", "r875", "r948", "r974", "r1300", "r1301" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Net of Tax Amount", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), net of tax (Note\u00a016):", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized pension (costs) credits", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r9", "r193" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails_1": { "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": -1.0, "order": 2.0 }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Other comprehensive income (loss)", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r11", "r371", "r375", "r783", "r809", "r810", "r869", "r873", "r875", "r948", "r974" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxAbstract", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax (Expense) Benefit", "label": "Other Comprehensive Income (Loss), Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred income tax (expense) benefit", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r13", "r24", "r248" ] }, "us-gaap_OtherComprehensiveIncomeOtherNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeOtherNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive income (loss)", "label": "Other Comprehensive Income, Other, Net of Tax", "documentation": "Amount of increase (decrease) in other comprehensive income, after tax, from changes classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain (loss) on available-for-sale investments", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r358", "r361", "r512" ] }, "us-gaap_OtherIncomeAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndExpensesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Other Income and Expenses [Abstract]", "label": "Other Income and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENET" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER INCOME, NET", "label": "Other Income and Other Expense Disclosure [Text Block]", "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions." } } }, "auth_ref": [ "r229", "r237" ] }, "ew_OtherIncomeExpenseItems": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "OtherIncomeExpenseItems", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERINCOMENETDetails": { "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Other Income Expense Items", "documentation": "Reflects all other income and expense recognized by the entity in the period not otherwise specified in the income statement." } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods inventories held on consignment", "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross", "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller." } } }, "auth_ref": [ "r1298" ] }, "us-gaap_OtherInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherInvestmentsMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Other Investments [Member]", "documentation": "Primary financial statement caption encompassing other investments." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails": { "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Liabilities, Fair Value Disclosure", "documentation": "Fair value portion of other liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofChangesinFairValueofContingentConsiderationObligationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other liabilities." } } }, "auth_ref": [ "r152", "r165" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r52" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r212" ] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofLocationandFairValueAmountsofDerivativeInstrumentsReportedinConsolidatedCondensedBalanceSheetsDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 }, "http://www.edwards.com/role/OTHERINCOMENETDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/OTHERINCOMENETDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other income, net (Note\u00a017)", "terseLabel": "Other income, net", "netLabel": "Other income, net", "negatedTotalLabel": "Total other income, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r205" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income, net", "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "us-gaap_OtherNonrecurringIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonrecurringIncomeExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Special charge and separation costs (Note\u00a04)", "negatedLabel": "Special charge and separation costs", "label": "Other Nonrecurring (Income) Expense", "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature." } } }, "auth_ref": [ "r207" ] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income, net", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_OtherPaymentsToAcquireBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPaymentsToAcquireBusinesses", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments for acquisition options (Note 8)", "terseLabel": "Payment for acquisition options", "label": "Other Payments to Acquire Businesses", "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs." } } }, "auth_ref": [ "r64" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1236" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherReceivables", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other receivables", "label": "Other Receivables", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r342", "r1046" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1203", "r1215", "r1225", "r1251" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r1206", "r1218", "r1228", "r1254" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r1206", "r1218", "r1228", "r1254" ] }, "country_PR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "PR", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Puerto Rico", "label": "PUERTO RICO" } } }, "auth_ref": [] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParentMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Total Edwards Lifesciences Corporation Stockholders' Equity", "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentsMember", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Patents", "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r246" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r1232" ] }, "us-gaap_PaymentsForLegalSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForLegalSettlements", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for legal settlements", "label": "Payments for Legal Settlements", "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period." } } }, "auth_ref": [ "r14" ] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r1273", "r1303" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of treasury stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r66" ] }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of available-for-sale investments (Note\u00a07)", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r63", "r381", "r480" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total purchase price, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r64" ] }, "ew_PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Business combination, net of cash (Note\u00a09)", "label": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options", "documentation": "Payments To Acquire Businesses, Net Of Cash Acquired, Excluding Options" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireHeldToMaturitySecurities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of held-to-maturity investments (Note\u00a07)", "label": "Payments to Acquire Held-to-Maturity Securities", "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities." } } }, "auth_ref": [ "r63", "r480" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Investments in intangible assets", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r209" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r209" ] }, "us-gaap_PaymentsToAcquireReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireReceivables", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Issuances of notes receivable", "label": "Payments to Acquire Receivables", "documentation": "The cash outflow for the purchase of all receivables." } } }, "auth_ref": [ "r208" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r1235" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1235" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANS" ], "lang": { "en-us": { "role": { "terseLabel": "EMPLOYEE BENEFIT PLANS", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r650", "r674", "r676", "r682", "r701", "r703", "r704", "r705", "r706", "r707", "r722", "r723", "r725", "r1160" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined benefit pension plans", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r651", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r697", "r699", "r700", "r702", "r705", "r708", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r725", "r726", "r737", "r1160", "r1161", "r1165", "r1166", "r1167" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1234" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r1244" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r1237" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1233" ] }, "us-gaap_PlanAssetCategoriesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanAssetCategoriesDomain", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "documentation": "Defined benefit plan asset investment." } } }, "auth_ref": [ "r674", "r675", "r677", "r678", "r679", "r680", "r681", "r682", "r702", "r1158", "r1159", "r1160" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1463", "r1464", "r1465", "r1466", "r1467" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1463", "r1464", "r1465", "r1466", "r1467" ] }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PortionAtFairValueFairValueDisclosureMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion at Fair Value Measurement", "label": "Portion at Fair Value Measurement [Member]", "documentation": "Measured at fair value for financial reporting purposes." } } }, "auth_ref": [ "r860" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r182", "r621" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, authorized shares (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r182", "r1038" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r182", "r1038", "r1057", "r1506", "r1507" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r182", "r961", "r1177" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r348", "r539", "r540", "r1129" ] }, "us-gaap_PrepaidRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidRoyalties", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INTELLECTUALPROPERTYAGREEMENTANDEXPENSEDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid royalty asset", "label": "Prepaid Royalties", "documentation": "Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1130", "r1148", "r1343" ] }, "us-gaap_ProceedsFromCollectionOfNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromCollectionOfNotesReceivable", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Collections of notes receivable", "label": "Proceeds from Collection of Notes Receivable", "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r61" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Proceeds from issuance of debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r65", "r1012" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r1274", "r1304" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sales and maturities of available-for-sale investments (Note\u00a07)", "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale", "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)." } } }, "auth_ref": [ "r381", "r382", "r1324" ] }, "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sales and maturities of held-to-maturity investments (Note\u00a07)", "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities", "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities." } } }, "auth_ref": [ "r61", "r1324" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash from exercises of stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r12", "r31" ] }, "us-gaap_ProceedsFromStockPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockPlans", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from stock plans", "label": "Proceeds from Stock Plans", "documentation": "The cash inflow associated with the amount received from the stock plan during the period." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Information [Line Items]", "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r468", "r931", "r994", "r995", "r996", "r997", "r998", "r999", "r1124", "r1156", "r1178", "r1276", "r1363", "r1364", "r1375", "r1501" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued warranties", "label": "Product Warranty Accrual, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r48", "r1366", "r1367" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r468", "r931", "r994", "r995", "r996", "r997", "r998", "r999", "r1124", "r1156", "r1178", "r1276", "r1363", "r1364", "r1375", "r1501" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "verboseLabel": "Net income (loss)", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r328", "r365", "r368", "r384", "r392", "r410", "r418", "r419", "r443", "r457", "r463", "r466", "r519", "r577", "r578", "r580", "r581", "r582", "r584", "r586", "r588", "r589", "r819", "r822", "r823", "r846", "r862", "r953", "r971", "r1016", "r1059", "r1077", "r1078", "r1143", "r1172", "r1173", "r1189", "r1302", "r1369" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r17" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total property, plant and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r220", "r334", "r969" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant, and equipment, net (Note\u00a05)", "totalLabel": "Total property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r17", "r957", "r969", "r1177" ] }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNetAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant, and equipment, net", "label": "Property, Plant and Equipment, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r17", "r288", "r294", "r967" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r220" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful life (in years)", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "ew_PuertoRicoPurchasesCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "PuertoRicoPurchasesCreditMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Puerto Rico purchases credit", "label": "Puerto Rico Purchases Credit [Member]", "documentation": "Puerto Rico Purchases Credit [Member]" } } }, "auth_ref": [] }, "ew_PurchaseCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "PurchaseCreditMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase credit", "label": "Purchase Credit [Member]", "documentation": "Represents information pertaining to purchase credit carryforward." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r1232" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r1232" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r572", "r573", "r574", "r575", "r674", "r731", "r764", "r765", "r766", "r902", "r929", "r1000", "r1028", "r1029", "r1085", "r1089", "r1091", "r1092", "r1105", "r1121", "r1122", "r1144", "r1155", "r1168", "r1179", "r1182", "r1356", "r1373", "r1488", "r1489", "r1490", "r1491", "r1492" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/LEASESNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r572", "r573", "r574", "r575", "r674", "r731", "r764", "r765", "r766", "r902", "r929", "r1000", "r1028", "r1029", "r1085", "r1089", "r1091", "r1092", "r1105", "r1121", "r1122", "r1144", "r1155", "r1168", "r1179", "r1182", "r1356", "r1373", "r1488", "r1489", "r1490", "r1491", "r1492" ] }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts reclassified from accumulated other comprehensive loss to affected line on Consolidated Statements of Operations", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of prior service credit", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r59", "r372", "r869", "r874", "r875", "r974", "r1300" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "crdr": "debit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeOtherNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Amortization of prior service credit", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r42", "r59", "r372", "r869", "r874", "r875", "r1300" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss", "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r59" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAociCurrentPeriodTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails": { "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of prior service credit", "label": "Reclassification from AOCI, Current Period, Tax", "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r11", "r364", "r371", "r974" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "documentation": "Item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount Reclassified from Accumulated Other Comprehensive Loss", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r373" ] }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Amounts Reclassified from Accumulated Other Comprehensive Loss", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss)." } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unallocated amounts:", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r1198", "r1210", "r1220", "r1246" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r702", "r891", "r892", "r1031", "r1032", "r1033", "r1034", "r1035", "r1056", "r1058", "r1084" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r702", "r891", "r892", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r1031", "r1032", "r1033", "r1034", "r1035", "r1056", "r1058", "r1084", "r1484" ] }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments on debt and finance lease obligations", "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security", "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation." } } }, "auth_ref": [ "r67" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of pre-existing notes", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r68" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r395", "r396", "r594", "r623", "r893", "r1136", "r1137" ] }, "ew_ResearchAndDevelopmentAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ResearchAndDevelopmentAccruals", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development accruals", "label": "Research And Development Accruals", "documentation": "Aggregate carrying amount, as of the balance sheet date, of current obligations associated with research and development and clinical trials." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r176", "r775", "r1493" ] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development expenses", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development Costs", "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r774" ] }, "us-gaap_ResearchMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research expenditure tax credits", "label": "Research Tax Credit Carryforward [Member]", "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes." } } }, "auth_ref": [ "r120" ] }, "ew_RestOfWorldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "RestOfWorldMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rest of World", "label": "Rest of World [Member]", "documentation": "Represents the geographic areas of the world other than the United States, Europe and Japan." } } }, "auth_ref": [] }, "ew_RestOfWorldSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "RestOfWorldSegmentMember", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Rest of World", "terseLabel": "Rest of World", "label": "Rest of World Segment [Member]", "documentation": "Represents the reportable segment of the entity comprised of regions other than the United States, Europe and Japan (Rest of World)." } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r1199", "r1211", "r1221", "r1247" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r1200", "r1212", "r1222", "r1248" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r1207", "r1219", "r1229", "r1255" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash included in other current assets", "label": "Restricted Cash, Current", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r1292", "r1307" ] }, "us-gaap_RestrictedCashNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashNoncurrent", "crdr": "debit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash included in other assets", "label": "Restricted Cash, Noncurrent", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r283", "r1295", "r1307" ] }, "ew_RestrictedStockAndRestrictedStockUnitAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "RestrictedStockAndRestrictedStockUnitAwardsMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock or restricted stock units", "label": "Restricted Stock and Restricted Stock Unit Awards [Member]", "documentation": "Restricted stock and restricted stock units awarded by a company to their employees as a form of incentive compensation." } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock units", "verboseLabel": "Nonvested restricted stock unit activity", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "ew_RestructuringContingentConsiderationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "RestructuringContingentConsiderationGainLoss", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring contingent consideration gain", "label": "Restructuring, Contingent Consideration, Gain (Loss)", "documentation": "Restructuring, Contingent Consideration, Gain (Loss)" } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r562", "r563", "r564", "r565", "r566", "r567", "r568" ] }, "us-gaap_RestructuringCostsAndAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostsAndAssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Special charge", "label": "Restructuring Costs and Asset Impairment Charges", "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r16" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveCurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails": { "parentTag": "ew_AccruedAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSScheduleofComponentsofSelectedCaptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued realignment reserves", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r1297", "r1357", "r1358" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r185", "r227", "r964", "r1004", "r1006", "r1013", "r1039", "r1177" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r325", "r407", "r408", "r409", "r411", "r417", "r419", "r520", "r521", "r770", "r771", "r772", "r801", "r802", "r835", "r837", "r838", "r840", "r844", "r1001", "r1003", "r1017", "r1506" ] }, "us-gaap_RetirementPlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanNameAxis", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Name [Axis]", "label": "Retirement Plan Name [Axis]", "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans." } } }, "auth_ref": [ "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r1168", "r1275", "r1378", "r1379", "r1380", "r1381", "r1382", "r1383", "r1384", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1410", "r1411", "r1412", "r1413", "r1414", "r1415", "r1416", "r1417", "r1418", "r1419", "r1420", "r1421", "r1422", "r1423", "r1424", "r1425", "r1426", "r1427", "r1428", "r1429", "r1430", "r1431", "r1432", "r1433", "r1434", "r1435", "r1436", "r1437" ] }, "us-gaap_RetirementPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanNameDomain", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Name [Domain]", "label": "Retirement Plan Name [Domain]", "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans." } } }, "auth_ref": [ "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r1168", "r1275", "r1378", "r1379", "r1380", "r1381", "r1382", "r1383", "r1384", "r1385", "r1386", "r1387", "r1388", "r1389", "r1390", "r1391", "r1392", "r1393", "r1394", "r1395", "r1396", "r1397", "r1398", "r1399", "r1400", "r1401", "r1402", "r1403", "r1404", "r1405", "r1406", "r1407", "r1408", "r1409", "r1410", "r1411", "r1412", "r1413", "r1414", "r1415", "r1416", "r1417", "r1418", "r1419", "r1420", "r1421", "r1422", "r1423", "r1424", "r1425", "r1426", "r1427", "r1428", "r1429", "r1430", "r1431", "r1432", "r1433", "r1434", "r1435", "r1436", "r1437" ] }, "us-gaap_RetirementPlanSponsorLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationAxis", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Axis]", "label": "Retirement Plan Sponsor Location [Axis]", "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r697", "r698", "r699", "r700", "r702", "r705", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r1439", "r1440", "r1441" ] }, "us-gaap_RetirementPlanSponsorLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanSponsorLocationDomain", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Sponsor Location [Domain]", "label": "Retirement Plan Sponsor Location [Domain]", "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [ "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r697", "r698", "r699", "r700", "r702", "r705", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r1439", "r1440", "r1441" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r651", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r697", "r699", "r700", "r702", "r705", "r708", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r725", "r726", "r727", "r737", "r1160", "r1161", "r1162", "r1163", "r1164", "r1165", "r1166", "r1167" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r651", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r697", "r699", "r700", "r702", "r705", "r708", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r725", "r726", "r727", "r737", "r1160", "r1161", "r1162", "r1163", "r1164", "r1165", "r1166", "r1167" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "verboseLabel": "Total segment net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r444", "r445", "r456", "r461", "r462", "r468", "r470", "r472", "r646", "r647", "r931" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition and Shipping and Handling Costs", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r299", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r1123" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period (in years)", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r291" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation." } } }, "auth_ref": [] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Net Sales", "verboseLabel": "Net Sales by Geographic Area and by Major Product Area", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Enterprise-Wide Information", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r887", "r1176" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1264" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1264" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r55" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Activity for Each Component of Accumulated Other Comprehensive Loss", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r59", "r1480", "r1481" ] }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Target Weighted-Average Asset Allocations and Fair Value", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall." } } }, "auth_ref": [ "r232" ] }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Change in Unrealized Pension Costs", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost." } } }, "auth_ref": [ "r231" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r76" ] }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted-Average Assumptions Used to Determine Benefit Obligations", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate." } } }, "auth_ref": [ "r696" ] }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Available-for-sale [Line Items]", "label": "Debt Securities, Available-for-Sale [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r124", "r126", "r815" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash and Cash Equivalents", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings." } } }, "auth_ref": [ "r159" ] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash Flow Information", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Provision for Income Taxes", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r240" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of the Notes", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r51", "r98", "r99", "r170", "r171", "r173", "r175", "r225", "r226", "r1151", "r1153", "r1311" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Tax Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r239" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofChangesinFairValueofDefinedBenefitPlanAssetsClassifiedasLevel3Details", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofInformationRegardingDefinedBenefitPensionPlansDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofNetPeriodicBenefitCostDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails", "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofWeightedAverageAssumptionsUsedtoDetermineBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r18", "r106", "r107", "r108", "r109" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effect of Derivative Instruments on Consolidated Condensed Statements of Operations and Consolidated Condensed Statements of Comprehensive Income", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r153", "r158", "r832" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1320" ] }, "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in Fair Value of Defined Benefit Plan Assets Classified as Level 3", "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]", "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period." } } }, "auth_ref": [ "r1402" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r238" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r115" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r115" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r516", "r517", "r518" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments [Line Items]", "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r392", "r516", "r517", "r518", "r519", "r862" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESInvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments [Table]", "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r328", "r392", "r516", "r517", "r518", "r519", "r862" ] }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Benefit Payments Which Reflect Expected Future Service", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter." } } }, "auth_ref": [ "r233" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r849", "r850" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofOtherIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r89", "r92", "r932" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Other Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r89", "r92" ] }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Location and Fair Value Amounts of Derivative Instruments Reported in Consolidated Condensed Balance Sheets", "label": "Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block]", "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts." } } }, "auth_ref": [ "r156" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r1149" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in the Carrying Amount of Goodwill, by Segment", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r1149", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354" ] }, "us-gaap_ScheduleOfHeldToMaturitySecuritiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfHeldToMaturitySecuritiesTable", "presentation": [ "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Held-to-maturity [Table]", "label": "Debt Securities, Held-to-Maturity [Table]", "documentation": "Disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511" ] }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income Before Provisions for Income Taxes", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions." } } }, "auth_ref": [ "r1310" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESGoodwillandIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity." } } }, "auth_ref": [ "r33", "r219" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Other Intangible Assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r33", "r219" ] }, "us-gaap_ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investments in Unconsolidated Affiliates", "label": "Schedule of Investments in and Advances to Affiliates, Schedule of Investments [Table Text Block]", "documentation": "A tabular presentation of the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates, as prescribed by the SEC. It reflects specified information about ownership, financial results from, and financial position in such entities. Includes the tabular presentations that disaggregate investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Periodic Benefit Cost", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r234" ] }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Stock Unit Activity", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units." } } }, "auth_ref": [ "r113" ] }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Financial Instruments Used to Manage Currency Exchange and Interest Rate Risk", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions." } } }, "auth_ref": [ "r146" ] }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERINCOMENETTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Income, Net", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Product Information [Table]", "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r17" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Values of Assets Acquired and Liabilities Assumed", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r245" ] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Cash", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r40", "r255", "r1500" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r562", "r563", "r564", "r565", "r566", "r567", "r568" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Enterprise-Wide Information", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r85", "r198" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries." } } }, "auth_ref": [ "r85", "r194" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r81", "r82", "r83", "r86" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Information About Reportable Segments and Reconciliation of Segment Net Sales and Pre-Tax Income", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r81", "r82", "r83", "r86" ] }, "ew_ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ScheduleOfSelectedCaptionsBalanceSheetDisclosuresTableTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Selected Captions in the Consolidated Balance Sheets", "label": "Schedule of Selected Captions Balance Sheet Disclosures [Table Text Block]", "documentation": "Schedule of the aggregate supplemental balance sheet disclosures, including descriptions and amounts, related to assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r738", "r740", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r29", "r30", "r112" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted-Average Assumptions for ESPP Subscriptions", "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r236" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted-Average Assumptions for Options Granted", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r236" ] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]", "label": "Debt and Equity Securities, FV-NI [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "presentation": [ "http://www.edwards.com/role/INVESTMENTSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [] }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTS" ], "lang": { "en-us": { "role": { "terseLabel": "VALUATION AND QUALIFYING ACCOUNTS", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "documentation": "The entire disclosure for valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r303", "r406" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Variable Interest Entities [Table]", "label": "Schedule of Variable Interest Entities [Table]", "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r136", "r137", "r138", "r139", "r140", "r820", "r821", "r825", "r826", "r910", "r911", "r912" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Estimated Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r92" ] }, "ew_SecuredOvernightFinancingRateSOFRMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "SecuredOvernightFinancingRateSOFRMember", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured Overnight Financing Rate", "label": "Secured Overnight Financing Rate (SOFR) [Member]", "documentation": "Secured Overnight Financing Rate [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1191" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1194" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r440", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r466", "r472", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r565", "r568", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r1149", "r1276", "r1501" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r304", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r470", "r471", "r1021", "r1024", "r1026", "r1086", "r1090", "r1093", "r1106", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1125", "r1157", "r1182", "r1375", "r1501" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "SEGMENT INFORMATION", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r439", "r440", "r441", "r442", "r443", "r455", "r460", "r464", "r465", "r466", "r467", "r468", "r469", "r472" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofReconciliationofSegmentNetSalesandPreTaxIncomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative expenses", "negatedLabel": "Selling, general, and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r201" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.edwards.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofEffectofFairValueandCashFlowHedgeAccountingontheConsolidatedCondensedStatementsofOperationsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative expenses", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "ew_SeniorNotesDue2018Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "SeniorNotesDue2018Member", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2018 Notes", "label": "Senior Notes Due 2018 [Member]", "documentation": "Represents information pertaining to senior notes which are due in 2018." } } }, "auth_ref": [] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotesMember", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails", "http://www.edwards.com/role/DEBTANDCREDITFACILITIESScheduleoftheNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation (Notes\u00a02 and 15)", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting period (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r1169" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r758" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r758" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r756" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r756" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r753", "r754" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in dollars per share)", "periodEndLabel": "Ending balance (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r753", "r754" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted- Average Grant-Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r757" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r757" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r765" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r764" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r766" ] }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueOfStockOptionsExercisedAndVestedRestrictedStockUnits", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intrinsic value of stock options exercised and restricted stock units vested", "label": "Share Based Compensation Arrangement by Share Based Payment Award, Intrinsic Value of Stock Options Exercised and Vested Restricted Stock Units", "documentation": "This element represents the intrinsic value of stock options exercised and restricted stock units that vested during the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r738", "r740", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum percentage of compensation employees can authorize to be withheld for common stock purchases (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate", "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan." } } }, "auth_ref": [ "r110" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock available for issuance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r1171" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable as of period end (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r747" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable as of period end (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r747" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Options forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r751" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures", "documentation": "Net number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r1449" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value, per share (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r759" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding as of period end", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r110" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r745", "r746" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in dollars per share)", "periodEndLabel": "Ending balance (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r745", "r746" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted- Average Exercise Price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest as of period end", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r761" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest as of period end (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r761" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest as of period end (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r761" ] }, "ew_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGrantDateFairValue", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total grant date fair value of stock options vested", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options Vested in Period, Grant Date Fair Value", "documentation": "Represents the total grant-date fair value of options that vested during the period." } } }, "auth_ref": [] }, "ew_ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual award to nonemployee director", "label": "Share-based Compensation Arrangements Award Granted Annually to Nonemployee Director [Member]", "documentation": "This element represents details pertaining to an award granted annually to a nonemployee director." } } }, "auth_ref": [] }, "ew_ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Awards granted in 2012 and later", "label": "Share Based Compensation Arrangements Awards Granted 2012 and after [Member]", "documentation": "This element represents details pertaining to awards granted in 2012 and years after." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofRestrictedStockUnitActivityDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails", "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options exercised (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r750" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options forfeited (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r751" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options granted (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r749" ] }, "ew_ShareInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "ShareInformationAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Share information (Note\u00a02):", "label": "Share Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareRepurchaseProgramAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramAxis", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Axis]", "label": "Share Repurchase Program [Axis]", "documentation": "Information by share repurchase program." } } }, "auth_ref": [] }, "us-gaap_ShareRepurchaseProgramDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareRepurchaseProgramDomain", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share Repurchase Program [Domain]", "label": "Share Repurchase Program [Domain]", "documentation": "Name of the share repurchase program." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESStockbasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage vesting upon retirement for each full year of employment subsequent to the grant date (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1442" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration date (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1170" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofWeightedAverageAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r763" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable as of period end", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r110" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable as of period end", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r110" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding as of period end", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r235" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest as of period end", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r761" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKEmployeeandDirectorStockPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of lower of fair market value of common stock on effective date of subscription or date of purchase (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "documentation": "Purchase price of common stock expressed as a percentage of its fair value." } } }, "auth_ref": [] }, "us-gaap_ShippingAndHandlingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShippingAndHandlingMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESShippingandHandlingCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shipping and Handling", "label": "Shipping and Handling [Member]", "documentation": "Packing and transport of product." } } }, "auth_ref": [ "r1376" ] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments (Note\u00a07)", "label": "Short-Term Investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r263", "r264", "r1299" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "lang": { "en-us": { "role": { "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r213", "r389" ] }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyPlantandEquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software", "label": "Software and Software Development Costs [Member]", "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "ew_SpecialChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "SpecialChargeMember", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Special Charge", "label": "Special Charge [Member]", "documentation": "Special Charge" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and local jurisdiction", "verboseLabel": "United States state net operating losses", "netLabel": "California research expenditure tax credits", "label": "State and Local Jurisdiction [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r327", "r440", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r466", "r472", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r561", "r565", "r568", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r1149", "r1276", "r1501" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofAmountsReclassifiedfromAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofChangeinUnrealizedPensionCostsDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r26", "r54", "r325", "r371", "r372", "r373", "r407", "r408", "r409", "r411", "r417", "r419", "r438", "r520", "r521", "r635", "r770", "r771", "r772", "r801", "r802", "r835", "r836", "r837", "r838", "r839", "r840", "r844", "r869", "r871", "r872", "r873", "r874", "r875", "r890", "r1001", "r1002", "r1003", "r1017", "r1079" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r304", "r314", "r470", "r471", "r1021", "r1024", "r1026", "r1086", "r1090", "r1093", "r1106", "r1109", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1125", "r1157", "r1182", "r1375", "r1501" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r407", "r408", "r409", "r438", "r931", "r1007", "r1018", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1038", "r1041", "r1042", "r1043", "r1044", "r1045", "r1047", "r1048", "r1049", "r1050", "r1052", "r1053", "r1054", "r1055", "r1056", "r1058", "r1060", "r1061", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1079", "r1183" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r407", "r408", "r409", "r438", "r931", "r1007", "r1018", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1038", "r1041", "r1042", "r1043", "r1044", "r1045", "r1047", "r1048", "r1049", "r1050", "r1052", "r1053", "r1054", "r1055", "r1056", "r1058", "r1060", "r1061", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1079", "r1183" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r1202", "r1214", "r1224", "r1250" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockCompensationPlanMember", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESEarningsperShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation plan", "label": "Share-Based Payment Arrangement [Member]", "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares." } } }, "auth_ref": [ "r1321" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under equity plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r26", "r182", "r183", "r227" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Options exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r26", "r182", "r183", "r227", "r750" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under equity plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r114", "r182", "r183", "r227" ] }, "ew_StockRepurchaseProgramAdditionalAuthorizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "StockRepurchaseProgramAdditionalAuthorizedAmount", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional authorized amount", "label": "Stock Repurchase Program, Additional Authorized Amount", "documentation": "Stock Repurchase Program, Additional Authorized Amount" } } }, "auth_ref": [] }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Authorized amount for share repurchase", "terseLabel": "Amount Paid", "label": "Stock Repurchase Program, Authorized Amount", "documentation": "Amount of stock repurchase plan authorized." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSScheduleofActivityforEachComponentofAccumulatedOtherComprehensiveLossDetails", "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total Edwards Lifesciences Corporation stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r183", "r186", "r187", "r214", "r1040", "r1057", "r1080", "r1081", "r1177", "r1190", "r1309", "r1340", "r1479", "r1506" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r132", "r133", "r141", "r325", "r326", "r372", "r407", "r408", "r409", "r411", "r417", "r520", "r521", "r635", "r770", "r771", "r772", "r801", "r802", "r835", "r836", "r837", "r838", "r839", "r840", "r844", "r869", "r871", "r875", "r890", "r1002", "r1003", "r1015", "r1040", "r1057", "r1080", "r1081", "r1107", "r1189", "r1309", "r1340", "r1479", "r1506" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' equity (Note\u00a015)", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/COMMONSTOCK" ], "lang": { "en-us": { "role": { "terseLabel": "COMMON STOCK", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r224", "r391", "r620", "r622", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r634", "r635", "r843", "r1082", "r1083", "r1108" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r876", "r895" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r876", "r895" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r876", "r895" ] }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Beginning and Ending Amount of Uncertain Tax Positions", "label": "Summary of Income Tax Contingencies [Table Text Block]", "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months." } } }, "auth_ref": [ "r23", "r241", "r242" ] }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Operating Loss Carryforwards", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r120" ] }, "us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfTaxCreditCarryforwardsTextBlock", "presentation": [ "http://www.edwards.com/role/INCOMETAXESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Tax Credit Carryforwards", "label": "Summary of Tax Credit Carryforwards [Table Text Block]", "documentation": "Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances." } } }, "auth_ref": [ "r120" ] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILS" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r1291" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.edwards.com/role/OTHERCONSOLIDATEDFINANCIALSTATEMENTDETAILSSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash paid during the year for:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ew_SurgicalHeartValveTherapyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "SurgicalHeartValveTherapyMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Surgical Structural Heart", "label": "Surgical Heart Valve Therapy [Member]", "documentation": "This element represents the surgical heart valve therapy product line." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r1243" ] }, "ew_TaxCarryforwardsExpirationPeriodEnds2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TaxCarryforwardsExpirationPeriodEnds2025Member", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Carryforwards Expiration Period Ends 2025", "label": "Tax Carryforwards Expiration Period Ends 2025 [Member]", "documentation": "Tax Carryforwards Expiration Period Ends 2025" } } }, "auth_ref": [] }, "ew_TaxCarryforwardsExpirationPeriodYears20262039Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TaxCarryforwardsExpirationPeriodYears20262039Member", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Carryforwards Expiration Period Years 2026-2039", "label": "Tax Carryforwards Expiration Period Years 2026-2039 [Member]", "documentation": "Tax Carryforwards Expiration Period Years 2026-2039" } } }, "auth_ref": [] }, "ew_TaxCarryforwardsExpirationPeriodYears20262041Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TaxCarryforwardsExpirationPeriodYears20262041Member", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carryforward Period Ends 2026-2041", "label": "Tax Carryforwards Expiration Period Years 2026-2041 [Member]", "documentation": "Tax Carryforwards Expiration Period Years 2026-2041 [Member]" } } }, "auth_ref": [] }, "ew_TaxCarryforwardsExpirationPeriodYears20302033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TaxCarryforwardsExpirationPeriodYears20302033Member", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Carryforwards Expiration Period Years 2030-2033", "label": "Tax Carryforwards Expiration Period Years 2030-2033 [Member]", "documentation": "Tax Carryforwards Expiration Period Years 2030-2033" } } }, "auth_ref": [] }, "ew_TaxCarryforwardsNoExpirationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TaxCarryforwardsNoExpirationMember", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Carryforward period indefinite", "terseLabel": "Carryforward Period Indefinite", "label": "Tax Carryforwards, No Expiration [Member]", "documentation": "Represents tax carryforwards with no expiration." } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails": { "parentTag": "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carryforward amount", "verboseLabel": "Carryforward Amount", "label": "Tax Credit Carryforward, Amount", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r121" ] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward [Axis]", "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r120" ] }, "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "crdr": "debit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Tax Benefit", "label": "Tax Credit Carryforward, Deferred Tax Asset, Net of Valuation Allowance", "documentation": "Represents the amount after allocation of valuation allowances of deferred tax asset attributable to tax credit carryforwards." } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardLineItems", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax credit carryforwards and the related carryforward periods", "label": "Tax Credit Carryforward [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward, Name [Domain]", "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r120" ] }, "us-gaap_TaxCreditCarryforwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardTable", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Credit Carryforward [Table]", "label": "Tax Credit Carryforward [Table]", "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances." } } }, "auth_ref": [ "r120" ] }, "us-gaap_TaxCreditCarryforwardValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardValuationAllowance", "crdr": "credit", "calculation": { "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails": { "parentTag": "ew_TaxCreditCarryforwardDeferredTaxAssetNetOfValuationAllowance", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation Allowance", "label": "Tax Credit Carryforward, Valuation Allowance", "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r119" ] }, "us-gaap_TaxPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodAxis", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Period [Axis]", "label": "Tax Period [Axis]", "documentation": "Information about the period subject to enacted tax laws." } } }, "auth_ref": [] }, "us-gaap_TaxPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxPeriodDomain", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Period [Domain]", "label": "Tax Period [Domain]", "documentation": "Identified tax period." } } }, "auth_ref": [] }, "us-gaap_TaxesPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxesPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes payable (Note 18)", "label": "Taxes Payable", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes." } } }, "auth_ref": [ "r178", "r258", "r1498" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1235" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r1242" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r271", "r272", "r273", "r475", "r476", "r478" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r1263" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1265" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.edwards.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ew_TranscatheterAorticValveReplacementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TranscatheterAorticValveReplacementMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transcatheter Aortic Valve Replacement", "label": "Transcatheter Aortic Valve Replacement [Member]", "documentation": "Transcatheter Aortic Valve Replacement [Member]" } } }, "auth_ref": [] }, "ew_TranscatheterMitralAndTricuspidTherapiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "TranscatheterMitralAndTricuspidTherapiesMember", "presentation": [ "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transcatheter Mitral and Tricuspid Therapies", "label": "Transcatheter Mitral And Tricuspid Therapies [Member]", "documentation": "Transcatheter Mitral And Tricuspid Therapies [Member]" } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r615", "r633", "r842", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r913", "r914", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925", "r926", "r927", "r928", "r975", "r1278", "r1279", "r1280", "r1281", "r1282", "r1283", "r1284", "r1335", "r1336", "r1337", "r1338" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1266" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1267" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1265" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1265" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1268" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1266" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r100" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock (in shares)", "periodStartLabel": "Treasury stock, beginning balance (in shares)", "periodEndLabel": "Treasury stock, ending balance (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r100" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost, 49.4 and 38.0 shares, respectively", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r56", "r100", "r103" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofAcceleratedShareRepurchasesDetails", "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "netLabel": "Purchases of treasury stock (in shares)", "verboseLabel": "Shares Received (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r26", "r183", "r227" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKTreasuryStockDetails", "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of treasury stock", "verboseLabel": "Purchases of treasury stock", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r26", "r100", "r227" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofNetOperatingLossCarryforwardsDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofTaxCreditCarryforwardsDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofEnterpriseWideInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "label": "UNITED STATES" } } }, "auth_ref": [] }, "us-gaap_USGovernmentDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USGovernmentDebtSecuritiesMember", "presentation": [ "http://www.edwards.com/role/EMPLOYEEBENEFITPLANSScheduleofTargetWeightedAverageAssetAllocationsandFairValueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States government bonds", "label": "US Government Debt Securities [Member]", "documentation": "Debt securities issued by the United States government." } } }, "auth_ref": [ "r1494" ] }, "us-gaap_USTreasuryAndGovernmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "USTreasuryAndGovernmentMember", "presentation": [ "http://www.edwards.com/role/FAIRVALUEMEASUREMENTSScheduleofFinancialInstrumentsMeasuredatFairValueonaRecurringBasisDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofInvestmentsinDebtSecuritiesDetails", "http://www.edwards.com/role/INVESTMENTSScheduleofUnrealizedLossesonDebtSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. government and agency securities", "verboseLabel": "United States government and agency securities", "label": "US Treasury and Government [Member]", "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)." } } }, "auth_ref": [ "r954", "r1158", "r1502" ] }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UndistributedEarningsOfForeignSubsidiaries", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign earnings to be indefinitely reinvested", "label": "Undistributed Earnings of Foreign Subsidiaries", "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile." } } }, "auth_ref": [ "r19", "r20", "r777", "r813" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r1262" ] }, "ew_UnitedStatesSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "UnitedStatesSegmentMember", "presentation": [ "http://www.edwards.com/role/GOODWILLANDOTHERINTANGIBLEASSETSScheduleofChangesintheCarryingAmountofGoodwillbySegmentDetails", "http://www.edwards.com/role/SEGMENTINFORMATIONScheduleofInformationaboutReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "United States", "terseLabel": "United States", "label": "United States Segment [Member]", "documentation": "Represents the United States reportable segment of the entity." } } }, "auth_ref": [] }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Investments in Debt Securities", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "documentation": "Tabular disclosure of unrealized gains and losses on investments." } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails", "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability for income taxes associated with uncertain tax positions", "periodStartLabel": "Uncertain gross tax positions, beginning balance", "periodEndLabel": "Uncertain gross tax positions, ending balance", "label": "Unrecognized Tax Benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r778", "r786" ] }, "ew_UnrecognizedTaxBenefitsAccruedInterestTaxBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "UnrecognizedTaxBenefitsAccruedInterestTaxBenefit", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax benefit of accrued interest", "label": "Unrecognized Tax Benefits, Accrued Interest, Tax Benefit", "documentation": "The tax benefits pertaining to the amount of interest expense accrued on unrecognized tax benefits." } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease in prior year tax positions", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r787" ] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Settlements", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities." } } }, "auth_ref": [ "r789" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current year tax positions", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return." } } }, "auth_ref": [ "r788" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in prior year tax positions", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r787" ] }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest related to unrecognized tax benefits, net of tax benefit", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "documentation": "Amount of interest expense accrued for an underpayment of income taxes." } } }, "auth_ref": [ "r1469" ] }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense (benefit), net of tax benefit", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense", "documentation": "Amount of interest expense for an underpayment of income taxes." } } }, "auth_ref": [ "r1469" ] }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESScheduleofReconciliationofUncertainTaxPositionsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Lapse of statutes of limitations", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations." } } }, "auth_ref": [ "r790" ] }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/INCOMETAXESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net amounts that would favorably affect effective tax rate", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate." } } }, "auth_ref": [ "r791" ] }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/SPECIALCHARGEANDSEPARATIONCOSTS" ], "lang": { "en-us": { "role": { "terseLabel": "SPECIAL CHARGE AND SEPARATION COSTS", "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]", "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both." } } }, "auth_ref": [ "r206" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r78", "r79", "r80", "r286", "r287", "r289", "r290" ] }, "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceOfDeferredTaxAssetsMember", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax valuation allowance", "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]", "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward." } } }, "auth_ref": [ "r1312", "r1313", "r1314", "r1315", "r1316" ] }, "us-gaap_ValuationAllowancesAndReservesBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesBalance", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at Beginning of Period", "periodEndLabel": "Balance at End of Period", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "documentation": "Amount of valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r399", "r405" ] }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charged to Costs and Expenses", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense." } } }, "auth_ref": [ "r402" ] }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "crdr": "credit", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charged to Other Accounts", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense." } } }, "auth_ref": [ "r403" ] }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDeductions", "crdr": "debit", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deductions", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "documentation": "Amount of decrease in valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r404" ] }, "us-gaap_ValuationAllowancesAndReservesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesDomain", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "documentation": "Valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r399", "r400", "r401", "r404", "r405" ] }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowancesAndReservesTypeAxis", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "documentation": "Information by valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r399", "r400", "r401", "r404", "r405" ] }, "srt_ValuationAndQualifyingAccountsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsAbstract", "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "auth_ref": [] }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Valuation and Qualifying Accounts Disclosure", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r303", "r399", "r400", "r401", "r404", "r405" ] }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ValuationAndQualifyingAccountsDisclosureTable", "presentation": [ "http://www.edwards.com/role/VALUATIONANDQUALIFYINGACCOUNTSDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "documentation": "Disclosure of valuation and qualifying accounts and reserves." } } }, "auth_ref": [ "r303", "r399", "r400", "r401", "r404", "r405" ] }, "ew_VariableInterestEntitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "VariableInterestEntitiesAbstract", "lang": { "en-us": { "role": { "label": "Variable Interest Entities [Abstract]", "documentation": "Variable Interest Entities" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityDisclosureTextBlock", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIES" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENTS IN VARIABLE INTEREST ENTITIES", "label": "Variable Interest Entity Disclosure [Text Block]", "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss." } } }, "auth_ref": [ "r247" ] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity [Line Items]", "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r820", "r821", "r825", "r826", "r910", "r911", "r912" ] }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "presentation": [ "http://www.edwards.com/role/INVESTMENTSINVARIABLEINTERESTENTITIESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity, Not Primary Beneficiary", "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityPrimaryBeneficiaryMember", "presentation": [ "http://www.edwards.com/role/BUSINESSCOMBINATIONSNarrativeDetails", "http://www.edwards.com/role/BUSINESSCOMBINATIONSScheduleofFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity, Primary Beneficiary", "label": "Variable Interest Entity, Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity." } } }, "auth_ref": [ "r136", "r820", "r821", "r825", "r826" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.edwards.com/role/DEBTANDCREDITFACILITIESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Dilutive weighted-average shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r422", "r435" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average number of common shares outstanding attributable to Edwards Lifesciences Corporation:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.edwards.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.edwards.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofComputationofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r420", "r435" ] }, "ew_WeightedAverageRemainingContractualTermYearsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.edwards.com/20231231", "localname": "WeightedAverageRemainingContractualTermYearsAbstract", "presentation": [ "http://www.edwards.com/role/COMMONSTOCKScheduleofStockOptionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted- Average Remaining Contractual Term", "label": "Weighted Average Remaining Contractual Term Years [Abstract]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "b", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "740", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481141/942-740-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "740", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480135/944-740-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "30", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "e", "SubTopic": "470", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-13" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a),(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b),(f(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-4A" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a),(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220/tableOfContent" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//220-20/tableOfContent" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r214": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r215": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r216": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r217": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r218": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r219": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r220": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r221": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r222": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r223": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r224": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r225": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r226": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r227": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r228": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481138/505-30-25-5" }, "r229": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "610", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//610/tableOfContent" }, "r230": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r231": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r232": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(d)(5)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r233": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(f)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r234": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r235": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r236": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r237": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "720", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//720/tableOfContent" }, "r238": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r239": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r240": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r241": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r242": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r243": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r244": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r245": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r246": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r247": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r248": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r249": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r250": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r251": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "25", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r252": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r253": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r254": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "940", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//940-320/tableOfContent" }, "r255": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r256": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r257": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r258": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r259": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r260": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r261": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r262": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r263": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r264": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r265": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r266": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r267": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r268": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "b.", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481160/942-230-45-1" }, "r269": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//942-320/tableOfContent" }, "r270": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//946-320/tableOfContent" }, "r271": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r272": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r273": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r274": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r275": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r276": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r277": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r278": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r279": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r280": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-6" }, "r281": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-7" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1403", "Paragraph": "(b)", "Publisher": "SEC" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "09", "Publisher": "SEC" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "(m)", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-5" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482620/740-10-25-3" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-6" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r950": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r951": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r952": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r953": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r954": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r955": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3" }, "r956": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A" }, "r957": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r958": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r959": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r960": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r961": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r962": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r963": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r964": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r965": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r966": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r967": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r968": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r969": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r970": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r971": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r972": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r973": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r974": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r975": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r976": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r977": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r978": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r979": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r980": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r981": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r982": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r983": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r984": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r985": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r986": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r987": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r988": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r989": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r990": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r991": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r992": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r993": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r994": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r995": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r996": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r997": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r998": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r999": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r1000": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r1001": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r1002": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r1003": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r1004": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r1005": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r1006": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r1007": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r1008": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r1009": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r1010": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r1011": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r1012": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r1013": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r1014": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r1015": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r1016": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r1017": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1018": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r1019": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1020": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1021": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1022": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1023": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r1024": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r1025": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1026": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1027": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1028": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1029": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1030": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1031": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1032": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1033": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1034": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1035": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1036": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1037": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1038": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1039": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1040": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1041": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1042": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1043": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1044": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1045": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1046": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1047": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1048": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1049": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1050": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1051": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1052": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1053": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1054": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1055": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1056": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r1057": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r1058": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1059": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r1060": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1061": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1062": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1063": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1064": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1065": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1066": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1067": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1068": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1069": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1070": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1071": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1072": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1073": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1074": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1075": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1076": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1077": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1078": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1079": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1080": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1081": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1082": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r1083": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r1084": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1085": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1086": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1087": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r1088": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r1089": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1090": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1091": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1092": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1093": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1094": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r1095": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r1096": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r1097": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r1098": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1099": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r1102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r1103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r1104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r1105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r1108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r1109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r1110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r1111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r1121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r1122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r1123": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r1124": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1125": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1126": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r1127": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r1128": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r1129": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r1130": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r1131": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1132": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1133": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1134": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r1135": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20" }, "r1136": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r1137": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r1138": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r1139": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r1140": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r1141": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r1142": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r1143": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r1144": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r1145": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "79", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79" }, "r1146": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "80", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80" }, "r1147": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r1148": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r1149": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r1150": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1151": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r1152": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r1153": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r1154": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r1155": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r1156": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1157": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1158": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1159": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1160": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r1161": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r1162": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r1163": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r1164": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r1165": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r1166": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r1167": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r1168": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r1169": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1170": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1171": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1172": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r1173": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r1174": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r1175": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1176": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r1177": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r1178": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r1179": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r1180": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1181": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1182": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r1183": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1184": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1185": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1186": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1187": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1188": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r1189": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r1190": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r1191": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1192": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1193": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r1194": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1195": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r1196": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r1197": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r1198": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r1199": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r1200": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1201": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1202": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1203": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1204": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1205": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r1206": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r1207": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r1208": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r1209": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r1210": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r1211": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r1212": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1213": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1214": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1215": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1216": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1217": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r1218": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r1219": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r1220": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r1221": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r1222": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1223": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1224": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1225": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1226": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1227": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r1228": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r1229": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r1230": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1231": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r1232": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r1233": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r1234": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r1235": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r1236": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r1237": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r1238": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r1239": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r1240": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r1241": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r1242": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r1243": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r1244": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r1245": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r1246": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r1247": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r1248": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1249": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1250": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1251": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1252": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1253": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1254": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1255": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1256": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1257": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1258": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1259": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1260": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1261": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1262": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1263": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1264": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1265": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1266": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1267": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1268": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1269": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1270": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1271": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r1272": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1273": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r1274": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r1275": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1276": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r1277": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1278": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r1279": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1280": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1281": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1282": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1283": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1284": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1285": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1404", "Paragraph": "(a)", "Publisher": "SEC" }, "r1286": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r1287": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(ii)", "Publisher": "SEC" }, "r1288": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iii)", "Publisher": "SEC" }, "r1289": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1290": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r1291": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//210/tableOfContent" }, "r1292": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1293": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1294": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1295": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1296": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1297": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1298": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1299": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1300": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1301": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1302": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1303": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r1304": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1305": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1306": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1307": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r1308": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1309": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1310": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1311": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1312": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1313": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SX 210.12-09(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4" }, "r1317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r1323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r1324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11" }, "r1325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r1330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1331": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1332": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1333": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1334": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r1335": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r1336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r1342": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r1343": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r1344": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r1354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r1355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r1356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r1358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r1359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r1361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r1362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1" }, "r1366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r1373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r1375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r1378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r1426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r1427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r1428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r1438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4" }, "r1439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r1440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r1441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r1442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r1470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r1475": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r1476": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r1477": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1478": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1479": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1480": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r1481": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r1482": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1483": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1484": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1485": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1486": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1487": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1488": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1489": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1490": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1491": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1492": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1493": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r1494": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2" }, "r1495": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3" }, "r1496": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3" }, "r1497": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3" }, "r1498": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1499": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1500": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1501": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1502": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r1503": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1504": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1505": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1506": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1507": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1508": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1509": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1510": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1511": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1512": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" } } } ZIP 157 0001099800-24-000004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001099800-24-000004-xbrl.zip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�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�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�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�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ί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�V!;K,K76(]1/C8S<3> E:N M(.XY%1RL((ZF4G1?[E*B@T>"-%I$+8R&M5+ZZZ!E:,NQH;(>JGL#R0VL\$^X M-"XN+ZX(=]8+ZM&6Y>31JE'GB6-0)AY',#HFDZKXH_=>.K#2-U'9K(;\-E;\ M-YB'60W5^^]W28\!LF&^: H%$"C##4US(A1Z4%%*(ZNL]GLO'69_J*;ZC>4W MJ.JK;8\'XRGL+^%B,8HB"Q>](CX83B0KSE#@D8B891%"I*EV27H]ZH>M'AS0 M21D8" V);8*)5./=HS0J,JEP,Q+G",6V(U<&9!IO]#WIMNMW4L M:X)/%-TY#S]I2?91+TTMT>=T_<+*(9+"O12@ DC9ND_?D0 XB@.&W-A)UZIU M793LPQW#EY$1D3&4TOK!L17M+SP/M"?V6A^!?8#0P0&X6A[YG^G%UZMWJZO* MXI^3Y%B2CJZTP-2J5DF!QRI;YY,6##':UM6V3Q+TPL/)-E!MI[)QLU-/\G$M MZZM) V_^KNNF)T2\9EY:2*+NW?4V09"U-$E6-C#E/JB2S:^?)U^_TXR#[/\+_H_^LS9:@G/P#4$4=.PE@ M^"H/(:TKJ1B0'F-M]&+D9A:RFB4:YE6Q)KZ<*H^;FJK-(\ZM8L%UB!N#2,:6 M DH%2_]@%F))=*0+ZL1C"D&UGM[V+%'=UF;L@HW'R]M:J**/E_*[K\**Q5"T M+B!%E* ,HP!-IP",W&-N;8BB; 6E%U=VT5BUSU54["+G/G#RP-.QC,R6VD]K M5=T:'M! U/5!B!L9N3#2J?^3*BIVTNE6%16["+@#G__*"SBY\0(V3P IU"FW M7(.0J3J=4D!D'B'I(I(KCJ-HODOZ,6)&1\VABKY_*361>@?P^=7PWD0M.BH9 MB]%07&V!"+4Y4%L$XZ.V4D:/S2>//4'.R)7[@UQ5K;70 :!J"/*Q_#&?Y]M' M[LO\/$^\I&=?S::;P7Y(%3:3_ MHA,#;U?3V5?+S@;.!3SPI>.%_\^Q.7S$GU00+I';)0B:!%3#"4R"@/%UGF\)>6WE!=;WM((03*EK'.DHA1@2%*N#M8HKHX>; M6?X49=W&_KN@Y(G9!JV4TD-%XRIR<>B848;L,2(#)4DN3D0.FD3BZ1\LFQ:! MW&[5KT<(]=MI\L'JUEW$V@,6-F$#>BM8Y=0R1BZDC@%BKB]-W$E66&)ANY*- MEU7=NI.R'JENW45R756W:I>R"3%"\H8B11]$?:GAD!,KVA5TG#4I<>RONG4G ME3U:W;J+_$:O;GW._OWZMX@?PK=-VQ!%!*(D#9[5,AY3CPD+-8?N/),^Q:"W MFJ'Q#%(.H;&7Z'R0V^5HRAO9/CW&QR9A)E0I:*0ER;&Z[Y4"4\>Y!"F2]UR0 M;-56\?LS,'R:BO$LV/%0,!]$)>,66%T1O_SWO(8)JX5I&T-NK G)>K+<7"$H M)BE"L#J"])R%3!PH=F_ R -54X___O$0TU)Y\]:2["!7^*S9ODF*J524M-I" M2LJ!4B)!)"<",HF)%\&4BZUSA]M3-VZQW8"7W\"*Z@""#_/S\:\9?>'K]/LG M7*2JRS.Q_9[HF!]#52\Z MU;U)N]4=:#C]48_YP!GOQS]XO,3WEDP/G__FI0BN2P07'%WB=?U6,-Y"K6L7 M1F+,KO6==(S\]Y5\/\POGWZ2S,$GWW1NKK:\7&Q(VEP\4DHVN% M<0.1:P$\F*21L1#<<,,-=R*UVPSY+CAZRB#Q5BZB"@I"%!BRL MR%@LA:"M"U^WI:V79Y+A/8I!M39N*OO7 /13^+F>'KX@1JQA,GD;Z7@Z2=+2 M&H+WF6[EZ JB#_RH'8+*!YD@8V D6V#M#Y\>(K+JZ9>1_H-T_#^?++Y??OY]-5@/4>%^EKF.7I$O\D M3WCQ:CY;3L]F-22:,-1%.VY!9%/3OU%"L%Q!2C9(YZUOOPGV((+'70\[$%*/ MI\(7'=!^6LR_X^+BYZ?S0)^^B@6ZOHVE MF]PH4+H(0GVMG&%"9%[0E=)Z#]&1IO;)JV;F/E79#RY R?5HKIX.I^E)O??I[2KUB]SQ9)D5H= M=A1$G8%9=[YX81"HG)^,W8UL2-FW@>&F[#Z*B'JM255^&MP"PM>14VU*@I M>X@ZJ[JGCYP+@110-9OKT%,?]@!^_?Z"[0$-5[5[%$6K:!QP$>MP+^[!ZYJ@ MMDIR&8/!^ ^<\[&3LAZK4=Y!.V4IE@3DOB7G&('CZ8S0J>>YU3+S\ M0VN4=U'9HS7*N\BOLQIE(Y6) 1U@J'M>LP\0O0T@R0\7W"JG9(N.A!YKE/=5 M_=[RZZ)&^=%K[]UU460PM4L_9+#2JEP[V M,=*!^ZFF@_#F48[^7&*Y/'\W+3C)Q9 #[@0(7L<1!Z<@)OH'ZIRM"U)XT[J$ M80NR.DW/[(F$;8&VIUHZ0-IKI"^GZ4I#$YERYHX50%\T*"1GSGGB(G&>LTMD M\$/K!//M[W>:?6F#G;T%_:+K NJ\XK^FYR32_+:^BI]-R=B?+)$M2*Q1C7."[ MZ0_\1=B;IB?!4-1%6IRKVI7/% 29= UA"\D@Z\);\[X;A=U6"NR"FL)?/CJ*QO--XP=FM>G1,J)$?\%)YR;6&)X),,4+PSBG%.X5?K M6K$=21P7E8-!97M('JRW<9N0-B\_F$\Q?9W-S^=G]17R[8R\[H3+Y6?2)Y'V ME?[NUAO15<8IAX 2-:18&ZR09.N]([<;@V%UKJ+6S[>T'4! M]@['!/SHRNH M ^NX)5.V:"X]@D-'P9YV$H*KBUXUBS(9D91M79G0#HV#1NHBD_R, M8W/[0KF5>DBQ*!\->%T,*.;)T2G1@;5>:!^TC*KUC,I]Z.SED7IPYW%P)?9@ M)[]]#]/%:A1GN<_@#?_GE?_K->M7F8Y)XJ$4P3@(AW0L<>_XX=%T'[['4FW?,+XG]U]8_4(0P*O_99I_PX^+5_-OQ,A7G"WI M?['^RSLO_3-[/(;KJ<%3*SA6D4LD'F@.$!FA%B8A\@"]QZ%4]O5![4Y M -R.J[-[^GH] *G%_UD<'6)STN5S>7ZJ_/R6UA.4R '<'I^>4&R#8O:$;S\ MA(LO7U>5A8.^)AQ&U/$>&AH*[PAO$-&1JY5K3ZQ-Y']E 2XI!>BMQ$A@UVFK M\JDNWB#NRW0E\FM6!7F7*0G M9U_IVCBA7QK.\,-ES;M\+"LQ+C]>7BQKNSO)=LT>R\GR.KG4*R-!)?04'1@$ MINND+"E)T%L-[MT!B#L1.*Z[.AP,A]-2%R!\4' 3HPD+ AUDHPJQ430XH3*( MF+P2FD71W(5XD)!QJRR' ]7A4N\2/!L_^%I$L0YB,Z(0!Z4N[4(#$:4F_DI* M+ADN4^L7^6=(ZGNKAMZ9 M5FG.<+XY6BO&3BXN%M-X>;$^=%?N!.;-"/"3 MQ:)V&:WF'$PRCTK8%"!X%NC@>0:^^ @\<&:B\77:7_/GSD.I[LL); G8(VNT M7U.Z$>HO)W7",YU#2:YU,C6HIZNB.D@>C.>9$W)CF!.F^AJ M?RC.Z; ,&;Q,&,]H';G>*0@$)4,$.DL%+'$4.2=OO'FWSB.DC#OYX*Q%\WXC@0UBLA_4._.3V['>/]ZJVFPB.,-H3H]=<<' RUY7SQ=1; M-0%&&ZW+,I?T$IMW3NCWYWK 2+)?,%TNIA?TG?4K.N;?Z>#?>M3\6.Z?S751 MEU8B,V\X9"L+J%SH9"I.+C-FK3,+9/A;OX.TY:#;I[E=4/?$,M-C*[D#9_) MGG_[^? O6+4;F$@Z,,%#B9I$88V":'2=SL!R%"JF8EO7V0W(3B_-1\='Z?WE M:IU IMO3/@ J^0(S"@F'61Q*V4U(=Y0CTTJ[4#7BV O6> MFNP F:N4<14ESI;K%5'G8;9I2PB"?VW75]JU(UD4'RI&@T@XI%0.22@]8V9.>3RLVG MX+>BO9<.DI?N >P'AI=_"-8K@R;1YFB*(WX%J_4MFD$0%+%(CT7Z1/R'UH]; M30COT5 /C;FVP-\# /^0>OG53;AZ@+E]';[YN_YXO +YK:@8HR)^=_$,G\D+ MQEG!D@);ATFIX&Q=$$7W17!)E1!=C*V+)8^1R7M#L)K_1#J^BQ_3A#*#<05-E^"^@0YO:371@/+KW4-3337+P@W 7:.-J4Z9)?D0=Y0<0Z< ML1FT%#X9ZQ)3K?>@/TG0V.W6C=2^'9SVT$$'@*I'[&/Y$L[Q:DU#4G0?)!]! MD(2( ?K)ET*BX5HIQY7)H76Q_2]$= FG0@%6'J9A0YSH8B"KP2'+0 EL#LC$+O63L>PDJQD1(!P=DP]FF M\/:Q?-M$"ZMT1@\Y::Q;YQ+$2*QQ+;3QWM&-T[R&;2O*1NY_&A,\]Q/Q[379 M 3ZWDO!I^/LW\I'*].+JO>$^UR%&*5QPH(M+H#0J<((B1F+6Y"2]PMBZSK - MY2.W576$[Q&0L#O^_1K_,SRK)_'TR&;Z U)42B*8,.?1I1PAL&PI%%#D!4;A M01I+0E9,2]M\5L].%([2NO[7[POCF.U,VSY]2,^C.XA MCN$?1$FREBN"NW&!T"C)HW A%S!H8Y;9&Z=?8FO#(P;A5H/D;S]_[9^L>EW' M(SXE:64BL409086Z^[O$U9E5VA2IG&A>3=B*^&X?/G?!VN,/G\=4;0?N\YIR M^H\WRPY4D2%JH+NBCE N%"=[P8#I4K(OJ;#FN+Q#0"\/FD<%P?W[?F^-= "G M_05WP_8LUY+?6^7$)2&Y-(Y!D:ZN5_,>G#:&9% WF =#(FV]SF0(/D8VG/O# MZKZM'%O''>#\,]*E,TW5*Z]^UY^SZ<7R,SEJZQPX:BF"R!HT8W6'0:#CSX6& MY%U0M80]-F]:?)*@DXV+Z8Y4J&GJ5[P-?.EZ:[#DVAT^)&>E"EMR""77S0TP18A(95)*( M+"AE<^O;=KB4V/OP]_3;Y;=W.#N[^/JQG$Z_X>_S!4[/9J\N"?ZS]/-56'[] M_7S^U[\PTW$*NC O0JFOB0%4U@Y\#@&\=#*R$HS-K>NG=R2QV_36+KBY;QN' M5%.G5N_MA],W[]Z]>77ZY\F[3Y\_?GKS^?1_G?SQ^;_^_3F MPY]NZ'7]_"PMW"$N-[%H=%SB]6+FU%).]FJ^@2O@AH+Z>+M/Y?'FYP&O( MLN"5JD^I)=7);(5KB+E(4#*AJC,#DVWM5^U$X*'6KPZ>O?.)M4O/R&,H/#KR M&>J$SVSJ3.5$KHP)G+OB)?+6U; /4S*N+1L.*_?-6P,]C!C;+!<7DW?3B^G9 M2C-DB-A[^\KBH M::'+>3/!=@6+F@G;I+]\?>7W68.QO! /BD/4,H*+ED==E ]FJP5$.X'CYOOC M0*2%/A^%QI["'7<-]WO,%XOY;)K>SM(F?5ERQ%("K\/)$T%ORX-N/F/'W!BXMSO'+0WN%9'0>^O%A.+,.B MF47@LI3U1&7OF"!?C"=1F!2&N6=MR//?ZP"S\\Q M75R&\T^+^7=<7/P\.5O@BJ]37'R;>,$-LSF2[A."BM& $PS!*4/G*'*9I'X6 M)\]^IC,S)KW@_U!#GC5A4WAE)K\7> I(&0N<51%Y"(Z\/V^-$,1/ M,+EU,ND))XY-I/99NA" G/U:\V1( M1IY9*,+XY!.+'%N/5KY/P[B;%8:R/X<(NM/7@R^?WKQZ>_+NU;]./O_QYN3# MZR]O/IU\/CE]^_'#JX]?3K_L_T*ZW>]M\AZZ!PN-7@D^7GS%Q;H-G=S?JRD$ M-R]9=/-@K=&V3M86="L@FL((>P9SBB9*;)T??YJB=HT!J]*R2W+M%G3(Z$N? M\;RV[MQJ159U9J*7!K(3LK8BUU2,SJ,7H*TOF#P31K1N[GJA4\AV4OM.4\AVT<&X M><3"';FC6N/]RN,'$D@/ M_.(ND;"/QN;-Q->!-7E@*!JKO2CUR)C6V:']1M"- M-!ML'ZRTD78'X+OI#\QO22.SLRG=S"?+)=:2^O?AO^:+5^=AN5YC M(ETTY!X*XJHX6,V?"BIQ<"JKDG/F6;3NN-F!O%YZ%8;U>X;25]]0O&'L5G>2 ME<6;NO;$V]JC8ZWTEN'@ 9)K+Z0,(LHP&URL1CN MN7@FC748 =UB[W!,S(^NH ZLXYUKI5XFJZMEB8L?MU:(9%VBBAHA"1Y 12$@ M2E5KV(TM3J(/S8MBMZ%KW!?!8UW-S374(^IJJ<7J'+_]]CU,%_4\K:.EY<0@ MNL*$(V'QNK^&97",HJ6L66:)^*+[96CP/4[>N/:P/3:> U\C176 P1L&/I;[ ME\G;6<:RNFO.ZUVS7GA4AS7/Y_FOZ?GY),J2)7,9M*:877E!!]IZ#XF+7&S" ME%3KF.40>L<-8@9'Z=%4.:[?>$^.F\?@"_II.24-KO3Y![D]]:UXPB171BD' MQN2Z=(LGB-E($)F7$D.@WUR>=11W^>*XM_%@&!M2[IT^H'\\_=>;SZ\^?OCR M\=W;UR>G;U[__O;#R8?Z(/WEE/Y8.]9>OSD]>?ONUD:OVK<]G]6ZI7GY@K5" MCAR@\+U2LG]/\E"$M'BB/XJ06KWI+\[";/H_ZT)\^M;\?)K7)W.6/]T2P,=" M 5:8U5SU=5;SY@G7:I4QFKR>-J3J&XBO(^)5K$:32QY3Z[FC30@__"'M!_VZ M^>+G![RXV=05:P0I/ 19ZV2*]N"DIV/.M6=6\,P'V.+S*QTCO_D?'5>_/K = MJ)LNRMVNN?@<_GI/\EF0H):KJ;";*XRN%>^+0A,!):.KR[H P5 LR5%G;E0N M1;4.P9^G:NRGND-U_QB8VJBAAQCGBJ/_S!?_?9V_NLN23K%XGP-(4W.T AU$ M3[)SC)B148?(6Z_GW8*LL5_VAH)6(T7TA*V:E%V2BU,CJOO'1>3D;&* 3">* MK<@9=F35@7G'N-%>9]&Z[GL+LL9>\3,4MAHIHB=L$11UYHJ N(8'DC"QH@LZY-=[J=\?UO=MK\WX[TZZB'3U.(S6,:XVN"?_/].+KJ\OEQ?P;_=J)HD/@ M(WE[J,A95*86L6M10)@0AK4T#679@75Z%[U/RPNN2 MJ_H(<4F_^IJBK9!E7RRR&JJC@VS224J7WRY7I9JOD8A(TW7[#GX_QTUJY.3;?'&Q M29L\ROQ$$^,)(X)-M*1A>]MM#-NNFTCM<\8B96Z,%Q)@\: KAML%>H(+B0% MW!N?9 K6Z.=;].[^SG&3^<.CXC A=J#]?].O/KX1T&O[&Y?JG MKV&V'AJP^KLKI$=?%%WU'%R2A'27!<2@)61M8S0Z,RO"=H YA(QQ+\/C8>QH MJAJ]6>2!)M6-!)83)WG)AD065*[#1!+Q->\@3WQCW3> H M@&HHY Z,6)76U1#15;_S\G)!?B=>5Y&I[+TD68#0/()2+-$Y4!(PN,BY3DQM M\7R]U:?&S?T?\\)K*/(.G.X;;C8<7!E.[X).219@;+7SE\(4%UTMG/84H.AH M$;=:>K)+EB]U$%QU@:B.Q!VYC(9P1TA0@(YLHXO44(KBJMIHHP-8W6P3?2#X#%EF*TH (84%Y96!$*P$Q47) M7+ED?.OQB$_1,VZ:_GC@:J:3#O"UD=K[L/AOO+B:GG!]5E"S("AZ8$S1M5Z8 M@) L@DY9:.&3+ZYU3?M3](R;@3^Z\3I<)_W@BR+9@LLEJ8H"6[PY+1Z5%[)$ MD(4K4-EY(UDG6F56 M1^/R*$"1YPA>20;,J9(H;'%6MBX:>X*<[0#V#\B=MU))%RF'SWB^F9MZUQA+ M],IS!!87 CX)XD,YK/(I$I]?3_7D)[:#RS\DJ7ZPC#NP1&10,Z'^/V&Q M"+.+GYLLVVKDW[1,,5^QI46R3!=%]W@@ ROJ O2D:T&2RLD(%WGS.15;DK8= MY%YPCGU(576 P)6L?I7B%3#)9[*]14,PB8.H 8O1H:XY;0R\IRG: M#F\O. 4_@&*ZN!0?D-,5+TK3_R!5,3$D,6$@]Q')A^2116M%\!0(;WLQ/OZ9 M[9#SCTC -Y)UL^*LT69Y77[_OEX;1Y8Z++_^?C[_Z^VLS!??-C63PP_QVHZ" M(T_OVD,L78WMBD*:D"D8B,(74!$9>&0.&(\\!BF=3%SD+%,1_ M"M-V%&0J(!/WD+!/@O0^L;N70KO6=]S E(X_P M/P*$&FB@@\S'E70^S&>)?JQ#I)87ZVT'F]N??DX7TQ^K^.GU=)G.Y\O+!5Z+ MT%M%$8FM>.F6F<^L>N4-I'K=^\1C8/*I6N["'GZ=G7R\^ MEC^7Z^GP'R-%;[-:S?+F[_0US,[P]_GB[HF]2@O\G&0?DB[,0Q&ISO\P'D)T M%C &NA-RJG=#Z]>N_FK M_-OEQ8?YQ?_"E<<[X3KIY+,#U+FVK68!0:="ML*:9(/53+1^%-F6MG'=R%&1 M.HCZ1C6T^->$R,;E9TPX_5&7'[V:DT@7%YA/Y[7S]>+G6L2KMFJFM16!;BN1 MK :5M(48K0/M(A+'V9G[BZ4>2&9O_[UQOS+#\>H2L]RYD'#?UO;> NLI_%^.*11_Z[:H>_=4^#)Q:NP6/PD4_/O<'Z)=+'$Y%0PX**M18^R0)1) M0$*MA4?N0VR=1=J*L']"[GL7Y#T4FK757@?>ZEW3<5W7S9(6H9;MJ-I( M%VO^5JD0T+5/0#U&RS]A[$@[H.VIHPZP]H!_=)>UD_O>TJW_?/E0ZWIK!U: M>X=&C_R>%K'--B0V"DY6><,;9,EJK82NB4);F].PKGVD4#U[:8/DBLG8.LJX M2\'!G=NX7"*N?N=K7*;%=+66<+V^NC#TL?8*I\09*&$.&!@?H_9<&[48B'_$J7"XN)I]K2OWD[^ERDA6&F$, 1I1 MR+>:)X^".YNWP0G]UEL8H3_=X./.!\=&0B/US0^590\ >(_?(BXFT90D177A M7-%T'A(#5U*J15_)Q6R2MEM5&VX#@?4GQP'! RPM]/9]-OE]\V MA.N@ E.9:%:*_B'K;,QH"QAI;-)>(*&]@^CLGD+^8WZMK,B/?Q] MBW3)M->H+/"0R*LE'X]B-?J'$U%)QQESQK=0_>V/CI.F::;ZO>771?W$PW?> MN^L-ZU8;+E7R8'VJ.RSI\O/9:! :DW3(N0SR*)[B-4GC9O5:^PA#Z*,J: MG;LU&:>X^/:Q4*R_=K1=061>D6=-5VU=52@A.!200E84.V?![\\>:X2LIZCJ MT0'=$P0/ JR91CK V%U>:B/T)#,E0V0).).U"-,+\,4QD$P(J55B/F\5K^Q= M!ENIZ-% M<'0@1(?MQ/SH0.P^L>Z*N?5_-LWG"6L^P,NZ[1B;U$7+DE.C/R! M8A0$J2)HEF*,043ZT[.5++M]<]QGA"& ,ZS8.RU86> M[%+O](UV+O7^K WC4J+&DX&IG0D) T13+ B5Z/]Y%IEL75PW1/7#(T?B MJFGW]25^(/F=_H7G/_#]?';Q=3F1=%J$X!J"9TB<6SHM0F*>0DPY B.<*V()TT1X8^H>7!A*+# M,5X'GZ*QJ\#A6.C;63DO#7S3'S@)RGDGDP2;M0(56(98! ]B9-)&Q5G.6C9>L3HMK2- MNY9K!,3MI(P.-LH_R=>?LSQ=IOK2C_G-WXG^T\V[/_FL/B3CZM8"6S= 90B, M.,W..,L9*XRWWBR_%Z'C+NXZ%OR:J&EW+/HU%F=XMEHA/N3[@S!,64\^:U%" MDQ>!!IP3B229)'FV193<>D+K(>\/@ZWJ:HBH%J+NHB;Z+B/_P5H8@/F$/A'. M\#-^"]/9[0I*/A'<:"M3!ITYG0JL T253Y"XYTJ6E'1I722]*XTC+^L:#&:- MM=.ID_9Z8XT_DUV<"*%K<64=$.D$J$BQCXM2@"7W +.4AN763Z?/T33RIJZ! MK\6]I=_0FHW]GCJYYV(.\Z(ZX2.]J=YG[_I5]?_>4\)O/_S[S9?3.GOKRY?T M%?/E.<[+S6"VY73V&N/%%TP;$O=^MM[W0RWDW(3)1@_8MSY;/WHRR^MA>#=? MO[8/(I6$/&B(&B4HC75T@PV0=#2!":U-\Z>-[:D[>$O&1A$?R[_P/)_.-Z?@ MUI?6S4J18>"A:(HE)0DA1_JI2 ;*Y*Q923S>K,IKM25C.]+&?=8>"$>_K,(8 M0$T=."_7LUK>SNI*RRK&53^UM=F3?"QD;6OP*"V$X@+PH!PK.C@;6R>4'B%E MY,480ZA]WEX'7<1AIXLP6]*WZZZP+[CX,:T#56_- [KA;WE*OW+Y\+]Z/:\A MP81+EW,MX@Y!1U!UK;T3/ ,R@XYS8;UJ747?DOYQ8=L$4O-.M-N!F?PMS/[[ M=/H-7^/W^7)ZL=QTCQN=?>*%CKET'!13#*H$P2I50E;%E>T&+^R T8(E2"98^VG93Q$T;DU9-_AKI[0.$/C^1HG4L0/"*%=4J""SF"2UQD1-0^MC9[#]$Q;AE9-W@[6$5=Q,LWR042 M;"91WLI9;79B;_[%NH/_W?5L!\^%(9\6P:=4ZB*26$L[ZRX[C]84);&Y$[@W ML2,OJ3Q" NNS ,CXFPIM=>%G8Y)D%X2)9^KJYQFGT8(4@,1)7(K0N@WR. MIE[RAX-"8SZ@GCK&W20SQJRE8ZJEI[@JD_&/+CH0)0C'O2^9M[Z5'Z-E7)RU MU?B6<-I)_!U4.CXJI)0NOUV>UQJV/V<+3/.SV?1_,/]K?EX/YA_560FUA*"4 M!$S5+>I),0B&..6.W RC*'P7K=M;]J=VW!MW%"@V5F''-N]I3M_-E\M)B29R MCP6$#:Q.P@ETB<@"+,C(8]11I]8MT?M3.VX&IT.P[JS"+NIV'^/U]S!=K%=E M&2RQ)"% >DF7A4X20EW%$7W&(DB>%/<="9771(V;OAD%?/LII .#>/(C3,]K MK/;[?/$EG.,#\E(R65L<^,P!I MK*L.T718:_&Q?CCP4Y%-7/".>5X>H+_X9EOL#3\/>$ M9.A]$!:DK;7V+GJ(-EGPM4M(N^!E:OZ:UX+P<8WJN- =0+7]&]A'F:[N\BVF MO1;(O03'$@=5! ,G9 )) O M8PQ6 68K0&5C(+@H08A4#%.!:=+)R[#^559"^];QR?&::AY+?M3/WK29W32&9"VR81XX*S7/0I8DQN@@A;H.V7OR MFUK7FN]&X8MIL=D%5=MFK!HHK0/_=CON/N#%J[!8_*SYF-4$AYL]IYA+X=R# M199J5WZ"*&,!X[W) G/4[EA/G5N2W.>+: LT[07<-JKM!,D7\V_/LOOWQ>?Y M.?V2L]LC8.\D7B8QYQ"2UL"=OLHQUD+!$)G2NLB"IG5G9SOJ7P*^&X'N <"/ M@( 7@_T-UYO9LZ=?%_/+LZ]U -E=WE&BP* <9%E7U49M:D3+((HZ/#X6R6WK M9$5+^OLL,^@'_P.@X*6=@-7TO5.<51G<._C&D@(,SZ!Y]*!^-0]]5DX M@7Z0H(J6$+@M8*W30CGAK6L]IK0-Y2_!N3YB\J2IHCLVHEM%T##]D?#Y!N^F&&CEK,@I<]U-;!UF4IRL<'XCD@S>>2(V@T:Y&Y!8( M1B$XFZTLY%0Q/%X'U0&U4(/YST>JA1I4<1T8R*WY^Z5/Y[%S7ZQ&KHH'S3&3 MM(L%AUI ,L9Y8[1SS>=C-V>BUX:L%IC;%^"# . %G8!MJFC6#6S*R,@-DF# 3+^0$# /*/8_(, AY04=DNT*;M0A*9,QX MNH6SJUV>EJ+HF+#N)15%:&8YZM8)E '8Z+7]L>=C,A1*7MY!N=Z)>HJS!YBW M*L=<-V3P3.&-RC* #TF!,ZBX<\)8W;HRJRD#O?92OH##T1 9+^A8/)I_NENU MQIB5K#88.AT0%/>%]& Y6)9#8B[D',?RK[;CH-=FSIX/Q@#8Z/!D/#L< S7C MS(< M4ZHCD=5$+G.(!7/FNMB8SAR7_U^9G^P[&7?Z&ZJWQ>4UWPV6\QT2,XE M$G(RDMR[G"!ZE8 1\RAS"#*,Y>OT72'69;*HJ;H[---[EPFQK$U@!H&92(&_ MDV1+6&1@21[<\VR4:5T&V8KVEY$1:HN\MHF@_6#P@N"_1:F0X@*%\0(XBQ2Y M,&G *R. XORLR#W3UK:N%VM'_'F'X'8$?[MVR&AOI0<>G"=? M,M*]ZRB$%[%H&7VVP8V<]7R0[I>1R>D)^(>K_P5!?INZH92Y(O[(X615],K7 MYEJ$P+PMJB2!@\>M+[5\[$7!OS$4NC\$MQJ[8O$J%XJIA*D+!@47$)0VD$7V M#"5ZG5KO FHZ/6[TE,R( -Y3C8,7=WG",NY_=FI+6=(+?MUP:;#[<7 MN\>?_B:\RR5'#LZH4).+'@(/BA#NC9)69_*%&QN-XTU_NY?MO'<"U_N^N%". MNT0^4$FK0DY+40"=OJ)5T"7&XIH7RVQ!UHN9\[8+?NZ;Q-;JZ>"R?FS?NB]2 M""TDH'8%E-4>/-,6K!1,9I_()6D]6/ 14L9%5G.5S]O+OP,8-=VOJ7/]?\C MY[H.D]66B2PH\E.H->.9!-QZ%U]+^L<%;!- S3O1;@?(?GH]NJCU5 4-.'0, M5 F.0K,H@#Q?SWCQ63>/T@_?:3\8]L;#R4X[[7=16@<(?&I%.M>1>TY<2",X MJ/HX$EF]>AQ+427$G%IO%3]TI_U@Z?YNT-=*81U@[^GUZ-ZEQ$NTH'7(H)#7 MO=4\ .8<60G"*-]ZB,?A.^T'R[IW@[]V2NL @0\N3'=1:QYKRHDL-CDS0H&3 MA8$IC*6D@C6B=1)@[YWV@Z6YN\';P2KJ &8WV^8>SWN^N]XP)TIQSI@(J.JS ME,5:=,8=R&@C"^ASDJTCE)T('/'5K1S3V>7\\MZRH4_S MY725!L;E\O1KF'&QKJ"9)(5TKGT"D5P Y80&7W*$Z(OP)@9O0NLYY6TY&#>B M&1!J.^46!]7[/P[UMQ9SK782RVP"0R0?QQJL4_Y2-38,;9EM9%A(,R MU,MBUI=U)@Y!Q:%KV4X[.2E7LOBX>#>?G9&;AN23)4&!@.>QKE*V' (Y:)#H M1B[<6L>4[.IHW.=@W)COI9R%@_3^XN^'^]S?MP0B&<70!N"J;LG3,4%P1E-< M[(S'[+76K;-H@S(T;ESZ4L_$(:AX*??#PY*8.(KN,RH+,GD.*K! UD!F8)D9 MEE1D4K6NQ-J'SG&KLGK!=0,==M (MP^/]T^H"I$"L7F_TP4'Z+A@VWP\4L,[VQ@_7.6YK/E_'R:*S4GI4S/I_13 MXSK#G3XY6+'A_HP?O^)0ND!W/06&= 84**<=Q+KX1S-K@U0L(V^=/3A>Q>'Z M][['BZ_S?//5ZX>"+Z1PK'_S&;_/%U4[JX4?-\(Q*$U.P4)1]3U31T=!=)(@ M=$@F2.ZE;MV>=B#)+Z92<1?]QU1K!^'AP^PN)\9)) E:<$6ZNJ,1(933F0(NHZU*M%P[;W-OO7#WD-T='.;-M/W@^;K .%W *!;,GD[ MN_&OOUS&Y31/PZ(>O^5RGE9_2V?S_YE/9Q?_IO_\DO0YD2GQ%'0&RWV=8*\R MQ& -T#FTR4:>6,+A3-KN!(_[(G!\2S>P2OMOV?L0%@OZ=3^P1:3\RR]K' ,_ M3>SQHULFBD0F# 0?:D%J8K6ON)"IS%@]NQ1\ZT:?XT6W-\FNTT7(T]G9K4_, M\NJ^V/R+5('\(W7'7UD.Q*+DA72*!(2LF0P#,I@:D< M'?'JD6_5#$J$W((I_>D&HH?2V$L!UV#PF8^@RY$Q^Q@?FV)B121GFQU8Y%A[ MS10XAPB)<;'Z5SQL=:<\@\JGJ1@'=\=%P7P0E8P(+OQK\@'_>A\6_[TZBW^_ MHD]/K_JV'!>&!\&AF.#)7V9(HF$,@_\%!87/U<]#^12D%:6O_V\_6]6AX<.2@Z* AGE(W&FD +]XA&TBF2_ M;18NM3B-RU M#J-^I6)<5VLH?3\!JSV$WP%\WDV_36N!PS3$Z3E9_E?S;]_#[.?&.D=>%!JR MR8;N+5#<" J6R%A[Y5ETT2?3_+GY28+Z =4^VIX/)?H.<+2K27]W7=9C='#, MHB4[CK'NGTX0=%;@G=/HLK,)6]?[[4UL+P7>Q[HVCZ/5#N#[Z,.P$$JZVCG* M-;%!SBK$* 0=RN@REYPQU_J]HIX+I >)>5L@P) /U=S>D/R! MBS@_/*OQR+&Z^9'XFL[SI"@=O"L6^[]@,YCBT_ M]K)NUL/0-9 *NK%T-\+;#!3^C"2[\Y^OD;[T;3I;55Y?C8O]\WM]G_RTF"8\ MR?]UN>;^9#:[#.?KRJ])BMDDS1GXX N04TQ'2R #$@;/GJ521.N.J"'XZ*41 MZOCV\0!*BEBQ:1Y%G4""YT86T%()L/7IU&$YZ M::3J_%RTQL3+/!D/6H=7ZS:=]1+:E1R<,BD;"YS56]/'2,&O46"8\\PK:VUI M/1)G*%YZ:=#J_'2TQ\7+/!^/6(E?),%-M$)*#U*+!"I$"K4 M2PN!10^Q&.%0&>U-BRJTA[[=R\-!0P7/&TI[9+1\QN^7B_0U+/'D;(&KQL?[ M+%V77GENG-6@7&&5*0TNBTP26JA=(.,4T]?9_'Q^=J_H) ENA/6QFMU<)^&2%0XQ0Z1;'),MRD6^+3H> M^<8XSXC'1$@+X8[NP]S,0+GV]ZJ53<%JI3.'$E5=5R$E1*(?$@:IK<]6V*WJ M(9[U8Q[^?B]OT$/Y,@VDWB%R-J>*[N% (4*!E%65C9?@:ZV<,D)X632)S ^$ MG?$]EA::?08J>XBY@R3G@T?IYX?YQ:?%]%M8_/P-9UBF:4H_;NRH-189%QS0 MU8*VZ!)$QDF$F4M==,XRMU[#O3.1?4%M'V3,CZFF#G!8^T;OK2FS+ @>@P;T M=8JA=0*\9PD,PQ1$]I&KUD#[E8I>"F/:7WF-)-\==FX[D@')K@LRZL0_*$F. M9#0<:P%NJJ/OA="MTXF/T3+^ZLI#=/PD9/84^+B1&-GI'[BXF-+I^43BFBZ7 M\T6UI[@QGT4PGE)2D%*==FDR!0JVAB1*FD2&50=V[PW[@5#LF8_TA(E]E3@? M1*(=&)6';]R;U\-0O/ ,'=WAPI"4C*O3RP*@,45FIJS9KK'Y8#?HW4[=$4>H M_KM\ML[G-67ZE?A>TC$V20;%D)] MF(Y:$D/*^UIUER$X':W"R,/]K7H/6*'MOC6N,6JJV?F08N[ -*V*&CZ%G^M] M;O.3]+\OIPO\[7))XEHND:3EZ6)7=1+9JA"M& .^T$_.>)>D$47JUFTSS]$T M;NIH"'@-HHT.T%6O[%MGYH]%';[M@XT2DP.#@03$=0*O@X),X:2V6AAG6B/J M(3K&C<:&1-'!4A_W/OOXO2KA&OTWC1171>..&QE)%G3)TQFH<^,C(U]0H;6H M9))D?Y^]R)[YR+C^ST W6$O!CCS,Y;*& 1_+W>!@^68EKSQQ-AKT4H);83U+ M!&^T Q:<]$2LU_EY5^?I;XQ;ZCX00!J*=5Q\_#)=]=\?WF[\M;N\36RRQM;9 M-T:J BJJ3!=J2!"R99[K$FA->I@ M(= 16;_^!%$' J,P.3N?&"^'X.C!KXY;+7U\.!TN^OY0=9>9CY<7RXNPBB@G MELX&(XE!;88#53OD0JCOB]J)Z#,KY?X0QBTA]>@GM\*3^P?@J8W0.PBP'APC M[@M*EYV$+#"1H#3=V"%X/>>I:'F72QQPQW_Y+0U$SJ_9FA1V.#B9+2 M82'Q*(ET(GBJ->$R0?)HO"0G4-P?6[RE&7KTD]NE#]E+0LZ@4N\/39O[^B3G MU?JU58-D8]T[*SZR>W0]-+RT8/ M)_47@*;'CXV4PH;5."%!<87R@4)4+@6DDD5)OF3-&\'K0.OUHM+3Q]5+IXV( MO_WYY>V'-U^^O/KX_K>W'TY.WW[\T&!%Q%:_M47CX>[D-UH:Y&8;O^ MQ:OOWOK(\K>?M_ZT?N6FX-8'D0UX[\EX&T61;CV[+!F'F9N<_'"-C-O1..Z# M[X (>[S)<0#E=1!//L#5JL)+.JU$JD\#K.0ZJ$> <[72@LGL'8_R"'T/V^OC$XQM780KJK$;%:6O!(%SKCJD]0",>TTF!#(5R7^+#\&NNX0 MU8=).TCU6\!I?SUTW?P6,)GD+04XIGA0 DE,.7MR-Y77+J*.XBC-;T?%QP&Z MW+KQ;1?!CHN0?X7%]_E\MN'G[2S]7U>UH]I3P)$B)%L[/*6H0^)=!$&18Z*66^??\-[_COC%AX-AI'& AX7+:_Q!Y[/OV.^,8044KR= M?5K,$PGO,^F,2/M*?[?Y+VN68\,ET]IB+@+H9& =]"HADGT$*QF%&-PE(9XO M]S^ @'%KEP;#U[%4TF'7[ @L422A'5V]1"9P/N603BO!;+?!X MX?W: \9=S<3?(82N^D9MK0.MPT0QI\TX!(X<2E*.?+=:PM5B\LR+:MS>2;-; M-F[O(.8.(O2'WPP>;0>.UF>I*>HL*9$!3W5J,U,:6"XJV)*$8JVG>.]&85\@ MVP<36S4K-5%0!_#[?3J;7N"[Z0^DZ_PBS,YJW]]ZPN9O/]^'_YHO7IV'Y?JP M>E&TX9J!YW7N:]1T6)E6=9DEB[$(EZ5LC+T=R.NEP_L(R)2.F5Q8*;[UC.H=21PW63485+:'Y,%ZZP"6VX4Z MR+CGF9BRTCNZ9DB*4>'JX;W.-9,V-!^ITBXJ'0."AT-C/K2>.@#? ]'WY^G9 M5Q+?FAV1DF>9'(U<9 &5E03OD,YME#&:[)/&UBWLSY T;L!Z3,"UU,VH"ZVN M&'J/87FY6(WU>SO[?GEQ2O^[U>T@F#?&!0'1,G)LT=4RHN(AT3^(&8[.M"Z% M>(R67B8D','5:Z*.#FS80WQ<'3_AD'P+)/W7-82I, B)@C/#6);,^<1=ZUOS M<6K&O2K;:'L+".TA^@Y!]'JZ3+5[]G.XGD[C7/3&1@VEN#ISU 4(1BC(B$'F MXHUNON7L>:KZ ]4^^G\&5@UGV-4XJUGUKZA-C-]M./Y=_SB^GL["K3N-P\WN5)-"*8 MI#Q@'8JM EIP=;YI-L9$9XJ1@Q7F[D9I=Y4Y>R+E>0BV5MNX;^X/E?&N J8K M7NY;^PE:(:WP"03]$U0=N!03&D@R%BD3[J_$Y#%^#2[X[ M5!$+=Q,TX4Z"YLW?WS%=8'XUIW,T"3QC+'1JF%>:W)- (;I7!2QYNU:($K4, M^V!L%R*ZJQ@: G&#::6#*_?MM^]ANE@M'"_WTT%O9QG+*EMT7K-%;_Y.YY>U M%?V/^3S_-3T_GVB?C4LL0'9>5@>9/!CM#6@*NEBP)K+[/6V'9W0/H+>[\J,V MU^_15-A%!NZ)].5ZG%B.645DG(Z=270!& N>YP+>:KH ;)T&W!J4S]$T;C@R M&/":JJ(AN(;OKKR*\.;E>O'EB9T2;R;AC@]7]?S+)>7WS W[<8\F(JA MNC?;BF><;D_AG$]"!$ K>9UG&2!B0B@)N<@RA6BV6B3RS^GV+*DHQNEN**QF M687#:BH\Z&1D#!X%SZV3A__H;L]=$'9PM^_-;U-GO(OX.X30)JE?#/,B*PY)\P)* MUO7LB4G@D0N7B@U,V(% U&V=\4Z:W:[.>!Y5V,H2_9]59[P3)@ZK,]Y%01W [[&FZD0B$NAZN$%)29:2-,A"S@296/(C7)20>;3< M:F;%_2J ?]QP@YUTN?5P@UT$VZ?INS3J>/)1U?'6Y MJ+I:_Y>3XI3AJ0[M3K4;SE@#L39[%..U34R[?'^X]1")OS;,=& M5_D=G(+K9SR4*2DN$V#1KNZY3!"+]Y"5$%&I&EZ)QJ#=Z55UG**30S"VEVAW MAX1?0V*&%]V9Q9LWO27%TR0X2PZP\%&#*IF33'T '0M+03CO8\]&\18K'5>L M]&(2]U5\!P9Q@)OAUK^8<)E#K*.D$ND$E&3D?=75'H(C3Q(Y"MWS,?B5HXY+ M8GHY#0?"X( KX:SF4$^[/!NO-YR M4V 1=&H^G&8@5L9=%M?;B6BJ^/U]J/E%.!^BT>%&RA_+._IWIU_#C#.VZ?#X M,)^E^>R"2#B_U>1Q7?95V3N>S!F22;DLK$G@C TB)V3*OI+[_S+!E+\2A ME(V[I*XYC'O0WS_;BE?Q/2RP28G9V%(<:!<\*&;R>H"H#HIN/($\\M:3=H[+ MX;@;^%Z4S6\$DQ&O@BOIO K+KU;V+Z4IVN*3+YF.YS?%$2Y>4 M=1F\K^EX@0:\+08T-RRH+'0LK>M?=J%OY'6 @Z%N,!UUT4'4W$F:R!R\R4D M3]9"G2]?^UPR&%XS1<9G7HZ0%CR,B9&7$1[S@C^BMKOK,#Z,]_4:O9/\7Y>; M[7E>2^%B+B!SK;.4-?CQ=? MZG9M!K%-;&:^#=8:JZ1Z6 ML^WP_8]XAAL;%YVN.?[CX\?7_WG[[MW)A]FIT5S M_C%%UJA-_U9F]?Y0B3I#\7Q>QSU=]U#;P!Q/' &+DW7"1 #'Z2#JC%8Y[A!% MZR3D3@2V:]*_^NRZ#)P"3NL5*^ =V1D5&/$M+ <>=> EL2A$:\?C$5+&+3$> M#BV/=]SOKXD.W) OI)O5M+2K>V=SI#>-P"(:S1!!8WV>4":"EUZ#MX9');0A MG[TUK)XBJ)>6^P-4?A]&S>3? Y@VU\&Z]4GGF+PI!6*F?ZBB"@5UD=C((11R MQW-PK8N_[A P,EC:*?8^9/:6\KC9QS_K=*B\DLN5,#;M;#[P+$2V$&*=T8BU MG3+Q"$5KJV(*R=V_M1_(&C[ZZT?&P?[:FC<6W:BO+<3%F\O%_#O>I5\+S;Q) M!2P%[[5T5D/0.A 3Q6D>21PV/ZOZ!W[QR/WI+91^J+C&5O=G7%Y\+/^9+\[S M728$&L5MBB"EJDP81O=E_6.V,G%C2%SJ69T_]MM'[M]LH?@F@NOB:?7*3[I) MC0AI&;G<))(8+"CF&?V$$6SB+@OKG8NMIS'^0D0OLRO:>9&'R;D#S_&*@<_S M\_/?YXN:MICD$KVUHE8.A$0LJ#JY663ZB15AD&F'0\7RM\CH(Y[=4[&/P&1? M*7<$E$GA02HI)/C5HFRL.584=7,H_7]HBBV\=2G03AVN@T-B;R4^UMBZBT3W M1L)W7$SGU9-=M&EPO:*>)('3L]FZ.2O]7*6ZSU)9_8 + . M<@4/42A5(+,Z/"6S.CA/TV'E)C!-;@"%-H.]4SY'71]^?7M,/?YTV51?'=RK M-^M-MMOA[ES2CN@ 4Q>=J+HF*B8NZ<:1(1JC.(^MJZ-V)+&7%\^V2/EE#_EP M:NL?E0]NV58V%>F\!4_.#ZA(P7C468-4)1;!9(RY=0O)'F2.B\Y!8;,;1 _6 M81_L( M;TR#WMM#J:L#8_@$:P\>9JXM\8 %M%&UE- A.)8E1&:"*BA2%OEX:.SOKAX, M*MM#\F"]=0#+3^&BUI!M[#OS4

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end XML 158 ew-20231231_htm.xml IDEA: XBRL DOCUMENT 0001099800 2023-01-01 2023-12-31 0001099800 2023-06-30 0001099800 2024-01-31 0001099800 2023-12-31 0001099800 2022-12-31 0001099800 2022-01-01 2022-12-31 0001099800 2021-01-01 2021-12-31 0001099800 2021-12-31 0001099800 2020-12-31 0001099800 us-gaap:CommonStockMember 2020-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2020-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001099800 us-gaap:RetainedEarningsMember 2020-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001099800 us-gaap:ParentMember 2020-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2020-12-31 0001099800 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001099800 us-gaap:ParentMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001099800 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0001099800 us-gaap:CommonStockMember 2021-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2021-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001099800 us-gaap:RetainedEarningsMember 2021-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001099800 us-gaap:ParentMember 2021-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2021-12-31 0001099800 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001099800 us-gaap:ParentMember 2022-01-01 2022-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001099800 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001099800 us-gaap:CommonStockMember 2022-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2022-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001099800 us-gaap:RetainedEarningsMember 2022-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001099800 us-gaap:ParentMember 2022-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2022-12-31 0001099800 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001099800 us-gaap:ParentMember 2023-01-01 2023-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001099800 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001099800 us-gaap:CommonStockMember 2023-12-31 0001099800 us-gaap:TreasuryStockCommonMember 2023-12-31 0001099800 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001099800 us-gaap:RetainedEarningsMember 2023-12-31 0001099800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001099800 us-gaap:ParentMember 2023-12-31 0001099800 us-gaap:NoncontrollingInterestMember 2023-12-31 0001099800 ew:HemodynamicMonitorsMember srt:MinimumMember 2023-12-31 0001099800 ew:HemodynamicMonitorsMember srt:MaximumMember 2023-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-12-31 0001099800 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-12-31 0001099800 srt:MinimumMember ew:InvesteesVotingStockMember 2023-12-31 0001099800 srt:MinimumMember 2023-01-01 2023-12-31 0001099800 srt:MaximumMember 2023-01-01 2023-12-31 0001099800 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2023-12-31 0001099800 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2023-12-31 0001099800 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2023-12-31 0001099800 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2023-12-31 0001099800 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-12-31 0001099800 srt:MaximumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-12-31 0001099800 ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:StockCompensationPlanMember 2023-01-01 2023-12-31 0001099800 us-gaap:StockCompensationPlanMember 2022-01-01 2022-12-31 0001099800 us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001099800 us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0001099800 us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001099800 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001099800 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001099800 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001099800 2023-04-12 2023-04-12 0001099800 ew:MedtronicIncMember 2023-04-12 2023-04-12 0001099800 ew:MedtronicIncMember 2023-03-01 2023-03-31 0001099800 ew:MedtronicIncMember 2023-04-30 0001099800 ew:MedtronicIncMember 2023-04-01 2023-04-30 0001099800 2023-12-07 2023-12-07 0001099800 2022-09-01 2022-09-30 0001099800 ew:SpecialChargeMember 2022-09-01 2022-09-30 0001099800 us-gaap:CostOfSalesMember 2022-09-01 2022-09-30 0001099800 ew:DevelopedTechnologyAndInProcessResearchAndDevelopmentMember 2022-09-01 2022-09-30 0001099800 srt:MinimumMember 2023-12-31 0001099800 srt:MaximumMember 2023-12-31 0001099800 us-gaap:BankTimeDepositsMember 2023-12-31 0001099800 us-gaap:BankTimeDepositsMember 2022-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:MunicipalBondsMember 2022-12-31 0001099800 ew:NewMarketsTaxCreditMember us-gaap:LimitedLiabilityCompanyMember 2023-12-31 0001099800 us-gaap:LimitedLiabilityCompanyMember 2023-01-01 2023-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2023-03-01 2023-03-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2023-03-01 2023-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember ew:ConvertiblePromissoryNoteMember 2023-03-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-08-01 2022-08-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-08-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-06-01 2022-06-30 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2023-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2019-01-01 2019-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2022-05-01 2022-05-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2021-01-01 2021-12-31 0001099800 2022-05-01 2022-05-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2023-12-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2022-05-31 0001099800 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember ew:MedicalDeviceCompanyMember 2022-05-31 0001099800 2021-04-30 0001099800 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2023-02-28 0001099800 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember ew:MedicalTechnologyCompanyMember 2023-02-28 2023-02-28 0001099800 ew:MedicalTechnologyCompanyMember us-gaap:MeasurementInputDiscountRateMember 2023-02-28 0001099800 ew:MedicalTechnologyCompanyMember 2023-02-28 0001099800 ew:HarpoonMedicalInc.Member us-gaap:InProcessResearchAndDevelopmentMember 2022-09-01 2022-09-30 0001099800 ew:CardiAQValveTechnologiesInc.Member 2015-07-03 0001099800 ew:CardiAQValveTechnologiesInc.Member us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001099800 ew:UnitedStatesSegmentMember 2021-12-31 0001099800 ew:EuropeSegmentMember 2021-12-31 0001099800 ew:RestOfWorldSegmentMember 2021-12-31 0001099800 ew:UnitedStatesSegmentMember 2022-01-01 2022-12-31 0001099800 ew:EuropeSegmentMember 2022-01-01 2022-12-31 0001099800 ew:RestOfWorldSegmentMember 2022-01-01 2022-12-31 0001099800 ew:UnitedStatesSegmentMember 2022-12-31 0001099800 ew:EuropeSegmentMember 2022-12-31 0001099800 ew:RestOfWorldSegmentMember 2022-12-31 0001099800 ew:UnitedStatesSegmentMember 2023-01-01 2023-12-31 0001099800 ew:EuropeSegmentMember 2023-01-01 2023-12-31 0001099800 ew:RestOfWorldSegmentMember 2023-01-01 2023-12-31 0001099800 ew:UnitedStatesSegmentMember 2023-12-31 0001099800 ew:EuropeSegmentMember 2023-12-31 0001099800 ew:RestOfWorldSegmentMember 2023-12-31 0001099800 us-gaap:PatentsMember 2023-12-31 0001099800 us-gaap:PatentsMember 2022-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001099800 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2023-12-31 0001099800 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2023-12-31 0001099800 us-gaap:InProcessResearchAndDevelopmentMember 2022-12-31 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2018-06-30 0001099800 ew:SeniorNotesDue2018Member 2018-06-01 2018-06-30 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2023-12-31 0001099800 ew:FixedRate4.3002018NotesMember us-gaap:SeniorNotesMember 2022-12-31 0001099800 us-gaap:SeniorNotesMember 2023-12-31 0001099800 us-gaap:SeniorNotesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member ew:SeniorNotesDue2018Member 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member ew:SeniorNotesDue2018Member 2022-12-31 0001099800 us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember 2023-01-01 2023-12-31 0001099800 us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember 2023-12-31 0001099800 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember ew:SecuredOvernightFinancingRateSOFRMember 2023-01-01 2023-12-31 0001099800 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember ew:SecuredOvernightFinancingRateSOFRMember 2023-01-01 2023-12-31 0001099800 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember 2023-01-01 2023-12-31 0001099800 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember 2023-01-01 2023-12-31 0001099800 us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember ew:SecuredOvernightFinancingRateSOFRMember 2023-01-01 2023-12-31 0001099800 us-gaap:RevolvingCreditFacilityMember ew:CreditAgreementMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember 2022-12-31 0001099800 ew:ContingentConsiderationLiabilityMember ew:MeasurementInputProbabilityOfMilestoneAchievementMember 2023-12-31 0001099800 ew:ContingentConsiderationLiabilityMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member ew:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:OtherLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 ew:AccruedAndOtherLiabilitiesCurrentMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 ew:AccruedAndOtherLiabilitiesCurrentMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2023-12-31 0001099800 us-gaap:CurrencySwapMember 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember 2022-12-31 0001099800 us-gaap:CurrencySwapMember 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2023-01-01 2023-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestIncomeMember 2022-01-01 2022-12-31 0001099800 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2022-01-01 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2021-01-01 2021-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001099800 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanDebtSecurityMember us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:OtherInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2023-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:USGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:DefinedBenefitPlanRealEstateMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:MortgagesMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001099800 ew:InsuranceContractsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-12-31 0001099800 country:US 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignPlanMember 2023-01-01 2023-12-31 0001099800 ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember 2023-12-31 0001099800 ew:NonqualifiedDeferredCompensationPlanSelectEmployeeGroupMember 2022-12-31 0001099800 ew:July2022StockRepurchaseProgramMember 2022-07-31 0001099800 ew:July2022StockRepurchaseProgramMember 2023-12-31 0001099800 ew:InitialDeliveryOfSharesSettledJanuary2022Member 2022-01-31 0001099800 ew:InitialDeliveryOfSharesSettledJanuary2022Member 2022-01-01 2022-01-31 0001099800 ew:January2022StockRepurchaseProgramSharesSoldInFebruary2022Member 2022-02-01 2022-02-28 0001099800 ew:InitialDeliveryOfSharesSettledOctober2022Member 2022-10-01 0001099800 ew:InitialDeliveryOfSharesSettledOctober2022Member 2022-10-01 2022-10-31 0001099800 ew:October2022StockRepurchaseProgramSharesSoldInDecember2022Member 2022-12-01 2022-12-31 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2023Member 2023-02-28 0001099800 ew:InitialDeliveryOfSharesSettledFebruary2023Member 2023-02-01 2023-02-28 0001099800 ew:February2023StockRepurchaseProgramSharesSoldInMarch2023Member 2023-03-01 2023-03-31 0001099800 ew:InitialDeliveryOfSharesSettledDecember2023Member 2023-12-31 0001099800 ew:InitialDeliveryOfSharesSettledDecember2023Member 2023-12-01 2023-12-31 0001099800 ew:December2023StockRepurchaseProgramSharesSoldInDecember2023Member 2023-12-01 2023-12-31 0001099800 srt:MinimumMember ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2023-01-01 2023-12-31 0001099800 srt:MaximumMember ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2023-01-01 2023-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember ew:LongTermStockIncentiveCompensationProgramMember 2023-01-01 2023-12-31 0001099800 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember ew:LongTermStockIncentiveCompensationProgramMember 2023-01-01 2023-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember ew:LongTermStockIncentiveCompensationProgramMember 2023-01-01 2023-12-31 0001099800 ew:LongTermStockIncentiveCompensationProgramMember 2023-12-31 0001099800 srt:MaximumMember ew:RestrictedStockAndRestrictedStockUnitAwardsMember ew:LongTermStockIncentiveCompensationProgramMember 2023-12-31 0001099800 srt:MaximumMember ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember ew:EmployeeAndNonemployeeStockOptionsMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2023-12-31 0001099800 srt:MaximumMember ew:ShareBasedCompensationArrangementsAwardGrantedAnnuallyToNonemployeeDirectorMember us-gaap:RestrictedStockUnitsRSUMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2023-12-31 0001099800 ew:ShareBasedCompensationArrangementsAwardsGranted2012AndAfterMember ew:EmployeeAndNonemployeeStockOptionsMember ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2023-01-01 2023-12-31 0001099800 ew:NonemployeeDirectorsStockIncentiveCompensationProgramMember 2023-12-31 0001099800 us-gaap:EmployeeStockMember ew:EmployeeStockPurchasePlanMember 2023-01-01 2023-12-31 0001099800 us-gaap:EmployeeStockMember ew:EmployeeStockPurchasePlanMember 2023-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2023-01-01 2023-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2022-01-01 2022-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2021-01-01 2021-12-31 0001099800 us-gaap:EmployeeStockMember 2023-01-01 2023-12-31 0001099800 us-gaap:EmployeeStockMember 2022-01-01 2022-12-31 0001099800 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2023-01-01 2023-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2022-01-01 2022-12-31 0001099800 ew:MarketBasedRestrictedStockUnitsMember 2021-01-01 2021-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2022-12-31 0001099800 ew:EmployeeAndNonemployeeStockOptionsMember 2023-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001099800 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001099800 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001099800 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2023-01-01 2023-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2023-01-01 2023-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2022-01-01 2022-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2022-01-01 2022-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2021-01-01 2021-12-31 0001099800 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2021-01-01 2021-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:CarryforwardPeriodEnds20332037Member 2023-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:TaxCarryforwardsNoExpirationMember 2023-12-31 0001099800 country:US us-gaap:StateAndLocalJurisdictionMember ew:TaxCarryforwardsExpirationPeriodYears20262041Member 2023-12-31 0001099800 country:US us-gaap:StateAndLocalJurisdictionMember ew:TaxCarryforwardsNoExpirationMember 2023-12-31 0001099800 us-gaap:NonUsMember us-gaap:ForeignCountryMember ew:TaxCarryforwardsNoExpirationMember 2023-12-31 0001099800 country:US us-gaap:DomesticCountryMember ew:CapitalLossCarryforwardPeriodEnds2024Member 2023-12-31 0001099800 stpr:CA us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember ew:TaxCarryforwardsNoExpirationMember 2023-12-31 0001099800 country:US us-gaap:DomesticCountryMember us-gaap:ResearchMember ew:TaxCarryforwardsExpirationPeriodYears20262039Member 2023-12-31 0001099800 us-gaap:NonUsMember us-gaap:ForeignCountryMember ew:ForeignTaxCreditMember ew:TaxCarryforwardsExpirationPeriodYears20302033Member 2023-12-31 0001099800 country:PR us-gaap:ForeignCountryMember ew:PurchaseCreditMember ew:TaxCarryforwardsExpirationPeriodEnds2025Member 2023-12-31 0001099800 country:PR us-gaap:ForeignCountryMember ew:PurchaseCreditMember ew:TaxCarryforwardsNoExpirationMember 2023-12-31 0001099800 country:PR us-gaap:ForeignCountryMember ew:PuertoRicoPurchasesCreditMember ew:TaxCarryforwardsNoExpirationMember 2023-12-31 0001099800 us-gaap:ForeignCountryMember 2023-01-01 2023-12-31 0001099800 us-gaap:ForeignCountryMember 2022-01-01 2022-12-31 0001099800 us-gaap:ForeignCountryMember 2021-01-01 2021-12-31 0001099800 srt:MinimumMember us-gaap:SubsequentEventMember 2024-04-01 2024-06-30 0001099800 srt:MaximumMember us-gaap:SubsequentEventMember 2024-04-01 2024-06-30 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:UnitedStatesSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:EuropeSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:JapanSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:OperatingSegmentsMember ew:RestOfWorldSegmentMember 2021-01-01 2021-12-31 0001099800 us-gaap:OperatingSegmentsMember 2023-01-01 2023-12-31 0001099800 us-gaap:OperatingSegmentsMember 2022-01-01 2022-12-31 0001099800 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2022-01-01 2022-12-31 0001099800 us-gaap:MaterialReconcilingItemsMember 2021-01-01 2021-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-12-31 0001099800 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-12-31 0001099800 country:US 2023-01-01 2023-12-31 0001099800 country:US 2022-01-01 2022-12-31 0001099800 country:US 2021-01-01 2021-12-31 0001099800 srt:EuropeMember 2023-01-01 2023-12-31 0001099800 srt:EuropeMember 2022-01-01 2022-12-31 0001099800 srt:EuropeMember 2021-01-01 2021-12-31 0001099800 country:JP 2023-01-01 2023-12-31 0001099800 country:JP 2022-01-01 2022-12-31 0001099800 country:JP 2021-01-01 2021-12-31 0001099800 ew:RestOfWorldMember 2023-01-01 2023-12-31 0001099800 ew:RestOfWorldMember 2022-01-01 2022-12-31 0001099800 ew:RestOfWorldMember 2021-01-01 2021-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2023-01-01 2023-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2022-01-01 2022-12-31 0001099800 ew:TranscatheterAorticValveReplacementMember 2021-01-01 2021-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2023-01-01 2023-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2022-01-01 2022-12-31 0001099800 ew:TranscatheterMitralAndTricuspidTherapiesMember 2021-01-01 2021-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2023-01-01 2023-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2022-01-01 2022-12-31 0001099800 ew:SurgicalHeartValveTherapyMember 2021-01-01 2021-12-31 0001099800 ew:CriticalCareMember 2023-01-01 2023-12-31 0001099800 ew:CriticalCareMember 2022-01-01 2022-12-31 0001099800 ew:CriticalCareMember 2021-01-01 2021-12-31 0001099800 country:US 2023-12-31 0001099800 country:US 2022-12-31 0001099800 country:US 2021-12-31 0001099800 srt:EuropeMember 2023-12-31 0001099800 srt:EuropeMember 2022-12-31 0001099800 srt:EuropeMember 2021-12-31 0001099800 country:JP 2023-12-31 0001099800 country:JP 2022-12-31 0001099800 country:JP 2021-12-31 0001099800 ew:RestOfWorldMember 2023-12-31 0001099800 ew:RestOfWorldMember 2022-12-31 0001099800 ew:RestOfWorldMember 2021-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2022-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2023-01-01 2023-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2023-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2023-01-01 2023-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2023-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2021-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2022-01-01 2022-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-01-01 2022-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2020-12-31 0001099800 us-gaap:AllowanceForCreditLossMember 2021-01-01 2021-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2020-12-31 0001099800 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2021-01-01 2021-12-31 0001099800 2023-10-01 2023-12-31 0001099800 ew:DonaldBoboJrMember 2023-01-01 2023-12-31 0001099800 ew:DonaldBoboJrMember 2023-10-01 2023-12-31 0001099800 ew:DonaldBoboJrMember 2023-12-31 iso4217:USD shares iso4217:USD shares pure ew:note iso4217:EUR ew:lawsuit 0001099800 false 2023 FY http://fasb.org/us-gaap/2023#OtherNonrecurringIncomeExpense http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20231231#AccruedAndOtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://www.edwards.com/20231231#AccruedAndOtherLiabilitiesCurrent P3Y P339D 10-K true 2023-12-31 --12-31 false 1-15525 EDWARDS LIFESCIENCES CORPORATION DE 36-4316614 One Edwards Way Irvine CA 92614 949 250-2500 Common Stock, par value $1.00 per share EW NYSE Yes No Yes Yes Large Accelerated Filer false false true false false 56849824065 601300000 <div style="margin-bottom:6pt;margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant's proxy statement for the 2024 Annual Meeting of Stockholders (to be filed within 120 days of December 31, 2023) are incorporated by reference into Part III, as indicated herein.</span></div> 238 583900000 PricewaterhouseCoopers LLP Irvine, California 1144000000 769000000.0 500500000 446300000 8300000 7900000 775100000 643000000.0 61800000 56100000 1168200000 875500000 146800000 110000000.0 239300000 195900000 4035700000 3095800000 583900000 1239000000 1749400000 1632800000 94000000.0 92300000 1253500000 1164300000 428400000 285200000 754600000 484000000.0 463700000 299100000 9363200000 8292500000 201400000 201900000 969100000 795000000.0 24900000 25500000 1195400000 1022400000 597000000.0 596300000 0 26200000 80600000 143400000 73000000.0 69500000 339300000 267500000 94200000 143000000.0 264300000 217500000 2643800000 2485800000 0.01 0.01 50000000.0 50000000.0 0 0 0 0 1.00 1.00 1050000000 1050000000 650500000 646300000 601100000 608300000 650500000 646300000 2274400000 1969300000 8992400000 7590000000 -242800000 -254900000 49400000 38000000.0 5024500000 4144000000 6650000000 5806700000 69400000 0 6719400000 5806700000 9363200000 8292500000 6004800000 5382400000 5232500000 1379800000 1080400000 1248900000 4625000000 4302000000 3983600000 1824600000 1567600000 1493700000 1071800000 945200000 903100000 203500000 15800000 20600000 -26200000 -35800000 -124100000 17200000 60700000 0 1534100000 1748500000 1690300000 17600000 19200000 18400000 67200000 35500000 17400000 14400000 2600000 12700000 1598100000 1767400000 1702000000 198700000 245500000 198900000 1399400000 1521900000 1503100000 -3000000.0 0 0 1402400000 1521900000 1503100000 2.31 2.46 2.41 2.30 2.44 2.38 606700000 619000000.0 623300000 609400000 624200000 631200000 1399400000 1521900000 1503100000 4300000 -46300000 -50100000 -23100000 -5900000 57400000 9900000 -13700000 -11600000 40800000 -58700000 -15500000 12100000 -97200000 3400000 1411500000 1424700000 1506500000 -3000000.0 0 0 1414500000 1424700000 1506500000 1399400000 1521900000 1503100000 144900000 139600000 134800000 28200000 27200000 28500000 139400000 126800000 109300000 0 55100000 4000000.0 -26200000 -35800000 -124100000 -100000 -51500000 36800000 272100000 254500000 41400000 -8400000 -7800000 -9400000 141200000 84100000 91100000 289000000.0 213400000 -19000000.0 81800000 -100000 -7900000 146000000.0 -21400000 195200000 -33000000.0 -45000000.0 -29200000 -5800000 -5600000 62000000.0 109900000 0 0 11600000 52000000.0 18500000 895800000 1218200000 1732100000 253000000.0 244600000 325800000 66400000 353500000 250000000.0 97900000 419500000 138000000.0 9100000 315800000 1629300000 617900000 939600000 391200000 95200000 0 0 30000000.0 109600000 13100000 62500000 52300000 5100000 0 18000000.0 20000000.0 13300000 20200000 4000000.0 12500000 28800000 44400000 173800000 252300000 -1722500000 0 0 5200000 300000 200000 7000000.0 879600000 1727100000 512800000 169900000 146400000 158600000 -1000000.0 -3600000 -300000 -711000000.0 -1584500000 -356300000 16800000 19200000 13900000 375400000 -94800000 -332800000 772600000 867400000 1200200000 1148000000 772600000 867400000 636400000 636400000 12100000 -1904100000 1438100000 4565000000 -161100000 4574300000 0 4574300000 1503100000 1503100000 1503100000 3400000 3400000 3400000 5600000 5600000 153000000.0 158600000 158600000 109300000 109300000 109300000 5800000 512800000 512800000 512800000 642000000.0 642000000.0 17900000 -2416900000 1700400000 6068100000 -157700000 5835900000 0 5835900000 1521900000 1521900000 1521900000 -97200000 -97200000 -97200000 4300000 4300000 142100000 146400000 146400000 126800000 126800000 126800000 20100000 1727100000 1727100000 1727100000 646300000 646300000 38000000.0 -4144000000 1969300000 7590000000 -254900000 5806700000 0 5806700000 1402400000 1402400000 -3000000.0 1399400000 12100000 12100000 12100000 4200000 4200000 165700000 169900000 169900000 139400000 139400000 139400000 11400000 880500000 880500000 880500000 72400000 72400000 650500000 650500000 49400000 -5024500000 2274400000 8992400000 -242800000 6650000000 69400000 6719400000 DESCRIPTION OF BUSINESS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences Corporation ("Edwards Lifesciences," "Edwards," or the "Company") conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. Edwards Lifesciences is focused on technologies that treat structural heart disease and critically ill patients. The products and technologies provided by Edwards Lifesciences are categorized into the following main groups: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural Heart ("Surgical"), and Critical Care. On December 7, 2023, the Company announced its intention to complete a tax-free spin-off of its Critical Care product group around the end of 2024. The planned separation will enable the Company to pursue expanded opportunities for TAVR, TMTT, and Surgical patients, as well as new investments in interventional heart failure technologies.</span></div> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of Edwards Lifesciences, its wholly-owned subsidiaries, and variable interest entities for which the Company is the primary beneficiary (see Note 8). The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, which is recognized ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2023 and 2022, $13.3 million and $10.6 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" During 2023, the Company recognized as revenue $7.6 million that was included in the balance of deferred revenue as of December 31, 2022, and during 2022, the Company recognized as revenue $7.2 million that was included in the balance of deferred revenue as of December 31, 2021.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." For the years ended December 31, 2023, 2022, and 2021, shipping costs of $99.4 million, $87.4 million, and $85.3 million, respectively, were included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. These investments are valued at cost, which approximates fair value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 3% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Income relating to investments in debt securities is recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities in an unrealized loss position are written down to fair value through "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the length of time and the extent to which the security's fair value has been below cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. </span></div><div style="padding-left:36pt;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract inception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply). </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. During the years ended December 31, 2023, 2022, and 2021, the Company allocated $96.9 million, $88.1 million, and $77.9 million, respectively, of general and administrative costs to inventory. General and administrative costs included in inventory at December 31, 2023 and 2022 were $45.7 million and $43.7 million, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023 and 2022, $164.6 million and $128.6 million, respectively, of the Company's finished goods inventories were held on consignment.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for property, plant, and equipment was $138.9 million, $133.9 million, and $127.0 million for the years ended December 31, 2023, 2022, and 2021, respectively. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Right-of-Use Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” on the Company’s consolidated balance sheets. See Note 6 for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Businesses that the Company acquires are included in its results of operations as of the acquisition date. The purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. Contingent consideration obligations incurred in connection with a business combination are recorded at their fair values on the acquisition date and remeasured on a quarterly basis, with changes in their fair value recorded as an adjustment to earnings, until the related contingencies have been resolved. When the assets acquired do not meet the definition of a business combination, the transactions is accounted for as an asset acquisition. In an asset acquisition, the cost of the acquisition is allocated to the assets acquired and liabilities assumed based on their relative fair values. Upfront payments related to in-process research and development projects with no alternative future use are expensed upon acquisition.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2023, 2022, and 2021, the Company did not record any goodwill impairment loss.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In 2022, the Company recorded a $52.7 million <span style="-sec-ix-hidden:f-488">impairment</span> of certain developed technology and in-process research and development assets. For further information, see Note 4 and Note 9. In 2023 and 2021, the Company did not record any impairment loss related to its in-process research and development assets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense when incurred.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.7 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.0 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.7 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.0 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.38 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding stock options, unvested restricted stock units, and unvested market-based restricted stock units to purchase approximately 6.6 million, 3.6 million, and 1.8 million shares for the years ended December 31, 2023, 2022, and 2021, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over each award's requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.4 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.8 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies, resulting principally from intercompany and local currency transactions. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Upon settlement, cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is curently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the FASB issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial results or disclosures.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div>The accompanying consolidated financial statements include the accounts of Edwards Lifesciences, its wholly-owned subsidiaries, and variable interest entities for which the Company is the primary beneficiary (see Note 8). The Company attributes the net income or losses of its consolidated variable interest entities to controlling and noncontrolling interests using the hypothetical liquidation at book value method. All intercompany accounts and transactions have been eliminated in consolidation. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The consolidated financial statements of Edwards Lifesciences have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") which have been applied consistently in all material respects. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the local currency of the Company's foreign entities is the functional currency, all assets and liabilities are translated into United States dollars at the rate of exchange in effect at the balance sheet date. Income and expense items are translated at the weighted-average exchange rate prevailing during the period. The effects of foreign currency translation adjustments for these entities are deferred and reported in stockholders' equity as a component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The effects of foreign currency transactions denominated in a currency other than an entity's functional currency are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those products or services.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates nearly all of its revenue from direct product sales and sales of products under consignment arrangements. Revenue from direct product sales is recognized at a point in time when the performance obligation is satisfied upon delivery of the product. Revenue from sales of consigned inventory is recognized at a point in time when the performance obligation is satisfied once the product has been implanted or used by the customer. The Company periodically reviews consignment inventories to confirm the accuracy of customer reporting. The Company also generates a small portion of its revenue from service contracts, which is recognized ratably over the term of the contracts. Sales taxes and other similar taxes that the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company does not typically have any significant unusual payment terms beyond 90 days in its contracts with customers. In addition, the Company </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receives royalty payments for the licensing of certain intellectual property and recognizes the royalty when the subsequent sale of product using the intellectual property occurs.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of consideration the Company ultimately receives varies depending upon the return terms, sales rebates, discounts, and other incentives that the Company may offer, which are accounted for as variable consideration when estimating the amount of revenue to recognize. The Company includes estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely upon an assessment of historical payment experience, historical relationship to revenues, estimated customer inventory levels, and current contract sales terms with direct and indirect customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's sales adjustment related to distributor rebates given to the Company's United States distributors represents the difference between the Company's sales price to the distributor and the negotiated price to be paid by the end-customer. This distributor rebate is recorded as a reduction to sales and a reduction to the distributor's accounts receivable at the time of sale to a distributor. The Company periodically monitors current pricing trends and distributor inventory levels to ensure the credit for future distributor rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers volume rebates to certain group purchasing organizations ("GPOs") and customers based upon targeted sales levels. Volume rebates offered to GPOs are recorded as a reduction to sales and an obligation to the GPOs, as the Company expects to pay in cash. Volume rebates offered to customers are recorded as a reduction to sales and either a reduction to accounts receivable if the Company expects a net payment from the customer, or as an obligation to the customer if the Company expects to pay in cash. The provision for volume rebates is estimated based upon customers' contracted rebate programs, projected sales levels, and historical experience of rebates paid. The Company periodically monitors its customer rebate programs to ensure that the allowance and liability for accrued rebates is fairly stated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product returns are typically not significant because returns are generally not allowed unless the product is damaged at time of receipt. In limited circumstances, the Company may allow customers to return previously purchased products, such as for next-generation product offerings. For these transactions, the Company defers recognition of revenue on the sale of the earlier generation product based upon an estimate of the amount of product to be returned when the next-generation products are shipped to the customer.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells separately priced service contracts, which range from 12 to 36 months, to owners of its hemodynamic monitors. The Company invoices the customer the total amount of consideration at the inception of the contract and recognizes revenue ratably over the term of the contract. As of December 31, 2023 and 2022, $13.3 million and $10.6 million, respectively, of deferred revenue associated with outstanding service contracts was recorded in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Liabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" During 2023, the Company recognized as revenue $7.6 million that was included in the balance of deferred revenue as of December 31, 2022, and during 2022, the Company recognized as revenue $7.2 million that was included in the balance of deferred revenue as of December 31, 2021.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the transaction price is allocated to each performance obligation based on its relative standalone selling price charged to other customers.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the optional exemption of not disclosing the amount of the transaction price allocated to unsatisfied performance obligations for contracts with an original expected duration of one year or less.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping costs, which are costs incurred to physically move product from the Company's premises or third party distribution centers, including storage, to the customer's premises, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General, and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Handling costs, which are costs incurred to store at the Company's premises, move, and prepare products for shipment, are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span>." P12M P36M 13300000 10600000 7600000 7200000 99400000 87400000 85300000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. These investments are valued at cost, which approximates fair value.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in debt securities, including time deposits, commercial paper, United States government and agency securities, asset-backed securities, corporate debt securities, and municipal debt securities. Investments with maturities of one year or less are classified as short-term, and investments with maturities greater than one year are classified as long-term. Investments that the Company has the ability and intent to hold until maturity are classified as held-to-maturity and carried at amortized cost. Investments in debt securities that are classified as available-for-sale are carried at fair value with unrealized gains and losses included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." The Company determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation at each balance sheet date.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has long-term equity investments in companies that are in various stages of development. These investments are reported at fair value or under the equity method of accounting, as appropriate. Equity investments that do not have readily determinable fair values are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. The Company accounts for investments in limited partnerships and limited liability corporations, whereby the Company owns a minimum of 3% of the investee's outstanding voting stock, under the equity method of accounting. These investments are recorded at the amount of the Company's investment and adjusted each period for the Company's share of the investee's income or loss, and dividends paid. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gains and losses on investments that are sold are determined using the specific identification method, or the first-in, first-out method, depending on the investment type, and recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." Income relating to investments in debt securities is recorded to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments without readily determinable fair value are considered impaired when there is an indication that the fair value of the Company's interest is less than the carrying amount. Equity method investments are considered impaired when there is an indication of an other-than-temporary decline in value below the carrying amount. Impairments of equity investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities in an unrealized loss position are written down to fair value through "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, net"</span> if the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. For debt securities in an unrealized loss position that do not meet the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, the Company considers the length of time and the extent to which the security's fair value has been below cost, changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. When a credit loss exists, the Company compares the present value of cash flows expected to be collected from the debt security to the amortized cost basis of the security to determine the allowance amount that should be recorded, if any. 0.03 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company’s accounts receivable arise from direct product sales and sales of products under consignment arrangements, and have payment terms that generally require payment within 30 to 90 days. The Company does not adjust its receivables for the effects of a significant financing component at contract inception if collection of the receivable is expected within one year or less from the time of sale. In countries where the Company has experienced a pattern of payments extending beyond the stated terms and collection of the receivable is expected beyond one year from the time of sale, the Company assesses whether the customer has a significant financing component and discounts the receivable and reduces the related revenues over the period of time that the Company estimates those amounts will be paid using the country’s market-based borrowing rate for such period.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides reserves against accounts receivable for estimated losses that may result from a customer’s inability to pay based on customer-specific analysis and general matters such as current assessments of past due balances, economic conditions and forecasts, and historical credit loss activity. Amounts determined to be uncollectible are charged or written-off against the reserve.</span></div> P30D P90D <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. Market value for raw materials is based on replacement costs, and for other inventory classifications is based on net realizable value.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A write-down for excess or slow moving inventory is recorded for inventory which is obsolete, damaged, nearing its expiration date (generally triggered at six months prior to expiration), or slow moving (generally defined as quantities in excess of a two-year supply). </span></div>The Company allocates to inventory general and administrative costs that are related to the production process. These costs include insurance, manufacturing accounting and human resources personnel, and information technology. P6M P2Y 96900000 88100000 77900000 45700000 43700000 164600000 128600000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant, and Equipment</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment are recorded at cost. Depreciation is principally calculated for financial reporting purposes on the straight-line method over the estimated useful lives of the related assets, which range from 10 to 40 years for buildings and improvements, from 3 to 15 years for machinery and equipment, and from 3 to 5 years for software. Leasehold improvements are amortized over the life of the related facility leases or the asset, whichever is shorter. Straight-line and accelerated methods of depreciation are used for income tax purposes. Construction in progress is not depreciated until the asset is ready for its intended use.</span></div> P10Y P40Y P3Y P15Y P3Y P5Y 138900000 133900000 127000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. The Company's incremental borrowing rate is determined based on the estimated rate of interest for collateralized borrowing over a similar term as the associated lease. Right-of-use assets also include any lease payments made at or before lease commencement and any initial direct costs incurred, and exclude any lease incentives received.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the lease term as the noncancellable period of the lease, and may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Leases with a term of 12 months or less are not recognized on the balance sheet. Certain of the Company’s leases include variable lease payments that are based on costs incurred or actual usage, or adjusted periodically based on an index or a rate. The Company’s leases do not contain any residual value guarantees.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the lease and non-lease components as a single lease component for all of its leases except vehicle leases, for which the lease and non-lease components are accounted for separately.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases are included in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Right-of-Use Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” and “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">” on the Company’s consolidated balance sheets. See Note 6 for further information.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Businesses that the Company acquires are included in its results of operations as of the acquisition date. The purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. Contingent consideration obligations incurred in connection with a business combination are recorded at their fair values on the acquisition date and remeasured on a quarterly basis, with changes in their fair value recorded as an adjustment to earnings, until the related contingencies have been resolved. When the assets acquired do not meet the definition of a business combination, the transactions is accounted for as an asset acquisition. In an asset acquisition, the cost of the acquisition is allocated to the assets acquired and liabilities assumed based on their relative fair values. Upfront payments related to in-process research and development projects with no alternative future use are expensed upon acquisition.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment of Goodwill and Long-lived Assets</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the Company performs a quantitative impairment test. The Company determined, after performing a qualitative review of each reporting unit, that it is more likely than not that the fair value of each of its reporting units substantially exceeds the respective carrying amounts. Accordingly, in 2023, 2022, and 2021, the Company did not record any goodwill impairment loss.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets relate to in-process research and development acquired in business combinations. The estimated fair values of in-process research and development projects acquired in a business combination which have not reached technological feasibility are capitalized and accounted for as indefinite-lived intangible assets subject to impairment testing until completion or abandonment of the projects. Upon successful completion of the project, the capitalized amount is amortized over its estimated useful life. If the project is abandoned, all remaining capitalized amounts are written off immediately. Indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year, or whenever an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment loss is recognized when the asset's carrying value exceeds its fair value. In-process research and development projects acquired in an asset acquisition are expensed unless the project has an alternative future use. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the carrying amounts of other finite-lived intangible assets and long-lived tangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable, based on undiscounted estimated cash flows over the remaining amortization periods, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. </span></div> In 2022, the Company recorded a $52.7 million <span style="-sec-ix-hidden:f-488">impairment</span> of certain developed technology and in-process research and development assets. For further information, see Note 4 and Note 9. In 2023 and 2021, the Company did not record any impairment loss related to its in-process research and development assets. 52700000 0 0 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating the Company's uncertain tax positions and determining its provision for income taxes. The Company recognizes the financial statement benefit of a tax position only after determining that a position would more likely than not be sustained based upon its technical merit if challenged by the relevant taxing authority and taken by management to the court of last resort. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in income tax expense. The Company has made an accounting policy election to recognize the United States tax effects of global intangible low-taxed income as a component of income tax expense in the period the tax arises. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns. The Company evaluates quarterly the realizability of its deferred tax assets by assessing its valuation allowance and adjusting the amount, if necessary. The factors used to assess the likelihood of realization are both historical experience and the Company's forecast of future taxable income and available tax planning strategies that could be implemented to realize the net deferred tax assets. Failure to achieve forecasted taxable income in the applicable taxing jurisdictions could affect the ultimate realization of deferred tax assets and could result in an increase in the Company's effective tax rate on future earnings.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are charged to expense when incurred.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average common shares outstanding during the period. Diluted earnings per share is computed based on the weighted-average common shares outstanding plus the effect of dilutive potential common shares outstanding during the period calculated using the treasury stock method. Dilutive potential common shares include employee equity share options, nonvested shares, and similar equity instruments granted by the Company. Potential common share equivalents have been excluded where their inclusion would be anti-dilutive.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.7 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.0 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Edwards Lifesciences Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.7 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.0 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.3 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">631.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.38 </span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1402400000 1521900000 1503100000 606700000 619000000.0 623300000 2.31 2.46 2.41 1402400000 1521900000 1503100000 606700000 619000000.0 623300000 2700000 5200000 7900000 609400000 624200000 631200000 2.30 2.44 2.38 6600000 3600000 1800000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based awards based on estimated fair values. Stock-based awards consist of stock options, restricted stock units (service-based and market-based), and employee stock purchase subscriptions. Stock-based compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over each award's requisite service period (vesting period) on a straight-line basis. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Upon exercise of stock options or vesting of restricted stock units, the Company issues common stock.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a participant's retirement, all unvested stock options are immediately forfeited. In addition, upon retirement, a participant will immediately vest in 25% of service-based restricted stock units for each full year of employment with the Company measured from the grant date. All remaining unvested service-based restricted stock units are immediately forfeited. For market-based restricted stock units, upon retirement and in certain other specified cases, a participant will receive a pro-rated portion of the shares that would ultimately be issued based on attainment of the performance goals as determined on the vesting date. The pro-rated portion is based on the participant's whole months of service with the Company during the performance period prior to the date of termination.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense was as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.4 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.8 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.3 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 23600000 22800000 20400000 82400000 75300000 65600000 33400000 28700000 23300000 139400000 126800000 109300000 24100000 21600000 18900000 115300000 105200000 90400000 0.25 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk. It is the Company's policy not to enter into derivative financial instruments for speculative purposes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative financial instruments involve credit risk in the event the counterparty should default. It is the Company's policy to execute such instruments with global financial institutions that the Company believes to be creditworthy. The Company diversifies its derivative financial instruments among counterparties to minimize exposure to any one of these entities. The Company also uses International Swap Dealers Association master-netting agreements. The master-netting agreements provide for the net settlement of all contracts through a single payment in a single currency in the event of default, as defined by the agreements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign currency forward exchange contracts and cross currency swap contracts to manage its exposure to changes in currency exchange rates from (1) future cash flows associated with intercompany transactions and certain local currency expenses expected to occur within approximately 1 year (designated as cash flow hedges), (2) its net investment in certain foreign subsidiaries (designated as net investment hedges) and (3) foreign currency denominated assets or liabilities (designated as fair value hedges). The Company also uses foreign currency forward exchange contracts that are not designated as hedging instruments to offset the transaction gains and losses associated with the revaluation of certain assets and liabilities denominated in currencies other than their functional currencies, resulting principally from intercompany and local currency transactions. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative financial instruments are recognized at fair value in the consolidated balance sheets. For each derivative instrument that is designated as a fair value hedge, the gain or loss on the derivative included in the assessment of hedge effectiveness is recognized immediately to earnings, and offsets the loss or gain on the underlying hedged item. The Company reports in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" the gain or loss on derivative financial instruments that are designated, and that qualify, as cash flow hedges. The Company reclassifies these gains and losses into earnings in the same line item and in the same period in which the underlying hedged transactions affect earnings. Changes in the fair value of net investment hedges are reported in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as a part of the cumulative translation adjustment and would be reclassified into earnings if the underlying net investment is sold or substantially liquidated. The portion of the change in fair value related to components excluded from the hedge effectiveness assessment are amortized into earnings over the life of the derivative. The gains and losses on derivative financial instruments for which the Company does not elect hedge accounting treatment are recognized in the consolidated statements of operations in each period based upon the change in the fair value of the derivative financial instrument. Upon settlement, cash flows from net investment hedges are reported as investing activities in the consolidated statements of cash flows, and cash flows from all other derivative financial instruments are reported as operating activities.</span></div> P1Y <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board ("FASB") issued an amendment to the accounting guidance on income taxes which requires entities to provide additional information in the rate reconciliation and additional disaggregated disclosures about income taxes paid. This guidance requires public entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes and to provide more details about the reconciling items in some categories if the items meet a quantitative threshold. The guidance is effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this guidance to impact its financial statements, but the guidance will impact its income tax disclosures.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued an amendment to the accounting guidance on segment reporting. The amendments require disclosure of significant segment expenses and other segment items and requires entities to provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. The amendment also requires disclosure of the title and position of the chief operating decision maker ("CODM") and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. The Company is curently evaluating the impact the guidance will have on its consolidated financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the FASB issued an amendment to the accounting guidance on investments in tax credit structures to allow entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. The guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial results or disclosures.</span></div> INTELLECTUAL PROPERTY AGREEMENT AND EXPENSE<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred intellectual property litigation expenses, including settlements and external legal costs, of $203.5 million, $15.8 million and $20.6 million during 2023, 2022 and 2021, respectively. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2023, Edwards entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") with Medtronic, Inc. ("Medtronic") pursuant to which the parties agreed to a 15-year global covenant not to sue ("CNS") for infringement of certain patents in the structural heart space owned or controlled by each other. In consideration for the global CNS and related mutual access to certain intellectual property rights, Edwards paid to Medtronic a one-time, lump sum payment of $300.0 million and is paying annual royalty payments that are tied to net sales of certain Edwards products. Based upon the terms of the Intellectual Property Agreement, the Company identified the relevant elements for accounting purposes and allocated the $300.0 million upfront payment based on their respective fair values. The Company recorded a $37.0 million pre-tax charge in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in March 2023 related primarily to prior commercial sales incurred through March 31, 2023. The Company recorded a prepaid royalty asset of $124.0 million in April </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 related to future commercial sales, which will be amortized to expense during the term of the Intellectual Property Agreement. Separately, the Company recorded a $139.0 million pre-tax charge in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intellectual Property Agreement and Litigation Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in April 2023 related to products currently in development.</span></div> 203500000 15800000 20600000 P15Y 300000000 300000000 37000000 124000000 139000000 SPECIAL CHARGE AND SEPARATION COSTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2023, the Company announced its intention to complete a spin-off of its Critical Care product group as a separate publicly traded company to Edwards Lifesciences' shareholders. The proposed spin-off is intended to be a tax-free transaction for U.S. federal income tax purposes and is expected to be completed around the end of 2024, subject to the satisfaction of customary conditions including final approval by the Company's board of directors, receipt of a favorable opinion and Internal Revenue Service ruling with respect to the tax-free nature of the transaction, and the effectiveness of a registration statement on Form 10. The Company recorded a charge to its United States segment of $17.2 million, primarily related to costs incurred for consulting, legal, tax, and other professional advisory services associated with the planned spin-off. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Company decided to exit its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HARPOON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> surgical mitral repair system program. As a result, the Company recorded a charge to its United States segment of $62.3 million, of which $60.7 million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Special Charge and Separation Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and $1.6 million was included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span>" on the consolidated statements of operations. The charge primarily related to the full impairment of intangible assets associated with the technology for $52.7 million (see Note 9 and Note 10) and other related exit costs. The Company believes that no additional contingent consideration is due and, in September 2022, recorded an $11.7 million contingent consideration gain associated with the exit (see Note 12). 17200000 62300000 60700000 1600000 52700000 11700000 OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Composition of Certain Financial Statement Captions</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,749.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance (Notes 3 and 19)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranties</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of notes receivable to equity investment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Amounts included in restricted cash primarily represent funds placed in escrow related to litigation. <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of selected captions in the consolidated balance sheets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment with customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,749.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and withholdings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, payroll, and other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal and insurance (Notes 3 and 19)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued realignment reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued relocation costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranties</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 252600000 156400000 220100000 177400000 695500000 541700000 1168200000 875500000 116400000 116300000 1234200000 1189200000 775800000 697600000 37900000 37400000 87200000 87500000 355300000 255200000 2606800000 2383200000 857400000 750400000 1749400000 1632800000 371200000 268700000 131400000 116100000 63000000.0 45600000 74100000 66900000 30700000 28100000 69100000 53300000 59300000 50600000 15200000 20700000 15000000.0 17000000.0 8800000 6600000 12300000 15600000 19200000 25200000 10000000.0 8400000 89800000 72200000 969100000 795000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the year for:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures accruals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of notes receivable to equity investment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 19900000 19300000 20200000 470100000 504100000 182500000 28800000 28100000 31900000 29300000 31900000 28700000 45500000 42600000 54300000 0 0 21500000 <div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1144000000 769000000.0 862800000 3300000 500000 1500000 700000 3100000 3100000 1148000000 772600000 867400000 LEASES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain office space, manufacturing facilities, land, apartments, warehouses, vehicles, and equipment with remaining lease terms ranging from less than 1 year to 17 years, some of which include options to extend or terminate the leases.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs for the years ended December 31, 2023, 2022, and 2021 were $30.1 million, $28.8 million, and $29.7 million, respectively. Short-term and variable lease costs were not material for the years ended December 31, 2023, 2022, and 2021.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, long-term portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities at December 31, 2023 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the lease terms and discount rates:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div>As of December 31, 2023, the Company had additional operating lease commitments of $16.0 million for office spaces that have not yet commenced. P1Y P17Y 30100000 28800000 29700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to operating leases was as follows (in millions, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, long-term portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 94000000.0 92300000 24900000 25500000 73000000.0 69500000 97900000 95000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities at December 31, 2023 were as follows (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the lease terms and discount rates:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 26800000 19600000 16300000 12900000 9500000 20700000 105800000 7900000 97900000 P5Y10M24D P6Y4M24D 0.023 0.018 16000000 INVESTMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Debt Securities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2023 were as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage- and asset-backed securities.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from the contractual maturities due to call or prepayment rights.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2023 and 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:32.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.287%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its investments in debt securities to determine if there has been an other-than-temporary decline in fair value. Consideration is given to 1) the financial condition and near-term prospects of the issuer, including the credit quality of the security's issuer, 2) the Company's intent to sell the security, and 3) whether it is more likely than not the Company will have to sell the security before recovery of its amortized cost. The decline in fair value of the debt securities was largely due to changes in interest rates, not credit quality, and as of December 31, 2023, the Company did not intend to sell the securities, and it was not more likely than not that it will be required to sell the securities before recovery of the unrealized losses, and, therefore, the unrealized losses are considered temporary. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investments in Unconsolidated Entities</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets, and are as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company made $12.1 million of equity investments in limited liability companies that invest in qualified community development entities ("CDEs") through the New Markets Tax Credit ("NMTC") program. The NMTC program provides federal tax incentives to investors to make investments in distressed communities and promotes economic improvements through the development of successful businesses in these communities. The NMTC is equal to 39% of the qualified investment and is taken over seven years. These limited liability companies are variable interest entities ("VIEs"). The Company determined that it is not the primary beneficiary of the VIEs because it does not have the power to direct the activities that most significantly impact the economic performance of the VIEs, and, therefore, the Company does not consolidate these entities. Instead, the NMTC investments are accounted for as equity method investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities consist of investments in privately held companies without readily determinable fair values, and are reported at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. During 2023, the Company did not record any upward or downward adjustments due to observable price changes or impairments. During 2022, the Company recorded an upward adjustment of $0.8 million based on observable price changes and a downward adjustment of $0.5 million due to an impairment. As of December 31, 2023, the Company had recorded cumulative upward adjustments of $8.8 million based on observable price changes, and cumulative downward adjustments of $3.1 million due to impairments and observable price changes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, 2022, and 2021, the gross realized gains or losses from sales of available-for-sale investments were not material.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities at the end of each period were as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Held-to-maturity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Available-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 64500000 0 0 64500000 96000000.0 0 0 96000000.0 72700000 100000 2800000 70000000.0 137700000 0 6100000 131600000 192100000 0 7800000 184300000 380600000 0 14000000.0 366600000 658500000 0 16700000 641800000 1028100000 0 47800000 980300000 2800000 0 200000 2600000 2700000 0 200000 2500000 926100000 100000 27500000 898700000 1549100000 0 68100000 1481000000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost and fair value of investments in debt securities, by contractual maturity, as of December 31, 2023 were as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-to-Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Available-for-Sale</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 1 year through 5 years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after 10 years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments not due at a single maturity date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Consists of mortgage- and asset-backed securities.</span></div> 64500000 64500000 443200000 436000000.0 0 0 267800000 257000000.0 0 0 900000 900000 0 0 214200000 204800000 64500000 64500000 926100000 898700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present gross unrealized losses and fair values for those investments that were in an unrealized loss position as of December 31, 2023 and 2022, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:32.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.287%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or Greater</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agency securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">973.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,111.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 67100000 2800000 67100000 2800000 10200000 1800000 172700000 6000000.0 182900000 7800000 25000000.0 100000 601300000 16600000 626300000 16700000 0 0 2600000 200000 2600000 200000 35200000 1900000 843700000 25600000 878900000 27500000 61600000 1500000 69500000 4600000 131100000 6100000 103300000 1300000 254600000 12700000 357900000 14000000.0 189000000.0 5300000 784800000 42500000 973800000 47800000 0 0 2500000 200000 2500000 200000 353900000 8100000 1111400000 60000000.0 1465300000 68100000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of equity investments in unconsolidated entities. These investments are recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets, and are as follows:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of equity method investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of non-marketable equity securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total investments in unconsolidated entities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 33600000 21400000 87600000 86900000 121200000 108300000 12100000 0.39 P7Y 0 0 800000 500000 8800000 3100000 INVESTMENTS IN VARIABLE INTEREST ENTITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company reviews its investments in other entities to determine whether the Company is the primary beneficiary of a variable interest entity ("VIE"). The Company would be the primary beneficiary of the VIE, and would be required to consolidate the VIE, if it has the power to direct the significant activities of the entity and the obligation to absorb losses or receive benefits from the entity that may be significant to the VIE. The Company's maximum loss exposure to variable interest entities, prior to the exercise of options to acquire the entities, is limited to its investment in the variable interest entities, which include equity investments, options to acquire, and promissory notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, the Company acquired a majority equity interest in a medical technology company pursuant to a preferred stock purchase agreement, and amended and restated a previous option agreement to acquire the remaining equity interest. Edwards concluded that it is the primary beneficiary and consolidated the VIE. See Note 9 for additional information. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unconsolidated VIEs</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has relationships with various VIEs that it does not consolidate as Edwards lacks the power to direct the activities that significantly impact the economic success of these entities.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, the Company agreed to pay a medical device company up to $45.0 million as consideration for an option to acquire the medical device company, of which $30.0 million had been paid as of December 31, 2023. Also, in March 2023, Edwards advanced $5.0 million to the medical device company under a convertible promissory note. The option and the note are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheet as of December 31, 2023.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into an option agreement with a medical device company. Under the option agreement, Edwards paid $47.1 million for an option to acquire the medical device company. The $47.1 million option is included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company entered into a convertible promissory note and amended its existing warrant agreement with a medical device company. Under the convertible promissory note agreement, the Company agreed to loan the medical device company up to $47.5 million, of which $32.5 million had been advanced as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, in 2019, the Company paid $35.0 million for an option to acquire the medical device company. The $35.0 million option and the $32.5 million note receivable are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company entered into an option agreement with a medical technology company. Under the option agreement, Edwards paid $60.0 million for an option to acquire the medical technology company, of which $10.0 million was paid in 2021. In addition, during 2023, the Company entered into two promissory notes totaling $25.0 million with the medical technology company. The $60.0 million option and the $25.0 million note receivable are included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a $45.0 million secured promissory note agreement with a privately-held medical device company (the "Investee"), of which $30.0 million had been advanced as of December 31, 2023. Also in 2021, the Company invested $39.3 million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," in the Investee's preferred equity securities and paid $13.1 million, included in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," for an option to acquire the Investee. Pursuant to the agreement, the Company may be required to invest up to an additional $6.5 million in the Investee's preferred equity securities and up to an additional $14.4 million for the option to acquire the Investee.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Edwards has made equity investments through the NMTC program in limited liability companies that are considered VIEs. For more information, see Note 7.</span></div> 45000000 30000000 5000000 47100000 47100000 47500000 32500000 35000000 35000000 32500000 60000000 10000000 2 25000000 60000000 25000000 45000000 30000000 39300000 13100000 6500000 14400000 BUSINESS COMBINATIONS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2023, the Company acquired 61% of the then outstanding shares of a medical technology company in an all cash transaction. The Company determined it was the primary beneficiary of this VIE, and the VIE has been consolidated in the Company's consolidated financial statements. In addition, the Company amended and restated its previous option agreement with the medical technology company. The option agreement gives Edwards the option to acquire the remaining equity interest in the medical technology company. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology company is dedicated to developing technologies for detecting and managing patients with cardiovascular disease. The transaction was accounted for as a business combination. Tangible and intangible assets and liabilities acquired were recorded based on their estimated fair values at the acquisition date. The excess of the purchase price over the fair value of net assets acquired was recorded to goodwill. The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)     Includes $22.5 million paid in a previous year under option agreements, $5.3 million for the settlement of a pre-existing note, and $46.0 million of cash paid directly to the acquired company which was included in Edwards' consolidated cash balance and offset against goodwill post acquisition.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill includes expected synergies and other benefits the Company believes will result from the acquisition. Goodwill was assigned to the Company’s Rest of World segment and is not deductible for tax purposes. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma results have not been presented as the results of the medical technology company are not material in relation to the consolidated financial statements of Edwards Lifesciences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-process Research and Development Assets</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business combination referred to above and the Company's previous acquisitions of Harpoon Medical, Inc ("Harpoon") on December 1, 2017 and CardiAQ Valve Technologies, Inc. ("CardiAQ") on July 3, 2015 included the acquisition of in-process research and development assets. The in-process research and development assets were capitalized at fair value, which was determined using the income approach. This approach determines fair value based on cash flow projections which are discounted to present value using a risk-adjusted rate of return. Completion of successful design developments, bench testing, pre-clinical studies and human clinical studies are required prior to selling any product. The risks and uncertainties associated with completing development within a reasonable period of time include those related to the design, development, and manufacturability of the product, the success of pre-clinical and clinical studies, and the timing of regulatory approvals. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate used to determine the fair value of the in-process research and development assets acquired from the medical technology company referred to above was 13.0%. The valuation assumed $68.6 million of additional research and development expenditures would be incurred prior to the date of product introduction and net cash inflows were modeled to commence in 2028. Upon completion of development, the underlying research and development intangible asset will be amortized over its estimated useful life. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the Company decided to exit the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HARPOON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program and recorded a $28.1 million impairment charge to fully write off the in-process research and development assets. See Note 4 for further information. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation for CardiAQ assumed $97.7 million of additional research and development expenditures would be incurred prior to the date of product introduction and that net cash inflows would commence in late 2018. As a result of certain design enhancements to increase the product's commercial life and applicability to a broader group of patients, the Company has incurred incremental research and development expenditures. Net cash inflows commenced in Europe in late 2023 and the associated in-process research and development assets of $69.0 million were reclassified to developed technology. Net cash inflows in the United States are now expected to commence in 2024. </span></div>Upon completion of development, the underlying research and development intangible assets will commence amortization over their estimated useful lives. 0.61 The following table summarizes the fair values of the assets acquired and liabilities assumed (in millions):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price, net of cash acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Includes the fair value of the noncontrolling interest of $94.4 million, offset by the purchase consideration allocated to the option of $22.0 million, which was ascribed to the noncontrolling interest.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)     Includes $22.5 million paid in a previous year under option agreements, $5.3 million for the settlement of a pre-existing note, and $46.0 million of cash paid directly to the acquired company which was included in Edwards' consolidated cash balance and offset against goodwill post acquisition.</span></div> 8100000 133200000 136600000 1700000 28000000.0 248200000 72400000 175800000 6800000 169000000.0 94400000 22000000 22500000 5300000 46000000 0.130 68600000 28100000 97700000 69000000 GOODWILL AND OTHER INTANGIBLE ASSETS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and in-process research and development assets resulting from purchase business combinations are not subject to amortization. Other acquired intangible assets with finite lives are amortized over their expected useful lives on a straight-line basis, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be used. The Company expenses costs incurred to renew or extend the term of acquired intangible assets.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.8 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.8 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to other intangible assets for the years ended December 31, 2023, 2022, and 2021 was $6.1 million, $5.7 million, and $7.7 million, respectively. Estimated amortization expense for each of the years ending December 31 is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill, by segment, during the years ended December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United<br/>States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill at December 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 773700000 63000000.0 331200000 1167900000 0 -3600000 0 -3600000 773700000 59400000 331200000 1164300000 0 0 87200000 87200000 0 2000000.0 0 2000000.0 773700000 61400000 418400000 1253500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.8 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.8 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consist of the following (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Useful Life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.8 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.4)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428.4 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.8 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.6)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.2 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P9Y10M24D 119300000 87600000 31700000 205500000 185000000.0 20500000 P10Y9M18D 197600000 61900000 135700000 128100000 57900000 70200000 P10Y 12300000 8900000 3400000 12200000 7700000 4500000 P10Y7M6D 329200000 158400000 170800000 345800000 250600000 95200000 257600000 257600000 190000000.0 190000000.0 586800000 158400000 428400000 535800000 250600000 285200000 6100000 5700000 7700000 Estimated amortization expense for each of the years ending December 31 is as follows (in millions):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5800000 7000000.0 9400000 10900000 14800000 DEBT AND CREDIT FACILITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company issued $600.0 million of fixed-rate unsecured senior notes (the "Notes") due June 15, 2028. Interest is payable semi-annually in arrears, with payments due in June and December of each year. The Company may redeem the Notes, in whole or in part, at any time and from time to time at specified redemption prices. In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase all or a portion of the Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest. The Notes also include covenants that limit the Company's ability to incur secured indebtedness, enter into sale and leaseback transactions, and consolidate, merge, or transfer all or substantially all of its assets. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Notes as of December 31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate 4.3% Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and 2022, the fair value of the Notes was $591.6 million and $575.2 million, respectively, based on observable market prices in less active markets and categorized as Level 2 (Note 12). The debt issuance costs, as well as the discount, are being amortized to interest expense over the term of the Notes. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Five-Year Credit Agreement ("the Credit Agreement") which provides for a $750.0 million multi-currency unsecured revolving credit facility and matures on July 15, 2027. Subject to certain terms and conditions and the agreement of the lenders, the Company may increase the amount available under the Credit Agreement by up to an additional $250.0 million in the aggregate and extend the maturity date for an additional year. Borrowings under the Credit Agreement bear interest at a variable rate based on the Secured Overnight Financing Rate ("SOFR"), plus a spread ranging from 0.785% to 1.3%, depending on the leverage ratio or credit rating, as defined in the Credit Agreement, plus a 0.1% credit spread adjustment. The Company will also pay a facility fee ranging from 0.09% to 0.20%, depending on the Company's leverage ratio or credit rating, on the entire credit commitment available, whether or not drawn. The facility fee is expensed as incurred. During 2023, under the Credit Agreement, the spread over SOFR was 0.9% and the facility fee was 0.1%. Issuance costs of $2.1 million are being amortized to interest expense over the term of the Credit Agreement. As of December 31, 2023 and 2022, there were no borrowings outstanding. Amounts outstanding under the Credit Agreement, if any from time to time, are classified as long-term obligations in accordance with the terms of the Credit Agreement. The Credit Agreement is unsecured and contains various financial and other covenants, including a maximum leverage ratio, as defined in the Credit Agreement. The Company was in compliance with all covenants under the Credit Agreement at December 31, 2023.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average interest rate under all debt obligations, including the impact of the cross currency swap contract (see Note 13), was 3.4% at both December 31, 2023 and 2022.</span> 600000000 1.01 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Notes as of December 31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective<br/>Interest Rate</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-rate 4.3% Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.329 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 0.043 600000000.0 0.04329 600000000.0 0.04329 700000 900000 2300000 2800000 597000000.0 596300000 591600000 575200000 P5Y 750000000 250000000 0.00785 0.013 0.001 0.0009 0.0020 0.009 0.001 2100000 0 0 0.034 0.034 FAIR VALUE MEASUREMENTS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The Company prioritizes the inputs used to determine fair values in one of the following three categories:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1—Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2—Inputs, other than quoted prices in active markets, that are observable, either directly or indirectly.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3—Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include financial instruments for which the fair market value of such instruments may differ from amounts reflected on a historical cost basis. Financial instruments of the Company consist of cash deposits, accounts and other receivables, investments, accounts payable, certain accrued liabilities, and borrowings under a revolving credit agreement. The carrying value of these financial instruments generally approximates fair value due to their short-term nature. Financial instruments also include Notes payable. See Note 11 for further information on the fair value of the Notes payable.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2023 and 2022 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Equivalents and Available-for-sale Investments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents included money market funds for the periods presented above. The Company estimates the fair values of its money market funds based on quoted prices in active markets for identical assets. The Company estimates the fair values of its corporate debt securities, asset-backed securities, United States and foreign government and agency securities, and municipal securities by taking into consideration valuations obtained from third-party pricing services. The pricing services use industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades and broker-dealer quotes on the same or similar securities, benchmark yields, credit spreads, prepayment and default projections based on historical data, and other observable inputs. The Company independently reviews and validates the pricing received from the third-party pricing service by comparing the prices to prices reported by a secondary pricing source. The Company’s validation procedures have not resulted in an adjustment to the pricing received from the pricing service. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Compensation Plans</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in a variety of money market and mutual funds related to its deferred compensation plans. The fair values of these investments are based on quoted market prices.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and cross currency swap contracts to manage foreign currency exposures. All derivatives contracts are recognized on the balance sheet at their fair value. The fair value of the derivative financial instruments was estimated based on quoted market foreign exchange rates, cross currency swap basis rates, and market discount rates. Judgment was employed in interpreting market data to develop estimates of fair value; accordingly, the estimates presented herein are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions or valuation methodologies could have a material effect on the estimated fair value amounts.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Consideration Liabilities</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's acquisitions involve contingent consideration arrangements. Payment of additional consideration is contingent upon the acquired company reaching certain performance milestones, such as attaining specified sales levels or obtaining regulatory approvals. These contingent consideration liabilities are measured at estimated fair value using either a probability weighted discounted cash flow analysis or a Monte Carlo simulation model, both of which consider significant unobservable inputs. As of December 31, 2023, the probability of milestone achievement was determined to be 0% and, accordingly, the contingent consideration liability was zero.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis for the years ended December 31, 2023 and 2022 (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1085">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1092">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis as of December 31, 2023 and 2022 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">980.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments held for deferred compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,939.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 579200000 0 0 579200000 0 641800000 0 641800000 0 184300000 0 184300000 0 70000000.0 0 70000000.0 0 2600000 0 2600000 125800000 0 0 125800000 0 47100000 0 47100000 705000000.0 945800000 0 1650800000 0 15200000 0 15200000 0 0 10300000 10300000 0 15200000 10300000 25500000 280400000 0 0 280400000 0 980300000 0 980300000 0 366600000 0 366600000 37100000 94500000 0 131600000 0 2500000 0 2500000 112100000 0 0 112100000 0 65500000 0 65500000 429600000 1509400000 0 1939000000 0 27200000 0 27200000 0 0 26200000 26200000 0 0 14000000.0 14000000.0 0 27200000 40200000 67400000 0 0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis for the years ended December 31, 2023 and 2022 (in millions):</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1085">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-1092">Changes in fair value</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, December 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 62000000.0 14000000.0 76000000.0 -35800000 0 -35800000 26200000 14000000.0 40200000 -26200000 -3700000 -29900000 0 10300000 10300000 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.139%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1106"><span style="-sec-ix-hidden:f-1107">Assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1112"><span style="-sec-ix-hidden:f-1113">Liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.298%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) <br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:69.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that during 2024 it will reclassify to earnings a $2.7 million gain currently recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." For the years ended December 31, 2023, 2022, and 2021, the Company did not record any gains or losses due to hedge ineffectiveness.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to manage its currency exchange rate risk and its interest rate risk as summarized below. Notional amounts are stated in United States dollar equivalents at spot exchange rates at the respective dates. The Company does not enter into these arrangements for trading or speculation purposes.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1786200000 1678400000 300000000.0 300000000.0 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and fair value amounts of derivative instruments reported in the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.139%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1106"><span style="-sec-ix-hidden:f-1107">Assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1112"><span style="-sec-ix-hidden:f-1113">Liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 23700000 24900000 23400000 40600000 15200000 20700000 0 6500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.298%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of master-netting agreements and rights of offset on the consolidated balance sheets (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.298%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts Not Offset in the Consolidated Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amounts<br/>Offset in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Amounts<br/>Presented in the<br/>Consolidated<br/>Balance Sheet</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash<br/>Collateral<br/>Received</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 23700000 0 23700000 9400000 0 14300000 23400000 0 23400000 0 0 23400000 15200000 0 15200000 9400000 0 5800000 24900000 0 24900000 12000000.0 0 12900000 40600000 0 40600000 0 0 40600000 27200000 0 27200000 12000000.0 0 15200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of derivative and non-derivative hedging instruments on the consolidated statements of operations and consolidated statements of comprehensive income:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.847%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss) <br/>Recognized in OCI<br/>on Derivative<br/>(Effective Portion)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or (Loss)<br/>Recognized in Income on Derivative (Amount Excluded from<br/> Effectiveness Testing)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swap contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cross currency swap contracts have an expiration date of June 15, 2028. At maturity of the cross currency swap contracts, the Company will deliver the notional amount of €257.2 million and will receive $300.0 million from the counterparties. The Company receives semi-annual interest payments from the counterparties based on a fixed interest rate until maturity of the agreements.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of Gain or<br/>(Loss) Recognized in<br/>Income on Derivative</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 29200000 81700000 58900000 88400000 -17300000 21600000 6900000 7000000.0 257200000 300000000 13900000 -3900000 11600000 7400000 44000000.0 27400000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the effect of fair value and cash flow hedge accounting on the consolidated statements of operations:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:69.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location and Amount of Gain or (Loss) Recognized in Income on Fair Value and Cash Flow Hedging Relationships</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other income, net</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amounts of income and expense line items shown in the consolidated statements of operations in which the effects of fair value or cash flow hedges are recorded</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The effects of fair value and cash flow hedging:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on fair value hedging relationships:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount excluded from effectiveness testing recognized in earnings based on an amortization approach</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on cash flow hedging relationships:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) reclassified from accumulated OCI into income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1379800000 14400000 0 -9200000 0 9200000 0 4700000 58900000 0 1080400000 2600000 0 5500000 0 -5500000 0 1600000 88400000 0 2700000 EMPLOYEE BENEFIT PLANS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans in Japan and certain European countries. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in projected benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underfunded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amounts recognized on the consolidated balance sheet:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial (loss) gain</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation ("ABO") for all defined benefit pension plans was $106.8 million and $86.7 million as of December 31, 2023 and 2022, respectively. The projected benefit obligation and ABO were in excess of plan assets for all pension plans as of December 31, 2023 and 2022. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic pension benefit cost are as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected long-term returns for each of the plans' strategic asset classes were developed through consultation with investment advisors. Several factors were considered, including a survey of investment managers' expectations, current market data, minimum guaranteed returns in certain insurance contracts, and historical market returns over long periods. Using policy target allocation percentages and the asset class expected returns, a weighted-average expected return was calculated.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To select the discount rates for the defined benefit pension plans, the Company uses a modeling process that involves matching the expected duration of its benefit plans to a yield curve constructed from a portfolio of AA-rated fixed-income debt instruments, or their equivalent. For each country, the Company uses the implied yield of this hypothetical portfolio at the appropriate duration as a discount rate benchmark.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the benefit obligations are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan Assets</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment strategy for plan assets is to seek a competitive rate of return relative to an appropriate level of risk and to earn performance rates of return in accordance with the benchmarks adopted for each asset class. Risk management practices include diversification across asset classes and investment styles, and periodic rebalancing toward asset allocation targets.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Administrative and Investment Committee decides on the defined benefit plan provider in each location and that provider decides the target allocation for the Company's defined benefit plan at that location. The target asset allocation selected reflects a risk/return profile the Company feels is appropriate relative to the plans' liability structure and return goals. In certain plans, asset allocations may be governed by local requirements. Target weighted-average asset allocations at December 31, 2023, by asset category, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company's defined benefit plan assets at December 31, 2023 and 2022, by asset category, are as follows (in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets measured at fair value</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2023 and 2022 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.281%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance<br/>Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets still held at December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets still held at December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity and debt securities are valued at fair value based on quoted market prices reported on the active markets on which the individual securities are traded. Real estate investments are valued by discounting to present value the cash flows expected to be generated by the specific properties. Investments in mortgages are valued at cost, which is deemed to approximate its fair value. The insurance contracts are valued at the cash surrender value of the contracts, which is deemed to approximate its fair value. Alternative investments include hedge funds, private equity funds and other miscellaneous investments, and are valued using the net asset value provided by the fund administrator as a practical expedient. The net asset value is based on the fair value of the underlying assets owned by the fund divided by the number of shares outstanding.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2023, are expected to be paid (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029-2033</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, expected employer contributions for 2024 are $2.7 million.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plans </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's employees in the United States and Puerto Rico are eligible to participate in a qualified defined contribution plan. In the United States, participants may contribute up to 25% of their eligible compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of the participant's annual eligible compensation contributed to the plan on a dollar-for-dollar basis. Edwards Lifesciences matches the next 2% of the participant's annual eligible compensation to the plan on a 50% basis. In Puerto Rico, participants may contribute up to 25% of their annual compensation (subject to tax code limitation) to the plan. Edwards Lifesciences matches the first 4% of participant's annual eligible compensation contributed to the plan on a 50% basis. The Company also provides a 2% profit sharing contribution calculated on eligible earnings for each employee. Matching contributions relating to Edwards Lifesciences employees were $51.0 million, $45.1 million, and $38.6 million in 2023, 2022, and 2021, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has nonqualified deferred compensation plans for a select group of employees. The plans provide eligible participants the opportunity to defer eligible compensation to future dates specified by the participant with a return based on investment alternatives selected by the participant. The amount accrued under these nonqualified plans was $125.6 million and $112.6 million at December 31, 2023 and 2022, respectively.</span></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit pension plans in Japan and certain European countries. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in projected benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in fair value of plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate changes and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded Status</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets at fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underfunded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net amounts recognized on the consolidated balance sheet:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial (loss) gain</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 94100000 117900000 4300000 5500000 2300000 500000 1900000 1600000 -9900000 22600000 3800000 600000 400000 300000 0 1800000 -3400000 6100000 111700000 94100000 70600000 76900000 800000 -4900000 3500000 3500000 1900000 1600000 0 1800000 3800000 600000 2500000 -4100000 75500000 70600000 111700000 94100000 75500000 70600000 -36200000 -23500000 36200000 23500000 -10300000 1500000 -5200000 -5300000 -900000 1100000 4200000 -5700000 106800000 86700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic pension benefit cost are as follows (in millions):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements and curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 4300000 5500000 6500000 2300000 500000 400000 2700000 1500000 1100000 0 -100000 0 0 -500000 -1700000 -800000 -700000 -700000 3100000 4400000 6800000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the benefit obligations are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used to determine the net periodic pension benefit cost are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest crediting rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Social securities increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension increase</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.018 0.025 0.029 0.029 0.015 0.015 0.018 0.018 0.022 0.022 0.025 0.005 0.003 0.037 0.021 0.015 0.029 0.026 0.026 0.015 0.015 0.025 0.018 0.016 0.016 0.022 0.018 0.018 Target weighted-average asset allocations at December 31, 2023, by asset category, are as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company's defined benefit plan assets at December 31, 2023 and 2022, by asset category, are as follows (in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets measured at fair value</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States equities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International government bonds</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alternative investments measured at net asset value (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     Certain investments that were measured at net asset value per share have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div> 0.313 0.389 0.114 0.184 1.000 2000000.0 0 0 2000000.0 2600000 0 0 2600000 21000000.0 0 0 21000000.0 3500000 0 0 3500000 26000000.0 0 0 26000000.0 0 8700000 0 8700000 0 4000000.0 0 4000000.0 0 0 800000 800000 55100000 12700000 800000 68600000 6900000 75500000 3600000 0 0 3600000 1500000 0 0 1500000 17500000 0 0 17500000 4400000 0 0 4400000 25600000 0 0 25600000 0 7600000 0 7600000 0 3500000 0 3500000 0 0 800000 800000 52600000 11100000 800000 64500000 6100000 70600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in fair value of the Company's defined benefit plan assets that have been classified as Level 3 for the years ended December 31, 2023 and 2022 (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.281%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance<br/>Contracts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets still held at December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency exchange rate impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relating to assets still held at December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 900000 200000 -200000 -100000 800000 200000 -200000 800000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments, which reflect expected future service, as appropriate, at December 31, 2023, are expected to be paid (in millions):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029-2033</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 7300000 5900000 6900000 6800000 8100000 39000000.0 2700000 0.25 0.04 0.02 0.50 0.25 0.04 0.50 0.02 51000000 45100000 38600000 125600000 112600000 COMMON STOCK<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $1.5 billion of the Company's common stock, effective July 28, 2022. In December 2023, the Board of Directors approved an additional $1.0 billion of repurchases of the Company's common stock under this program. The repurchase program does not have an expiration date. Stock repurchased under these programs may be used to offset the impact of the Company's employee stock-based benefit programs and stock-based business acquisitions, and will reduce the total shares outstanding.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, 2022, and 2021, the Company repurchased 11.4 million, 20.1 million, and 5.8 million shares, respectively, at an aggregate cost of $880.5 million, $1,727.1 million, and $512.8 million, respectively, including shares purchased under a Rule 10b5-1 trading plan, the accelerated share repurchase ("ASR") agreements described below, and shares acquired to satisfy tax withholding obligations in connection with the vesting of restricted stock units issued to employees. The timing and size of any future stock repurchases are subject to a variety of factors, including expected dilution from stock plans, cash capacity, and the market price of the Company's common stock.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accelerated Share Repurchase</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023 and 2022, the Company entered into ASR agreements providing for the repurchase of the Company's common stock based on the volume-weighted average price ("VWAP") of the Company's common stock during the term of the applicable agreements, less a discount. The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:20.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASR agreements were each accounted for as two separate transactions: (1) the value of the initial delivery of shares was recorded as shares of common stock acquired in a treasury stock transaction on the acquisition date and (2) the remaining amount of the purchase price paid was recorded as a forward contract indexed to the Company's own common stock and was initially recorded in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Paid-in Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and subsequently, upon settlement, was transferred to "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated balance sheets. The initial delivery of shares resulted in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. The Company determined that the forward contracts indexed to the Company's common stock met all the applicable criteria for equity classification and, therefore, were not accounted for as a derivative instrument.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee and Director Stock Plans</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Edwards Lifesciences Corporation Long-term Stock Incentive Compensation Program (the "Program") provides for the grant of incentive and non-qualified stock options, restricted stock, and restricted stock units for eligible employees of the Company. Under the Program, these grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options to purchase shares of the Company's common stock granted under the Program generally vest over predetermined periods of between <span style="-sec-ix-hidden:f-1448">three</span> to four years and expire seven years after the date of grant. Service-based restricted stock units of the Company's common stock granted under the Program generally vest over predetermined periods, typically four years after the date of grant. Market-based restricted stock units of the Company's common stock granted under the Program vest over three years based on a combination of certain service and market conditions. The actual number of shares issued will be determined based on the Company's total stockholder return relative to a selected industry peer group. Under the Program, the number of shares of common stock authorized for issuance under the Program was 327.6 million shares. No more than 33.6 million shares reserved for issuance may be granted in the form of restricted stock or restricted stock units.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains the Nonemployee Directors Stock Incentive Compensation Program (the "Nonemployee Directors Program"). Under the Nonemployee Directors Program, annually each nonemployee director may receive up to 120,000 stock options or 48,000 restricted stock units of the Company's common stock, or a combination thereof. These grants generally vest over one year from the date of grant. Under the Nonemployee Directors Program, an aggregate of 8.4 million shares of the Company's common stock has been authorized for issuance.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an employee stock purchase plan for United States employees and a plan for employees outside of the United States (collectively "ESPP"). Under the ESPP, eligible employees may purchase shares of the Company's common stock at 85% of the lower of the fair market value of Edwards Lifesciences common stock on the effective date of subscription or the date of purchase. Under the ESPP, employees can authorize the Company to withhold up to 15% of their compensation for common stock purchases, subject to certain limitations. The ESPP is available to all active employees of the Company paid from the United States payroll and to eligible employees of the Company outside of the United States, to the extent permitted </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by local law. The ESPP for United States employees is qualified under Section 423 of the Internal Revenue Code. The number of shares of common stock authorized for issuance under the ESPP was 50.4 million shares.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option award and employee stock purchase subscription is estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the following tables. The risk-free interest rate is estimated using the United States Treasury yield curve and is based on the expected term of the award. Expected volatility is estimated based on a blend of the weighted-average of the historical volatility of Edwards Lifesciences' stock and the implied volatility from traded options on Edwards Lifesciences' stock. The expected term of awards granted is estimated from the vesting period of the award, as well as historical exercise behavior, and represents the period of time that awards granted are expected to be outstanding. The Company uses historical data to estimate forfeitures and has estimated an annual forfeiture rate of 6.4%.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Awards</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.97 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of market-based restricted stock units was determined using a Monte Carlo simulation model, which uses multiple input variables to determine the probability of satisfying the market condition requirements. The weighted-average assumptions used to determine the fair value of the market-based restricted stock units granted during the years ended December 31, 2023, 2022, and 2021 included a risk-free interest rate of 3.6%, 2.9%, and 0.4%, respectively, and an expected volatility rate of 32.6%, 33.9%, and 34.4%, respectively.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.27 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></div></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 years</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.30 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.03 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.82 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of stock options exercised and restricted stock units vested during the years ended December 31, 2023, 2022, and 2021 were $162.7 million, $264.5 million, and $359.8 million, respectively. The intrinsic value of stock options is calculated as the amount by which the market price of the Company's common stock exceeds the exercise price of the option. During the years ended December 31, 2023, 2022, and 2021, the Company received cash from exercises of stock options of $83.4 million, $64.8 million, and $82.2 million, respectively, and tax benefits from exercises of stock options and vesting of restricted stock units of $35.9 million, $56.9 million, and $76.5 million, respectively. The total grant-date fair value of stock options vested during the years ended December 31, 2023, 2022, and 2021 were $41.3 million, $40.4 million, and $36.2 million, respectively.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the total remaining unrecognized compensation expense related to nonvested stock options, restricted stock units, market-based restricted stock units, and employee stock purchase plan subscription awards amounted to $224.9 million, which will be amortized on a straight-line basis over each award's requisite service period. The weighted-average remaining requisite service period is 31 months.</span></div> 1500000000 1000000000 11400000 20100000 5800000 880500000 1727100000 512800000 The following table summarizes the terms of the ASR agreements (dollars and shares in millions, except per share data):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:20.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Delivery</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Settlement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Agreement Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Price per<br/>Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value of<br/>Shares as %<br/>of Contract<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlement<br/>Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shares<br/>Received</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price<br/>per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 250000000.0 1900000 104.87 0.80 2300000 110.31 750000000.0 8300000 72.43 0.80 10300000 72.91 200000000.0 2000000.0 80.44 0.80 2500000 79.28 400000000.0 4600000 70.31 0.80 5300000 72.91 P4Y P7Y P4Y P3Y 327600000 33600000 120000 48000 P1Y 8400000 0.85 0.15 50400000 0.064 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for options granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option Awards</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.97 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.034 0.030 0.008 0 0 0 0.328 0.314 0.335 P5Y1M6D P5Y P5Y 30.97 34.59 28.90 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model was used with the following weighted-average assumptions for ESPP subscriptions granted during the following periods:</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value, per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.18 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.07 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.046 0.005 0.001 0 0 0 0.315 0.320 0.366 P0Y7M6D P0Y7M6D P0Y7M6D 19.03 28.18 23.07 0.036 0.029 0.004 0.326 0.339 0.344 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program was as follows (in millions, except years and per-share amounts):</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.67 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.27 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.32 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.90 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></div></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3 </span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.68 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 years</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.91 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 11600000 63.67 2000000.0 88.27 2200000 38.54 400000 97.32 11000000.0 71.90 P3Y6M 136900000 7300000 61.68 P2Y4M24D 135500000 10500000 70.91 P3Y4M24D 136700000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes nonvested restricted stock unit activity during the year ended December 31, 2023 under the Program and the Nonemployee Directors Program (in millions, except per-share amounts):</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.30 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.03 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.82 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested as of December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2000000.0 92.30 1100000 89.03 800000 83.17 200000 99.82 2100000 94.35 162700000 264500000 359800000 83400000 64800000 82200000 35900000 56900000 76500000 41300000 40400000 36200000 224900000 P31M ACCUMULATED OTHER COMPREHENSIVE LOSS<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is a summary of activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for the years ended December 31, 2023, 2022, and 2021. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on<br/>Available-for-sale<br/>Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>(Costs) Credits (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">For the years ended December 31, 2023, 2022, and 2021, the change in unrealized pension costs consisted of the following (in millions):</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax (Expense) Benefit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net of Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension credits, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension credits, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other Comprehensive Loss<br/>Components</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on available-for-sale investments</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension adjustments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presented below is a summary of activity for each component of "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" for the years ended December 31, 2023, 2022, and 2021. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized (Loss) Gain on Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on<br/>Available-for-sale<br/>Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Pension<br/>(Costs) Credits (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (expense) benefit </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -122400000 -27700000 8600000 -19600000 -161100000 -39200000 66300000 -29200000 12800000 10700000 6400000 -12000000.0 -8600000 -1000000.0 -15200000 4500000 20900000 -5100000 2200000 22500000 -172500000 29700000 -6900000 -8000000.0 -157700000 -33900000 75200000 -77900000 17300000 -19300000 7000000.0 84500000 -18800000 100000 72800000 5400000 -3400000 -400000 3500000 5100000 -218800000 23800000 -65600000 5700000 -254900000 6900000 43300000 32600000 -11100000 71700000 6900000 72800000 -8100000 800000 72400000 -4300000 -6400000 -100000 -2000000.0 -12800000 -214500000 700000 -24800000 -4200000 -242800000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">For the years ended December 31, 2023, 2022, and 2021, the change in unrealized pension costs consisted of the following (in millions):</span><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-Tax<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax (Expense) Benefit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net of Tax<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension costs, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension credits, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit arising during period</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net prior service cost arising during period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain arising during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized pension credits, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 700000 -900000 1600000 800000 100000 700000 -100000 -1000000.0 900000 -11800000 -1000000.0 -10800000 -11900000 -2000000.0 -9900000 0 1100000 -1100000 700000 300000 400000 -700000 800000 -1500000 17900000 2700000 15200000 17200000 3500000 13700000 100000 0 100000 700000 100000 600000 -600000 -100000 -500000 14400000 2300000 12100000 13800000 2200000 11600000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about amounts reclassified from "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about Accumulated Other Comprehensive Loss<br/>Components</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line on Consolidated<br/>Statements of Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain on hedges</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on available-for-sale investments</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of pension adjustments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr></table></div> 6900000 7000000.0 1700000 1700000 5200000 5300000 -58900000 -88400000 13900000 -3900000 72800000 84500000 15800000 22200000 57000000.0 62300000 -8100000 -18800000 -2200000 -4600000 -5900000 -14200000 800000 100000 200000 0 600000 100000 OTHER INCOME, NET<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service cost components of net periodic pension benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on insurance settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-service cost components of net periodic pension benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on insurance settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 10500000 -1200000 5000000.0 -700000 -1100000 5800000 -1200000 -1100000 300000 0 3800000 0 3400000 0 2200000 14400000 2600000 12700000 INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496.4 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.9)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets and liabilities are as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Capitalized research and development expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits from uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     As required by the 2017 Tax Cuts and Jobs Act, effective January 1, 2022, the Company's research and development expenditures were capitalized and amortized which resulted in substantially higher cash paid for taxes in 2023 and 2022 with an equal amount of deferred tax benefits.</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, net deferred tax assets increased $256.8 million, including items that were recorded to stockholders' equity and which did not impact the Company's income tax provision.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance of $90.2 million as of December 31, 2023 reduces certain deferred tax assets to amounts that are more likely than not to be realized. This allowance primarily relates to the net operating loss carryforwards of certain non-United States subsidiaries and certain non-United States credit carryforwards.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax Benefit<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033-2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2041</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States capital losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain tax attributes are subject to an annual limitation as a result of the acquisition of CASMED, which constitute a change of ownership as defined under Internal Revenue Code Section 382.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross tax credit carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research expenditure tax credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research expenditure tax credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax and general business credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2033</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.7 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.4)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $211.3 million of gross California research expenditure tax credits it expects to use in future periods. The credits may be carried forward indefinitely. Based upon anticipated future taxable income, the Company expects that it is more likely than not that all California research expenditure tax credits will be utilized, although the utilization of the full benefit is expected to occur over a number of years into the distant future. Accordingly, no valuation allowance has been provided. The Company has $27.4 million of Puerto Rico purchases credits. Throughout its history and into the future, the Company's Puerto Rico operations generate, or are expected to generate, credits each year in excess of its ability to utilize credits in those years. As a result, even though the credits currently have an indefinite life, the Company continues to record a valuation allowance on the purchases credits carryforwards. The Company recently renegotiated its tax grant under Puerto Rico Act 52-2022 ("Act 52") effective January 1, 2023. Among other items, Act 52 introduced new requirements and limitations on the availability and claiming of tax credits. As a result, the Company now expects that its purchases credits generated through December 31, 2022 will expire in 2025 while the purchases credits generated after December 31, 2022 will have an indefinite life.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, Public Law 115-97, commonly referred to as the Tax Cuts and Jobs Act (the "2017 Act"), was signed into law. The 2017 Act a) reduced the United States federal corporate tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017, b) required companies to pay a one-time mandatory deemed repatriation tax on the cumulative earnings of certain foreign subsidiaries that were previously tax deferred, and c) created new taxes on certain foreign earnings in future years. The Company elected to pay the repatriation tax in installments over eight years.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company asserts that $961.6 million of its foreign earnings continue to be indefinitely reinvested and it intends to repatriate $1.2 billion of its foreign earnings as of December 31, 2023. The estimated net tax liability on the indefinitely reinvested earnings if repatriated is $5.1 million. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received tax incentives in certain non-United States tax jurisdictions, the primary benefit for which will expire in 2029. The tax reductions as compared to the local statutory rates were $333.2 million ($0.55 per diluted share), $247.4 million ($0.40 per diluted share), and $208.0 million ($0.33 per diluted share) for the years ended December 31, 2023, 2022, and 2021, respectively. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at United States federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income taxed at different rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits, federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Build of reserve for prior years' uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on global intangible low-taxed income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal deductible employee share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible employee share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate for 2023 decreased in comparison to 2022 primarily due to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the impact of temporary relief provided by the Internal Revenue Service ("IRS") relating to U.S. foreign tax credit regulations. On July 21, 2023, the IRS issued Notice 2023-55 which delayed the application of certain U.S. foreign tax credit regulations that had previously limited the Company's ability to claim credits on certain foreign taxes for tax years 2022 and 2023. In addition, there was a tax benefit from the Intellectual Property Agreement with Medtronic (see Note 3), partially offset by a reduced tax benefit from employee share-based compensation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's effective tax rate for 2022 increased in comparison to 2021 primarily due to the decrease in the tax benefit from the change in fair value of contingent consideration liabilities and the decrease in the excess tax benefit from employee share-based compensation. </span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Uncertain Tax Positions</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023 and 2022, the gross uncertain tax positions were $583.9 million and $475.3 million, respectively. The Company estimates that these liabilities would be reduced by $250.7 million and $182.1 million, respectively, from offsetting tax benefits associated with the correlative effects of potential transfer pricing adjustments, state income taxes, and timing adjustments. The net amounts of $333.2 million and $293.2 million, respectively, if not required, would favorably affect the Company's effective tax rate.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year tax positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statutes of limitations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above summarizes the gross amounts of uncertain tax positions without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such uncertain tax positions were settled. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties, if any, related to uncertain tax positions in the provision for income taxes. As of December 31, 2023, the Company had accrued $41.4 million (net of $29.9 million tax benefit) of interest related to uncertain tax positions, and as of December 31, 2022, the Company had accrued $29.1 million (net of $15.4 million tax benefit) of interest related to uncertain tax positions. During 2023, 2022, and 2021, the Company recognized interest expense, net of tax benefit, of $12.3 million, $9.6 million, and $5.2 million, respectively, in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" on the consolidated statements of operations.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the IRS and other taxing authorities are in different stages of examining various years of the Company's tax filings. During these audits the Company may receive proposed audit adjustments that could be material. Therefore, there is a possibility that an adverse outcome in these audits could have a material effect on the Company's results of operations and financial condition. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for matters it believes are more likely than not to require settlement, the final outcome with a tax authority may result in a tax liability that is materially different from that reflected in the consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal. The uncertain tax positions are reviewed quarterly and adjusted as events occur that affect potential liabilities for additional taxes, such as lapsing of applicable statutes of limitations, proposed assessments by tax authorities, negotiations between tax authorities, identification of new issues, and issuance of new legislation, regulations, or case law. Management believes that adequate amounts of tax and related penalty and interest have been provided for any adjustments that may result from these uncertain tax positions.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed an Advance Pricing Agreement (“APA”) in 2018 between the United States and Switzerland governments for tax years 2009 through 2020 covering various, but not all, transfer pricing matters. The unagreed transfer pricing matters, namely Surgical Structural Heart and Transcatheter Aortic Valve Replacement (collectively "Surgical/TAVR") intercompany royalty transactions, then reverted to IRS examination for further consideration as part of the respective years' regular tax audits. In addition, the Company executed other bilateral APAs as follows: during 2017, an APA between the United States and Japan covering tax years 2015 through 2019; and during 2018, APAs between Singapore and Japan and between Switzerland and Japan covering tax years 2015 through 2019. The Company has filed to renew all three of the APAs with Japan for the years 2020 and forward. An APA between Switzerland and Japan covering tax years 2020 through 2024 was executed in 2021. An APA between the United States and Japan covering tax years 2020 through 2024 was executed in 2023. The execution of some or all these APA renewals depends on many variables outside of Edwards' control.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audits of the Company’s United States federal income tax returns through 2014 have been closed. The IRS audit field work for the 2015 through 2017 tax years was completed during the second quarter of 2021, except for transfer pricing and related matters. The IRS is currently examining the 2018 through 2020 tax years. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2023, all material state, local, and foreign income tax matters have been concluded for years through 2015. While not material, the Company continues to address matters in India for years from 2010 and on.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company received a Notice of Proposed Adjustment (“NOPA”) from the IRS for the 2015 through 2017 tax years relating to transfer pricing involving Surgical/TAVR intercompany royalty transactions between the Company's United States and Switzerland subsidiaries. The NOPA proposed a substantial increase to the Company's United States taxable income, which could result in additional tax expense for this period of approximately $230.0 million and represented a departure from a transfer pricing method the Company had previously agreed upon with the IRS. The Company disagreed with the NOPA and pursued an administrative appeal with the IRS Independent Office of Appeals ("Appeals"). The Appeals process culminated in the third quarter of 2023 when the Company and Appeals concluded that a satisfactory resolution of the matter at the administrative level was not possible. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2023, Appeals issued a notice of deficiency ("NOD") increasing the Company's 2015 through 2017 United States federal income tax in amounts resulting from the income adjustments previously reflected in the NOPA. The additional tax sought in excess of the Company's filing position is $269.3 million before consideration of interest and a repatriation tax offset.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company plans to vigorously contest the additional tax claimed by the IRS through the judicial process. Final resolution of this matter is not likely within the next 12 months. The Company believes the amounts previously accrued related to this uncertain tax position are appropriate for a number of reasons, including the interpretation and application of relevant tax law and accounting standards to the Company's facts and, accordingly, has not accrued any additional amount based on the NOD and other proceedings to date. Nonetheless, the outcome of the judicial process cannot be predicted with certainty, and it is possible that the outcome of that process could have a material impact on the Company's consolidated financial statements. As noted below, similar material tax disputes may arise for the 2018 through 2023 tax years. While no payment of any amount related to the NOPA or NOD has yet been required, the Company made a partial deposit with the IRS in November 2022 to prevent the further accrual of interest on that portion of any additional tax the Company may ultimately be found to owe. The Company intends to make an additional deposit in the range of $200 million to $300 million with the IRS by the second quarter of 2024 in order to further mitigate interest on potential tax liabilities while the Company prepares to contest through the judicial process the IRS's entitlement to any of the additional tax claimed by the IRS. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical/TAVR intercompany royalty transactions covering tax years 2018 through 2023 remain subject to IRS examination, and those transactions and related tax positions remain uncertain as of December 31, 2023. The Company has considered this information, as well as information regarding the NOD and other proceedings described above, in its evaluation of its uncertain tax positions. The impact of these unresolved transfer pricing matters, net of any correlative tax adjustments, may be significant to the Company’s consolidated financial statements. Based on the information currently available and numerous possible outcomes, the Company cannot reasonably estimate what, if any, changes in its existing uncertain tax positions may occur in the next 12 months and, therefore, has continued to record the uncertain tax positions as a long-term liability.</span> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's income before provision for income taxes was generated from operations in the United States and outside of the United States as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 348000000.0 634400000 610900000 1250100000 1133000000 1091100000 1598100000 1767400000 1702000000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consists of the following (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current income tax expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496.4 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of the United States, including Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250.9)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.0)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 317300000 369100000 125200000 58100000 60600000 25100000 85300000 66700000 92600000 460700000 496400000 242900000 -187500000 -187700000 -9400000 -54200000 -58900000 -25400000 -20300000 -4300000 -9200000 -262000000.0 -250900000 -44000000.0 198700000 245500000 198900000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of deferred tax assets and liabilities are as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Capitalized research and development expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits from uncertain tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow and net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax on foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)     As required by the 2017 Tax Cuts and Jobs Act, effective January 1, 2022, the Company's research and development expenditures were capitalized and amortized which resulted in substantially higher cash paid for taxes in 2023 and 2022 with an equal amount of deferred tax benefits.</span></div> 371100000 199700000 117900000 100600000 63400000 42100000 172900000 160800000 75900000 71700000 132800000 93700000 15300000 11900000 1600000 6600000 200000 300000 600000 600000 5800000 6700000 800000 1900000 958300000 696600000 78200000 80200000 3600000 19200000 4700000 6000000.0 53000000.0 19900000 2500000 2900000 142000000.0 128200000 90200000 99100000 726100000 469300000 256800000 90200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss and capital loss carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax Benefit<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033-2037</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2041</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States state net operating losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-United States net operating losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States capital losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 9000000.0 1900000 0 1900000 1800000 400000 0 400000 35700000 1800000 1700000 100000 2600000 100000 100000 0 416500000 71600000 54500000 17100000 33400000 100000 100000 0 499000000.0 75900000 56400000 19500000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross tax credit carryforwards and the related carryforward periods at December 31, 2023 are summarized as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation<br/>Allowance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Tax<br/>Benefit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carryforward<br/>Period Ends</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California research expenditure tax credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research expenditure tax credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax and general business credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030-2033</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puerto Rico purchases credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240.7 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.4)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 211300000 0 211300000 1300000 0 1300000 700000 0 700000 26200000 26200000 0 1200000 1200000 0 240700000 27400000 213300000 211300000 27400000 961600000 1200000000 5100000 333200000 0.55 247400000 0.40 208000000 0.33 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at United States federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign income taxed at different rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits, federal and state</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Build of reserve for prior years' uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax on global intangible low-taxed income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-derived intangible income deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States federal deductible employee share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible employee share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 335600000 371100000 357400000 -128300000 -123900000 -122200000 18700000 21100000 11900000 62500000 50000000.0 48400000 -2900000 11600000 3600000 78700000 61400000 56500000 23000000.0 15000000.0 1300000 5500000 7500000 26100000 13100000 31600000 47800000 6600000 5800000 5300000 -5600000 2500000 10000000.0 198700000 245500000 198900000 583900000 475300000 250700000 182100000 333200000 293200000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of uncertain tax positions, excluding interest, penalties, and foreign exchange, is as follows (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year tax positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year tax positions</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statutes of limitations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain gross tax positions, December 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 475300000 358400000 281800000 127000000.0 120600000 82100000 800000 3800000 2300000 16200000 600000 4800000 3000000.0 400000 300000 0 6500000 2700000 583900000 475300000 358400000 41400000 29900000 29100000 15400000 12300000 9600000 5200000 230000000 269300000 200000000 300000000 LEGAL PROCEEDINGS <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company initiated an internal review and investigation into whether business activities in Japan and other markets violated certain provisions of the Foreign Corrupt Practices Act ("FCPA"). The Company voluntarily notified the SEC and the United States Department of Justice ("DOJ") during 2021 that it has engaged outside counsel to conduct this review and investigation. The Company has provided status updates to the SEC and DOJ since that time. Any determination that the Company’s operations or activities are not in compliance with existing laws, including the FCPA, could result in the imposition of fines, penalties, and equitable remedies. The Company cannot currently predict the final outcome of the investigation or any potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2021, Aortic Innovations LLC, a non-practicing entity, filed a lawsuit against Edwards Lifesciences Corporation and certain of its subsidiaries ("Edwards") in the United States District Court for the District of Delaware alleging that Edwards’ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SAPIEN 3 Ultra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain of its patents. The Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure; therefore, no amounts have been accrued. The Company intends to vigorously defend itself in this litigation.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Commission (the "Commission") is investigating certain business practices of Edwards including its unilateral pro-innovation (anti-copycat) policy and patent practices. The Company is committed to healthy competition and is cooperating with the Commission. The Company cannot predict the outcome of the investigation or the potential impact on its financial statements.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is or may be a party to, or may otherwise be responsible for, pending or threatened lawsuits including those related to products and services currently or formerly manufactured or performed, as applicable, by the Company, workplace and employment matters, matters involving real estate, Company operations or health care regulations, contingent consideration, or governmental investigations (the "Lawsuits"). The Lawsuits raise difficult and complex factual and legal issues and are subject to many uncertainties, including, but not limited to, the facts and circumstances of each particular case or claim, the jurisdiction in which each suit is brought, and differences in applicable law. Management does not believe that any loss relating to the Lawsuits would have a material adverse effect on the Company's overall financial condition, results of operations or cash flows. However, the resolution of one or more of the Lawsuits in any reporting period, could have a material adverse impact on the Company's financial results for that period. The Company is not able to estimate the amount or range of any loss for legal contingencies related to the Lawsuits for which there is no reserve or additional loss for matters already reserved.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various environmental laws and regulations both within and outside of the United States. The Company's operations, like those of other medical device companies, involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws, management believes that such compliance will not have a material impact on the Company's financial results. The Company's threshold of disclosing material environmental legal proceedings involving a governmental authority where potential monetary sanctions are involved is $1 million.</span></div> 1 1000000 SEGMENT INFORMATION<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edwards Lifesciences conducts operations worldwide and is managed in the following geographical regions: United States, Europe, Japan, and Rest of World. All regions sell products that are used to treat advanced cardiovascular disease.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (the Chief Executive Officer). The Company evaluates the performance of its geographic segments based on net sales and operating income. The accounting policies of the segments are the same as those described in Note 2. Segment net sales and segment operating income are based on internally derived foreign exchange rates and do not include inter-segment profits. Because of the interdependence of the reportable segments, the operating profit as presented may not be representative of the geographical distribution that would occur if the segments were not interdependent. Net sales by geographic area are based on the location of the customer. There were no customers that represented 10% or more of the Company's total net sales.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at the corporate level and are not allocated to the segments. The non-allocated items include corporate research and development expenses, manufacturing variances, corporate headquarters costs, net interest income, global marketing expenses, special gains and charges, stock-based compensation, foreign currency hedging activities, certain litigation costs, changes in the fair value of contingent consideration liabilities, and most of the Company's amortization expense. Although most of the Company's depreciation expense is included in segment operating income, due to the Company's methodology for cost build-up, it is impractical to determine the amount of depreciation expense included in each segment and, therefore, a portion is maintained at the corporate level. The Company neither discretely allocates assets to its operating segments, nor evaluates the operating segments using discrete asset information.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999.7 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,516.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,516.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,382.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,920.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,714.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charge and separation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,690.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enterprise-Wide Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions)</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of or for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,382.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,879.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,422.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,382.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived Tangible Assets by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents information about Edwards Lifesciences' reportable segments (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment net sales</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999.7 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,516.3 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,306.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,130.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,051.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585.1 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407.5 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,516.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,123.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,382.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pre-tax Income Reconciliation</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,920.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,714.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,613.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special charge and separation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual property agreement and litigation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,690.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,767.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,702.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3508700000 3132600000 2963100000 1337400000 1213700000 1099600000 436700000 559300000 528000000.0 716900000 610700000 533200000 5999700000 5516300000 5123900000 2306100000 2130900000 2051000000 709500000 652200000 569100000 259100000 376700000 348000000.0 310400000 247700000 185200000 3585100000 3407500000 3153300000 5999700000 5516300000 5123900000 5100000 -133900000 108600000 6004800000 5382400000 5232500000 3585100000 3407500000 3153300000 1920900000 1714100000 1613800000 17200000 60700000 0 203500000 15800000 20600000 -26200000 -35800000 -124100000 64400000 95800000 47300000 1534100000 1748500000 1690300000 64000000.0 18900000 11700000 1598100000 1767400000 1702000000 <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated financial statements.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of or for the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,508.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,963.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,190.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,382.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales by Major Product Group</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Aortic Valve Replacement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,879.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,422.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transcatheter Mitral and Tricuspid Therapies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Structural Heart</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,382.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,232.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived Tangible Assets by Geographic Region</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,725.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3508700000 3132600000 2963100000 1334500000 1174800000 1190300000 452400000 473600000 528900000 709200000 601400000 550200000 6004800000 5382400000 5232500000 3879800000 3518200000 3422500000 197600000 116100000 86000000.0 999300000 893100000 889100000 928100000 855000000.0 834900000 6004800000 5382400000 5232500000 1269700000 1188500000 1195800000 196400000 191800000 197900000 23800000 13200000 19700000 353500000 331600000 335500000 1843400000 1725100000 1748900000 VALUATION AND QUALIFYING ACCOUNTS<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to<br/>Other<br/>Accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses (a)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax valuation allowance (b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    The deductions related to allowances for credit losses represent accounts receivable which are written off.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)     The tax valuation allowances are provided for other-than-temporary impairments and unrealized losses related to certain investments that may not be recognized due to the uncertainty of the ready marketability of certain impaired investments, and net operating loss and credit carryforwards that may not be recognized due to insufficient taxable income.</span></div> 11700000 2000000.0 0 1900000 11800000 99100000 0 100000 9000000.0 90200000 15700000 900000 100000 5000000.0 11700000 82500000 3000000.0 14200000 600000 99100000 16400000 1200000 600000 2500000 15700000 71600000 12400000 0 1500000 82500000 false false false <div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 14, 2023, Donald Bobo, Jr., Corporate Vice President, Strategy &amp; Corporate Development, entered into a 10b5-1 trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The Plan provides for the potential sale of 70,500 shares of the Company’s stock commencing May 10, 2024. The Plan terminates on the earlier of April 14, 2025 or the date all shares are sold.</span></div> December 14, 2023 Donald Bobo, Jr Corporate Vice President, Strategy & Corporate Development true 70500

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end GRAPHIC 21 ew-20231231_g4.jpg begin 644 ew-20231231_g4.jpg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end GRAPHIC 22 ew-20231231_g5.jpg begin 644 ew-20231231_g5.jpg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end GRAPHIC 23 ew-20231231_g6.jpg begin 644 ew-20231231_g6.jpg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ew-20231231_g7.jpg begin 644 ew-20231231_g7.jpg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end GRAPHIC 25 ew-20231231_g8.jpg begin 644 ew-20231231_g8.jpg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end GRAPHIC 26 ew-20231231_g9.jpg begin 644 ew-20231231_g9.jpg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